{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "4_XB-1xS4WYq"
      },
      "source": [
        "##Installing libraries\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "HQMaHTBiG6z-"
      },
      "outputs": [],
      "source": [
        "%%capture\n",
        "!pip install -U sentence-transformers"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "RwU8qkodHJ7n"
      },
      "source": [
        "## Importing libraries"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "06kqDYsnHGNF"
      },
      "outputs": [],
      "source": [
        "from sentence_transformers import SentenceTransformer\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "# import nltk\n",
        "from sklearn.metrics.pairwise import cosine_similarity\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "biHJFQSWFO4d"
      },
      "source": [
        "## Information Retrieval using cross-encoder/ms-marco-MiniLM-L6-v2'"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# %%capture\n",
        "# !pip install -U sentence-transformers"
      ],
      "metadata": {
        "id": "cFc7x-c5dvSD"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "HhBEAxssFRt8"
      },
      "outputs": [],
      "source": [
        "from sentence_transformers import CrossEncoder\n",
        "\n",
        "model = CrossEncoder('cross-encoder/ms-marco-MiniLM-L6-v2')\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install pymupdf  # Install the library\n",
        "\n",
        "import fitz  # PyMuPDF\n",
        "\n",
        "def read_pdf_paragraphs(file_path):\n",
        "    doc = fitz.open(file_path)\n",
        "    text = \"\"\n",
        "    for page in doc:\n",
        "        text += page.get_text() + \"\\n\"  # Collect text with spacing\n",
        "\n",
        "    paragraphs = [para.strip() for para in text.split(\"\\n\\n\") if para.strip()]  # Split and clean paragraphs\n",
        "    return paragraphs\n",
        "\n",
        "# Example usage\n",
        "pdf_pages = read_pdf_paragraphs(\"2025_tech_notes_2024_10_03_0.pdf\")\n",
        "print(pdf_pages)"
      ],
      "metadata": {
        "id": "E_UH8qGydUgD",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "117858e1-24a1-4da5-9407-b94481ee3770"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: pymupdf in /usr/local/lib/python3.11/dist-packages (1.25.5)\n",
            "['Medicare \\n2025 Part C & D \\nStar Ratings \\nTechnical Notes \\n \\nUpdated – 10/03/2024', '(Last Updated 10/03/2024)  \\nPage i \\n \\nDocument Change Log \\nPrevious \\nVersion \\nDescription of Change \\nRevision \\nDate \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nOMB Approved Data Sources \\nThe data collected for the Part C & D Star Ratings come from a variety of different data sources approved under \\nthe following Office of Management and Budget (OMB) Paperwork Reduction Act numbers: \\nData Source \\nOMB Number \\nConsumer Assessment of Healthcare Providers and Systems (CAHPS) Surveys 0938-0732 \\nHealth Outcomes Survey (HOS) \\n0938-0701 \\nHealthcare Effectiveness Data and Information Set (HEDIS) \\n0938-1028 \\nPart C Reporting Requirements \\n0938-1054 \\nPart D Reporting Requirements \\n0938-0992 \\nData Validation of Part C/D Reporting Requirements data \\n0938-1115', '(Last Updated 10/03/2024)  \\nPage ii \\n \\nTable of Contents \\nDOCUMENT CHANGE LOG ................................................................................................................................. I \\nOMB APPROVED DATA SOURCES ................................................................................................................... I \\nINTRODUCTION .................................................................................................................................................. 1 \\nNOTE ON REFERENCES TO THE 2024 STAR RATINGS ................................................................................. 1 \\nDIFFERENCES BETWEEN THE 2024 STAR RATINGS AND 2025 STAR RATINGS ....................................... 1 \\nHEALTH/DRUG ORGANIZATION TYPES INCLUDED IN THE STAR RATINGS .............................................. 2 \\nTable 1: Contract Year 2025 Organization Types Reported in the 2025 Star Ratings ................................................. 3 \\nTHE STAR RATINGS FRAMEWORK ................................................................................................................. 3 \\nFigure 1: The Four Levels of Star Ratings ....................................................................................................................... 4 \\nTable 2: 5-Star Scale .......................................................................................................................................................... 4 \\nTable 3: Relation of 2025 Organization Types to Contract Types and Highest Rating in the 2025 Star Ratings ..... 4 \\nSOURCES OF THE STAR RATINGS MEASURE DATA .................................................................................... 5 \\nFigure 2: The Four Categories of Data Sources .............................................................................................................. 5 \\nIMPROVEMENT MEASURES .............................................................................................................................. 5 \\nTable 4: Minimum Number of Measure Scores Required for an Improvement Measure Rating by Contract Type . 6 \\nCONTRACT ENROLLMENT DATA ..................................................................................................................... 6 \\nHANDLING OF BIASED, ERRONEOUS, AND/OR NOT REPORTABLE (NR) DATA ....................................... 6 \\nDATA HANDLING OF MEASURES FOR CONTRACTS AFFECTED BY A MAJOR DISASTER ..................... 7 \\nMETHODOLOGY FOR ASSIGNING STARS TO THE PART C AND PART D MEASURES ............................. 9 \\nA. Clustering ....................................................................................................................................................................... 9 \\nB. Relative Distribution and Significance Testing (CAHPS) ........................................................................................ 10 \\nMETHODOLOGY FOR CALCULATING STARS AT THE DOMAIN LEVEL .................................................... 10 \\nTable 5: Minimum Number of Rated Measures Required for a Domain Rating by Contract Type ........................... 11 \\nSUMMARY AND OVERALL RATINGS: WEIGHTING OF MEASURES ........................................................... 11 \\nMETHODOLOGY FOR CALCULATING PART C AND PART D SUMMARY RATINGS ................................. 11 \\nTable 6: Minimum Number of Rated Measures Required for Part C and Part D Ratings by Contract Type ........... 12 \\nMETHODOLOGY FOR CALCULATING THE OVERALL MA-PD RATING ...................................................... 12 \\nTable 7: Minimum Number of Rated Measures Required for an Overall Rating by Contract Type ......................... 13 \\nCOMPLETING THE SUMMARY AND OVERALL RATING CALCULATIONS ................................................. 13 \\nAPPLYING THE IMPROVEMENT MEASURE(S) .............................................................................................. 13 \\nAPPLYING THE REWARD FACTOR ................................................................................................................ 14 \\nTable 8: Performance Summary Thresholds ................................................................................................................. 15 \\nTable 9: Variance Thresholds.......................................................................................................................................... 15 \\nCATEGORICAL ADJUSTMENT INDEX (CAI) .................................................................................................. 15 \\nTable 10: Categorization of Contract’s Members into LIS/DE Initial Groups for the Overall Rating ....................... 17 \\nTable 11: Categorization of Contract’s Members into Disability Quintiles for the Overall Rating ........................... 18 \\nTable 12: Final Adjustment Categories and CAI Values for the Overall Rating ......................................................... 18 \\nTable 13: Categorization of Contract’s Members into LIS/DE Initial Groups for the Part C Summary .................... 19 \\nTable 14: Categorization of Contract’s Members into Disability Quintiles for the Part C Summary ....................... 19 \\nTable 15: Final Adjustment Categories and CAI Values for the Part C Summary ..................................................... 20', '(Last Updated 10/03/2024)  \\nPage iii \\n \\nTable 16: Categorization of Contract’s Members into LIS/DE Initial Groups for the MA-PD Part D Summary ....... 20 \\nTable 17: Categorization of Contract’s Members into Disability Quintiles for the MA-PD Part D Summary .......... 21 \\nTable 18: Final Adjustment Categories and CAI Values for the MA-PD Part D Summary ........................................ 21 \\nTable 19: Categorization of Contract’s Members into  Quartiles of LIS/DE for the PDP Part D Summary ............. 21 \\nTable 20: Categorization of Contract’s Members into  Quartiles of Disability for the PDP Part D Summary ......... 22 \\nTable 21: Final Adjustment Categories and CAI Values for the PDP Part D Summary ............................................. 22 \\nCALCULATION PRECISION ............................................................................................................................. 22 \\nROUNDING RULES FOR MEASURE SCORES ............................................................................................... 22 \\nROUNDING RULES FOR SUMMARY AND OVERALL RATINGS ................................................................... 23 \\nTable 22: Rounding Rules for Summary and Overall Ratings ..................................................................................... 23 \\nMETHODOLOGY FOR CALCULATING THE HIGH PERFORMING ICON ...................................................... 23 \\nFigure 3: The High Performing Icon ............................................................................................................................... 24 \\nMETHODOLOGY FOR CALCULATING THE LOW PERFORMING ICON ....................................................... 24 \\nFigure 4: The Low Performing Icon ................................................................................................................................ 24 \\nTable 23: Example LPI Contracts .................................................................................................................................... 24 \\nMERGERS, NOVATIONS, AND CONSOLIDATIONS ....................................................................................... 24 \\nRELIABILITY REQUIREMENT FOR LOW-ENROLLMENT CONTRACTS ...................................................... 25 \\nSPECIAL NEEDS PLAN (SNP) DATA .............................................................................................................. 25 \\nSTAR RATINGS AND MARKETING ................................................................................................................. 26 \\nCONTACT INFORMATION ................................................................................................................................ 26 \\nFRAMEWORK AND DEFINITIONS FOR THE DOMAIN AND MEASURE DETAILS SECTION ...................... 28 \\nPART C DOMAIN AND MEASURE DETAILS ................................................................................................... 30 \\nDomain: 1 - Staying Healthy: Screenings, Tests and Vaccines ................................................................................... 30 \\nMeasure: C01 - Breast Cancer Screening ........................................................................................................................ 30 \\nMeasure: C02 - Colorectal Cancer Screening .................................................................................................................. 32 \\nMeasure: C03 - Annual Flu Vaccine ................................................................................................................................. 34 \\nMeasure: C04 - Monitoring Physical Activity ..................................................................................................................... 35 \\nDomain: 2 - Managing Chronic (Long Term) Conditions ............................................................................................. 37 \\nMeasure: C05 - Special Needs Plan (SNP) Care Management ....................................................................................... 37 \\nMeasure: C06 - Care for Older Adults – Medication Review ............................................................................................ 39 \\nMeasure: C07 - Care for Older Adults – Pain Assessment............................................................................................... 40 \\nMeasure: C08 - Osteoporosis Management in Women who had a Fracture .................................................................... 42 \\nMeasure: C09 - Diabetes Care – Eye Exam ..................................................................................................................... 44 \\nMeasure: C10 - Diabetes Care – Blood Sugar Controlled ................................................................................................ 46 \\nMeasure: C11 - Controlling Blood Pressure ..................................................................................................................... 48 \\nMeasure: C12 - Reducing the Risk of Falling ................................................................................................................... 50 \\nMeasure: C13 - Improving Bladder Control ...................................................................................................................... 51 \\nMeasure: C14 - Medication Reconciliation Post-Discharge .............................................................................................. 53 \\nMeasure: C15 - Plan All-Cause Readmissions ................................................................................................................. 54 \\nMeasure: C16 - Statin Therapy for Patients with Cardiovascular Disease ....................................................................... 56 \\nMeasure: C17 - Transitions of Care .................................................................................................................................. 58 \\nMeasure: C18 - Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions ... 60 \\nDomain: 3 - Member Experience with Health Plan ........................................................................................................ 62 \\nMeasure: C19 - Getting Needed Care .............................................................................................................................. 62 \\nMeasure: C20 - Getting Appointments and Care Quickly ................................................................................................. 63 \\nMeasure: C21 - Customer Service .................................................................................................................................... 64 \\nMeasure: C22 - Rating of Health Care Quality ................................................................................................................. 66 \\nMeasure: C23 - Rating of Health Plan .............................................................................................................................. 67 \\nMeasure: C24 - Care Coordination ................................................................................................................................... 68', \"(Last Updated 10/03/2024)  \\nPage iv \\n \\nDomain: 4 - Member Complaints and Changes in the Health Plan's Performance ................................................... 70 \\nMeasure: C25 - Complaints about the Health Plan ........................................................................................................... 70 \\nMeasure: C26 - Members Choosing to Leave the Plan .................................................................................................... 71 \\nMeasure: C27 - Health Plan Quality Improvement ........................................................................................................... 73 \\nDomain: 5 - Health Plan Customer Service .................................................................................................................... 75 \\nMeasure: C28 - Plan Makes Timely Decisions about Appeals ......................................................................................... 75 \\nMeasure: C29 - Reviewing Appeals Decisions ................................................................................................................. 76 \\nMeasure: C30 - Call Center – Foreign Language Interpreter and TTY Availability .......................................................... 78 \\nPART D DOMAIN AND MEASURE DETAILS ................................................................................................... 80 \\nDomain: 1 - Drug Plan Customer Service ...................................................................................................................... 80 \\nMeasure: D01 - Call Center – Foreign Language Interpreter and TTY Availability .......................................................... 80 \\nDomain: 2 - Member Complaints and Changes in the Drug Plan’s Performance ...................................................... 82 \\nMeasure: D02 - Complaints about the Drug Plan ............................................................................................................. 82 \\nMeasure: D03 - Members Choosing to Leave the Plan .................................................................................................... 83 \\nMeasure: D04 - Drug Plan Quality Improvement .............................................................................................................. 85 \\nDomain: 3 - Member Experience with the Drug Plan .................................................................................................... 87 \\nMeasure: D05 - Rating of Drug Plan ................................................................................................................................. 87 \\nMeasure: D06 - Getting Needed Prescription Drugs ........................................................................................................ 88 \\nDomain: 4 - Drug Safety and Accuracy of Drug Pricing ............................................................................................... 90 \\nMeasure: D07 - MPF Price Accuracy ................................................................................................................................ 90 \\nMeasure: D08 - Medication Adherence for Diabetes Medications .................................................................................... 92 \\nMeasure: D09 - Medication Adherence for Hypertension (RAS antagonists) ................................................................... 95 \\nMeasure: D10 - Medication Adherence for Cholesterol (Statins) ..................................................................................... 98 \\nMeasure: D11 - MTM Program Completion Rate for CMR ............................................................................................. 100 \\nMeasure: D12 - Statin Use in Persons with Diabetes (SUPD) ....................................................................................... 103 \\nATTACHMENT A: CAHPS CASE-MIX ADJUSTMENT .................................................................................. 106 \\nCAHPS Case-Mix Adjustment ....................................................................................................................................... 106 \\nTable A-1: Coefficients of Part C Getting Needed Care (C19) CAHPS Measure Composite Items............................... 107 \\nTable A-2: Coefficients of Part C Getting Appointments and Care Quickly (C20) CAHPS Measure Composite Items . 108 \\nTable A-3: Coefficients of Part C Customer Service (C21) CAHPS Measure Composite Items .................................... 109 \\nTable A-4: Coefficients of Part C Stand-alone CAHPS Measures .................................................................................. 110 \\nTable A-5: Coefficients of Part C Care Coordination (C24) CAHPS Measure Composite Items ................................... 111 \\nTable A-6: Coefficients of Part D CAHPS Stand-alone Measures .................................................................................. 112 \\nTable A-7: Coefficients of Part D Getting Needed Prescription Drugs (D06) CAHPS Measure Composite Items ......... 113 \\nATTACHMENT B: CALCULATING MEASURE DATA FOR THE SURVIVING CONTRACT OF A \\nCONSOLIDATION ............................................................................................................................................ 114 \\nFirst Year Following a Consolidation ........................................................................................................................... 114 \\nTable B-1: Enrollment Month Used in Calculating Measure Scores for the Surviving Contract of a Consolidation ....... 114 \\nTable B-2: Example of Calculating the Measure Score for the Surviving Contract of a Consolidation .......................... 114 \\nSecond Year Following a Consolidation ...................................................................................................................... 114 \\nATTACHMENT C: NATIONAL AVERAGES FOR PART C AND D MEASURES ........................................... 115 \\nTable C-1: National Averages for Part C Measures ........................................................................................................ 115 \\nTable C-2: National Averages for Part D Measures ........................................................................................................ 116 \\nATTACHMENT D: PART C AND D DATA TIME FRAMES ............................................................................ 117 \\nTable D-1: Part C Measure Data Time Frames .............................................................................................................. 117 \\nTable D-2: Part D Measure Data Time Frames .............................................................................................................. 118 \\nATTACHMENT E: SNP MEASURE SCORING METHODOLOGIES .............................................................. 119 \\n1. Medicare Part C Reporting Requirements Measure (C05: SNP Care Management) .............................................. 119 \\n2. NCQA HEDIS Measures - (C06 – C07: Care for Older Adults) ................................................................................ 120 \\nTable E-1: Example Calculation Using Effectiveness of Care Rate ............................................................................... 121 \\nATTACHMENT F: CALCULATING MEASURE C15: PLAN ALL-CAUSE READMISSIONS ........................ 122 \\nExample: Calculating the final rate for Contract 1 ........................................................................................................... 122\", '(Last Updated 10/03/2024)  \\nPage v \\n \\nATTACHMENT G: WEIGHTS ASSIGNED TO INDIVIDUAL PERFORMANCE MEASURES ........................ 123 \\nTable G-1: Part C Measure Weights ............................................................................................................................... 123 \\nTable G-2: Part D Measure Weights ............................................................................................................................... 124 \\nATTACHMENT H: CALCULATION OF WEIGHTED STAR RATING AND VARIANCE ESTIMATES ........... 125 \\nATTACHMENT I: CALCULATING THE IMPROVEMENT MEASURE AND THE MEASURES USED .......... 126 \\nCalculating the Improvement Measure ........................................................................................................................ 126 \\nGeneral Standard Error Formula................................................................................................................................... 127 \\nImprovement Change Score Standard Error Numerical Example ............................................................................. 127 \\nStandard Error Formulas (SEF) for Specific Measures .............................................................................................. 128 \\n1. SEF for Measures: C01, C02, C04, C05, C08 – C14, C16, C18, C26, C28 – C30, D01, D03, D08 – D12 ............. 128 \\n2. SEF for Measures: C06, C07 .................................................................................................................................... 128 \\n3. SEF for Measure C15................................................................................................................................................ 128 \\n4. SEF for Measure C17................................................................................................................................................ 128 \\n5. SEF for Measures: C03, C19 – C24, and D05, D06 ................................................................................................. 129 \\n6. SEF for Measures: C25, D02 .................................................................................................................................... 129 \\n7. SEF for Measure D07................................................................................................................................................ 129 \\nStar Ratings Measures Used in the Improvement Measures ..................................................................................... 131 \\nTable I-1: Part C Measures Used in the Improvement Measure .................................................................................... 131 \\nATTACHMENT J: STAR RATINGS MEASURE HISTORY ............................................................................. 133 \\nTable J-1: Part C Measure History .................................................................................................................................. 133 \\nTable J-2: Part D Measure History .................................................................................................................................. 138 \\nTable J-3: Common Part C & Part D Measure History ................................................................................................... 142 \\nATTACHMENT K: INDIVIDUAL MEASURE STAR ASSIGNMENT PROCESS ............................................. 143 \\nClustering Methodology Introduction .......................................................................................................................... 143 \\nFigure K-1: Diagram showing gaps in data where cut points are assigned. ................................................................... 143 \\nExample 1 – Clustering Methodology for a Higher is Better measure ...................................................................... 143 \\nTable K-1: Medication Adherence for Diabetes Medications cut points example: cut points are for illustrative purposes\\n \\n144 \\nFigure K-2: Diagram showing star assignment based cut points. ................................................................................... 144 \\nExample 2 – Clustering Methodology for a Lower is Better measure....................................................................... 144 \\nTable K-2: Members Choosing to Leave the Plan cut points example: cut points are for illustrative purposes ............. 144 \\nClustering Methodology Detail ...................................................................................................................................... 145 \\n1. Produce the individual measure distance matrix. ..................................................................................................... 145 \\n2. Create a tree of cluster assignments. ....................................................................................................................... 146 \\n3. Select the final set of clusters from the tree of cluster assignments. ........................................................................ 146 \\n4. Final Thresholds ........................................................................................................................................................ 147 \\nDetermining Stars from Scores and Thresholds ......................................................................................................... 147 \\nTable K-3: 2025 Star Ratings Part C non-CAHPS Measure Mean Resampling Estimated Thresholds ........................ 148 \\nTable K-4: 2025 Star Ratings Part D non-CAHPS Measure Mean Resampling Estimated Thresholds ........................ 149 \\nTable K-5: 2025 Star Ratings Part C non-CAHPS Measure Tukey Outlier Cutoffs ........................................................ 150 \\nTable K-6: 2025 Star Ratings Part D non-CAHPS Measure Tukey Outlier Cutoffs ........................................................ 151 \\nRelative Distribution and Significance Testing (CAHPS) Methodology ................................................................... 153 \\nTable K-8: CAHPS Star Assignment Rules .................................................................................................................... 154 \\nTable K-9: CAHPS Star Assignment Alternate Representation ...................................................................................... 155 \\nTable K-10: CAHPS Measure 12% Reliability Cutoffs .................................................................................................... 155 \\nATTACHMENT L: MEDICATION ADHERENCE MEASURE CALCULATIONS............................................. 156 \\nProportion of Days Covered Calculation ..................................................................................................................... 156 \\nExample 1: Non-Overlapping Fills of Two Different Drugs ........................................................................................ 156 \\nTable L-1: No Adjustment ............................................................................................................................................... 156 \\nExample 2: Overlapping Fills of the Same Generic Ingredient across Single and Combination Products .......... 156 \\nTable L-2: Before Overlap Adjustment ............................................................................................................................ 157 \\nTable L-3: After Overlap Adjustment ............................................................................................................................... 157', '(Last Updated 10/03/2024)  \\nPage vi \\n \\nExample 3: Overlapping Fills of the Same and Different Target Drugs .................................................................... 157 \\nTable L-4: Before Overlap Adjustment ............................................................................................................................ 157 \\nTable L-5: After Overlap Adjustment ............................................................................................................................... 158 \\nPDC Adjustment for Inpatient, and Skilled Nursing Facility Stays Examples ......................................................... 158 \\nCalculating the PDC Adjustment for IP Stays and SNF Stays ................................................................................... 159 \\nExample 1: Gap in Coverage after IP Stay ................................................................................................................... 159 \\nTable L-6: Before Adjustment ......................................................................................................................................... 159 \\nTable L-7: After Adjustment ............................................................................................................................................ 160 \\nExample 2: Gap in Coverage before IP Stay ................................................................................................................ 160 \\nTable L-8: Before Adjustment ......................................................................................................................................... 160 \\nTable L-9: After Adjustment ............................................................................................................................................ 160 \\nExample 3: Gap in Coverage Before and After IP Stay .............................................................................................. 160 \\nTable L-10: Before Adjustment ....................................................................................................................................... 161 \\nTable L-11: After Adjustment .......................................................................................................................................... 161 \\nExample 4: Gap in Coverage After IP Stay and Overlap with Subsequent Fill of the Same Drug Class ............... 161 \\nTable L-12: Before Adjustment ....................................................................................................................................... 161 \\nTable L-13: After Adjustment .......................................................................................................................................... 162 \\nATTACHMENT M: METHODOLOGY FOR MPF PRICE ACCURACY MEASURE ........................................ 163 \\nContract Selection .......................................................................................................................................................... 163 \\nMPF Composite Price Accuracy Score ........................................................................................................................ 163 \\nExample of Accuracy Index Calculation ...................................................................................................................... 166 \\nTable M-1: Example of Price Accuracy Index Calculation .............................................................................................. 167 \\nATTACHMENT N: MTM CMR COMPLETION RATE MEASURE SCORING METHODOLOGIES ................ 168 \\nMedicare Part D Reporting Requirements Measure (D11: MTM CMR Completion Rate Measure) ........................ 168 \\nATTACHMENT O: METHODOLOGY FOR THE PUERTO RICO MODEL ...................................................... 170 \\nModel ............................................................................................................................................................................... 171 \\nExample ........................................................................................................................................................................... 172 \\nATTACHMENT P: IDENTIFICATION OF CONTRACTS AFFECTED BY DISASTERS ................................. 173 \\nOperational Steps to Calculating Enrollment Impacted in Affected Contracts. ...................................................... 173 \\nTable P-1: Section 1135 waivers issued in relation to the FEMA major disaster declarations ....................................... 173 \\nTable P-2: Individual Assistance counties in FEMA Major Disaster Declared States .................................................... 174 \\nTable P-3: Organization type service areas and necessary transformations ................................................................. 174 \\nTable P-4: Major Disasters with associated enrollment months ..................................................................................... 175 \\nTable P-5: How enrollment periods were combined for contracts experiencing multiple disasters ................................ 175 \\nExample: .......................................................................................................................................................................... 176 \\nTable P-6: Example Contract HAAAA’s Service Areas and Enrollment during Relevant Disasters ............................... 176 \\nATTACHMENT Q: MISSING DATA MESSAGES ........................................................................................... 178 \\nMeasure level messages ................................................................................................................................................ 178 \\nTable Q-1: Measure level missing data messages ......................................................................................................... 178 \\nAssignment rules for Part C measure messages........................................................................................................ 178 \\nAssignment rules for Part D measure messages........................................................................................................ 182 \\nTable Q-2: MTM CMR Reason(s) for Display Message conversion ............................................................................... 184 \\nDomain, Summary, and Overall level messages ......................................................................................................... 184 \\nTable Q-3: Domain, Summary, and Overall level missing data messages ..................................................................... 184 \\nAssignment rules for Part C & Part D domain rating level messages ...................................................................... 184 \\nAssignment rules for Part C & Part D summary rating level messages ................................................................... 184 \\nAssignment rules for overall rating level messages .................................................................................................. 185 \\nDisenrollment Reasons messages ............................................................................................................................... 185 \\nTable Q-4: Disenrollment Reason missing data messages ............................................................................................ 185 \\nATTACHMENT R: GLOSSARY OF TERMS ................................................................................................... 186', '(Last Updated 10/03/2024)  \\nPage vii \\n \\nATTACHMENT S: HEALTH PLAN MANAGEMENT SYSTEM MODULE REFERENCE ............................... 190 \\nHPMS Star Ratings Module ........................................................................................................................................... 190 \\n1. Measure Data page ................................................................................................................................................... 190 \\nTable S-1: Measure Data page sample .......................................................................................................................... 190 \\n2. Measure Detail – CTM Summary page ..................................................................................................................... 190 \\nTable S-2: Measure Detail – CTM Summary page fields ................................................................................................ 191 \\n3. Measure Detail – Part C Appeals page ..................................................................................................................... 191 \\nTable S-3: Measure Detail – Part C Appeals page fields ................................................................................................ 191 \\n4. Measure Detail – SNP CM page ............................................................................................................................... 192 \\nTable S-4: Measure Detail – SNP CM page fields .......................................................................................................... 192 \\n5. Measure Detail – HEDIS page .................................................................................................................................. 192 \\nTable S-5: Measure Detail – HEDIS page fields ............................................................................................................. 193 \\nTable S-6: HEDIS 2023 Audit Designations and 2025 Star Ratings .............................................................................. 193 \\n6. Measure Detail – CTM page ..................................................................................................................................... 193 \\nTable S-7: Measure Detail – CTM page fields ................................................................................................................ 194 \\n7. Measure Detail – Disenrollment ................................................................................................................................ 194 \\nTable S-8: Measure Detail – Disenrollment page fields .................................................................................................. 194 \\n8. Measure Detail – DR (Disenrollment Reasons) ........................................................................................................ 194 \\nTable S-9: Measure Detail – Disenrollment Reasons page fields .................................................................................. 195 \\n9. Measure Detail – MTM page ..................................................................................................................................... 195 \\nTable S-10: Measure Detail – MTM page fields .............................................................................................................. 195 \\n10. Measure Detail – CAHPS page ................................................................................................................................. 196 \\nTable S-11: Measure Detail – CAHPS page fields ......................................................................................................... 196 \\n11. Calculation Detail – MD ............................................................................................................................................. 196 \\nTable S-12: Calculation Detail – MD page fields ............................................................................................................ 197 \\n12. Calculation Detail – CAI ............................................................................................................................................ 197 \\nTable S-13: Measure Detail – CAI page fields ................................................................................................................ 198 \\n13. Measure Detail – HEDIS LE page ............................................................................................................................. 198 \\nTable S-14: Measure Detail – HEDIS LE page fields ..................................................................................................... 199 \\n14. Measure Detail – C MD Results ................................................................................................................................ 199 \\nTable S-15: Measure Detail – C MD Results .................................................................................................................. 199 \\n15. Measure Detail – D MD Results ................................................................................................................................ 199 \\nTable S-16: Measure Detail – D MD Results .................................................................................................................. 200 \\n16. Measure Detail – C Improvement page .................................................................................................................... 200 \\nTable S-17: Part C Measure Improvement Results ........................................................................................................ 200 \\n17. Measure Detail – D Improvement page .................................................................................................................... 200 \\nTable S-18: Part D Measure Improvement Results ........................................................................................................ 201 \\n18. Measure Stars page .................................................................................................................................................. 201 \\nTable S-19: Measure Stars page sample........................................................................................................................ 201 \\n19. Domain Stars page .................................................................................................................................................... 201 \\nTable S-20: Domain Star page sample ........................................................................................................................... 202 \\n20. Part C Summary Rating page ................................................................................................................................... 202 \\nTable S-21: Part C Summary Rating page fields ............................................................................................................ 202 \\n21. Part D Summary Rating page ................................................................................................................................... 203 \\nTable S-22: Part D Summary Rating View ...................................................................................................................... 203 \\n22. Overall Rating page ................................................................................................................................................... 203 \\nTable S-23: Overall Rating View ..................................................................................................................................... 204 \\n23. Low Performing Contract List .................................................................................................................................... 204 \\nTable S-24: Low Performing Contract List ...................................................................................................................... 205 \\n24. High Performing Contract List ................................................................................................................................... 205 \\nTable S-25: High Performing Contract List ..................................................................................................................... 205 \\n25. Technical Notes link .................................................................................................................................................. 205 \\n26. Medication NDC List .................................................................................................................................................. 206 \\n27. Part C and Part D Example Measure Data ............................................................................................................... 206', '(Last Updated 10/03/2024)  \\nPage 1 \\n \\nIntroduction \\nCMS created the Part C & D Star Ratings to provide quality and performance information to Medicare \\nbeneficiaries to assist them in choosing their health and drug services during the annual fall open enrollment \\nperiod. We refer to them as the ‘2025 Medicare Part C & D Star Ratings’ because they are posted prior to the \\n2025 open enrollment period. \\nThis document describes the methodology for creating the Part C & D Star Ratings displayed on the Medicare \\nPlan Finder (MPF) at http://www.medicare.gov/ and posted on the CMS website at \\nhttp://go.cms.gov/partcanddstarratings. A Glossary of Terms used in this document can be found in Attachment \\nR. \\nThe Star Ratings data are also displayed in the Health Plan Management System (HPMS). In HPMS, the data \\ncan be found by selecting: “Quality and Performance,” then “Performance Metrics,” then “Reports,” then “Star \\nRatings and Display Measures,” then “Star Ratings” for the report type, and “2025” for the report period. See \\nAttachment S: Health Plan Management System Module Reference for descriptions of the HPMS pages. \\nThe Star Ratings Program is consistent with the “Meaningful Measures” framework which focuses on measures \\nrelated to person-centered care, equity, safety, affordability and efficiency, chronic conditions, wellness and \\nprevention, seamless care coordination, and behavioral health. With Meaningful Measures 2.0, CMS plans to \\nbetter address health care priorities and gaps, emphasize digital quality measurement, and promote patient \\nperspectives of care. The Star Ratings include measures applying to the following five broad categories: \\n Outcomes: Outcome measures reflect improvements in a beneficiary’s health and are central to assessing \\nquality of care. \\n Intermediate outcomes: Intermediate outcome measures reflect actions taken which can assist in \\nimproving a beneficiary’s health status. Diabetes Care – Blood Sugar Controlled is an example of an \\nintermediate outcome measure where the related outcome of interest would be better health status for \\nbeneficiaries with diabetes. \\n Patient experience: Patient experience measures reflect beneficiaries’ perspectives of the care they \\nreceived. \\n Access: Access measures reflect processes and issues that could create barriers to receiving needed care. \\nPlan Makes Timely Decisions about Appeals is an example of an access measure. \\n Process: Process measures capture the health care services provided to beneficiaries which can assist in \\nmaintaining, monitoring, or improving their health status. \\nNote on References to the 2024 Star Ratings \\nThroughout these technical notes, previous year and 2024 Star Ratings refer to the recalculated 2024 Star \\nRatings and cut points which were recalculated using the published 2023 Star Ratings cut points to determine \\nthe guardrails for 2024 Star Ratings (i.e., Tukey outliers were not removed from the 2023 Star Ratings measure \\nscores when determining cut points). \\nDifferences between the 2024 Star Ratings and 2025 Star Ratings \\nThere have been several changes between the 2024 Star Ratings and the 2025 Star Ratings. This section \\nprovides a synopsis of the notable differences; the reader should examine the entire document for full details', '(Last Updated 10/03/2024)  \\nPage 2 \\n \\nabout the 2025 Star Ratings. A table with the complete history of measures used in the Star Ratings can be \\nfound in Attachment J. \\n Changes \\na. The weight of the Part C Plan All-Cause Readmissions measure was increased to 3.   \\nb. Since the Medicare Plan Finder measure is no longer treated as a new measure, guardrails are now \\napplied after mean resampling \\n Transitioned measures (Moved to the display page on the CMS website: \\nhttp://go.cms.gov/partcanddstarratings) \\n None \\n Retired measures \\n None \\nHealth/Drug Organization Types Included in the Star Ratings \\nAll health and drug plan quality and performance measure data described in this document are reported at the \\ncontract/sponsor level. Table 1 lists the contract year 2025 organization types and whether they are included in \\nthe Part C and/or Part D Star Ratings.', '(Last Updated 10/03/2024)  \\nPage 3 \\n \\nTable 1: Contract Year 2025 Organization Types Reported in the 2025 Star Ratings \\nOrganization Type \\nTechnical \\nNotes \\nAbbreviation \\nMedicare \\nAdvantage \\n(MA) \\nCan \\nOffer \\nSNPs \\nPart C \\nRatings \\nPart D Ratings \\n1876 Cost \\n1876 Cost \\nNo \\nNo \\nYes \\nYes (if drugs \\noffered) \\nDemonstration (Medicare-Medicaid \\nPlan) † \\nMMP \\nNo \\nNo \\nNo \\nNo \\nEmployer/Union Only Direct \\nContract Local Coordinated Care \\nPlan (CCP) \\nCCP \\nYes \\nNo \\nYes \\nYes \\nEmployer/Union Only Direct \\nContract Prescription Drug Plan \\n(PDP) \\nPDP \\nNo \\nNo \\nNo \\nYes \\nEmployer/Union Only Direct \\nContract Private Fee-for-Service \\n(PFFS) \\nPFFS \\nYes \\nNo \\nYes \\nYes (if drugs \\noffered) \\nHCPP 1833 Cost \\nHCPP \\nNo \\nNo \\nNo \\nNo \\nLocal Coordinated Care Plan \\n(CCP) \\nCCP \\nYes \\nYes \\nYes \\nYes \\nMedical Savings Account (MSA) \\nMSA \\nYes \\nNo \\nYes \\nNo \\nNational PACE \\nPACE \\nNo \\nNo \\nNo \\nNo \\nMedicare Prescription Drug Plan \\n(PDP) \\nPDP \\nNo \\nNo \\nNo \\nYes \\nPrivate Fee-for-Service (PFFS) \\nPFFS \\nYes \\nNo \\nYes \\nYes (if drugs \\noffered) \\nRegional Coordinated Care Plan \\n(CCP) \\nCCP \\nYes \\nYes \\nYes \\nYes \\nReligious Fraternal Benefit Private \\nFee-for-Service (RFB PFFS) \\nPFFS \\nYes \\nNo \\nYes \\nYes (if drugs \\noffered) \\n† Note: The measure scores from these organizations are displayed in HPMS only during the first plan preview. Data from these \\norganizations are not used in calculating the Part C & D Star Ratings. \\nThe Star Ratings Framework \\nThe Star Ratings are based on health and drug plan quality and performance measures.  Each measure is \\nreported in two ways: \\nScore: \\nA score is either a numeric value or an assigned ‘missing data’ message. \\nStar: \\nThe measure numeric value is converted to a Star Rating. \\nThe measure Star Ratings are combined into three groups and each group is assigned 1 to 5 stars. The three \\ngroups are: \\nDomain: Domains group together measures of similar services. Star Ratings for domains are calculated \\nusing the non-weighted average Star Ratings of the included measures. \\nSummary: Part C measures are grouped to calculate a Part C Rating; Part D measures are grouped to \\ncalculate a Part D Rating. Summary ratings are calculated from the weighted average Star Ratings \\nof the included measures.', '(Last Updated 10/03/2024)  \\nPage 4 \\n \\nOverall: \\nFor MA-PDs, all unique Part C and Part D measures are grouped to create an overall rating. The \\noverall rating is calculated from the weighted average Star Ratings of the included measures. \\n \\nFigure 1 shows the four levels of Star Ratings that are calculated and reported publicly. \\nFigure 1: The Four Levels of Star Ratings \\n \\nThe whole star scale used at the measure and domain levels is shown in Table 2. \\nTable 2: 5-Star Scale \\nNumeric \\nGraphic \\nDescription \\n5 \\nExcellent \\n4 \\nAbove Average \\n3 \\nAverage \\n2 \\nBelow Average \\n1 \\nPoor \\nTo allow for more variation across contracts, CMS assigns half stars to the summary and overall ratings. \\nAs different organization types offer different benefits, CMS classifies contracts into three contract types. The \\nhighest level Star Rating differs among the contract types because the set of required measures differs by contract \\ntype. Table 3 clarifies how CMS classifies contracts for purposes of the Star Ratings and indicates the highest \\nrating available for each organization type. \\n \\nTable 3: Relation of 2025 Organization Types to Contract Types and Highest Rating in the 2025 Star Ratings \\nOrganization \\nType \\n1876 Cost (no \\ndrugs) † \\n1876 Cost \\n(offers drugs) † \\nCCP \\nMSA \\nPDP \\nPFFS (no drugs) \\nPFFS (offers \\ndrugs) \\nRated As \\nMA-Only \\nMA-PD \\nMA-PD \\nMA-Only \\nPDP \\nMA-Only \\nMA-PD \\nHighest Rating Part C rating \\nOverall Rating \\nOverall \\nRating \\nPart C Rating Part D Rating \\nPart C Rating \\nOverall Rating \\n† Note: While 1876 contracts are not MA contracts, for the purposes of determining the highest rating they are considered to be rated \\nas either “MA-only” or “MA-PD” depending on whether they offer drugs.', '(Last Updated 10/03/2024)  \\nPage 5 \\n \\nSources of the Star Ratings Measure Data \\nThe 2025 Star Ratings include a maximum of 9 domains comprised of a maximum of 42 measures. \\n MA-Only contracts are measured on 5 domains with a maximum of 30 measures. \\n PDPs are measured on 4 domains with a maximum of 12 measures. \\n MA-PD contracts are measured on all 9 domains with a maximum of 42 measures, 40 of which are \\nunique measures. Two of the measures are shown in both Part C and Part D so that the results for a MA-\\nPD contract can be compared to an MA-Only contract or a PDP contract. Only one instance of those two \\nmeasures is used in calculating the overall rating. The two duplicated measures are Complaints about the \\nHealth/Drug Plan (CTM) and Members Choosing to Leave the Plan (MCLP). \\n \\nFor a health and/or drug plan to be included in the Part C & D Star Ratings, they must have an active contract \\nwith CMS to provide health and/or drug services to Medicare beneficiaries. All of the data used to rate the plans \\nare collected through normal contractual requirements or directly from CMS systems. Information about \\nMedicare Advantage contracting can be found at: https://www.cms.gov/Medicare/Medicare-\\nAdvantage/MedicareAdvantageApps/index.html and Prescription Drug Coverage contracting at: \\nhttps://www.cms.gov/Medicare/Prescription-Drug-coverage/PrescriptionDrugCovContra/index.html. \\nThe data used in the Star Ratings come from four categories of data sources which are shown in Figure 2. \\nFigure 2: The Four Categories of Data Sources \\n \\nImprovement Measures \\nUnlike the other Star Rating measures which are derived from data sources external to the Star Ratings, the Part \\nC and Part D improvement measures are derived through comparisons of a contract’s current and prior year \\nmeasure scores. For a measure to be included in the improvement calculation the measure must not have had a \\nsignificant specification change during those years. The Part C improvement measure includes only Part C \\nmeasure scores and the Part D improvement measure includes only Part D measure scores. The measures and \\nformulas for the improvement measure calculations are found in Attachment I. If a scaled reduction is applied to \\nthe Part C appeals measure in the previous year, the associated appeals measures will not be included in the \\nHealth Plan Quality Improvement measure. \\nThe numeric results of these calculations are not publicly posted; only the measure ratings are reported publicly. \\nFurther, to receive a Star Rating in the improvement measures, a contract must have measure scores for both \\nyears in at least half of the required measures used to calculate the Part C improvement or Part D improvement \\nmeasures. Improvement scores are not calculated for reconfigured regional contracts until data is available for \\nthe reconfigured structure from both years. Improvement scores are not calculated for consolidated contracts in \\ntheir first year. Table 4 presents the minimum number of measure scores required to receive a rating for the \\nimprovement measures.', '(Last Updated 10/03/2024)  \\nPage 6 \\n \\nTable 4: Minimum Number of Measure Scores Required for an Improvement Measure Rating by Contract Type \\nPart \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nC \\n11 of 22 \\n13 of 26 \\n15 of 29 \\n9 of 17 \\n13 of 25 \\nN/A \\n13 of 26 \\nD \\n5 of 10* \\n6 of 11 \\n6 of 11 \\n5 of 9 \\nN/A \\n6 of 11 \\n6 of 11* \\n* Note: Does not apply to MA-Only, 1876 Cost, and PFFS contracts which do not offer drug benefits. \\nFor a detailed description of all Part C and Part D measures, see the section entitled “Framework and \\nDefinitions for the Domain and Measure Details.” \\nContract Enrollment Data \\nThe enrollment data used in the Part C and Part D \"Complaints about the Health/Drug Plan\" measures are \\npulled from HPMS. These data may also be accessed on the Monthly Enrollment by Contract page on \\nCMS.gov.  These enrollment files represent the number of enrolled beneficiaries the contract was paid for in a \\nspecific month. For these measures, twelve months of enrollment files are pulled (January 2023 through \\nDecember 2023) and the average enrollment across those months is used in the calculations. \\nEnrollment data are also used when combining the plan-level data into contract-level data in the two Part C \\n“Care for Older Adults” Healthcare Effectiveness Data and Information Set (HEDIS) measures. (“The Care for \\nOlder Adults – Functional Status Assessment” measure is currently on the display page). When there is a \\nreported rate, the eligible population in the plan benefit package (PBP) submitted with the HEDIS data is used. \\nIf the audit designation for the PBP level HEDIS data is set to “Not Reported” (NR) or “Biased Rate” (BR) by \\nthe auditor (see following section), there is no value in the eligible population field. In these instances, twelve \\nmonths of PBP-level enrollment files are pulled (January 2023 through December 2023), and the average \\nenrollment in the plan across those months is used in calculating the combined rate. \\nHandling of Biased, Erroneous, and/or Not Reportable (NR) Data \\nThe data used for CMS’s Star Ratings must be accurate and reliable. CMS has identified issues with some \\ncontracts’ data and has taken steps to protect the integrity of the data. For any measure scores CMS identifies to \\nbe based on inaccurate or biased data, CMS’s policy is to reduce a contract’s measure rating to 1 star and set the \\nmeasure score to “CMS identified issues with this plan’s data.” \\nInaccurate or biased data result from the mishandling of data, inappropriate processing, or implementation of \\nincorrect practices. Examples include, but are not limited to: a contract’s failure to adhere to HEDIS, Health \\nOutcomes Survey (HOS), or CAHPS reporting requirements; a contract’s failure to adhere to Medicare Plan \\nFinder data requirements; a contract’s errors in processing organization determinations and appeals; compliance \\nactions taken against the contract due to errors in operational areas that impact the data reported or processed \\nfor specific measures; or a contract’s failure to pass validation of the data reported for specific measures. \\nFor HEDIS data, CMS uses the audit designation information assigned by the HEDIS auditor. An audit \\ndesignation of ‘NR’ (Not reported) is assigned when the contract chooses not to report the measure. An audit \\ndesignation of ‘BR’ (Biased rate) is assigned when the individual measure score is materially biased (e.g., the \\nauditor informs the contract the data cannot be reported to the National Committee for Quality Assurance \\n(NCQA) or to CMS). When either a ‘BR’ or ‘NR’ designation is assigned to a HEDIS measure audit \\ndesignation, the contract receives 1 star for the measure and the measure score is set to “CMS identified issues \\nwith this plan’s data.” In addition, CMS reduces contracts’ HEDIS measure ratings to 1 star if the patient-level \\ndata files are not successfully submitted and validated by the submission deadline. Also, if the HEDIS \\nsummary-level data value varies substantially from the value in the patient-level data, the measure is reduced to \\na rating of 1 star. If an approved CAHPS or HOS vendor does not submit a contract’s CAHPS or HOS data by', '(Last Updated 10/03/2024)  \\nPage 7 \\n \\nthe data submission deadline, the contract automatically receives a rating of 1 star for the CAHPS or HOS \\nmeasures and the measure scores are set to “CMS identified issues with this plan’s data.” \\nData Handling of Measures for Contracts Affected by a Major Disaster \\nCMS has a policy for making adjustments in the Star Ratings to take into account major disasters. That policy \\nwas described in the 2025 Rate Announcement (https://www.cms.gov/Medicare/Health-\\nPlans/MedicareAdvtgSpecRateStats/Announcements-and-Documents.html.)  This is also codified in regulation \\nat §422.166(i) and §423.186(i). \\nThis section describes how the policy is implemented for measures from each of the different data sources in the \\n2025 Star Ratings. The methodology used by CMS to identify the major disaster geographic areas, determine \\nwhich contracts were affected, and how much of their geographic service area and percent of enrollment resided \\nin an affected area can be found in Attachment P. \\nThe disaster policy specified two distinct thresholds of “25% or more” and “60% or more” of the contract’s \\nmembership at the time of the disaster resided in a FEMA-designated Individual Assistance area. CMS \\ncalculated the percentage of enrollment affected for every contract being rated and applied the following rules \\nto the data from those contracts that meet or exceed either of the two thresholds. \\n• CAHPS adjustments: \\no All contracts were required to administer the 2024 CAHPS survey unless the contract requested \\nand CMS approved an exemption. \\no All affected contracts with at least 25% of beneficiaries in Individual Assistance areas at the time \\nof the disaster receive the higher of the 2024 or the 2025 Star Rating (and corresponding measure \\nscore) for each CAHPS measure (including the annual flu vaccine measure). \\no In some cases, contracts with at least 25% of enrollees residing in FEMA-designated individual \\nAssistance areas that were affected by disasters that began in 2023 were also affected by \\ndisasters in 2022.  These doubly-affected contracts receive the higher of the 2025 Star Rating or \\nwhat the 2024 Star Ratings would have been in the absence of any adjustments that took into \\naccount the effects of the 2022 disaster for each measure (we use the corresponding measure \\nscore for the Star Ratings year selected).  For example, if a doubly-affected contract reverted \\nback to the 2023 Star Rating on a given measure in the 2024 Star Ratings, the 2023 Star Rating is \\nnot used in determining the 2025 Star Rating.  Rather the 2025 Star Rating is compared to what \\nthe 2024 Star Rating would have been absent any disaster adjustments. \\n HEDIS-HOS adjustments: \\no The HEDIS-HOS data used in the 2025 Star Ratings are adjusted for 2022 disasters (see \\nAttachment P of the 2024 Star Ratings Technical Notes for the identification of contracts \\naffected by 2022 disasters).  \\no All affected contracts (i.e., contracts affected by 2022 disasters) with at least 25% of \\nbeneficiaries in Individual Assistance areas at the time of the disaster received the higher of the \\n2024 or the 2025 Star Rating (and corresponding measure score) for each HEDIS-HOS measure. \\no In some cases, contracts with at least 25% of enrollees residing in FEMA-designated Individual \\nAssistance areas affected by disasters that began in 2022 were also affected by disasters in 2021. \\nThese doubly-affected contracts receive the higher of the 2025 Star Rating or what the 2024 Star \\nRating would have been in the absence of any adjustments that took into account the effects of \\nthe 2021 disaster for each measure (we use the corresponding measure score for the Star Ratings \\nyear selected).', '(Last Updated 10/03/2024)  \\nPage 8 \\n \\n• HEDIS adjustments: \\no All contracts were required to report HEDIS MY 2023 unless the contract requested and CMS \\napproved an exemption. Contracts were able to work with NCQA to adjust samples if necessary. \\no Contracts with 25% or more affected members received the higher of the 2024 or 2025 Star \\nRating (and corresponding measure scores) for each HEDIS measure. \\no In some cases, contracts with at least 25% of enrollees residing in FEMA-designated Individual \\nAssistance areas affected by disasters that began in 2023 were also affected by disasters in 2022. \\nThese doubly-affected contracts receive the higher of the 2025 Star Rating or what the 2024 Star \\nRating would have been in the absence of any adjustments that took into account the effects of \\nthe 2022 disaster for each measure (we use the corresponding measure score for the Star Ratings \\nyear selected). \\n• Part C and D Call Center: \\no For all contracts, no adjustments were made. \\n New measures: \\no Contracts with 25% or more affected members have a hold harmless provision applied which \\ncompares the result of a contract’s overall rating “with” and “without” including any new \\nmeasure(s) and/or respecified measure(s). If the “with” result is lower than the “without” result, \\nthen we use the “without” result as the final highest level rating.  Please note that there are no \\nnew or respecified measures for the 2025 Star Ratings. \\no A similar hold harmless provision is applied for the Part C and D summary ratings. If a contract \\nhas 25% or more affected members, the Part C and D summary ratings are calculated “with” and \\n“without” any new measure(s) and/or respecified measure(s), and if the “with” result is lower \\nthan the “without” result, then we use the “without” result for the final summary ratings. Please \\nnote that there are no new or respecified measures for the 2025 Star Ratings. \\n• All other measures: \\no Contracts with 25% or more affected members receive the higher of the 2024 or 2025 measure \\nstars (and corresponding measure scores). \\no In some cases, contracts with at least 25% of enrollees residing in FEMA-designated Individual \\nAssistance areas affected by disasters that began in 2023 were also affected by disasters in 2022. \\nThese doubly-affected contracts receive the higher of the 2025 Star Rating or what the 2024 Star \\nRating would have been in the absence of any adjustments that took into account the effects of \\nthe 2022 disaster for each measure (we use the corresponding measure score for the Star Ratings \\nyear selected). \\n• All adjustments: \\no For all adjustments, if the Star Rating is the same in both years, the Star Rating and the measure \\nscore from the most recent year are used. \\n• Improvement measures: \\no For affected contracts that reverted back to the data underlying the previous year’s Star Rating \\nfor a particular measure for either 2024 or 2025 Star Ratings, that measure is excluded from both \\nthe count of measures (used to determine whether the contract has at least half of the measures \\nneeded to calculate the relevant improvement measure) and the improvement measures’ \\ncalculation. Affected contracts do not have the option of reverting to the prior year’s \\nimprovement rating.', '(Last Updated 10/03/2024)  \\nPage 9 \\n \\n• Affected contracts with missing data: \\no If an affected contract has missing data in either the current or previous year (e.g., because of a \\ndata integrity issue, it is too new, or it is too small), the final measure rating comes from the \\ncurrent year. Missing data includes data where there is a data integrity issue. \\n• Reward Factor: \\no Affected contracts with 60% or more of their enrollees impacted by a 2023 disaster are excluded \\nfrom the determination of the performance summary and variance thresholds for the Reward \\nFactor.  \\n• Cut points: \\no Clustering Methodology: For all measures that use the clustering methodology for cut point \\ngeneration, the measure scores for contracts with 60% or more of their enrollment affected by a \\ndisaster are excluded from creating those cut points. \\nMethodology for Assigning Stars to the Part C and Part D Measures \\nCMS assigns stars for each numeric measure score by applying one of two methods: clustering, or relative \\ndistribution and significance testing. Each method is described below. Attachment K explains the clustering and \\nrelative distribution and significance testing (used for CAHPS measures) methods in greater detail. \\nA. Clustering \\nThis method is applied to the majority of the Star Ratings measures, ranging from operational and process-\\nbased measures, to HEDIS and other clinical care measures. Using this method, the Star Rating for each \\nmeasure is determined by applying a clustering algorithm to the measure’s numeric value scores from all \\ncontracts. Conceptually, the clustering algorithm identifies the “gaps” among the scores and creates four cut \\npoints resulting in the creation of five levels (one for each Star Rating). The scores in the same Star Rating level \\nare as similar as possible; the scores in different Star Rating levels are as different as possible. Star Rating levels \\n1 through 5 are assigned with 1 being the worst and 5 being the best. \\nTechnically, the variance in measure scores is separated into within-cluster and between-cluster sum of squares \\ncomponents. The clusters reflect the groupings of numeric value scores that minimize the variance of scores \\nwithin the clusters. The Star Ratings levels are assigned to the clusters that minimize the within-cluster sum of \\nsquares. The cut points for star assignments are derived from the range of measure scores per cluster, and the \\nstar levels associated with each cluster are determined by ordering the means of the clusters. \\nTukey outlier deletion is used to determine the cut points for all non-CAHPS measures. Tukey outlier deletion \\ninvolves removing Tukey outer fence outlier contract scores, those defined as measure-specific scores outside \\nthe bounds of 3.0 times the measure-specific interquartile range subtracted from the 1st quartile or added to the \\n3rd quartile. Outliers are removed prior to applying mean resampling within the hierarchical clustering \\nalgorithm. \\nMean resampling is used to determine the cut points for all non-CAHPS measures.  With mean resampling, \\nmeasure-specific scores for the current year’s Star Ratings are randomly separated into 10 equal-sized groups.  \\nThe hierarchal clustering algorithm is then applied 10 times, each time leaving one of the 10 groups out of the \\nclustered data.  The method results in 10 sets of measure-specific cut points.  The mean for each 1 through 5 \\nstar level cut point is taken across the 10 sets for each measure to produce the final cut points.', '(Last Updated 10/03/2024)  \\nPage 10 \\n \\nGuardrails are used to cap the amount of increase or decrease in measure cut point values from one year to the \\nnext. Specifically, each 1 to 5 star level cut point is compared to the prior year’s value and capped at an increase \\nor decrease of at most 5 percentage points for measures having a 0 to 100 scale (absolute percentage cap) or at \\nmost 5 percent of the prior year’s restricted score range for measures not having a 0 to 100 scale (restricted \\nrange cap). The final capped cut points after comparing each 1 through 5 star level cut point to the prior year’s \\nvalues are used for assigning measure stars. \\nB. Relative Distribution and Significance Testing (CAHPS) \\nThis method is applied to determine valid star cut points for CAHPS measures. In order to account for the \\nreliability of scores produced from the CAHPS survey, the method combines evaluating the relative percentile \\ndistribution with significance testing. For example, to obtain 5 stars, a contract’s CAHPS measure score needs \\nto be ranked at least at the 80th percentile and be statistically significantly higher than the national average \\nCAHPS measure score, as well as either have not low reliability or have a measure score more than one \\nstandard error above the 80th percentile. To obtain 1 star, a contract’s CAHPS measure score needs to be ranked \\nbelow the 15th percentile and be statistically significantly lower than the national average CAHPS measure \\nscore, as well as either have not low reliability or have a measure score more than one standard error below the \\n15th percentile. \\nMethodology for Calculating Stars at the Domain Level \\nA domain rating is the average, unweighted mean, of the domain’s measure stars. To receive a domain rating, a \\ncontract must meet or exceed the minimum number of rated measures required for the domain. The minimum \\nnumber of rated measures required for a domain is determined based on whether the total number of measures \\nin the domain for a contract type is odd or even: \\n• If the total number of measures that comprise the domain for a contract type is odd, divide the number of \\nmeasures in the domain by two and round the quotient to the next whole number. \\no Example: If the total number of measures required in a domain for a contract type is 3, the value \\n3 is divided by 2. The quotient, in this case 1.5, is then rounded to the next whole number. To \\nreceive a domain rating, the contract must have a Star Rating for at least 2 of the 3 required \\nmeasures. \\n• If the total number of measures that comprise the domain for a contract type is even, divide the number \\nof measures in the domain by two and add one to the quotient. \\no Example: If the total number of measures required in a domain for a contract type is 6, the value \\n6 is divided by 2. In this example, 1 is then added to the quotient of 3. To receive a domain \\nrating, the contract must have a Star Rating for at least 4 of the 6 required measures. \\nTable 5 details the minimum number of rated measures required for a domain rating by contract type.', \"(Last Updated 10/03/2024)  \\nPage 11 \\n \\nTable 5: Minimum Number of Rated Measures Required for a Domain Rating by Contract Type \\nPart \\nDomain Name (Identifier) \\n1876  \\nCost † \\nCCP  \\nw/o SNP \\nCCP  \\nwith SNP \\nCCP with \\nOnly I-SNP \\nMSA \\nPDP \\nPFFS \\nC \\nStaying Healthy: Screenings, \\nTests and Vaccines (HD1) \\n3 of 4 \\n3 of 4 \\n3 of 4 \\n2 of 2 \\n3 of 4 \\nN/A \\n3 of 4 \\nC \\nManaging Chronic (Long \\nTerm) Conditions (HD2) \\n5 of 8 \\n6 of 11 \\n8 of 14 \\n6 of 10 \\n6 of 11 \\nN/A \\n6 of 11 \\nC \\nMember Experience with \\nHealth Plan (HD3) \\n4 of 6 \\n4 of 6 \\n4 of 6 \\nN/A \\n4 of 6 \\nN/A \\n4 of 6 \\nC \\nMember Complaints and \\nChanges in the Health Plan's \\nPerformance (HD4) \\n2 of 3 \\n2 of 3 \\n2 of 3 \\n2 of 3 \\n2 of 3 \\nN/A \\n2 of 3 \\nC \\nHealth Plan Customer \\nService (HD5) \\n2 of 2 \\n2 of 3 \\n2 of 3 \\n2 of 3 \\n2 of 2 \\nN/A \\n2 of 3 \\nD \\nDrug Plan Customer Service \\n(DD1) \\nN/A* \\n1 of 1 \\n1 of 1 \\n1 of 1 \\nN/A \\n1 of 1 \\n1 of 1* \\nD \\nMember Complaints and \\nChanges in the Drug Plan’s \\nPerformance (DD2) \\n2 of 3* \\n2 of 3 \\n2 of 3 \\n2 of 3 \\nN/A \\n2 of 3 \\n2 of 3* \\nD \\nMember Experience with the \\nDrug Plan (DD3) \\n2 of 2* \\n2 of 2 \\n2 of 2 \\nN/A \\nN/A \\n2 of 2 \\n2 of 2* \\nD \\nDrug Safety and Accuracy of \\nDrug Pricing (DD4) \\n4 of 6* \\n4 of 6 \\n4 of 6 \\n4 of 6 \\nN/A \\n4 of 6 \\n4 of 6* \\n* Note: Does not apply to MA-Only, 1876 Cost, and PFFS contracts which do not offer drug benefits. \\n† Note: 1876 Cost contracts that offer drug benefits and which do not submit data for the MPF measure must have a rating in 3 out of 5 \\nDrug Safety and Accuracy of Drug Pricing (DD4) measures to receive a rating in that domain. \\nSummary and Overall Ratings: Weighting of Measures \\nThe summary and overall ratings are calculated as weighted averages of the measure stars. For the 2025 Star \\nRatings, CMS assigns the highest weight to the improvement measures, followed by patient \\nexperience/complaints and access measures, then by outcome and intermediate outcome measures, and finally \\nprocess measures. New measures included in the Star Ratings are given a weight of 1 for their first year of \\ninclusion in the ratings; in subsequent years the weight associated with the measure weighting category is used. \\nThe weights assigned to each measure and their weighting category are shown in Attachment G. \\nIn calculating the summary and overall ratings, a measure given a weight of 3 counts three times as much as a \\nmeasure given a weight of 1. For any given contract, any measure without a rating is not included in the \\ncalculation. The first step in the calculation is to multiply each measure’s weight by the measure’s rating and \\nsum these results. The second step is to divide this sum by the sum of the weights of the contract’s rated \\nmeasures. For the summary and overall ratings, half stars are assigned to allow for more variation across \\ncontracts. \\nMethodology for Calculating Part C and Part D Summary Ratings \\nThe Part C and Part D summary ratings are calculated by taking a weighted average of the measure stars for \\nParts C and D, respectively. To receive a Part C and/or Part D summary rating, a contract must meet the \\nminimum number of rated measures. The Parts C and D improvement measures are not included in the count of \\nthe minimum number of rated measures. The minimum number of rated measures required is determined as \\nfollows:\", '(Last Updated 10/03/2024)  \\nPage 12 \\n \\n• If the total number of measures required for the organization type is odd, divide the number by two and \\nround it to a whole number. \\no Example: if there are 13 required Part D measures for the organization, 13 / 2 = 6.5, when \\nrounded the result is 7. The contract needs at least 7 measures with ratings out of the 13 total \\nmeasures to receive a Part D summary rating. \\n• If the total number of measures required for the organization type is even, divide the number of \\nmeasures by two. \\no Example: if there are 30 required Part C measures for the organization, 30 / 2 = 15. The contract \\nneeds at least 15 measures with ratings out of the 30 total measures to receive a Part C summary \\nrating. \\nTable 6 shows the minimum number of rated measures required by each contract type to receive a summary \\nrating. \\nTable 6: Minimum Number of Rated Measures Required for Part C and Part D Ratings by Contract Type \\nRating \\n1876 Cost † CCP w/o SNP CCP with SNP CCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nPart C summary \\n11 of 22 \\n13 of 26 \\n15 of 29 \\n9 of 17 \\n13 of 25 \\nN/A \\n13 of 26 \\nPart D summary \\n5 of 10* \\n6 of 11 \\n6 of 11 \\n5 of 9 \\nN/A \\n6 of 11 \\n6 of 11* \\n* Note: Does not apply to MA-Only, 1876 Cost, and PFFS contracts which do not offer drug benefits. \\n† Note: 1876 Cost contracts which do not submit data for the MPF measure must have ratings in 5 out of 9measures to receive a Part \\nD rating. \\nMethodology for Calculating the Overall MA-PD Rating \\nFor MA-PDs to receive an overall rating, the contract must have stars assigned to both the Part C and Part D \\nsummary ratings. If an MA-PD contract has only one of the two required summary ratings, the overall rating \\nwill show as “Not enough data available.” \\nThe overall rating for a MA-PD contract is calculated using a weighted average of the Part C and Part D \\nmeasure stars. The weights assigned to each measure are shown in Attachment G. \\nThere are a total of 42 measures (30 in Part C, 12 in Part D) in the 2025 Star Ratings. The following two \\nmeasures are contained in both the Part C and D measure lists: \\n• Complaints about the Health/Drug Plan (CTM) \\n• Members Choosing to Leave the Plan (MCLP) \\nThese measures share the same data source, so CMS includes only one instance of each of these two measures \\nin the calculation of the overall rating. In addition, the Part C and D improvement measures are not included in \\nthe count for the minimum number of measures. Therefore, a total of 38 distinct measures plus the two \\nimprovement measures are used in the calculation of the overall rating. \\nThe minimum number of rated measures required for an overall MA-PD rating is determined using the same \\nmethodology as for the Part C and D summary ratings. Table 7 provides the minimum number of rated \\nmeasures required for an overall Star Rating by contract type.', '(Last Updated 10/03/2024)  \\nPage 13 \\n \\nTable 7: Minimum Number of Rated Measures Required for an Overall Rating by Contract Type \\nRating \\n1876 Cost † CCP w/o SNP CCP with SNP CCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nOverall Rating \\n15 of 30* \\n18 of 35 \\n19 of 38 \\n12 of 24 \\nN/A \\nN/A \\n18 of 35* \\n* Note: Does not apply to MA-Only, 1876 Cost, and PFFS contracts which do not offer drug benefits. \\n† Note: 1876 Cost contracts which do not submit data for the MPF measure must have ratings in 15 out of 29 measures to receive an \\noverall rating. \\n \\nThe overall and summary Star Ratings are calculated based on the measures required to be collected and \\nreported for the contract type being offered for the Star Ratings year.  For example, the 2025 Star Ratings are \\ncalculated for the 2025 contract year using data primarily from measurement year 2023.  If a contract offered a \\nSNP PBP in measurement year 2023, but is no longer offering a SNP PBP for the 2025 contract year, the 2025 \\nStar Ratings exclude the SNP-only measures and the contract is rated as ‘‘Coordinated Care Plan without \\nSNP.’’ \\nCompleting the Summary and Overall Rating Calculations \\nThere are two adjustments made to the results of the summary and overall calculations described above.  First, \\nto reward consistently high performance, CMS utilizes both the mean and the variance of the measure stars to \\ndifferentiate contracts for the summary and overall ratings. If a contract has both high and stable relative \\nperformance, a reward factor is added to the contract’s ratings. Details about the reward factor can be found in \\nthe section entitled “Applying the Reward Factor.” Second, the summary and overall ratings include a \\nCategorical Adjustment Index (CAI) factor, which is added to or subtracted from a contract’s summary and \\noverall ratings. Details about the CAI can be found in the section entitled “Categorical Adjustment Index \\n(CAI).” \\nThe summary and overall rating calculations are run twice, once including the improvement measures and once \\nwithout including the improvement measures. Based on a comparison of the results of these two calculations a \\ndecision is made as to whether the improvement measures are to be included in calculating a contract’s final \\nsummary and overall ratings. Details about the application of the improvement measures can be found in the \\nsection entitled “Applying the Improvement Measure(s).” \\nLastly, standard rounding rules are applied to convert the results of the final summary and overall ratings \\ncalculations into the publicly reported Star Ratings. Details about the rounding rules are presented in the section \\n“Rounding Rules for Summary and Overall Ratings.” \\nApplying the Improvement Measure(s) \\nThe Part C Improvement Measure - Health Plan Quality Improvement (C27) and the Part D Improvement \\nMeasure - Drug Plan Quality Improvement (D04) were introduced earlier in this document in the section \\nentitled “Improvement Measures.” The measures and formulas for the improvement measures can be found in \\nAttachment I. This section discusses whether and how to apply the improvement measures in calculating a \\ncontract’s final summary and overall ratings. \\nSince high performing contracts have less room for improvement and consequently may have lower ratings on \\nthese measure(s), CMS has developed the following rules to not penalize contracts receiving 4 or more stars for \\ntheir highest rating.', '(Last Updated 10/03/2024)  \\nPage 14 \\n \\nMA-PD Contracts \\n1. There are separate Part C and Part D improvement measures (C27 & D04) for MA-PD contracts. \\na. C27 is used in calculating the Part C summary rating of an MA-PD contract. \\nb. D04 is used in calculating the Part D summary rating for an MA-PD contract. \\nc. Both improvement measures will be used when calculating the overall rating in step 3. \\n2. Calculate the overall rating for MA-PD contracts without including either improvement measure. \\n3. Calculate the overall rating for MA-PD contracts with both improvement measures included. \\n4. If an MA-PD contract in step 2 has 4 or more stars, compare the two overall ratings. If the rating in step \\n3 is less than the value in step 2, use the overall rating from step 2; otherwise use the result from step 3. \\n5. For all other MA-PD contracts, use the overall rating from step 3. \\n \\nMA-Only Contracts \\n1. Only the Part C improvement measure (C27) is used for MA-Only contracts. \\n2. Calculate the Part C summary rating for MA-Only contracts without including the improvement \\nmeasure. \\n3. Calculate the Part C summary rating for MA-Only contracts with the Part C improvement measure. \\n4. If an MA-Only contract in step 2 has 4 or more stars, compare the two Part C summary ratings. If the \\nrating in step 3 is less than the value in step 2, use the Part C summary rating from step 2; otherwise use \\nthe result from step 3. \\n5. For all other MA-Only contracts, use the Part C summary rating from step 3. \\n \\nPDP Contracts \\n1. Only the Part D improvement measure (D04) is used for PDP contracts. \\n2. Calculate the Part D summary rating for PDP contracts without including the improvement measure. \\n3. Calculate the Part D summary rating for PDP contracts with the Part D improvement measure. \\n4. If a PDP contract in step 2 has 4 or more stars, compare the two Part D summary ratings. If the rating in \\nstep 3 is less than the value in step 2, use the Part D summary rating from step 2; otherwise use the result \\nfrom step 3. \\n5. For all other PDP contracts, use the Part D summary rating from step 3. \\nApplying the Reward Factor \\nThe following represents the steps taken to calculate and include the reward factor (r-Factor) in the Star Ratings \\nsummary and overall ratings. These calculations are performed both with and without the improvement \\nmeasures included. \\n• Calculate the mean and the variance of all of the individual quality and performance measure stars at the \\ncontract level. \\no The mean is equal to the summary or overall rating before the reward factor is applied, which is \\ncalculated as described in the section entitled “Weighting of Measures.” \\no Using weights in the variance calculation accounts for the relative importance of measures in the \\nreward factor calculation. To incorporate the weights shown in Attachment G into the variance \\ncalculation of the available individual performance measures for a given contract, the steps are as \\nfollows:', '(Last Updated 10/03/2024)  \\nPage 15 \\n \\n• Subtract the summary or overall star from each performance measure’s star; square the \\nresults; and multiply each squared result by the corresponding individual performance \\nmeasure weight. \\n• Sum these results; call this ‘SUMWX.’ \\n• Set n equal to the number of individual performance measures available for the given \\ncontract. \\n• Set W equal to the sum of the weights assigned to the n individual performance measures \\navailable for the given contract. \\n• The weighted variance for the given contract is calculated as: n * SUMWX / (W * (n-1)). \\nFor the complete formula, please see Attachment H: Calculation of Weighted Star Rating \\nand Variance Estimates. \\n• Categorize the variance into three categories: \\no low (0 to < 30th percentile), \\no medium (≥ 30th to < 70th percentile) and \\no high (≥ 70th percentile) \\n• Develop the reward factor as follows: \\no r-Factor = 0.4 (for contract w/ low variance & high mean (mean ≥ 85th percentile)) \\no r-Factor = 0.3 (for contract w/ medium variance & high mean (mean ≥ 85th percentile)) \\no r-Factor = 0.2 (for contract w/ low variance & relatively high mean (mean ≥ 65th & < 85th \\npercentile)) \\no r-Factor = 0.1 (for contract w/ medium variance & relatively high mean (mean ≥ 65th & < 85th \\npercentile)) \\no r-Factor = 0.0 (for all other contracts) \\nTables 8 and 9 show the final threshold values used in reward factor calculations for the 2025 Star Ratings. \\nTable 8: Performance Summary Thresholds \\nImprovement Percentile \\nPart C Rating \\nPart D Rating (MA-PD) \\nPart D Rating (PDP) \\nOverall Rating \\nWith \\n65th \\n3.703125 \\n3.666667 \\n3.535714 \\n3.646465 \\nWith \\n85th \\n4.014493 \\n4.000000 \\n4.035714 \\n3.949495 \\nWithout \\n65th \\n3.707692 \\n3.718750 \\n3.687500 \\n3.662921 \\nWithout \\n85th \\n4.044118 \\n4.062500 \\n4.173913 \\n3.977528 \\n \\nTable 9: Variance Thresholds \\nImprovement Percentile \\nPart C Rating  \\nPart D Rating (MA-PD) \\nPart D Rating (PDP) \\nOverall Rating \\nWith \\n30th \\n0.820452 \\n0.742679 \\n0.847865 \\n0.828220 \\nWith \\n70th \\n1.275376 \\n1.268610 \\n1.533170 \\n1.240423 \\nWithout \\n30th \\n0.807024 \\n0.654297 \\n0.717578 \\n0.795388 \\nWithout \\n70th \\n1.256410 \\n1.210645 \\n1.508203 \\n1.216635 \\nCategorical Adjustment Index (CAI) \\nCMS has implemented an analytical adjustment called the Categorical Adjustment Index (CAI). The CAI is a \\nfactor that is added to or subtracted from a contract’s Overall and/or Summary Star Ratings to adjust for the', '(Last Updated 10/03/2024)  \\nPage 16 \\n \\naverage within-contract disparity in performance for Low Income Subsidy/Dual Eligible (LIS/DE) beneficiaries \\nand disabled beneficiaries.  The CAI value (factor) depends on the contract’s percentage of beneficiaries with \\nLIS/DE and the contract’s percentage of beneficiaries with disabled status. These adjustments are performed \\nboth with and without the improvement measures included. The value of the CAI varies by the contract’s \\npercentage of beneficiaries with LIS/DE and disability status. \\nThe CAI values use data collected for the 2024 Star Ratings. To calculate the CAI, case-mix adjustment is \\napplied to all clinical Star Rating measure scores that are not adjusted for SES using a beneficiary-level logistic \\nregression model with contract fixed effects and beneficiary-level indicators of LIS/DE and disability status, \\nsimilar to the approach currently used to adjust CAHPS patient experience measures. However, unlike CAHPS \\ncase-mix adjustment, the only adjusters are LIS/DE and disability status. Adjusted measure scores are then \\nconverted to measure stars using the 2024 rating year measure cutoffs and used to calculate Adjusted Overall \\nand Summary Star Ratings. Unadjusted Overall and Summary Star Ratings are also determined for each \\ncontract. \\nThe 2024 measures used in the 2025 CAI adjustment calculations are: \\n• Breast Cancer Screening (Part C) \\n• Colorectal Cancer Screening (Part C) \\n• Annual Flu Vaccine (Part C) \\n• Monitoring Physical Activity (Part C) \\n• Osteoporosis Management in Women who had a Fracture (Part C) \\n• Diabetes Care – Eye Exam (Part C) \\n• Diabetes Care – Blood Sugar Controlled (Part C) \\n• Controlling Blood Pressure (Part C) \\n• Reducing the Risk of Falling (Part C) \\n• Improving Bladder Control (Part C) \\n• Medication Reconciliation Post-Discharge (Part C) \\n• Plan All-Cause Readmissions (Part C) \\n• Statin Therapy for Patients with Cardiovascular Disease (Part C) \\n• Transitions of Care (Part C) \\n• Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions \\n(Part C) \\n• Medication Adherence for Diabetes Medication (Part D) \\n• Medication Adherence for Hypertension (RAS antagonists) (Part D) \\n• Medication Adherence for Cholesterol (Statins) (Part D) \\n• MTM Program Completion Rate for CMR (Part D) \\n• Statin Use in Patients with Diabetes (SUPD) (Part D) \\nTo determine the value of the CAI, contracts are first divided into an initial set of categories based on the \\ncombination of a contract’s LIS/DE and disability percentages. For the adjustment for the overall and summary \\nratings for MA-Only and MA-PD contracts, the initial groups are formed by the ten groups of LIS/DE and \\nquintiles of disability, thus resulting in 50 initial categories. For PDPs, the initial groups are formed using quartiles \\nfor both LIS/DE and disability. The mean differences between the Adjusted Overall or Summary Star Rating and \\nthe corresponding Unadjusted Star Rating for contracts in each initial category are determined and examined. \\nThe initial categories are collapsed to form final adjustment groups. The CAI values are the mean differences \\nbetween the Adjusted Overall or Summary Star Rating and the corresponding Unadjusted Star Rating for \\ncontracts within each final adjustment group. Separate CAI values are computed for the overall and summary', '(Last Updated 10/03/2024)  \\nPage 17 \\n \\nratings, and the rating-specific CAI value is the same for all contracts that fall within the same final adjustment \\ncategory. \\nThe categorization of contracts into final adjustment categories for the CAI relies on both the use of a contract’s \\npercentages of LIS/DE and disabled beneficiaries. Categories were chosen to enforce monotonicity. Puerto Rico \\nhas a unique health care market with a large percentage of low-income individuals in both Medicare and \\nMedicaid and a complex legal history that affects the health care system in many ways. Puerto Rican \\nbeneficiaries are not eligible for LIS. Since the percentage of LIS/DE is a critical element in the categorization \\nof contracts to identify the contract’s CAI, an additional adjustment is done for contracts that solely serve the \\npopulation of beneficiaries in Puerto Rico to address the lack of LIS. The additional analysis for the adjustment \\nresults in a modified percentage of LIS/DE beneficiaries that is subsequently used to categorize the contract in \\nits final adjustment category for the CAI. Details regarding the methodology for the Puerto Rico model are \\nprovided in Attachment O. \\nTables 10 and 11 provide the range of the percentages that correspond to the LIS/DE initial groups and \\ndisability quintiles for the determination of the CAI values for the Overall Rating. For example, if a contract’s \\npercentage of LIS/DE beneficiaries is 13.60%, the contract’s LIS/DE initial group would be L4. The upper limit \\nfor each initial category is only included for the highest categories (L10 and D5), and the upper limit is equal to \\n100% for both of these categories. \\n \\nTable 10: Categorization of Contract’s Members into LIS/DE Initial Groups for the Overall Rating \\nLIS/DE Initial Group \\nPercentage of Contract’s Beneficiaries who are LIS/DE \\n1 \\n \\n0.000000 to less than 6.130891 \\n2 \\n \\n6.130891 to less than 9.037945 \\n3 \\n \\n9.037945 to less than 13.131086 \\n4 \\n \\n13.131086 to less than 18.030927 \\n5 \\n \\n18.030927 to less than 25.257942 \\n6 \\n \\n25.257942 to less than 35.188560 \\n7 \\n \\n35.188560 to less than 50.161404 \\n8 \\n \\n50.161404 to less than 79.983090 \\n9 \\n \\n79.983090 to less than 100.000000 \\n10 \\n100.000000', '(Last Updated 10/03/2024)  \\nPage 18 \\n \\nTable 11: Categorization of Contract’s Members into Disability Quintiles for the Overall Rating \\nDisability Quintile \\nPercentage of Contract’s Beneficiaries who are Disabled \\n1 \\n \\n0.000000 to less than 14.607385 \\n2 \\n \\n14.607385 to less than 21.923598 \\n3 \\n \\n21.923598 to less than 31.057866 \\n4 \\n \\n31.057866 to less than 44.050502 \\n5 \\n \\n44.050502 to 100.000000 \\n \\nTable 12 provides the description of each of the final adjustment categories and the associated value of the CAI \\nper category for the overall rating. \\n \\nTable 12: Final Adjustment Categories and CAI Values for the Overall Rating \\nFinal Adjustment Category \\nLIS/DE Initial Group \\nDisability Quintile \\nCAI Value \\n1 \\nL1- L2 \\nD1 \\n-0.058127 \\n  \\nL1 \\nD2 \\n \\n2 \\nL1- L2 \\nD3 \\n-0.033597 \\n  \\nL2-L3 \\nD2 \\n \\n  \\nL3 \\nD1 \\n \\n3 \\nL4-L6 \\nD1 \\n-0.014802 \\n  \\nL4-L5 \\nD2 \\n \\n4 \\nL1-L5 \\nD4-D5 \\n0.002506 \\n  \\nL3-L6 \\nD3 \\n \\n  \\nL6-L7 \\nD2 \\n \\n  \\nL7-L8 \\nD1 \\n \\n5 \\nL6-L7 \\nD4-D5 \\n0.045230 \\n  \\nL7-L9 \\nD3 \\n \\n  \\nL8 \\nD2 \\n \\n  \\nL9-L10 \\nD1-D2 \\n \\n6 \\nL8 \\nD4-D5 \\n0.064707 \\n  \\nL9-L10 \\nD4 \\n \\n  \\nL10 \\nD3 \\n \\n7 \\nL9 \\nD5 \\n0.112056 \\n8 \\nL10 \\nD5 \\n0.134761 \\n \\nTables 13 and 14 provide the range of the percentages that correspond to the LIS/DE initial groups and \\ndisability quintiles for the initial categories for the determination of the CAI values for the Part C summary.', '(Last Updated 10/03/2024)  \\nPage 19 \\n \\nTable 13: Categorization of Contract’s Members into LIS/DE Initial Groups for the Part C Summary \\nLIS/DE Initial Group \\nPercentage of Contract’s Beneficiaries who \\nare LIS/DE \\n1 \\n \\n0.000000 to less than 5.855856 \\n2 \\n \\n5.855856 to less than 8.734793 \\n3 \\n \\n8.734793 to less than 12.640171 \\n4 \\n \\n12.640171 to less than 17.492877 \\n5 \\n \\n17.492877 to less than 24.793782 \\n6 \\n \\n24.793782 to less than 34.766754 \\n7 \\n \\n34.766754 to less than 49.936168 \\n8 \\n \\n49.936168 to less than 79.344262 \\n9 \\n \\n79.344262 to less than 100.000000 \\n10 \\n100.000000 \\n \\nTable 14: Categorization of Contract’s Members into Disability Quintiles for the Part C Summary \\nDisability Quintile \\nPercentage of Contract’s \\nBeneficiaries who are Disabled \\n1 \\n \\n0.000000 to less than 14.372597 \\n2 \\n \\n14.372597 to less than 21.743800 \\n3 \\n \\n21.743800 to less than 30.716563 \\n4 \\n \\n30.716563 to less than 44.001563 \\n5 \\n \\n44.001563 to 100.000000 \\n \\nTable 15 provides the description of each of the final adjustment categories for the Part C summary and the \\nassociated value of the CAI for each final adjustment category.', '(Last Updated 10/03/2024)  \\nPage 20 \\n \\nTable 15: Final Adjustment Categories and CAI Values for the Part C Summary  \\nFinal \\nAdjustment \\nCategory \\nLIS/DE Initial \\nGroup \\nDisability \\nQuintile \\nCAI Value \\n1 \\nL1 \\nD1 \\n-0.037897 \\n2 \\n L2 \\nD1 \\n-0.025930 \\n \\n L1-L2 \\nD2-D3 \\n \\n3 \\nL3-L4 \\nD1-D2 \\n-0.013018 \\n4 \\nL5-L8 \\nD1 \\n0.004257 \\n \\nL5-L7 \\nD2 \\n \\n \\nL3-L7 \\nD3 \\n \\n \\nL1-L5 \\nD4-D5 \\n \\n5 \\nL6-L7 \\nD4-D5 \\n0.023880 \\n6 \\nL8 \\nD2-D5 \\n0.038923 \\n \\nL9-10 \\nD1-D2 \\n \\n \\nL9 \\nD3 \\n \\n7 \\nL9 \\nD4-D5 \\n0.078480 \\n \\nL10 \\nD3-D4 \\n \\n8 \\nL10 \\nD5 \\n0.094759 \\n \\nTables 16 and 17 provide the range of the percentages that correspond to the LIS/DE initial groups and the \\ndisability quintiles for the initial categories for the determination of the CAI values for the Part D summary \\nrating for MA-PDs. \\n \\nTable 16: Categorization of Contract’s Members into LIS/DE Initial Groups for the MA-PD Part D Summary \\nLIS/DE Initial Group \\nPercentage of Contract’s Beneficiaries \\nwho are LIS/DE \\n1 \\n \\n0.000000 to less than 6.229975 \\n2 \\n \\n6.229975 to less than 9.567309 \\n3 \\n \\n9.567309 to less than 14.176508 \\n4 \\n \\n14.176508 to less than 19.916254 \\n5 \\n \\n19.916254 to less than 27.960199 \\n6 \\n \\n27.960199 to less than 40.979534 \\n7 \\n \\n40.979534 to less than 59.964116 \\n8 \\n \\n59.964116 to less than 91.207503 \\n9 \\n \\n91.207503 to less than 100.000000 \\n10 \\n100.000000', '(Last Updated 10/03/2024)  \\nPage 21 \\n \\nTable 17: Categorization of Contract’s Members into Disability Quintiles for the MA-PD Part D Summary \\nDisability Quintile \\nPercentage of Contract’s \\nBeneficiaries who are Disabled \\n1 \\n \\n0.000000 to less than 14.987453 \\n2 \\n \\n14.987453 to less than 22.882693 \\n3 \\n \\n22.882693 to less than 32.500000 \\n4 \\n \\n32.500000 to less than 45.560408 \\n5 \\n \\n45.560408 to 100.000000 \\n \\nTable 18 provides the description of each of the final adjustment categories for the MA-PD Part D summary and \\nthe associated values of the CAI for each final adjustment category. \\n \\nTable 18: Final Adjustment Categories and CAI Values for the MA-PD Part D Summary \\nFinal Adjustment \\nCategory \\nLIS/DE Initial \\nGroup \\nDisability \\nQuintile \\nCAI Value \\n1 \\nL1-L4 \\nD1 \\n-0.048532 \\n \\nL1 \\nD2 \\n \\n2 \\nL2-L4 \\nD2 \\n-0.031119 \\n3 \\nL1-L5 \\nD3 \\n-0.002424 \\n \\nL5-L8  \\nD1-D2 \\n \\n \\nL9-L10 \\nD1 \\n \\n4 \\nL1-L6 \\nD4-D5 \\n0.022709 \\nL6-L8 \\nD3 \\n \\n5 \\nL7-L8 \\nD4-D5 \\n0.074098 \\n \\nL9-L10 \\nD2-D4 \\n \\n6 \\nL9-L10 \\nD5 \\n0.126344 \\n \\nTables 19 and 20 provide the range of the percentages that correspond to the LIS/DE and disability quartiles for \\nthe initial categories for the determination of the CAI values for the PDP Part D summary. Quartiles are used \\nfor both dimensions due to the limited number of PDPs as compared to MA-PD contracts. \\n \\nTable 19: Categorization of Contract’s Members into Quartiles of LIS/DE for the PDP Part D Summary \\nLIS/DE Quartile \\nPercentage of Contract’s \\nBeneficiaries who are LIS/DE \\n1 \\n \\n0.000000 to less than 1.542070 \\n2 \\n \\n1.542070 to less than 3.159360 \\n3 \\n \\n3.159360 to less than 8.410224 \\n4 \\n \\n8.410224 to 100.000000', '(Last Updated 10/03/2024)  \\nPage 22 \\n \\nTable 20: Categorization of Contract’s Members into Quartiles of Disability for the PDP Part D Summary \\nDisability Quartile \\nPercentage of Contract’s \\nBeneficiaries who are Disabled \\n1 \\n \\n0.000000 to less than 6.593595 \\n2 \\n6.593595 to less than 10.621062 \\n3 \\n \\n10.621062 to less than 14.589481 \\n4 \\n \\n14.589481 to 100.000000 \\n \\nTable 21 provides the description of each of the final adjustment categories for the PDP Part D summary and \\nthe associated value of the CAI per final adjustment category. Note that the CAI values for the PDP Part D \\nsummary are different from the CAI values for the MA-PD Part D summary. There are three final adjustment \\ncategories for the PDP Part D summary. \\n \\nTable 21: Final Adjustment Categories and CAI Values for the PDP Part D Summary \\nFinal Adjustment \\nCategory \\nLIS/DE Quartile \\nDisability Quartile \\nCAI Value \\n1 \\nL1-L2 \\nD1-D2 \\n-0.230036 \\n2 \\nL1-L3 \\nD3-D4 \\n-0.081240 \\n  \\nL3-L4 \\nD1-D2 \\n \\n3 \\nL4 \\nD3-D4 \\n0.004293 \\nCalculation Precision \\nCMS and its contractors have always used software called SAS (an integrated system of software products \\nprovided by SAS Institute Inc.) to perform the calculations used in producing the Star Ratings. For all measures, \\nexcept the improvement measures, the precision used in scoring the measure is indicated next to the label “Data \\nDisplay” within the detailed description of each measure. The improvement measures are discussed below. The \\ndomain ratings are the unweighted average of the star measures and are rounded to the nearest integer. \\nThe improvement measures, summary, and overall ratings are calculated with at least six digits of precision \\nafter the decimal whenever the data allow it. The HEDIS measure scores have two digits of precision after the \\ndecimal. All other measures have at least six digits of precision when used in the improvement calculation. \\nContracts may request a contract-specific calculation spreadsheet which emulates the actual SAS calculations \\nfrom the Star Ratings mailbox during the second plan preview. \\nIt is not possible to replicate CMS’s calculations exactly due to factors including, but not limited to: using \\npublished measure data from sources other than CMS’s Star Rating program which use different rounding rules, \\nand exclusion of some contracts’ ratings from publicly-posted data (e.g., terminated contracts). \\nRounding Rules for Measure Scores \\nMeasure scores are rounded to the precision indicated next to the label “Data Display” within the detailed \\ndescription of each measure. Measure scores are rounded using traditional rounding rules. These are standard \\n“round to nearest” rules prior to cut point analysis. To obtain a value with the specified level of precision, the \\nsingle digit following the level of precision will be rounded. If the digit to be rounded is 0, 1, 2, 3 or 4, the value', '(Last Updated 10/03/2024)  \\nPage 23 \\n \\nis rounded down, with no adjustment to the preceding digit. If the digit to be rounded is 5, 6, 7, 8 or 9, the value \\nis rounded up, and a value of one is added to the preceding digit. After rounding, all digits after the specified \\nlevel of precision are removed. If rounding to a whole number, the digit to be rounded is in the first decimal \\nplace. If the digit in the first decimal place is below 5, then after rounding the whole number remains unchanged \\nand fractional parts of the number are deleted. If the digit in the first decimal place is 5 or greater, then the \\nwhole number is rounded up by adding a value of 1 and fractional parts of the number are deleted.  For \\nexample, a measure listed with a Data Display of “Percentage with no decimal point” that has a value of \\n83.499999 rounds down to 83, while a value of 83.500000 rounds up to 84. \\nRounding Rules for Summary and Overall Ratings \\nThe results of the summary and overall calculations are rounded to the nearest half star (i.e., 0.5, 1.0, 1.5, 2.0, \\n2.5, 3.0, 3.5, 4.0, 4.5, 5.0). Table 22 summarizes the rounding rules for converting the Part C and D summary \\nand overall ratings into the publicly reported Star Ratings. \\nTable 22: Rounding Rules for Summary and Overall Ratings \\nRaw Summary / Overall Score \\nFinal Summary / Overall \\nRating \\n≥ 0.000000 and < 0.250000 \\n0 \\n≥ 0.250000 and < 0.750000 \\n0.5 \\n≥ 0.750000 and < 1.250000 \\n1.0 \\n≥ 1.250000 and < 1.750000 \\n1.5 \\n≥ 1.750000 and < 2.250000 \\n2.0 \\n≥ 2.250000 and < 2.750000 \\n2.5 \\n≥ 2.750000 and < 3.250000 \\n3.0 \\n≥ 3.250000 and < 3.750000 \\n3.5 \\n≥ 3.750000 and < 4.250000 \\n4.0 \\n≥ 4.250000 and < 4.750000 \\n4.5 \\n≥ 4.750000 and ≤ 5.000000 \\n5.0 \\n \\nFor example, a summary or overall rating of 3.749999 rounds down to a rating of 3.5, and a rating of 3.750000 \\nrounds up to rating of 4. That is, a score would need to be at least halfway between 3.5 and 4 (having a \\nminimum value of 3.750000) in order to obtain the higher rating of 4. \\nMethodology for Calculating the High Performing Icon \\nA contract may receive a high performing icon as a result of its performance on the Parts C and/or D measures. \\nThe high performing icon is assigned to an MA-Only contract for achieving a 5-star Part C summary rating, a \\nPDP contract for a 5-star Part D summary rating, and an MA-PD contract for a 5-star overall rating. Figure 3 \\nshows the high performing icon used in the MPF:', '(Last Updated 10/03/2024)  \\nPage 24 \\n \\nFigure 3: The High Performing Icon \\n \\nMethodology for Calculating the Low Performing Icon \\nA contract can receive a low performing icon as a result of its performance on the Part C and/or Part D \\nsummary ratings. The low performing icon is calculated by evaluating the Part C and Part D summary ratings \\nfor the current year and the past two years (i.e., the 2023, 2024, and 2025 Star Ratings). If the contract had any \\ncombination of Part C and/or Part D summary ratings of 2.5 or lower in all three years of data, it is marked with \\na low performing icon (LPI). A contract must have a rating in either Part C and/or Part D for all three years to \\nbe considered for this icon. \\nFigure 4 shows the low performing contract icon used in the MPF: \\nFigure 4: The Low Performing Icon \\n \\n \\nTable 23 shows example contracts which would receive an LPI. \\nTable 23: Example LPI Contracts \\nContract/Rating Rated As 2023 C 2024 C 2025 C 2023 D 2024 D 2025 D LPI Awarded LPI Reason \\nHAAAA \\nMA-PD \\n2 \\n2.5 \\n2.5 \\n3 \\n3 \\n3 \\nYes \\nPart C \\nHBBBB \\nMA-PD \\n3 \\n3 \\n3 \\n2.5 \\n2 \\n2.5 \\nYes \\nPart D \\nHCCCC \\nMA-PD \\n2.5 \\n3 \\n3 \\n3 \\n2.5 \\n2.5 \\nYes \\nPart C or D \\nHDDDD \\nMA-PD \\n3 \\n2.5 \\n3 \\n2.5 \\n3 \\n2.5 \\nYes \\nPart C or D \\nHEEEE \\nMA-PD \\n2.5 \\n2 \\n2.5 \\n2 \\n2.5 \\n2.5 \\nYes \\nPart C and D \\nHFFFF \\nMA-Only \\n2.5 \\n2 \\n2.5 \\n- \\n- \\n- \\nYes \\nPart C \\nSAAAA \\nPDP \\n- \\n- \\n- \\n2.5 \\n2.5 \\n2 \\nYes \\nPart D \\nMergers, Novations, and Consolidations \\nThis section covers how the Star Ratings are affected by mergers, novation and consolidations. To ensure a \\ncommon understanding, we begin by defining each of the terms. \\n Merger: when two (or more) companies join together to become a single business. Each of these \\nseparate businesses had one or more contracts with CMS for offering health and/or drug services to \\nMedicare beneficiaries. After the merger, all of those individual contracts with CMS are still intact, only \\nthe ownership changes in each of the contracts to the name of the new single business. Mergers can \\noccur at any time during a contract year. \\n Novation: when one company acquires another company. Each of these separate businesses had one or \\nmore contracts with CMS for offering health and/or drug services to beneficiaries. After the novation, all \\nof those individual contracts with CMS are still intact. The owner’s names of the contracts acquired are \\nchanged to the new owner’s name. Novations can occur at any time during the contract year.', '(Last Updated 10/03/2024)  \\nPage 25 \\n \\n Consolidation: when an organization/sponsor that has at least two contracts with CMS for offering \\nhealth and/or drug services to beneficiaries combines multiple contracts into a single contract with CMS. \\nConsolidations occur only at the change of the contract year. The one or more contracts that will no \\nlonger exist at contract year’s end are known as the consumed contracts. The contract that will still exist \\nis known as the surviving contract and all of the beneficiaries still enrolled in the consumed contract(s) \\nare moved to the surviving contract.  \\nMergers and novations do not change the ratings earned by an individual contract in any way. \\nFor a merger or novation, the only change is the company listed as owning the contract; there is no change in \\ncontract structure, so the Star Ratings earned by the contract remains with them until the next rating cycle. This \\nincludes any High Performing or Low Performing icons earned by any of the contracts. \\nConsolidations become effective the first day of the calendar year. The Star Ratings are released the previous \\nOctober so they are available when open enrollment begins. In the first year following a consolidation, the \\nmeasure values used in calculating the Star Ratings of the surviving contract will be based on the enrollment-\\nweighted mean of all contracts in the consolidation (see Attachment B). The surviving contract’s ratings are \\nposted publicly, used in determining QBP ratings, and included in the Past Performance Analysis. \\nReliability Requirement for Low-enrollment Contracts \\nHEDIS measures for contracts whose enrollment as of July 2023 was at least 500 but less than 1,000 will be \\nincluded in the Star Ratings in 2025 when the contract-specific measure score reliability is equal to or greater \\nthan 0.7. The reliability calculations are implemented using SAS PROC MIXED as documented on pages 31-32 \\nof the report “The Reliability of Provider Profiling – A Tutorial,” available at \\nhttps://www.rand.org/pubs/technical_reports/TR653.html. \\nThe within-contract variance for the Transitions of Care composite measure utilizes a different formula than \\nother HEDIS pass/fail measures because it is an average of four component measures. First, the binomial \\nvariances and standard deviations (i.e. the square root of a variance term), as discussed in the report “The \\nReliability of Provider Profiling – A Tutorial”, are calculated for each of the four component measures. Next, \\npairwise correlations are computed among the four component measures. Pairwise covariance terms among the \\nfour component measures are calculated by multiplying the respective pairwise correlation and two items’ \\nstandard deviations together. The final within-contract variance for the Transitions of Care composite measure \\nis computed by summing the four variance terms and each pairwise covariance term multiplied by 2.0. \\nSpecial Needs Plan (SNP) Data \\nA Special Needs Plan (SNP) is a Medicare Advantage (MA) coordinated care plan (CCP) specifically designed \\nto provide targeted care and limits enrollment to special needs individuals. There are three major types of SNPs: \\n1) Chronic Condition SNP (C-SNP), 2) Dual Eligible SNP (D-SNP), and 3) Institutional SNP (I-SNP).  Further \\ndetails on SNP plans can be found in the glossary, Attachment R. \\nCMS has included three SNP-specific measures in the 2025 Star Ratings. The Part C ‘Special Needs Plan Care \\nManagement’ measure is based on data reported by contracts through the Medicare Part C Reporting \\nRequirements. The two Part C ‘Care for Older Adults’ measures are based on HEDIS data. The data for all of \\nthese measures are reported at the plan benefit package (PBP) level, while the Star Ratings are reported at the \\ncontract level.', '(Last Updated 10/03/2024)  \\nPage 26 \\n \\nThe methodology used to combine the PBP data to the contract level is different between the two data sources. \\nThe Part C Reporting Requirements data are summed into a contract-level rate after excluding PBPs that do not \\nmap to any PBP offered by the contract in the calendar year for which the Reporting Requirements data \\nunderwent data validation. The HEDIS data are summed into a contract-level rate as long as the contract will be \\noffering a SNP PBP in the Star Ratings year. \\nThe two methodologies used to combine the PBP data within a contract for these measures are described further \\nin Attachment E. \\nStar Ratings and Marketing \\nPlan sponsors must ensure the Star Ratings document and all marketing of Star Ratings information is \\ncompliant with CMS’s Medicare Marketing Guidelines. Failure to follow CMS’s guidance may result in \\ncompliance action against the contract. The Medicare Marketing Guidelines were issued as Chapters 2 and 3 of \\nthe Prescription Drug Benefit Manual and the Medicare Managed Care Manual, respectively. Please direct \\nquestions about marketing Star Ratings information to your Account Manager. \\nContact Information \\nThe contact below can assist you with various aspects of the Star Ratings. \\n• Part C & D Star Ratings: PartCandDStarRatings@cms.hhs.gov \\nIf you have questions or require information about the specific subject areas associated with the Star \\nRatings please write to those contacts directly and cc the Part C & D Star Ratings mailbox. \\n• CAHPS (MA & Part D): MP-CAHPS@cms.hhs.gov \\n• Call Center Monitoring: CallCenterMonitoring@cms.hhs.gov \\n• Compliance Activity Module issues (Part C): PartCCompliance@cms.hhs.gov \\n• Compliance Activity Module issues (Part D): PartD_Monitoring@cms.hhs.gov \\n• Demonstration (Medicare-Medicaid Plan) Ratings: mmcocapsmodel@cms.hhs.gov \\n• Disenrollment Reasons Survey: DisenrollSurvey@cms.hhs.gov \\n• HEDIS: HEDISquestions@cms.hhs.gov \\n• HOS: HOS@cms.hhs.gov \\n• HPMS Access issues: HPMS_Access@cms.hhs.gov \\n• HPMS Help Desk (all other HPMS issues): HPMS@cms.hhs.gov \\n• Marketing: marketing@cms.hhs.gov \\n• Part C Compliance Activity issues: PartCCompliance@cms.hhs.gov \\n• Part D Compliance Activity issues: PartD_Monitoring@cms.hhs.gov \\n• Plan Reporting (Part C): Partcplanreporting@cms.hhs.gov \\n• Plan Reporting (Part D): Partd-planreporting@cms.hhs.gov \\n• Plan Reporting Data Validation (Part C & D): PartCandD_Data_Validation@cms.hhs.gov', '(Last Updated 10/03/2024)  \\nPage 27 \\n \\n• QBP Ratings and Appeals questions: QBPAppeals@cms.hhs.gov \\n• QBP Payment or Risk Analysis questions: riskadjustment@cms.hhs.gov', '(Last Updated 10/03/2024)  \\nPage 28 \\n \\nFramework and Definitions for the Domain and Measure Details Section \\nThis page contains the formatting framework and definition of each sub-section that is used to describe the \\ndomain and measure details on the following pages. \\nDomain: The name of the domain to which the measures following this heading belong \\nMeasure: The measure ID and common name of the ratings measure \\nTitle \\nDescription \\nLabel for Stars: The label that appears with the stars for this measure on Medicare.gov. \\nLabel for Data: The label that appears with the numeric data for this measure on HPMS and \\nCMS.gov. \\nDescription: The English language description shown for the measure on Medicare.gov. The text \\nin this sub-section has been prepared to aid beneficiaries’ understanding of the \\nnature and the purpose of the measure. We strongly encourage any public-facing \\nexplanation of the measure to use this description. \\n \\nHEDIS Label: Optional – contains the full NCQA HEDIS measure name. \\nMeasure Reference: Optional – this sub-section contains the location of the detailed measure specification \\nin the NCQA documentation for all HEDIS and HEDIS-HOS measures. \\nMetric: Defines how the measure is calculated. \\nPrimary Data Source: The primary source of the data used in the measure. \\nData Source Description: Optional – contains information about additional data sources needed for calculating \\nthe measure. \\nData Source Category: The category of this data source. \\nExclusions: Optional – lists any exclusions applied to the data used for the measure. \\nGeneral Notes: Optional – contains additional information about the measure and the data used. \\nData Time Frame: The time frame of data used from the data source. In some HEDIS measures this \\ndate range may appear to conflict with the specific data time frame defined in the \\nNCQA Technical Specifications. In those cases, the data used by CMS are \\nunchanged from what was submitted to NCQA. CMS uses the data time frame of the \\noverall HEDIS submission which is the HEDIS measurement year. \\nGeneral Trend: Indicates whether high values are better or low values are better for the measure. \\nStatistical Method: The methodology used for assigning stars in this measure; see the section entitled \\n“Methodology for Assigning Part C and Part D Measure Star Ratings” for an \\nexplanation of each of the possible entries in this sub-section. \\nImprovement Measure: Indicates whether this measure is included in the improvement measure. \\nCAI Usage: Indicates if the measure is used in the Categorical Adjustment Index calculation. \\nCase-Mix Adjusted: Indicates if the data are case mix adjusted prior to being used for the Star Ratings.', '(Last Updated 10/03/2024)  \\nPage 29 \\n \\nTitle \\nDescription \\nWeighting Category: The weighting category of this measure. \\nWeighting Value: The numeric weight for this measure in the summary and overall rating calculations. \\nMeaningful Measure Area: Contains the area where this measure fits into the Meaningful Measure Framework. \\nCMIT #: The CMS Measure Inventory Tool (CMIT) is the repository of record for information \\nabout the measures which CMS uses to promote healthcare quality and quality \\nimprovement. \\nData Display: The format used to the display the numeric data on Medicare.gov \\nReporting Requirements: Table indicating which organization types are required to report the measure. “Yes” \\nfor organizations required to report; “No” for organizations not required to report. \\nCut Points: Table containing the cut points used in the measure.  For non-CAHPS measures, \\nexcluding new measures and measures with substantive specification changes that \\nhave been in the Part C and D Star Ratings for three years or less, the cut points are \\nafter the application of Tukey outlier deletion, mean resampling, and guardrails. New \\nmeasures and measures with substantive specification changes that have been in \\nthe Part C and D Star Ratings program for three years or less, and the Health Plan \\nQuality Improvement and Drug Plan Quality Improvement measure cut points are \\nafter the application of Tukey outlier deletion and mean resampling. For CAHPS \\nmeasures, the table contains the base group cut points which are used prior to the \\nfinal star assignment rules being applied.', '(Last Updated 10/03/2024)  \\nPage 30 \\n \\nPart C Domain and Measure Details \\nSee Attachment C for the national averages of individual Part C measures. \\nDomain: 1 - Staying Healthy: Screenings, Tests and Vaccines \\nMeasure: C01 - Breast Cancer Screening \\nTitle \\nDescription \\nLabel for Stars: Breast Cancer Screening \\nLabel for Data: Breast Cancer Screening \\nDescription: Percent of female plan members aged 52-74 who had a mammogram during the past \\ntwo years. \\nHEDIS Label: Breast Cancer Screening (BCS) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 606 \\nMetric: The percentage of women MA enrollees 50 to 74 years of age (denominator) as of \\nDecember 31 of the measurement year who had a mammogram to screen for breast \\ncancer in the past two years (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: • Members in hospice or using hospice services any time during the measurement \\nperiod. \\n• Members receiving palliative care any time during the measurement period. \\n• Medicare members 66 years of age and older as of December 31 of the measurement \\nyear who meet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \\nto determine if a member had an LTI flag during the measurement year. \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nfrailty and advanced illness during the measurement year. Members must meet BOTH \\nof the following frailty and advanced illness criteria to be excluded: \\n– At least two indications of frailty with different dates of service during the \\nmeasurement period. \\n– At least two outpatient visits, observation visits, ED visits, telephone visits, e-visits or \\nvirtual check-ins, or nonacute inpatient encounters or nonacute inpatient discharges on \\ndifferent dates of service, with an advanced illness diagnosis. Visit type need not be the \\nsame for the two visits.  \\n• Members receiving palliative care during the measurement year \\n• Members who had a bilateral mastectomy or both right and left unilateral \\nmastectomies any time during the member’s history through December 31 of the \\nmeasurement year. Any of the following meet criteria for bilateral mastectomy: \\n– Bilateral mastectomy.  \\n– Unilateral mastectomy with a bilateral modifier (same procedure). \\n– Two unilateral mastectomies found in clinical data with a bilateral modifier (same \\nprocedure).', '(Last Updated 10/03/2024)  \\nPage 31 \\n \\nTitle \\nDescription \\n– History of bilateral mastectomy.  \\n• Any combination of the following that indicate a mastectomy on both the left and right \\nside on the same or on different dates of service: \\n–Unilateral mastectomy with a right-side modifier (same procedure). \\n– Unilateral mastectomy with a left-side modifier (same procedure). \\n        \\n– Absence of the left breast. \\n– Absence of the right breast.    \\n– Left unilateral mastectomy. \\n– Right unilateral mastectomy.  \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00093-02-C-PARTC \\nData Display: Percentage with no decimal place', '(Last Updated 10/03/2024)  \\nPage 32 \\n \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 53 % \\n>= 53 % to < 67 % \\n>= 67 % to < 75 % \\n>= 75 % to < 82 % \\n>= 82 % \\n \\nMeasure: C02 - Colorectal Cancer Screening \\nTitle \\nDescription \\nLabel for Stars: Colorectal Cancer Screening \\nLabel for Data: Colorectal Cancer Screening \\nDescription: Percent of plan members aged 50-75 who had appropriate screening for colon cancer. \\nHEDIS Label: Colorectal Cancer Screening (COL) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 102 \\nMetric: The percentage of MA enrollees aged 50 to 75 (denominator) as of December 31 of the \\nmeasurement year who had appropriate screenings for colorectal cancer (numerator). \\nPrimary Data Source: HEDIS Patient-level Data \\nData Source Category: Health and Drug Plans \\nExclusions: • Medicare members 66 years of age and older as of December 31 of the measurement \\nyear who meet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File. \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nfrailty and advanced illness during the measurement year. Members must meet both of \\nthe frailty and advanced illness criteria to be excluded: \\n1. – At least two indications of frailty with different dates of service during the \\nmeasurement year. \\n2. – Any of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years): \\n– At least two outpatient visits, observation visits, ED visits, telephone visits, e-\\nvisits or virtual check-ins, nonacute inpatient encounters, or nonacute inpatient \\ndischarges. Visit type need not be the same for the two visits.  \\n– At least one acute inpatient encounter with an advanced illness diagnosis. \\n– At least one acute inpatient discharge with an advanced illness diagnosis on \\nthe discharge claim.  \\n– A dispensed dementia medication.  \\n \\n• (Required) Exclude members who meet any of the following criteria: \\n– Members who had colorectal cancer or a total colectomy any time during the \\nmember’s history through December 31 of the measurement year. \\n– Members receiving palliative care during the measurement year. \\n– Members in hospice or using hospice services during the measurement year.', '(Last Updated 10/03/2024)  \\nPage 33 \\n \\nTitle \\nDescription \\n– Members receiving palliative care during the measurement year. \\n– Members who died during the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the enrollment \\nreport and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00139-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 53 % \\n>= 53 % to < 65 % \\n>= 65 % to < 75 % \\n>= 75 % to < 83 % \\n>= 83 %', \"(Last Updated 10/03/2024)  \\nPage 34 \\n \\nMeasure: C03 - Annual Flu Vaccine \\nTitle \\nDescription \\nLabel for Stars: Yearly Flu Vaccine \\nLabel for Data: Yearly Flu Vaccine \\nDescription: Percent of plan members who got a vaccine (flu shot). \\nMetric: The percentage of sampled Medicare enrollees (denominator) who received an \\ninfluenza vaccination (numerator). \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Question (question number varies depending on survey type): \\n \\n• Have you had a flu shot since July 1, 2023? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: This measure is not case-mix adjusted. \\n \\nCAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00259-01-C-PARTC \\nData Display: Percentage with no decimal place\", '(Last Updated 10/03/2024)  \\nPage 35 \\n \\nTitle \\nDescription \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 61 \\n>= 61 to < 65 \\n>= 65 to < 71 \\n>= 71 to < 76 \\n>= 76 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C04 - Monitoring Physical Activity \\nTitle \\nDescription \\nLabel for Stars: Monitoring Physical Activity \\nLabel for Data: Monitoring Physical Activity \\nDescription: Percent of senior plan members who discussed exercise with their doctor and were \\nadvised to start, increase, or maintain their physical activity during the year. \\nHEDIS Label: Physical Activity in Older Adults (PAO) \\nMeasure Reference: NCQA HEDIS Measurement Year 2022 Specifications for the Medicare Health \\nOutcomes Survey Volume 6, page 36 \\nMetric: The percentage of sampled Medicare members 65 years of age or older who had a \\ndoctor’s visit in the past 12 months (denominator) and who received advice to start, \\nincrease or maintain their level exercise or physical activity (numerator). \\nPrimary Data Source: HEDIS-HOS \\nData Source Description: Cohort 24 Follow-up Data collection (2023) and Cohort 26 Baseline data collection \\n(2023). \\n \\nHOS Survey Question 42: In the past 12 months, did you talk with a doctor or other \\nhealth provider about your level of exercise or physical activity? For example, a doctor \\nor other health provider may ask if you exercise regularly or take part in physical \\nexercise. \\n \\nHOS Survey Question 43: In the past 12 months, did a doctor or other health care \\nprovider advise you to start, increase or maintain your level of exercise or physical \\nactivity? For example, in order to improve your health, your doctor or other health \\nprovider may advise you to start taking the stairs, increase walking from 10 to 20 \\nminutes every day or to maintain your current exercise program. \\nData Source Category: Survey of Enrollees \\nExclusions: Members who responded \"I had no visits in the past 12 months\" to Question 42 are \\nexcluded from results calculations for Question 43. Contracts must achieve a \\ndenominator of at least 100 to obtain a reportable result. If the denominator is less than \\n100, the measure result will be \"Not enough data available.\" Members with evidence \\nfrom CMS administrative records of a hospice start date are excluded. \\nData Time Frame: 07/17/2023 – 11/01/2023', '(Last Updated 10/03/2024)  \\nPage 36 \\n \\nTitle \\nDescription \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2022 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00450-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 41 % \\n>= 41 % to < 47 % \\n>= 47 % to < 52 % \\n>= 52 % to < 60 % \\n>= 60 %', '(Last Updated 10/03/2024)  \\nPage 37 \\n \\nDomain: 2 - Managing Chronic (Long Term) Conditions \\nMeasure: C05 - Special Needs Plan (SNP) Care Management \\nTitle \\nDescription \\nLabel for Stars: Members Whose Plan Did an Assessment of Their Health Needs and Risks \\nLabel for Data: Members Whose Plan Did an Assessment of Their Health Needs and Risks \\nDescription: Percent of members whose plan did an assessment of their health needs and risks in \\nthe past year. The results of this review are used to help the member get the care they \\nneed. (Medicare does not collect this information from all plans. Medicare collects it only \\nfor Special Needs Plans. These plans are a type of Medicare Advantage plan designed \\nfor certain people with Medicare. Some Special Needs Plans are for people with certain \\nchronic diseases and conditions, some are for people who have both Medicare and \\nMedicaid, and some are for people who live in an institution such as a nursing home.) \\nMetric: This measure is defined as the percent of eligible Special Needs Plan (SNP) enrollees \\nwho received a health risk assessment (HRA) during the measurement year. The \\ndenominator for this measure is the sum of the number of new enrollees due for an \\nInitial HRA (Element A) and the number of enrollees eligible for an annual reassessment \\nHRA (Element B). The numerator for this measure is the sum of the number of initial \\nHRAs performed on new enrollees (Element C) and the number of annual \\nreassessments performed on enrollees eligible for a reassessment (Element F). The \\nequation for calculating the SNP Care Management Assessment Rate is: \\n \\n [Number of initial HRAs performed on new enrollees (Element C)  \\n + Number of annual reassessments performed on enrollees eligible for a reassessment \\n(Element F)]  \\n / [Number of new enrollees due for an Initial HRA (Element A)  \\n + Number of enrollees eligible for an annual reassessment HRA (Element B)] \\nPrimary Data Source: Part C Plan Reporting \\nData Source Description: Data reported by contracts to CMS per the 2023 Part C Reporting Requirements. \\nValidation for data performed during the 2024 Data Validation cycle (data pulled June \\n2023). Validation of these data was performed retrospectively during the 2024 data \\nvalidation cycle (deadline June 15, 2024 and data validation results pulled July 2024). \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts and PBPs with an effective termination date on or before the deadline to \\nsubmit data validation results to CMS (June 15, 2024) are excluded and listed as “No \\ndata available.” \\n \\nSNP Care Management Assessment Rates are not provided for contracts that did not \\nscore at least 95% on data validation for the SNP Care Management reporting section \\nor were not compliant with data validation standards/sub-standards for any of the \\nfollowing SNP Care Management data elements. We define a contract as being non-\\ncomplaint if either it receives a \"No\" or a 1, 2, or 3 on the 5-point Likert scale in the \\nspecific data element\\'s data validation. \\n   • Number of new enrollees due for an initial HRA (Element A) \\n   • Number of enrollees eligible for an annual reassessment HRA (Element B) \\n   • Number of initial HRAs performed on new enrollees (Element C)', '(Last Updated 10/03/2024)  \\nPage 38 \\n \\nTitle \\nDescription \\n   • Number of annual reassessments performed on enrollees eligible for reassessment \\n(Element F) \\n \\nContracts excluded from the SNP Care Management Assessment Rates due to data \\nvalidation issues are shown as “CMS identified issues with this plan\\'s data.” \\n \\nContracts can view their data validation results in HPMS (https://hpms.cms.gov/). To \\naccess this page, from the top menu select “Monitoring,” then “Plan Reporting Data \\nValidation.” Select the appropriate contract year. Select the PRDVM Reports. Select \\n“Score Detail Report.” Select the applicable reporting section.  If you cannot see the \\nPlan Reporting Data Validation module, contact CMSHPMS_Access@cms.hhs.gov. \\n \\nAdditionally, contracts must have 30 or more enrollees in the denominator [Number of \\nnew enrollees due for an Initial HRA (Element A) + Number of enrollees eligible for an \\nannual HRA (Element B) ≥ 30] in order to have a calculated rate. Contracts with fewer \\nthan 30 eligible enrollees are listed as \"No data available.” \\nGeneral Notes: More information about the data used to calculate this measure can be found in \\nAttachment E. \\n \\nThe Part C reporting requirement fields listed below are not used in calculating this \\nmeasure: \\n      • Data Element D Number of initial HRA refusals \\n      • Data Element E Number of initial HRAs where SNP is unable to reach new \\nenrollees \\n      • Data Element G Number of annual reassessment refusals \\n      • Data Element H Number of annual reassessments where SNP is unable to reach \\nenrollee \\n \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions', '(Last Updated 10/03/2024)  \\nPage 39 \\n \\nTitle \\nDescription \\nCMIT #: 00685-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nNo \\nYes \\nYes \\nNo \\nNo \\nNo \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 46 % \\n>= 46 % to < 62 % \\n>= 62 % to < 76 % \\n>= 76 % to < 89 % \\n>= 89 % \\n \\nMeasure: C06 - Care for Older Adults – Medication Review \\nTitle \\nDescription \\nLabel for Stars: Yearly Review of All Medications and Supplements Being Taken \\nLabel for Data: Yearly Review of All Medications and Supplements Being Taken \\nDescription: Percent of plan members whose doctor or clinical pharmacist reviewed a list of \\neverything they take (prescription and non-prescription drugs, vitamins, herbal \\nremedies, other supplements) at least once a year.  \\n(Medicare does not collect this information from all plans. Medicare collects it only for \\nSpecial Needs Plans. These plans are a type of Medicare Advantage plan designed for \\ncertain people with Medicare. Some Special Needs Plans are for people with certain \\nchronic diseases and conditions, some are for people who have both Medicare and \\nMedicaid, and some are for people who live in an institution such as a nursing home.) \\nHEDIS Label: Care for Older Adults (COA) – Medication Review \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 115 \\nMetric: The percentage of Medicare Advantage Special Needs Plan enrollees 66 years and \\nolder (denominator) who received at least one medication review (Medication Review \\nValue Set) conducted by a prescribing practitioner or clinical pharmacist during the \\nmeasurement year and the presence of a medication list in the medical record \\n(Medication List Value Set) (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: SNP benefit packages whose enrollment was less than 30 as of February 2023 SNP \\nComprehensive Report were excluded from this measure. \\n \\nExclude members in hospice or using hospice services or who died any time during the \\nmeasurement year. \\nGeneral Notes: The formula used to calculate this measure can be found in Attachment E. \\nData Time Frame: 01/01/2023 – 12/31/2023', '(Last Updated 10/03/2024)  \\nPage 40 \\n \\nTitle \\nDescription \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00110-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nNo \\nYes \\nYes \\nNo \\nNo \\nNo \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 53 % \\n>= 53 % to < 80 % \\n>= 80 % to < 92 % \\n>= 92 % to < 98 % \\n>= 98 % \\n \\nMeasure: C07 - Care for Older Adults – Pain Assessment \\nTitle \\nDescription \\nLabel for Stars: Yearly Pain Screening or Pain Management Plan \\nLabel for Data: Yearly Pain Screening or Pain Management Plan \\nDescription: Percent of plan members who had a pain screening at least once during the year.  \\n(Medicare does not collect this information from all plans. Medicare collects it only for \\nSpecial Needs Plans. These plans are a type of Medicare Advantage plan designed for \\ncertain people with Medicare. Some Special Needs Plans are for people with certain \\nchronic diseases and conditions, some are for people who have both Medicare and \\nMedicaid, and some are for people who live in an institution such as a nursing home.) \\nHEDIS Label: Care for Older Adults (COA) – Pain Screening \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 115', '(Last Updated 10/03/2024)  \\nPage 41 \\n \\nTitle \\nDescription \\nMetric: The percentage of Medicare Advantage Special Needs Plan enrollees 66 years and \\nolder (denominator) who received at least one pain assessment (Pain Assessment \\nValue Set) plan during the measurement year (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: SNP benefit packages whose enrollment was less than 30 as of February 2023 SNP \\nComprehensive Report were excluded from this measure. \\n \\nExclude members in hospice or using hospice services or who died any time during the \\nmeasurement year. \\nGeneral Notes: The formula used to calculate this measure can be found in Attachment E. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00111-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nNo \\nYes \\nYes \\nNo \\nNo \\nNo \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 60 % \\n>= 60 % to < 81 % \\n>= 81 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 %', '(Last Updated 10/03/2024)  \\nPage 42 \\n \\nMeasure: C08 - Osteoporosis Management in Women who had a Fracture \\nTitle \\nDescription \\nLabel for Stars: Osteoporosis Management \\nLabel for Data: Osteoporosis Management \\nDescription: Percent of female plan members who broke a bone and got screening or treatment for \\nosteoporosis within 6 months. \\nHEDIS Label: Osteoporosis Management in Women Who Had a Fracture (OMW) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 232 \\nMetric: The percentage of woman MA enrollees 67 - 85 who suffered a fracture (denominator) \\nand who had either a bone mineral density (BMD) test or prescription for a drug to treat \\nosteoporosis in the six months after the fracture (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: • Members who had a BMD test (Bone Mineral Density Tests Value Set) during the 730 \\ndays (24 months) prior to the IESD.  \\n• Members who had a claim/encounter for osteoporosis therapy (Osteoporosis \\nMedications Value Set) during the 365 days (12 months) prior to the IESD. \\n• Members who received a dispensed prescription or had an active prescription to treat \\nosteoporosis (Osteoporosis Medications List) during the 365 days (12 months) prior to \\nthe IESD.  \\n• Members in hospice or using hospice services any time during the measurement year. \\n• Members who died any time during the measurement year. \\n• Members who received palliative care any time during the intake period through the \\nend of the measurement year. \\n• Members 67 years of age and older as of December 31 of the measurement year who \\nmeet either of the following: \\n– \\nMembers who are enrolled in an Institutional SNP (I-SNP) any time during \\nthe measurement year. \\n– \\nMembers living long-term in an institution any time during the measurement \\nyear. \\n• Members 67-80 years of age as of December 31 of the measurement year with frailty \\nand advanced illness. Members must meet both of the following frailty and advanced \\nillness criteria to be excluded: \\n• At least two indications of frailty with different dates of service during the intake \\nperiod through the end of the measurement year. \\n• Any of the following during the measurement year or the year prior to the \\nmeasurement year: \\n• At least two outpatient visits, observation visits, ED visits, telephone \\nvisits, e-visits or virtual check-ins, nonacute inpatient encounters or \\nnonacute inpatient discharges on different dates of service, with an \\nadvanced illness diagnosis.  \\n• At least one acute inpatient encounter with an advanced illness \\ndiagnosis.  \\n• At least on acute inpatient discharge with an advanced illness diagnosis \\non the discharge claim.', '(Last Updated 10/03/2024)  \\nPage 43 \\n \\nTitle \\nDescription \\n• A dispenses dementia medication. \\n• Members 81 years of age and older as of December 31 of the measurement year with \\nat least two indications of frailty with different dates of service during the intake period \\nthrough the end of the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00484-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 27 % \\n>= 27 % to < 39 % \\n>= 39 % to < 52 % \\n>= 52 % to < 71 % \\n>= 71 %', '(Last Updated 10/03/2024)  \\nPage 44 \\n \\nMeasure: C09 - Diabetes Care – Eye Exam \\nTitle \\nDescription \\nLabel for Stars: Eye Exam to Check for Damage from Diabetes \\nLabel for Data: Eye Exam to Check for Damage from Diabetes \\nDescription: Percent of plan members with diabetes who had an eye exam to check for damage from \\ndiabetes during the year. \\nHEDIS Label: Eye Exam for Patients with Diabetes (EED) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 203 \\nMetric: The percentage of diabetic MA enrollees age 18-75 with diabetes (type 1 and type 2) \\n(denominator) who had an eye exam (retinal) performed during the measurement year \\n(numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: • Medicare members 66 years of age and older as of December 31 of the measurement \\nyear who meet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File.  \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nboth frailty and advanced illness during the measurement year. Members must meet \\nboth the following frailty and advanced illness criteria to be excluded: \\n \\nAt least two indications of frailty with different dates of service during the \\nmeasurement year.  \\n \\nAny of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years): \\no At least two outpatient visits, observation visits, ED visits, telephone \\nvisits, e-visits or virtual check-ins, nonacute inpatient encounters, \\nnonacute inpatient discharges on different dates of service, with an \\nadvanced illness diagnosis.  \\no At least one acute inpatient encounter with an advanced illness \\ndiagnosis.  \\no At least one acute inpatient discharge with an advanced illness diagnosis \\non the discharge claim.  \\no A dispensed dementia medication.  \\n \\n• (Required) Exclude members who meet any of the following criteria: \\n– Members who did not have a diagnosis of diabetes, in any setting, during the \\nmeasurement year or the year prior to the measurement year and who had a diagnosis \\nof polycystic ovarian syndrome, gestational diabetes or steroid-induced diabetes, in any \\nsetting, during the measurement year or the year prior to the measurement year. \\n– Members in hospice or using hospice services any time during the measurement year.', '(Last Updated 10/03/2024)  \\nPage 45 \\n \\nTitle \\nDescription \\n– Members who died any time during the measurement year.  \\n– Members receiving palliative care any time during the measurement year.  \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00203-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 57 % \\n>= 57 % to < 70 % \\n>= 70 % to < 77 % \\n>= 77 % to < 83 % \\n>= 83 %', '(Last Updated 10/03/2024)  \\nPage 46 \\n \\nMeasure: C10 - Diabetes Care – Blood Sugar Controlled \\nTitle \\nDescription \\nLabel for Stars: Plan Members with Diabetes whose Blood Sugar is Under Control \\nLabel for Data: Plan Members with Diabetes whose Blood Sugar is Under Control \\nDescription: Percent of plan members with diabetes who had an A1c lab test during the year that \\nshowed their average blood sugar is under control. \\nHEDIS Label: Hemoglobin A1c Control for Patients with Diabetes (HBD) – HbA1c poor control (>9.0%) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 184 \\nMetric: The percentage of diabetic MA enrollees age 18-75 (denominator) whose most recent \\nHbA1c level is greater than 9%, or who were not tested during the measurement year \\n(numerator). (This measure for public reporting is reverse scored so higher scores are \\nbetter.) To calculate this measure, subtract the submitted rate from 100. \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: • Medicare members 66 years of age and older as of December 31 of the measurement \\nyear who meet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File.  \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nboth frailty and advanced illness during the measurement year. Members must meet \\nboth the following frailty and advanced illness criteria to be excluded: \\n \\n \\nAt least two indications of frailty with different dates of service during the \\nmeasurement year.  \\n \\nAny of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years): \\no At least two outpatient visits, observation visits, ED visits, telephone \\nvisits, e-visits or virtual check-ins, nonacute inpatient encounters, or \\nnonacute inpatient discharges on different dates of service, with an \\nadvanced illness diagnosis.  \\no At least one acute inpatient encounter with an advanced illness \\ndiagnosis.  \\no At least one acute inpatient discharge with an advanced illness diagnosis \\non the discharge claim.  \\no A dispensed dementia medication.  \\n \\n• (Required) Exclude members who meet any of the following criteria: \\n– Members who did not have a diagnosis of diabetes, in any setting, during the \\nmeasurement year or the year prior to the measurement year and who had a diagnosis \\nof polycystic ovarian syndrome, gestational diabetes or steroid-induced diabetes, in any \\nsetting, during the measurement year or the year prior to the measurement year.', '(Last Updated 10/03/2024)  \\nPage 47 \\n \\nTitle \\nDescription \\n \\n– Members in hospice or using hospice services any time during the measurement year.  \\n– Members who died any time during the measurement year.  \\n– Members receiving palliative care any time during the measurement year.  \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00204-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 49 % \\n>= 49 % to < 72 % \\n>= 72 % to < 84 % \\n>= 84 % to < 90 % \\n>= 90 %', '(Last Updated 10/03/2024)  \\nPage 48 \\n \\nMeasure: C11 - Controlling Blood Pressure \\nTitle \\nDescription \\nLabel for Stars: Controlling Blood Pressure \\nLabel for Data: Controlling Blood Pressure \\nDescription: Percent of plan members with high blood pressure who got treatment and were able to \\nmaintain a healthy pressure. \\nHEDIS Label: Controlling High Blood Pressure (CBP) \\nMeasure Reference: NCQA HEDIS MY 2023 Technical Specifications Volume 2, page 152 \\nMetric: The percentage of MA members 18–85 years of age who had a diagnosis of \\nhypertension (HTN) (denominator) and whose blood pressure (BP) was adequately \\ncontrolled (<140/90 mm Hg) (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Exclude members who meet any of the following criteria: \\n• Members 66 years of age and older as of December 31 of the measurement year who \\nmeet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \\nto determine if a member had an LTI flag during the measurement year. \\n• Members 81 years of age and older as of December 31 of the measurement year with \\nat least two indications of frailty with different dates of service during the measurement \\nyear. \\n• Members 66–80 years of age and older as of December 31 of the measurement year \\nwith frailty and advanced illness. Members must meet both of the following frailty and \\nadvanced illness criteria to be excluded: \\n• \\nAt least two indications of frailty with different dates of service during the \\nmeasurement year.  \\n• \\nAny of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years): \\n• \\nAt least two outpatient visits, observation visits, ED visits, \\ntelephone visits, e-visits or virtual check-ins, nonacute inpatient \\nencounters, or nonacute inpatient discharges on different dates \\nof service, with an advanced illness diagnosis.  \\n• \\nAt least one acute inpatient encounter with an advanced illness \\ndiagnosis. \\n• \\nAt least one acute inpatient discharge with an advanced illness \\ndiagnosis on the discharge claim.  \\n• \\nA dispensed dementia medication. \\n  \\n• (Required) Exclude members who meet any of the following criteria: \\n \\n– • Members with evidence of end-stage renal', '(Last Updated 10/03/2024)  \\nPage 49 \\n \\nTitle \\nDescription \\ndisease (ESRD), dialysis, nephrectomy, or kidney transplant any time during the \\nmember’s history on or prior to December 31 of the measurement year.   \\n– • Members receiving palliative care during the measurement year. \\n– • Members with a diagnosis of pregnancy \\n  during the measurement year. \\n– • Members in hospice or using hospice services any time during the \\nmeasurement year. \\n– • Members who died any time during the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcomes Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00167-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 69 % \\n>= 69 % to < 74 % \\n>= 74 % to < 80 % \\n>= 80 % to < 85 % \\n>= 85 %', '(Last Updated 10/03/2024)  \\nPage 50 \\n \\nMeasure: C12 - Reducing the Risk of Falling \\nTitle \\nDescription \\nLabel for Stars: Reducing the Risk of Falling \\nLabel for Data: Reducing the Risk of Falling \\nDescription: Percent of plan members with a problem falling, walking, or balancing who discussed it \\nwith their doctor and received a recommendation for how to prevent falls during the \\nyear. \\nHEDIS Label: Fall Risk Management (FRM) \\nMeasure Reference: NCQA HEDIS Measurement Year 2022 Specifications for the Medicare Health \\nOutcomes Survey Volume 6, page 38 \\nMetric: The percentage of Medicare members 65 years of age and older who had a fall or had \\nproblems with balance or walking in the past 12 months, who were seen by a \\npractitioner in the past 12 months (denominator) and who received a recommendation \\nfor how to prevent falls or treat problems with balance or walking from their current \\npractitioner (numerator). \\nPrimary Data Source: HEDIS-HOS \\nData Source Description: Cohort 24 Follow-up Data collection (2023) and Cohort 26 Baseline data collection \\n(2023). \\n \\nHOS Survey Question 44: A fall is when your body goes to the ground without being \\npushed. In the past 12 months, did you talk with your doctor or other health provider \\nabout falling or problems with balance or walking? \\n \\nHOS Survey Question 45: Did you fall in the past 12 months? \\n \\nHOS Survey Question 46: In the past 12 months have you had a problem with balance \\nor walking? \\n \\nHOS Survey Question 47: Has your doctor or other health provider done anything to \\nhelp prevent falls or treat problems with balance or walking? Some things they might do \\ninclude:  \\n   • Suggest that you use a cane or walker. \\n   • Suggest that you do an exercise or physical therapy program. \\n   • Suggest a vision or hearing test. \\nData Source Category: Survey of Enrollees \\nExclusions: Members who responded \"I had no visits in the past 12 months\" to Question 44 or \\nQuestion 47 are excluded from results calculations. Contracts must achieve a \\ndenominator of at least 100 to obtain a reportable result. If the denominator is less than \\n100, the measure result will be \"Not enough data available.\"  Members with evidence \\nfrom CMS administrative records of a hospice start date are excluded. \\nData Time Frame: 07/17/2023 – 11/01/2023 \\nGeneral Trend: Higher is better', '(Last Updated 10/03/2024)  \\nPage 51 \\n \\nTitle \\nDescription \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2022 disasters. \\nMeaningful Measure Area: Safety \\nCMIT #: 00646-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 50 % \\n>= 50 % to < 56 % \\n>= 56 % to < 63 % \\n>= 63 % to < 73 % \\n>= 73 % \\n \\nMeasure: C13 - Improving Bladder Control \\nTitle \\nDescription \\nLabel for Stars: Improving Bladder Control \\nLabel for Data: Improving Bladder Control \\nDescription: Percent of plan members with a urine leakage problem in the past 6 months who \\ndiscussed treatment options with a provider. \\nHEDIS Label: Management of Urinary Incontinence in Older Adults (MUI) \\nMeasure Reference: NCQA HEDIS Measurement Year 2022 Specifications for the Medicare Health \\nOutcomes Survey Volume 6, page 33 \\nMetric: The percentage of Medicare members 65 years of age or older who reported having any \\nurine leakage in the past six months (denominator) and who discussed treatment \\noptions for their urinary incontinence with a provider (numerator). \\nPrimary Data Source: HEDIS-HOS \\nData Source Description: Cohort 24 Follow-up Data collection (2023) and Cohort 26 Baseline data collection \\n(2023).', '(Last Updated 10/03/2024)  \\nPage 52 \\n \\nTitle \\nDescription \\n \\nHOS Survey Question 38: Many people experience leaking of urine, also called urinary \\nincontinence. In the past six months, have you experienced leaking of urine? \\n \\nHOS Survey Question 41: There are many ways to control or manage the leaking of \\nurine, including bladder training exercises, medication and surgery. Have you ever \\ntalked with a doctor, nurse, or other health care provider about any of these \\napproaches?  \\n \\nMember choices must be as follows to be included in the denominator: \\n  • Q38 = \"Yes.\" \\n  • Q41 = \"Yes\" or \"No.\" \\n \\nThe numerator contains the number of members in the denominator who indicated they \\ndiscussed treatment options for their urinary incontinence with a health care provider. \\n \\nMember choice must be as follows to be included in the numerator: \\n  • Q41 = \"Yes.\" \\nData Source Category: Survey of Enrollees \\nExclusions: Contracts must achieve a denominator of at least 100 to obtain a reportable result. If the \\ndenominator is less than 100, the measure result will be \"Not enough data available.\" \\nMembers with evidence from CMS administrative records of a hospice start date are \\nexcluded. \\nData Time Frame: 07/17/2023 – 11/01/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2022 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00378-01-C-PARTC \\nData Display: Percentage with no decimal place', '(Last Updated 10/03/2024)  \\nPage 53 \\n \\nTitle \\nDescription \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 39 % \\n>= 39 % to < 44 % \\n>= 44 % to < 48 % \\n>= 48 % to < 52 % \\n>= 52 % \\n \\n \\nMeasure: C14 - Medication Reconciliation Post-Discharge \\nTitle \\nDescription \\nLabel for Stars: The Plan Makes Sure Member Medication Records Are Up-to-Date After Hospital \\nDischarge \\nLabel for Data: The Plan Makes Sure Member Medication Records Are Up-to-Date After Hospital \\nDischarge \\nDescription: This shows the percent of plan members whose medication records were updated \\nwithin 30 days after leaving the hospital. To update the record, a doctor or other health \\ncare professional looks at the new medications prescribed in the hospital and compares \\nthem with the other medications the patient takes. Updating medication records can \\nhelp to prevent errors that can occur when medications are changed. \\nHEDIS Label: Medication Reconciliation Post-Discharge (MRP) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 330 \\nMetric: The percentage of discharges from January 1–December 1 of the measurement year for \\nmembers 18 years of age and older for whom medications were reconciled the date of \\ndischarge through 30 days after discharge (31 total days). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Members in hospice or using hospice services any time during the measurement year. \\n \\nMembers who died any time during the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included', '(Last Updated 10/03/2024)  \\nPage 54 \\n \\nTitle \\nDescription \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00441-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 42 % \\n>= 42 % to < 57 % \\n>= 57 % to < 73 % \\n>= 73 % to < 87 % \\n>= 87 % \\n \\n \\nMeasure: C15 - Plan All-Cause Readmissions \\nTitle \\nDescription \\nLabel for Stars: Readmission to a Hospital within 30 Days of Being Discharged (more stars are better \\nbecause it means fewer members are being readmitted) \\nLabel for Data: Readmission to a Hospital within 30 Days of Being Discharged (lower percentages are \\nbetter because it means fewer members are being readmitted) \\nDescription: Percent of plan members aged 18 and older discharged from a hospital stay who were \\nreadmitted to a hospital within 30 days, either for the same condition as their recent \\nhospital stay or for a different reason.  \\n(Patients may have been readmitted back to the same hospital or to a different one. \\nRates of readmission take into account how sick patients were when they went into the \\nhospital the first time. This “risk-adjustment” helps make the comparisons between \\nplans fair and meaningful.)  \\nHEDIS Label: Plan All-Cause Readmissions (PCR) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 498 \\nMetric: The percentage of acute inpatient stays during the measurement year that were \\nfollowed by an unplanned acute readmission for any diagnosis within 30 days, for \\nmembers 18 years of age and older using the following formula to control for differences \\nin the case mix of patients across different contracts. \\n \\nFor contract A, their case-mix adjusted readmission rate relative to the national average', '(Last Updated 10/03/2024)  \\nPage 55 \\n \\nTitle \\nDescription \\nis the observed readmission rate for contract A divided by the expected readmission \\nrate for contract A. This ratio is then multiplied by the national average observed rate. \\n \\nSee Attachment F: Calculating Measure C15: Plan All-Cause Readmissions (18+) for \\nthe complete formula, example calculation and National Average Observation value \\nused to complete this measure. \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Exclude hospital stays for the following reasons: \\n• The member died during the stay. \\n• Members with a principal diagnosis of pregnancy on the discharge claim.  \\n• A principal diagnosis of a condition originating in the perinatal period on the discharge \\nclaim. \\n \\n(Required) Exclude members in hospice or using hospice services any time during the \\nmeasurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\n \\nAs listed in the HEDIS Technical Specifications. CMS has excluded contracts whose \\ndenominator was less than 150. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Admissions and Readmissions to Hospitals', '(Last Updated 10/03/2024)  \\nPage 56 \\n \\nTitle \\nDescription \\nCMIT #: 00561-02-C-PARTC \\n \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n> 14 % \\n> 12 % to <= 14 % \\n> 10 % to <= 12 % \\n> 8 % to <= 10 % \\n<= 8 % \\n \\nMeasure: C16 - Statin Therapy for Patients with Cardiovascular Disease \\nTitle \\nDescription \\nLabel for Stars: The Plan Makes Sure Members with Heart Disease Get the Most Effective Drugs to \\nTreat High Cholesterol \\nLabel for Data: The Plan Makes Sure Members with Heart Disease Get the Most Effective Drugs to \\nTreat High Cholesterol \\nDescription: This rating is based on the percent of plan members with heart disease who get the \\nright type of cholesterol-lowering drugs. Health plans can help make sure their members \\nare prescribed medications that are more effective for them. \\nHEDIS Label: Statin Therapy for Patients with Cardiovascular Disease (SPC) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 168 \\nMetric: The percentage of males 21–75 years of age and females 40–75 years of age during \\nthe measurement year, who were identified as having clinical atherosclerotic \\ncardiovascular disease (ASCVD) (denominator) and were dispensed at least one high \\nor moderate-intensity statin medication during the measurement year (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Exclude members who meet any of the following criteria: \\n• Pregnancy during the measurement year or year prior to the measurement year. \\n• In vitro fertilization in the measurement year or year prior to the measurement year. \\n• Dispensed at least one prescription for clomiphene (Table SPC-A) during the \\nmeasurement year or the year prior to the measurement year.  \\n• ESRD or dialysis during the measurement year or the year prior to the measurement \\nyear. \\n• Cirrhosis during the measurement year or the year prior to the measurement year. \\n• Myalgia, myositis, myopathy, or rhabdomyolysis during the measurement year. \\n• Members in hospice or using hospice services any time during the measurement year. \\n• Members who died any time during the measurement year.  \\n• Members receiving palliative care any time during the measurement year. \\n• Members 66 years of age and older as of December 31 of the measurement year who \\nmeet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year.', '(Last Updated 10/03/2024)  \\nPage 57 \\n \\nTitle \\nDescription \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \\nto determine if a member had an LTI flag during the measurement year. \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nfrailty and advanced illness during the measurement year. Members must meet both of \\nthe following frailty and advanced illness criteria to be excluded:  \\n– At least two indications of frailty with different dates of service during the \\nmeasurement year.  \\n– Any of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years):  \\n1. At least two outpatient visits, observation visits, ED visits, telephone \\nvisits, e-visits, virtual check-ins, nonacute inpatient encounters, or \\nnonacute inpatient discharges on different dates of service, with an \\nadvanced illness diagnosis. Visit type need not be the same for the \\ntwo visits.  \\n2. At least one acute inpatient encounter with an advanced illness \\ndiagnosis.  \\n3. At least one acute inpatient discharge with an advanced illness \\ndiagnosis on the discharge claim. \\n4. A dispensed dementia medication. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00700-01-C-PARTC', '(Last Updated 10/03/2024)  \\nPage 58 \\n \\nTitle \\nDescription \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 81 % \\n>= 81 % to < 85 % \\n>= 85 % to < 88 % \\n>= 88 % to < 92 % \\n>= 92 % \\n \\nMeasure: C17 - Transitions of Care \\nTitle \\nDescription \\nLabel for Stars: After hospital stay, members receive information and care they need  \\nLabel for Data: After hospital stay, members receive information and care they need  \\nDescription: This rating is based on the percent of plan members who got follow-up care after a \\nhospital stay. Follow-up care includes: getting information about their health problem \\nand what to do next, having a visit or call with a doctor, and having a doctor or \\npharmacist make sure the plan member’s medication records are up to date. \\nHEDIS Label: Transitions of Care (TRC) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 330 \\nMetric: The average of the rates for Transitions of Care - Medication Reconciliation Post-\\nDischarge, Transitions of Care - Notification of Inpatient Admission, Transitions of Care \\n- Patient Engagement After Inpatient Discharge, and Transitions of Care - Receipt of \\nDischarge Information. \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: If the discharge is followed by a readmission or direct transfer to an acute or nonacute \\ninpatient care setting on the date of discharge through 30 days after discharge (31 days \\ntotal), use the admit date from the first admission and the discharge date from the last \\ndischarge. To identify readmissions and direct transfers during the 31-day period: \\n1. Identify all acute and nonacute inpatient stays (Inpatient Stay Value Set). \\n2. Identify the admission date for the stay (the admission date must occur during the 31-\\nday period). \\n3. Identify the discharge date for the stay (the discharge date is the event date). \\n \\nIf the admission dates and the discharge date for an acute inpatient stay occur between \\nthe admission and discharge dates for a nonacute inpatient stay, include only the \\nnonacute inpatient discharge.  \\n \\nRequired exclusions: \\n• \\nMembers in hospice or using hospice services any time during the measurement \\nyear. \\n• \\nMembers who died any time during the measurement year.', '(Last Updated 10/03/2024)  \\nPage 59 \\n \\nTitle \\nDescription \\n \\nExclude both the initial and the readmission/direct transfer discharge if the last \\ndischarge occurs after December 1 of the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\n \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00729-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 44 % \\n>= 44 % to < 52 % \\n>= 52 % to < 63 % \\n>= 63 % to < 77 % \\n>= 77 %', '(Last Updated 10/03/2024)  \\nPage 60 \\n \\nMeasure: C18 - Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic \\nConditions \\nTitle \\nDescription \\nLabel for Stars: Members with 2 or more chronic conditions receive follow-up care within 7 days after an \\nemergency department visit  \\n \\nLabel for Data: Members with 2 or more chronic conditions receive follow-up care within 7 days after an \\nemergency department visit  \\nDescription: This rating is based on the percent of plan members with 2 or more chronic conditions \\nwho got follow-up care within 7 days after they had an emergency department (ED) visit. \\nDepending on the person’s needs this might be a visit with a health care provider, an \\nappointment with a case manager, or a home visit. \\nHEDIS Label: Follow-up After Emergency Department Visit for People with Multiple High-Risk Chronic \\nConditions (FMC) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 340 \\nMetric: The percentage of emergency department (ED) visits for members 18 years and older \\nwho have multiple high-risk chronic conditions who had a follow-up service within 7 days \\nof the ED visit. \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Exclude ED visits that result in an inpatient stay. Exclude ED visits followed by \\nadmission to an acute or nonacute inpatient care setting on the date of the ED visit or \\nwithin 7 days after the ED visit, regardless of the principal diagnosis for admission. To \\nidentify admissions to an acute or nonacute inpatient care setting: \\n1. Identify all acute and nonacute inpatient stays. \\n2. Identify the admission date for the stay. \\n \\nThese events are excluded from the measure because admission to an acute or \\nnonacute setting may prevent an outpatient follow-up visit from taking place \\n \\nRequired exclusions: \\n• \\nMembers in hospice or using hospice services any time during the measurement \\nyear. \\n• \\nMembers who died any time during the measurement year.  \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering', '(Last Updated 10/03/2024)  \\nPage 61 \\n \\nTitle \\nDescription \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00263-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 39 % \\n>= 39 % to < 53 % \\n>= 53 % to < 60 % \\n>= 60 % to < 69 % \\n>= 69 %', \"(Last Updated 10/03/2024)  \\nPage 62 \\n \\nDomain: 3 - Member Experience with Health Plan \\nMeasure: C19 - Getting Needed Care \\nTitle \\nDescription \\nLabel for Stars: Ease of Getting Needed Care and Seeing Specialists \\nLabel for Data: Ease of Getting Needed Care and Seeing Specialists (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned on how easy it is for members to get \\nneeded care, including care from specialists. \\nMetric: This case-mix adjusted composite measure is used to assess how easy it was for a \\nmember to get needed care and see specialists. The Consumer Assessment of \\nHealthcare Providers and Systems (CAHPS) score uses the mean of the distribution of \\nresponses converted to a scale from 0 to 100. The score shown is the percentage of the \\nbest possible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type): \\n \\n• In the last 6 months, how often did you get an appointment to see a specialist as soon \\n  as you needed? \\n \\n• In the last 6 months, how often was it easy to get the care, tests or treatment you  \\n  needed? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters.\", \"(Last Updated 10/03/2024)  \\nPage 63 \\n \\nTitle \\nDescription \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00293-02-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 77 \\n>= 77 to < 79 \\n>= 79 to < 82 \\n>= 82 to < 83 \\n>= 83 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C20 - Getting Appointments and Care Quickly \\nTitle \\nDescription \\nLabel for Stars: Getting Appointments & Care Quickly \\nLabel for Data: Getting Appointments & Care Quickly (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned on how quickly members get \\nappointments and care. \\nMetric: This case-mix adjusted composite measure is used to assess how quickly the member \\nwas able to get appointments and care. The Consumer Assessment of Healthcare \\nProviders and Systems (CAHPS) score uses the mean of the distribution of responses \\nconverted to a scale from 0 to 100. The score shown is the percentage of the best \\npossible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type): \\n \\n• In the last 6 months, when you needed care right away, how often did you get care as \\n  soon as you needed? \\n \\n• In the last 6 months, how often did you get an appointment for a check-up or routine  \\n  care as soon as you needed? \\n \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better\", '(Last Updated 10/03/2024)  \\nPage 64 \\n \\nTitle \\nDescription \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00292-01-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 80 \\n>= 80 to < 82 \\n>= 82 to < 84 \\n>= 84 to < 86 \\n>= 86 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C21 - Customer Service \\nTitle \\nDescription \\nLabel for Stars: Health Plan Provides Information or Help When Members Need It \\nLabel for Data: Health Plan Provides Information or Help When Members Need It (on a scale from 0 to \\n100) \\nDescription: Percent of the best possible score the plan earned on how easy it is for members to get \\ninformation and help from the plan when needed. \\nMetric: This case-mix adjusted composite measure is used to assess how easy it was for the \\nmember to get information and help when needed. The Consumer Assessment of \\nHealthcare Providers and Systems (CAHPS) score uses the mean of the distribution of \\nresponses converted to a scale from 0 to 100. The score shown is the percentage of the \\nbest possible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type): \\n \\n• In the last 6 months, how often did your health plan’s customer service give you the', \"(Last Updated 10/03/2024)  \\nPage 65 \\n \\nTitle \\nDescription \\n  information or help you needed? \\n \\n• In the last 6 months, how often did your health plan’s customer service treat you with \\n  courtesy and respect? \\n \\n• In the last 6 months, how often were the forms from your health plan easy to fill out? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00181-01-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 88 \\n>= 88 to < 89 \\n>= 89 to < 91 \\n>= 91 to < 92 \\n>= 92 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules.\", \"(Last Updated 10/03/2024)  \\nPage 66 \\n \\nMeasure: C22 - Rating of Health Care Quality \\nTitle \\nDescription \\nLabel for Stars: Members' Rating of Health Care Quality \\nLabel for Data: Members' Rating of Health Care Quality (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned from members who rated the quality \\nof the health care they received. \\nMetric: This case-mix adjusted measure is used to assess members' view of the quality of care \\nreceived from the health plan. The Consumer Assessment of Healthcare Providers and \\nSystems (CAHPS) score uses the mean of the distribution of responses converted to a \\nscale from 0 to 100. The score shown is the percentage of the best possible score each \\ncontract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Question (question numbers vary depending on survey type): \\n \\n• Using any number from 0 to 10, where 0 is the worst health care possible and 10 is \\n  the best health care possible, what number would you use to rate all your health care \\n  in the last 6 months? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00642-01-C-PARTC\", \"(Last Updated 10/03/2024)  \\nPage 67 \\n \\nTitle \\nDescription \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 84 \\n>= 84 to < 85 \\n>= 85 to < 87 \\n>= 87 to < 88 \\n>= 88 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C23 - Rating of Health Plan \\nTitle \\nDescription \\nLabel for Stars: Members' Rating of Health Plan \\nLabel for Data: Members’ Rating of Health Plan (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned from members who rated the health \\nplan. \\nMetric: This case-mix adjusted measure is used to assess members' overall view of their health \\nplan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score \\nuses the mean of the distribution of responses converted to a scale from 0 to 100. The \\nscore shown is the percentage of the best possible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Question (question numbers vary depending on survey type): \\n \\n• Using any number from 0 to 10, where 0 is the worst health plan possible and 10 is \\n  the best health plan possible, what number would you use to rate your health plan? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes\", \"(Last Updated 10/03/2024)  \\nPage 68 \\n \\nTitle \\nDescription \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\n Person-Centered Care \\nCMIT #: 00643-02-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 84 \\n>= 84 to < 86 \\n>= 86 to < 88 \\n>= 88 to < 89 \\n>= 89 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C24 - Care Coordination \\nTitle \\nDescription \\nLabel for Stars: Coordination of Members' Health Care Services \\nLabel for Data: Coordination of Members' Health Care Services (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned on how well the plan coordinates \\nmembers’ care. (This includes whether doctors had the records and information they \\nneeded about members’ care and how quickly members got their test results.) \\nMetric: This case-mix adjusted composite measure is used to assess Care Coordination. The \\nConsumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the \\nmean of the distribution of responses converted to a scale of 0 to 100. The score shown \\nis the percentage of the best possible score each contract earned.  \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type):  \\n \\n• In the last 6 months, when you talked with your personal doctor during a scheduled \\n  appointment, how often did he or she have your medical records or other information \\n  about your care? \\n• In the last 6 months, when your personal doctor ordered a blood test, x-ray or other \\n  test for you, how often did someone from your personal doctor’s office follow up to \\n  give you those results? \\n• In the last 6 months, when your personal doctor ordered a blood test, x-ray or other \\n  test for you, how often did you get those results as soon as you needed them? \\n• In the last 6 months, how often did you and your personal doctor talk about all the \\n  prescription medicines you were taking?\", \"(Last Updated 10/03/2024)  \\nPage 69 \\n \\nTitle \\nDescription \\n• In the last 6 months, did you get the help you needed from your personal doctor’s \\n  office to manage your care among these different providers and services? \\n• In the last 6 months, how often did your personal doctor seem informed and up-to- \\n  date about the care you got from specialists? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00106-02-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 84 \\n>= 84 to < 85 \\n>= 85 to < 87 \\n>= 87 to < 88 \\n>= 88 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules.\", \"(Last Updated 10/03/2024)  \\nPage 70 \\n \\nDomain: 4 - Member Complaints and Changes in the Health Plan's Performance \\nMeasure: C25 - Complaints about the Health Plan \\nTitle \\nDescription \\nLabel for Stars: Complaints about the Health Plan (more stars are better because it means fewer \\ncomplaints) \\nLabel for Data: Complaints about the Health Plan (lower numbers are better because it means fewer \\ncomplaints) \\nDescription: Rate of complaints filed with Medicare about the health plan. \\nMetric: Rate of complaints about the health plan per 1,000 members. For each contract, this \\nrate is calculated as:  \\n[ (Total number of all complaints logged into the Complaints Tracking Module (CTM))  \\n/ (Average Contract enrollment) ] * 1,000 * 30 / (Number of Days in Period). \\n \\nNumber of Days in Period = 366 for leap years, 365 for all other years. \\n \\n• Complaints data are pulled after the end of the measurement timeframe to serve as a  \\n  snapshot of CTM data. \\n• Enrollment numbers used to calculate the complaint rate were based on the average \\n  enrollment for the time period measured for each contract. \\n• A contract’s failure to follow CMS’s CTM Standard Operating Procedures will not result \\nin CMS’s adjustment of the data used for these measures. \\nPrimary Data Source: Complaints Tracking Module (CTM) \\nData Source Description: Data were obtained from the CTM in the Health Plan Management System (HPMS) \\nbased on the contract entry date (the date that complaints are assigned or re-assigned \\nto contracts; also known as the contract assignment/reassignment date) for the \\nreporting period specified. The status of any specific complaint at the time the data are \\npulled stands for use in the reports. Any changes to the complaints data subsequent to \\nthe data pull cannot be excluded retroactively. CMS allows for an approximate 6-month \\n“wash out” period to account for any adjustments per CMS’s CTM Standard Operating \\nProcedures. Therefore, all Plan Requests for 2023 complaints made by the June 28, \\n2024 deadline are captured. Complaint rates per 1,000 enrollees are adjusted to a 30-\\nday basis. Monthly enrollment files from HPMS were used to calculate the average \\nenrollment for the contract for the measurement period.   \\nData Source Category: CMS Administrative Data \\nExclusions: On May 10, 2019, CMS released an HPMS memo on the Complaints Tracking Module \\n(CTM) Updated Standard Operating Procedures (SOP). Plans should review all \\ncomplaints at intake and verify the contract assignment and issue level. The APPENDIX \\nA - Category and Subcategory Listing in the SOP lists the subcategories that are \\nexcluded. \\n \\nComplaint rates are not calculated for contracts with average enrollment of less than \\n800 enrollees during the measurement period. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better\", '(Last Updated 10/03/2024)  \\nPage 71 \\n \\nTitle \\nDescription \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00142-02-C-PARTC \\nData Display: Numeric with 2 decimal places \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n> 1.39 \\n> 0.76 to <= 1.39 \\n> 0.37 to <= 0.76 \\n> 0.12 to <= 0.37 \\n<= 0.12 \\n \\nMeasure: C26 - Members Choosing to Leave the Plan \\nTitle \\nDescription \\nLabel for Stars: Members Choosing to Leave the Plan (more stars are better because it means fewer \\nmembers choose to leave the plan) \\nLabel for Data: Members Choosing to Leave the Plan (lower percentages are better because that \\nindicates fewer members choose to leave the plan) \\nDescription: Percent of plan members who chose to leave the plan. \\nMetric: The percent of members who chose to leave the contract comes from disenrollment \\nreason codes in Medicare’s enrollment system. The percent is calculated as the number \\nof members who chose to leave the contract between January 1, 2023–December 31, \\n2023 (numerator) divided by all members enrolled in the contract at any time during \\n2023 (denominator). \\nPrimary Data Source: MBDSS \\nData Source Description: Medicare Beneficiary Database Suite of Systems (MBDSS) \\nData Source Category: CMS Administrative Data', '(Last Updated 10/03/2024)  \\nPage 72 \\n \\nTitle \\nDescription \\nExclusions: Members who involuntarily left their contract due to circumstances beyond their control \\nare removed from the final numerator, specifically: \\n    • Members affected by a contract service area reduction \\n    • Members affected by PBP termination \\n    • Members in PBPs that were granted special enrollment exceptions \\n    • Members affected by PBP service area reductions where there are no PBPs left  \\n      within the contract that the enrollee is eligible to enroll into \\n    • Members affected by LIS reassignments \\n    • Members who are enrolled in employer group plans \\n    • Members who were passively enrolled into a Demonstration (MMP) \\n    • Contracts with less than 1,000 enrollees \\n    • 1876 Cost contract disenrollments into the transition MA contract (H contract) \\n    • Members who moved out of the service area of the contract from which they \\n      disenrolled (based on the member’s address as submitted by the plan into which \\n      the member enrolled or the member’s current SSA address if there is no address \\n      submitted by the plan into which the member enrolled) or where the service area \\n      of the contract they enrolled into does not intersect with the service area of the \\n      contract from which they disenrolled. \\n \\nGeneral Notes: This measure includes members with a disenrollment effective date between 1/1/2023 \\nand 12/31/2023 who disenrolled from the contract with any one of the following \\ndisenrollment reason codes: \\n    11 - Voluntary Disenrollment through plan \\n    13 - Disenrollment because of enrollment in another Plan  \\n    14 - Retroactive \\n    99 - Other (not supplied by beneficiary). \\n \\nIf all potential members in the numerator meet one or more of the exclusion criteria, the \\nmeasure result will be “Not enough data available”. \\n \\nThe Disenrollment Reasons Survey (DRS) data available in the HPMS plan preview and \\nin the CMS downloadable Master Table, are not used in the calculation of this measure. \\nThe DRS data are presented in each of the systems for information purposes only. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4', '(Last Updated 10/03/2024)  \\nPage 73 \\n \\nTitle \\nDescription \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00446-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n> 36 % \\n> 24 % to <= 36 % \\n> 17 % to <= 24 % \\n> 8 % to <= 17 % \\n<= 8 % \\n \\nMeasure: C27 - Health Plan Quality Improvement \\nTitle \\nDescription \\nLabel for Stars: Improvement (if any) in the Health Plan’s Performance \\nLabel for Data: Improvement (if any) in the Health Plan’s Performance \\nDescription: This shows how much the health plan’s performance improved or declined from one \\nyear to the next. \\nIf a plan receives 1 or 2 stars, it means, on average, the plan’s scores declined (got \\nworse). \\nIf a plan receives 3 stars, it means, on average, the plan’s scores stayed about the \\nsame. \\nIf a plan receives 4 or 5 stars, it means, on average, the plan’s scores improved. \\n  \\nKeep in mind that a plan that is already doing well in most areas may not show much \\nimprovement. It is also possible that a plan can start with low ratings, show a lot of \\nimprovement, and still not be performing very well. \\nMetric: The numerator is the net improvement, which is a weighted sum of the number of \\nsignificantly improved measures minus the number of significantly declined measures. \\nThe denominator is the sum of the weights associated with the measures eligible for the \\nimprovement measure (i.e., the measures that were included in the 2024 and 2025 Star \\nRatings for this contract and had no specification changes). \\nPrimary Data Source: Star Ratings \\nData Source Description: 2024 and 2025 Star Ratings \\nData Source Category: Star Ratings \\nExclusions: Contracts must have data in at least half of the measures used to calculate \\nimprovement to be rated in this measure. \\nGeneral Notes: Attachment H contains the formulas used to calculate the improvement measure and \\nlists indicating which measures were used.', '(Last Updated 10/03/2024)  \\nPage 74 \\n \\nTitle \\nDescription \\nData Time Frame: Not Applicable \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Not Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Improvement Measure \\nWeighting Value: 5 \\nMajor Disaster: Includes only measures which have data from both years. \\nMeaningful Measure Area: Person-centered Care \\nCMIT #: 00300-01-C-PARTC \\nData Display: Not Applicable \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< -0.179809 \\n>= -0.179809 to < 0 \\n>= 0 to < 0.174445 \\n>= 0.174445 to < 0.421057 \\n>= 0.421057', '(Last Updated 10/03/2024)  \\nPage 75 \\n \\nDomain: 5 - Health Plan Customer Service \\nMeasure: C28 - Plan Makes Timely Decisions about Appeals \\nTitle \\nDescription \\nLabel for Stars: Health Plan Makes Timely Decisions about Appeals \\nLabel for Data: Health Plan Makes Timely Decisions about Appeals \\nDescription: This rating shows how fast a plan sends information for an independent review. \\nMetric: Percent of appeals timely processed by the plan (numerator) out of all the plan‘s \\nappeals decided by the Independent Review Entity (IRE) (includes upheld, overturned, \\npartially overturned appeals and appeals not evaluated by the IRE because plan agreed \\nto cover) (denominator). This is calculated as: \\n \\n([Number of Timely Appeals] / ([Appeals Upheld] + [Appeals Overturned] + [Appeals \\nPartially Overturned] + [Appeals Not Evaluated by the IRE Because Plan Agreed to \\nCover])) * 100. \\n \\nPrimary Data Source: Independent Review Entity (IRE) \\nData Source Description: Data were obtained from the Independent Review Entity (IRE) contracted by CMS for \\nPart C appeals. The appeals used in this measure are based on the date in the calendar \\nyear the appeal was received by the IRE, not the date a decision was reached by the \\nIRE. The timeliness is based on the actual IRE received date and is compared to the \\ndate the appeal should have been received by the IRE. \\nData Source Category: Data Collected by CMS Contractors \\nExclusions: If the denominator is ≤ 10, the result is “Not enough data available.” Dismissed appeals \\n(except appeals not evaluated by the IRE because plan agreed to cover) and Withdrawn \\nappeals are excluded from this measure. \\nGeneral Notes: This measure includes all Standard Coverage, Standard Claim, and Expedited appeals \\nreceived by the IRE, regardless of the appellant. This includes appeals requested by a \\nbeneficiary, appeals requested by a party on behalf of a beneficiary, and appeals \\nrequested by non-contract providers. \\n \\nThe number of timely appeals can be calculated using this formula:  \\n[Number of Timely Appeals] = ([Appeals Upheld] + [Appeals Overturned] + [Appeals \\nPartially Overturned]) + [Appeals Not Evaluated by the IRE Because Plan Agreed to \\nCover]) - [Late] \\n \\nNote: Appeals Not Evaluated by the IRE Because Plan Agreed to Cover were formerly \\ncalled Dismissed Because Plan Agreed to Cover. \\n \\nWhen reviewing IRE data from the Maximus appeals website found at  \\nhttp://www.medicareappeal.com/AppealSearch and in data files, appeal disposition \\ncodes have been updated from the prior codes. Below is a crosswalk of previous appeal \\ndisposition codes and current codes:', '(Last Updated 10/03/2024)  \\nPage 76 \\n \\nTitle \\nDescription \\n \\n \\n \\n \\nPrevious Field Name \\nCurrent Field Name \\nUpheld \\nUnfavorable \\nOverturn \\nFavorable \\nPartially Overturn \\nPartially favorable \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Measures Capturing Access \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Affordability and Efficiency \\nCMIT #: 00562-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 69 % \\n>= 69 % to < 85 % \\n>= 85 % to < 95 % \\n>= 95 % to < 99 % \\n>= 99 % \\n \\n \\nMeasure: C29 - Reviewing Appeals Decisions \\nTitle \\nDescription \\n \\nLabel for Stars: Fairness of the Health Plan’s Appeal Decisions, Based on an Independent Reviewer \\nLabel for Data: Fairness of the Health Plan’s Appeal Decisions, Based on an Independent Reviewer \\nDescription: This rating shows how often an independent reviewer found the health plan’s decision to \\ndeny coverage to be reasonable.', '(Last Updated 10/03/2024)  \\nPage 77 \\n \\nTitle \\nDescription \\n \\nMetric: Percent of appeals where a plan‘s decision was “upheld” by the Independent Review \\nEntity (IRE) (numerator) out of all the plan‘s appeals (upheld, overturned, and partially \\noverturned appeals only) that the IRE reviewed (denominator). This is calculated as: \\n \\n([Appeals Upheld] / ([Appeals Upheld] + [Appeals Overturned] + [Appeals Partially \\nOverturned]))* 100. \\nPrimary Data Source: Independent Review Entity (IRE) \\nData Source Description: Data were obtained from the Independent Review Entity (IRE) contracted by CMS for \\nPart C appeals. The appeals used in this measure are based on the date in the calendar \\nyear the appeal was received by the IRE, not the date a decision was reached by the \\nIRE. If a Reopening occurs and is decided prior to June 30, 2024, the Reopened \\ndecision is used in place of the Reconsideration decision. Reopenings decided on or \\nafter June 30, 2024 are not reflected in these data and the original decision result is \\nused. The results of appeals that occur beyond Level 2 (i.e., Administrative Law Judge \\nor Medicare Appeals Council appeals) are not included in the data. \\nData Source Category: Data Collected by CMS Contractors \\nExclusions: If the minimum number of appeals (upheld + overturned + partially overturned) is ≤ 10, \\nthe result is “Not enough data available.” Dismissed and Withdrawn appeals are \\nexcluded from this measure. \\nGeneral Notes: This measure includes all Standard Coverage, Standard Claim, and Expedited appeals \\nreceived by the IRE, regardless of the appellant. This includes appeals requested by a \\nbeneficiary, appeals requested by a party on behalf of a beneficiary, and appeals \\nrequested by non-contract providers. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Measures Capturing Access \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Affordability and Efficiency \\nCMIT #: 00652-01-C-PARTC', '(Last Updated 10/03/2024)  \\nPage 78 \\n \\nTitle \\nDescription \\n \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 78 % \\n>= 78 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 % to < 99 % \\n>= 99 % \\n \\n \\nMeasure: C30 - Call Center – Foreign Language Interpreter and TTY Availability \\nTitle \\nDescription \\nLabel for Stars: Availability of TTY Services and Foreign Language Interpretation When Prospective \\nMembers Call the Health Plan \\nLabel for Data: Availability of TTY Services and Foreign Language Interpretation When Prospective \\nMembers Call the Health Plan \\nDescription: Percent of time that TTY services and foreign language interpretation were available \\nwhen needed by people who called the health plan’s prospective enrollee customer \\nservice phone line. \\nMetric: The calculation of this measure is the number of completed contacts with the interpreter \\nand TTY divided by the number of attempted contacts.  Completed contact with an \\ninterpreter is defined as establishing contact with an interpreter and confirming that the \\ncustomer service representative can answer questions about the plan’s Medicare Part C \\nbenefit within eight minutes. Completed TTY contact is defined as establishing contact \\nwith and confirming that the customer service representative can answer questions \\nabout the plan’s Medicare Part C benefit within seven minutes.  \\nPrimary Data Source: Call Center \\nData Source Description: Call center monitoring data collected by CMS. The Customer Service Contact for \\nProspective Members phone number associated with each contract was monitored. \\nData Source Category: Data Collected by CMS Contractors \\nExclusions: Data were collected from contracts that cover U.S territories but were not collected from \\nthe following organization types: 1876 Cost, Employer/Union Only Direct Contract PDP, \\nEmployer/Union Only Direct Contract PFFS, National PACE, MSA, employer contracts, \\norganizations that did not have a phone number accessible to survey callers, and \\nMAOs, MA-PDs, and MMPs under sanction. \\nGeneral Notes: Specific questions about Call Center Monitoring and requests for detail data should be \\ndirected to CallCenterMonitoring@cms.hhs.gov. \\nData Time Frame: 02/2024 – 05/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering', '(Last Updated 10/03/2024)  \\nPage 79 \\n \\nTitle \\nDescription \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Measures Capturing Access \\nWeighting Value: 4 \\nMajor Disaster: No adjustment for 2022 or 2023 disasters. \\nMeaningful Measure Area: Person-centered Care \\nCMIT #: 00096-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nYes \\nNo \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 46 % \\n>= 46 % to < 69 % \\n>= 69 % to < 93 % \\n>= 93 % to < 100 % \\n 100 %', '(Last Updated 10/03/2024)  \\nPage 80 \\n \\nPart D Domain and Measure Details \\nSee Attachment C for the national averages of individual Part D measures. \\nDomain: 1 - Drug Plan Customer Service \\nMeasure: D01 - Call Center – Foreign Language Interpreter and TTY Availability \\nTitle \\nDescription \\nLabel for Stars: Availability of TTY Services and Foreign Language Interpretation When Prospective \\nMembers Call the Drug Plan \\nLabel for Data: Availability of TTY Services and Foreign Language Interpretation When Prospective \\nMembers Call the Drug Plan \\nDescription: Percent of time that TTY services and foreign language interpretation were available \\nwhen needed by people who called the drug plan’s prospective enrollee customer \\nservice line. \\nMetric: The calculation of this measure is the number of completed contacts with the interpreter \\nand TTY divided by the number of attempted contacts.  Completed contact with an \\ninterpreter is defined as establishing contact with an interpreter and confirming that the \\ncustomer service representative can answer questions about the plan’s Medicare Part D \\nbenefit within eight minutes. Completed TTY contact is defined as establishing contact \\nwith and confirming that the customer service representative can answer questions \\nabout the plan’s Medicare Part D benefit within seven minutes.  \\nPrimary Data Source: Call Center \\nData Source Description: Call center monitoring data collected by CMS. The Customer Service Contact for \\nProspective Members phone number associated with each contract was monitored. \\nData Source Category: Data Collected by CMS Contractors \\nExclusions: Data were collected from contracts that cover U.S territories but were not collected from \\nthe following organization types: 1876 Cost, Employer/Union Only Direct Contract PDP, \\nEmployer/Union Only Direct Contract PFFS, National PACE, MSA, employer contracts, \\norganizations that did not have a phone number accessible to survey callers, and MA-\\nPDs, PDPs, and MMPs under sanction. \\nGeneral Notes: Specific questions about Call Center Monitoring and requests for detail data should be \\ndirected to CallCenterMonitoring@cms.hhs.gov. \\nData Time Frame: 02/2024 – 05/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Measures Capturing Access', '(Last Updated 10/03/2024)  \\nPage 81 \\n \\nTitle \\nDescription \\nWeighting Value: 4 \\nMajor Disaster: No adjustment for 2022 or 2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00096-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: Type \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 40 % \\n>= 40 % to < 74 % \\n>= 74 % to < 90 % \\n>= 90 % to < 100 % \\n 100 % \\nPDP \\n< 70 % \\n>= 70 % to < 85 % \\n>= 85 % to < 98 % \\n>= 98 % to < 100 % \\n 100 %', '(Last Updated 10/03/2024)  \\nPage 82 \\n \\nDomain: 2 - Member Complaints and Changes in the Drug Plan’s Performance \\nMeasure: D02 - Complaints about the Drug Plan \\nTitle \\nDescription \\nLabel for Stars: Complaints about the Drug Plan (more stars are better because it means fewer \\ncomplaints) \\nLabel for Data: Complaints about the Drug Plan (number of complaints for every 1,000 members). \\n(Lower numbers are better because it means fewer complaints.) \\nDescription: Rate of complaints filed with Medicare about the drug plan. \\nMetric: Rate of complaints about the drug plan per 1,000 members. For each contract, this rate \\nis calculated as:  \\n[ (Total number of all complaints logged into the Complaints Tracking Module (CTM))  \\n/ (Average Contract enrollment) ] * 1,000 * 30 / (Number of Days in Period). \\n \\nNumber of Days in Period = 366 for leap years, 365 for all other years. \\n \\n• Complaints data are pulled after the end of the measurement timeframe to serve as a  \\n  snapshot of CTM data. \\n• Enrollment numbers used to calculate the complaint rate were based on the average \\n  enrollment for the time period measured for each contract. \\n• A contract’s failure to follow CMS’s CTM Standard Operating Procedures will not result \\nin CMS’s adjustment of the data used for these measures. \\nPrimary Data Source: Complaints Tracking Module (CTM) \\nData Source Description: Data were obtained from the CTM in the Health Plan Management System (HPMS) \\nbased on the contract entry date (the date that complaints are assigned or re-assigned \\nto contracts; also known as the contract assignment/reassignment date) for the \\nreporting period specified. The status of any specific complaint at the time the data are \\npulled stands for use in the reports. Any changes to the complaints data subsequent to \\nthe data pull cannot be excluded retroactively. CMS allows for an approximate 6-month \\n“wash out” period to account for any adjustments per CMS’s CTM Standard Operating \\nProcedures. Therefore, all Plan Requests for 2023 complaints made by the June 28, \\n2024 deadline are captured. Complaint rates per 1,000 enrollees are adjusted to a 30-\\nday basis. Monthly enrollment files from HPMS were used to calculate the average \\nenrollment for the contract for the measurement period.   \\nData Source Category: CMS Administrative Data \\nExclusions: On May 10, 2019, CMS released an HPMS memo on the Complaints Tracking Module \\n(CTM) Updated Standard Operating Procedures (SOP). Plans should review all \\ncomplaints at intake and verify the contract assignment and issue level. The APPENDIX \\nA - Category and Subcategory Listing in the SOP lists the subcategories that are \\nexcluded.  \\n \\nComplaint rates are not calculated for contracts with average enrollment of less than \\n800 enrollees during the measurement period. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better', '(Last Updated 10/03/2024)  \\nPage 83 \\n \\nTitle \\nDescription \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00142-02-C-PARTD \\nData Display: Numeric with 2 decimal places \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n> 1.39 \\n> 0.76 to <= 1.39 \\n> 0.37 to <= 0.76 \\n> 0.12 to <= 0.37 \\n<= 0.12 \\nPDP \\n> 0.32 \\n> 0.2 to <= 0.32 \\n> 0.11 to <= 0.2 \\n> 0.04 to <= 0.11 \\n<= 0.04 \\n \\nMeasure: D03 - Members Choosing to Leave the Plan \\nTitle \\nDescription \\nLabel for Stars: Members Choosing to Leave the Plan (more stars are better because it means fewer \\nmembers choose to leave the plan) \\nLabel for Data: Members Choosing to Leave the Plan (lower percentages are better because that \\nindicates fewer members choose to leave the plan) \\nDescription: Percent of plan members who chose to leave the plan. \\nMetric: The percent of members who chose to leave the contract comes from disenrollment \\nreason codes in Medicare’s enrollment system. The percent is calculated as the number \\nof members who chose to leave the contract between January 1, 2023–December 31, \\n2023 (numerator) divided by all members enrolled in the contract at any time during \\n2023 (denominator). \\nPrimary Data Source: MBDSS \\nData Source Description: Medicare Beneficiary Database Suite of Systems (MBDSS)', '(Last Updated 10/03/2024)  \\nPage 84 \\n \\nTitle \\nDescription \\nData Source Category: CMS Administrative Data \\nExclusions: Members who involuntarily left their contract due to circumstances beyond their control \\nare removed from the final numerator, specifically: \\n    • Members affected by a contract service area reduction \\n    • Members affected by PBP termination \\n    • Members in PBPs that were granted special enrollment exceptions \\n    • Members affected by PBP service area reductions where there are no PBPs left  \\n      within the contract that the enrollee is eligible to enroll into \\n    • Members affected by LIS reassignments \\n    • Members who are enrolled in employer group plans \\n    • Members who were passively enrolled into a Demonstration (MMP) \\n    • Contracts with less than 1,000 enrollees \\n    • 1876 Cost contract disenrollments into the transition MA contract (H contract) \\n    • Members who moved out of the service area of the contract from which they \\n      disenrolled (based on the member’s address as submitted by the plan into which \\n      the member enrolled or the member’s current SSA address if there is no address \\n      submitted by the plan into which the member enrolled) or where the service area \\n      of the contract they enrolled into does not intersect with the service area of the \\n      contract from which they disenrolled. \\n \\nGeneral Notes: This measure includes members with a disenrollment effective date between 1/1/2023 \\nand 12/31/2023 who disenrolled from the contract with any one of the following \\ndisenrollment reason codes: \\n    11 - Voluntary Disenrollment through plan \\n    13 - Disenrollment because of enrollment in another Plan  \\n    14 - Retroactive \\n    99 - Other (not supplied by beneficiary). \\n \\nIf all potential members in the numerator meet one or more of the exclusion criteria, the \\nmeasure result will be “Not enough data available”. \\n \\nThe Disenrollment Reasons Survey (DRS) data available in the HPMS plan preview and \\nin the CMS downloadable Master Table, are not used in the calculation of this measure. \\nThe DRS data are presented in each of the systems for information purposes only. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Patients’ Experience and Complaints Measure', '(Last Updated 10/03/2024)  \\nPage 85 \\n \\nTitle \\nDescription \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00446-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n> 36 % \\n> 24 % to <= 36 % \\n> 17 % to <= 24 % \\n> 8 % to <= 17 % \\n<= 8 % \\nPDP \\n> 22 % \\n> 16 % to <= 22 % \\n> 9 % to <= 16 % \\n> 5 % to <= 9 % \\n<= 5 % \\n \\nMeasure: D04 - Drug Plan Quality Improvement \\nTitle \\nDescription \\nLabel for Stars: Improvement (if any) in the Drug Plan’s Performance \\nLabel for Data: Improvement (If any) in the Drug Plan’s Performance \\nDescription: This shows how much the drug plan’s performance has improved or declined from one \\nyear to the next year. \\nIf a plan receives 1 or 2 stars, it means, on average, the plan’s scores declined (got \\nworse). \\nIf a plan receives 3 stars, it means, on average, the plan’s scores stayed about the \\nsame. \\nIf a plan receives 4 or 5 stars, it means, on average, the plan’s scores improved. \\n  \\nKeep in mind that a plan that is already doing well in most areas may not show much \\nimprovement. It is also possible that a plan can start with low ratings, show a lot of \\nimprovement, and still not be performing very well. \\nMetric: The numerator is the net improvement, which is a weighted sum of the number of \\nsignificantly improved measures minus the number of significantly declined measures. \\nThe denominator is the sum of the weights associated with the measures eligible for the \\nimprovement measure (i.e., the measures that were included in the 2024 and 2025 Star \\nRatings for this contract and had no specification changes). \\nPrimary Data Source: Star Ratings \\nData Source Description: 2024 and 2025 Star Ratings \\nData Source Category: Star Ratings', '(Last Updated 10/03/2024)  \\nPage 86 \\n \\nTitle \\nDescription \\nExclusions: Contracts must have data in at least half of the measures used to calculate \\nimprovement to be rated in this measure. \\nGeneral Notes: Attachment I contains the formulas used to calculate the improvement measure and lists \\nindicating which measures were used. \\nData Time Frame: Not Applicable \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Not Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Improvement Measure \\nWeighting Value: 5 \\nMajor Disaster: Includes only measures which have data from both years. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00224-01-C-PARTD \\nData Display: Not Applicable \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: Type \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< -0.218869 \\n>= -0.218869 to < 0 \\n>= 0 to < 0.242468 \\n>= 0.242468 to < \\n0.496603 \\n>= 0.496603 \\nPDP \\n< -0.282500 \\n>= -0.282500 to < 0 \\n>= 0 to < 0.273334 \\n>= 0.273334 to < \\n0.576667 \\n>= 0.576667', \"(Last Updated 10/03/2024)  \\nPage 87 \\n \\nDomain: 3 - Member Experience with the Drug Plan \\nMeasure: D05 - Rating of Drug Plan \\nTitle \\nDescription \\nLabel for Stars: Members’ Rating of Drug Plan \\nLabel for Data: Members’ Rating of Drug Plan (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned from members who rated the \\nprescription drug plan. \\nMetric: This case-mix adjusted measure is used to assess members' overall view of their \\nprescription drug plan. The Consumer Assessment of Healthcare Providers and \\nSystems (CAHPS) score uses the mean of the distribution of responses converted to a \\nscale from 0 to 100. The score shown is the percentage of the best possible score each \\ncontract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Question (question numbers vary depending on survey type): \\n \\n• Using any number from 0 to 10, where 0 is the worst prescription drug plan possible \\n  and 10 is the best prescription drug plan possible, what number would you use to rate \\n  your prescription drug plan? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care\", \"(Last Updated 10/03/2024)  \\nPage 88 \\n \\nTitle \\nDescription \\nCMIT #: 00641-01-C-PARTD \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nNo \\nYes \\nYes \\nBase Group Cut Points: Type \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\nMA-PD \\n< 84 \\n>= 84 to < 86 \\n>= 86 to < 87 \\n>= 87 to < 89 \\n>= 89 \\nPDP \\n< 79 \\n>= 79 to < 82 \\n>= 82 to < 85 \\n>= 85 to < 87 \\n>= 87 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: D06 - Getting Needed Prescription Drugs \\nTitle \\nDescription \\nLabel for Stars: Ease of Getting Prescriptions Filled When Using the Plan \\nLabel for Data: Ease of Getting Prescriptions Filled When Using the Plan (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned on how easy it is for members to get \\nthe prescription drugs they need using the plan. \\nMetric: This case-mix adjusted measure is used to assess the ease with which a beneficiary \\ngets the medicines their doctor prescribed. The Consumer Assessment of Healthcare \\nProviders and Systems (CAHPS) score uses the mean of the distribution of responses \\nconverted to a scale from 0 to 100. The score shown is the percentage of the best \\npossible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type): \\n \\n• In the last 6 months, how often was it easy to use your prescription drug plan to get \\n  the medicines your doctor prescribed? \\n \\n• In the last 6 months, how often was it easy to use your prescription drug plan to fill a \\n  prescription at your local pharmacy? \\n \\n• In the last 6 months, how often was it easy to use your prescription drug plan to fill a \\n  prescription by mail? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better\", '(Last Updated 10/03/2024)  \\nPage 89 \\n \\nTitle \\nDescription \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00294-01-C-PARTD \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nNo \\nYes \\nYes \\nBase Group Cut Points: \\nType \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\nMA-PD \\n< 87 \\n>= 87 to < 88 \\n>= 88 to < 90 \\n>= 90 to < 91 \\n>= 91 \\nPDP \\n< 86 \\n>= 86 to < 87 \\n>= 87 to < 89 \\n>= 89 to < 90 \\n>= 90 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules.', '(Last Updated 10/03/2024)  \\nPage 90 \\n \\nDomain: 4 - Drug Safety and Accuracy of Drug Pricing \\nMeasure: D07 - MPF Price Accuracy \\nTitle \\nDescription \\nLabel for Stars: Plan Provides Accurate Drug Pricing Information for This Website \\nLabel for Data: Plan Provides Accurate Drug Pricing Information for This Website (higher scores are \\nbetter because they mean more accurate prices) \\nDescription:  A score comparing the drug’s total cost at the pharmacy to the drug prices the plan \\nprovided for the Medicare Plan Finder (MPF) website. Higher scores are better because \\nthey mean the plan provided more accurate prices. \\n \\nMetric: This measure evaluates the accuracy of drug prices posted on the MPF tool. A \\ncontract’s score is based on the accuracy index, or magnitude of difference, and the \\nclaim percentage index, or frequency of difference. \\n \\nThe accuracy index – or magnitude of difference - considers both ingredient cost and \\ndispensing fee and measures the amount that the PDE price is higher than the MPF \\nprice. The claim percentage index – or frequency of difference - also considers both \\ningredient cost and dispensing fee while measuring how often the PDE price is higher \\nthan the MPF price. Therefore, prices that are overstated on MPF will not count against \\na plan’s score. \\n \\nThe accuracy index is computed as: (Total amount that PDE is higher than MPF + Total \\nPDE cost) / (Total PDE cost).  \\n \\nThe claim percentage index is computed as: (Total number of PDEs where PDE cost is \\nhigher than MPF) / (Total number of PDEs). \\n  \\nThe best possible accuracy index is 1 and claim percentage index is 0. Indexes with \\nthese values indicate that a plan did not have PDE prices greater than MPF prices.  \\n \\nA contract’s score is computed using its accuracy index and claim percentage index as: \\n0.5 x (100 – ((accuracy index – 1) x 100)) + 0.5 x ((1 – claim percentage index) x 100). \\nPrimary Data Source: PDE data, MPF Pricing Files \\nData Source Description: Data used in this measure are obtained from a number of sources: MPF Pricing Files \\nand PDE data are the primary data sources. The PDE data were submitted by drug \\nplans to CMS Drug Data Processing Systems (DDPS) and accepted by the 2023 PDE \\nsubmission deadline for annual Part D payment reconciliation with dates of service from \\nJanuary 1, 2023- September 30, 2023. If the PDE edit results in the PDE being rejected \\nby DDPS, then the PDE is not used in the measure. If the PDE edit is informational, and \\ntherefore does not result in the PDE being rejected, then the PDE is used. Reminder, \\nCMS uses the term “final action” PDE to describe the most recently accepted original, \\nadjustment, or deleted PDE record representing a single dispensing event. Original and \\nadjustment final action PDEs submitted by the sponsor and accepted by DDPS prior to \\nthe 2023 PDE submission deadline are used to calculate this measure. The HPMS-\\napproved formulary extracts, and data from First DataBank and Medi-span are also \\nused.   \\nData Source Category: Data Collected by CMS Contractors', '(Last Updated 10/03/2024)  \\nPage 91 \\n \\nTitle \\nDescription \\nExclusions: A contract with less than 30 PDE claims over the measurement period. PDEs must also \\nmeet the following criteria:  \\n \\n• If the NPI in the Pharmacy Cost (PC) file represents a retail only pharmacy or retail \\nand limited access drug only pharmacy, all corresponding PDEs will be eligible for the \\nmeasure. However, if the NPI in the PC file represents a retail and other pharmacy type \\n(such as Mail, Home Infusion or Long Term Care pharmacy), only the PDE where the \\npharmacy service type is identified as either Community/Retail or Managed Care \\nOrganization (MCO) will be eligible. \\n• Drug must appear in formulary file and in MPF pricing file  \\n• PDE must be a 28-34, 60-62, or 90-93 day supply. If a plan’s bid indicates a 1, 2, or 3 \\nmonth retail days supply amount outside of the 28-34, 60-62, or 90-93 windows, then \\nadditional days supply values may be included in the accuracy measure for the plan. \\n• Date of service must occur at a time that data are not suppressed for the plan on MPF \\n• PDE must not be a compound claim \\n• PDE must not be a non-covered drug \\nGeneral Notes: Please see Attachment M: Methodology for Price Accuracy Measure for more \\ninformation about this measure. \\nData Time Frame: 01/01/2023 – 09/30/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Affordability and Efficiency \\nCMIT #: 00452-01-C-PARTD \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes', '(Last Updated 10/03/2024)  \\nPage 92 \\n \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 97 \\n>= 97 to < 98 \\n>= 98 to < 99 \\n>= 99 to < 100 \\n 100 \\nPDP \\n< 97 \\n>= 97 to < 98 \\n>= 98 to < 99 \\n>= 99 to < 100 \\n 100 \\n \\nMeasure: D08 - Medication Adherence for Diabetes Medications \\nTitle \\nDescription \\nLabel for Stars: Taking Diabetes Medication as Directed \\nLabel for Data: Taking Diabetes Medication as Directed \\nDescription: Percent of plan members with a prescription for diabetes medication who fill their \\nprescription often enough to cover 80% or more of the time they are supposed to be \\ntaking the medication.  \\n  \\nOne of the most important ways people with diabetes can manage their health is by \\ntaking their medication as directed. The plan, the doctor, and the member can work \\ntogether to find ways to do this. (“Diabetes medication” means a biguanide drug, a \\nsulfonylurea drug, a thiazolidinedione drug, a DPP-4 inhibitor, a GIP/GLP-1 receptor \\nagonist, a meglitinide drug, or an SGLT2 inhibitor. Plan members who take insulin are \\nnot included.) \\nMetric: This measure is defined as the percent of Medicare Part D beneficiaries 18 years and \\nolder who adhere to their prescribed drug therapy across classes of diabetes \\nmedications: biguanides, sulfonylureas, thiazolidinediones, DiPeptidyl Peptidase (DPP)-\\n4 Inhibitors, GIP/GLP-1 receptor agonists, meglitinides, and sodium glucose \\ncotransporter 2 (SGLT2) inhibitors. This percentage is calculated as the number of \\nmember-years of enrolled beneficiaries 18 years and older with a proportion of days \\ncovered (PDC) at 80 percent or higher across the classes of diabetes medications \\nduring the measurement period (numerator) divided by the number of member-years of \\nenrolled beneficiaries 18 years and older with at least two fills of diabetes medication(s) \\non unique dates of service during the measurement period (denominator). \\n \\nThe PDC is the percent of days in the measurement period “covered” by prescription \\nclaims for the same medication or another in its therapeutic category. Beneficiaries are \\nonly included in the measure calculation if the first fill of their diabetes medication occurs \\nat least 91 days before the end of the enrollment period, end of measurement period, or \\ndeath, whichever comes first. \\n \\nThe Medication Adherence measure is adapted from the Medication Adherence-\\nProportion of Days Covered measure that was developed and endorsed by the \\nPharmacy Quality Alliance (PQA).  \\n \\nSee the medication list for this measure. The Medication Adherence rate is calculated \\nusing the National Drug Code (NDC) list maintained by the PQA. The complete NDC \\nlist, including diagnosis codes, is posted along with these technical notes. \\nPrimary Data Source: Prescription Drug Event (PDE) data \\nData Source Description: The data for this measure come from PDE data submitted by drug plans to CMS Drug \\nData Processing Systems (DDPS) and accepted by the 2023 PDE submission deadline \\nfor annual Part D payment reconciliation with dates of service from January 1, 2023-\\nDecember 31, 2023. If the PDE edit results in the PDE being rejected by DDPS, then', '(Last Updated 10/03/2024)  \\nPage 93 \\n \\nTitle \\nDescription \\nthe PDE is not used in the Patient Safety measure calculations. If the PDE edit is \\ninformational and therefore, does not result in the PDE being rejected, then the PDE is \\nused in the Patient Safety measure calculations. Reminder, CMS uses the term “final \\naction” PDE to describe the most recently accepted original, adjustment, or deleted PDE \\nrecord representing a single dispensing event. Original and adjustment final action \\nPDEs submitted by the sponsor and accepted by DDPS prior to the 2023 PDE \\nsubmission deadline are used to calculate this measure. PDE claims are limited to \\nmembers who received at least two prescriptions on unique dates of service for \\ndiabetes medication(s). PDE adjustments made post-reconciliation were not reflected in \\nthis measure.  \\n \\nAdditional data sources include the Common Medicare Environment (CME), the \\nMedicare Enrollment Database (EDB), the Common Working File (CWF), and the \\nEncounter Data Systems (EDS). The data cut off date for all the additional data sources \\nlisted below such as the CME, CWF, and EDS is determined by the same PDE \\nsubmission deadline for the annual Part D payment reconciliation.  \\n• CME is used for enrollment information. \\n• EDB is used to identify beneficiaries who elected to receive hospice care or with ESRD \\nstatus (dialysis start and end dates within the measurement period). Due to CMS’s \\nmigration of the beneficiary database, including the EDB and CME, to the Amazon Web \\nServices (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated \\nData Repository (CME IDRC), sourced from the same upstream database. \\n• CWF is used to identify exclusion diagnoses based on ICD-10-CM codes, inpatient \\n(IP) and skilled nursing facility (SNF) stays for PDPs and MA-PDs (if available). \\n• EDS is used to identify diagnoses based on ICD-10-CM codes, and SNF/IP stays for \\nMA-PD beneficiaries.  \\n \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts with 30 or fewer enrolled member-years (in the denominator). The following \\nbeneficiaries are also excluded from the denominator if at any time during the \\nmeasurement period: \\n \\n• In hospice \\n• ESRD diagnosis or dialysis coverage dates \\n• One or more prescriptions for insulin \\n \\nGeneral Notes: Part D drugs do not include drugs or classes of drugs, or their medical uses, which may \\nbe excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, \\nexcept for smoking cessation agents. As such, these drugs, which may be included in \\nthe PQA medication or NDC lists, are excluded from CMS analyses. Also, the member-\\nyears of enrollment adjustment is made by CMS to account for partial enrollment within \\nthe benefit year. Enrollment is measured at the episode level, and inclusion in the \\nmeasure is determined separately for each episode – i.e., to be included for a given \\nepisode, the beneficiary must meet the initial inclusion criteria for the measure during \\nthat episode.  \\n \\nThe measure is weighted based on the total number of member-years for each \\nenrollment episode in which the beneficiary meets the measure criteria. For instance, if \\na beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode,', '(Last Updated 10/03/2024)  \\nPage 94 \\n \\nTitle \\nDescription \\nreenrolled for a three-month episode, and meets the measure criteria during each \\nenrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + \\n3/12 = 6/12).  \\n \\nThe PDC calculation is adjusted for overlapping prescriptions for the same drug which is \\ndefined by the active ingredient at the generic name level using the NDC list maintained \\nby PQA. The calculation also adjusts for Part D beneficiaries’ stays in IP settings, and \\nstays in SNFs. The discharge date is included as an adjustment for IP/SNF stays. \\nPlease see Attachment L: Medication Adherence Measure Calculations for more \\ninformation about these calculation adjustments. \\n \\nWhen available, beneficiary death date from the CME is the end date of a beneficiary’s \\nmeasurement period. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00436-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: Type \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 91 % \\n>= 91 % \\nPDP \\n< 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 %', '(Last Updated 10/03/2024)  \\nPage 95 \\n \\nMeasure: D09 - Medication Adherence for Hypertension (RAS antagonists) \\nTitle \\nDescription \\nLabel for Stars: Taking Blood Pressure Medication as Directed \\nLabel for Data: Taking Blood Pressure Medication as Directed \\nDescription: Percent of plan members with a prescription for a blood pressure medication who fill \\ntheir prescription often enough to cover 80% or more of the time they are supposed to \\nbe taking the medication.  \\n  \\nOne of the most important ways people with high blood pressure can manage their \\nhealth is by taking medication as directed. The plan, the doctor, and the member can \\nwork together to do this. (“Blood pressure medication” means an ACEI (angiotensin \\nconverting enzyme inhibitor), an ARB (angiotensin receptor blocker), or a direct renin \\ninhibitor drug.) \\nMetric: This measure is defined as the percent of Medicare Part D beneficiaries 18 years and \\nolder who adhere to their prescribed drug therapy for renin angiotensin system (RAS) \\nantagonists: angiotensin converting enzyme inhibitor (ACEI), angiotensin receptor \\nblocker (ARB), or direct renin inhibitor medications. This percentage is calculated as the \\nnumber of member-years of enrolled beneficiaries 18 years and older with a proportion \\nof days covered (PDC) at 80 percent or higher for RAS antagonist medications during \\nthe measurement period (numerator) divided by the number of member-years of \\nenrolled beneficiaries 18 years and older with at least two RAS antagonist medication \\nfills on unique dates of service during the measurement period (denominator).  \\n \\nThe PDC is the percent of days in the measurement period “covered” by prescription \\nclaims for the same medication or another in its therapeutic category. Beneficiaries are \\nonly included in the measure calculation if the first fill of their RAS antagonist medication \\noccurs at least 91 days before the end of the enrollment period, end of measurement \\nperiod, or death, whichever comes first. \\n \\nThe Part D Medication Adherence measure is adapted from the Medication Adherence-\\nProportion of Days Covered measure that was developed and endorsed by the PQA.  \\n \\nSee the medication list for this measure. The Part D Medication Adherence rate is \\ncalculated using the NDC list maintained by the PQA. The complete NDC list, including \\ndiagnosis codes, is posted along with these technical notes. \\nPrimary Data Source: Prescription Drug Event (PDE) data \\nData Source Description: The data for this measure come from PDE data submitted to the CMS DDPS and \\naccepted by the 2023 PDE submission deadline for annual Part D payment \\nreconciliation with dates of service from January 1, 2023-December 31, 2023. If the \\nPDE edit results in the PDE being rejected by DDPS, then the PDE is not used in the \\nPatient Safety measure calculations. If the PDE edit is informational and therefore, does \\nnot result in the PDE being rejected, then the PDE is used in the Patient Safety \\nmeasure calculations. Reminder, CMS uses the term “final action” PDE to describe the \\nmost recently accepted original, adjustment, or deleted PDE record representing a \\nsingle dispensing event. Original and adjustment final action PDEs submitted by the \\nsponsor and accepted by DDPS prior to the 2023 PDE submission deadline are used to \\ncalculate this measure. PDE claims are limited to members who received at least two', '(Last Updated 10/03/2024)  \\nPage 96 \\n \\nTitle \\nDescription \\nprescriptions on unique dates of service for RAS antagonist medication(s). PDE \\nadjustments made post-reconciliation were not reflected in this measure. \\n \\nAdditional data sources include the CME, the EDB, and the CWF, and the EDS. The \\ndata cut off date for all the additional data sources listed below such as the CME, CWF, \\nand EDS is determined by the same PDE submission deadline for the annual Part D \\npayment reconciliation.   \\n• CME is used for enrollment information.  \\n• EDB is used to identify beneficiaries who elected to receive hospice care or with ESRD \\nstatus (dialysis start and end dates within the measurement period). Due to CMS’s \\nmigration of the beneficiary database, including the EDB and CME, to the Amazon Web \\nServices (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated \\nData Repository (CME IDRC), sourced from the same upstream database. \\n• CWF is used to identify exclusion diagnoses based on ICD-10-CM codes, inpatient  \\n  and SNF stays for PDPs and MA-PDs (if available). \\n• EDS is used to identify diagnoses based on ICD-10-CM codes, and SNF/IP stays for \\nMA-PD beneficiaries.  \\n \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts with 30 or fewer enrolled member-years (in the denominator). The following \\nbeneficiaries are also excluded from the denominator if at any time during the \\nmeasurement period: \\n \\n• In hospice \\n• ESRD diagnosis or dialysis coverage dates \\n• One or more prescriptions for sacubitril/valsartan \\n \\nGeneral Notes: Part D drugs do not include drugs or classes of drugs, or their medical uses, which may \\nbe excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, \\nexcept for smoking cessation agents. As such, these drugs, which may be included in \\nthe PQA medication or NDC lists, are excluded from CMS analyses. Also, the member-\\nyears of enrollment adjustment is made by CMS to account for partial enrollment within \\nthe benefit year. Enrollment is measured at the episode level, and inclusion in the \\nmeasure is determined separately for each episode – i.e., to be included for a given \\nepisode, the beneficiary must meet the initial inclusion criteria for the measure during \\nthat episode. \\n \\nThe measure is weighted based on the total number of member-years for each \\nenrollment episode in which the beneficiary meets the measure criteria. For instance, if \\na beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode, \\nreenrolled for a three-month episode, and meets the measure criteria during each \\nenrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + \\n3/12 = 6/12).  \\n \\nThe PDC calculation is adjusted for overlapping prescriptions for the same drug which is \\ndefined by active ingredient at the generic name level using the NDC list maintained by \\nPQA. The calculation also adjusts for Part D beneficiaries’ stays in IP settings, and \\nstays in SNFs. The discharge date is included as an adjustment day for IP/SNF stays.', '(Last Updated 10/03/2024)  \\nPage 97 \\n \\nTitle \\nDescription \\nPlease see Attachment L: Medication Adherence Measure Calculations for more \\ninformation about these calculation adjustments. \\n \\nWhen available, beneficiary death date from the CME is the end date of a beneficiary’s \\nmeasurement period. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00437-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: Type \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 83 % \\n>= 83 % to < 87 % \\n>= 87 % to < 90 % \\n>= 90 % to < 92 % \\n>= 92 % \\nPDP \\n< 87 % \\n>= 87 % to < 89 % \\n>= 89 % to < 90 % \\n>= 90 % to < 92 % \\n>= 92 %', '(Last Updated 10/03/2024)  \\nPage 98 \\n \\nMeasure: D10 - Medication Adherence for Cholesterol (Statins) \\nTitle \\nDescription \\nLabel for Stars: Taking Cholesterol Medication as Directed \\nLabel for Data: Taking Cholesterol Medication as Directed \\nDescription: Percent of plan members with a prescription for a cholesterol medication (a statin drug) \\nwho fill their prescription often enough to cover 80% or more of the time they are \\nsupposed to be taking the medication. \\n  \\nOne of the most important ways people with high cholesterol can manage their health is \\nby taking medication as directed. The plan, the doctor, and the member can work \\ntogether to do this. \\nMetric: This measure is defined as the percent of Medicare Part D beneficiaries 18 years and \\nolder who adhere to their prescribed drug therapy for statin cholesterol medications. \\nThis percentage is calculated as the number of member-years of enrolled beneficiaries \\n18 years and older with a proportion of days covered (PDC) at 80 percent or higher for \\nstatin cholesterol medication(s) during the measurement period (numerator) divided by \\nthe number of member-years of enrolled beneficiaries 18 years and older with at least \\ntwo statin cholesterol medication fills on unique dates of service during the \\nmeasurement period (denominator).  \\n \\nThe PDC is the percent of days in the measurement period “covered” by prescription \\nclaims for the same medication or another in the therapeutic category. Beneficiaries are \\nonly included in the measure calculation if the first fill of their statin medication occurs at \\nleast 91 days before the end of the enrollment period, end of measurement period, or \\ndeath, whichever comes first. \\n \\nThe Medication Adherence measure is adapted from the Medication Adherence-\\nProportion of Days Covered measure that was developed and endorsed by the PQA.  \\n \\nSee the medication list for this measure. The Medication Adherence rate is calculated \\nusing the NDC list maintained by the PQA. The complete NDC list, including diagnosis \\ncodes, is posted along with these technical notes. \\nPrimary Data Source: Prescription Drug Event (PDE) data \\nData Source Description: The data for this measure come from PDE data submitted by drug plans to the CMS \\nDDPS and accepted by the 2023 PDE submission deadline for annual Part D payment \\nreconciliation with dates of service from January 1, 2023-December 31, 2023. If the \\nPDE edit results in the PDE being rejected by DDPS, then the PDE is not used in the \\nPatient Safety measure calculations. If the PDE edit is informational and therefore, does \\nnot result in the PDE being rejected, then the PDE is used in the Patient Safety \\nmeasure calculations. Reminder, CMS uses the term “final action” PDE to describe the \\nmost recently accepted original, adjustment, or deleted PDE record representing a \\nsingle dispensing event. Original and adjustment final action PDEs submitted by the \\nsponsor and accepted by DDPS prior to the 2023 PDE submission deadline are used to \\ncalculate this measure. PDE claims are limited to members who received at least two \\nprescriptions on unique dates of service for statin medication. PDE adjustments made \\npost-reconciliation were not reflected in this measure.', '(Last Updated 10/03/2024)  \\nPage 99 \\n \\nTitle \\nDescription \\nAdditional data sources include the CME, the EDB, the CWF, and the EDS. The data \\ncut off date for all the additional data sources listed below such as the CME, CWF, and \\nEDS is determined by the same PDE submission deadline for the annual Part D \\npayment reconciliation.    \\n• CME is used for enrollment information. \\n• EDB is used to identify beneficiaries who elected to receive hospice care or with ESRD \\nstatus (dialysis start and end dates within the measurement period). Due to CMS’s \\nmigration of the beneficiary database, including the EDB and CME, to the Amazon Web \\nServices (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated \\nData Repository (CME IDRC), sourced from the same upstream database. \\n• CWF is used to identify exclusion diagnoses based on ICD-10-CM codes, IP and SNF \\nstays for PDPs and MA-PDs (if available). \\n• EDS is used to identify diagnoses based on ICD-10-CM codes, and SNF/IP stays for \\nMA-PD beneficiaries.  \\n \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts with 30 or fewer enrolled member-years (in the denominator). The following \\nbeneficiaries are also excluded from the denominator if at any time during the \\nmeasurement period: \\n \\n• In hospice \\n• ESRD diagnosis or dialysis coverage dates  \\n \\nGeneral Notes: Part D drugs do not include drugs or classes of drugs, or their medical uses, which may \\nbe excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, \\nexcept for smoking cessation agents. As such, these drugs, which may be included in \\nthe PQA medication or NDC lists, are excluded from CMS analyses. Also, the member-\\nyears of enrollment adjustment is made by CMS to account for partial enrollment within \\nthe benefit year. Enrollment is measured at the episode level, and inclusion in the \\nmeasure is determined separately for each episode – i.e., to be included for a given \\nepisode, the beneficiary must meet the initial inclusion criteria for the measure during \\nthat episode.  \\n \\nThe measure is weighted based on the total number of member-years for each \\nenrollment episode in which the beneficiary meets the measure criteria. For instance, if \\na beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode, \\nreenrolled for a three-month episode, and meets the measure criteria during each \\nenrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + \\n3/12 = 6/12).  \\n \\nThe PDC calculation is adjusted for overlapping prescriptions for the same drug which is \\ndefined by active ingredient at the generic name level using the NDC list maintained by \\nPQA. The calculation also adjusts for Part D beneficiaries’ stays in IP settings, and \\nstays in SNFs. The discharge date is included as an adjustment day for IP/SNF stays. \\nPlease see Attachment L: Medication Adherence Measure Calculations for more \\ninformation about these calculation adjustments. \\n \\nWhen available, beneficiary death date from the CME is the end date of a beneficiary’s \\nmeasurement period.', '(Last Updated 10/03/2024)  \\nPage 100 \\n \\nTitle \\nDescription \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00435-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % >= 85 % to < 89 % >= 89 % to < 93 % \\n>= 93 % \\nPDP \\n< 86 % \\n>= 86 % to < 88 % >= 88 % to < 89 % >= 89 % to < 92 % \\n>= 92 % \\n \\nMeasure: D11 - MTM Program Completion Rate for CMR \\nTitle \\nDescription \\nLabel for Stars: Members Who Had a Pharmacist (or Other Health Professional) Help them Understand \\nand Manage Their Medications \\nLabel for Data: Members Who Had a Pharmacist (or Other Health Professional) Help them Understand \\nand Manage Their Medications \\nDescription: Some plan members are in a program (called a Medication Therapy Management \\nprogram) to help them manage their drugs. The measure shows how many members in \\nthe program had an assessment of their medications from the plan. \\nThe assessment includes a discussion between the member and a pharmacist (or other \\nhealth care professional) about all of the member’s medications. The member also \\nreceives a written summary of the discussion, including an action plan that recommends \\nwhat the member can do to better understand and use his or her medications.', '(Last Updated 10/03/2024)  \\nPage 101 \\n \\nTitle \\nDescription \\nMetric: This measure is defined as the percent of Medication Therapy Management (MTM) \\nprogram enrollees who received a Comprehensive Medication Review (CMR) during the \\nreporting period.  \\n \\nNumerator = Number of beneficiaries from the denominator who received a CMR at any \\ntime during their period of MTM enrollment in the reporting period. \\n \\nDenominator = Number of beneficiaries who were at least 18 years or older as of the \\nbeginning of the reporting period and who were enrolled in the MTM program for at least \\n60 days during the reporting period. Only those beneficiaries who meet the contracts’ \\nspecified targeting criteria per CMS – Part D requirements pursuant to §423.153(d) of \\nthe regulations at any time in the reporting period are included in this measure. \\nBeneficiaries who were in hospice at any point during the reporting period are excluded. \\nBeneficiaries who were enrolled in the contract’s MTM program for less than 60 days at \\nany time in the measurement year are only included in the denominator and the \\nnumerator if they received a CMR within this timeframe. Beneficiaries are excluded from \\nthe measure calculation if they were enrolled in the contract’s MTM program for less \\nthan 60 days and did not receive a CMR within this timeframe. The date of enrollment is \\ncounted towards the 60 days but the opt-out date is not. \\n \\nA beneficiary’s MTM eligibility, receipt of CMRs, etc., is determined for each contract \\nhe/she was enrolled in during the measurement period. Similarly, a contract’s CMR \\ncompletion rate is calculated based on each of its eligible MTM enrolled beneficiaries. \\nFor example, a beneficiary must meet the inclusion criteria for the contract to be \\nincluded in the contract’s CMR rate. A beneficiary who is enrolled in two different \\ncontracts’ MTM programs for 30 days each is therefore excluded from both contracts’ \\nCMR rates. The beneficiary is only included in the measure calculation for the \\ncontract(s) where they were enrolled at least 60 days or received a CMR if enrolled for \\nless than 60 days. Beneficiaries with multiple records that contain varying information \\nfor the same contract are excluded from the measure calculation for that contract. \\n \\nBeneficiaries may be enrolled in MTM based on the contracts’ specified targeting criteria \\nper CMS – Part D requirements and/or based on expanded, other plan-specific targeting \\ncriteria. Beneficiaries who were initially enrolled in MTM due to other plan-specific \\n(expanded) criteria and then later met the contracts’ specified targeting criteria per CMS \\n– Part D requirements at any time in the reporting period are included in this measure. \\nIn these cases, a CMR received after the date of MTM enrollment but before the date \\nthe beneficiary met the specified targeting criteria per CMS – Part D requirements are \\nincluded. \\nPrimary Data Source: Part D Plan Reporting \\nData Source Description: The data for this measure were reported by contracts to CMS per the 2023 Part D \\nReporting Requirements (data pulled June 2024). Validation of these data was \\nperformed retrospectively during the 2024 data validation cycle (deadline June 15, 2024 \\nand data validation results pulled July 2024). Additionally, the Medicare Enrollment \\nDatabase (EDB) from the Integrated Data Repository (CME IDRC) is used to identify \\nbeneficiaries in hospice (data pulled June 2024).  \\n \\nData Source Category: Health and Drug Plans', '(Last Updated 10/03/2024)  \\nPage 102 \\n \\nTitle \\nDescription \\nExclusions: Contracts with an effective termination date on or before the deadline to submit data \\nvalidation results to CMS (June 15, 2024) are excluded and listed as “Not required to \\nreport.”  \\n \\nMTM CMR rates are not provided for contracts that did not score at least 95% on data \\nvalidation for the Medication Therapy Management Program reporting section or were \\nnot compliant with data validation standards/sub-standards for any of the following \\nMedication Therapy Management Program data elements. We define a contract as \\nbeing non-complaint if either it receives a \"No\" or a 1, 2, or 3 on the 5-point Likert scale \\nin the specific data element\\'s data validation. \\n \\n• MBI Number (Element B) \\n• Date of MTM program enrollment (Element H) \\n• Met the specified targeting criteria per CMS – Part D requirements (Element I) \\n• Date met the specified targeting criteria per CMS – Part D requirements (Element J) \\n• Date of MTM program opt-out, if applicable (Element K) \\n• Received annual CMR with written summary in CMS standardized format (Element O) \\n• Date(s) of CMR(s) (Element P) \\n \\nMTM CMR rates are also not provided for contracts that failed to submit their MTM file \\nand pass system validation by the reporting deadline or who had a missing data \\nvalidation score for MTM.  Contracts excluded from the MTM CMR Rates due to data \\nvalidation issues are shown as “CMS identified issues with this plan\\'s data.” See \\nAttachment N for more details on the MTM CMR completion rate measure scoring \\nmethodology. \\n \\nContracts can view their data validation results in HPMS (https://hpms.cms.gov/). To \\naccess this page, from the top menu select “Monitoring,” then “Plan Reporting Data \\nValidation.” Select the appropriate contract year. Select the PRDVM Reports. Select \\n“Score Detail Report.” Select the applicable reporting section.  If you cannot see the \\nPlan Reporting Data Validation module, contact CMS at HPMS_Access@cms.hhs.gov. \\n \\nAdditionally, contracts must have 31 or more enrollees in the denominator in order to \\nhave a calculated rate. Contracts with fewer than 31 eligible enrollees are listed as \"Not \\nenough data available\". \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure', '(Last Updated 10/03/2024)  \\nPage 103 \\n \\nTitle \\nDescription \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00454-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 57 % \\n>= 57 % to < 77 % \\n>= 77 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nPDP \\n< 30 % \\n>= 30 % to < 55 % \\n>= 55 % to < 68 % \\n>= 68 % to < 80 % \\n>= 80 % \\n \\nMeasure: D12 - Statin Use in Persons with Diabetes (SUPD) \\nTitle \\nDescription \\nLabel for Stars: The Plan Makes Sure Members with Diabetes Take the Most Effective Drugs to Treat \\nHigh Cholesterol \\nLabel for Data: The Plan Makes Sure Members with Diabetes Take the Most Effective Drugs to Treat \\nHigh Cholesterol \\nDescription: To lower their risk of developing heart disease, most people with diabetes should take \\ncholesterol medication. This rating is based on the percent of plan members with \\ndiabetes who take the most effective cholesterol-lowering drugs. Plans can help make \\nsure their members get these prescriptions filled. \\nMetric: This measure is defined as the percent of Medicare Part D beneficiaries 40-75 years old \\nwho were dispensed at least two diabetes medication fills on unique dates of service \\nand received a statin medication fill during the measurement period. The percentage is \\ncalculated as the number of member-years of enrolled beneficiaries 40-75 years old \\nwho received a statin medication fill during the measurement period (numerator) divided \\nby the number of member-years of enrolled beneficiaries 40-75 years old with at least \\ntwo diabetes medication fills on unique dates of service during the measurement period \\n(denominator).  \\n \\nBeneficiaries are only included in the measure calculation if the first fill of their diabetes \\nmedication occurs at least 90 days before the end of the measurement year or end of \\nthe enrollment episode. \\n \\nThe SUPD measure is adapted from the measure concept that was developed and \\nendorsed by the PQA.  \\n \\nSee the medication list for this measure. The SUPD measure is calculated using the \\nNDC lists updated by the PQA. The complete NDC lists, including diagnosis codes, are \\nposted along with these technical notes.', '(Last Updated 10/03/2024)  \\nPage 104 \\n \\nTitle \\nDescription \\nPrimary Data Source: Prescription Drug Event (PDE) data \\nData Source Description: The data for this measure come from Prescription Drug Event (PDE) data submitted by \\ndrug plans to the CMS DDPS and accepted by the 2023 PDE submission deadline for \\nannual Part D payment reconciliation with dates of service from January 1, 2023 – \\nDecember 31, 2023. If the PDE edit results in the PDE being rejected by DDPS, then \\nthe PDE is not used in the Patient Safety measure calculations. If the PDE edit is \\ninformational and therefore, does not result in the PDE being rejected, then the PDE is \\nused in the Patient Safety measure calculations. Reminder, CMS uses the term “final \\naction” PDE to describe the most recently accepted original, adjustment, or deleted PDE \\nrecord representing a single dispensing event. Original and adjustment final action \\nPDEs submitted by the sponsor and accepted by DDPS prior to the 2023 PDE \\nsubmission deadline are used to calculate this measure. PDE adjustments made post-\\nreconciliation were not reflected in this measure.  \\n \\nAdditional data sources include the CME, the EDB, the CWF, and the EDS. The data \\ncut off date for all the additional data sources listed below such as the CME, CWF, and \\nEDS is determined by the same PDE submission deadline for the annual Part D \\npayment reconciliation. \\n• CME is used for enrollment information. \\n• EDB is used to identify beneficiaries who elected to receive hospice care or with ESRD \\nstatus (dialysis start and end dates within the measurement period). Due to CMS’s \\nmigration of the beneficiary database, including the EDB and CME, to the Amazon Web \\nServices (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated \\nData Repository (CME IDRC), sourced from the same upstream database. \\n• CWF is used to identify exclusion diagnoses based on ICD-10-CM codes. \\n• EDS is used to identify diagnoses based on ICD-10-CM codes. \\n \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts with 30 or fewer enrolled member-years (in the denominator). The following \\nbeneficiaries are excluded from the denominator if at any time during the measurement \\nperiod: \\n \\n• Hospice enrollment \\n• ESRD diagnosis or dialysis coverage dates \\n• Rhabdomyolysis and myopathy \\n• Pregnancy, Lactation, and fertility \\n• Cirrhosis \\n• Pre-Diabetes \\n• Polycystic Ovary Syndrome  \\n \\nGeneral Notes: Part D drugs do not include drugs or classes of drugs, or their medical uses, which may \\nbe excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, \\nexcept for smoking cessation agents. As such, these drugs, which may be included in \\nthe PQA medication or NDC lists, are excluded from CMS analyses. Also, the member-\\nyears of enrollment adjustment is made by CMS to account for partial enrollment within \\nthe benefit year. Enrollment is measured at the episode level, and inclusion in the \\nmeasure is determined separately for each episode – i.e., to be included for a given', '(Last Updated 10/03/2024)  \\nPage 105 \\n \\nTitle \\nDescription \\nepisode, the beneficiary must meet the initial inclusion criteria for the measure during \\nthat episode.  \\n \\nThe measure is weighted based on the total number of member years for each episode \\nin which the beneficiary meets the measure criteria. For instance, if a beneficiary is \\nenrolled for a three-month episode, disenrolled for a six-month episode, reenrolled for a \\nthree-month episode, and meets the measure criteria during each enrollment episode, \\ns/he will count as 0.5 member years in the rate calculation (3/12 + 3/12 = 6/12). \\n \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00702-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 81 % \\n>= 81 % to < 86 % \\n>= 86 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nPDP \\n< 80 % \\n>= 80 % to < 83 % \\n>= 83 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 %', '(Last Updated 10/03/2024)  \\nPage 106 \\n \\nAttachment A: CAHPS Case-Mix Adjustment \\nCAHPS Case-Mix Adjustment \\nThe CAHPS measures are case-mix adjusted to take into account the mix of enrollees. Case-mix variables \\ninclude administrative age, dual eligibility status, low-income subsidy (LIS) indicator, and use of Asian \\nlanguage survey, and self-reported education, general health status, mental health status, and proxy usage status. \\nThe tables below include the case-mix variables and show the case-mix coefficients for each of the CAHPS \\nmeasures included in the Star Ratings. The coefficients indicate how much higher or lower people with a given \\ncharacteristic tend to respond compared to otherwise similar people with the baseline value for that \\ncharacteristic (e.g. reference group), on the original scale of the item or composite, as presented in plan reports. \\nThe reference group for each characteristic will have a coefficient value of zero. \\nFor example, for the Part C measure \"Rating of Health Plan,\" the model coefficient for \"age 75-79\" is 0.0511, \\nindicating that respondents in that age range tend to score their plans 0.0511 points higher than otherwise similar \\npeople in the 70-74 age range (the baseline or reference category). Similarly, respondents who had a proxy help \\naside from answering for them tend to respond 0.0850 points lower on this item than otherwise similar \\nrespondents without proxy help. Contracts with higher proportions of beneficiaries who are in the 75-79 age range \\nwill be adjusted downward on this measure to compensate for the positive response tendency of their respondents. \\nSimilarly, contracts with higher proportions of respondents who had proxy help will be adjusted upward on this \\nmeasure to compensate for their respondents’ negative response tendency. The case-mix patterns are not always \\nconsistent across measures. Missing case-mix adjustors are imputed as the contract mean. \\nThe composites consist of multiple items, each of which is adjusted separately before combining the adjusted \\nscores into a composite score. Item-level coefficients are presented below separately for each composite. For \\nmore detailed information on the application of CAHPS case-mix adjustment, please review the materials at \\nhttps://ma-pdpcahps.org/en/scoring-and-star-ratings/.', \"(Last Updated 10/03/2024)  \\nPage 107 \\n \\nTable A-1: Coefficients of Part C Getting Needed Care (C19) CAHPS Measure Composite Items \\nPredictor \\nGet appointment with specialist Easy to get care \\nAge: 64 or under \\n0.0576 \\n-0.0150 \\nAge: 65 – 69 \\n-0.0251 \\n-0.0157 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0043 \\n0.0207 \\nAge: 80 – 84 \\n0.0083 \\n-0.0005 \\nAge: 85 and older \\n0.0364 \\n0.0224 \\nEducation: Less than an 8th grade education \\n0.0136 \\n-0.0402 \\nEducation: Some high school \\n-0.0119 \\n0.0065 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0661 \\n-0.0536 \\nEducation: College graduate \\n-0.0921 \\n-0.0552 \\nEducation: More than a bachelor's degree \\n-0.1588 \\n-0.0844 \\nGeneral health rating: excellent \\n0.1392 \\n0.0480 \\nGeneral health rating: very good \\n0.0816 \\n0.0596 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0612 \\n-0.0669 \\nGeneral health rating: poor \\n-0.0762 \\n-0.1168 \\nMental health rating: excellent \\n0.1772 \\n0.1754 \\nMental health rating: very good \\n0.0943 \\n0.0933 \\nMental health rating: good \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0630 \\n-0.0547 \\nMental health rating: poor \\n-0.1618 \\n-0.1287 \\nProxy helped \\n-0.0084 \\n0.0039 \\nProxy answered \\n0.0104 \\n0.0574 \\nMedicaid dual eligible \\n0.0075 \\n0.0107 \\nLow-income subsidy (LIS) \\n-0.0226 \\n0.0136 \\nAsian survey language \\n-0.0145 \\n0.0455\", \"(Last Updated 10/03/2024)  \\nPage 108 \\n \\nTable A-2: Coefficients of Part C Getting Appointments and Care Quickly (C20) CAHPS Measure Composite \\nItems \\nPredictor \\nGetting needed care as soon \\nas wanted \\nGetting routine care as soon \\nas wanted \\nAge: 64 or under \\n0.0052 \\n0.0177 \\nAge: 65 – 69 \\n0.0448 \\n-0.0035 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0285 \\n0.0115 \\nAge: 80 – 84 \\n0.0628 \\n0.0301 \\nAge: 85 and older \\n0.0724 \\n0.0412 \\nEducation: Less than an 8th grade education \\n0.0703 \\n-0.0390 \\nEducation: Some high school \\n0.0187 \\n-0.0160 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0269 \\n-0.0469 \\nEducation: College graduate \\n-0.0042 \\n-0.0517 \\nEducation: More than a bachelor's degree \\n-0.0735 \\n-0.0857 \\nGeneral health rating: excellent \\n0.0512 \\n0.0604 \\nGeneral health rating: very good \\n0.0377 \\n0.0348 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0808 \\n-0.0496 \\nGeneral health rating: poor \\n-0.1089 \\n-0.0725 \\nMental health rating: excellent \\n0.0984 \\n0.1447 \\nMental health rating: very good \\n0.0586 \\n0.0665 \\nMental health rating: good \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0341 \\n-0.0278 \\nMental health rating: poor \\n-0.2374 \\n-0.1584 \\nProxy helped \\n0.0194 \\n0.0273 \\nProxy answered \\n0.1571 \\n0.0589 \\nMedicaid dual eligible \\n0.0120 \\n0.0277 \\nLow-income subsidy (LIS) \\n0.0166 \\n-0.0116 \\nAsian survey language \\n-0.1069 \\n-0.2643\", \"(Last Updated 10/03/2024)  \\nPage 109 \\n \\nTable A-3: Coefficients of Part C Customer Service (C21) CAHPS Measure Composite Items \\nPredictor \\nPaperwork easy \\nPlan customer service gives \\ninformation \\nPlan customer service \\ncourtesy and respect \\nAge: 64 or under \\n0.0067 \\n-0.0433 \\n-0.0186 \\nAge: 65 – 69 \\n0.0039 \\n-0.0283 \\n-0.0223 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n-0.0126 \\n-0.0091 \\n0.0032 \\nAge: 80 – 84 \\n-0.0191 \\n0.0003 \\n-0.0052 \\nAge: 85 and older \\n-0.0239 \\n0.0045 \\n0.0078 \\nEducation: Less than an 8th grade education \\n-0.0235 \\n-0.0688 \\n-0.0201 \\nEducation: Some high school \\n-0.0090 \\n-0.0231 \\n-0.0195 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0196 \\n-0.0765 \\n-0.0353 \\nEducation: College graduate \\n-0.0184 \\n-0.1060 \\n-0.0363 \\nEducation: More than a bachelor's degree \\n-0.0397 \\n-0.1479 \\n-0.0425 \\nGeneral health rating: excellent \\n0.0259 \\n0.0870 \\n0.0223 \\nGeneral health rating: very good \\n0.0134 \\n0.0376 \\n-0.0053 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0402 \\n-0.0437 \\n-0.0171 \\nGeneral health rating: poor \\n-0.0413 \\n-0.0276 \\n0.0087 \\nMental health rating: excellent \\n0.0509 \\n0.1242 \\n0.1019 \\nMental health rating: very good \\n0.0205 \\n0.0551 \\n0.0648 \\nMental health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0361 \\n-0.0286 \\n0.0012 \\nMental health rating: poor \\n-0.0703 \\n-0.1172 \\n-0.1081 \\nProxy helped \\n-0.0304 \\n0.0160 \\n0.0023 \\nProxy answered \\n0.0124 \\n0.0268 \\n0.0287 \\nMedicaid dual eligible \\n-0.0443 \\n0.0649 \\n0.0278 \\nLow-income subsidy (LIS) \\n-0.0180 \\n0.0242 \\n0.0426 \\nAsian survey language \\n-0.0613 \\n-0.0596 \\n-0.1666\", \"(Last Updated 10/03/2024)  \\nPage 110 \\n \\nTable A-4: Coefficients of Part C Stand-alone CAHPS Measures \\nPredictor \\nC22: Rating of Health Care \\nQuality \\nC23: Rating of Health \\nPlan \\nAge: 64 or under \\n-0.0683 \\n-0.0969 \\nAge: 65 – 69 \\n-0.0669 \\n-0.0754 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0311 \\n0.0511 \\nAge: 80 – 84 \\n0.0347 \\n0.0804 \\nAge: 85 and older \\n0.0006 \\n0.0934 \\nEducation: Less than an 8th grade education \\n0.0607 \\n0.1276 \\nEducation: Some high school \\n0.0131 \\n0.0340 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.1325 \\n-0.2128 \\nEducation: College graduate \\n-0.1729 \\n-0.3380 \\nMore than a bachelor's degree \\n-0.2509 \\n-0.4173 \\nGeneral health rating: excellent \\n0.3339 \\n0.2631 \\nGeneral health rating: very good \\n0.1949 \\n0.1386 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.2529 \\n-0.1497 \\nGeneral health rating: poor \\n-0.5774 \\n-0.3155 \\nMental health rating: excellent \\n0.5053 \\n0.3642 \\nMental health rating: very good \\n0.2545 \\n0.1767 \\nMental health rating: good \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.1320 \\n-0.1231 \\nMental health rating: poor \\n-0.4610 \\n-0.4146 \\nProxy helped \\n-0.1008 \\n-0.0850 \\nProxy answered \\n0.1089 \\n0.0348 \\nMedicaid dual eligible \\n0.0297 \\n0.3065 \\nLow-income subsidy (LIS) \\n0.0581 \\n0.0833 \\nAsian survey language \\n0.3586 \\n-0.0170\", \"(Last Updated 10/03/2024)  \\nPage 111 \\n \\nTable A-5: Coefficients of Part C Care Coordination (C24) CAHPS Measure Composite Items \\nPredictor \\nMD/office help to \\nmanage care \\nMD informed \\nabout specialist \\ncare \\nMD follows up \\nabout test \\nresults and gives \\nresults as soon as \\nneeded \\nTalk with MD \\nabout medicines \\nMD has medical \\nrecords about \\ncare \\nAge: 64 or under \\n-0.0404 \\n-0.0041 \\n0.0356 \\n0.0425 \\n-0.0061 \\nAge: 65 – 69 \\n-0.0251 \\n-0.0170 \\n-0.0259 \\n0.0149 \\n-0.0136 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n-0.0102 \\n-0.0218 \\n-0.0080 \\n-0.0555 \\n-0.0049 \\nAge: 80 – 84 \\n-0.0051 \\n-0.0313 \\n-0.0090 \\n-0.1083 \\n-0.0133 \\nAge: 85 and older \\n-0.0266 \\n-0.0063 \\n-0.0133 \\n-0.1635 \\n-0.0106 \\nEducation: Less than an 8th grade education \\n-0.0246 \\n0.0271 \\n-0.0308 \\n-0.0168 \\n-0.0375 \\nEducation: Some high school \\n-0.0010 \\n-0.0244 \\n0.0147 \\n0.0249 \\n-0.0091 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0510 \\n-0.0476 \\n-0.0252 \\n-0.0008 \\n-0.0048 \\nEducation: College graduate \\n-0.0379 \\n-0.1104 \\n-0.0310 \\n-0.0753 \\n-0.0164 \\nEducation: More than a bachelor's degree \\n-0.0738 \\n-0.0889 \\n-0.0302 \\n-0.0625 \\n0.0017 \\nGeneral health rating: excellent \\n0.0385 \\n-0.0025 \\n0.0792 \\n0.0775 \\n0.0122 \\nGeneral health rating: very good \\n0.0009 \\n0.0080 \\n0.0469 \\n0.0468 \\n0.0154 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0492 \\n0.0003 \\n-0.0734 \\n-0.0501 \\n-0.0346 \\nGeneral health rating: poor \\n-0.0881 \\n-0.0275 \\n-0.1290 \\n-0.1341 \\n-0.0521 \\nMental health rating: excellent \\n0.0986 \\n0.1768 \\n0.1502 \\n0.1614 \\n0.0852 \\nMental health rating: very good \\n0.0071 \\n0.0787 \\n0.0791 \\n0.0788 \\n0.0450 \\nMental health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0564 \\n-0.0687 \\n-0.0206 \\n-0.0232 \\n-0.0299 \\nMental health rating: poor \\n-0.1419 \\n-0.2305 \\n-0.0954 \\n-0.1066 \\n-0.0564 \\nProxy helped \\n0.0165 \\n0.0216 \\n-0.0137 \\n0.1030 \\n0.0004 \\nProxy answered \\n0.0379 \\n-0.0010 \\n0.0008 \\n0.0992 \\n0.0375 \\nMedicaid dual eligible \\n-0.0100 \\n0.0766 \\n-0.0199 \\n0.0224 \\n-0.0219 \\nLow-income subsidy (LIS) \\n-0.0464 \\n0.0204 \\n-0.0139 \\n0.0548 \\n-0.0098 \\nAsian survey language \\n0.1072 \\n-0.0794 \\n0.1495 \\n-0.2609 \\n-0.1476\", \"(Last Updated 10/03/2024)  \\nPage 112 \\n \\nTable A-6: Coefficients of Part D CAHPS Stand-alone Measures \\nPredictor \\nMA-PD D05: Rating of Drug Plan \\nPDP D05: Rating of Drug Plan \\nAge: 64 or under \\n-0.1745 \\n-0.1359 \\nAge: 65 – 69 \\n-0.1126 \\n-0.1746 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0812 \\n0.1899 \\nAge: 80 – 84 \\n0.1529 \\n0.2057 \\nAge: 85 and older \\n0.1693 \\n0.3164 \\nEducation: Less than an 8th grade education \\n-0.0030 \\n0.0608 \\nEducation: Some high school \\n0.0428 \\n-0.0614 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.2084 \\n-0.2944 \\nEducation: College graduate \\n-0.3313 \\n-0.1121 \\nEducation: More than a bachelor's degree \\n-0.4213 \\n-0.4179 \\nGeneral health rating: excellent \\n0.2766 \\n0.1603 \\nGeneral health rating: very good \\n0.1651 \\n0.1845 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.1816 \\n-0.2015 \\nGeneral health rating: poor \\n-0.3960 \\n-0.4735 \\nMental health rating: excellent \\n0.3083 \\n0.2269 \\nMental health rating: very good \\n0.1538 \\n-0.0462 \\nMental health rating: good \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0273 \\n-0.2564 \\nMental health rating: poor \\n-0.3236 \\n-0.0325 \\nProxy helped \\n-0.0567 \\n-0.1165 \\nProxy answered \\n-0.0633 \\n0.0282 \\nMedicaid dual eligible \\n0.5296 \\n0.7997 \\nLow-income subsidy (LIS) \\n0.3751 \\n0.8174 \\nAsian survey language \\n-0.3403 \\n0.0000\", \"(Last Updated 10/03/2024)  \\nPage 113 \\n \\nTable A-7: Coefficients of Part D Getting Needed Prescription Drugs (D06) CAHPS Measure Composite Items \\nPredictor \\nMA-PD: Get needed \\nprescription drugs \\nMA-PD: Get \\nprescription drugs \\nfrom mail or \\npharmacy \\nPDP: Get needed \\nprescription drugs \\nPDP: Get \\nprescription drugs \\nfrom mail or \\npharmacy \\nAge: 64 or under \\n-0.0756 \\n-0.0361 \\n-0.0220 \\n-0.0216 \\nAge: 65 – 69 \\n-0.0437 \\n-0.0178 \\n-0.0322 \\n-0.0191 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0032 \\n0.0069 \\n0.0131 \\n0.0043 \\nAge: 80 – 84 \\n0.0197 \\n0.0014 \\n0.0063 \\n0.0059 \\nAge: 85 and older \\n0.0158 \\n-0.0083 \\n0.0017 \\n0.0091 \\nEducation: Less than an 8th grade education \\n-0.0518 \\n-0.0477 \\n-0.1331 \\n-0.0453 \\nEducation: Some high school \\n0.0003 \\n0.0033 \\n-0.1127 \\n-0.0492 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0366 \\n-0.0400 \\n-0.0942 \\n-0.1147 \\nEducation: College graduate \\n-0.0405 \\n-0.0579 \\n-0.0563 \\n-0.0801 \\nEducation: More than a bachelor's degree \\n-0.0638 \\n-0.0784 \\n-0.1285 \\n-0.1741 \\nGeneral health rating: excellent \\n0.0200 \\n0.0621 \\n0.0942 \\n0.1142 \\nGeneral health rating: very good \\n0.0530 \\n0.0570 \\n0.1182 \\n0.0770 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0611 \\n-0.0548 \\n-0.0367 \\n-0.0675 \\nGeneral health rating: poor \\n-0.0913 \\n-0.0676 \\n-0.1688 \\n-0.0735 \\nMental health rating: excellent \\n0.0856 \\n0.0862 \\n0.0591 \\n0.0890 \\nMental health rating: very good \\n0.0544 \\n0.0532 \\n0.0056 \\n0.0065 \\nMental health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0299 \\n-0.0438 \\n0.0195 \\n-0.0041 \\nMental health rating: poor \\n-0.1165 \\n-0.1001 \\n-0.0153 \\n-0.0692 \\nProxy helped \\n0.0036 \\n0.0117 \\n0.0688 \\n0.0576 \\nProxy answered \\n0.0331 \\n0.0030 \\n0.1382 \\n0.1257 \\nMedicaid dual eligible \\n0.0571 \\n0.0223 \\n0.0252 \\n0.0005 \\nLow-income subsidy (LIS) \\n0.0487 \\n-0.0139 \\n-0.0508 \\n0.0457 \\nAsian survey language \\n-0.0582 \\n-0.0015 \\n0.0000 \\n0.0000\", '(Last Updated 10/03/2024)  \\nPage 114 \\n \\nAttachment B: Calculating Measure Data for the Surviving Contract of a Consolidation \\nFirst Year Following a Consolidation \\nIn the first year following a consolidation, the measure values for the surviving contract of a consolidation are \\ncalculated as the enrollment-weighted mean of all contracts in the consolidation. The month(s) of enrollment \\nused to calculate the enrollment weighted means varies by the type of measure. Table B-1 below lists the \\nenrollment used for each type of measure and the rule followed to determine the month(s) of enrollment. Table \\nB-2 provides an example calculation. \\nTable B-1: Enrollment Month Used in Calculating Measure Scores for the Surviving Contract of a Consolidation \\nType of Measure Rule for Which Month of Enrollment is Used Month(s) of Enrollment Used for 2025 Star Ratings \\nCAHPS \\nEnrollment at the time survey sample is pulled \\nJanuary 2024 \\nCall Center \\nAverage enrollment during the study period \\nFeb 2024 – May 2024 \\nHOS \\nEnrollment at the time survey sample is pulled \\nApril 2023 \\nHEDIS-HOS \\nEnrollment at the time survey sample is pulled \\nApril 2023 \\nHEDIS \\nEnrollment in July of the measurement period \\nJuly 2023 \\nAll Other Measures Enrollment in July of the measurement period \\nJuly 2023 \\n \\nTable B-2: Example of Calculating the Measure Score for the Surviving Contract of a Consolidation \\nContract ID Surviving or Consumed Contract Value for Breast Cancer Screening (BCS) Measure July 2023 Enrollment \\nHAAAA \\nSurviving \\n75.13 \\n43,326 \\nHAAAB \\nConsumed \\n50.91 \\n20,933 \\nValue for BCS for HAAAA  =   \\n75.13∗43,326+50.91∗20,933\\n43,326+20,933\\n = 67.240097 \\nSecond Year Following a Consolidation \\nIn the second year following a consolidation, the measure values for the surviving contract of a consolidation \\nare as reported for CAHPS, call center, HOS, and HEDIS measures. For all other measures, the measure values \\nfor the surviving contract of a consolidation are calculated as the enrollment weighted mean of all contracts in \\nthe consolidation.', '(Last Updated 10/03/2024)  \\nPage 115 \\n \\nAttachment C: National Averages for Part C and D Measures \\nThe tables below contain the average of contract numeric and star values for each measure reported in the 2025 \\nStar Ratings. The averages are calculated after the disaster adjustment has been applied. \\nTable C-1: National Averages for Part C Measures \\nMeasure ID \\nMeasure Name \\nNumeric Average \\nStar Average \\nC01 \\nBreast Cancer Screening \\n73% \\n3.4 \\nC02 \\nColorectal Cancer Screening \\n73% \\n3.4 \\nC03 \\nAnnual Flu Vaccine \\n69% \\n3.2 \\nC04 \\nMonitoring Physical Activity \\n50% \\n3.1 \\nC05 \\nSpecial Needs Plan (SNP) Care Management \\n75% \\n3.4 \\nC06 \\nCare for Older Adults – Medication Review \\n93% \\n4.1 \\nC07 \\nCare for Older Adults – Pain Assessment \\n93% \\n4.2 \\nC08 \\nOsteoporosis Management in Women who had a \\nFracture \\n43% \\n2.7 \\nC09 \\nDiabetes Care – Eye Exam \\n75% \\n3.4 \\nC10 \\nDiabetes Care – Blood Sugar Controlled \\n83% \\n3.7 \\nC11 \\nControlling Blood Pressure \\n76% \\n3.0 \\nC12 \\nReducing the Risk of Falling \\n57% \\n2.6 \\nC13 \\nImproving Bladder Control \\n45% \\n3.0 \\nC14 \\nMedication Reconciliation Post-Discharge \\n73% \\n3.6 \\nC15 \\nPlan All-Cause Readmissions \\n11% \\n3.1 \\nC16 \\nStatin Therapy for Patients with Cardiovascular \\nDisease \\n86% \\n3.0 \\nC17 \\nTransitions of Care \\n59% \\n3.0 \\nC18 \\nFollow-up after Emergency Department Visit for \\nPeople with Multiple High-Risk Chronic Conditions \\n58% \\n3.2 \\nC19 \\nGetting Needed Care \\n81 \\n3.3 \\nC20 \\nGetting Appointments and Care Quickly \\n84 \\n3.5 \\nC21 \\nCustomer Service \\n90 \\n3.5 \\nC22 \\nRating of Health Care Quality \\n87 \\n3.5 \\nC23 \\nRating of Health Plan \\n87 \\n3.2 \\nC24 \\nCare Coordination \\n87 \\n3.6 \\nC25 \\nComplaints about the Health Plan \\n0.23 \\n4.2 \\nC26 \\nMembers Choosing to Leave the Plan \\n17% \\n3.6 \\nC27 \\nHealth Plan Quality Improvement \\nMedicare only shows a Star \\nRating for this measure \\n3.6 \\nC28 \\nPlan Makes Timely Decisions about Appeals \\n96% \\n4.2 \\nC29 \\nReviewing Appeals Decisions \\n95% \\n3.7 \\nC30 \\nCall Center – Foreign Language Interpreter and \\nTTY Availability \\n94% \\n4.0', '(Last Updated 10/03/2024)  \\nPage 116 \\n \\nTable C-2: National Averages for Part D Measures \\nMeasure ID \\nMeasure Name \\nMA-PD \\nNumeric \\nAverage \\nMA-PD  \\nStar \\nAverage \\nPDP  \\nNumeric \\nAverage \\nPDP  \\nStar \\nAverage \\nD01 \\nCall Center – Foreign Language Interpreter and TTY Availability \\n94 \\n4.0 \\n97 \\n3.6 \\nD02 \\nComplaints about the Drug Plan \\n0.23 \\n4.2 \\n0.04 \\n4.6 \\nD03 \\nMembers Choosing to Leave the Plan \\n17 \\n3.6 \\n10 \\n3.7 \\nD04 \\nDrug Plan Quality Improvement \\nMedicare \\nonly shows \\na Star \\nRating for \\nthis \\nmeasure \\n3.3 \\nMedicare \\nonly shows \\na Star \\nRating for \\nthis \\nmeasure \\n3.0 \\nD05 \\nRating of Drug Plan \\n87 \\n3.4 \\n84 \\n3.5 \\nD06 \\nGetting Needed Prescription Drugs \\n89 \\n3.3 \\n89 \\n3.7 \\nD07 \\nMPF Price Accuracy \\n98 \\n3.4 \\n97 \\n3.1 \\nD08 \\nMedication Adherence for Diabetes Medications \\n86 \\n3.2 \\n86 \\n2.4 \\nD09 \\nMedication Adherence for Hypertension (RAS antagonists) \\n89 \\n3.3 \\n89 \\n2.9 \\nD10 \\nMedication Adherence for Cholesterol (Statins) \\n88 \\n3.3 \\n88 \\n2.9 \\nD11 \\nMTM Program Completion Rate for CMR \\n87 \\n3.7 \\n55 \\n3.0 \\nD12 \\nStatin Use in Persons with Diabetes (SUPD) \\n86 \\n2.8 \\n83 \\n2.7', '(Last Updated 10/03/2024)  \\nPage 117 \\n \\nAttachment D: Part C and D Data Time Frames \\n \\nTable D-1: Part C Measure Data Time Frames \\nMeasure \\nID \\nMeasure Name \\nPrimary Data Source \\nData Time Frame \\nC01 \\nBreast Cancer Screening \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC02 \\nColorectal Cancer Screening \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC03 \\nAnnual Flu Vaccine \\nCAHPS \\n03/2024 – 06/2024 \\nC04 \\nMonitoring Physical Activity \\nHEDIS-HOS \\n07/17/2023 – 11/01/2023 \\nC05 \\nSpecial Needs Plan (SNP) Care Management \\nPart C Plan Reporting \\n01/01/2023 – 12/31/2023 \\nC06 \\nCare for Older Adults – Medication Review \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC07 \\nCare for Older Adults – Pain Assessment \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC08 \\nOsteoporosis Management in Women who had a Fracture \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC09 \\nDiabetes Care – Eye Exam \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC10 \\nDiabetes Care – Blood Sugar Controlled \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC11 \\nControlling Blood Pressure \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC12 \\nReducing the Risk of Falling \\nHEDIS-HOS \\n07/17/2023 – 11/01/2023 \\nC13 \\nImproving Bladder Control \\nHEDIS-HOS \\n07/17/2023 – 11/01/2023 \\nC14 \\nMedication Reconciliation Post-Discharge \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC15 \\nPlan All-Cause Readmission \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC16 \\nStatin Therapy for Patients with Cardiovascular Disease \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC17 \\nTransitions of Care \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC18 \\nFollow-up after Emergency Department Visit for People with Multiple \\nHigh-Risk Chronic Conditions \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC19 \\nGetting Needed Care \\nCAHPS \\n03/2024 – 06/2024 \\nC20 \\nGetting Appointments and Care Quickly \\nCAHPS \\n03/2024 – 06/2024 \\nC21 \\nCustomer Service \\nCAHPS \\n03/2024 – 06/2024 \\nC22 \\nRating of Health Care Quality \\nCAHPS \\n03/2024 – 06/2024 \\nC23 \\nRating of Health Plan \\nCAHPS \\n03/2024 – 06/2024 \\nC24 \\nCare Coordination \\nCAHPS \\n03/2024 – 06/2024 \\nC25 \\nComplaints about the Health Plan \\nComplaints Tracking Module \\n(CTM) \\n01/01/2023 – 12/31/2023 \\nC26 \\nMembers Choosing to Leave the Plan \\nMBDSS \\n01/01/2023 – 12/31/2023 \\nC27 \\nHealth Plan Quality Improvement \\nStar Ratings \\nNot Applicable \\nC28 \\nPlan Makes Timely Decisions about Appeals \\nIndependent Review Entity (IRE) \\n01/01/2023 – 12/31/2023 \\nC29 \\nReviewing Appeals Decisions \\nIndependent Review Entity (IRE) \\n01/01/2023 – 12/31/2023 \\nC30 \\nCall Center – Foreign Language Interpreter and TTY Availability \\nCall Center \\n02/2024 – 05/2024', '(Last Updated 10/03/2024)  \\nPage 118 \\n \\nTable D-2: Part D Measure Data Time Frames \\nMeasure \\nID \\nMeasure Name \\nPrimary Data Source \\nData Time Frame \\nD01 \\nCall Center – Foreign Language Interpreter and TTY Availability \\nCall Center \\n02/2024 – 05/2024 \\nD02 \\nComplaints about the Drug Plan \\nComplaints Tracking Module \\n(CTM) \\n01/01/2023 – 12/31/2023 \\nD03 \\nMembers Choosing to Leave the Plan \\nMBDSS \\n01/01/2023 – 12/31/2023 \\nD04 \\nDrug Plan Quality Improvement \\nStar Ratings \\nNot Applicable \\nD05 \\nRating of Drug Plan \\nCAHPS \\n03/2024 – 06/2024 \\nD06 \\nGetting Needed Prescription Drugs \\nCAHPS \\n03/2024 – 06/2024 \\nD07 \\nMPF Price Accuracy \\nPDE data, MPF Pricing Files \\n01/01/2023 – 09/30/2023 \\nD08 \\nMedication Adherence for Diabetes Medications \\nPrescription Drug Event (PDE) \\ndata \\n01/01/2023 – 12/31/2023 \\nD09 \\nMedication Adherence for Hypertension (RAS antagonists) \\nPrescription Drug Event (PDE) \\ndata \\n01/01/2023 – 12/31/2023 \\nD10 \\nMedication Adherence for Cholesterol (Statins) \\nPrescription Drug Event (PDE) \\ndata \\n01/01/2023 – 12/31/2023 \\nD11 \\nMTM Program Completion Rate for CMR \\nPart D Plan Reporting \\n01/01/2023 – 12/31/2023 \\nD12 \\nStatin Use in Persons with Diabetes (SUPD) \\nPrescription Drug Event (PDE) \\ndata \\n01/01/2023 – 12/31/2023', '(Last Updated 10/03/2024)  \\nPage 119 \\n \\nAttachment E: SNP Measure Scoring Methodologies \\n \\n1. Medicare Part C Reporting Requirements Measure (C05: SNP Care Management) \\nStep 1: Start with all contracts that offer at least one SNP plan that was active at any point during contract \\nyear 2023. \\nStep 2: Exclude contracts that did not have 30 or more enrollees in the denominator [Number of new \\nenrollees due for an Initial HRA (Element A) + Number of enrollees eligible for an annual HRA \\n(Element B) ≥ 30] during contract year 2023.   \\nExclude any contracts with an effective termination date on or before the deadline to submit data \\nvalidation results to CMS (June 15, 2024), or that were not required to participate in data validation. \\nThis exclusion is consistent with the statement from page 6 of the CY 2023 Medicare Part C Plan \\nReporting Requirements Technical Specifications Document: “Note: If a contract terminates before \\nJuly 1 in the following year after the contract year (CY) reporting period, the contract is not \\nrequired to report any data for the respective two years – the CY reporting period, and the following \\nyear… If a PBP (Plan) under a contract terminates at any time in the CY reporting period and the \\ncontract remains active through July 1 of the following year, the contract must still report data for \\nall PBPs, including the terminated PBP.” \\nThis excludes: \\n• Contracts that terminate on or before 07/01/2024 according to the Contract Info extract. \\nAdditionally, exclude contracts that did not score at least 95% on data validation for their plan \\nreporting of the SNP Care Management section and contracts that scored 95% or higher on data \\nvalidation for the SNP Care Management section but that were not compliant with data validation \\nstandards/sub-standards for at least one of the following SNP data elements. We define a contract \\nas being non-complaint if either it receives a \"No\" or a 1, 2, or 3 on the 5-point Likert scale in the \\nspecific data element\\'s data validation. \\n \\n• Number of new enrollees due for an initial HRA (Element A) \\n• Number of enrollees eligible for an annual reassessment HRA (Element B) \\n• Number of initial HRAs performed on new enrollees (Element C) \\n• Number of annual reassessments performed on enrollees eligible for reassessment (Element \\nF) \\n \\nStep 3: After removing contract data excluded above, suppress contract rates based on the following rules: \\nSection-level DV failure: Contracts that score less than 95% in DV for their CY 2023 SNP Care \\nReporting Requirements data are listed as “CMS identified issues with this plan’s data.” \\nElement-level DV failure: Contracts that score 95% or higher in DV for their CY 2023 SNP Care \\nReporting Requirements data but that failed at least one of the four data elements (elements A, B, \\nC, and F) are listed as “CMS identified issues with this plan’s data.” \\nSmall size: Contracts that have not yet been suppressed and have a SNP Care Assessment rate \\ndenominator [Number of New Enrollees due for an Initial HRA (Element A) + Number of enrollees \\neligible for an annual reassessment HRA (Element B)] of fewer than 30 are listed as “No data \\navailable.”', '(Last Updated 10/03/2024)  \\nPage 120 \\n \\nOrganizations can view their own plan reporting data validation results in HPMS \\n(https://hpms.cms.gov/). From the home page, select Monitoring | Plan Reporting Data Validation. \\nStep 4: Calculate the rate for the remaining contract using the formula: \\n[ Number of initial HRAs performed on new enrollees (Element C) \\n+ Number of annual reassessments performed on enrollees eligible for a reassessment (Element F) ] \\n/ [ Number of new enrollees due for an Initial HRA (Element A) \\n+ Number of enrollees eligible for an annual reassessment HRA (Element B) ] \\n2. NCQA HEDIS Measures - (C06 – C07: Care for Older Adults) \\nThe example NCQA measure combining methodology specifications below are written for two Plan Benefit \\nPackage (PBP) submissions, which we distinguish as 1 and 2, but the methodology easily extends to any \\nnumber of submissions. \\nRates are produced for any contract offering a SNP in the ratings year which provided SNP HEDIS data in \\nthe measurement year. \\nDefinitions \\nLet N1 = The Total Number of Members Eligible for the HEDIS measure in the first PBP (\"fixed\" and \\nauditable) \\nLet N2 = The Total Number of Members Eligible for the HEDIS measure in the second PBP (\"fixed\" and \\nauditable) \\nLet P1 = The estimated rate (mean) for the HEDIS measure in the first PBP (auditable) \\nLet P2 = The estimated rate (mean) for the same HEDIS measure in the second PBP (auditable) \\nSetup Calculations \\nBased on the above definitions, there are two additional calculations: \\nLet W1 = The weight assigned to the first PBP results (estimated, auditable). This is estimated from the \\nformula W1 = N1 / (N1 + N2) \\nLet W2 = The weight assigned to the second PBP results (estimated, auditable). This is estimated from the \\nformula W2 = N2 / (N1 + N2) \\nPooled Analysis \\nThe pooled result from the two rates (means) is calculated as: Ppooled = W1 * P1 + W2 * P2 \\nNOTES: \\nWeights are based on the eligible member population. While it may be more accurate to remove all \\nexcluded members before weighting, NCQA and CMS have chosen not to do this (to simplify the method) \\nfor two reasons: 1) the number of exclusions relative to the size of the population should be small, and 2) \\nexclusion rates (as a percentage of the eligible population) should be similar for each PBP and negligibly \\naffect the weights. \\nIf one or more of the submissions has a status of NA, those submissions are dropped and not included in the \\nweighted rate (mean) calculations. If one or more of the submissions has an audit designation of BR or NR \\n(which has been determined to be biased or is not reported by choice of the contract), the rate is set to zero as \\ndetailed in the section titled “Handling of Biased, Erroneous and/or Not Reportable (NR) Data” and the', '(Last Updated 10/03/2024)  \\nPage 121 \\n \\naverage enrollment for the year is used for the eligible population in the PBP. An example is shown in table E-\\n1. \\nTable E-1: Example Calculation Using Effectiveness of Care Rate \\nNumeric Example Using an Effectiveness of Care Rate \\n  \\n# of Total Members Eligible for the HEDIS measure in PBP 1, N1 =  \\n1500 \\n# of Total Members Eligible for the HEDIS measure in PBP 2, N2 =  \\n2500 \\nHEDIS Result for PBP 1, Enter as a Proportion between 0 and 1, P1 = \\n0.75 \\nHEDIS Result for PBP 2, Enter as a Proportion between 0 and 1, P2 = \\n0.5 \\nSetup Calculations - Initialize Some Intermediate Results \\n \\nThe weight for PBP 1 product estimated by W1 = N1 / (N1 + N2) \\n0.375 \\nThe weight for PBP 2 product estimated by W2 = N2 / (N1 + N2) \\n0.625 \\nPooled Results \\n \\nPpooled = W1 * P1 + W2 * P2 \\n0.59375', '(Last Updated 10/03/2024)  \\nPage 122 \\n \\nAttachment F: Calculating Measure C15: Plan All-Cause Readmissions \\nAll data are available in the CMS MY 2023 HEDIS® Public Use File (PUF)1 and can be looked up by \\nIndicatorKey (row) and Variable name (column). \\nThe calculations below use the Denominator, ObservedCount and ExpectedCount values from the PCR (18-64) \\nindicator (IndicatorKey = 202025_20) and the PCR (65+) indicator (IndicatorKey = 202111_20). \\nFor each contract, calculate the (18+) Denominator, ObservedCount, and ExpectedCount: \\n \\nDenominator(18+)  \\n= Denominator(18-64) + Denominator(65+) \\n \\nObservedCount(18+)  = ObservedCount(18-64) + ObservedCount(65+) \\n \\nExpectedCount(18+)  = ExpectedCount(18-64) + ExpectedCount(65+) \\n \\nUsing these (18+) values, calculate the (18+) Observed-over-Expected ratio (OE): \\nOE(18+) = ቀ\\nObservedCount(18+)\\nExpectedCount(18+)ቁ \\nAnd the national average of the (18+) Observed Rate: \\nNatAvgObs(18+) = Average ቆ൬\\nObservedCount(18+)1\\nDenominator(18+)1 ൰ + … + ൬\\nObservedCount(18+)n\\nDenominator(18+)n ൰ቇ \\nWhere 1 through n are all contracts with a (18+) Denominator larger than or equal to 150, and a (18+) OE larger \\nthan or equal to 0.2 and less than or equal to 5.0. \\nFor each contract, calculate the Final Rate and convert to percentages: \\nFinal Rate(18+) = OE(18+) x NatAvgObs(18+) x 100  \\nAnd round to the nearest integer. \\nExample: Calculating the final rate for Contract 1 \\nContract IndicatorKey Denominator ObservedCount ExpectedCount \\nContract 1 \\n202025_20 \\n214 \\n8 \\n12 \\nContract 1 \\n202111_20 \\n4,792 \\n641 \\n642 \\nContract 2 \\n202025_20 \\n225 \\n12 \\n7 \\nContract 2 \\n202111_20 \\n4,761 \\n688 \\n668 \\nContract 3 \\n202025_20 \\n573 \\n31 \\n35 \\nContract 3 \\n202111_20 \\n8,629 \\n1,126 \\n1,070 \\nContract 4 \\n202025_20 \\n12 \\n0 \\n1 \\nContract 4 \\n202111_20 \\n533 \\n79 \\n73 \\nNatAvgObs = Average ቆቀ\\n8+641 \\n214+4,792ቁ + ቀ\\n12+688\\n225+4,761ቁ + ቀ\\n31+1,126\\n573+8,629ቁ + ቀ\\n0+79\\n12+533ቁቇ \\nNatAvgObs = 0.135181 \\nOE Contract 1 = ቀ\\n8+641\\n12+642ቁ = 0.992355 \\nFinal Rate Contract 1 = 0.992355 ×  0.135181 x 100 =  13.41 \\nFinal Rate reported for Contract 1 = 13% \\n \\nThe actual calculated National Observed Rate used in the 2025 Star Ratings was 0.110821345940212. \\n \\n1 https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-\\nReports/MCRAdvPartDEnrolData/MA-HEDIS-Public-Use-Files', '(Last Updated 10/03/2024)  \\nPage 123 \\n \\n \\nAttachment G: Weights Assigned to Individual Performance Measures \\n \\nTable G-1: Part C Measure Weights \\nMeasure \\nID \\nMeasure Name \\nWeighting Category \\nPart C \\nSummary and \\nMA-PD Overall \\nC01 \\nBreast Cancer Screening \\nProcess Measure \\n1 \\nC02 \\nColorectal Cancer Screening \\nProcess Measure \\n1 \\nC03 \\nAnnual Flu Vaccine \\nProcess Measure \\n1 \\nC04 \\nMonitoring Physical Activity \\nProcess Measure \\n1 \\nC05 \\nSpecial Needs Plan (SNP) Care Management \\nProcess Measure \\n1 \\nC06 \\nCare for Older Adults – Medication Review \\nProcess Measure \\n1 \\nC07 \\nCare for Older Adults – Pain Assessment \\nProcess Measure \\n1 \\nC08 \\nOsteoporosis Management in Women who had a Fracture \\nProcess Measure \\n1 \\nC09 \\nDiabetes Care – Eye Exam \\nProcess Measure \\n1 \\nC10 \\nDiabetes Care – Blood Sugar Controlled \\nIntermediate Outcome Measure \\n3 \\nC11 \\nControlling Blood Pressure \\nIntermediate Outcome Measure \\n3 \\nC12 \\nReducing the Risk of Falling \\nProcess Measure \\n1 \\nC13 \\nImproving Bladder Control \\nProcess Measure \\n1 \\nC14 \\nMedication Reconciliation Post-Discharge \\nProcess Measure \\n1 \\nC15 \\nPlan All-Cause Readmissions \\nOutcome Measure \\n3 \\nC16 \\nStatin Therapy for Patients with Cardiovascular Disease \\nProcess Measure \\n1 \\nC17 \\nTransitions of Care \\nProcess Measure \\n1 \\nC18 \\nFollow-up after Emergency Department Visit for People with Multiple \\nHigh-Risk Chronic Conditions \\nProcess Measure \\n1 \\nC19 \\nGetting Needed Care \\nPatients’ Experience and Complaints Measure \\n4 \\nC20 \\nGetting Appointments and Care Quickly \\nPatients’ Experience and Complaints Measure \\n4 \\nC21 \\nCustomer Service \\nPatients’ Experience and Complaints Measure \\n4 \\nC22 \\nRating of Health Care Quality \\nPatients’ Experience and Complaints Measure \\n4 \\nC23 \\nRating of Health Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nC24 \\nCare Coordination \\nPatients’ Experience and Complaints Measure \\n4 \\nC25 \\nComplaints about the Health Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nC26 \\nMembers Choosing to Leave the Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nC27 \\nHealth Plan Quality Improvement \\nImprovement Measure \\n5 \\nC28 \\nPlan Makes Timely Decisions about Appeals \\nMeasures Capturing Access \\n4 \\nC29 \\nReviewing Appeals Decisions \\nMeasures Capturing Access \\n4 \\nC30 \\nCall Center – Foreign Language Interpreter and TTY Availability \\nMeasures Capturing Access \\n4', '(Last Updated 10/03/2024)  \\nPage 124 \\n \\nTable G-2: Part D Measure Weights \\nMeasure \\nID \\nMeasure Name \\nWeighting Category \\nPart D \\nSummary and \\nMA-PD Overall \\nD01 \\nCall Center – Foreign Language Interpreter and TTY Availability \\nMeasures Capturing Access \\n4 \\nD02 \\nComplaints about the Drug Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nD03 \\nMembers Choosing to Leave the Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nD04 \\nDrug Plan Quality Improvement \\nImprovement Measure \\n5 \\nD05 \\nRating of Drug Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nD06 \\nGetting Needed Prescription Drugs \\nPatients’ Experience and Complaints Measure \\n4 \\nD07 \\nMPF Price Accuracy \\nProcess Measure \\n1 \\nD08* \\nMedication Adherence for Diabetes Medications \\nIntermediate Outcome Measure \\n3 \\nD09* \\nMedication Adherence for Hypertension (RAS antagonists) \\nIntermediate Outcome Measure \\n3 \\nD10* \\nMedication Adherence for Cholesterol (Statins) \\nIntermediate Outcome Measure \\n3 \\nD11 \\nMTM Program Completion Rate for CMR \\nProcess Measure \\n1 \\nD12 \\nStatin Use in Persons with Diabetes (SUPD) \\nProcess Measure \\n1 \\n*For contracts whose service area only covers Puerto Rico, the weight for each adherence measure is set to zero (0) when calculating \\nthe summary and overall rating.', '(Last Updated 10/03/2024)  \\nPage 125 \\n \\nAttachment H: Calculation of Weighted Star Rating and Variance Estimates \\nThe weighted summary (or overall) Star Rating for contract j is estimated as: \\n𝑥𝑥̅𝑗𝑗=\\n\\u0dcd\\n𝑤𝑤𝑖𝑖𝑖𝑖𝑥𝑥𝑖𝑖𝑖𝑖\\n𝑛𝑛𝑗𝑗\\n𝑖𝑖=1\\n\\u0dcd\\n𝑤𝑤𝑖𝑖𝑖𝑖\\n𝑛𝑛𝑗𝑗\\n𝑖𝑖=1\\n \\nwhere nj is the number of performance measures for which contract j is eligible; wij is the weight assigned to \\nperformance measure i for contract j; and xij is the measure star for performance measure i for contract j. The \\nvariance of the Star Ratings for each contract 𝑗𝑗, 𝑠𝑠𝑗𝑗\\n2, must also be computed in order to estimate the reward factor \\n(r-Factor): \\n𝑠𝑠𝑗𝑗\\n2 =\\n𝑛𝑛𝑗𝑗\\n൫𝑛𝑛𝑗𝑗−1൯൫∑\\n𝑤𝑤𝑖𝑖𝑖𝑖\\n𝑛𝑛𝑗𝑗\\n𝑖𝑖=1\\n൯\\n\\u0d64\\u0dcd\\n𝑤𝑤𝑖𝑖𝑖𝑖\\n𝑛𝑛𝑗𝑗\\n𝑖𝑖=1\\n൫𝑥𝑥𝑖𝑖𝑖𝑖−𝑥𝑥𝚥𝚥ഥ൯\\n2൨ \\nThus, the 𝑥𝑥𝚥𝚥ഥ’s are the new summary (or overall) Star Ratings for the contracts. The variance estimate, 𝑠𝑠𝑗𝑗\\n2, simply \\nreplaces the non-weighted variance estimate that was previously used for the r-Factor calculation. For all \\ncontracts j, wij = wi (i.e., the performance measure weights are the same for all contracts when estimating a \\ngiven Star Rating (Part C or Part D summary or MA-PD overall ratings).', '(Last Updated 10/03/2024)  \\nPage 126 \\n \\nAttachment I: Calculating the Improvement Measure and the Measures Used \\nCalculating the Improvement Measure \\nContracts must have data for at least half of the attainment measures used to calculate the Part C or Part D \\nimprovement measure to be eligible to receive a rating in that improvement measure. \\nThe improvement change score was determined for each measure for which a contract was eligible by \\ncalculating the difference in measure scores between Star Rating years 2024 and 2025.  \\nFor measures where a higher score is better: \\nImprovement\\u2008Change\\u2008Score\\u2008=\\u2008Score\\u2008in\\u20082025\\u2008-\\u2008Score\\u2008in\\u20082024 \\nFor measures where a lower score is better: \\nImprovement\\u2008Change\\u2008Score\\u2008=\\u2008Score\\u2008in\\u20082024\\u2008-\\u2008Score\\u2008in\\u20082025 \\nAn eligible measure was defined as a measure for which a contract was scored in both the 2024 and 2025 Star \\nRatings, and there were no significant measure specification changes or a regional contract reconfiguration for \\nwhich only contract data is available from the original contract in one or both years. \\nFor each measure, significant improvement or decline between Star Ratings years 2024 and 2025 was \\ndetermined by a two-sided t-test at the 0.05 significance level: \\nIf \\nImprovement Change Score\\nStandard Error of Improvement Change Score  > 1.96, then YES = significant improvement \\nIf \\nImprovement Change Score\\nStandard Error of Improvement Change Score  < -1.96, then YES = significant decline \\nHold Harmless Provision for Individual Measures: If a contract demonstrated statistically significant decline (at \\nthe 0.05 significance level) on an attainment measure for which they received five stars during both the current \\ncontract year and the prior contract year, then this measure will be counted as showing no significant change. \\nMeasures that are held harmless as described here will be considered eligible for the improvement measure. \\nNet improvement is calculated for each class of measures (e.g., outcome, access, and process) by subtracting the \\nnumber of significantly declined measures from the number of significantly improved measures. \\nNet Improvement = Number of significantly improved measures - Number of significantly declined measures \\nThe improvement measure score is calculated for Parts C and D separately by taking a weighted sum of net \\nimprovement divided by the weighted sum of the number of eligible measures. \\nMeasures are generally weighted as follows: \\nOutcome or intermediate outcome measure: Weight of 3 \\nAccess or patient experience/complaints measure: Weight of 4 \\nProcess measure: Weight of 1 \\nSpecific weights for each measure, which may deviate from the general scheme above are described in \\nAttachment G. When the weight of an individual measure changes over the two years of data used, the newer \\nweight value is used in the improvement calculation. \\nImprovement Measure Score = Net_Imp_Process + 3 * Net_Imp_Outcome + 4 * Net_Imp_PtExp\\nElig_Process  + 3 * Elig_Outcome + 4 * Elig_PtExp', '(Last Updated 10/03/2024)  \\nPage 127 \\n \\n \\nNet_Imp_Process = Net improvement for process measures \\nNet_Imp_Outcome = Net improvement for outcome and intermediate outcome measures \\nNet_Imp_PtExp = Net improvement for patient experience/complaints and access measures \\nElig_Process = Number of eligible process measures \\nElig_Outcome = Number of eligible outcome and intermediate outcome measures \\nElig_PtExp = Number of eligible patient experience/complaints and access measures \\n \\nThe improvement measure score is converted into a Star Rating using the clustering method. Conceptually, the \\nclustering algorithm identifies the “gaps” in the data and creates cut points that result in the creation of five \\ncategories (one for each Star Rating) such that scores of contracts in the same score category (Star Rating) are \\nas similar as possible, and scores of contracts in different categories are as different as possible. Improvement \\nscores of 0 (equivalent to no net change on the attainment measures included in the improvement measure \\ncalculation) will be centered at 3 stars when assigning the improvement measure Star Rating. Then, the \\nremaining contracts are split into two groups and clustered:  1) improvement scores less than zero receive one or \\ntwo stars on the improvement measure and 2) improvement scores greater than or equal to zero receive 3, 4, or \\n5 stars. \\nGeneral Standard Error Formula \\nBecause a contract’s score on a given measure in one year is not independent of its score in the next year, the \\nstandard error for the improvement change score for each measure is calculated using the standard approach for \\nestimating the variance of the difference between two variables that may not be independent. In particular, the \\nstandard error of the improvement change score is calculated using the formula: \\nඥ𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2)2 + 𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1)2 −2 ∗𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) \\nUsing measure C01 as an example, the change score standard error is: \\n𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2) Represents the 2025 standard error for contract i on measure C01 \\n𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1) Represents the 2024 standard error for contract i on measure C01 \\n𝑌𝑌𝑖𝑖2 \\nRepresents the 2025 rate for contract i on measure C01 \\n𝑌𝑌𝑖𝑖1 \\nRepresents the 2024 rate for contract i on measure C01 \\n𝑐𝑐𝑐𝑐𝑐𝑐 \\nRepresents the covariance between 𝑌𝑌𝑖𝑖2 and 𝑌𝑌𝑖𝑖1computed using the correlation across all contracts \\nobserved at both time points (2025 and 2024). In other words: \\n𝑐𝑐𝑐𝑐𝑐𝑐(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) = 𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2) ∗𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1) ∗𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1)  \\nwhere the correlation 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) is assumed to be the same for all contracts and is computed using data for \\nall contracts for which both years’ measure scores are available and not excluded by the disaster policy. This \\nassumption is needed because only one score is observed for each contract in each year; therefore, it is not \\npossible to compute a contract-specific correlation. \\nImprovement Change Score Standard Error Numerical Example \\nFor measure C03, contract A: \\n𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2) = 2.805 \\n𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1) = 3.000 \\n𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) = 0.901', '(Last Updated 10/03/2024)  \\nPage 128 \\n \\nImprovement change score standard error for measure C03 for contract A = sqrt (2.8052 + 3.0002 – 2 * 0.901 * \\n2.805 * 3.000) = 1.305 \\nStandard Error Formulas (SEF) for Specific Measures \\nThe following formulas are used for calculating the contract-specific standard errors for specific measures in the \\n2025 Star Ratings. These standard errors are used in calculating the improvement change score standard error. \\n1. SEF for Measures: C01, C02, C04, C05, C08 – C14, C16, C18, C26, C28 – C30, D01, D03, D08 – D12 \\nSEy= ඨ\\nScorey*(100-Scorey)\\nDenominatory\\n \\nfor y = 2024, 2025 \\nDenominatory is as defined in the Measure Details section for each measure. \\n2. SEF for Measures: C06, C07 \\nThese measures are rolled up from the plan level to the contract level following the formula outlined in \\nAttachment E: NCQA HEDIS Measures. The standard error at the contract level is calculated as shown below.  \\nThe specifications are written for two PBP submissions, which we distinguish as 1 and 2, but the methodology \\neasily extends to any number of submissions. \\nThe plan level standard error is calculated as: \\nSEyj= ඨ\\nScoreyj*(100-Scoreyj)\\nDenominatoryj\\n \\nfor y = 2024, 2025 and j = Plan 1, Plan 2 \\nThe contract level standard error is then calculated as: \\nLet Wy1 = The weight assigned to the first PBP results (estimated, auditable) for year y, where y = 2024, 2025. \\nThis result is estimated by the formula Wy1 = Ny1 / (N y1 + Ny2) \\nLet Wy2 = The weight assigned to the second PBP results (estimated, auditable) for year y, where y = 2024, \\n2025. This result is estimated by the formula  \\nWy2 = Ny2 / (Ny1+ Ny2) \\nSEyi= ට(Wy1)2*(SEy1)2+(Wy2)2*(SEy2)2   \\nfor y = Contract Year 2024, Contract Year 2025 and i = Contract i \\n3. SEF for Measure C15 \\nSEy = 100 ∗National Observed Ratey ∗ඨ\\nOberved County\\nExpected County2  \\nfor y = 2024, 2025 \\nNational Observed Rate, Observed Count, and Expected Count as defined in Attachment F. \\n4. SEF for Measure C17 \\nLet T1y, T2y, T3y, and T4y be the four Transitions of Care component measures.  \\nLet Zy be the Transitions of Care measure, which is calculated as an average of the four component measures.', '(Last Updated 10/03/2024)  \\nPage 129 \\n \\nVar(Zy) = 1\\n16 ∗[Var൫T1y൯+ Var൫T2y൯+ Var൫T3y൯+ Var൫T4y൯+ 2Cov൫T1y, T2y൯+ 2Cov൫T1y, T3y൯\\n+ 2Cov൫T1y, T4y൯+ 2Cov൫T2y, T3y൯+ 2Cov൫T2y, T4y൯+ 2Cov൫T3y, T4y൯] \\nSEy = ටVar(Zy) \\nfor y = 2024, 2025 \\nIn the above formula, 𝑉𝑉𝑉𝑉𝑉𝑉൫𝑇𝑇1𝑦𝑦൯= (100 ∗\\n𝑛𝑛1𝑦𝑦\\n𝑑𝑑1𝑦𝑦) ∗\\n(100−(100∗\\n𝑛𝑛1𝑦𝑦\\n𝑑𝑑1𝑦𝑦)\\n𝑑𝑑1𝑦𝑦\\n where n1y is the numerator for T1y and d1y the \\ndenominator, and so on for each of the four component measures.  \\n𝐶𝐶𝐶𝐶𝐶𝐶൫𝑇𝑇1𝑦𝑦, 𝑇𝑇2𝑦𝑦൯= 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶൫𝑇𝑇1𝑦𝑦, 𝑇𝑇2𝑦𝑦൯∗ඥ𝑉𝑉𝑉𝑉𝑉𝑉(𝑇𝑇1𝑦𝑦) ∗ඥ𝑉𝑉𝑉𝑉𝑉𝑉(𝑇𝑇2𝑦𝑦)  and so on for each pair of component measures. \\nWe estimate the correlations between pairs of component measures by calculating the sample correlation across \\nall contract scores. These correlations are shown in the table below. \\n \\nMeasures \\n2024 Correlation \\n2025 Correlation \\nPatient Engagement After Inpatient Discharge \\nReceipt of Discharge Information \\n0.5365156597 \\n0.5723177632 \\nPatient Engagement After Inpatient Discharge \\nNotification of Inpatient Admission \\n0.5772548760 \\n0.4998099740 \\nPatient Engagement After Inpatient Discharge \\nMedication Reconciliation Post-Discharge \\n0.6402980802 \\n0.5632670669 \\nReceipt of Discharge Information \\nNotification of Inpatient Admission \\n0.8834120211 \\n0.7605860074 \\nReceipt of Discharge Information \\nMedication Reconciliation Post-Discharge \\n0.4149497554 \\n0.4270200633 \\nNotification of Inpatient Admission \\nMedication Reconciliation Post-Discharge \\n0.5010530425 \\n0.5317177847 \\n \\n5. SEF for Measures: C03, C19 – C24, and D05, D06 \\nThe CAHPS measure standard errors for 2024 and 2025 were provided to CMS by the CAHPS contractor \\nfollowing the formulas documented in the CAHPS Macro Manual. The actual values used for each contract are \\nincluded on the Measure Detail CAHPS page in the HPMS preview area. \\n6. SEF for Measures: C25, D02 \\nSEy=ඨ\\nTotal Number of Complaintsy\\n(Average Contract Enrollmenty)2 * 1000*30\\nNumDays \\nNumDays: 2024 = 365, 2025 = 365 \\n7. SEF for Measure D07 \\nThe standard error of the MPF Composite Price Accuracy Score for each contract is calculated by using \\nbinomial approximations for each of the component scores (Price Accuracy Score and Claim Percentage Score, \\nas described in Attachment M). Since the MPF Composite Price Accuracy Score is equal to (0.5 x Price \\nAccuracy Score) + (0.5 x Claim Percentage Score), the composite measure’s variance (and standard error) is a \\nfunction of the variance of the Price Accuracy Score, the variance of the Claim Percentage Score, and the \\ncovariance between them. We assume that the product of the total PDE cost and the Price Accuracy Score (on a \\n0-1 scale) follows a binomial distribution, and likewise that the product of the number of PDE claims and the \\nClaims Percentage Score (on a 0-1 scale) also follows a binomial distribution. With these assumptions in place, \\nthe standard error of the MPF Composite Accuracy Score is calculated as follows:', '(Last Updated 10/03/2024)  \\nPage 130 \\n \\n1. The contract’s component scores, on their original 0-100 scale, have variances calculable using formulas \\nbased on the binomial variance assumptions described above, separately for each year y = 2024, 2025. \\n \\na. For the Price Accuracy Score, the variance in year y is represented by  \\n \\n𝑉𝑉𝑉𝑉𝑉𝑉൫𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯=\\nቀ𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦× ൫100 −𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯ቁ\\n𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑃𝑃𝑃𝑃𝑃𝑃 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝑦𝑦\\n \\n \\nb. For the Claim Percentage Score, the variance in year y is represented by  \\n \\n𝑉𝑉𝑉𝑉𝑉𝑉൫𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯=\\nቀ𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦× ൫100 −𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯ቁ\\n𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 𝑜𝑜𝑜𝑜 𝑃𝑃𝑃𝑃𝑃𝑃 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝑦𝑦\\n \\n \\n2. The contract-specific covariance between the component scores, shown as \\n𝐶𝐶𝐶𝐶𝐶𝐶൫𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦, 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯ in step 3 below, is calculated as the product of:  \\na. the contract-specific standard errors of the two component scores, which are the square roots of \\nthe two variance estimates shown above in step 1, and  \\nb. the correlation between the two component scores estimated based on all contracts. The \\ncorrelations for the two measurement years are show below. \\n \\n2024 Correlation \\n2025 Correlation \\n0.6214825861 \\n0.5681259498 \\n \\n3. The standard error of the MPF Composite Price Accuracy Score is calculated from the components \\ncalculated in steps 1 and 2 as shown below: \\n \\n𝑆𝑆𝑆𝑆𝑦𝑦\\n= ඨ𝑉𝑉𝑉𝑉𝑉𝑉൫𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯\\n4\\n+ 𝑉𝑉𝑉𝑉𝑉𝑉൫𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯\\n4\\n+ 𝐶𝐶𝐶𝐶𝐶𝐶൫𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦, 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯\\n2\\n \\n \\nfor y = 2024, 2025', '(Last Updated 10/03/2024)  \\nPage 131 \\n \\nStar Ratings Measures Used in the Improvement Measures \\nTable I-1: Part C Measures Used in the Improvement Measure \\nMeasure ID \\nMeasure Name \\nMeasure Usage \\nCorrelation \\nC01 \\nBreast Cancer Screening \\nIncluded \\n0.950135 \\nC02 \\nColorectal Cancer Screening \\nIncluded \\n0.896510 \\nC03 \\nAnnual Flu Vaccine \\nIncluded \\n0.888026 \\nC04 \\nMonitoring Physical Activity \\nIncluded \\n0.845098 \\nC05 \\nSpecial Needs Plan (SNP) Care \\nManagement \\nIncluded \\n0.889508 \\nC06 \\nCare for Older Adults – Medication \\nReview \\nIncluded \\n0.651050 \\nC07 \\nCare for Older Adults – Pain \\nAssessment \\nIncluded \\n0.472401 \\nC08 \\nOsteoporosis Management in \\nWomen who had a Fracture \\nIncluded \\n0.848314 \\nC09 \\nDiabetes Care – Eye Exam \\nIncluded \\n0.855310 \\nC10 \\nDiabetes Care – Blood Sugar \\nControlled \\nIncluded \\n0.779129 \\nC11 \\nControlling Blood Pressure \\nIncluded \\n0.787937 \\nC12 \\nReducing the Risk of Falling \\nIncluded \\n0.842070 \\nC13 \\nImproving Bladder Control \\nIncluded \\n0.480390 \\nC14 \\nMedication Reconciliation Post-\\nDischarge \\nIncluded \\n0.818848 \\nC15 \\nPlan All-Cause Readmissions \\nIncluded \\n0.622494 \\nC16 \\nStatin Therapy for Patients with \\nCardiovascular Disease \\nIncluded \\n0.730543 \\nC17 \\nTransitions of Care \\nIncluded \\n0.845898 \\nC18 \\nFollow-up after Emergency \\nDepartment Visit for People with \\nMultiple High-Risk Chronic \\nConditions \\nIncluded \\n0.739526 \\nC19 \\nGetting Needed Care \\nIncluded \\n0.796622 \\nC20 \\nGetting Appointments and Care \\nQuickly \\nIncluded \\n0.477681 \\nC21 \\nCustomer Service \\nIncluded \\n0.709932 \\nC22 \\nRating of Health Care Quality \\nIncluded \\n0.715693 \\nC23 \\nRating of Health Plan \\nIncluded \\n0.859045 \\nC24 \\nCare Coordination \\nIncluded \\n0.670450 \\nC25 \\nComplaints about the Health Plan \\nIncluded \\n0.826982 \\nC26 \\nMembers Choosing to Leave the \\nPlan \\nIncluded \\n0.887075 \\nC27 \\nHealth Plan Quality Improvement \\nNot Included \\n - \\nC28 \\nPlan Makes Timely Decisions about \\nAppeals \\nIncluded \\n0.329153 \\nC29 \\nReviewing Appeals Decisions \\nIncluded \\n0.610325 \\nC30 \\nCall Center – Foreign Language \\nInterpreter and TTY Availability \\nIncluded \\n0.280278', '(Last Updated 10/03/2024)  \\nPage 132 \\n \\nTable I-2: Part D Measures Used in the Improvement Measure \\nMeasure ID \\nMeasure Name \\nMeasure Usage \\nCorrelation \\nD01 \\nCall Center – Foreign Language \\nInterpreter and TTY Availability \\nIncluded \\n0.303658 \\nD02 \\nComplaints about the Drug Plan \\nIncluded \\n0.832704 \\nD03 \\nMembers Choosing to Leave the \\nPlan \\nIncluded \\n0.881507 \\nD04 \\nDrug Plan Quality Improvement \\nNot Included \\n - \\nD05 \\nRating of Drug Plan \\nIncluded \\n0.817940 \\nD06 \\nGetting Needed Prescription Drugs \\nIncluded \\n0.659200 \\nD07 \\nMPF Price Accuracy \\nIncluded \\n0.643115 \\nD08 \\nMedication Adherence for Diabetes \\nMedications \\nIncluded \\n0.644643 \\nD09 \\nMedication Adherence for \\nHypertension (RAS antagonists) \\nIncluded \\n0.812564 \\nD10 \\nMedication Adherence for \\nCholesterol (Statins) \\nIncluded \\n0.807284 \\nD11 \\nMTM Program Completion Rate for \\nCMR \\nIncluded \\n0.867800 \\nD12 \\nStatin Use in Persons with Diabetes \\n(SUPD) \\nIncluded \\n0.836392', '(Last Updated 10/03/2024)  \\nPage 133 \\n \\nAttachment J: Star Ratings Measure History \\nThe tables below cross-reference the measures code in each of the yearly Star Ratings releases. Measure codes that begin with DM are display measures \\nwhich are posted on CMS.gov on this page: http://go.cms.gov/partcanddstarratings. \\nTable J-1: Part C Measure History \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Access to Primary Care Doctor Visits \\nHEDIS \\n \\n \\nDMC08 DMC09 DMC09 DMC09 DMC09 DMC10 DMC10 DMC11 DMC10 DMC12 DMC12 C11 \\nC Adult BMI Assessment \\nHEDIS \\n \\n \\n \\n \\nC07 \\nC07 \\nC07 \\nC07 \\nC07 \\nC07 \\nC08 \\nC10 \\nC10 \\nC12 \\nC Annual Flu Vaccine \\nCAHPS \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC04 \\nC06 \\nC06 \\nC06 \\nC Antidepressant Medication \\nManagement (6 months) \\nHEDIS \\nDMC02 DMC02 DMC02 DMC02 DMC02 DMC02 DMC02 DMC02 DMC02 DMC03 DMC03 DMC03 DMC03 DMC03 \\nC Appropriate Monitoring of Patients \\nTaking Long-term Medications \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\nDMC04 DMC04 DMC05 DMC05 DMC05 DMC05 DMC05 \\nC Asthma Medication Ratio \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\nDMC18 DMC27   \\n  \\n  \\n  \\n  \\nC Beneficiary Access and Performance \\nProblems \\nAdministrative \\nData \\nDME07 DME07 DME07 DME07 DME07 DME07 DME07 C30 \\nC28 \\nC28 \\nDME08 C31 \\nC31 \\nC32 \\nC Breast Cancer Screening \\nHEDIS \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nDMC22 C01 \\nC01 \\nC01 \\nC Call Answer Timeliness \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\nDMC02 DMC02 DMC02 DMC02 DMC02 \\nC Call Center – Beneficiary Hold Time \\nCall Center \\nMonitoring \\nDMC06 DMC06 DMC06 DMC07 DMC07 DMC07 DMC07 DMC08 DMC08 DMC09   \\nDMC09 DMC09 DMC09 \\nC Call Center - Calls Disconnected When \\nCustomer Calls Health Plan \\nCall Center \\nMonitoring \\nDMC09 DMC09 DMC09 DMC10 DMC10 DMC10 DMC10 DMC11 DMC11 DMC12   \\nDMC15 DMC15   \\nC Call Center – CSR Understandability \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nC Call Center – Foreign Language \\nInterpreter and TTY Availability \\nCall Center \\nMonitoring \\nC30 \\nC30 \\nC28 \\nC28 \\nC32 \\nC33 \\nC34 \\nC34 \\nC32 \\nC32 \\n  \\nC36 \\nC36 \\nC36 \\nC Call Center – Information Accuracy \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\nDMC10 DMC10 DMC10 \\nC Cardiac Rehabilitation – Achievement  HEDIS \\nDMC25 DMC25 DMC29  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Cardiac Rehabilitation – Engagement 1 HEDIS \\nDMC26 DMC26 DMC30  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Cardiac Rehabilitation – Engagement 2 HEDIS \\nDMC27 DMC27 DMC31  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Cardiac Rehabilitation – Initiation \\nHEDIS \\nDMC28 DMC28 DCM32  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Cardiovascular Care – Cholesterol \\nScreening \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nC02 \\nC03 \\nC03 \\nC03 \\nC Care Coordination \\nCAHPS \\nC24 \\nC24 \\nC22 \\nC22 \\nC26 \\nC27 \\nC28 \\nC27 \\nC25 \\nC25 \\nC28 \\nC29 \\nC29', '(Last Updated 10/03/2024)  \\nPage 134 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Care for Older Adults – Functional \\nStatus Assessment \\nHEDIS \\nDMC21 DMC21 DMC25 DCM25 C10 \\nC10 \\nC10 \\nC10 \\nC10 \\nC10 \\nC11 \\nC12 \\nC12 \\nC14 \\nC Care for Older Adults – Medication \\nReview \\nHEDIS \\nC06 \\nC06 \\nC06 \\nC06 \\nC09 \\nC09 \\nC09 \\nC09 \\nC09 \\nC09 \\nC10 \\nC11 \\nC11 \\nC13 \\nC Care for Older Adults – Pain \\nAssessment \\nHEDIS \\nC07 \\nC07 \\nC07 \\nC07 \\nC11 \\nC11 \\nC11 \\nC11 \\nC11 \\nC11 \\nC12 \\nC13 \\nC13 \\nC15 \\nC Colorectal Cancer Screening \\nHEDIS \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC01 \\nC02 \\nC02 \\nC02 \\nC Colorectal Cancer Screening – Age 45-\\n75 \\nHEDIS \\nDMC29 DMC29  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Complaints about the Health Plan \\nCTM \\nC25/D02 C25/D02 C23/D02 C23/D02 C27/ \\nD04 \\nC28/ \\nD04 \\nC29 / \\nD04 \\nC28 / \\nD04 \\nC26 / \\nD04 \\nC26 / \\nD04 \\nC29 / \\nD03 \\nC30 / \\nD04 \\nC30 / \\nD06 \\nC31 / \\nD06 \\nC Computer use by provider helpful \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC20 DMC21 DMC20   \\n  \\n  \\nC Computer use made talking to provider \\neasier \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC21 DMC22 DMC21   \\n  \\n  \\nC Computer used during office visits \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC19 DMC20 DMC19   \\n  \\n  \\nC Continuous Beta Blocker Treatment \\nHEDIS \\nDMC03 DMC03 DMC03 DMC03 DMC03 DMC03 DMC03 DMC03 DMC03 DMC04 DMC04 DMC04 DMC04 DMC04 \\nC Controlling Blood Pressure \\nHEDIS \\nC11 \\nC11 \\nC12 \\nDMC16 DMC16 DMC17 C16 \\nC16 \\nC16 \\nC16 \\nC18 \\nC19 \\nC19 \\nC21 \\nC Customer Service \\nCAHPS \\nC21 \\nC21 \\nC19 \\nC19 \\nC23 \\nC24 \\nC25 \\nC24 \\nC22 \\nC22 \\nC25 \\nC26 \\nC26 \\nC28 \\nC Diabetes Care – Blood Sugar \\nControlled \\nHEDIS \\nC10 \\nC10 \\nC11 \\nC11 \\nC15 \\nC15 \\nC15 \\nC15 \\nC15 \\nC15 \\nC16 \\nC17 \\nC17 \\nC19 \\nC Diabetes Care – Cholesterol Controlled HEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nC17 \\nC18 \\nC18 \\nC20 \\nC Diabetes Care – Cholesterol Screening HEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nC03 \\nC04 \\nC04 \\nC04 \\nC Diabetes Care – Eye Exam \\nHEDIS \\nC09 \\nC09 \\nC09 \\nC09 \\nC13 \\nC13 \\nC13 \\nC13 \\nC13 \\nC13 \\nC14 \\nC15 \\nC15 \\nC17 \\nC Diabetes Care – Kidney Disease \\nMonitoring \\nHEDIS \\n \\n \\nC10 \\nC10 \\nC14 \\nC14 \\nC14 \\nC14 \\nC14 \\nC14 \\nC15 \\nC16 \\nC16 \\nC18 \\nC Doctors who Communicate Well \\nCAHPS \\nDMC05 DMC05 DMC05 DMC06 DMC06 DMC06 DMC06 DMC07 DMC07 DMC08 DMC08 DMC08 DMC08 DMC08 \\nC Engagement of Substance Use \\nDisorder (SUD) Treatment \\nHEDIS \\nDMC13 DMC13 DMC13 DMC14 DMC14 DMC14 DMC14 DMC15 DMC15 DMC16 DMC15 DMC19   \\n  \\nC Enrollment Timeliness \\nMARx \\n \\n \\n \\n \\n \\n \\n  \\nDME01 DME01 DME01 DME01 DME01 C37 / \\nD05 \\nD05 \\nC Follow-up after Emergency Department \\nVisit for People with Multiple High-Risk \\nChronic Conditions \\nHEDIS \\nC18 \\nC18 \\nDMC15 DMC17 DMC17 DMC18', '(Last Updated 10/03/2024)  \\nPage 135 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Follow-up visit after Hospital Stay for \\nMental Illness (within 30 days of \\nDischarge) \\nHEDIS \\nDMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 \\nC Getting Appointments and Care Quickly CAHPS \\nC20 \\nC20 \\nC18 \\nC18 \\nC22 \\nC23 \\nC24 \\nC23 \\nC21 \\nC21 \\nC24 \\nC25 \\nC25 \\nC27 \\nC Getting Needed Care \\nCAHPS \\nC19 \\nC19 \\nC17 \\nC17 \\nC21 \\nC22 \\nC23 \\nC22 \\nC20 \\nC20 \\nC23 \\nC24 \\nC24 \\nC26 \\nC Glaucoma Testing \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\nC05 \\nC05 \\nC05 \\nC Grievance Rate \\nPart C & D \\nPlan Reporting \\nDME01 DME01 DME01 DME01 DME01 DME01 DME01 DME02 DME02 DME02 DME02 DMC13 \\n/ \\nDMD11 \\nDMC13 \\n/ \\nDMD11 \\n  \\nC Health Plan Quality Improvement \\nStar Ratings \\nC27 \\nC27 \\nC25 \\nC25 \\nC29 \\nC30 \\nC31 \\nC31 \\nC29 \\nC29 \\nC31 \\nC33 \\nC33 \\n  \\nC Hospitalizations for Potentially \\nPreventable Complications \\nHEDIS \\nDMC15 DMC15 DMC14 DMC15 DMC15 DMC15 DMC15 DMC16 DMC24   \\n  \\n  \\n  \\n  \\nC Improving Bladder Control \\nHEDIS-HOS \\nC13 \\nC13 \\nC14 \\nC14 \\nC18 \\nC18 \\nC19 \\nC19 \\nDMC22 DMC23 C20 \\nC21 \\nC21 \\nC23 \\nC Improving or Maintaining Mental Health HOS \\nDMC23 DMC23 DMC27 DMC27 C05 \\nC05 \\nC05 \\nC05 \\nC05 \\nC05 \\nC06 \\nC08 \\nC08 \\nC09 \\nC Improving or Maintaining Physical \\nHealth \\nHOS \\nDMC24 DMC24 DMC28 DMC28 C04 \\nC04 \\nC04 \\nC04 \\nC04 \\nC04 \\nC05 \\nC07 \\nC07 \\nC08 \\nC Initiation and Engagement of Substance \\nUse Disorder (SUD) Treatment Average \\nHEDIS \\nDMC14 DMC14  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Initiation of Substance Use Disorder \\n(SUD) Treatment \\nHEDIS \\nDMC12 DMC12 DMC12 DMC13 DMC13 DMC13 DMC13 DMC14 DMC14 DMC15 DMC14 DMC18   \\n  \\nC Kidney Health Evaluation for Patients \\nwith Diabetes \\nHEDIS \\nDMC22 DMC22 DMC26  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Medication Management for People \\nWith Asthma \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC26   \\n  \\n  \\n  \\n  \\nC Medication Reconciliation Post-\\nDischarge \\nHEDIS \\nC14 \\nC14 \\nC15 \\nC15 \\nC19 \\nC19 \\nC20 \\nC20 \\nDMC23   \\n  \\n  \\n  \\n  \\nC Members Choosing to Leave the Plan \\nMBDSS \\nC26/D03 C26/D03 C24/D03 C24/D03 C28/ \\nD05 \\nC29/ \\nD05 \\nC30 / \\nD05 \\nC29 / \\nD05 \\nC27 / \\nD05 \\nC27 / \\nD05 \\nC30 / \\nD04 \\nC32 / \\nD06 \\nC32 / \\nD08 \\nC33 / \\nD08 \\nC Monitoring Physical Activity \\nHEDIS-HOS \\nC04 \\nC04 \\nC04 \\nC04 \\nC06 \\nC06 \\nC06 \\nC06 \\nC06 \\nC06 \\nC07 \\nC09 \\nC09 \\nC10 \\nC Osteoporosis Management in Women \\nwho had a Fracture \\nHEDIS \\nC08 \\nC08 \\nC08 \\nC08 \\nC12 \\nC12 \\nC12 \\nC12 \\nC12 \\nC12 \\nC13 \\nC14 \\nC14 \\nC16 \\nC Osteoporosis Testing \\nHEDIS-HOS \\n \\n \\n \\nDMC04 DMC04 DMC04 DMC04 DMC05 DMC05 DMC06 DMC06 DMC06 DMC06 DMC06 \\nC Pharmacotherapy Management of \\nCOPD Exacerbation – Bronchodilator \\nHEDIS \\nDMC11 DMC11 DMC11 DMC12 DMC12 DMC12 DMC12 DMC13 DMC13 DMC14 DMC13 DMC17', '(Last Updated 10/03/2024)  \\nPage 136 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Pharmacotherapy Management of \\nCOPD Exacerbation – Systemic \\nCorticosteroid \\nHEDIS \\nDMC10 DMC10 DMC10 DMC11 DMC11 DMC11 DMC11 DMC12 DMC12 DMC13 DMC12 DMC16   \\n  \\nC Physical Functioning Activities of Daily \\nLiving \\nHOS \\nDMC20 DMC20 DMC24  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Plan All-Cause Readmissions \\nHEDIS \\nC15 \\nC15 \\nDMC21 DMC23 DMC23 C20 \\nC21 \\nC21 \\nC19 \\nC19 \\nC22 \\nC23 \\nC23 \\nC25 \\nC Plan Makes Timely Decisions about \\nAppeals \\nIndependent \\nReview Entity \\n(IRE) / \\nMaximus \\nC28 \\nC28 \\nC26 \\nC26 \\nC30 \\nC31 \\nC32 \\nC32 \\nC30 \\nC30 \\nC32 \\nC34 \\nC34 \\nC34 \\nC Pneumonia Vaccine \\nCAHPS \\nDMC07 DMC07 DMC07 DMC08 DMC08 DMC08 DMC08 DMC09 DMC09 DMC10 DMC09 DMC11 DMC11 C07 \\nC Rating of Health Care Quality \\nCAHPS \\nC22 \\nC22 \\nC20 \\nC20 \\nC24 \\nC25 \\nC26 \\nC25 \\nC23 \\nC23 \\nC26 \\nC27 \\nC27 \\nC29 \\nC Rating of Health Plan \\nCAHPS \\nC23 \\nC23 \\nC21 \\nC21 \\nC25 \\nC26 \\nC27 \\nC26 \\nC24 \\nC24 \\nC27 \\nC28 \\nC28 \\nC30 \\nC Reducing the Risk of Falling \\nHEDIS-HOS \\nC12 \\nC12 \\nC13 \\nC13 \\nC17 \\nC17 \\nC18 \\nC18 \\nC18 \\nC18 \\nC21 \\nC22 \\nC22 \\nC24 \\nC Reminders for appointments \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC16 DMC17 DMC16   \\n  \\n  \\nC Reminders for immunizations \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC17 DMC18 DMC17   \\n  \\n  \\nC Reminders for screening tests \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC18 DMC19 DMC18   \\n  \\n  \\nC Reviewing Appeals Decisions \\nIndependent \\nReview Entity \\n(IRE) / \\nMaximus \\nC29 \\nC29 \\nC27 \\nC27 \\nC31 \\nC32 \\nC33 \\nC33 \\nC31 \\nC31 \\nC33 \\nC35 \\nC35 \\nC35 \\nC Rheumatoid Arthritis Management \\nHEDIS \\n \\n \\n \\nC12 \\nC16 \\nC16 \\nC17 \\nC17 \\nC17 \\nC17 \\nC19 \\nC20 \\nC20 \\nC22 \\nC Special Needs Plan (SNP) Care \\nManagement \\nPart C Plan \\nReporting \\nC05 \\nC05 \\nC05 \\nC05 \\nC08 \\nC08 \\nC08 \\nC08 \\nC08 \\nC08 \\nC09 \\nDMC14 DMC14   \\nC Statin Therapy for Patients with \\nCardiovascular Disease \\nHEDIS \\nC16 \\nC16 \\nC16 \\nC16 \\nC20 \\nC21 \\nC22 \\nDMC17 DMC25   \\n  \\n  \\n  \\n  \\nC Testing to Confirm Chronic Obstructive \\nPulmonary Disease \\nHEDIS \\nDMC04 DMC04 DMC04 DMC05 DMC05 DMC05 DMC05 DMC06 DMC06 DMC07 DMC07 DMC07 DMC07 DMC07 \\nC Transitions of Care – Average \\nHEDIS \\nC17 \\nC17 \\nDMC20 DMC22 DMC22 DMC23  \\n \\n \\n \\n \\n \\n \\n \\nC Transitions of Care – Medication \\nReconciliation Post-Discharge \\nHEDIS \\nDMC16 DMC16 DMC16 DMC18 DMC18 DMC19  \\n \\n \\n \\n \\n \\n \\n \\nC Transitions of Care – Notification of \\nInpatient Admission \\nHEDIS \\nDMC17 DMC17 DMC17 DMC19 DMC19 DMC20  \\n \\n \\n \\n \\n \\n \\n \\nC Transitions of Care – Patient \\nEngagement After Inpatient Discharge \\nHEDIS \\nDMC18 DMC18 DMC18 DMC20 DMC20 DMC21', '(Last Updated 10/03/2024)  \\nPage 137 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Transitions of Care – Receipt of \\nDischarge Information \\nHEDIS \\nDMC19 \\n \\nDMC19 DMC19 DMC21 DMC21 DMC22', '(Last Updated 10/03/2024)  \\nPage 138 \\n \\nTable J-2: Part D Measure History \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 Notes \\nD 4Rx Timeliness \\nAcumen / OIS (4Rx)  \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nDMD03 \\nD Adherence – Proportion of Days Covered Prescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nD Antipsychotic Use in Persons with \\nDementia \\nPrescription Drug \\nEvent (PDE) Data \\nDMD08 DMD08 DMD08 \\nDMD08 DMD12 DMD14 DMD16 DMD18   \\n  \\n  \\n  \\n  \\n  \\nD Appeals Auto–Forward \\nIndependent Review \\nEntity (IRE) / \\nMaximus \\n \\n \\n \\n \\nD02 \\nD02 \\nD02 \\nD02 \\nD02 \\nD02 \\nD01 \\nD02 \\nD03 \\nD03 \\nD Appeals Upheld \\nIndependent Review \\nEntity (IRE) / \\nMaximus \\n \\n \\n \\n \\nD03 \\nD03 \\nD03 \\nD03 \\nD03 \\nD03 \\nD02 \\nD03 \\nD04 \\nD04 \\nD Beneficiary Access and Performance \\nProblems \\nAdministrative Data DME07 DME07 DME07 \\nDME07 DME07 DME07 DME07 D06 \\nD06 \\nD06 \\nDME08 D05 \\nD07 \\nD07 \\nD Call Center – Beneficiary Hold Time \\nCall Center \\nMonitoring \\nDMD02 DMD02 DMD02 \\nDMD02 DMD04 DMD04 DMD04 DMD04 DMD04 DMD04   \\nDMD04 DMD04 DMD05 \\n \\nD Call Center – Calls Disconnected – \\nPharmacist \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nD Call Center – Calls Disconnected When \\nCustomer Calls Drug Plan \\nCall Center \\nMonitoring \\nDMD01 DMD01 DMD01 \\nDMD01 DMD03 DMD03 DMD03 DMD03 DMD03 DMD03   \\nDMD03 DMD03 DMD04 \\nD Call Center – CSR Understandability \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nD Call Center – Foreign Language \\nInterpreter and TTY Availability \\nCall Center \\nMonitoring \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\n  \\nD01 \\nD02 \\nD02 \\nD Call Center – Information Accuracy \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nDMD05 DMD05 DMD06 \\nD Call Center – Pharmacy Hold Time \\nCall Center \\nMonitoring \\nDMD04 DMD04 DMD04 \\nDMD04 DMD08 DMD09 DMD09 DMD09 DMD11 DMD11   \\nDMD15 D01 \\nD01 \\nD Complaint Resolution \\nComplaints Tracking \\nModule (CTM) \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nD Complaints – Enrollment \\nComplaints Tracking \\nModule (CTM) \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nD Complaints – Other \\nComplaints Tracking \\nModule (CTM)', '(Last Updated 10/03/2024)  \\nPage 139 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 Notes \\nD Complaints about the Drug Plan \\nComplaints Tracking \\nModule (CTM) \\nC25/ \\nD02 \\nC25/ \\nD02 \\nC23/ \\nD02 \\nC23/ \\nD02 \\nC27 / \\nD04 \\nC28 / \\nD04 \\nC29 / \\nD04 \\nC28 / \\nD04 \\nC26 / \\nD04 \\nC26 / \\nD04 \\nC29 / \\nD03 \\nC30 / \\nD04 \\nC30 / \\nD06 \\nC31 / \\nD06 \\nD Diabetes Medication Dosing \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\n \\nDMD06 DMD06 DMD06 DMD06 DMD06 DMD04 DMD07 DMD07 DMD08 \\nD Diabetes Treatment \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\nD10 \\nD12 \\nD15 \\nD14 \\nD Drug Plan Provides Current Information \\non Costs and Coverage for Medicare’s \\nWebsite \\nAcumen / OIT (LIS \\nMatch Rates) \\n \\n \\n \\n \\nDMD06 DMD07 DMD07 DMD07 DMD07 DMD07 DMD05 DMD08 DMD08 DMD09 \\nD Drug Plan Quality Improvement \\nStar Ratings \\nD04 \\nD04 \\nD04 \\nD04 \\nD06 \\nD06 \\nD06 \\nD07 \\nD07 \\nD07 \\nD05 \\nD07 \\nD09 \\n  \\nD Drug-Drug Interactions \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\nDMD05 DMD05 DMD05 DMD05 DMD05 DMD05 DMD03 DMD06 DMD06 DMD07 \\n \\nD Enrollment Timeliness \\nMARx \\n \\n \\n \\n \\n  \\n  \\n  \\nDME01 DME01 DME01 DME01 DME01 C37 / \\nD05 \\nD05 \\n \\nD Formulary Administration Analysis \\nPart D Sponsor \\n \\n \\n \\n \\n \\n \\nDMD15 DMD17   \\n  \\n  \\n  \\n  \\n  \\nD Getting Information From Drug Plan \\nCAHPS \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nDMD10 DMD10 DMD09 DMD14 D10 \\nD09 \\n \\nD Getting Needed Prescription Drugs \\nCAHPS \\nD06 \\nD06 \\nD06 \\nD06 \\nD08 \\nD08 \\nD08 \\nD09 \\nD09 \\nD09 \\nD07 \\nD09 \\nD12 \\nD11 \\nD Grievance Rate \\nPart C & D Plan \\nReporting \\nDME01 DME01 DME01 \\nDME01 DME01 DME01 DME01 DME02 DME02 DME02 DME02 DMC13 \\n/ \\nDMD11 \\nDMC13 \\n/ \\nDMD11 \\n  \\nD High Risk Medication \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\n \\nDMD14 DMD14 DMD16 D11 \\nD11 \\nD09 \\nD11 \\nD14 \\nD13 \\nD Initial Opioid Prescribing \\nPrescription Drug \\nEvent (PDE) Data \\nDMD15 DMD15 DMD15 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Medication Adherence for Cholesterol \\n(Statins) \\nPrescription Drug \\nEvent (PDE) Data \\nD10 \\nD10 \\nD10 \\nD10 \\nD12 \\nD12 \\nD12 \\nD13 \\nD14 \\nD14 \\nD13 \\nD15 \\nD18 \\nD17 \\nD Medication Adherence for Diabetes \\nMedications \\nPrescription Drug \\nEvent (PDE) Data \\nD08 \\nD08 \\nD08 \\nD08 \\nD10 \\nD10 \\nD10 \\nD11 \\nD12 \\nD12 \\nD11 \\nD13 \\nD16 \\nD15 \\n \\nD Medication Adherence for Hypertension \\n(RAS antagonists) \\nPrescription Drug \\nEvent (PDE) Data \\nD09 \\nD09 \\nD09 \\nD09 \\nD11 \\nD11 \\nD11 \\nD12 \\nD13 \\nD13 \\nD12 \\nD14 \\nD17 \\nD16 \\nD Members Choosing to Leave the Plan \\nMBDSS \\nC26/ \\nD03 \\nC26/ \\nD03 \\nC24/ \\nD03 \\nC24/ \\nD03 \\nC28 / \\nD05 \\nC29 / \\nD05 \\nC30 / \\nD05 \\nC29 / \\nD05 \\nC27 / \\nD05 \\nC27 / \\nD05 \\nC30 / \\nD04 \\nC32 / \\nD06 \\nC32 / \\nD08 \\nC33 / \\nD08 \\nD MPF – Composite \\nPDE Data, MPF \\nPricing Files \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nD12 \\nB', '(Last Updated 10/03/2024)  \\nPage 140 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 Notes \\nD MPF – Stability \\nPDE Data, MPF \\nPricing Files \\nDMD03 DMD03 DMD03 \\nDMD03 DMD07 DMD08 DMD08 DMD08 DMD08 DMD08 DMD06 DMD10 DMD10   \\nA \\nD MPF – Updates \\nPDE Data, MPF \\nPricing Files \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nDMD09 DMD09 DMD10 \\nD MPF Price Accuracy \\nPDE Data, MPF \\nPricing Files \\nD07 \\nD07 \\nD07 \\nD07 \\nD09 \\nD09 \\nD09 \\nD10 \\nD10 \\nD10 \\nD08 \\nD10 \\nD13 \\n  \\nA \\nD MTM Program Completion Rate for CMR Prescription Drug \\nEvent (PDE) Data \\nD11 \\nD11 \\nD11 \\nD11 \\nD13 \\nD13 \\nD13 \\nD14 \\nD15 \\nD15 \\nDMD07 DMD12 DMD12   \\nD Persistence to Basal Insulin (PST-INS) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD16 DMD16  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Plan Submitted Higher Prices for Display \\non MPF \\nPDE Data, MPF \\nPricing Files \\nDMD05 DMD05 DMD05 \\nDMD05 DMD09 DMD10 DMD10 DMD10 DMD12 DMD12 DMD10 DMD16   \\n  \\n \\nD Polypharmacy: Use of Multiple \\nAnticholinergic Medications in Older \\nAdults (Poly-ACH) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD13 DMD13 DMD13 \\nDMD13 DMD20  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Polypharmacy: Use of Multiple CNS-\\nActive Medications in Older Adults (Poly-\\nCNS) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD14 DMD14 DMD14 \\nDMD14 DMD21  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Rate of Chronic Use of Atypical \\nAntipsychotics by Elderly Beneficiaries in \\nNursing Homes \\nFu Associates \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nDMD09 DMD09 DMD08 DMD13 DMD13   \\nD Rating of Drug Plan \\nCAHPS \\nD05 \\nD05 \\nD05 \\nD05 \\nD07 \\nD07 \\nD07 \\nD08 \\nD08 \\nD08 \\nD06 \\nD08 \\nD11 \\nD10 \\n \\nD Reminders to fill prescriptions \\nCAHPS \\nDMD06 DMD06 DMD06 \\nDMD06 DMD10 DMD11 DMD12 DMD13 DMD15 DMD15 DMD13   \\n  \\n  \\nD Reminders to take medications \\nCAHPS \\nDMD07 DMD07 DMD07 \\nDMD07 DMD11 DMD12 DMD13 DMD14 DMD16 DMD16 DMD14   \\n  \\n  \\n \\nD Statin Use in Persons with Diabetes \\n(SUPD) \\nPrescription Drug \\nEvent (PDE) Data \\nD12 \\nD12 \\nD12 \\nD12 \\nD14 \\nD14 \\nD14 \\nDMD15 DMD17   \\n  \\n  \\n  \\n  \\nD Timely Effectuation of Appeals \\nIndependent Review \\nEntity (IRE) / \\nMaximus \\n \\n \\n \\n \\nDMD02 DMD02 DMD02 DMD02 DMD02 DMD02 DMD02 DMD02 DMD02 DMD02 \\nD Timely Receipt of Case Files for Appeals Independent Review \\nEntity (IRE) / \\nMaximus \\n \\n \\n \\n \\nDMD01 DMD01 DMD01 DMD01 DMD01 DMD01 DMD01 DMD01 DMD01 DMD01 \\nD Transition monitoring \\nTransition Monitoring \\nProgram Analysis \\n \\n \\n \\n \\n \\n \\nDMD11   \\n  \\n  \\n  \\n  \\n  \\n  \\nD \\nD Transition monitoring – failure rate for all \\nother drugs \\nTransition Monitoring \\nProgram Analysis \\n \\n \\n \\n \\n  \\n  \\n  \\nDMD12 DMD14 DMD14 DMD12   \\n  \\n  \\nC', '(Last Updated 10/03/2024)  \\nPage 141 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 Notes \\nD Transition monitoring – failure rate for \\ndrugs within classes of clinical concern \\nTransition Monitoring \\nProgram Analysis \\n \\n \\n \\n \\n  \\n  \\n  \\nDMD11 DMD13 DMD13 DMD11   \\n  \\n  \\nC \\nD Use of Opioids at High Dosage and from \\nMultiple Providers in Persons Without \\nCancer (OHDMP) \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\nDMD15  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Use of Opioids at High Dosage in \\nPersons Without Cancer (OHD) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD11 DMD11 DMD11 DMD11 DMD18  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Use of Opioids from Multiple Providers in \\nPersons Without Cancer (OMP) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD12 DMD12 DMD12 DMD12 DMD19  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNotes: \\nA: \\nPart of composite measure MPF - Composite in 2011 – 2012 \\nB: \\nComposite measure - combined MPF - Accuracy and MPF Stability \\nC: \\nPart of composite measure Transition Monitoring - Composite starting in 2019 \\nD: \\nComposite Measure – “Transition monitoring - failure rate for drugs within classes of clinical concern” and “Transition monitoring - failure rate for all other drugs”', '(Last Updated 10/03/2024)  \\nPage 142 \\n \\nTable J-3: Common Part C & Part D Measure History \\nPart \\nMeasure Name \\nData Source \\n2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 \\nE \\nBeneficiary Access and Performance Problems Administrative Data \\nDME07 DME07 DME07 DME07 DME07 DME07 DME07 C30 / \\nD06 \\nC28 / \\nD06 \\nC28 / \\nD06 \\nDME08 C31 / \\nD05 \\nC31 / \\nD07 \\nC32 / \\nD07 \\nE \\nDisenrollment Reasons - Financial Reasons for \\nDisenrollment (MA-PD, MA-Only, PDP) \\nDisenrollment Reasons \\nSurvey \\nDME04 DME04 DME04 DME04 DME04 DME04 DME04 DME05 DME05 DME05 DME05   \\n  \\n  \\nE \\nDisenrollment Reasons - Problems Getting \\nInformation and Help from the Plan (MA-PD, \\nPDP) \\nDisenrollment Reasons \\nSurvey \\nDME06 DME06 DME06 DME06 DME06 DME06 DME06 DME07 DME07 DME07 DME07   \\n  \\n  \\nE \\nDisenrollment Reasons - Problems Getting the \\nPlan to Provide and Pay for Needed Care (MA-\\nPD, MA-Only) \\nDisenrollment Reasons \\nSurvey \\nDME02 DME02 DME02 DME02 DME02 DME02 DME02 DME03 DME03 DME03 DME03   \\n  \\n  \\nE \\nDisenrollment Reasons - Problems with \\nCoverage of Doctors and Hospitals (MA-PD, \\nMA-Only) \\nDisenrollment Reasons \\nSurvey \\nDME03 DME03 DME03 DME03 DME03 DME03 DME03 DME04 DME04 DME04 DME04   \\n  \\n  \\nE \\nDisenrollment Reasons - Problems with \\nPrescription Drug Benefits and Coverage (MA-\\nPD, PDP) \\nDisenrollment Reasons \\nSurvey \\nDME05 DME05 DME05 DME05 DME05 DME05 DME05 DME06 DME06 DME06 DME06   \\n  \\n  \\nE \\nEnrollment Timeliness \\nMARx \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nDME01 DME01 DME01 DME01 DME01 C37 / \\nD05 \\nD05 \\nE \\nGrievance Rate \\nPart C & D Plan Reporting DME01 DME01 DME01 DME01 DME01 DME01 DME01 DME02 DME02 DME02 DME02 DMC13 \\n/ \\nDMD11 \\nDMC13 \\n/ \\nDMD11', '(Last Updated 10/03/2024)  \\nPage 143 \\n \\nAttachment K: Individual Measure Star Assignment Process \\nThis attachment provides detailed information about the clustering and the relative distribution and significance \\ntesting (CAHPS) methodologies used to assign stars to individual measures. \\nClustering Methodology Introduction \\nTo separate a distribution of scores into distinct groups or categories, a set of values must be identified to \\nseparate one group from another group. The set of values that break the distribution of the scores into non-\\noverlapping groups is the set of cut points. \\nFor each individual measure, CMS determines the measure cut points using the information provided from the \\nhierarchical clustering algorithm in SAS, described in “Clustering Methodology Detail” below. Conceptually, \\nthe clustering algorithm identifies the natural gaps that exist within the distribution of the scores and creates \\ngroups (clusters) that are then used to identify the cut points that result in the creation of a pre-specified number \\nof categories. \\nFor Star Ratings, the algorithm is run with the goal of determining the four cut points (labeled in the Figure J-1 \\nbelow as A, B, C, and D) that are used to create the five non-overlapping groups that correspond to each of the \\nStar Ratings (labeled in the diagram below as G1, G2, G3, G4, and G5). For Part D measures, CMS determines \\nMA-PD and PDP cut points separately. Data identified to be biased, erroneous, or excluded by disaster rules are \\nremoved from the algorithm. The scores are grouped such that scores within the same Star Rating category are \\nas similar as possible, and scores in different categories are as different as possible.  \\n \\nFigure K-1: Diagram showing gaps in data where cut points are assigned. \\n \\nAs mentioned, the cut points are used to create five non-overlapping groups. The value of the lower bound for \\neach group is included in the category, while the value of the upper bound is not included in the category. CMS \\ndoes not require the same number of observations (contracts) within each group. The groups are identified such \\nthat within a group the measure scores must be similar to each other and between groups, the measure scores in \\none group are not similar to measure scores in another group. The groups are then used for the conversion of the \\nmeasure scores to one of five Star Ratings categories. For most measures, a higher score is better, and thus, the \\ngroup with the highest range of measure scores is converted to a rating of five stars. An example of a measure \\nfor which higher is better is Medication Adherence for Diabetes Medications. For some measures a lower score \\nis better, and thus, the group with the lowest range of measure scores is converted to a rating of five stars. An \\nexample of a measure for which a lower score is better is Members Choosing to Leave the Plan. \\nExample 1 – Clustering Methodology for a Higher is Better measure \\nConsider the information provided for the cut points for Medication Adherence for Diabetes Medications in \\nTable K-1 below. As stated previously, for Part D measures CMS calculates MA-PD and PDP cut points \\nseparately (e.g., different cut points are calculated for MA-PD and PDPs). If the MA-PD cut points identified \\nusing the clustering algorithm are 80%, 85%, 87%, and 91%; for PDPs, the cut points are 84%, 86%, 88%, and \\n90%. (The set of values corresponds to the cut points in figure J-2 below as A, B, C, and D and the categories \\nfor each of the five Star Ratings are indicated above each group.) Since a measure score can only assume a \\nvalue between 0% and 100% (including 0% and 100%), the one-star and five-star categories contain only a \\nsingle value in the table below as the upper or lower bound.', '(Last Updated 10/03/2024)  \\nPage 144 \\n \\nTable K-1: Medication Adherence for Diabetes Medications cut points example: cut points are for illustrative \\npurposes \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 91 % \\n>= 91 % \\nPDP \\n< 84 % \\n>= 84 % to < 86 % \\n>= 86 % to < 88 % \\n>= 88 % to < 90 % \\n>= 90 % \\n \\nFigure K-2: Diagram showing star assignment based cut points. \\n \\n \\nSince higher is better for Medication Adherence for Diabetes Medications, a rating of one star is assigned to all \\nMA-PD measure scores below 80% in this example. For each of the other Star Rating categories, the value of \\nthe lower bound is included in the rating category, while the upper bound value is not included. Focusing solely \\non the cut points for MA-PDs, a rating of two stars is assigned to each measure score that is at least 80% (the \\nfirst cut point) to less than 85% (the second cut point) in this example. Since measure scores are reported as \\npercentages with no decimal places, any measure score of 80% to 84% would be assigned two stars, while a \\nmeasure score of 85% would be assigned a rating of three stars. Measure scores that are at least 85% to less than \\n87% would be assigned a rating of three stars. For a conversion to four stars, a measure score of at least 87% to \\nless than 91% would be needed. A rating of five stars would be assigned to any measure score of 91% or more. \\nPDPs have different cut points, but the same overall rules apply for converting the measure score to a Star \\nRating. \\nExample 2 – Clustering Methodology for a Lower is Better measure \\nConsider the information provided for the cut points for Members Choosing to Leave the Plan in Table K-2 \\nbelow. As stated previously, for Part D measures CMS calculates MA-PD and PDP cut points separately. In the \\nexample, the MA-PD cut points for Members Choosing to Leave the Plan determined using the clustering \\nalgorithm are 44%, 29%, 16%, and 9%; for PDPs, the cut points are 20%, 13%, 19%, and 6%. (These \\ncorrespond to the cut points in figure J-3 as A, B, C, and D). \\nSince lower is better for this measure, the five-star category will have the lowest measure score range, while the \\none-star category will have scores that are highest in value. For each of the other Star Rating categories, the \\nvalue of the lower bound is not included in the rating category, while the upper bound value is included. (The \\ninclusivity and exclusivity of the upper and lower bounds is opposite for a measure score where lower is better \\nas compared to higher is better.) For MA-PDs, a rating of five stars would be assigned to measure scores of 9% \\nor less. Measure scores that are greater than 9% up to a maximum value of 16% (including a measure score of \\n16%) would be assigned a rating of four stars. A rating of three stars would be assigned to measure scores \\ngreater than 16% up to a maximum value of 29%. A rating of two stars would be assigned to a measure score \\nthat is greater than 29% up to and including 44%. A rating of one star would be assigned to any measure score \\ngreater than 44%. PDPs have different cut points, but the same overall rules apply for converting the measure \\nscore to a Star Rating. \\nTable K-2: Members Choosing to Leave the Plan cut points example: cut points are for illustrative purposes \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n> 44 % \\n> 29 % to <= 44 % \\n> 16 % to <= 29 % \\n> 9 % to <= 16 % \\n<= 9 % \\nPDP \\n> 20 % \\n> 13 % to <= 20 % \\n> 9 % to <= 13 % \\n> 6 % to <= 9 % \\n<= 6 %', '(Last Updated 10/03/2024)  \\nPage 145 \\n \\nFigure J-3: Diagram showing star assignment based on cut points. \\n \\n \\nClustering Methodology Detail \\nThis section details the steps of the clustering method performed in SAS to allow the conversion of the measure \\nscores to measure-level stars. \\nTukey outlier deletion is used to determine the cut points for all non-CAHPS measures. Tukey outlier deletion \\ninvolves removing Tukey outer fence outlier contract scores, those defined as measure-specific scores outside \\nthe bounds of 3.0 times the measure-specific interquartile range subtracted from the 1st quartile or added to the \\n3rd quartile. Outliers are removed prior to applying mean resampling to the hierarchical clustering algorithm. \\nThe 1st and 3rd quartiles can be obtained by using the MEANS procedure in SAS. The Tukey outer fence outlier \\ncutoffs can then be calculated as: \\n• Lower outlier cutoff: first quartile – 3.0*(third quartile – first quartile) \\n• Upper outlier cutoff: third quartile + 3.0*(third quartile – first quartile). \\nMeasures with data displays of percentages with no decimal places ranging from 0 to 100 will have the lower \\nand upper outlier cutoffs capped at those values, respectively. Any other measures with range restrictions, such \\nas have a lower bound of zero, will have the respective outlier cutoff capped at the restricted value. \\nMean resampling is used to determine the cut points for all non-CAHPS measures.  With mean resampling, \\nmeasure-specific scores for the current year’s Star Ratings are separated into 10 equal-sized groups, using a \\nrandom assignment process to assign each contract’s measure score to a group.  The random assignment of \\ncontracts into 10 groups can be produced using the SURVEYSELECT procedure in SAS as follows: \\nproc surveyselect data=inclusterdat groups=10 seed=8675309 out=inclusterdat_random; \\nrun; \\nIn the above code, the input dataset, inclusterdat, is the list of contracts without missing, flagged, excluded by \\ndisaster rules or voluntary contract scores for a particular measure. The group=10 option identifies that 10 \\nrandom groupings of the data should be created. The seed=8675309 option specifies the seed value that controls \\nthe starting point of the random sequence of numbers and allows for future replication of the randomization \\nprocess. The output dataset, inclusterdat_random, is identical to the input dataset with the addition of a new \\ncolumn, named groupid, that has the group assignments (from 1 through 10) for each contract.  \\nThe hierarchal clustering algorithm (steps 1 through 4 below) is then applied 10 times, each time leaving out \\none of the 10 groups. For each measure and leave-one-out contract set, the clustering method does the \\nfollowing: \\n Produces the individual measure distance matrix. \\n Groups the measure scores into an initial set of clusters. \\n Selects the set of clusters.  \\n1. Produce the individual measure distance matrix. \\nFor each pair of contracts j and k (j>=k) among the n contracts with measure score data, compute the \\nEuclidian distance of their measure scores (e.g., the absolute value of the difference between the two', '(Last Updated 10/03/2024)  \\nPage 146 \\n \\nmeasure scores). Enter this distance in row j and column k of a distance matrix with n rows and n columns. \\nThis matrix can be produced using the DISTANCE procedure in SAS as follows: \\nproc distance data= inclusterdat_leave1out out=distancedat method=Euclid; \\n \\n \\nvar interval(measure_score); \\n \\n \\nid contract_id; \\n \\nrun; \\nIn the above code, the input data set, inclusterdat_leave1out, is the list of contracts (excluding the group left \\nout) without missing, flagged, excluded by disaster rules or voluntary contract scores for a particular \\nmeasure. Each record has a unique contract identifier, contract_id. The option method=Euclid specifies that \\ndistances between contract measure scores should be based on Euclidean distance. The input data contain a \\nvariable called measure_score that is formatted to the display criteria outlined in the Technical Notes. In the \\nvar call, the parentheses around measure_score indicate that measure_score is considered to be an interval \\nor numeric variable. The distances computed by this code are stored to an output data set called distancedat. \\n2. Create a tree of cluster assignments. \\nThe distance matrix calculated in Step 1 is the input to the clustering procedure. The stored distance \\nalgorithm is implemented to compute cluster assignments. The following process is implemented by using \\nthe CLUSTER procedure in SAS: \\n The input measure score distances are squared. \\n The clusters are initialized by assigning each contract to its own cluster. \\n In order to determine which pair of clusters to merge, Ward’s minimum variance method is used to \\nseparate the variance of the measure scores into within-cluster and between-cluster sum of squares \\ncomponents. \\n From the existing clusters, two clusters are selected for merging to minimize the within-cluster sum of \\nsquares over all possible sets of clusters that might result from a merge. \\n Steps 3 and 4 are repeated to reduce the number of clusters by one until a single cluster containing all \\ncontracts results. \\nThe result is a data set that contains a tree-like structure of cluster assignments, from which any number of \\nclusters between 1 and the number of contract measure scores could be computed. The SAS code for \\nimplementing these steps is: \\nproc cluster data=distancedat method=ward outtree=treedat noprint; \\n \\n \\nid contract_id; \\n \\nrun; \\nThe distancedat data set containing the Euclidian distances was created in Step 1. The option method=ward \\nindicates that Ward’s minimum variance method should be used to group clusters. The output data set is \\ndenoted with the outtree option and is called treedat. \\n3. Select the final set of clusters from the tree of cluster assignments. \\nThe process outlined in Step 2 will produce a tree of cluster assignments, from which the final number of \\nclusters is selected using the TREE procedure in SAS as follows: \\nproc tree data=treedat ncl=NSTARS horizontal out=outclusterdat noprint;', '(Last Updated 10/03/2024)  \\nPage 147 \\n \\n \\n \\nid contract_id; \\n \\nrun; \\nThe input data set, treedat, is created in Step 2 above. The syntax, ncl=NSTARS, denotes the desired final \\nnumber of clusters (or star levels). For most measures, NSTARS= 5. In cases where multiple clusters have \\nthe same score value range those clusters are combined, leading to fewer than 5 clusters. Since the \\nimprovement measures have a constraint that contracts with improvement scores of zero or greater are to be \\nassigned at least 3 stars for improvement, the clustering is conducted separately for contract measure scores \\nthat are greater than or equal to zero versus those that are less than zero. Specifically, Steps 1-3 are first \\napplied to contracts with improvement scores that meet or exceed zero, in which case NSTARS equals \\nthree. The resulting improvement measure stars can take on values of 3, 4, or 5. For those contracts with \\nimprovement scores less than zero, Steps 1-3 are applied with NSTARS=2 and these contracts will either \\nreceive 1 or 2 stars. \\n4. Final Thresholds \\nThe cluster assignments produced by the above approach have cluster labels that are unordered. The final \\nstep after applying the above steps to all contract measure scores is to order the cluster labels so that the 5-\\nstar category reflects the cluster with the best performance and the 1-star category reflects the cluster with \\nthe worst performance. With the exception of the improvement measures which are assigned lower \\nthresholds of zero for the 3-star category, the measure thresholds are defined by examining the range of \\nmeasure scores within each of the final clusters. The lower limit of each cluster becomes the cut point for \\nthe star categories. \\nDetermining Stars from Scores and Thresholds  \\nThe mean-resampling approach results in 10 sets of measure-specific cut points, one for each of the 10 \\nimplementations of the hierarchical clustering algorithm. For higher-is-better measures, the minimum score \\nobserved in each star category defines the effective cut points for the star categories. For lower-is-better \\nmeasures, the maximum score observed in each star category defines the effective cut points for the star \\ncategories.  These cut points are calculated after the application of Tukey outlier deletion. The final set of \\nestimated thresholds are then calculated as the mean cut point for each threshold per measure from the 10 \\ndifferent cut point values. Tables K-3 and K-4 show the mean resampling final estimated thresholds for the \\n2025 Star Ratings. Tables K-5 and K-6 show the upper and lower Tukey outlier cutoffs.', '(Last Updated 10/03/2024)  \\nPage 148 \\n \\nTable K-3: 2025 Star Ratings Part C non-CAHPS Measure Mean Resampling Estimated Thresholds \\nMeasure ID \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nC01 \\n< 58 % \\n>= 58 % to < 67 % \\n>= 67 % to < 75 % \\n>= 75 % to < 82 % \\n>= 82 % \\nC02 \\n< 58 % \\n>= 58 % to < 67 % \\n>= 67 % to < 75 % \\n>= 75 % to < 83 % \\n>= 83 % \\nC04 \\n< 41 % \\n>= 41 % to < 47 % \\n>= 47 % to < 52 % \\n>= 52 % to < 60 % \\n>= 60 % \\nC05 \\n< 46 % \\n>= 46 % to < 63 % \\n>= 63 % to < 76 % \\n>= 76 % to < 89 % \\n>= 89 % \\nC06 \\n< 83 % \\n>= 83 % to < 90 % \\n>= 90 % to < 94 % \\n>= 94 % to < 98 % \\n>= 98 % \\nC07 \\n< 79 % \\n>= 79 % to < 86 % \\n>= 86 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 % \\nC08 \\n< 27 % \\n>= 27 % to < 39 % \\n>= 39 % to < 52 % \\n>= 52 % to < 71 % \\n>= 71 % \\nC09 \\n< 62 % \\n>= 62 % to < 70 % \\n>= 70 % to < 77 % \\n>= 77 % to < 83 % \\n>= 83 % \\nC10 \\n< 69 % \\n>= 69 % to < 78 % \\n>= 78 % to < 84 % \\n>= 84 % to < 90 % \\n>= 90 % \\nC11 \\n< 69 % \\n>= 69 % to < 74 % \\n>= 74 % to < 80 % \\n>= 80 % to < 85 % \\n>= 85 % \\nC12 \\n< 50 % \\n>= 50 % to < 56 % \\n>= 56 % to < 63 % \\n>= 63 % to < 73 % \\n>= 73 % \\nC13 \\n< 39 % \\n>= 39 % to < 44 % \\n>= 44 % to < 48 % \\n>= 48 % to < 52 % \\n>= 52 % \\nC14 \\n< 42 % \\n>= 42 % to < 59 % \\n>= 59 % to < 73 % \\n>= 73 % to < 87 % \\n>= 87 % \\nC15 \\n> 14 % \\n> 12 % to <= 14 % \\n> 10 % to <= 12 % \\n> 8 % to <= 10 % \\n<= 8 % \\nC16 \\n< 81 % \\n>= 81 % to < 85 % \\n>= 85 % to < 88 % \\n>= 88 % to < 92 % \\n>= 92 % \\nC17 \\n< 44 % \\n>= 44 % to < 52 % \\n>= 52 % to < 63 % \\n>= 63 % to < 77 % \\n>= 77 % \\nC18 \\n< 39 % \\n>= 39 % to < 53 % \\n>= 53 % to < 60 % \\n>= 60 % to < 69 % \\n>= 69 % \\nC25 \\n> 0.66 \\n> 0.41 to <= 0.66 \\n> 0.24 to <= 0.41 \\n> 0.12 to <= 0.24 \\n<= 0.12 \\nC26 \\n> 36 % \\n> 24 % to <= 36 % \\n> 17 % to <= 24 % \\n> 8 % to <= 17 % \\n<= 8 % \\nC27 \\n< -0.179809 \\n>= -0.179809 to < 0 \\n>= 0 to < 0.174445 \\n>= 0.174445 to < \\n0.421057 \\n>= 0.421057 \\nC28 \\n< 87 % \\n>= 87 % to < 91 % \\n>= 91 % to < 95 % \\n>= 95 % to < 99 % \\n>= 99 % \\nC29 \\n< 88 % \\n>= 88 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 % to < 99 % \\n>= 99 % \\nC30 \\n< 89 % \\n>= 89 % to < 94 % \\n>= 94 % to < 97 % \\n>= 97 % to < 100 % \\n= 100 % \\nNotes: These are not the final thresholds for the 2025 Star Ratings. See the Measure Details section for final thresholds after guardrails \\nhave been applied.', '(Last Updated 10/03/2024)  \\nPage 149 \\n \\nTable K-4: 2025 Star Ratings Part D non-CAHPS Measure Mean Resampling Estimated Thresholds \\nNotes: These are not the final thresholds for the 2025 Star Ratings. See the Measure Details section for final thresholds after guardrails \\nhave been applied. \\n \\n \\n \\nMeasure ID \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nD01 \\nMA-PD \\n< 85 % \\n>= 85 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 % to < 100 % \\n= 100 % \\nD01 \\nPDP \\n< 94 % \\n>= 94 % to < 97 % \\n>= 97 % to < 98 % \\n>= 98 % to < 100 % \\n= 100 % \\nD02 \\nMA-PD \\n> 0.66 \\n> 0.41 to <= 0.66 \\n> 0.24 to <= 0.41 \\n> 0.12 to <= 0.24 \\n<= 0.12 \\nD02 \\nPDP \\n> 0.1 \\n> 0.06 to <= 0.1 \\n> 0.04 to <= 0.06 \\n> 0.02 to <= 0.04 \\n<= 0.02 \\nD03 \\nMA-PD \\n> 36 % \\n> 24 % to <= 36 % \\n> 17 % to <= 24 % \\n> 8 % to <= 17 % \\n<= 8 % \\nD03 \\nPDP \\n> 22 % \\n> 16 % to <= 22 % \\n> 9 % to <= 16 % \\n> 5 % to <= 9 % \\n<= 5 % \\nD04 \\nMA-PD \\n< -0.218869 \\n>= -0.218869 to < 0 \\n>= 0 to < 0.242468 \\n>= 0.242468 to < \\n0.496603 \\n>= 0.496603 \\nD04 \\nPDP \\n< -0.282500 \\n>= -0.282500 to < 0 \\n>= 0 to < 0.273334 \\n>= 0.273334 to < \\n0.576667 \\n>= 0.576667 \\nD07 \\nMA-PD \\n< 97 \\n>= 97 to < 98 \\n>= 98 to < 99 \\n>= 99 to < 100 \\n= 100 \\nD07 \\nPDP \\n< 97 \\n>= 97 to < 98 \\n>= 98 to < 99 \\n>= 99 to < 100 \\n= 100 \\nD08 \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 91 % \\n>= 91 % \\nD08 \\nPDP \\n< 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nD09 \\nMA-PD \\n< 83 % \\n>= 83 % to < 87 % \\n>= 87 % to < 90 % \\n>= 90 % to < 92 % \\n>= 92 % \\nD09 \\nPDP \\n< 87 % \\n>= 87 % to < 89 % \\n>= 89 % to < 90 % \\n>= 90 % to < 92 % \\n>= 92 % \\nD10 \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % \\n>= 85 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nD10 \\nPDP \\n< 86 % \\n>= 86 % to < 88 % \\n>= 88 % to < 89 % \\n>= 89 % to < 92 % \\n>= 92 % \\nD11 \\nMA-PD \\n< 76 % \\n>= 76 % to < 84 % \\n>= 84 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nD11 \\nPDP \\n< 30 % \\n>= 30 % to < 55 % \\n>= 55 % to < 68 % \\n>= 68 % to < 80 % \\n>= 80 % \\nD12 \\nMA-PD \\n< 81 % \\n>= 81 % to < 86 % \\n>= 86 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nD12 \\nPDP \\n< 80 % \\n>= 80 % to < 83 % \\n>= 83 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 %', '(Last Updated 10/03/2024)  \\nPage 150 \\n \\nTable K-5: 2025 Star Ratings Part C non-CAHPS Measure Tukey Outlier Cutoffs \\nMeasure ID \\nLower Cutoff \\nUpper Cutoff \\nC01 \\n31 \\n100 \\nC02 \\n24 \\n100 \\nC04 \\n21 \\n77 \\nC05 \\n0 \\n100 \\nC06 \\n71 \\n100 \\nC07 \\n66 \\n100 \\nC08 \\n0 \\n100 \\nC09 \\n29 \\n100 \\nC10 \\n52 \\n100 \\nC11 \\n48 \\n100 \\nC12 \\n17 \\n94 \\nC13 \\n24 \\n66 \\nC14 \\n0 \\n100 \\nC15 \\n4 \\n18 \\nC16 \\n72 \\n100 \\nC17 \\n0 \\n100 \\nC18 \\n22 \\n92 \\nC25 \\n0 \\n1.08 \\nC26 \\n0 \\n79 \\nC27 (improve) \\n0 \\n1 \\nC27 (decline) \\n-0.582088 \\n0 \\nC28 \\n80 \\n100 \\nC29 \\n82 \\n100 \\nC30 \\n82 \\n100 \\nNotes: If the calculated lower or upper outer fence exceeds the minimum or maximum range of the measure, then the minimum or \\nmaximum measure score is shown in the table. This means that no outliers were identified at that end of the measure score range. For \\nC27 (decline) group, the upper cut off is technically the lowest value below zero since zero is included in the C27 (improved) group.', '(Last Updated 10/03/2024)  \\nPage 151 \\n \\nTable K-6: 2025 Star Ratings Part D non-CAHPS Measure Tukey Outlier Cutoffs \\nMeasure ID \\nType \\nLower Cutoff \\nUpper Cutoff \\nD01 \\nMA-PD \\n74 \\n100 \\nD02 \\nMA-PD \\n0 \\n1.08 \\nD03 \\nMA-PD \\n0 \\n79 \\nD04 (improve) \\nMA-PD \\n0 \\n1 \\nD04 (decline) \\nMA-PD \\n-0.96875 \\n0 \\nD07 \\nMA-PD \\n95 \\n100 \\nD08 \\nMA-PD \\n72 \\n100 \\nD09 \\nMA-PD \\n75 \\n100 \\nD10 \\nMA-PD \\n74 \\n100 \\nD11 \\nMA-PD \\n61 \\n100 \\nD12 \\nMA-PD \\n68 \\n100 \\nD01 \\nPDP \\n86 \\n100 \\nD02 \\nPDP \\n0 \\n0.22 \\nD03 \\nPDP \\n0 \\n45 \\nD04 (improve) \\nPDP \\n0 \\n1 \\nD04 (decline) \\nPDP \\n-1 \\n0 \\nD07 \\nPDP \\n95 \\n100 \\nD08 \\nPDP \\n76 \\n97 \\nD09 \\nPDP \\n82 \\n96 \\nD10 \\nPDP \\n81 \\n95 \\nD11 \\nPDP \\n0 \\n100 \\nD12 \\nPDP \\n76 \\n90 \\nNote: If the calculated lower or upper outer fence exceeds the minimum or maximum range of the measure, then the minimum or \\nmaximum measure score is shown in the table. This means that no outliers were identified at that end of the measure score range. For \\nD04 (decline) group, the upper cut off is technically the lowest value below zero since zero is included in the D04 (improved) group. \\n \\nGuardrails are then applied to all non-CAHPS measures, with a few exceptions. Guardrails are not applied to \\nthe Part C and Part D improvement measures. Additionally, guardrails are not applied to new measures that \\nhave been in the Part C and D Star Rating program for 3 years or less. Measures returning to the Star Ratings \\nafter a substantive measure specification change are treated as new measures.  Cut points for these new \\nmeasures and improvement measures are based on the hierarchal clustering methodology with mean \\nresampling. When applying guardrails, the difference between the current year and prior year’s cut point is \\ncalculated for each of the 1 to 5 star levels. A cap value is then calculated and compared to the observed \\nthreshold difference.  \\n• For measures having a 0 to 100 scale, an absolute percentage cap of 5 percentage point is applied. \\no If the absolute difference between the current and prior year’s cut point is less than or equal \\nto 5 percentage points, the current year’s cut point is used as the final cut point value.', '(Last Updated 10/03/2024)  \\nPage 152 \\n \\no If the absolute difference between the current and prior year’s cut point is greater than 5 \\npercentage points, a 5 percentage point cap is applied. That is, 5 percentage points are added \\nto or subtracted from the prior year’s cut point value (depending on the direction of \\nmovement for the cut point value in the current year) to obtain the final cut point value for \\nthe current year. \\n• For measures not having a 0 to 100 scale, a restricted range cap of 5 percent of the prior year’s score \\nrange is applied. Specifically, the restricted range cap is equal to the prior year’s (maximum score \\nvalue – minimum score value excluding outer fence outliers) * 0.05.  \\no If the absolute difference between the current and prior year’s is less than or equal to the \\ncalculated restricted range cap value, the current year’s cut point is used as the final cut point \\nvalue.  \\no If the absolute difference between the current and prior year’s is greater than the calculated \\nrestricted range cap value, then the restricted range cap is applied. That is, the calculated \\nrestricted range cap value is added to or subtracted from the prior year’s cut point value \\n(depending on the direction of the movement of the cut point value in the current year) to \\nobtain the final cut point value for the current year.', '(Last Updated 10/03/2024)  \\nPage 153 \\n \\n \\n \\nRelative Distribution and Significance Testing (CAHPS) Methodology \\nThe CAHPS measures are case-mix adjusted to take into account differences in the characteristics of enrollees \\nacross contracts that may potentially impact survey responses. See Attachment A for the case-mix adjusters. \\nThe percentile cut points for base groups are defined by current-year distribution of case-mix adjusted contract \\nmeans. Percentile cut points are rounded to the nearest integer on the 0-100 reporting scale, and each base group \\nincludes those contracts whose rounded mean score is at or above the lower limit and below the upper limit. The \\nnumber of stars assigned is determined by the position of the contract mean score relative to percentile cutoffs \\nfrom the distribution of contract weighted mean scores from all contracts (which determines the base group); \\nstatistical significance of the difference of the contract mean from the national mean along with the direction of \\nthe difference; the statistical reliability of the estimate (based on the ratio of sampling variation for each \\ncontract mean to between-contract variation); and the standard error of the mean score. All statistical tests, \\nincluding comparisons involving standard errors, are computed using unrounded scores. \\nCAHPS reliability calculation details are provided under the section header, “MA & PDP CAHPS Between-\\nContract Variances for Reported Measures” at https://www.ma-pdpcahps.org/en/scoring-and-star-ratings.  \\nTables K-8 and K-9 contain the rules applied to determine the final CAHPS measure star value.', '(Last Updated 10/03/2024)  \\nPage 154 \\n \\nTable K-8: CAHPS Star Assignment Rules \\nStar \\nCriteria for Assigning Star Ratings \\n1 \\nA contract is assigned one star if both criteria (a) and (b) are met plus at least one of criteria (c) and (d): \\n(a) \\nits average CAHPS measure score is lower than the 15th percentile; AND \\n(b) \\nits average CAHPS measure score is statistically significantly lower than the national average CAHPS measure score; \\n(c) \\nthe reliability is not low; OR \\n(d) \\nits average CAHPS measure score is more than one standard error (SE) below the 15th percentile. \\n2 \\nA contract is assigned two stars if it does not meet the one-star criteria and meets at least one of these three criteria: \\n(a) \\nits average CAHPS measure score is lower than the 30th percentile and the measure does not have low reliability; OR \\n(b) \\nits average CAHPS measure score is lower than the 15th percentile and the measure has low reliability; OR \\n(c) \\nits average CAHPS measure score is statistically significantly lower than the national average CAHPS measure score and \\nbelow the 60th percentile. \\n3 \\nA contract is assigned three stars if it meets at least one of these three criteria: \\n(a) \\nits average CAHPS measure score is at or above the 30th percentile and lower than the 60th percentile, AND it is not \\nstatistically significantly different from the national average CAHPS measure score; OR \\n(b) \\nits average CAHPS measure score is at or above the 15th percentile and lower than the 30th percentile, AND the reliability is \\nlow, AND the score is not statistically significantly lower than the national average CAHPS measure score; OR \\n(c) \\nits average CAHPS measure score is at or above the 60th percentile and lower than the 80th percentile, AND the reliability is \\nlow, AND the score is not statistically significantly higher than the national average CAHPS measure score. \\n4 \\nA contract is assigned four stars if it does not meet the five-star criteria and meets at least one of these three criteria: \\n(a) \\nits average CAHPS measure score is at or above the 60th percentile and the measure does not have low reliability; OR \\n(b) \\nits average CAHPS measure score is at or above the 80th percentile and the measure has low reliability; OR \\n(c) \\nits average CAHPS measure score is statistically significantly higher than the national average CAHPS measure score and \\nabove the 30th percentile. \\n5 \\nA contract is assigned five stars if both criteria (a) and (b) are met plus at least one of criteria (c) and (d): \\n(a) \\nits average CAHPS measure score is at or above the 80th percentile; AND \\n(b) \\nits average CAHPS measure score is statistically significantly higher than the national average CAHPS measure score; \\n(c) \\nthe reliability is not low; OR \\n(d) \\nits average CAHPS measure score is more than one standard error (SE) above the 80th percentile.', '(Last Updated 10/03/2024)  \\nPage 155 \\n \\nTable K-9: CAHPS Star Assignment Alternate Representation \\nMean Score \\nBase \\nGroup \\nSignif. below \\navg., low \\nreliability \\nSignif. below \\navg., not low \\nreliability \\nNot signif. diff. \\nfrom avg., low \\nreliability \\nNot signif. diff. \\nfrom avg., not low \\nreliability \\nSignif. above \\navg., low \\nreliability \\nSignif. above \\navg., not low \\nreliability \\n< 15th percentile by > 1 SE \\n1 \\n1 \\n1 \\n2 \\n2 \\n2 \\n2 \\n< 15th percentile by ≤ 1 SE \\n2 \\n1 \\n2 \\n2 \\n2 \\n2 \\n≥ 15th to < 30th percentile \\n2 \\n2 \\n2 \\n3 \\n2 \\n3 \\n2 \\n≥ 30th to < 60th percentile \\n3 \\n2 \\n2 \\n3 \\n3 \\n4 \\n4 \\n≥ 60th to < 80th percentile \\n4 \\n3 \\n4 \\n3 \\n4 \\n4 \\n4 \\n≥ 80th percentile by ≤ 1 SE \\n5 \\n4 \\n4 \\n4 \\n4 \\n4 \\n5 \\n≥ 80th percentile by > 1 SE \\n4 \\n4 \\n4 \\n4 \\n5 \\n5 \\nNotes: If reliability is very low (<0.60), the contract does not receive a Star Rating. Low reliability scores are defined as those with at \\nleast 11 respondents and reliability ≥0.60 but <0.75 and also in the lowest 12% of contracts ordered by reliability. The SE is considered \\nwhen the measure score is below the 15th percentile (in base group 1), significantly below average, and has low reliability: in this case, \\n1 star is assigned if and only if the measure score is at least 1 SE below the unrounded base group 1/2 cut point. Similarly, the SE is \\nconsidered when the measure score is at or above the 80th percentile (in base group 5), significantly above average, and has low \\nreliability: in this case, 5 stars are assigned if and only if the measure score is at least 1 SE above the unrounded base group 4/5 cut \\npoint. \\nFor example, a contract in base group 4 that was not significantly different from average and had low reliability would receive 3 final \\nstars. \\nAs noted above, low reliability scores for CAHPS measures are defined as those with at least 11 respondents \\nand reliability ≥0.60 but <0.75 and also in the lowest 12% of contracts ordered by reliability. Table K-10 \\ncontains the 12% reliability cutoffs. \\n \\nTable K-10: CAHPS Measure 12% Reliability Cutoffs \\nMeasure \\n12% reliability cutoff \\nAnnual Flu Vaccine \\n0.827223* \\nGetting Needed Care \\n0.712319 \\nGetting Appointments and Care \\nQuickly \\n0.605448 \\nCustomer Service \\n0.624047 \\nRating of Health Care Quality \\n0.603043 \\nRating of Health Plan \\n0.802531* \\nCare Coordination \\n0.575592* \\nRating of Drug Plan (MA-PD) \\n0.729239 \\nGetting Needed Prescription Drugs \\n(MA-PD) \\n0.591102* \\nRating of Drug Plan (PDP) \\n0.950393* \\nGetting Needed Prescription Drugs \\n(PDP) \\n0.875199* \\n*Note: Reliabilities must be ≥0.60 but <0.75 and also in the lowest 12% of contracts ordered by reliability to be designated as low \\nreliability, thus these cutoffs did not affect low reliability designation.', '(Last Updated 10/03/2024)  \\nPage 156 \\n \\nAttachment L: Medication Adherence Measure Calculations \\n \\nPart D sponsors currently have access to monthly Patient Safety Reports via the Patient Safety Analysis Web \\nPortal to compare their performance to overall rates and monitor their progress in improving the Part D patient \\nsafety measures over time. Sponsors may use the website to view and download the reports for performance \\nmonitoring. \\n \\nReport User Guides are available on the Patient Safety Analysis Web Portal under Help Documents and provide \\ndetailed information about the measure calculations and reports. The following information is an excerpt from \\nthe Adherence Measures Report Guide (Appendices A and B) and illustrates the days covered calculation and \\nthe modification for inpatient stays and skilled nursing facility stays. \\nProportion of Days Covered Calculation \\n \\nIn calculating the Proportion of Days Covered (PDC), we first count the number of days the patient was \\n“covered” by at least one drug in the target drug class. The number of days is based on the prescription fill date \\nand days’ supply. PDC is calculated by dividing the number of covered days by the number of days in the \\nmeasurement period. Both of these numbers may be adjusted for IP/SNF stays, as described in the ‘Calculating \\nthe PDC Adjustment for IP Stays and SNF Stays’ section that follows. \\nExample 1: Non-Overlapping Fills of Two Different Drugs \\n \\nIn this example, a beneficiary fills Benazepril and Captopril, two drugs in the RAS antagonist hypertension \\ntarget drug class. The covered days do not overlap, meaning the beneficiary filled the Captopril prescription \\nafter the days’ supply for the Benazepril medication ended. \\nTable L-1: No Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX \\nBenazepril \\n15 \\n16 \\n15 \\n13 \\n \\n \\nCaptopril \\n \\n \\n \\n \\n15 \\n16 \\n \\nPDC Calculation \\nCovered Days: 90 \\nMeasurement Period: 90 \\nPDC: 90/90 = 100% \\nExample 2: Overlapping Fills of the Same Generic Ingredient across Single and Combination Products \\n \\nIn this example, a beneficiary fills a drug with the same target generic ingredient prior to the end of the days’ \\nsupply of the first fill. In rows one and two, there is an overlap between a single and combination drug product, \\nboth containing Lisinopril. For this scenario, the overlapping days are shifted because the combination drug \\nproduct includes the targeted generic ingredient. An adjustment is made to the PDC to account for the overlap \\nin days covered. \\n \\nIn rows two and three, there is an overlap between two combination drug products, both containing \\nHydrochlorothiazide. However, Hydrochlorothiazide is not a RAS antagonist or targeted generic ingredient, so \\nthis overlap is not shifted.', '(Last Updated 10/03/2024)  \\nPage 157 \\n \\nTable L-2: Before Overlap Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX \\nLisinopril \\n15 \\n16 \\n \\n \\n \\n \\nLisinopril & HCTZ \\n \\n16 \\n15 \\n \\n \\n \\nBenazepril & HCTZ \\n \\n \\n15 \\n13 \\n \\n \\n \\nPDC Calculation \\nCovered Days: 59 \\nMeasurement Period: 90 \\nPDC: 59/90 = 66% \\nTable L-3: After Overlap Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX \\nLisinopril \\n15 \\n16 \\n \\n \\n \\n \\nLisinopril & HCTZ \\n \\n \\n15 \\n13 \\n3 \\n \\nBenazepril & HCTZ \\n \\n \\n15 \\n13 \\n \\n \\n \\nPDC Calculation \\nCovered Days: 62 \\nMeasurement Period: 90 \\nPDC: 62/90 = 69% \\nExample 3: Overlapping Fills of the Same and Different Target Drugs \\nIn this example, a beneficiary is refilling both Lisinopril and Captopril. When a single and combination product \\nboth containing Lisinopril overlap, there is an adjustment to the PDC. When Lisinopril overlaps with Captopril, \\nwe do not make any adjustment to the days covered. \\nTable L-4: Before Overlap Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\nApril \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX 4/1/20XX 4/16/20XX \\nLisinopril \\n15 \\n16 \\n \\n \\n \\n \\n \\n \\nLisinopril & HCTZ  \\n16 \\n15 \\n \\n \\n \\n \\n \\nCaptopril \\n \\n \\n \\n \\n15 \\n16 \\n \\n \\nLisinopril \\n \\n \\n \\n \\n \\n16 \\n15 \\n \\n \\nPDC Calculation \\nCovered Days: 92 \\nMeasurement Period: 120 \\nPDC: 92/120: 77%', '(Last Updated 10/03/2024)  \\nPage 158 \\n \\nTable L-5: After Overlap Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\nApril \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX 4/1/20XX 4/16/20XX \\nLisinopril \\n15 \\n16 \\n \\n \\n \\n \\n \\n \\nLisinopril & HCTZ \\n \\n \\n15 \\n13 \\n3 \\n \\n \\n \\nCaptopril \\n \\n \\n \\n \\n15 \\n16 \\n \\n \\nLisinopril \\n \\n \\n \\n \\n \\n16 \\n15 \\n \\n \\nPDC Calculation \\nCovered Days: 105 \\nMeasurement Period: 120 \\nPDC: 105/120: 88% \\nPDC Adjustment for Inpatient, and Skilled Nursing Facility Stays Examples \\n \\nIn response to Part D sponsor feedback, CMS modified the PDC calculation, starting with the 2013 Star Ratings \\n(using 2011 PDE data) to adjust for beneficiary stays in inpatient (IP) facilities, and with the 2015 Star Ratings \\n(using 2013 PDE data) to also adjust for hospice enrollments and beneficiary stays in skilled nursing facilities \\n(SNF). These adjustments account for periods that the Part D sponsor would not be responsible for providing \\nprescription fills for targeted medications or more accurately reflect drugs covered under the hospice benefit or \\nwaived through the beneficiary’s hospice election; thus, their medication fills during an IP or SNF stay or \\nduring hospice enrollment would not be included in the PDE claims used to calculate the Patient Safety \\nadherence measures. \\n \\nThe PDC modification for IP stays, hospice enrollments, and SNF stays reflects this situation. Please note that \\nwhile this modification will enhance the adherence measure calculation, extensive testing indicates that most \\nPart D contracts will experience a negligible impact on their adherence rates. On average, the 2011 adherence \\nrates increased 0.4 to 0.6 percentage points due to the inpatient stay adjustment, and the adjustment may impact \\nthe rates positively or negatively. \\n \\nThe hospice and SNF adjustments were tested on 2013 PDE data and overall increased the rates by 0.13 to 0.15 \\npercentage points and 0.29 to 0.35 percentage points, respectively. Hospice information from the Medicare \\nEnrollment Database (EDB) and inpatient claims from the Common Working File (CWF) are available for both \\nPDPs and MA-PDs. NOTE: Due to CMS’s migration of the beneficiary database, including the EDB and CME, \\nto the Amazon Web Services (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated Data Repository (CME \\nIDRC), sourced from the same upstream database. \\n \\nSNF claims from the CWF have been used to adjust the SNF PDC adjustments for PDPs. Starting in the 2019 \\nmeasurement year, when available for MA-PDs in the CWF, adjust the SNF PDC adjustments. Additionally, \\nstarting in 2020 measurement year, when available for MA-PDs in the encounter data, adjust for SNF/IP stays \\nfor MA-PD beneficiaries.  \\n \\nNote: Hospice enrollment is no longer a PDC adjustment but rather an exclusion starting with the 2020 Star \\nRatings (2018 YOS).', '(Last Updated 10/03/2024)  \\nPage 159 \\n \\nCalculating the PDC Adjustment for IP Stays and SNF Stays \\n \\nThe PDC modification for IP stays and SNF stays is based on two assumptions: 1) a beneficiary receives their \\nmedications through the facility during the IP or SNF stay, and 2) if a beneficiary accumulates an extra supply \\nof their Part D medication during an IP stay or SNF stay, that supply can be used once he/she returns home. The \\nmodification is applied using the steps below: \\n Identify start and end dates of relevant types of stays for beneficiaries included in adherence measures. \\nThe discharge date is included in the PDC adjustment.  \\no Use IP claims from the CWF to identify IP stays, and when available for MA-PDs. \\no Use SNF claims from the CWF for PDPs, and when available for MA-PD beneficiaries, for SNF \\nPDC adjustments. (1) Use SNF claims from the CWF with either a positive or negative paid \\namount with Medicare utilization days to identify Medicare Part A covered SNF stays. (2) Use \\nSNF claims from the CWF with a condition code 04 (Beneficiary enrolled in a MA-PD) not \\nassociated with a condition code 21 and/or a no payment reason code.  \\no Use IP and SNF stay encounter data when available for MA-PD beneficiaries. Additionally, if IP \\nand SNF stay claims for MA-PD enrolled beneficiaries are reported in the CWF, the CWF will \\nremain as an additional data source.  \\n Remove days of relevant stays occurring during the measurement period from the numerator and \\ndenominator of the proportion of days covered calculation. \\n Shift days’ supply from Part D prescription fills that overlap with the stay or subsequent fills for the \\nsame drug class to uncovered days after the end of the relevant stay, if applicable. This assumes the \\nbeneficiary receives the relevant medication from a different source during the stay and accumulates the \\nPart D prescription fills for later use. \\nIf SNF and IP stays span all of the beneficiary’s enrollment episodes within the measurement period, that meets \\nthe inclusion criteria, the associated proportion of member-years is not included in the rate calculation.  \\n \\nThe following examples provide illustrations of the implementation of these assumptions when calculating PDC. \\nExample 1: Gap in Coverage after IP Stay \\n \\nIn this example, the measurement period is 15 days and the beneficiary qualifies for inclusion in the measure by \\nreceiving at least 2 fills on different dates of service. This beneficiary had drug coverage on days 1-8 and 12-15 \\nand an IP stay on days 5 and 6, as illustrated in Table L-6. \\nTable L-6: Before Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\n  \\n  \\n  \\nX2 \\nX2 \\nX2 \\nX2 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n+ \\n+ \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 12 \\nMeasurement Period: 15 \\nPDC: 12/15 = 80% \\n \\nWith the adjustment for the IP stay, days 5 and 6 are deleted from the measurement period.  Additionally, the \\ndrug coverage during the IP stay is shifted to subsequent days of no supply (in this case, days 9 and 10), based \\non the assumption that if a beneficiary received his/her medication through the hospital on days 5 and 6, then', '(Last Updated 10/03/2024)  \\nPage 160 \\n \\nhe/she accumulated two extra days’ supply during the IP stay. The two extra days’ supply is used to cover the \\ngaps in Part D drug coverage in days 9 and 10.  This is illustrated in Table L-7. \\nTable L-7: After Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\n+ \\n+ \\n  \\nX2 \\nX2 \\nX2 \\nX2 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 12 \\nMeasurement Period: 13 \\nPDC: 12/13 = 92% \\nExample 2: Gap in Coverage before IP Stay \\nIn this example, the measurement period is 15 days and the beneficiary qualifies for inclusion in the measure by \\nreceiving at least 2 fills on different dates of service. This beneficiary had drug coverage from days 1-7 and 12-\\n15, and an IP stay on days 12 and 13, as illustrated in Table L-8. \\nTable L-8: Before Adjustment  \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\n  \\n  \\n  \\n  \\nX2 \\nX2 \\nX2 \\nX2 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n+ \\n+ \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 11 \\nMeasurement Period: 15 \\nPDC: 11/15 = 73% \\n \\nWith the adjustment for the IP stay, days 12 and 13 are deleted from the measurement period. While there are \\ntwo days’ supply from the IP stay on days 12 and 13, there are no days without drug coverage after the IP stay.  \\nThus, the extra days’ supply are not shifted. This is illustrated in Table L-9. \\nTable L-9: After Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\n  \\n  \\n  \\n  \\nX2 \\nX2 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 9 \\nMeasurement Period: 13 \\nPDC: 9/13 = 69% \\nExample 3: Gap in Coverage Before and After IP Stay \\n \\nIn this example, the measurement period is 15 days and the beneficiary qualifies for inclusion in the measure by \\nreceiving at least 2 fills on different dates of service. This beneficiary had drug coverage from days 1-3, 6-9, \\nand 12-15, and an IP stay on days 6-9, as illustrated in Table L-10.', '(Last Updated 10/03/2024)  \\nPage 161 \\n \\nTable L-10: Before Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\n  \\n  \\nX2 \\nX2 \\nX2 \\nX2 \\n  \\n  \\nX3 \\nX3 \\nX3 \\nX3 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n+ \\n+ \\n+ \\n+ \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 11 \\nMeasurement Period: 15 \\nPDC: 11/15 = 73% \\n \\nWith the adjustment for the IP stay, days 6-9 are deleted from the measurement period. Additionally, the drug \\ncoverage during the IP stay can be applied to any days without drug coverage after the IP stay, based on the \\nassumption that the beneficiary received his/her medication through the hospital on days 6-9. In this case, only \\ndays 10 and 11 do not have drug coverage and are after the IP stay, so two days’ supply are shifted to days 10 \\nand 11. This is illustrated in Table L-11. \\nTable L-11: After Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\n  \\n  \\n+ \\n+ \\nX2 \\nX2 \\nX3 \\nX3 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 9 \\nMeasurement Period: 11 \\nPDC: 9/11 = 82% \\nExample 4: Gap in Coverage After IP Stay and Overlap with Subsequent Fill of the Same Drug Class \\n \\nIn this example, the measurement period is 15 days and the beneficiary qualifies for inclusion in the measure by \\nreceiving at least 2 fills on different dates of service. This beneficiary had drug coverage from days 1-4, and 7-\\n11 for the same drug class, and an IP stay on days 2-4, as illustrated in Table L-12. \\nTable L-12: Before Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\n \\nX2 \\nX2 \\nX2 \\nX2 \\nX2 \\n \\n \\n \\n \\nInpatient Stay \\n+ \\n+ \\n+ \\n  \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 9 \\nMeasurement Period: 15 \\nPDC: 9/15 = 60% \\n \\nWith the adjustment for the IP stay, days 2-4 are deleted from the measurement period. Additionally, the drug \\ncoverage during the IP stay can be applied to any days without drug coverage after the IP stay. In the case of \\noverlapping days with a subsequent fill of the same drug class, the days supply of the subsequent fill are shifted. \\nIn this example, the days supply of 2 to 4 during the IP stay are shifted to days 5 to 7 after the IP stay. Because \\nday 7 includes 1 days supply of a subsequent fill (X2) of the same drug class, days 7 to 11 that corresponds to \\nthe subsequent fill are shifted to days 8 to 12. This is illustrated in Table L-13.', '(Last Updated 10/03/2024)  \\nPage 162 \\n \\nTable L-13: After Adjustment \\nDay \\n1 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\n+ \\n+ \\n+ \\n X2 \\nX2  \\nX2 \\nX2 \\nX2 \\nInpatient Stay \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 9 \\nMeasurement Period: 12 \\nPDC: 9/12 = 75%', '(Last Updated 10/03/2024)  \\nPage 163 \\n \\nAttachment M: Methodology for MPF Price Accuracy Measure \\nCMS’s drug pricing performance measure evaluates the accuracy of prices displayed on Medicare Plan Finder \\n(MPF) for beneficiaries’ comparison of plan options. The accuracy score is calculated by comparing the MPF \\nprice to the PDE price and determining the magnitude and frequency of differences found when the PDE price \\nexceeds the MPF price. This document summarizes the methods currently used to construct each contract’s \\nMPF Composite Price Accuracy Score. \\n \\nContract Selection \\nThe Part D Star Ratings rely in part on the submission of pricing data to MPF. Therefore, only contracts with at \\nleast one plan meeting all of the following criteria are included in the analysis: \\nNot a PACE plan \\nNot a demonstration plan \\nNot an employer plan \\nPart D plan \\nPlan not terminated during the contract year \\nOnly contracts with at least 30 eligible claims throughout the year are included in the accuracy measure. This \\nensures that the sample size of PDEs is large enough to produce a reliable accuracy score. \\n \\nMPF Composite Price Accuracy Score \\nTo calculate the MPF Composite Price Accuracy Score, the point of sale cost (ingredient costs plus dispensing \\nfee) reported on each PDE claim is compared to the cost resulting from using the unit price reported on Plan \\nFinder.1 This comparison includes only PDEs for which a MPF cost can be assigned. In particular, a PDE must \\nmeet seven conditions to be included in the analysis: \\n1. If the NPI in the Pharmacy Cost (PC) file represents a retail only pharmacy or retail and limited access \\ndrug only pharmacy, all corresponding PDEs will be eligible for the measure. However, if the NPI in the \\nPC file represents a retail and other pharmacy type (such as Mail, Home Infusion or Long Term Care \\npharmacy), only the PDE where the pharmacy service type is identified as either Community/Retail or \\nManaged Care Organization (MCO) will be eligible. NCPDP numbers are mapped to their \\ncorresponding NPI numbers. \\n2. The corresponding reference NDC must appear under the relevant price ID for the pharmacy in the \\npricing file.2 \\n3. The reference NDC must be on the plan’s formulary. \\n4. Because the retail unit cost reported on Plan Finder is intended to apply to a 1, 2, or 3-month supply of a \\ndrugs, only claims with a Days Supply of 28-34, 60-62, or 90-93 are included. If a plan’s bid indicates a \\n1, 2, or 3 month retail days supply amount outside of the 28-34, 60-62, or 90-93 windows, then \\n \\n1 Medicare Plan Finder unit costs are reported by plan, drug, days of supply, and pharmacy.  The plan, drug, days of supply and \\npharmacy from the PDE are used to assign the corresponding Medicare Plan Finder unit cost posted on medicare.gov on the date of \\nthe PDE. \\n2 Medicare Plan Finder prices are reported at the reference NDC level.  A reference NDC is a representative NDC of drugs with the \\nsame brand name, generic name, strength, and dosage form.  To map NDCs on PDEs to a reference NDC, we use First Data Bank \\n(FDB) and Medi-Span to create an expanded list of NDCs for each reference NDC, consisting of NDCs with the same brand name, \\ngeneric name, strength, and dosage form as the reference NDC.  This expanded NDC list allows us to map PDE NDCs to MPF \\nreference NDCs.', '(Last Updated 10/03/2024)  \\nPage 164 \\n \\nadditional days supply values may be included in the accuracy measure for the plan. For example, a plan \\nthat submits a 3 month retail supply of 100 days in their bid will have claims with a days supply of 90-\\n100 included in their accuracy measure calculation. \\n5. PDEs for dates of service during which the plan was suppressed from Plan Finder or where the relevant \\npharmacy or drug was not reported in Plan Finder are not included since no Plan Finder cost can be \\nassigned.3 \\n6. PDEs for compound drugs or non-covered drugs are not included. \\n7. The PDE must occur in Quarter 1 through 3 of the year. Quarter 4 PDEs are not included because MPF \\nprices are not updated during this last quarter. \\nThe MPF Composite Price Accuracy Measure factors in both how much and how often PDE prices exceeded \\nthe prices reflected on the MPF. The contract’s MPF Composite Price Accuracy score is the average of the \\nPrice Accuracy Score, which measures the difference between PDE total cost and MPF total cost,4 and the \\nClaim Percentage Score, which measures the share of claims where PDE prices are less than or equal to MPF \\nprices. \\nOnce MPF unit ingredient costs are assigned, the MPF ingredient cost is calculated by multiplying the unit costs \\nreported on MPF by the quantity listed on the PDE. The PDE total cost (TC) is the sum of the PDE ingredient \\ncost paid and the PDE dispensing fee. Likewise, the MPF TC is the sum of the MPF ingredient cost and the \\nMPF dispensing fee that corresponds to the same pharmacy, plan, and days of supply as that observed in the \\nPDE. Each claim is then given a score based on the difference between the PDE TC and the MPF TC. If the \\nPDE TC is lower than or equal to the MPF TC, the claim receives a score equal to zero. In other words, \\ncontracts are not penalized when point of sale costs are lower than or equal to the advertised costs. However, if \\nthe PDE TC is higher than the MPF TC, then the claim receives a score equal to the difference between the PDE \\nTC and the MPF TC. 5, 6 The contract level MPF Price Accuracy Index is the sum of the claim level scores and \\nPDE TC across all PDEs that meet the inclusion criteria, divided by the PDE TC for those same claims.  \\nThe MPF Claim Percentage Index is the percent of all PDEs that meet the inclusion criteria with a PDE TC \\nhigher than the MPF TC. Note that the best possible MPF Price Accuracy Index is 1, and the best possible MPF \\nClaim Percentage Index is 0. This occurs when the MPF TC is never lower than the PDE TC. The formulas \\nbelow illustrate the calculation of the contract level MPF Price Accuracy Index and MPF Claim Percentage  \\nIndex: \\nPrice Accuracy Index= ∑max(TCiPDE - TCiMPF, 0)  + ∑TCiPDE\\ni\\ni\\n∑TCiPDE\\ni\\n \\nwhere \\nTCiPDE is the ingredient cost plus dispensing fee reported in PDEi, and \\n \\n3 Because CMS continues to display pharmacy and drug pricing data for sanctioned plans on MPF to their current enrollees, \\nsanctioned plans are not excluded from this measure. If, however, CMS completely suppresses a sanctioned contract’s data from MPF \\ndisplay, then they would be excluded from the measure. \\n4 MPF total costs are rounded to the nearest cent. For example, if the MPF total cost is $10.237, then it is rounded to $10.24. MPF unit \\ncosts are not rounded. \\n5 To account for potential rounding errors, this analysis requires that the PDE cost exceed the rounded MPF cost by at least a two cent \\n($0.02) in order to be counted towards the accuracy score. For example, if the PDE cost is $10.25 and the rounded MPF cost is $10.23, \\nthe 2-cent difference would be counted towards plan’s accuracy score. However, if the rounded MPF cost is higher than $10.23, the \\ndifference would not count towards the plan’s accuracy score. \\n6 The MPF data includes floor pricing.  For plan-pharmacy drugs with a floor price, if the MPF price is lower than the floor price, the \\nPDE price is compared against the floor price.', '(Last Updated 10/03/2024)  \\nPage 165 \\n \\nTCiMPF is the ingredient cost plus dispensing fee calculated from MPF data, based on the PDEi \\nreported NDC, days of supply, and pharmacy, then rounded to the nearest cent. \\nClaim Percentage Index= ∑ClaimsiPDE>MPF\\ni\\n∑ClaimsiTotal\\ni\\n \\nwhere \\nClaimsiPDE>MPF is the total number of claims where the PDE price is greater than the rounded \\nMPF price \\nClaimsiTotal is the total number of claims \\n \\nWe use the following formulas to convert the Claim Percentage Index and Price Accuracy Index into the MPF \\nComposite Price Accuracy score: \\n \\nPrice Accuracy Score= 100-[(Price Accuracy Index -1) x 100] \\nClaim Percentage Score=(1 - Claim Percentage Index) x 100 \\nMPF Composite Price Accuracy Score=(0.5 x Price Accuracy Score)+(0.5 x Claim Percentage Score) \\n \\nThe MPF Composite Price Accuracy Score is rounded to the nearest whole number.', '(Last Updated 10/03/2024)  \\nPage 166 \\n \\nExample of Accuracy Index Calculation \\nTable M-1 shows an example of the MPF Composite Price Accuracy Score calculation. This contract has 4 claims, for 4 different NDCs and 4 \\ndifferent pharmacies. This is an abbreviated example for illustrative purposes only; in the actual accuracy index, a contract must have 30 eligible \\nclaims to be evaluated. \\nFrom each of the 4 claims, the PDE ingredient cost, dispensing fee, and quantity dispensed are obtained. Additionally, the plan ID, days of supply, \\ndate of service, and pharmacy number are collected from each PDE to identify the MPF data that had been submitted by the contract and posted on \\nMPF on the PDE dates of service. The NDC on the claim is first assigned the appropriate reference NDC, based on the brand name, generic name, \\nstrength, and dosage form. Using the reference NDC, the following MPF data are obtained: brand/generic dispensing fee (as assigned by the \\npharmacy cost file) and unit cost (as assigned by the Price File corresponding to that pharmacy and days of supply on the date of service). The PDE \\ncost is the sum of the PDE ingredient cost and dispensing fee. The MPF cost is computed as the quantity dispensed from PDE multiplied by the MPF \\nunit cost plus the MPF brand/generic dispensing fee (brand or generic status is assigned based on the NDC), and then rounded to the nearest cent. \\nThe last column shows the amount by which the PDE cost is higher than the rounded MPF cost. When PDE cost is less than or equal to the rounded \\nMPF cost, this value is zero. The Price Accuracy Index is the sum of the last column plus the sum of PDE costs all divided by the sum of PDE costs. \\nThe Claim Percentage Index is the number of rows where the last column is greater than zero divided by the total number of rows.', '(Last Updated 10/03/2024)  \\nPage 167 \\n \\nTable M-1: Example of Price Accuracy Index Calculation \\nNDC Pharmacy \\nNumber \\nPDE Data \\nDOS \\nPDE Data \\nIngredient \\nCost \\nPDE Data \\nDispensing \\nFee \\nPDE Data \\nQuantity \\nDispensed \\nPDE \\nDays of \\nSupply \\nMPF Data \\nBiweekly \\nPosting \\nPeriod \\nMPF \\nData \\nUnit \\nCost \\nMPF Data \\nDispensing \\nFee Brand \\nMPF Data \\nDispensing \\nFee \\nGeneric \\nCalculated \\nValue \\nBrand or \\nGeneric \\nStatus \\nCalculated \\nValue Total \\nCost PDE \\nCalculated \\nValue Total \\nCost MPF \\nCalculated Value \\nAmount that PDE \\nis higher than \\nMPF \\nA \\n111 \\n01/08/2023 \\n3.82 \\n2 \\n60 \\n60 \\n01/06/23 - \\n01/19/23 \\n0.014 \\n2.25 \\n2.75 \\nB \\n5.82 \\n3.09 \\n2.73 \\nB \\n222 \\n01/24/2023 \\n0.98 \\n2 \\n30 \\n60 \\n01/20/23 - \\n02/02/23 \\n0.83 \\n1.75 \\n2.5 \\nG \\n2.98 \\n27.40 \\n0 \\nC \\n333 \\n02/11/2023 \\n10.48 \\n1.5 \\n24 \\n28 \\n02/03/23 - \\n02/16/23 \\n0.483 \\n2.5 \\n2.5 \\nB \\n11.98 \\n14.09 \\n0 \\nD \\n444 \\n02/21/2023 \\n47 \\n1.5 \\n90 \\n30 \\n02/17/23 - \\n03/01/23 \\n0.48 \\n1.5 \\n2.25 \\nG \\n48.50 \\n45.45 \\n3.05 \\n \\nPDE = Prescription Drug Event \\nMPF = Medicare Plan Finder \\n \\nTotals \\n69.28 \\n  \\n5.78 \\n \\nPrice Accuracy Index  \\n1.08343 \\n \\nClaim Percentage Index \\n0.5 \\n \\nMPF Composite Price Accuracy Score \\n71', '(Last Updated 10/03/2024)  \\nPage 168 \\n \\nAttachment N: MTM CMR Completion Rate Measure Scoring Methodologies \\nMedicare Part D Reporting Requirements Measure (D11: MTM CMR Completion Rate Measure) \\nStep 1: Start with all contracts that enrolled beneficiaries in MTM at any point during contract year 2023. \\nBeneficiaries with multiple records that contain varying information for the same contract are \\nexcluded from the measure calculation for that contract. \\n \\nStep 2: Exclude contracts that did not enroll 31 or more beneficiaries in their MTM program who met the \\nmeasure denominator criteria during contract year 2023. \\n \\nNext, exclude contracts with an effective termination date on or before the deadline to submit data \\nvalidation results to CMS (June 15, 2024), or that were not required to participate in data \\nvalidation.  \\n• Contracts that terminate on or before 07/01/2024 according to the Contract Info extract. \\n \\nAdditionally, exclude contracts that did not score at least 95% on data validation for their plan \\nreporting of the MTM Program section and contracts that scored 95% or higher on data validation \\nfor the MTM Program section but that were not compliant with data validation standards/sub-\\nstandards for at least one of the following MTM data elements. We define a contract as being non-\\ncomplaint if either it receives a \"No\" or a 1, 2, or 3 on the 5-point Likert scale in the specific data \\nelement\\'s data validation. \\n \\n• MBI Number (Element B) \\n• Date of MTM program enrollment (Element H) \\n• Met the specified targeting criteria per CMS – Part D requirements (Element I) \\n• Date met the specified targeting criteria per CMS – Part D requirements (Element J) \\n• Date of MTM program opt-out, if applicable (Element K) \\n• Received annual CMR with written summary in CMS standardized format (Element O) \\n• Date(s) of CMR(s) (Element P) \\nStep 3: After removing contracts’ and beneficiaries’ data excluded above, suppress contract rates based on \\nthe following rules: \\nFile DV failure: Contracts that failed to submit the CY 2023 MTM Program Reporting \\nRequirements data file or who had a missing DV score for MTM are listed as “CMS identified \\nissues with this plan\\'s data.” \\nSection-level DV failure: Contracts that score less than 95% in DV for their CY 2023 MTM \\nProgram Reporting Requirements data are listed as “CMS identified issues with this plan\\'s data.” \\nElement-level DV failure: Contracts that score 95% or higher in DV for their CY 2023 MTM \\nProgram Reporting Requirements data but that failed at least one of the seven data elements are \\nlisted as “CMS identified issues with this plan\\'s data.” \\nSmall size: Contracts that have not yet been suppressed and have fewer than 31 beneficiaries \\nenrolled are listed as “Not enough data available.” \\nOrganizations can view their own plan reporting data validation results in HPMS \\n(https://hpms.cms.gov/). From the home page, select Monitoring | Plan Reporting Data Validation. \\nStep 4: Calculate the rate for the remaining contracts using the following formula:', '(Last Updated 10/03/2024)  \\nPage 169 \\n \\nNumber of beneficiaries from the denominator who received a CMR at any time during their \\nperiod of MTM enrollment in the reporting period / Number of beneficiaries who were at least 18 \\nyears or older as of the beginning of the reporting period, met the specified targeting criteria per \\nCMS during the reporting period, weren’t in hospice at any point during the reporting period, and \\nwho were enrolled in the MTM program for at least 60 days during the reporting period. \\nBeneficiaries who were enrolled in the contract’s MTM program for less than 60 days at any time \\nin the measurement year are included in the denominator and the numerator if they received a \\nCMR within this timeframe. Beneficiaries are excluded from the measure calculation if they were \\nenrolled in the contract’s MTM program for less than 60 days and did not receive a CMR within \\nthis timeframe.', '(Last Updated 10/03/2024)  \\nPage 170 \\n \\nAttachment O: Methodology for the Puerto Rico Model \\nPuerto Rico has a unique health care market with a large percentage of low-income individuals in both \\nMedicare and Medicaid and a complex legal history that affects the health care system in many ways. Puerto \\nRican beneficiaries are not eligible for LIS. The categorization of contracts into final adjustment categories for \\nthe Categorical Adjustment Index (CAI) relies on both the use of a contract’s percentages of beneficiaries with \\nLow Income Subsidy/Dual Eligible (LIS/DE) and disabled beneficiaries.  Since the percentage of LIS/DE is a \\ncritical element in the categorization of contracts to identify the contract’s CAI, an additional adjustment is \\ndone for contracts that solely serve the population of beneficiaries in Puerto Rico to address the lack of LIS. The \\nadditional analysis for the adjustment results in a modified percentage of LIS/DE beneficiaries that is \\nsubsequently used to categorize the contract in its final adjustment category for the CAI. \\n \\nThe contract-level modified LIS/DE percentages for Puerto Rico contracts for the 2025 Star Ratings are \\ndeveloped using the following sources of information: \\n The 2022 1-year American Community Survey (ACS) estimates for the percentage of people living \\nbelow the Federal Poverty Level (FPL). \\n The 2022 ACS 5-year estimates for the percentage of people living below 150% of the FPL; for Puerto \\nRico and for the 10 poorest US states (which may include the District of Columbia). \\n The Medicare enrollment data file for those enrolled during 2023 provided for beneficiaries who were \\nalive at least through December 2023, the percentage of each contract’s beneficiaries who were DE, and \\nfor non-Puerto Rico contracts, the percentage who were LIS/DE. Beneficiary DE status was determined \\nusing a) the monthly beneficiary dual status codes, b) identification of Low Income Part D enrollees \\nwho reside in the US Territories, and c) beneficiaries with Medicaid coverage/who are Medicaid eligible \\nby the Point of Sale contractor. For non-Puerto Rico contracts, beneficiaries who were LIS were \\ndetermined using the monthly beneficiary LIS status codes, and beneficiaries were classified LIS/DE by \\ncombining the beneficiaries identified as DE and beneficiaries identified as LIS. \\nThe following steps are employed to determine the modified percentages of LIS/DE for MA contracts solely \\nserving the population of beneficiaries in Puerto Rico. All references to contracts in Puerto Rico are limited to \\nthe contracts solely serving the population of beneficiaries in Puerto Rico. \\n The 10 states with the highest proportion of people living below the FPL are identified, based on 2022 \\n1-year data from ACS \\n(https://www.census.gov/content/dam/Census/library/publications/2023/acs/acsbr-016.pdf, see Table 1). \\nThe states identified are: Alabama, Arkansas, Kentucky, Louisiana, Mississippi, New Mexico, New York, \\nOklahoma, South Carolina, and West Virginia. \\n Data are aggregated from Medicare Advantage contracts that had at least 90% of their beneficiaries \\nenrolled with mailing addresses within the 10 highest poverty states identified in step (1). \\nFor the 2025 Star Ratings adjustment, the data used for the model development included a total of 150 \\nMedicare Advantage contracts with at least 90% of their beneficiaries with mailing addresses in one of \\nthe ten poorest states listed above. \\n A linear regression model is developed using the known LIS/DE percentage and the corresponding DE \\npercentage from the MA contracts in the 10 highest poverty states with at least 90% of their \\nbeneficiaries with mailing addresses in one of the ten states. \\n \\nThe model for Puerto Rico is developed using the model in step (3) as its base. \\n \\nThe estimated slope from the linear fit in the previous step (3) is retained to approximate the expected', \"(Last Updated 10/03/2024)  \\nPage 171 \\n \\nrelationship between LIS/DE for each contract in Puerto Rico and its DE percentage. However, as \\nPuerto Rico contracts are expected to have a larger percentage of low-income beneficiaries, the intercept \\nterm is adjusted to be more suitable for use with Puerto Rico contracts as follows:  \\n \\nThe intercept term for the Puerto Rico model is estimated by assuming that the Puerto Rico model will \\npass through the point (x, y) where x is the observed average DE percentage in the Puerto Rico \\ncontracts, and y is the expected average percentage of LIS/DE in Puerto Rico. The expected average \\npercentage of LIS/DE in Puerto Rico (the y value) is not observable but is estimated by multiplying the \\nobserved average percentage of LIS/DE in the 10 highest poverty states identified in step (1) by the ratio \\nbased on the 2022 5-year ACS estimates of the percentage living below 150% of the FPL in Puerto Rico \\ncompared to the corresponding percentage in the 10 poorest US states. \\n To obtain each Puerto Rico contract’s modified LIS/DE percentage, a contract’s observed DE \\npercentage is used in the Puerto Rico model developed in the previous step (4). \\n \\nA contract’s observed DE percentage is multiplied by the slope estimate, and then, the newly derived \\nintercept term is added to the product. The estimated modified LIS/DE percentage is capped at 100%. \\nAny estimated LIS/DE percentage that exceeds 100% is categorized in the final adjustment category for \\nLIS/DE with an upper bound of 100%. \\n \\nNote that the District of Columbia is included with the 50 US states when determining the 10 poorest in \\n2022. All estimated modified LIS/DE values for Puerto Rico are rounded to six decimal places when \\nexpressed as a percentage. (This rounding rule aligns with the limits for the adjustment categories for \\nLIS/DE for the CAI.) \\nModel \\nThe generic model developed to estimate a contract’s LIS/DE percentage using its DE percentage is as follows: \\nLIS/DE\\n\\u0de3 = ( Slope × contract's DE percentage ) + ( intercept ) \\nUsing the data from the 10 highest poverty states, the estimated slope was calculated to be 0.946906. \\nLIS/DE\\n\\u0de3 = (0.946906 × contract's DE percentage ) + ( intercept ) \\nNext, the intercept for the Puerto Rico model was determined using the point (x, y) where x is the observed \\naverage DE percentage in Puerto Rico contracts (28.653926%) and y is an estimated expected average \\npercentage of LIS/DE in Puerto Rico. \\nTo calculate the estimated expected average percentage of LIS/DE in Puerto Rico, the observed average \\npercentage of LIS/DE in the 10 poorest US states identified in step (1) is multiplied by the ratio of the \\npercentage of Puerto Rico residents living below 150% of the FPL to the analogous percentage in the 10 poorest \\nUS states. \\nDescription \\nValue \\nPercent of PR residents below 150% of FPL \\n59.100000% \\nPercent of residents in the 10 poorest US states below 150% of FPL 24.390525% \\nObserved average LIS/DE percentage in the 10 poorest US states \\n45.503047% \\nObserved average DE percentage in Puerto Rico contracts  \\n28.653926%\", \"(Last Updated 10/03/2024)  \\nPage 172 \\n \\nThe product thus becomes ቀ45.503047 × \\n59.100000\\n24.390525  ቁ. \\nThe new intercept for the Puerto Rico model is as follows: \\nnew intercept = ൬45.503047 × 59.100000\\n24.390525  ൰- (0.946906 × 28.653926) \\nThe final model to estimate the percentage of LIS/DE in Puerto Rico model is as follows: \\nLIS/DE\\n\\u0de3=൫0.946906 × contract's DE percentage൯ + ൬45.503047 × 59.100000\\n24.390525  ൰- (0.946906 × 28.653926) \\nExample \\nTo calculate the contract-level modified LIS/DE percentage for a hypothetical contract from Puerto Rico with \\nan observed DE percentage of 15%, the value of 15.000000% is used in the model developed. \\nLIS/DE\\n\\u0de3=(0.946906 × contract's DE percentage) + ൬45.503047 × 59.100000\\n24.390525  ൰- (0.946906 × 28.653926) \\nThe contracts percentage of 15.000000% is substituted into the Puerto Rico model. \\nLIS/DE\\n\\u0de3=(0.946906 × 15.000000) + ൬45.503047 × 59.100000\\n24.3905251  ൰- (0.946906 × 28.653926) \\nThe contract-level modified LIS/DE percentage for a hypothetical Puerto Rico contract that has an observed DE \\npercentage of 15.000000% is 97.328178%. \\nThe final adjustment category for the CAI adjustment is identified using the LIS/DE percentage 97.328178%.\", '(Last Updated 10/03/2024)  \\nPage 173 \\n \\nAttachment P: Identification of Contracts Affected by Disasters \\nNatural disasters such as hurricanes and wildfires can directly affect Medicare beneficiaries and providers, as \\nwell as the Parts C and D organizations that provide them with important medical care and prescription drug \\ncoverage. These disasters may negatively affect the underlying operational and clinical systems that CMS relies \\non for accurate performance measurement in the Star Ratings program. \\nThe 2025 Rate Announcement (https://www.cms.gov/Medicare/Health-\\nPlans/MedicareAdvtgSpecRateStats/Announcements-and-Documents.html) describes CMS’s policy for making \\nadjustments in the Star Ratings to take into account the effects of extreme and uncontrollable circumstances \\nwhich occurred during the performance period. This is also codified in regulation at §422.166(i) and \\n§423.186(i). \\nOperational Steps to Calculating Enrollment Impacted in Affected Contracts. \\n Identify the areas which experienced both extreme and uncontrollable circumstances as defined in \\nSection 1135 (g) of the Act and also are within a county or statistically equivalent entity, U.S. territory \\nor tribal government designated in a major disaster declaration under the Stafford Act. \\no Areas where the Health and Human Services (HHS) Secretary exercised their authority under \\nSection 1135 of the Act can be found at the Public Health Emergency website at \\nhttps://www.phe.gov/emergency/news/healthactions/section1135/Pages/default.aspx \\no Major disaster areas are identified by the Federal Emergency Management Agency (FEMA) website \\nat: https://www.fema.gov/disasters. \\nTable P-1 lists the Section 1135 waivers issued by the HHS Secretary along with associated FEMA \\nmajor disaster information that falls within the performance period for the 2025 Star Ratings.  \\nTable P-1: Section 1135 waivers issued in relation to the FEMA major disaster declarations \\nSection 1135 \\nWaiver Date \\nIssued \\nWaiver or Modification of \\nRequirements Under Section 1135 of \\nthe Social Security Act \\nFEMA Incident Type \\nAffected State \\nIncident Start \\nDate \\n3/27/2023 \\nSevere Storms, Straight-Line Winds, and \\nTornadoes \\nSevere Storms, Straight-Line \\nWinds, and Tornadoes \\nMississippi \\n3/24/2023 \\n6/2/2023 \\nTyphoon Mawar \\nTyphoon Mawar \\nGuam \\n5/22/2023 \\n8/11/2023 \\nWildfires \\nWildfires \\nHawaii \\n8/8/2023 \\n8/30/2023 \\nHurricane Idalia \\nHurricane \\nFlorida \\n8/27/2023 \\n9/12/2023 \\nHurricane Idalia \\nHurricane \\nGeorgia \\n8/30/2023 \\n Identify the counties or statistically equivalent entities which were declared as Individual Assistance \\nareas by each of the FEMA major disaster declarations that meet the criteria set out in Step 1 below. \\nTable P-2 lists all of the relevant FEMA major disaster declarations along with the state and associated \\nIndividual Assistance counties.', '(Last Updated 10/03/2024)  \\nPage 174 \\n \\nTable P-2: Individual Assistance counties in FEMA Major Disaster Declared States  \\nFEMA \\nDeclaration \\nState \\nFEMA Individual Assistance Counties or County-Equivalents \\nDR-4697-MS \\nMississippi \\nCarroll, Humphreys, Monroe, Montgomery, Panola, Sharkey \\nDR-4715-GU \\nGuam \\nGuam \\nDR-4724-HI \\nHawaii \\nMaui \\nDR-4734-FL \\nFlorida \\nCharlotte, Citrus, Columbia, Dixie, Gilchrist, Hamilton, Hernando, Hillsborough, Jefferson, \\nLafayette, Levy, Madison, Manatee, Pasco, Pinellas, Sarasota, Suwannee, Taylor \\nDR-4738-GA \\nGeorgia \\nBerrien, Brooks, Cook, Glynn, Lowndes \\n \\n Identify the service area at the state/county level for each contract in operation during the performance \\nperiod. The service area of some organization types rated in the Star Ratings are not defined at the \\nstate/county level, so their service area must be transformed to include all states and counties covered by \\ntheir service area. \\nTable P-3 lists how the service area for each organization type rated in the Star Ratings is defined and \\nwhat transformation, if any, is needed to create a common state/county level file for all contracts. \\nTable P-3: Organization type service areas and necessary transformations \\nStar Rating Organization Types \\nHow Service \\nArea \\nis defined \\nHow Service Area is transformed \\n1876 Cost, E-CCP, E-PDP, E-PFFS, Local CCP, MSA, PFFS, R-PFFS \\n& R-CCP \\nState/County \\nNot necessary, service area is defined at the \\nstate/county level \\nRegional CCP \\nMA Region \\nA record is created for each state/county within the MA \\nregion \\nPDP \\nPDP Region \\nA record is created for each state/county within the PDP \\nregion \\n Compare the Individual Assistance states and counties from Step 2 below to the service area from all \\ncontracts created in Step 3 below with the state and counties. Create a list of all contracts which have \\nany county that matches in both lists. \\n Create a second list of all contracts that do not share any service area with the Individual Assistance \\ncounties, so that information on the status of all contracts is accounted for during the performance period. \\n Identify the timeframe for each disaster and the associated enrollment files. Each of the disasters \\noccurred during a specific period of time. Since the enrollment in a contract is constantly changing, \\nCMS used the enrollment the contract was paid for in a month that as closely matched the disaster \\nperiod in the specific state/county as possible for all further processing, following the months in the \\ntable below. \\nTable P-4 shows each of the disasters where relief was granted along with the disaster start date, and the \\nenrollment file month that was used for that specific disaster. The enrollment file choice was based on \\nthe enrollment file cut-off date the file was created.', '(Last Updated 10/03/2024)  \\nPage 175 \\n \\nTable P-4: Major Disasters with associated enrollment months \\nFEMA \\nDeclaration \\nState \\nStart Date \\nEnroll File \\nEnroll Cut Off \\nDR-4697-MS Mississippi \\n3/24/2023 \\nMay 2023 \\nApril 7, 2023 \\nDR-4715-GU Guam \\n5/22/2023 \\nJuly 2023 \\nJune 2, 2023 \\nDR-4724-HI \\nHawaii \\n8/8/2023 \\nSeptember 2023 \\nAugust 4, 2023 \\nDR-4734-FL \\nFlorida \\n8/27/2023 \\nOctober 2023 \\nSeptember 8, 2023 \\nDR-4738-GA Georgia \\n8/30/2023 \\nOctober 2023 \\nSeptember 8, 2023 \\n Calculate disaster impacted enrollment for contracts experiencing multiple disasters. Because the \\ncontracts serve areas of different sizes and can sometimes serve large, diverse areas, it is common for a \\ncontract to be affected by more than one of the disasters. To account for this, CMS averaged the \\ncounty/state level enrollments from each of corresponding enrollment periods in which the contract was \\naffected. \\nTable P-5 shows an example where all possible enrollment periods are accounted for and how the \\nenrollment for a contract in a state/county which matched the contract’s service area state/county was \\ncalculated. Enrollment in out of service area state/counties was not included. \\nTable P-5: How enrollment periods were combined for contracts experiencing multiple disasters \\nFormula \\nID \\nEnrolled \\n202X_10 \\nEnrolled \\n202X_11 \\nEnrolled \\n202X_12 \\nEnrollment Used \\nB \\nTrue \\nTrue \\nTrue \\n(202X_10 + 202X_11 + 202X_12) / 3 \\nC \\nTrue \\nTrue \\n \\n(202X_10 + 202X_11) / 2 \\nF \\nTrue \\nTrue \\n(202X_10 + 202X_12) / 2 \\nH \\nTrue \\n \\n \\n202X_10 \\nJ \\n \\nTrue \\nTrue \\n(202X_11 + 202X_12) / 2 \\nL \\n \\nTrue \\n \\n202X_11 \\nN \\n \\n \\nTrue \\n202X_12 \\nP \\n \\n \\n \\n0 (zero) \\n Using the enrollment for the contract developed in Step 7 below, take the sum of the enrollment in the \\nentire service area for the contract to be used in further processing. \\n Using the enrollment for the contract developed in Step 7 below, take the sum of the enrollment in all of \\nthe Individual Assistance counties that correspond to the contract service area. \\n Using the final list of affected contracts from Step 4 below, calculate the percentage of the contract’s \\ntotal service area enrollment that was affected by the Individual Assistance area enrollment. Create flags \\nfor the ≥25% and ≥60% thresholds for processing of the ratings data for those contracts.', '(Last Updated 10/03/2024)  \\nPage 176 \\n \\nExample: \\nSteps 1 and 2 use the disasters and counties that have already been defined in Tables P-1 & P-2. For Steps 3 \\nthrough 10, we use an example contract, HAAAA, which offers services to some counties from both \\nCalifornia and Texas. \\nStep 3, Table P-6 below contains the full list of counties that make up the service area for contract HAAAA. \\nStep 4, the Individual Assistance County column is included in Table P-6. Rows marked TRUE are matches \\nfrom Individual Assistance counties in the disasters for year 202X and the service areas of HAAAA. The rows \\nmarked FALSE were not Individual Assistance counties for any of the disasters in HAAAA. \\nStep 5, since the example contract HAAAA has service areas that coincide with disaster counties, it is not \\nincluded in the list of contracts not affected. \\nStep 6, there are two separate enrollment periods associated with the disasters that match example contract \\nHAAAA’s service area. Those enrollment periods are 202X/09 & 202X/11. Columns for all enrollment \\nperiods are included in Table P-6, but only the valid enrollment periods contain the necessary data. \\nStep 7, the average enrollment is calculated for the included enrollment periods. The result of each average \\nenrollment calculation for each county in the example contract’s service area is shown in the final column of \\nTable P-6. \\nTable P-6: Example Contract HAAAA’s Service Areas and Enrollment during Relevant Disasters \\nFIPS \\nCode \\nCounty \\nName \\nST \\nCD \\nEGHP \\nCounty \\nIndividual Assistance \\nCounty \\nEnrolled \\n202X/09 \\nEnrolled \\n202X/10 \\nEnrolled \\n202X/11 \\nAverage \\nEnrollment \\n06003 Alpine \\nCA \\nNo \\nFALSE \\n8 \\n- \\n8 \\n8 \\n06009 Calaveras CA \\nNo \\nFALSE \\n849 \\n- \\n850 \\n850 \\n06011 Colusa \\nCA \\nNo \\nFALSE \\n168 \\n- \\n166 \\n167 \\n06015 Del Norte CA \\nNo \\nFALSE \\n369 \\n- \\n360 \\n364 \\n06023 Humboldt CA \\nNo \\nFALSE \\n702 \\n- \\n710 \\n706 \\n06045 Mendocino CA \\nNo \\nTRUE \\n428 \\n- \\n429 \\n428 \\n06049 Modoc \\nCA \\nNo \\nFALSE \\n157 \\n- \\n158 \\n158 \\n06063 Plumas \\nCA \\nNo \\nFALSE \\n182 \\n- \\n181 \\n182 \\n06093 Siskiyou \\nCA \\nNo \\nFALSE \\n798 \\n- \\n800 \\n799 \\n06105 Trinity \\nCA \\nNo \\nFALSE \\n150 \\n- \\n150 \\n150 \\n48043 Brewster \\nTX \\nYes \\nFALSE \\n16 \\n- \\n15 \\n16 \\n48047 Brooks \\nTX \\nYes \\nFALSE \\n28 \\n- \\n27 \\n28 \\n48049 Brown \\nTX \\nYes \\nFALSE \\n64 \\n- \\n65 \\n64 \\n48057 Calhoun \\nTX \\nYes \\nTRUE \\n28 \\n- \\n28 \\n28 \\n48093 Comanche TX \\nYes \\nFALSE \\n33 \\n- \\n32 \\n32 \\n48103 Crane \\nTX \\nYes \\nFALSE \\n8 \\n- \\n8 \\n8 \\n48109 Culberson TX \\nYes \\nFALSE \\n3 \\n- \\n3 \\n3 \\n48123 DeWitt \\nTX \\nYes \\nTRUE \\n26 \\n- \\n26 \\n26 \\n48131 Duval \\nTX \\nYes \\nFALSE \\n30 \\n- \\n28 \\n29 \\n48133 Eastland \\nTX \\nYes \\nFALSE \\n64 \\n- \\n62 \\n63 \\n48143 Erath \\nTX \\nYes \\nFALSE \\n61 \\n- \\n59 \\n60 \\n48163 Frio \\nTX \\nYes \\nFALSE \\n43 \\n- \\n42 \\n42', '(Last Updated 10/03/2024)  \\nPage 177 \\n \\nFIPS \\nCode \\nCounty \\nName \\nST \\nCD \\nEGHP \\nCounty \\nIndividual Assistance \\nCounty \\nEnrolled \\n202X/09 \\nEnrolled \\n202X/10 \\nEnrolled \\n202X/11 \\nAverage \\nEnrollment \\n48171 Gillespie \\nTX \\nYes \\nFALSE \\n17 \\n- \\n17 \\n17 \\n48175 Goliad \\nTX \\nYes \\nTRUE \\n18 \\n- \\n18 \\n18 \\n48177 Gonzales TX \\nYes \\nTRUE \\n41 \\n- \\n41 \\n41 \\n48237 Jack \\nTX \\nYes \\nFALSE \\n35 \\n- \\n34 \\n34 \\n48239 Jackson \\nTX \\nYes \\nTRUE \\n30 \\n- \\n30 \\n30 \\n48255 Karnes \\nTX \\nYes \\nTRUE \\n19 \\n- \\n19 \\n19 \\n48265 Kerr \\nTX \\nYes \\nFALSE \\n85 \\n- \\n86 \\n86 \\n48283 La Salle \\nTX \\nYes \\nFALSE \\n25 \\n- \\n25 \\n25 \\n48297 Live Oak \\nTX \\nYes \\nFALSE \\n24 \\n- \\n24 \\n24 \\n48301 Loving \\nTX \\nYes \\nFALSE \\n0 \\n- \\n0 \\n0 \\n48311 McMullen TX \\nYes \\nFALSE \\n4 \\n- \\n4 \\n4 \\n48321 Matagorda TX \\nYes \\nTRUE \\n144 \\n- \\n140 \\n142 \\n48323 Maverick TX \\nYes \\nFALSE \\n160 \\n- \\n156 \\n158 \\n48371 Pecos \\nTX \\nYes \\nFALSE \\n20 \\n- \\n21 \\n20 \\n48377 Presidio \\nTX \\nYes \\nFALSE \\n50 \\n- \\n49 \\n50 \\n48389 Reeves \\nTX \\nYes \\nFALSE \\n8 \\n- \\n8 \\n8 \\n48391 Refugio \\nTX \\nYes \\nTRUE \\n21 \\n- \\n21 \\n21 \\n48443 Terrell \\nTX \\nYes \\nFALSE \\n9 \\n- \\n9 \\n9 \\n48463 Uvalde \\nTX \\nYes \\nFALSE \\n13 \\n- \\n10 \\n12 \\n48469 Victoria \\nTX \\nYes \\nTRUE \\n158 \\n- \\n154 \\n156 \\n48475 Ward \\nTX \\nYes \\nFALSE \\n15 \\n- \\n15 \\n15 \\n48495 Winkler \\nTX \\nYes \\nFALSE \\n20 \\n- \\n20 \\n20 \\nStep 8, sum the average enrollment from all rows from Table P-6. The total comes out to 5,120 for contract \\nHAAAA. \\nStep 9, sum the average enrollment from all the rows from Table P-6 where the Individual Assistance \\ncounties is TRUE for contract HAAAA. The Individual Assistance total comes out to 909. \\nStep 10, calculate the final percentage for contract HAAAA. (909 / 5,120) * 100 = 17.753906 = 18%. Both \\nflags for >=25% and >=60% are set to false since the example contract did not meet those thresholds.', '(Last Updated 10/03/2024)  \\nPage 178 \\n \\n \\nAttachment Q: Missing Data Messages \\nCMS uses a standard set of messages in the Star Ratings when there are no numeric data available for a contract. \\nThis attachment provides the rules for assignment of those messages in each level of the Star Ratings. \\nMeasure level messages \\nTable Q-1 contains all of the possible messages that could be assigned to missing data at the measure level. \\nTable Q-1: Measure level missing data messages \\nMessage \\nMeasure Level \\nComing Soon \\nUsed for all measures in MPF between Oct 1 and when the actual Star Rating data go live \\nMedicare shows only a Star Rating for this topic \\nUsed in the numeric data for the Part C & D improvement measures in MPF and Plan Preview 2 \\nNot enough data available \\nThere were data for the contract, but not enough to pass the measure exclusion rules \\nCMS identified issues with this plan’s data \\nData were materially biased, erroneous and/or not reported by a contract required to report \\nNot Applicable \\nUsed in the numeric data for the improvement measures in Plan Preview 1. In the HPMS \\nMeasure Star Page when a measure does not apply for a contract. When a Disenrollment \\nReasons Survey measure does not apply to the contract type. \\nBenefit not offered by plan \\nThe contract was required to report this HEDIS measure but doesn’t offer the benefit to members \\nPlan too new to be measured \\nThe contract is too new to have submitted measure data \\nNo data available \\nThere were no data for the contract included in the source data for the measure \\nPlan too small to be measured \\nThe contract had data but did not have enough enrollment to pass the measure exclusion rules \\nPlan not required to report measure \\nThe contract was not required to report the measure \\nAssignment rules for Part C measure messages \\nPart C uses a set of rules for assigning the missing data message that varies by the data source. The rules for \\neach data source are defined below. \\nAppeals (IRE) measures (C28 & C29): \\nHas CMS identified issues with the contract’s data? \\n \\nYes: Display message: CMS identified issues with this plan’s data \\n \\nNo: \\nIs there a valid numeric measure rate? \\n \\n \\nYes: Display the numeric measure rate \\n \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nCAHPS measures (C03, C19, C20, C21, C22, C23, & C24): \\nIs there a valid numeric CAHPS measure rate? \\n \\nYes: Display the numeric CAHPS measure rate  \\n \\nNo: \\nIs the contract effective date > 07/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nIs the CAHPS measure rate NR? \\n \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\n \\nNo: \\nIs the CAHPS measure rate NA? \\n \\n \\n \\n \\nYes: Display message: No data available \\n \\n \\n \\n \\nNo: \\nDisplay message: Plan too small to be measured', '(Last Updated 10/03/2024)  \\nPage 179 \\n \\nCall Center – Foreign Language Interpreter and TTY Availability measure (C30): \\nIs there a valid call center numeric rate? \\n \\nYes: Display the call center numeric rate \\n \\nNo: \\nIs the organization type 1876 Cost, MSA, or Employer/Union Only Direct Contract PDP? \\n \\n \\nYes: Display message: Plan not required to report measure \\n \\n \\nNo: \\nIs the contract effective date > 01/01/2024? \\n \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nComplaints (CTM) measure (C25): \\nIs the contract effective date > 01/01/2023? \\n \\nYes: Display message: Plan too new to be measured \\n \\nNo: \\nWas the average contract enrollment < 800 in 2023? \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\nNo: \\nIs there a valid numeric CTM rate? \\n \\n \\n \\nYes: Display the numeric CTM rate \\n \\n \\n \\nNo: \\nDisplay message: No data available \\nHEDIS measures except PCR and TRC (C01, C02, C08 – C11, C14, C16, C18): \\nWas the contract required to report HEDIS? \\n \\nYes: Was the contract enrollment < 500 in July 2023? \\n \\n \\nYes: Display message: Plan too small to be measured \\n \\n \\nNo: \\nWhat is the HEDIS measure audit designation? \\n \\n \\n \\nBD: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nBR: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nNB: Display message: Benefit not offered by plan \\n \\n \\n \\nNR: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nNQ: Display message: Plan not required to report measure \\n \\n \\n \\nR: \\nWas a valid patient level detail file 1 submitted and the measure data usable? \\n \\n \\n \\n \\nYes: Is the status NA? \\n \\n \\n \\n \\n \\n \\nYes:    Display message: Not enough data available \\n \\n \\n \\n \\n \\n \\nNo:      Was contract enrollment at least 500 but less than 1,000? \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Is the measure reliability at least 0.7? \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\nNo: \\nDisplay message: CMS identified issues with this plan’s data \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Plan not required to report measure', '(Last Updated 10/03/2024)  \\nPage 180 \\n \\nHEDIS PCR 18 and older (C15) \\nWas the contract required to report HEDIS? \\n \\nYes: Was the contract enrollment < 500 in July 2023? \\n \\n \\nYes: Display message: Plan too small to be measured \\n \\n \\nNo: \\nWhat is the HEDIS measure audit designation? \\n \\n \\n \\nBD: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nBR: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nNB: Display message: Benefit not offered by plan \\n \\n \\n \\nNR: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nNQ: Display message: Plan not required to report measure \\n \\n \\n \\nR: \\nWas a valid patient level detail file 1 submitted and the measure data usable? \\n \\n \\n \\n \\nYes: Is the combined denominator for the 18-64 and 65+ measures <150? \\n \\n \\n \\n \\n \\n \\nYes:    Display message: Not enough data available \\n \\n \\n \\n \\n \\n \\nNo:      Was contract enrollment at least 500 but less than 1,000? \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Is the measure reliability at least 0.7? \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\nNo: \\nDisplay message: CMS identified issues with this plan’s data \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Plan not required to report measure \\nHEDIS TRC average (C17): \\nWas the contract required to report HEDIS? \\n \\nYes: Was the contract enrollment < 500 in July 2023? \\n \\n \\nYes: Display message: Plan too small to be measured \\n \\n \\nNo: \\nIs the audit designation for all four TRC measures R? \\n \\n \\n \\nNo: \\nIs the audit designation for any of the four TRC measures BD, BR, or NR? \\n \\n \\n \\n \\nYes: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\n \\nNo: \\nIs the audit designation for any of the four TRC measures NB?  \\n \\n \\n \\n \\n \\nYes: Display message: Benefit not offered by plan \\n \\n \\n \\n \\n \\nNo:  The audit designation for one of the four TRC measures is NQ. \\n \\n \\n \\n \\n \\n \\nDisplay message: Plan not required to report measure \\n \\n \\n \\nYes: Was a valid patient level detail file 1 submitted and the measure data usable? \\n \\n \\n \\n \\nYes: Is the status for any component of the TRC average measure NA? \\n \\n \\n \\n \\n \\n \\nYes:    Display message: Not enough data available \\n \\n \\n \\n \\n \\n \\nNo:      Was contract enrollment at least 500 but less than 1,000? \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Is the measure reliability at least 0.7? \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\nNo: \\nDisplay message: CMS identified issues with this plan’s data \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Plan not required to report measure', '(Last Updated 10/03/2024)  \\nPage 181 \\n \\nHEDIS SNP measures (C06 & C07): \\nIs the organization type (1876 Cost, PFFS, MSA) or is SNP not offered in 2025? \\n \\nYes: \\nDisplay message: Plan not required to report measure \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: \\nDisplay message: Plan too new to be measured \\n \\n \\nNo: \\nWhat is the HEDIS measure audit designation? \\n \\n \\n \\nBD: \\nDisplay message: CMS identified issues with this plan’s data \\n \\n \\n \\nBR: \\nDisplay message: CMS identified issues with this plan’s data \\n \\n \\n \\n \\n \\nNB: \\nDisplay message: Benefit not offered by plan \\n \\n \\n \\nNR: \\nDisplay message: CMS identified issues with this plan’s data \\n \\n \\n \\nNQ: \\nDisplay message: Plan not required to report measure \\n \\n \\n \\nR: \\nIs there a valid HEDIS measure numeric rate? \\n \\n \\n \\n \\nYes: \\nWhat is the status? \\nNA:   Display message: Not enough data available \\nR:     Display the HEDIS measure numeric rate \\nNo: \\nDisplay message: No data available \\nHEDIS-HOS measures (C04, C12, & C13): \\nIs there a valid HEDIS-HOS numeric rate? \\n \\nYes: Display the HEDIS-HOS numeric rate \\n \\nNo: \\nIs the contract effective date > 01/01/2022? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nIs the February 2023 contract enrollment < 500? \\n \\n \\n \\nYes: Display message: Plan too small to be measured \\n \\n \\n \\nNo: \\nIs there a HEDIS-HOS rate code? \\n \\n \\n \\n \\nYes: Assign message according to value below: \\n \\n \\n \\n \\n \\nNA: Display message: Not enough data available \\n \\n \\n \\n \\n \\nNB: Display message: Benefit not offered by plan \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available \\nMembers Choosing to Leave the Plan (C26): \\nIs there a valid numeric voluntary disenrollment rate? \\n \\nYes: Display the numeric voluntary disenrollment rate \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nPlan Reporting SNP measure (C05): \\nIs the organization type (1876 Cost, PFFS, MSA) or is SNP not offered in 2025? \\n \\nYes: \\nDisplay message: Plan not required to report measure \\n \\nNo: \\nIs there a valid Plan Reporting numeric rate? \\n \\n \\nYes: \\nDisplay the Plan Reporting numeric rate \\n \\n \\nNo: \\nWere there Data Issues Found? \\n \\n \\n \\nYes: \\nDisplay message: CMS identified issues with this plan’s data \\n \\n \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\n \\n \\nYes: \\nDisplay message: Plan too new to be measured \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available', '(Last Updated 10/03/2024)  \\nPage 182 \\n \\nImprovement (Star Ratings) measure (C27): \\nIs there a valid improvement measure rate? \\n \\nYes: Display message: Medicare shows only a Star Rating for this topic \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nAssignment rules for Part D measure messages \\nCAHPS measures (D05, D06): \\nIs there a valid numeric CAHPS measure rate? \\n \\nYes: Display the numeric CAHPS measure rate  \\n \\nNo: \\nIs the contract effective date > 07/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nIs the CAHPS measure rate NR? \\n \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\n \\nNo: \\nIs the CAHPS measure rate NA? \\n \\n \\n \\n \\nYes: Display message: No data available \\n \\n \\n \\n \\nNo: \\nDisplay message: Plan too small to be measured \\nCall Center – Foreign Language Interpreter and TTY Availability measure (D01): \\nIs there a valid call center numeric rate? \\n \\nYes: Display the call center numeric rate \\n \\nNo: \\nIs the organization type 1876 Cost? \\n \\n \\nYes: Display message: Plan not required to report measure \\n \\n \\nNo: \\nIs the contract effective date > 01/01/2024? \\n \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nComplaints (CTM) measure (D02): \\nIs the contract effective date > 01/01/2023? \\n \\nYes:  Display message: Plan too new to be measured \\n \\nNo: \\n Was the average contract enrollment < 800 in 2023? \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\nNo: \\nIs there a valid numeric CTM rate? \\n \\n \\n \\nYes: Display the numeric CTM rate \\n \\n \\n \\nNo: \\nDisplay message: No data available \\nImprovement (Star Ratings) measure (D04): \\nIs there a valid improvement measure rate? \\n \\nYes: Display message: Medicare shows only a Star Rating for this topic \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available', '(Last Updated 10/03/2024)  \\nPage 183 \\n \\nMembers Choosing to Leave the Plan (D03): \\nIs there a valid numeric voluntary disenrollment rate? \\n \\nYes: Display the numeric voluntary disenrollment rate \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nMPF Price Accuracy measure (D07): \\nIs the contract effective date > 9/30/2023?  \\n \\nYes: Display message: Plan too new to be measured \\n \\nNo: \\nDoes contract have at least 30 claims over the measurement period for the price accuracy index? \\n \\n \\nYes: Display the numeric price accuracy rate \\n \\n \\nNo:  Is the organization type 1876 Cost and does not offer Drugs? \\n \\n \\n \\nYes: Display message: Plan not required to report measure \\n \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nPatient Safety measures – Adherence (D08 - D10) & SUPD (D12): \\n   Does the contract offer Part D? \\n      Yes: Is the contract effective date > 12/31/2023? \\n \\n     Yes:   Display message: Plan too new to be measured \\n \\n     No:     Does contract have 30 or fewer enrolled beneficiary member years (measure denominator)? \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\nNo: \\nDisplay numeric measure percentage \\n      No: Plan not required to report measure \\nPatient Safety measure – MTM CMR (D11) \\nIs the contract effective date > 12/31/2023? \\n \\nYes:  Display message: Plan too new to be measured \\n \\nNo: \\nIs Part D offered? \\n \\n \\nYes: \\nIs there a numeric rate? \\n \\n \\n \\nYes: \\nDisplay numeric measure percentage \\n \\n \\n \\nNo: \\nIs there a Reason(s) for Display Message? \\n \\n \\n \\n \\nYes: \\nDisplay appropriate message per table Q-2 \\n \\n \\nNo: \\nDisplay message: Plan not required to report measure', \"(Last Updated 10/03/2024)  \\nPage 184 \\n \\nTable Q-2: MTM CMR Reason(s) for Display Message conversion \\nReason(s) for Display Message \\nStar Ratings Message \\nContract failed to submit file and pass system validation by the reporting deadline CMS identified issues with this plan's data \\nContract did not pass element-level DV for at least one element \\nCMS identified issues with this plan's data \\nContract had missing score on MTM section DV \\nCMS identified issues with this plan's data \\nContract scored less than 95% on MTM section DV \\nCMS identified issues with this plan's data \\nContract had 30 or fewer beneficiaries meeting denominator criteria \\nNot enough data available \\nContract had all plans terminate by validation deadline \\nNot required to report \\nContract had no MTM enrollees to report \\nNot required to report \\nContract has 0 Part D enrollees \\nNot required to report \\nContract not required to submit MTM program \\nNot required to report \\nDomain, Summary, and Overall level messages \\nTable Q-3 contains all of the possible messages that could be assigned to missing data at the domain, summary, \\nand overall levels. \\nTable Q-3: Domain, Summary, and Overall level missing data messages \\nMessage \\nDomain Level \\nSummary & Overall Level \\nComing Soon \\nUsed for all domain ratings in MPF between Oct 1 and \\nwhen the actual Star Rating data go live \\nUsed for all summary and overall ratings in MPF between \\nOct 1 and when the actual Star Rating data go live \\nNot enough data available \\nThe contract did not have enough rated measures to \\ncalculate the domain rating \\nThe contract did not have enough rated measures to \\ncalculate the summary or overall rating \\nPlan too new to be measured The contract is too new to have submitted measure data \\nfor a domain rating to be calculated \\nThe contract is too new to have submitted data to be \\nrated in the summary or overall levels \\nAssignment rules for Part C & Part D domain rating level messages \\nPart C & D domain message assignment rules: \\nIs there a numeric domain star? \\n \\nYes: Display the numeric domain star \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nAssignment rules for Part C & Part D summary rating level messages \\nPart C & D summary rating message assignment rules: \\nIs there a numeric summary rating star? \\n \\nYes: Display the numeric summary rating star \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available\", '(Last Updated 10/03/2024)  \\nPage 185 \\n \\nAssignment rules for overall rating level messages \\nOverall rating message assignment rules: \\nIs there a numeric overall rating star? \\n \\nYes: Display the numeric overall rating star \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\n \\nDisenrollment Reasons messages \\nThe 2025 Star Ratings posted to the CMS downloadable Master Table and HPMS includes data collected from \\nthe Disenrollment Reasons Survey (DRS). The DRS data was not used at any point in the calculation of the Star \\nRatings. The data are provided for information only at this time and are shown in HPMS with the Star Ratings \\ndata and on the display page at http://go.cms.gov/partcanddstarratings. \\nBecause there are instances where a contract does not have data to display, a set of rules was developed to \\nassign messages where data was missing so the data area would not be left blank. \\nTable Q-4 contains all of the possible messages that could be assigned to missing data in the disenrollment \\nreason data displayed in HPMS. \\nTable Q-4: Disenrollment Reason missing data messages \\nMessage \\nMeaning \\nNot Applicable \\nUsed when the DRS measure does not apply to the contract type \\nNot Available \\nUsed when there is no numeric data available or data reliability indicated the value should be suppressed \\nPlan too new to be measured The contract is too new for data to be collected for the measure \\nDisenrollment Reasons message assignment rules: \\nIs the contract effective date > 1/1/2023? \\n \\nYes: Display message: Plan too new to be measured \\n \\nNo: \\nIs there numeric data for the contract in this DRS measure? \\n \\n \\nYes: Did the data reliability check indicate the data should be suppressed? \\n \\n \\n \\nYes: Display message: Not Available \\n \\n \\n \\nNo: Display the numeric DRS rate \\n \\n \\nNo: \\nDoes the DRS measure apply to the organization type \\n \\n \\n \\nYes: Display message: Not Available \\n \\n \\n \\nNo: \\nDisplay message: Not Applicable', '(Last Updated 10/03/2024)  \\nPage 186 \\n \\nAttachment R: Glossary of Terms \\nAEP \\nThe annual period from October 15 until December 7 when a Medicare beneficiary \\ncan enroll into a Medicare Part C or D plan or re-enroll into their existing Medicare \\nPart C or D Plan or change into another Medicare plan is known as the Annual \\nElection Period (AEP). The chosen Medicare Part C or D plan coverage begins on \\nJanuary 1st. \\nC-SNP \\nChronic Condition Special Needs Plans (C-SNPs) are SNPs that restrict enrollment to \\nspecial needs individuals with specific severe or disabling chronic conditions, defined \\nin 42 CFR 422.2. \\nCAHPS \\nThe term CAHPS refers to a comprehensive and evolving family of surveys that ask \\nconsumers and patients to evaluate the interpersonal aspects of health care. CAHPS \\nsurveys probe those aspects of care for which consumers and patients are the best \\nand/or only source of information, as well as those that consumers and patients have \\nidentified as being important. CAHPS initially stood for the Consumer Assessment of \\nHealth Plans Study, but as the products have evolved beyond health plans, the \\nacronym now stands for Consumer Assessment of Healthcare Providers and Systems. \\nCCP \\nA Coordinated Care Plan (CCP) is a health plan that includes a network of providers \\nthat are under contract or arrangement with the organization to deliver the benefit \\npackage approved by CMS. The CCP network is approved by CMS to ensure that all \\napplicable requirements are met, including access and availability, service area, and \\nquality requirements. CCPs may use mechanisms to control utilization, such as \\nreferrals from a gatekeeper for an enrollee to receive services within the plan, and \\nfinancial arrangements that offer incentives to providers to furnish high quality and \\ncost-effective care. CCPs include HMOs, PSOs, local and regional PPOs, and senior \\nhousing facility plans. SNPs can be offered under any type of CCP that meets CMS’s \\nrequirements. \\nCohort \\nA cohort is a group of people who share a common designation, experience, or \\ncondition (e.g., Medicare beneficiaries). For the HOS, a cohort refers to a random \\nsample of Medicare beneficiaries that is drawn from each Medicare Advantage \\nOrganization (MAO) with a minimum of 500 enrollees and surveyed every spring \\n(i.e., a baseline survey is administered to a new cohort each year). Two years later, \\nthe baseline respondents are surveyed again (i.e., follow up measurement). For data \\ncollection years 1998-2006, the MAO sample size was 1,000. Effective 2007, the \\nMAO sample size was increased to 1,200. \\nCost Plan \\nA plan operated by a Health Maintenance Organization (HMO) or Competitive \\nMedical Plan in accordance with a cost reimbursement contract under §1876(h) of the \\nAct. In the Star Ratings, CMS classifies a Cost Plan not offering Part D as MA-Only \\nand a Cost Plan offering Part D as MA-PD. \\nD-SNP \\nDual Eligible Special Needs Plans (D-SNPs) enroll individuals who are entitled to \\nboth Medicare (title XVIII) and medical assistance from a state plan under Medicaid \\n(title XIX).  States cover some Medicare costs, depending on the state and the \\nindividual’s eligibility.', '(Last Updated 10/03/2024)  \\nPage 187 \\n \\nDisability Status \\nBased on the original reason for entitlement for Medicare (Disability insurance \\nbenefits or both Disability insurance benefits and End-Stage Renal Disease). \\nDual eligibles \\nIndividuals who are entitled to Medicare Part A and/or Part B and are eligible for \\nsome form of Medicaid benefit. \\nEuclidean distance \\nThe absolute value of the difference between two points, x-y. \\nHEDIS \\nThe Healthcare Effectiveness Data and Information Set (HEDIS) is a widely used set \\nof performance measures in the managed care industry, developed and maintained by \\nthe National Committee for Quality Assurance (NCQA). \\nHOS \\nThe Medicare Health Outcomes Survey (HOS) is the first patient reported outcomes \\nmeasure used in Medicare managed care. The goal of the Medicare HOS program is \\nto gather valid, reliable, and clinically meaningful health status data in the Medicare \\nAdvantage (MA) program for use in quality improvement activities, pay for \\nperformance, program oversight, public reporting, and improving health. All \\nmanaged care organizations with MA contracts must participate. \\nI-SNP \\nInstitutional Special Needs Plans (I-SNPs) are SNPs that restrict enrollment to \\ninstitutionalized special needs individuals defined in 42 CFR 422.2. \\nIRE \\nThe Independent Review Entity (IRE) is an independent entity contracted by CMS to \\nreview Medicare health and drug plans’ adverse reconsiderations of organization \\ndeterminations. \\nLIS \\nThe Low Income Subsidy (LIS) from Medicare provides financial assistance for \\nbeneficiaries who have limited income and resources. Those who receive the LIS get \\nhelp paying for their monthly premium, yearly deductible, prescription coinsurance, \\nand copayments and they will have no gap in coverage. \\nLIS/DE \\nBeneficiaries who qualify at any point in the year for a low income subsidy through \\nthe application process and/or who are full or partial Dual (Medicare and Medicaid) \\nbeneficiaries. \\nMA \\nA Medicare Advantage (MA) organization is a public or private entity organized and \\nlicensed by a State as a risk-bearing entity (with the exception of provider-sponsored \\norganizations receiving waivers) that is certified by CMS as meeting the MA contract \\nrequirements. \\nMA-Only \\nAn MA organization that does not offer Medicare prescription drug coverage. \\nMA-PD \\nAn MA organization that offers Medicare prescription drug coverage and Part A and \\nPart B benefits in one plan. \\nMSA \\nMedicare Medical Savings Account (MSA) plans combine a high deductible MA plan \\nand a medical savings account (which is an account established for the purpose of \\npaying the qualified medical expenses of the account holder). \\nPercentage \\nA part of a whole expressed in hundredths. For example, a score of 45 out of 100 \\npossible points is the same as 45%.', \"(Last Updated 10/03/2024)  \\nPage 188 \\n \\nPercentile \\nThe value below which a certain percent of observations fall. For example, a score \\nequal to or greater than 97 percent of other scores attained on the same measure is \\nsaid to be in the 97th percentile. \\nPDP \\nA Prescription Drug Plan (PDP) is a stand-alone drug plan, offered by insurers and \\nother private companies to beneficiaries who receive their Medicare Part A and/or B \\nbenefits either through the Original Medicare Plan, Medicare Private Fee-for-Service \\nPlans that do not offer prescription drug coverage, or Medicare Cost Plans that do not \\noffer Medicare prescription drug coverage. \\nPFFS \\nPrivate Fee-for-Service (PFFS) is defined as an MA plan that pays providers of \\nservices at a rate determined by the plan on a fee-for-service basis without placing the \\nprovider at financial risk; does not vary the rates for a provider based on the \\nutilization of that provider's services; and does not restrict enrollees' choices among \\nproviders who are lawfully authorized to provide services and agree to accept the \\nplan's terms and conditions of payment. The Medicare Improvements for Patients and \\nProviders Act (MIPPA) added that although payment rates cannot vary based solely \\non utilization of services by a provider, a PFFS plan is permitted to vary the payment \\nrates for a provider based on the specialty of the provider, the location of the \\nprovider, or other factors related to the provider that are not related to utilization. \\nFurthermore, MIPPA also allows PFFS plans to increase payment rates to a provider \\nbased on increased utilization of specified preventive or screening services. See \\nsection 30.4 of the Medicare Managed Care Manual Chapter 1 for further details on \\nPFFS plans. \\nReliability \\nA measure of the fraction of the variation among the observed measure values that is \\ndue to real differences in quality (“signal”) rather than random variation (“noise”). On \\na scale from 0 (all differences among plans are due to randomness of sampling) to 1 \\n(every plan's quality is measured with perfect accuracy). \\nSNP \\nA Special Needs Plan (SNP) is a Medicare Advantage (MA) coordinated care plan \\n(CCP) specifically designed to provide targeted care and limits enrollment to special \\nneeds individuals. A special needs individual could be any one of the following: 1) an \\ninstitutionalized individual, 2) a dual eligible beneficiary, or 3) an individual with a \\nsevere or disabling chronic condition, as specified by CMS. A SNP may be any type \\nof MA CCP. There are three major types of SNPs: 1) Chronic Condition SNP (C-\\nSNP), 2) Dual Eligible SNP (D-SNP), and 3) Institutional SNP (I-SNP). \\nSponsor \\nAn entity that sponsors a health or drug plan. \\nStatistical Significance \\nStatistical significance assesses how likely differences observed are due to chance \\nwhen plans are actually the same. CMS uses statistical tests (e.g., t-test) to determine \\nif a contract’s measure value is statistically significantly greater or less than the \\nnational average for that measure, or whether conversely the observed differences \\nfrom the national average could have arisen by chance. \\nSum of Squares \\nMethod used to measure variation or deviation from the mean. \\nTTY \\nA teletypewriter (TTY) is an electronic device for text communication via a telephone \\nline, used when one or more of the parties has hearing or speech difficulties.\", '(Last Updated 10/03/2024)  \\nPage 189 \\n \\nVery Low Reliability \\nFor CAHPS, an indication that reliability is less than 0.6, indicating that 40% or more \\nof observed variation is due to random noise.', '(Last Updated 10/03/2024)  \\nPage 190 \\n \\nAttachment S: Health Plan Management System Module Reference \\nThis attachment is designed to assist reviewers of the data displayed in HPMS (https://hpms.cms.gov) to \\nunderstand the various pages and fields shown in the HPMS Star Ratings module. This module employs \\nstandard HPMS user access rights so that users can only see contracts associated with their user id. \\nHPMS Star Ratings Module \\nThe HPMS Star Ratings module contains the Part C & Part D data and stars for all contracts that were rated in \\nthe ratings year along with much of the detailed data that went into the various calculations. To access the Star \\nRatings module you must be logged into HPMS. If you do not have access to HPMS, information on how to \\nobtain access can be found here: https://www.cms.gov/Research-Statistics-Data-and-Systems/Computer-Data-\\nand-Systems/HPMS/Overview.html \\nOnce you are logged into HPMS, from the home page, select Performance Metrics from the Quality and \\nPerformance menu; the Performance Metrics page will be displayed. If you do not see Performance Metrics, \\nyour user id does not have the correct access permissions; please contact CMSHPMS_Access@cms.hhs.gov \\nFrom the Performance Metrics page, select Reports and then Star Ratings and Display Measures from the left \\nside menu. The Star Ratings and Display Measures home page will be displayed. \\nOn the Star Ratings and Display Measures home page, select Star Ratings as the Report Type and select a \\nreporting period. The remainder of this attachment describes the HPMS pages available for the 2025 Star \\nRatings. \\n1. Measure Data page \\nThe Measure Data page displays the numeric data for all Part C and Part D measures. This page is available \\nduring the first plan preview. \\nThe first four columns contain contract identifying information. The remaining columns contain the \\nmeasures which will display in MPF. There is one column for each of the Part C and Part D measures. The \\nmeasure columns are identified by measure id and measure name. The row immediately above this measure \\ninformation contains the domain name. The row immediately below the measure information contains the \\ndata time frame of the measure. All subsequent rows contain the data for all individual contracts associated \\nwith the user’s login id. Table S-1 below shows a sample of the left hand most columns shown in HPMS. \\nTable S-1: Measure Data page sample \\nMedicare Star Ratings Report Card Master Table \\nContract \\nNumber \\nOrganization \\nMarketing \\nName \\nContract \\nName \\nParent \\nOrganization \\nHD1: Staying Healthy: Screenings, Tests and Vaccines \\nC01: Breast Cancer Screening C02: Colorectal Cancer Screening C03: Annual Flu Vaccine \\n01/01/2023 - 12/31/2023 \\n01/01/2023 - 12/31/2023 \\n03/2024 - 06/2024 \\nHAAAA Market A \\nContract A PO A \\nPlan too new to be measured Plan too new to be measured \\nNot enough data available \\nHBBBB Market B \\nContract B PO B \\nNot enough data available \\n73% \\n81% \\nHCCCC Market C \\nContract C PO C \\n63% \\n71% \\n80% \\n2. Measure Detail – CTM Summary page \\nThe Measure Detail – CTM Summary page contains the underlying data used for the Part C and Part D \\nComplaints (C25/D02) measures. This page is available during the first plan preview. Table S-2 below \\nexplains each of the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 191 \\n \\nTable S-2: Measure Detail – CTM Summary page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nTotal Number of Complaints \\nNumber of non-excluded complaints for the contract \\nComplaint Average Enrollment \\nThe average enrollment used in the final calculation \\nComplaints Less Than 800 \\nEnrolled \\nYes / No, Yes = average enrollment < 800, No = average enrollment ≥ 800 \\n3. Measure Detail – Part C Appeals page \\nThe Measure Detail – Part C Appeals page contains the case-level data of the non-excluded cases used in \\nproducing the Part C Appeals measures Plan Makes Timely Decisions about Appeals (C28) and Reviewing \\nAppeals Decisions (C29). The data displayed on this page reflect the state of the appeals case at the time the \\ndata were pulled for use in the 2025 Star Ratings. This page is available during the first plan preview. Table \\nS-3 below explains each of the columns displayed on this page. \\nTable S-3: Measure Detail – Part C Appeals page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nAppeal Number \\nThe case ID assigned to the appeal request \\nAppeal Priority \\nThe priority of the appeal (Std Pre-Service, Exp Pre-Service, Pre-Service B Drug, or Retro) \\nStatus \\nThe status of the appeal (Closed, Decided, Pending, Promoted, Remanded, Reopened, Requested) \\nDate Appeal Filed \\nThe Date the Plan Reconsideration was requested, as reported by the Part C Plan \\nCorrected Appeal Date \\nThe Date Appeal Filed, as determined by the IRE/QIC \\nDate File Received (QIC) \\nThe Date the IRE/QIC received the Appeal from the Part C Plan \\nLevel 1 Extension \\nIndicates if the contract took an extension during their processing of the reconsideration, as reported by the contract \\nAdjusted Plan Interval \\nThe number of days between the Date Appeal Filed (or Corrected Appeal Date, if applicable) and the Date File \\nReceived (QIC) adjusted based on the Appeal Priority (Std Pre-Service, Exp Pre-Service, or Retro) and adjusted to \\naccount for 5 mailing days \\nAppeal Decision \\nDecision associated with the appeal: Dismiss Appeal, Dismissed – Plan Approved Coverage, Favorable (Overturn \\nMCO Denial), Partially Favorable (Partly Overturn MCO Denial), Unfavorable (Uphold MCO Denial), Withdraw \\nAppeal, Remand to Plan. \\nLate Indicator \\nIndicates if the appeal case was considered late or not (0=Not Late, 1=Late)', '(Last Updated 10/03/2024)  \\nPage 192 \\n \\n4. Measure Detail – SNP CM page \\nThe Measure Detail – SNP CM page contains the underlying data used in calculating the Part C SNP Care \\nManagement measure (C05). The formulas used to calculate the SNP CM measure are detailed in \\nAttachment E. This page is available during the first plan preview. Table S-4 below explains each of the \\ncolumns displayed on this page. \\nTable S-4: Measure Detail – SNP CM page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nNumber of new enrollees \\nNumber of new SNP enrollees eligible for an initial assessment (Data Element A) \\nNumber of enrollees eligible for an annual HRA \\nNumber of SNP enrollees eligible for an annual reassessment (Data Element B) \\nNumber of initial HRAs performed on new enrollees \\nNumber of initial assessments performed on new SNP enrollees (Data Element C) \\nNumber of annual reassessments performed \\nNumber of annual reassessments performed on eligible SNP enrollees (Data Element \\nF) \\nTotal Number of SNP Enrollees Eligible \\nFinal measure numerator (Data Elements A + B) \\nTotal Number of Assessments Performed \\nFinal measure denominator (Data Elements C + F) \\nPercent of Eligible SNP Enrollees Receiving an Assessment Final measure score \\nData Validation Score \\nThe data validation score for the contract \\nReason for Exclusion \\nReason (if any) contract submitted data was not used to generate a score \\n5. Measure Detail – HEDIS page \\nThe Measure Detail – HEDIS page contains the underlying data used in calculating the Part C HEDIS SNP \\nCare for Older Adults measures, the Transitions of Care measure and the Plan All-Cause readmissions \\nmeasure. The formulas used to calculate the SNP measures are detailed in Attachment E. The formula used \\nto calculate the PCR measure is detailed in Attachment F. This page is available during the first plan \\npreview. Table S-5 below explains each of the columns displayed on this page and Table S-6 explains the \\nHEDIS audit designations.', '(Last Updated 10/03/2024)  \\nPage 193 \\n \\nTable S-5: Measure Detail – HEDIS page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nPBP ID \\nThe Plan Benefit Package number associated with the data \\nMeasure ID \\nThe Star Ratings measure ID that corresponds to the data in the given row \\nMeasure Name \\nThe measure name that corresponds to the data in the given row \\nRate \\nThe measure rate \\nEligible Population \\nThe measure eligible population \\nObserved Count \\nThe measure observed count (only applicable for PCR) \\nExpected Count \\nThe expected count (only applicable for PCR) \\nDenominator \\nThe measure denominator \\nAudit Designation \\nThe audit designation (the audit codes are defined in the next table) \\nStatus \\nThe status (the status codes are defined in the next table) \\nAverage Plan Enrollment \\nThe average enrollment in the PBP during 2023 (see section Contract Enrollment Data) \\n \\nTable S-6: HEDIS 2023 Audit Designations and 2025 Star Ratings \\nAudit Designation \\nStatus \\nNCQA Description \\nResultant Star Rating \\nR  \\nR \\nReportable \\nAssigned 1 to 5 stars depending on reported value \\nBR \\nR or NA \\nBiased Rate  \\n1 star, numeric data set to “CMS identified issues with this plan’s data” \\nR \\nNA \\nSmall Denominator “Not enough data available” \\nNB \\nR or NA \\nNo Benefit \\n“Benefit not offered by plan” \\nNR \\nR or NA \\nNot Reported \\n1 star, numeric data set to “CMS identified issues with this plan’s data” \\nNQ \\nR or NA \\nNot Required \\n“Plan not required to report measure” (applies only to 1876 Cost in the PCRb measure) \\nUN \\n \\nUn-Audited \\nNot possible in Star Ratings measures which only use audited data \\n6. Measure Detail – CTM page \\nThe Measure Detail – CTM page contains the case level data of the non-excluded cases used in producing \\nthe Part C & Part D Complaints measure (C25/D02). This page is available during the first plan preview. \\nTable S-7 below explains each of the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 194 \\n \\nTable S-7: Measure Detail – CTM page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nComplaint ID \\nThe case number associated with the complaint in the HPMS CTM module \\nComplaint Category \\nThe complaint category code \\nCMS Issue \\nIs the complaint designated as a CMS issue? (Yes/No) \\nCategory \\nThe complaint category description of CMS or plan lead \\nSubcategory \\nThe complaint subcategory description associated with this case \\nSubcategory — Other \\nThe complaint additional subcategory description associated with this case \\nContract Assignment / Reassignment Date The date that complaints are assigned or re-assigned to contracts \\n7. Measure Detail – Disenrollment \\nThe Measure Detail – Disenrollment page contains data that are used in calculating the Part C & Part D \\ndisenrollment measure (C26/D03). The page shows the denominator, unadjusted numerator and original rate \\nreceived from the MBDSS annual report. It also contains the adjusted numerator and final rate after all \\nmembers meeting the measure exclusion criteria described in the measure description have been removed. \\nThis page is available during the first plan preview. Table S-8 below explains each of the columns displayed \\non this page. \\nTable S-8: Measure Detail – Disenrollment page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nNumber Enrolled \\nThe number of all members in the contract from MBDSS annual report \\nNumber Disenrolled \\nThe number disenrolled with a disenrollment reason code of 11, 13, 14 or 99, from the MBDSS annual report \\nOriginal Rate \\nThe disenrollment rate as calculated by the annual MBDSS report \\nAdjusted Disenrolled \\nThe adjusted numerator when all members who meet the measure exclusion criteria are removed \\nAdjusted Rate \\nThe final adjusted disenrollment rate used in the Star Ratings \\n>1000 Enrolled \\nFlag indicates contract non-employer group enrollment >1,000 members during the year or contracts that did not \\nhave any disenrollments meeting the inclusion criteria (True = Yes, False = No) \\n8. Measure Detail – DR (Disenrollment Reasons) \\nThe Measure Detail – Disenrollment Reasons page contains the data from the Disenrollment Reasons \\nSurvey (DRS). The Disenrollment Reasons data are not used at any point in the calculations of the Star \\nRatings but are provided in HPMS for information only at this time. The data come from surveys sent to \\nenrollees who disenrolled between 1/1/2023 and 12/31/2023. Scores are suppressed if they are measured \\nwith very low reliability (< 0.60) and not statistically different from the national mean. This page is \\navailable during the first plan preview. Table S-9 below explains each of the columns displayed on this \\npage.', \"(Last Updated 10/03/2024)  \\nPage 195 \\n \\nTable S-9: Measure Detail – Disenrollment Reasons page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nDR PGPPPNC \\nDisenrollment Reasons - Problems Getting the Plan to Provide and Pay for Needed Care (MA-PD, MA-Only) \\nDR PCDH \\nDisenrollment Reasons - Problems with Coverage of Doctors and Hospitals (MA-PD, MA-Only) \\nDR FRD \\nDisenrollment Reasons - Financial Reasons for Disenrollment (MA-PD, MA-Only, PDP) \\nDR PPDBC \\nDisenrollment Reasons - Problems with Prescription Drug Benefits and Coverage (MA-PD, PDP) \\nDR PGIHP \\nDisenrollment Reasons - Problems Getting Information and Help from the Plan (MA-PD, PDP) \\n9. Measure Detail – MTM page \\nThe Measure Detail – MTM page contains each contract’s underlying denominator and numerator after \\nmeasure specifications have been applied to the plan-reported validated data to calculate the Part D MTM \\nProgram Completion Rate for CMR (D11). The formulas used to calculate the MTM measure are detailed in \\nAttachment N. This page is available during the first plan preview. Table S-10 below explains each of the \\ncolumns displayed on this page. \\nTable S-10: Measure Detail – MTM page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nTotal Part D Enrollees \\nThe number of Part D enrollees in the contract (average monthly HPMS enrollment) \\nTotal MTM Enrollees, All \\nThe number of Part D enrollees enrolled in the contract’s MTM program (as reported in the Part D MTM plan-\\nreported data).  Includes beneficiaries that had an enrollment start date anytime in the measurement period, \\nregardless of age, hospice status, or duration of MTM enrollment.  Excludes records where the MBI could not be \\nmapped to a valid beneficiary or where the beneficiary was reported with multiple, conflicting records in the same \\ncontract's data. \\nTotal MTM Enrollees, Targeted \\nThe number of Part D enrollees enrolled in the contract’s MTM program that met the specified targeting criteria per \\nCMS-Part D requirements pursuant to §423.153(d) of the regulations (as reported in the Part D MTM plan-\\nreported data).  Includes beneficiaries that had an enrollment start date anytime in the measurement period, \\nregardless of age, hospice status, or duration of MTM enrollment.  Excludes records where the MBI could not be \\nmapped to a valid beneficiary or where the beneficiary was reported with multiple, conflicting records in the same \\ncontract's data. \\nTotal MTM Enrollees, Targeted, \\nAdjusted \\nThe number of Part D enrollees enrolled in the contract’s MTM program that met the specified targeting criteria per \\nCMS-Part D requirements pursuant to §423.153(d) of the regulations (as reported in the Part D plan-reported \\ndata) after measure specifications applied as detailed in Attachment N. (Measure Denominator) \\nTotal MTM Enrollees, Targeted, \\nAdjusted, Who Received a CMR \\nThe number of beneficiaries from the denominator who received a CMR. (Measure Numerator) \\nMTM Program Completion Rate for \\nCMR \\nThe percent of MTM program enrollees who received a CMR. (Measure Numerator)/(Measure Denominator) \\nMTM Section Data Validation \\nScore \\nContract’s score in data validation (DV) for their MTM Program Reporting Requirements data \\nReason(s) for Display Message  \\nReason(s) for display message assignment (if applicable)\", '(Last Updated 10/03/2024)  \\nPage 196 \\n \\n10. Measure Detail – CAHPS page \\nThe Measure Detail – CAHPS page contains the underlying data used in calculating the Part C & D CAHPS \\nmeasures: Annual Flu Vaccine (C03), Getting Needed Care (C19), Getting Appointments and Care Quickly \\n(C20), Customer Service (C21), Rating of Health Care Quality (C22), Rating of Health Plan (C23), Care \\nCoordination (C24), Rating of Drug Plan (D05), and Getting Needed Prescription Drugs (D06). This page is \\navailable during the first plan preview. Table S-11 below explains each of the columns displayed on this \\npage. \\nTable S-11: Measure Detail – CAHPS page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nCAHPS Measure \\nThe CAHPS measure identifier followed by the Star Ratings measure id in parenthesis \\nReliability \\nThe contract-level reliability of the measure data \\nStatistical Significance \\nThe statistical significance of the measure data (Below Average, No Difference, Above Average) \\nUse N \\nThe number of usable surveys with responses to the item, or at least one item of a composite \\nMean Score on Original Scale \\nThe mean score on the original survey response scale \\nVariance of Mean on Original Scale The sampling variance of contract mean (\"Mean score\") on the original scale \\nStandard Error on Original Scale \\nThe standard error of the contract mean (\"Mean score\") on the original scale; square root of \"variance\" \\nScaled Mean \\nThe contract mean score rescaled to a 0-100 scale \\nScaled SE \\nThe standard error of the 0-100 scaled mean \\nBase Group \\nCategories determined by the percentile cutoffs from the distribution of mean scores  \\nStar Rating \\nDetermined by the percentile cutoffs, statistical significance of the difference of the contract mean from the \\noverall mean, the statistical reliability of the estimate, and standard error of the mean score \\n \\n11. Calculation Detail – MD \\nThe Calculation Detail – MD page contains the summary of service area and enrollment data used to \\ncalculate the percentages for use in the Major Disaster rules for the individual measures. This page is \\navailable during the first plan preview. Table S-12 below explains the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 197 \\n \\nTable S-12: Calculation Detail – MD page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing \\nName \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nDisaster Flag 2023 \\nIndicates if the contract was affected by a 2023 disaster or not (valid values “Affected”, “Not Affected” or “Too New“) \\nTotal Cnty in SA 2023 \\nThe total number of counties in the contract’s 2023 service area (SA) \\nNum Cnty IA 2023 \\nThe number of counties from the contract’s total SA designated as FEMA Individual Assistance (IA) counties in a 2023 \\ndisaster \\nIA Enrolled 2023 \\nThe number of members residing in the contract SA designated FEMA IA counties in a 2023 disaster \\nTotal Enrolled 2023 \\nThe total number of members residing in the contract’s 2023 SA \\nIA % 2023 \\nThe percent of members living in IA areas in a 2023 disaster (IA Enrolled)/(Total Enrolled) \\nIA % Rounded 2023 \\nThe percent of members living in IA areas in a 2023 disaster rounded to an integer \\n>25% 2023 \\nFlag that indicates if the contract has met the 25% threshold for 2023 disasters (Yes: >= 25 %, No: <25%) \\n>60% 2023 \\nFlag that indicates if the contract has met the 60% threshold for 2023 disasters (Yes: >= 60 %, No: <60%) \\nDisaster Flag 2022 \\nIndicates if the contract was affected by a 2022 disaster or not (valid values “Affected”, “Not Affected” or “Too New“) \\nTotal Cnty in SA 2022 \\nThe total number of counties in the contract’s 2022 service area (SA) \\nNum Cnty IA 2022 \\nThe number of counties from the contract’s total SA designated as FEMA Individual Assistance (IA) counties in a 2022 \\ndisaster \\nIA Enrolled 2022 \\nThe number of members residing in the contract SA designated FEMA IA counties in a 2022 disaster \\nTotal Enrolled 2022 \\nThe total number of members residing in the contract’s 2022 SA \\nIA % 2022 \\nThe percent of members living in IA areas in a 2022 disaster (IA Enrolled)/(Total Enrolled) \\nIA % Rounded 2022 \\nThe percent of members living in IA areas in a 2022 disaster rounded to an integer \\n>=25% 2022 \\nFlag that indicates if the contract has met the 25% threshold for 2022 disasters (Yes: >= 25 %, No: <25%) \\n \\n12. Calculation Detail – CAI \\nThe Calculation Detail – CAI page contains the enrollment data used to calculate the percentages for use in \\nthe Categorical Adjustment Index (CAI) to determine the Final Adjustment Categories for each of the \\nsummary and overall rating calculations. This page is available during the first plan preview. Table S-13 \\nbelow explains the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 198 \\n \\nTable S-13: Measure Detail – CAI page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nPuerto Rico Only \\nDoes the contract’s non-employer service area only cover Puerto Rico? Yes or No \\nContract Type \\nThe contract plan type used to compute the ratings \\nPart D Offered \\nIs Part D offered by the contract? Yes or No \\nEnrolled \\nThe total number enrolled in the contract used to determine the % LIS/DE and % Disabled \\nNum LIS/DE \\nThe number of LIS/DE enrolled in the contract \\nNum Disabled \\nThe number of Disabled enrolled in the contract \\n% LIS/DE \\nThe percent of LIS/DE in the contract \\n% Disabled \\nThe percent Disabled in the contract \\nPart C LIS/DE Initial Group \\nThe Part C LIS/DE initial group this contract is in \\nPart C Disabled Quintile \\nThe Part C Disabled Quintile group this contract is in \\nPart C FAC \\nThe Part C Final adjustment category this contract is in \\nPart C CAI Value \\nThe CAI value that will be combined with the final Part C summary score prior to rounding to half stars \\nPart D MA-PD LIS/DE Initial Group The Part D MA-PD LIS/DE initial group this contract is in \\nPart D MA-PD Disabled Quintile \\nThe Part D MA-PD Disabled Quintile group this contract is in \\nPart D MA-PD FAC \\nThe Part D MA-PD Final adjustment category this contract is in \\nPart D MA-PD CAI Value \\nThe CAI value that will be combined with the final Part D MA-PD summary score prior to rounding to half stars \\nPart D PDP LIS/DE Quartile \\nThe Part D PDP LIS/DE Quartile group this contract is in \\nPart D PDP Disabled Quartile \\nThe Part D PDP Disabled Quartile group this contract is in \\nPart D PDP FAC \\nThe Part D PDP Final adjustment category this contract is in \\nPart D PDP CAI Value \\nThe CAI value that will be combined with the final Part D PDP summary score prior to rounding to half stars \\nOverall LIS/DE Initial Group \\nThe overall LIS/DE initial group this contract is in \\nOverall Disabled Quintile \\nThe overall disabled Quintile group this contract is in \\nOverall FAC \\nThe overall final adjustment category this contract is in \\nOverall CAI Value \\nThe CAI value that will be combined with the final overall score prior to rounding to half stars \\n13. Measure Detail – HEDIS LE page \\nThe Measure Detail – HEDIS LE page contains the data used to calculate the reliability of the HEDIS \\nmeasures (C01, C02, C08 – C11, C14 – C18) data for contracts with ≥ 500 and < 1,000 members enrolled in \\nJuly of the measurement year (July 01, 2023). This page is available during the second plan preview. Table \\nS-14 below explains each of the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 199 \\n \\nTable S-14: Measure Detail – HEDIS LE page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nMeasure ID \\nThe Star Ratings measure that the other data on this row is associated with \\nRate \\nThe submitted HEDIS rate \\nScore \\nThe rounded value used for the measure in the Star Ratings \\nEnrollment \\nThe contract enrollment for July 2023 \\nReliability \\nThe computed reliability for the contract measure \\nUsable \\nThe computed reliability ≥ 0.7 and rate is used = True, reliability < 0.7 and rate was not used = False \\n14. Measure Detail – C MD Results \\nThe Part C Disaster Results page displays the measure level data handling results for contracts which had \\n≥25% of their enrollment living in areas affected by major disasters during the measurement period. Only \\nthe measures where the disaster policy required a comparison between two ratings years are displayed in the \\ndata. This page is available during the second plan preview. Table S-15 below explains the columns \\ndisplayed on this page. \\nTable S-15: Measure Detail – C MD Results \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nMeasure ID \\nThe 2025 Star Ratings Part C measure ID \\n2024 Value \\nThe numeric measure value for the contract from the 2024 Star Ratings \\n2024 Star \\nThe measure star for the contract from the 2024 Star Ratings \\n2025 Value \\nThe numeric measure value for the contract from the 2025 Star Ratings \\n2025 Star \\nThe measure star for the contract from the 2025 Star Ratings \\nFinal Value \\nThe measure value to be used in the 2025 Star Ratings after the data handling policy for disasters was applied \\nFinal Star \\nThe measure star to be used in the 2025 Star Ratings after the data handling policy for disasters was applied \\nFinal From \\nThe Star Ratings year where the final data for the measure came from \\n15. Measure Detail – D MD Results \\nThe Part D Disaster Results page displays the measure level data handling results for contracts which had \\n≥25% of their enrollment living in areas affected by major disasters during the measurement period. Only \\nthe measures where the disaster policy required a comparison between two ratings years are displayed in the \\ndata. This page is available during the second plan preview. Table S-16 below explains the columns \\ndisplayed on this page.', '(Last Updated 10/03/2024)  \\nPage 200 \\n \\nTable S-16: Measure Detail – D MD Results \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nMeasure ID \\nThe 2025 Star Ratings Part D measure ID \\n2024 Value \\nThe numeric measure value for the contract from the 2024 Star Ratings \\n2024 Star \\nThe measure star for the contract from the 2024 Star Ratings \\n2025 Value \\nThe numeric measure value for the contract from the 2025 Star Ratings \\n2025 Star \\nThe measure star for the contract from the 2025 Star Ratings \\nFinal Value \\nThe measure value to be used in the 2025 Star Ratings after the data handling policy for disasters was applied \\nFinal Star \\nThe measure star to be used in the 2025 Star Ratings after the data handling policy for disasters was applied \\nFinal From \\nThe Star Ratings year where the final data for the measure came from \\n16. Measure Detail – C Improvement page \\nThe Improvement page is constructed in a similar manner as the Measure Data page. This page is available \\nduring the second plan preview. \\nThe first four columns contain contract identifying information. The remaining columns contain the results \\nof the improvement calculation for the specific Part C measures. There is one column for each Part C \\nmeasure. The measure columns are identified by measure id and measure name. There is an additional \\ncolumn to the right of the Part C measure columns which contains the final numeric Part C improvement \\nscore. This numeric result is described in Attachment I: “Calculating the Improvement Measure and the \\nMeasures Used.” \\nThe row immediately above this measure information contains the domain id and domain name. The row \\nimmediately below the measure information contains a flag (Included or Not Included) to show if the \\nmeasure was used to calculate the final improvement measure. All subsequent rows contain the data \\nassociated with an individual contract. The possible results for Part C measure calculations are shown in \\nTable S-17 below. \\nTable S-17: Part C Measure Improvement Results \\nImprovement Measure Result \\nDescription \\nNo significant change \\nThere was no significant change in the values between the two years \\nSignificant improvement \\nThere was a significant improvement from last year to this year \\nSignificant decline \\nThere was a significant decline from last year to this year \\nNot included in calculation \\nThere was only one year of data available so the calculation could not be completed \\nNot Applicable \\nThe measure is not an improvement measure \\nNot Eligible \\nThe contract did not have data in more than half of the improvement measures or was too new  \\nHeld Harmless \\nThe contract had 5 stars in this measure last year and this year \\nLow reliability and low enrollment The low-enrollment contract measure score did not have sufficiently high reliability \\n17. Measure Detail – D Improvement page \\nThe Improvement page is constructed in a similar manner as the Measure Data page. This page is available \\nduring the second plan preview.', '(Last Updated 10/03/2024)  \\nPage 201 \\n \\nThe first four columns contain contract identifying information. The remaining columns contain the results \\nof the improvement calculation for the specific Part D measures. There is one column for each Part D \\nmeasure. The measure columns are identified by measure id and measure name. There is an additional \\ncolumn to the right of the Part D measure columns which contains the final numeric Part D improvement \\nscore. This numeric result is described in Attachment I: “Calculating the Improvement Measure and the \\nMeasures Used.” \\nThe row immediately above this measure information contains the domain id and domain name. The row \\nimmediately below the measure information contains a flag (Included or Not Included) to show if the \\nmeasure was used to calculate the final improvement measure. All subsequent rows contain the data \\nassociated with an individual contract. The possible results for Part D measure calculations are shown in \\nTable S-18 below. \\nTable S-18: Part D Measure Improvement Results \\nImprovement Measure Result \\nDescription \\nNo significant change \\nThere was no significant change in the values between the two years \\nSignificant improvement \\nThere was a significant improvement from last year to this year \\nSignificant decline \\nThere was a significant decline from last year to this year \\nNot included in calculation \\nThere was only one year of data available so the calculation could not be completed \\nNot Applicable \\nThe measure is not an improvement measure \\nNot Eligible \\nThe contract did not have data in more than half of the improvement measures or was too new  \\nHeld Harmless \\nThe contract had 5 stars in this measure last year and this year \\n18. Measure Stars page \\nThe Measure Stars page displays the Star Rating for each Part C and Part D measure. This page is available \\nduring the second plan preview. \\nThe first four columns contain contract identifying information. The remaining columns contain the measure \\nstars which will display in MPF. There is one column for each of the Part C and Part D measures. The \\nmeasure columns are identified by measure id and measure name. The row immediately above this measure \\ninformation contains the domain id and domain name. The row immediately below the measure information \\ncontains the data time frame. All subsequent rows contain the data for all individual contracts associated \\nwith the user’s login id. Table S-19 below shows a sample of the left hand most columns shown in HPMS. \\nTable S-19: Measure Stars page sample \\nMedicare Star Ratings Report Card Master Table \\nContract \\nNumber \\nOrganization \\nMarketing Name \\nContract \\nName \\nParent \\nOrganization \\nHD1: Staying Healthy: Screenings, Tests and Vaccines \\nC01: Breast Cancer Screening C02: Colorectal Cancer Screening C03: Annual Flu Vaccine \\n01/01/2023 - 12/31/2023 \\n01/01/2023 - 12/31/2023 \\n03/2024 - 06/2024 \\nHAAAA Market A \\nContract A PO A \\nPlan too new to be measured \\nPlan too new to be measured \\nNot enough data available \\nHBBBB Market B \\nContract B PO B \\nNot enough data available \\n4 \\n5 \\nHCCCC Market C \\nContract C PO C \\n3 \\n4 \\n5 \\n19. Domain Stars page \\nThe Domain Stars page displays the Star Rating for each Part C and Part D domain. This page is available \\nduring the second plan preview.', '(Last Updated 10/03/2024)  \\nPage 202 \\n \\nThe first four columns contain contract identifying information. The remaining columns contain the domain \\nstars which will display in MPF. There is one column for each of the Part C and Part D domains. The \\ndomain columns are identified by the domain id and domain name. All subsequent rows contain the stars \\nassociated with an individual contract. Table S-20 below shows a sample of the left hand most columns \\nshown in HPMS. \\nTable S-20: Domain Star page sample \\nMedicare Star Ratings Report Card Master Table \\nContract \\nNumber \\nOrganization \\nMarketing Name \\nContract \\nName \\nParent \\nOrganization \\nHD1: Staying Healthy: Screenings, \\nTests and Vaccines \\nHD2: Managing Chronic \\n(Long Term) Conditions \\nHD3: Member Experience \\nwith Health Plan \\nHAAAA Market A \\nContract A PO A \\n4 \\n3 \\n4 \\nHBBBB Market B \\nContract B PO B \\n3 \\n3 \\n3 \\nHCCCC Market C \\nContract C PO C \\n3 \\n3 \\n4 \\n20. Part C Summary Rating page \\nThe Part C Summary Rating page displays the Part C rating and data associated with calculating the final \\nPart C summary rating. This page is available during the second plan preview. There are flags to indicate if \\nthe final rating came from the without improvement measures calculation. Table S-21 below explains each \\nof the columns contained on this page. \\nTable S-21: Part C Summary Rating page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nContract Type \\nThe contract plan type used to compute the ratings \\nSNP Plans \\nDoes the contract offer a SNP? (Yes/No) \\nMajor Disaster Percentage 2022 \\nThe percentage of members living in an Individual Assistance area in 2022 rounded to an integer \\nMajor Disaster Percentage 2023 \\nThe percentage of members living in an Individual Assistance area in 2023 rounded to an integer \\nNumber Measures Required \\nThe minimum number of measures required to calculate a rating out all required for the contract type. \\nNumber Missing Measures \\nThe number of measures that were missing stars \\nNumber Rated Measures \\nThe number of measures that were assigned stars \\nCalculated Summary Mean \\nContains the mean of the stars for rated measures \\nCalculated Variance \\nThe variance of the calculated summary mean \\nCalculated Score Percentile Rank Percentile ranking of Calculated Summary Mean \\nVariance Percentile Rank \\nPercentile ranking of Calculated Variance \\nVariance Category \\nThe reward factor variance category for the contract (low, medium, or high) \\nReward Factor \\nThe calculated reward factor for the contract (0, 0.1, 0.2, 0.3, or 0.4) \\nInterim Summary \\nThe sum of the Calculated Summary Mean and the Reward Factor \\nPart C Summary FAC \\nPart C summary final adjustment category for the contract \\nCAI Value \\nThe Part C summary CAI value for the contract \\nFinal Summary \\nThe sum of the Interim Summary and the CAI Value \\nImprovement Measure Usage \\nDid the final Part C summary rating come from the calculation using the improvement measure? (Yes/No) \\nNew Measure Usage \\nDid the final Part C summary rating come from the calculation using the new measures? (Yes/No) \\n2025 Part C Summary Rating \\nThe final rounded 2025 Part C Summary Rating', '(Last Updated 10/03/2024)  \\nPage 203 \\n \\n21. Part D Summary Rating page \\nThe Part D Summary Rating page displays the Part D rating and data associated with calculating the final \\nPart D summary rating. This page is available during the second plan preview. There are flags to indicate if \\nthe final rating came from the without improvement measures calculation. Table S-22 below explains each \\nof the columns contained on this page. \\nTable S-22: Part D Summary Rating View \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nContract Type \\nThe contract plan type used to compute the ratings \\nMajor Disaster Percentage 2022 \\nThe percentage of members living in an Individual Assistance area in 2022 rounded to an integer \\nMajor Disaster Percentage 2023 \\nThe percentage of members living in an Individual Assistance area in 2023 rounded to an integer \\nNumber Measures Required \\nThe minimum number of measures required to calculate a rating out all required for the contract type \\nNumber Missing Measures \\nThe number of measures that were missing stars \\nNumber Rated Measures \\nThe number of measures that were assigned stars \\nCalculated Summary Mean \\nContains the mean of the stars for rated measures \\nCalculated Variance \\nThe variance of the calculated summary mean \\nCalculated Score Percentile Rank Percentile ranking of Calculated Summary Mean \\nVariance Percentile Rank \\nPercentile ranking of Calculated Variance \\nVariance Category \\nThe reward factor variance category for the contract (low, medium, or high) \\nReward Factor \\nThe calculated reward factor for the contract (0, 0.1, 0.2, 0.3, or 0.4) \\nInterim Summary \\nThe sum of the Calculated Summary Mean and the Reward Factor \\nPart D Summary FAC \\nPart D summary final adjustment category for the contract \\nCAI Value \\nThe Part D summary CAI value for the contract \\nFinal Summary \\nThe sum of the Interim Summary and the CAI Value \\nImprovement Measure Usage \\nDid the final Part D summary rating come from the calculation using the improvement measure? (Yes/No) \\n2025 Part D Summary Rating \\nThe final rounded 2025 Part D Summary Rating \\n22. Overall Rating page \\nThe Overall Rating page displays the overall rating for MA-PD contracts and data associated with \\ncalculating the final overall rating. This page is available during the second plan preview. There are flags to \\nindicate if the final rating came from the without improvement measures calculation. Table S-23 below \\nexplains each of the columns contained on this page.', '(Last Updated 10/03/2024)  \\nPage 204 \\n \\nTable S-23: Overall Rating View \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nContract Type \\nThe contract plan type used to compute the ratings \\nSNP Plans \\nDoes the contract offer a SNP? (Yes/No) \\nMajor Disaster Percentage 2022 \\nThe percentage of members living in an Individual Assistance area in 2022 rounded to an integer \\nMajor Disaster Percentage 2023 \\nThe percentage of members living in an Individual Assistance area in 2023 rounded to an integer \\nNumber Measures Required \\nThe minimum number of measures required to calculate a rating out all required for the contract type \\nNumber Missing Measures \\nThe number of measures that were missing stars \\nNumber Rated Measures \\nThe number of measures that were assigned stars \\n2025 Part C Summary Rating \\nThe 2025 Part C Summary Rating \\n2025 Part D Summary Rating \\nThe 2025 Part D Summary Rating \\nCalculated Summary Mean \\nContains the weighted mean of the stars for rated measures  \\nCalculated Variance \\nThe variance of the calculated summary mean \\nCalculated Score Percentile Rank Percentile ranking of Calculated Summary Mean \\nVariance Percentile Rank \\nPercentile ranking of Calculated Variance \\nVariance Category \\nThe reward factor variance category for the contract (low, medium, or high) \\nReward Factor \\nThe calculated reward factor for the contract (0, 0.1, 0.2, 0.3, or 0.4) \\nInterim Summary \\nThe sum of the Calculated Summary Mean and the Reward Factor \\nOverall FAC \\nOverall final adjustment category for the contract \\nCAI Value \\nThe Overall CAI value for the contract \\nFinal Summary \\nThe sum of the Interim Summary and the CAI Value \\nImprovement Measure Usage \\nDid the final overall rating come from the calculation using the improvement measures? (Yes/No) \\nNew Measure Usage \\nDid the final overall rating come from the calculation using the new measures? (Yes/No) \\n2025 Overall Rating \\nThe final 2025 Overall Rating \\n23. Low Performing Contract List \\nThe Low Performing Contract List page displays the contracts that received a Low Performing Icon and the \\ndata used to calculate the assignment. This page is available during the second plan preview. HPMS users in \\ncontracting organizations will see only their own contracts in this list. None will be displayed if no contract \\nin the organization was assigned a Low Performing Icon. Table S-24 below explains each of the columns \\ncontained on this page.', '(Last Updated 10/03/2024)  \\nPage 205 \\n \\nTable S-24: Low Performing Contract List \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nRated As \\nThe type of rating for this contract, valid values are “MA-Only,” “MA-PD,” and “PDP” \\n2023 C Summary \\nThe 2023 Part C Summary Rating earned by the contract \\n2023 D Summary \\nThe 2023 Part D Summary Rating earned by the contract \\n2024 C Summary \\nThe 2024 Part C Summary Rating earned by the contract \\n2024 D Summary \\nThe 2024 Part D Summary Rating earned by the contract \\n2025 C Summary \\nThe 2025 Part C Summary Rating earned by the contract \\n2025 D Summary \\nThe 2025 Part D Summary Rating earned by the contract \\nReason for LPI \\nThe combination of ratings that met the Low Performing Icon rules. Valid values are “Part C,” “Part D,” “Part C and \\nD,” & “Part C or D.” See the section titled “Methodology for Calculating the Low Performing Icon” for details. \\n24. High Performing Contract List \\nThe High Performing Contract List page displays the contracts that received a High Performing Icon. This \\npage is available during the second plan preview. HPMS users in contracting organizations will see only \\ntheir own contracts in this list. None will be displayed if no contract in the organization was assigned a High \\nPerforming Icon. Table S-25 below explains each of the columns contained on this page. \\nTable S-25: High Performing Contract List \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nRated As \\nThe type of rating for this contract, valid values are “MA-Only,” “MA-PD,” and “PDP” \\nHighest Rating \\nThe highest level of rating that can be achieved for this organization, valid values are “Part C Summary,” “Part D \\nSummary,” “Overall Rating” \\nRating \\nThe star value attained in the highest rating for the organization type \\n25. Technical Notes link \\nThe Technical Notes link provides the user with a copy of the 2025 Star Ratings Technical Notes. A draft \\nversion of these technical notes is available during the first plan preview. The draft is then updated for the \\nsecond plan preview, and then finalized when the ratings data have been posted to MPF. Other updates may \\noccur to the technical notes if errors are identified outside of the plan preview periods and after MPF data \\nrelease. \\nLeft clicking on the Technical Notes link will open a new browser window which will display a PDF \\n(portable document format) copy of the 2025 Star Ratings Technical Notes. Right clicking on the Technical \\nNotes link will pop up a context menu which contains Save Target As…; clicking on this will allow the user \\nto download and save a copy of the PDF document.', '(Last Updated 10/03/2024)  \\nPage 206 \\n \\n26. Medication NDC List \\nThe Medication NDC List link provides the user a means to download a copy of the medication lists used \\nfor the Medication Adherence measures (D08 – D10) & SUPD (D12). This downloadable file is in Zip \\nformat and contains two Excel files. \\n27. Part C and Part D Example Measure Data \\nThe Part C and Part D Example Measure Data link provides the user with a means to download a copy of \\nthe data for the Breast Cancer Screening Part C measure, the Rating of Health Plan Part C measure, the \\nComplaints about the Plan Part C measure and the MTM Program Completion Rate for CMR Part D \\nmeasure for the full set of contracts used to calculate the cut points. The data are de-identified such that \\nindividual contract’s data cannot be determined. The data include the measure value, a flag for contracts that \\nhad data issues where applicable, and two flags identifying contracts with >= 25 percent and >= 60 percent \\nof enrollees living in an area affected by a disaster. There is also a flag in the Breast Cancer Screening Part \\nC measure file to identify HEDIS low enrollment contracts. There is also a flag in the MTM Program \\nCompletion Rate for CMR Part D measure file identifying contracts as MAPD or PDP. This downloadable \\nis in Zip format and contains four Excel files.']\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# abstracts_small = np.array(Df[:], dtype=object, ndmin = 1)"
      ],
      "metadata": {
        "id": "UmSMAfoCktRZ"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "C2QS6XvGwzum"
      },
      "outputs": [],
      "source": [
        "Df = np.array(pdf_pages[:], dtype=object, ndmin = 1)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "tIC6wY7qzKh8",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 252
        },
        "outputId": "3b24f095-4ce5-4604-f4b6-3d446110e7d8"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'(Last Updated 10/03/2024)  \\nPage vii \\n \\nATTACHMENT S: HEALTH PLAN MANAGEMENT SYSTEM MODULE REFERENCE ............................... 190 \\nHPMS Star Ratings Module ........................................................................................................................................... 190 \\n1. Measure Data page ................................................................................................................................................... 190 \\nTable S-1: Measure Data page sample .......................................................................................................................... 190 \\n2. Measure Detail – CTM Summary page ..................................................................................................................... 190 \\nTable S-2: Measure Detail – CTM Summary page fields ................................................................................................ 191 \\n3. Measure Detail – Part C Appeals page ..................................................................................................................... 191 \\nTable S-3: Measure Detail – Part C Appeals page fields ................................................................................................ 191 \\n4. Measure Detail – SNP CM page ............................................................................................................................... 192 \\nTable S-4: Measure Detail – SNP CM page fields .......................................................................................................... 192 \\n5. Measure Detail – HEDIS page .................................................................................................................................. 192 \\nTable S-5: Measure Detail – HEDIS page fields ............................................................................................................. 193 \\nTable S-6: HEDIS 2023 Audit Designations and 2025 Star Ratings .............................................................................. 193 \\n6. Measure Detail – CTM page ..................................................................................................................................... 193 \\nTable S-7: Measure Detail – CTM page fields ................................................................................................................ 194 \\n7. Measure Detail – Disenrollment ................................................................................................................................ 194 \\nTable S-8: Measure Detail – Disenrollment page fields .................................................................................................. 194 \\n8. Measure Detail – DR (Disenrollment Reasons) ........................................................................................................ 194 \\nTable S-9: Measure Detail – Disenrollment Reasons page fields .................................................................................. 195 \\n9. Measure Detail – MTM page ..................................................................................................................................... 195 \\nTable S-10: Measure Detail – MTM page fields .............................................................................................................. 195 \\n10. Measure Detail – CAHPS page ................................................................................................................................. 196 \\nTable S-11: Measure Detail – CAHPS page fields ......................................................................................................... 196 \\n11. Calculation Detail – MD ............................................................................................................................................. 196 \\nTable S-12: Calculation Detail – MD page fields ............................................................................................................ 197 \\n12. Calculation Detail – CAI ............................................................................................................................................ 197 \\nTable S-13: Measure Detail – CAI page fields ................................................................................................................ 198 \\n13. Measure Detail – HEDIS LE page ............................................................................................................................. 198 \\nTable S-14: Measure Detail – HEDIS LE page fields ..................................................................................................... 199 \\n14. Measure Detail – C MD Results ................................................................................................................................ 199 \\nTable S-15: Measure Detail – C MD Results .................................................................................................................. 199 \\n15. Measure Detail – D MD Results ................................................................................................................................ 199 \\nTable S-16: Measure Detail – D MD Results .................................................................................................................. 200 \\n16. Measure Detail – C Improvement page .................................................................................................................... 200 \\nTable S-17: Part C Measure Improvement Results ........................................................................................................ 200 \\n17. Measure Detail – D Improvement page .................................................................................................................... 200 \\nTable S-18: Part D Measure Improvement Results ........................................................................................................ 201 \\n18. Measure Stars page .................................................................................................................................................. 201 \\nTable S-19: Measure Stars page sample........................................................................................................................ 201 \\n19. Domain Stars page .................................................................................................................................................... 201 \\nTable S-20: Domain Star page sample ........................................................................................................................... 202 \\n20. Part C Summary Rating page ................................................................................................................................... 202 \\nTable S-21: Part C Summary Rating page fields ............................................................................................................ 202 \\n21. Part D Summary Rating page ................................................................................................................................... 203 \\nTable S-22: Part D Summary Rating View ...................................................................................................................... 203 \\n22. Overall Rating page ................................................................................................................................................... 203 \\nTable S-23: Overall Rating View ..................................................................................................................................... 204 \\n23. Low Performing Contract List .................................................................................................................................... 204 \\nTable S-24: Low Performing Contract List ...................................................................................................................... 205 \\n24. High Performing Contract List ................................................................................................................................... 205 \\nTable S-25: High Performing Contract List ..................................................................................................................... 205 \\n25. Technical Notes link .................................................................................................................................................. 205 \\n26. Medication NDC List .................................................................................................................................................. 206 \\n27. Part C and Part D Example Measure Data ............................................................................................................... 206'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 14
        }
      ],
      "source": [
        "Df[7]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "eZOtzumrFd0b",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 178
        },
        "outputId": "4284c5a3-a188-49c7-ec86-1dc8a811d22d"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'(Last Updated 10/03/2024)  \\nPage 22 \\n \\nTable 20: Categorization of Contract’s Members into Quartiles of Disability for the PDP Part D Summary \\nDisability Quartile \\nPercentage of Contract’s \\nBeneficiaries who are Disabled \\n1 \\n \\n0.000000 to less than 6.593595 \\n2 \\n6.593595 to less than 10.621062 \\n3 \\n \\n10.621062 to less than 14.589481 \\n4 \\n \\n14.589481 to 100.000000 \\n \\nTable 21 provides the description of each of the final adjustment categories for the PDP Part D summary and \\nthe associated value of the CAI per final adjustment category. Note that the CAI values for the PDP Part D \\nsummary are different from the CAI values for the MA-PD Part D summary. There are three final adjustment \\ncategories for the PDP Part D summary. \\n \\nTable 21: Final Adjustment Categories and CAI Values for the PDP Part D Summary \\nFinal Adjustment \\nCategory \\nLIS/DE Quartile \\nDisability Quartile \\nCAI Value \\n1 \\nL1-L2 \\nD1-D2 \\n-0.230036 \\n2 \\nL1-L3 \\nD3-D4 \\n-0.081240 \\n  \\nL3-L4 \\nD1-D2 \\n \\n3 \\nL4 \\nD3-D4 \\n0.004293 \\nCalculation Precision \\nCMS and its contractors have always used software called SAS (an integrated system of software products \\nprovided by SAS Institute Inc.) to perform the calculations used in producing the Star Ratings. For all measures, \\nexcept the improvement measures, the precision used in scoring the measure is indicated next to the label “Data \\nDisplay” within the detailed description of each measure. The improvement measures are discussed below. The \\ndomain ratings are the unweighted average of the star measures and are rounded to the nearest integer. \\nThe improvement measures, summary, and overall ratings are calculated with at least six digits of precision \\nafter the decimal whenever the data allow it. The HEDIS measure scores have two digits of precision after the \\ndecimal. All other measures have at least six digits of precision when used in the improvement calculation. \\nContracts may request a contract-specific calculation spreadsheet which emulates the actual SAS calculations \\nfrom the Star Ratings mailbox during the second plan preview. \\nIt is not possible to replicate CMS’s calculations exactly due to factors including, but not limited to: using \\npublished measure data from sources other than CMS’s Star Rating program which use different rounding rules, \\nand exclusion of some contracts’ ratings from publicly-posted data (e.g., terminated contracts). \\nRounding Rules for Measure Scores \\nMeasure scores are rounded to the precision indicated next to the label “Data Display” within the detailed \\ndescription of each measure. Measure scores are rounded using traditional rounding rules. These are standard \\n“round to nearest” rules prior to cut point analysis. To obtain a value with the specified level of precision, the \\nsingle digit following the level of precision will be rounded. If the digit to be rounded is 0, 1, 2, 3 or 4, the value'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 15
        }
      ],
      "source": [
        "Df1 = Df\n",
        "Df1[29]"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "len(Df1)"
      ],
      "metadata": {
        "id": "35duzv1xhe8g",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "bba3d18b-4fa9-4d00-f5fd-7c40250a95d4"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "214"
            ]
          },
          "metadata": {},
          "execution_count": 16
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#Question 1\n",
        "\n",
        "Question1 = [\"What is (CAI)?\"] * len(Df)\n",
        "Question_list_1 = list((zip(Question1, Df)))\n",
        "Question_list_1[40:41]\n",
        "\n",
        "#Question 2\n",
        "\n",
        "Question2 = [\"What is BCS, describe what BCS stand for? or What measure it is?\"] * len(Df)\n",
        "Question_list_2 = list((zip(Question2, Df)))\n",
        "Question_list_2[30:31]\n",
        "\n",
        "#Question 3\n",
        "\n",
        "Question3 = [\"CBP calculation?\"] * len(Df)\n",
        "Question_list_3 = list((zip(Question3, Df)))\n",
        "Question_list_3[20:21]\n",
        "\n",
        "#Question 4\n",
        "\n",
        "Question4 = [\"Changes for rating year 2025 compared to rating year 2024?\"] * len(Df)\n",
        "Question_list_4 = list((zip(Question4, Df)))\n",
        "Question_list_4[50:51]\n",
        "\n",
        "#Question 5\n",
        "\n",
        "Question5 = [\"What is clustering?\"] * len(Df)\n",
        "Question_list_5 = list((zip(Question5, Df)))\n",
        "Question_list_5[60:61]"
      ],
      "metadata": {
        "id": "JCLDkgy8ooxi",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "c9506bbe-76f9-46f4-b7bc-3175e3af0499"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[('What is clustering?',\n",
              "  '(Last Updated 10/03/2024)  \\nPage 53 \\n \\nTitle \\nDescription \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 39 % \\n>= 39 % to < 44 % \\n>= 44 % to < 48 % \\n>= 48 % to < 52 % \\n>= 52 % \\n \\n \\nMeasure: C14 - Medication Reconciliation Post-Discharge \\nTitle \\nDescription \\nLabel for Stars: The Plan Makes Sure Member Medication Records Are Up-to-Date After Hospital \\nDischarge \\nLabel for Data: The Plan Makes Sure Member Medication Records Are Up-to-Date After Hospital \\nDischarge \\nDescription: This shows the percent of plan members whose medication records were updated \\nwithin 30 days after leaving the hospital. To update the record, a doctor or other health \\ncare professional looks at the new medications prescribed in the hospital and compares \\nthem with the other medications the patient takes. Updating medication records can \\nhelp to prevent errors that can occur when medications are changed. \\nHEDIS Label: Medication Reconciliation Post-Discharge (MRP) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 330 \\nMetric: The percentage of discharges from January 1–December 1 of the measurement year for \\nmembers 18 years of age and older for whom medications were reconciled the date of \\ndischarge through 30 days after discharge (31 total days). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Members in hospice or using hospice services any time during the measurement year. \\n \\nMembers who died any time during the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included')]"
            ]
          },
          "metadata": {},
          "execution_count": 17
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "h7-t81YoGEaN"
      },
      "outputs": [],
      "source": [
        "# Question_list = []\n",
        "# Question = [\"Describe (CAI) Categorical Adjustment Index?\"]\n",
        "# x = False\n",
        "# i = 21\n",
        "# while not x:\n",
        "#   b = Df1[i]\n",
        "#   B = Question + [b]\n",
        "#   Question_list.append(B)\n",
        "#   i = i + 1\n",
        "#   if i == 25:\n",
        "#     x = True\n",
        "# print(Question_list) # Print the tuple if needed"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Question_list[]"
      ],
      "metadata": {
        "id": "yBZtp0fMnevA"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "lUTkgiemFcQb",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "35788965-1cec-48c9-8f52-e52ff714e801"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "-8.940077\n",
            "-8.416224\n",
            "-9.202217\n",
            "-4.328757\n",
            "-9.698146\n"
          ]
        }
      ],
      "source": [
        "#Question 1 score\n",
        "scores1 = model.predict(Question_list_1[:])\n",
        "print(scores1[4])\n",
        "\n",
        "#Question 2 score\n",
        "scores2 = model.predict(Question_list_2[:])\n",
        "print(scores2[4])\n",
        "\n",
        "#Question 3 score\n",
        "scores3 = model.predict(Question_list_3[:])\n",
        "print(scores3[4])\n",
        "\n",
        "#Question 4 score\n",
        "scores4 = model.predict(Question_list_4[:])\n",
        "print(scores4[4])\n",
        "\n",
        "#Question 5 score\n",
        "scores5 = model.predict(Question_list_5[:])\n",
        "print(scores5[4])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "W3vohgPB67Fs",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "e43e0fa4-b4b3-49ee-f0d8-8b2239edfbc8"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "sorted_array:  -11.322069\n",
            "sorted_array:  -11.135099\n",
            "sorted_array:  -10.804609\n",
            "sorted_array:  -8.243604\n",
            "sorted_array:  -11.397772\n"
          ]
        }
      ],
      "source": [
        "# sorted for score1\n",
        "sorted_array1 = np.sort(scores1[:])\n",
        "print(\"sorted_array: \", sorted_array1[4])\n",
        "\n",
        "# sorted for score2\n",
        "sorted_array2 = np.sort(scores2[:])\n",
        "print(\"sorted_array: \", sorted_array2[4])\n",
        "\n",
        "# sorted for score3\n",
        "sorted_array3 = np.sort(scores3[:])\n",
        "print(\"sorted_array: \", sorted_array3[4])\n",
        "\n",
        "# sorted for score4\n",
        "sorted_array4 = np.sort(scores4[:])\n",
        "print(\"sorted_array: \", sorted_array4[4])\n",
        "\n",
        "# sorted for score5\n",
        "sorted_array5 = np.sort(scores5[:])\n",
        "print(\"sorted_array: \", sorted_array5[4])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "DHqDgFie6Vay",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "68abe900-35f2-4e48-9785-bed1e0742bc6"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "descending_array:  -2.8424182\n",
            "descending_array:  -5.6528134\n",
            "descending_array:  -4.7711406\n",
            "descending_array:  0.7878732\n",
            "descending_array:  -1.6613616\n"
          ]
        }
      ],
      "source": [
        "# sorted for descending sort1\n",
        "descending_order_array1 = sorted_array1[::-1]\n",
        "print(\"descending_array: \", descending_order_array1[4])\n",
        "\n",
        "# sorted for descending sort2\n",
        "descending_order_array2 = sorted_array2[::-1]\n",
        "print(\"descending_array: \", descending_order_array2[4])\n",
        "\n",
        "# sorted for descending sort3\n",
        "descending_order_array3 = sorted_array3[::-1]\n",
        "print(\"descending_array: \", descending_order_array3[4])\n",
        "\n",
        "# sorted for descending sort4\n",
        "descending_order_array4 = sorted_array4[::-1]\n",
        "print(\"descending_array: \", descending_order_array4[4])\n",
        "\n",
        "# sorted for descending sort5\n",
        "descending_order_array5 = sorted_array5[::-1]\n",
        "print(\"descending_array: \", descending_order_array5[4])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "oiosGMnj6VSG",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "08a2f0cc-08e9-48a8-be0a-f0351db06803"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "with stopwrods descending_indices:  [177  24  86  23  35  68 205  29  20  43  96  61 211  81  27  83  78  71\n",
            "  58  90 104   3  40  52 107  47  93 210  25  69  91  28  50  66 178  79\n",
            "  62  26  54  98 179  59  64  84  48  94  73  45  16 108  72  76 153  56\n",
            "   2 193 112  74 102 150   7 194   6 195  87   4 187 134  38 154  17  14\n",
            "  32 106 100  53  99 163   8  55   5 113 161  65  82 103 111 188 133  15\n",
            " 209 171 152 110 105 181 160  44  12 198 186  80  51 191 129  67 185  21\n",
            "  37  10 208  39 201 162 180  75 206 166 126 204  31  92 170  13 207  63\n",
            "  77 167  18 136  97  30 168 151 165  36  89 158  95  49  46 197  57 135\n",
            "  42 203 189 109 159 175 127  19  41 173 155  22 202 121 196 172 199 101\n",
            " 212 182 143  85 192 183 156 142 190 137 200 132 138 118 141  11 122  70\n",
            " 120 116 176 145 149 213 130 124  33 146 184  60 115 164 117 140 147 148\n",
            " 114 139   9 119 131 128 157 144   1 174 123  88 125   0 169  34]\n",
            "with stopwrods descending_indices:  [ 37 121  36 108 150  35  14   8  16 188 160 187 113 203  80 161 110  69\n",
            "   9  17 133 153  93 100  53 102 126 111 201 185  73  82  84  90 186  13\n",
            "  41  87 154  70  91  44  75 106   5   7  51  86  71  77 198 140  55  32\n",
            "  89 194 134 211  29  62  78 107 208  92 105  59 103 175 206  47 195  61\n",
            "  68  94 207  96  99 200  98 209   4  12 170 189 199  67  11 163  57  48\n",
            " 155  97  46 193  20 143  43  72 130 205 112  18  95  83  58  79  76  63\n",
            "  15  40  19  23  10 138  81  45  65 104 122 162 152  74 131 124 129  66\n",
            "  21 191 210 202  50 101  85  52  39 177   2  49 127 141 109 192  56 136\n",
            " 158 180  42 142 197 139 117  64  54 118 156 171 115 151   3 157 116  22\n",
            " 132 144 165 135 119 114 123  38 125   6 213 120 190  88  60 178 149  31\n",
            "  24   1 128  26 204  33  28 146 166 167 176 148 145 159  25 168 137  30\n",
            " 196 169 181  27 147   0 212 179 164 174 173 182  34 172 184 183]\n",
            "with stopwrods descending_indices:  [ 55 101 129  93 104  21  22 128  80 134  29  20  10 135 127  68  65  96\n",
            " 108 110 153  46  43 151  88  12  39  18  63  86  90  99 112  19 150 168\n",
            "  16  31  81  92 155 193  95  75  78  85  61  13 208  17 156   5 163  42\n",
            " 133  71 158 171 204 195 167 169 136 186 198  74 210  58 184 211 172 209\n",
            " 100  32 102 107 154 191 178  70 177 205 203 161  47 207  77  84  60 173\n",
            " 199 152 170  11 165 188  28   2  48   7  83 182  87 105 166 126   3   6\n",
            " 121  35 132  79 206  14  97 187 183  91  23 122 116 164 120 111 160 181\n",
            " 162  15  44  53 174 118 185  30  62 113  56 201  98  33 179  82 175  40\n",
            " 143  24  89   4 157 200 137 115 202 114  37 106 119 117   8 130  25 141\n",
            " 159  26 180 192 189  51  27 123  67 212 138 103 109 149  57  66  72 124\n",
            "  52  34  73  69 213  45 194  50 142  76 176 140  59  36  54  94 190  49\n",
            " 197 146 131  41  64 196 148 125 139 145   9 147 144  38   0   1]\n",
            "with stopwrods descending_indices:  [133   9 135  15 134  92 207 137  31  14  12  80 158  61 136 156  32  16\n",
            "  43 206 107 104 129  90  47  40  66 188  68  83  44  78  52  58 110 144\n",
            "   8 155 192  75  88  96 142  50  17  54  23 212 211 148 149  71  20  10\n",
            " 143  62 180 146 141   2  69 189  77  76  84  72 147  86 145  18 186 187\n",
            "  64 178  94 209  67  89 122 177 204  73 182 109 126 124  41 168  59 125\n",
            " 157  30  28  56  97 210  48 175 101   0 190 111   4  98  38  85 191  46\n",
            " 163 159  79  22  60  95 140 113  19 121 105 150  57 112 154  74  55  45\n",
            " 153 167  91 100  42  29  65 197 103  21 184  82 181  26  25  70 165   1\n",
            " 102 179   5 152  99  24  53 108 185 171 161 169   6 205  49 196  51 170\n",
            " 208 198  13 166 164  27 194  93 195 106  87  39 193  63 183  11  81 162\n",
            "   7  35 203 151 139 138  37 201 174 115 132 127 128 130 173 117 160 118\n",
            " 200 120   3 176 119 116 114 123 172 131  36 199 202  33  34 213]\n",
            "with stopwrods descending_indices:  [150  16 152 154 153 134  43  90  78  81  58  47 107  83  93  67  85 151\n",
            "  40 104  66  59  52  54  98  91  50  84 112  79  64  45  87  48   6   2\n",
            " 158  56  62 193 108  32  17  60 177   7 113   4 163  38 195 102 171 194\n",
            "  75   5  99 100 110 160 187 161 209 168  61 106  92  14 105  24 178  15\n",
            "  36  71   8  65 181 205  30 208 191   3  21 162  53  31  29 133  35 211\n",
            " 167 103  10  80 188 185 201  55  12 166 111  95 129  20  44  51 155  42\n",
            " 173  37 204  28 170 206  77 198  18 186  63 136 210  82  39 197 165  19\n",
            "  97 180 207 126  69  96 156 101  13 127  57  89 202 203  22  23  49 121\n",
            " 135  70 182 159  25 175  33 196  46 130 109 172 183  73  11 179  74 212\n",
            " 141  94  27 164 143 199  86  26 189 145 192 149 176 118 137 122 138  76\n",
            " 142 157  68 132  72 200 184 116 131 120  88 128 190 124 148 140 174 115\n",
            " 139 146 147 114  41 213 117 119   9 125 123   1 169 144   0  34]\n"
          ]
        }
      ],
      "source": [
        "\n",
        "# descending indices sort 1\n",
        "ascending_indices1 = scores1[:].argsort()\n",
        "descending_indices1 = ascending_indices1[::-1]\n",
        "print(\"with stopwrods descending_indices: \", descending_indices1)\n",
        "\n",
        "# descending indices sort 2\n",
        "ascending_indices2 = scores2[:].argsort()\n",
        "descending_indices2 = ascending_indices2[::-1]\n",
        "print(\"with stopwrods descending_indices: \", descending_indices2)\n",
        "\n",
        "# descending indices sort 3\n",
        "ascending_indices3 = scores3[:].argsort()\n",
        "descending_indices3 = ascending_indices3[::-1]\n",
        "print(\"with stopwrods descending_indices: \", descending_indices3)\n",
        "\n",
        "\n",
        "# descending indices sort 4\n",
        "ascending_indices4 = scores4[:].argsort()\n",
        "descending_indices4 = ascending_indices4[::-1]\n",
        "print(\"with stopwrods descending_indices: \", descending_indices4)\n",
        "\n",
        "# descending indices sort 5\n",
        "ascending_indices5 = scores5[:].argsort()\n",
        "descending_indices5 = ascending_indices5[::-1]\n",
        "print(\"with stopwrods descending_indices: \", descending_indices5)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "YM0S6OKO6VKG",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "2aea0225-24ed-48ac-859e-fce2bf216fdc"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "top_3_indices:  [177  24  86  23  35]\n",
            "With stopwords embedding retrieved abstract :  What is (CAI)? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 170 \n",
            " \n",
            "Attachment O: Methodology for the Puerto Rico Model \n",
            "Puerto Rico has a unique health care market with a large percentage of low-income individuals in both \n",
            "Medicare and Medicaid and a complex legal history that affects the health care system in many ways. Puerto \n",
            "Rican beneficiaries are not eligible for LIS. The categorization of contracts into final adjustment categories for \n",
            "the Categorical Adjustment Index (CAI) relies on both the use of a contract’s percentages of beneficiaries with \n",
            "Low Income Subsidy/Dual Eligible (LIS/DE) and disabled beneficiaries.  Since the percentage of LIS/DE is a \n",
            "critical element in the categorization of contracts to identify the contract’s CAI, an additional adjustment is \n",
            "done for contracts that solely serve the population of beneficiaries in Puerto Rico to address the lack of LIS. The \n",
            "additional analysis for the adjustment results in a modified percentage of LIS/DE beneficiaries that is \n",
            "subsequently used to categorize the contract in its final adjustment category for the CAI. \n",
            " \n",
            "The contract-level modified LIS/DE percentages for Puerto Rico contracts for the 2025 Star Ratings are \n",
            "developed using the following sources of information: \n",
            " The 2022 1-year American Community Survey (ACS) estimates for the percentage of people living \n",
            "below the Federal Poverty Level (FPL). \n",
            " The 2022 ACS 5-year estimates for the percentage of people living below 150% of the FPL; for Puerto \n",
            "Rico and for the 10 poorest US states (which may include the District of Columbia). \n",
            " The Medicare enrollment data file for those enrolled during 2023 provided for beneficiaries who were \n",
            "alive at least through December 2023, the percentage of each contract’s beneficiaries who were DE, and \n",
            "for non-Puerto Rico contracts, the percentage who were LIS/DE. Beneficiary DE status was determined \n",
            "using a) the monthly beneficiary dual status codes, b) identification of Low Income Part D enrollees \n",
            "who reside in the US Territories, and c) beneficiaries with Medicaid coverage/who are Medicaid eligible \n",
            "by the Point of Sale contractor. For non-Puerto Rico contracts, beneficiaries who were LIS were \n",
            "determined using the monthly beneficiary LIS status codes, and beneficiaries were classified LIS/DE by \n",
            "combining the beneficiaries identified as DE and beneficiaries identified as LIS. \n",
            "The following steps are employed to determine the modified percentages of LIS/DE for MA contracts solely \n",
            "serving the population of beneficiaries in Puerto Rico. All references to contracts in Puerto Rico are limited to \n",
            "the contracts solely serving the population of beneficiaries in Puerto Rico. \n",
            " The 10 states with the highest proportion of people living below the FPL are identified, based on 2022 \n",
            "1-year data from ACS \n",
            "(https://www.census.gov/content/dam/Census/library/publications/2023/acs/acsbr-016.pdf, see Table 1). \n",
            "The states identified are: Alabama, Arkansas, Kentucky, Louisiana, Mississippi, New Mexico, New York, \n",
            "Oklahoma, South Carolina, and West Virginia. \n",
            " Data are aggregated from Medicare Advantage contracts that had at least 90% of their beneficiaries \n",
            "enrolled with mailing addresses within the 10 highest poverty states identified in step (1). \n",
            "For the 2025 Star Ratings adjustment, the data used for the model development included a total of 150 \n",
            "Medicare Advantage contracts with at least 90% of their beneficiaries with mailing addresses in one of \n",
            "the ten poorest states listed above. \n",
            " A linear regression model is developed using the known LIS/DE percentage and the corresponding DE \n",
            "percentage from the MA contracts in the 10 highest poverty states with at least 90% of their \n",
            "beneficiaries with mailing addresses in one of the ten states. \n",
            " \n",
            "The model for Puerto Rico is developed using the model in step (3) as its base. \n",
            " \n",
            "The estimated slope from the linear fit in the previous step (3) is retained to approximate the expected \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is (CAI)? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 17 \n",
            " \n",
            "ratings, and the rating-specific CAI value is the same for all contracts that fall within the same final adjustment \n",
            "category. \n",
            "The categorization of contracts into final adjustment categories for the CAI relies on both the use of a contract’s \n",
            "percentages of LIS/DE and disabled beneficiaries. Categories were chosen to enforce monotonicity. Puerto Rico \n",
            "has a unique health care market with a large percentage of low-income individuals in both Medicare and \n",
            "Medicaid and a complex legal history that affects the health care system in many ways. Puerto Rican \n",
            "beneficiaries are not eligible for LIS. Since the percentage of LIS/DE is a critical element in the categorization \n",
            "of contracts to identify the contract’s CAI, an additional adjustment is done for contracts that solely serve the \n",
            "population of beneficiaries in Puerto Rico to address the lack of LIS. The additional analysis for the adjustment \n",
            "results in a modified percentage of LIS/DE beneficiaries that is subsequently used to categorize the contract in \n",
            "its final adjustment category for the CAI. Details regarding the methodology for the Puerto Rico model are \n",
            "provided in Attachment O. \n",
            "Tables 10 and 11 provide the range of the percentages that correspond to the LIS/DE initial groups and \n",
            "disability quintiles for the determination of the CAI values for the Overall Rating. For example, if a contract’s \n",
            "percentage of LIS/DE beneficiaries is 13.60%, the contract’s LIS/DE initial group would be L4. The upper limit \n",
            "for each initial category is only included for the highest categories (L10 and D5), and the upper limit is equal to \n",
            "100% for both of these categories. \n",
            " \n",
            "Table 10: Categorization of Contract’s Members into LIS/DE Initial Groups for the Overall Rating \n",
            "LIS/DE Initial Group \n",
            "Percentage of Contract’s Beneficiaries who are LIS/DE \n",
            "1 \n",
            " \n",
            "0.000000 to less than 6.130891 \n",
            "2 \n",
            " \n",
            "6.130891 to less than 9.037945 \n",
            "3 \n",
            " \n",
            "9.037945 to less than 13.131086 \n",
            "4 \n",
            " \n",
            "13.131086 to less than 18.030927 \n",
            "5 \n",
            " \n",
            "18.030927 to less than 25.257942 \n",
            "6 \n",
            " \n",
            "25.257942 to less than 35.188560 \n",
            "7 \n",
            " \n",
            "35.188560 to less than 50.161404 \n",
            "8 \n",
            " \n",
            "50.161404 to less than 79.983090 \n",
            "9 \n",
            " \n",
            "79.983090 to less than 100.000000 \n",
            "10 \n",
            "100.000000 \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is (CAI)? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 79 \n",
            " \n",
            "Title \n",
            "Description \n",
            "Improvement Measure: Included \n",
            "CAI Usage: Not Included \n",
            "Case-Mix Adjusted: No \n",
            "Weighting Category: Measures Capturing Access \n",
            "Weighting Value: 4 \n",
            "Major Disaster: No adjustment for 2022 or 2023 disasters. \n",
            "Meaningful Measure Area: Person-centered Care \n",
            "CMIT #: 00096-01-C-PARTC \n",
            "Data Display: Percentage with no decimal place \n",
            "Reporting Requirements: \n",
            "1876 Cost \n",
            "CCP w/o SNP \n",
            "CCP with SNP \n",
            "CCP with Only I-SNP \n",
            "MSA \n",
            "PDP \n",
            "PFFS \n",
            "No \n",
            "Yes \n",
            "Yes \n",
            "Yes \n",
            "No \n",
            "No \n",
            "Yes \n",
            "Cut Points: \n",
            "1 Star \n",
            "2 Stars \n",
            "3 Stars \n",
            "4 Stars \n",
            "5 Stars \n",
            "< 46 % \n",
            ">= 46 % to < 69 % \n",
            ">= 69 % to < 93 % \n",
            ">= 93 % to < 100 % \n",
            " 100 % \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is (CAI)? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 16 \n",
            " \n",
            "average within-contract disparity in performance for Low Income Subsidy/Dual Eligible (LIS/DE) beneficiaries \n",
            "and disabled beneficiaries.  The CAI value (factor) depends on the contract’s percentage of beneficiaries with \n",
            "LIS/DE and the contract’s percentage of beneficiaries with disabled status. These adjustments are performed \n",
            "both with and without the improvement measures included. The value of the CAI varies by the contract’s \n",
            "percentage of beneficiaries with LIS/DE and disability status. \n",
            "The CAI values use data collected for the 2024 Star Ratings. To calculate the CAI, case-mix adjustment is \n",
            "applied to all clinical Star Rating measure scores that are not adjusted for SES using a beneficiary-level logistic \n",
            "regression model with contract fixed effects and beneficiary-level indicators of LIS/DE and disability status, \n",
            "similar to the approach currently used to adjust CAHPS patient experience measures. However, unlike CAHPS \n",
            "case-mix adjustment, the only adjusters are LIS/DE and disability status. Adjusted measure scores are then \n",
            "converted to measure stars using the 2024 rating year measure cutoffs and used to calculate Adjusted Overall \n",
            "and Summary Star Ratings. Unadjusted Overall and Summary Star Ratings are also determined for each \n",
            "contract. \n",
            "The 2024 measures used in the 2025 CAI adjustment calculations are: \n",
            "• Breast Cancer Screening (Part C) \n",
            "• Colorectal Cancer Screening (Part C) \n",
            "• Annual Flu Vaccine (Part C) \n",
            "• Monitoring Physical Activity (Part C) \n",
            "• Osteoporosis Management in Women who had a Fracture (Part C) \n",
            "• Diabetes Care – Eye Exam (Part C) \n",
            "• Diabetes Care – Blood Sugar Controlled (Part C) \n",
            "• Controlling Blood Pressure (Part C) \n",
            "• Reducing the Risk of Falling (Part C) \n",
            "• Improving Bladder Control (Part C) \n",
            "• Medication Reconciliation Post-Discharge (Part C) \n",
            "• Plan All-Cause Readmissions (Part C) \n",
            "• Statin Therapy for Patients with Cardiovascular Disease (Part C) \n",
            "• Transitions of Care (Part C) \n",
            "• Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions \n",
            "(Part C) \n",
            "• Medication Adherence for Diabetes Medication (Part D) \n",
            "• Medication Adherence for Hypertension (RAS antagonists) (Part D) \n",
            "• Medication Adherence for Cholesterol (Statins) (Part D) \n",
            "• MTM Program Completion Rate for CMR (Part D) \n",
            "• Statin Use in Patients with Diabetes (SUPD) (Part D) \n",
            "To determine the value of the CAI, contracts are first divided into an initial set of categories based on the \n",
            "combination of a contract’s LIS/DE and disability percentages. For the adjustment for the overall and summary \n",
            "ratings for MA-Only and MA-PD contracts, the initial groups are formed by the ten groups of LIS/DE and \n",
            "quintiles of disability, thus resulting in 50 initial categories. For PDPs, the initial groups are formed using quartiles \n",
            "for both LIS/DE and disability. The mean differences between the Adjusted Overall or Summary Star Rating and \n",
            "the corresponding Unadjusted Star Rating for contracts in each initial category are determined and examined. \n",
            "The initial categories are collapsed to form final adjustment groups. The CAI values are the mean differences \n",
            "between the Adjusted Overall or Summary Star Rating and the corresponding Unadjusted Star Rating for \n",
            "contracts within each final adjustment group. Separate CAI values are computed for the overall and summary \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is (CAI)? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 28 \n",
            " \n",
            "Framework and Definitions for the Domain and Measure Details Section \n",
            "This page contains the formatting framework and definition of each sub-section that is used to describe the \n",
            "domain and measure details on the following pages. \n",
            "Domain: The name of the domain to which the measures following this heading belong \n",
            "Measure: The measure ID and common name of the ratings measure \n",
            "Title \n",
            "Description \n",
            "Label for Stars: The label that appears with the stars for this measure on Medicare.gov. \n",
            "Label for Data: The label that appears with the numeric data for this measure on HPMS and \n",
            "CMS.gov. \n",
            "Description: The English language description shown for the measure on Medicare.gov. The text \n",
            "in this sub-section has been prepared to aid beneficiaries’ understanding of the \n",
            "nature and the purpose of the measure. We strongly encourage any public-facing \n",
            "explanation of the measure to use this description. \n",
            " \n",
            "HEDIS Label: Optional – contains the full NCQA HEDIS measure name. \n",
            "Measure Reference: Optional – this sub-section contains the location of the detailed measure specification \n",
            "in the NCQA documentation for all HEDIS and HEDIS-HOS measures. \n",
            "Metric: Defines how the measure is calculated. \n",
            "Primary Data Source: The primary source of the data used in the measure. \n",
            "Data Source Description: Optional – contains information about additional data sources needed for calculating \n",
            "the measure. \n",
            "Data Source Category: The category of this data source. \n",
            "Exclusions: Optional – lists any exclusions applied to the data used for the measure. \n",
            "General Notes: Optional – contains additional information about the measure and the data used. \n",
            "Data Time Frame: The time frame of data used from the data source. In some HEDIS measures this \n",
            "date range may appear to conflict with the specific data time frame defined in the \n",
            "NCQA Technical Specifications. In those cases, the data used by CMS are \n",
            "unchanged from what was submitted to NCQA. CMS uses the data time frame of the \n",
            "overall HEDIS submission which is the HEDIS measurement year. \n",
            "General Trend: Indicates whether high values are better or low values are better for the measure. \n",
            "Statistical Method: The methodology used for assigning stars in this measure; see the section entitled \n",
            "“Methodology for Assigning Part C and Part D Measure Star Ratings” for an \n",
            "explanation of each of the possible entries in this sub-section. \n",
            "Improvement Measure: Indicates whether this measure is included in the improvement measure. \n",
            "CAI Usage: Indicates if the measure is used in the Categorical Adjustment Index calculation. \n",
            "Case-Mix Adjusted: Indicates if the data are case mix adjusted prior to being used for the Star Ratings. \n",
            "\n"
          ]
        }
      ],
      "source": [
        "# top 5 retrieved text for question 1\n",
        "top_3_indices1 = descending_indices1[:5]\n",
        "print(\"top_3_indices: \", top_3_indices1)\n",
        "for index in top_3_indices1:\n",
        "  print(\"With stopwords embedding retrieved abstract : \",Question1[0],'\\n',Df1[index], '\\n')\n",
        "\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# top 5 retrieved text for question 2\n",
        "top_3_indices2 = descending_indices2[:5]\n",
        "print(\"top_3_indices: \", top_3_indices2)\n",
        "for index in top_3_indices2:\n",
        "  print(\"With stopwords embedding retrieved abstract : \",Question2[0],'\\n',Df1[index], '\\n')\n"
      ],
      "metadata": {
        "id": "hHYvCIY2gb9B",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "fec8fd47-683d-423c-abd7-91e2cad5d45a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "top_3_indices:  [ 37 121  36 108 150]\n",
            "With stopwords embedding retrieved abstract :  What is BCS, describe what BCS stand for? or What measure it is? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 30 \n",
            " \n",
            "Part C Domain and Measure Details \n",
            "See Attachment C for the national averages of individual Part C measures. \n",
            "Domain: 1 - Staying Healthy: Screenings, Tests and Vaccines \n",
            "Measure: C01 - Breast Cancer Screening \n",
            "Title \n",
            "Description \n",
            "Label for Stars: Breast Cancer Screening \n",
            "Label for Data: Breast Cancer Screening \n",
            "Description: Percent of female plan members aged 52-74 who had a mammogram during the past \n",
            "two years. \n",
            "HEDIS Label: Breast Cancer Screening (BCS) \n",
            "Measure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 606 \n",
            "Metric: The percentage of women MA enrollees 50 to 74 years of age (denominator) as of \n",
            "December 31 of the measurement year who had a mammogram to screen for breast \n",
            "cancer in the past two years (numerator). \n",
            "Primary Data Source: HEDIS \n",
            "Data Source Category: Health and Drug Plans \n",
            "Exclusions: • Members in hospice or using hospice services any time during the measurement \n",
            "period. \n",
            "• Members receiving palliative care any time during the measurement period. \n",
            "• Medicare members 66 years of age and older as of December 31 of the measurement \n",
            "year who meet either of the following: \n",
            "– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \n",
            "– Living long-term in an institution any time during the measurement year as identified \n",
            "by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \n",
            "to determine if a member had an LTI flag during the measurement year. \n",
            "• Members 66 years of age and older as of December 31 of the measurement year with \n",
            "frailty and advanced illness during the measurement year. Members must meet BOTH \n",
            "of the following frailty and advanced illness criteria to be excluded: \n",
            "– At least two indications of frailty with different dates of service during the \n",
            "measurement period. \n",
            "– At least two outpatient visits, observation visits, ED visits, telephone visits, e-visits or \n",
            "virtual check-ins, or nonacute inpatient encounters or nonacute inpatient discharges on \n",
            "different dates of service, with an advanced illness diagnosis. Visit type need not be the \n",
            "same for the two visits.  \n",
            "• Members receiving palliative care during the measurement year \n",
            "• Members who had a bilateral mastectomy or both right and left unilateral \n",
            "mastectomies any time during the member’s history through December 31 of the \n",
            "measurement year. Any of the following meet criteria for bilateral mastectomy: \n",
            "– Bilateral mastectomy.  \n",
            "– Unilateral mastectomy with a bilateral modifier (same procedure). \n",
            "– Two unilateral mastectomies found in clinical data with a bilateral modifier (same \n",
            "procedure). \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is BCS, describe what BCS stand for? or What measure it is? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 114 \n",
            " \n",
            "Attachment B: Calculating Measure Data for the Surviving Contract of a Consolidation \n",
            "First Year Following a Consolidation \n",
            "In the first year following a consolidation, the measure values for the surviving contract of a consolidation are \n",
            "calculated as the enrollment-weighted mean of all contracts in the consolidation. The month(s) of enrollment \n",
            "used to calculate the enrollment weighted means varies by the type of measure. Table B-1 below lists the \n",
            "enrollment used for each type of measure and the rule followed to determine the month(s) of enrollment. Table \n",
            "B-2 provides an example calculation. \n",
            "Table B-1: Enrollment Month Used in Calculating Measure Scores for the Surviving Contract of a Consolidation \n",
            "Type of Measure Rule for Which Month of Enrollment is Used Month(s) of Enrollment Used for 2025 Star Ratings \n",
            "CAHPS \n",
            "Enrollment at the time survey sample is pulled \n",
            "January 2024 \n",
            "Call Center \n",
            "Average enrollment during the study period \n",
            "Feb 2024 – May 2024 \n",
            "HOS \n",
            "Enrollment at the time survey sample is pulled \n",
            "April 2023 \n",
            "HEDIS-HOS \n",
            "Enrollment at the time survey sample is pulled \n",
            "April 2023 \n",
            "HEDIS \n",
            "Enrollment in July of the measurement period \n",
            "July 2023 \n",
            "All Other Measures Enrollment in July of the measurement period \n",
            "July 2023 \n",
            " \n",
            "Table B-2: Example of Calculating the Measure Score for the Surviving Contract of a Consolidation \n",
            "Contract ID Surviving or Consumed Contract Value for Breast Cancer Screening (BCS) Measure July 2023 Enrollment \n",
            "HAAAA \n",
            "Surviving \n",
            "75.13 \n",
            "43,326 \n",
            "HAAAB \n",
            "Consumed \n",
            "50.91 \n",
            "20,933 \n",
            "Value for BCS for HAAAA  =   \n",
            "75.13∗43,326+50.91∗20,933\n",
            "43,326+20,933\n",
            " = 67.240097 \n",
            "Second Year Following a Consolidation \n",
            "In the second year following a consolidation, the measure values for the surviving contract of a consolidation \n",
            "are as reported for CAHPS, call center, HOS, and HEDIS measures. For all other measures, the measure values \n",
            "for the surviving contract of a consolidation are calculated as the enrollment weighted mean of all contracts in \n",
            "the consolidation. \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is BCS, describe what BCS stand for? or What measure it is? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 29 \n",
            " \n",
            "Title \n",
            "Description \n",
            "Weighting Category: The weighting category of this measure. \n",
            "Weighting Value: The numeric weight for this measure in the summary and overall rating calculations. \n",
            "Meaningful Measure Area: Contains the area where this measure fits into the Meaningful Measure Framework. \n",
            "CMIT #: The CMS Measure Inventory Tool (CMIT) is the repository of record for information \n",
            "about the measures which CMS uses to promote healthcare quality and quality \n",
            "improvement. \n",
            "Data Display: The format used to the display the numeric data on Medicare.gov \n",
            "Reporting Requirements: Table indicating which organization types are required to report the measure. “Yes” \n",
            "for organizations required to report; “No” for organizations not required to report. \n",
            "Cut Points: Table containing the cut points used in the measure.  For non-CAHPS measures, \n",
            "excluding new measures and measures with substantive specification changes that \n",
            "have been in the Part C and D Star Ratings for three years or less, the cut points are \n",
            "after the application of Tukey outlier deletion, mean resampling, and guardrails. New \n",
            "measures and measures with substantive specification changes that have been in \n",
            "the Part C and D Star Ratings program for three years or less, and the Health Plan \n",
            "Quality Improvement and Drug Plan Quality Improvement measure cut points are \n",
            "after the application of Tukey outlier deletion and mean resampling. For CAHPS \n",
            "measures, the table contains the base group cut points which are used prior to the \n",
            "final star assignment rules being applied. \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is BCS, describe what BCS stand for? or What measure it is? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 101 \n",
            " \n",
            "Title \n",
            "Description \n",
            "Metric: This measure is defined as the percent of Medication Therapy Management (MTM) \n",
            "program enrollees who received a Comprehensive Medication Review (CMR) during the \n",
            "reporting period.  \n",
            " \n",
            "Numerator = Number of beneficiaries from the denominator who received a CMR at any \n",
            "time during their period of MTM enrollment in the reporting period. \n",
            " \n",
            "Denominator = Number of beneficiaries who were at least 18 years or older as of the \n",
            "beginning of the reporting period and who were enrolled in the MTM program for at least \n",
            "60 days during the reporting period. Only those beneficiaries who meet the contracts’ \n",
            "specified targeting criteria per CMS – Part D requirements pursuant to §423.153(d) of \n",
            "the regulations at any time in the reporting period are included in this measure. \n",
            "Beneficiaries who were in hospice at any point during the reporting period are excluded. \n",
            "Beneficiaries who were enrolled in the contract’s MTM program for less than 60 days at \n",
            "any time in the measurement year are only included in the denominator and the \n",
            "numerator if they received a CMR within this timeframe. Beneficiaries are excluded from \n",
            "the measure calculation if they were enrolled in the contract’s MTM program for less \n",
            "than 60 days and did not receive a CMR within this timeframe. The date of enrollment is \n",
            "counted towards the 60 days but the opt-out date is not. \n",
            " \n",
            "A beneficiary’s MTM eligibility, receipt of CMRs, etc., is determined for each contract \n",
            "he/she was enrolled in during the measurement period. Similarly, a contract’s CMR \n",
            "completion rate is calculated based on each of its eligible MTM enrolled beneficiaries. \n",
            "For example, a beneficiary must meet the inclusion criteria for the contract to be \n",
            "included in the contract’s CMR rate. A beneficiary who is enrolled in two different \n",
            "contracts’ MTM programs for 30 days each is therefore excluded from both contracts’ \n",
            "CMR rates. The beneficiary is only included in the measure calculation for the \n",
            "contract(s) where they were enrolled at least 60 days or received a CMR if enrolled for \n",
            "less than 60 days. Beneficiaries with multiple records that contain varying information \n",
            "for the same contract are excluded from the measure calculation for that contract. \n",
            " \n",
            "Beneficiaries may be enrolled in MTM based on the contracts’ specified targeting criteria \n",
            "per CMS – Part D requirements and/or based on expanded, other plan-specific targeting \n",
            "criteria. Beneficiaries who were initially enrolled in MTM due to other plan-specific \n",
            "(expanded) criteria and then later met the contracts’ specified targeting criteria per CMS \n",
            "– Part D requirements at any time in the reporting period are included in this measure. \n",
            "In these cases, a CMR received after the date of MTM enrollment but before the date \n",
            "the beneficiary met the specified targeting criteria per CMS – Part D requirements are \n",
            "included. \n",
            "Primary Data Source: Part D Plan Reporting \n",
            "Data Source Description: The data for this measure were reported by contracts to CMS per the 2023 Part D \n",
            "Reporting Requirements (data pulled June 2024). Validation of these data was \n",
            "performed retrospectively during the 2024 data validation cycle (deadline June 15, 2024 \n",
            "and data validation results pulled July 2024). Additionally, the Medicare Enrollment \n",
            "Database (EDB) from the Integrated Data Repository (CME IDRC) is used to identify \n",
            "beneficiaries in hospice (data pulled June 2024).  \n",
            " \n",
            "Data Source Category: Health and Drug Plans \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is BCS, describe what BCS stand for? or What measure it is? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 143 \n",
            " \n",
            "Attachment K: Individual Measure Star Assignment Process \n",
            "This attachment provides detailed information about the clustering and the relative distribution and significance \n",
            "testing (CAHPS) methodologies used to assign stars to individual measures. \n",
            "Clustering Methodology Introduction \n",
            "To separate a distribution of scores into distinct groups or categories, a set of values must be identified to \n",
            "separate one group from another group. The set of values that break the distribution of the scores into non-\n",
            "overlapping groups is the set of cut points. \n",
            "For each individual measure, CMS determines the measure cut points using the information provided from the \n",
            "hierarchical clustering algorithm in SAS, described in “Clustering Methodology Detail” below. Conceptually, \n",
            "the clustering algorithm identifies the natural gaps that exist within the distribution of the scores and creates \n",
            "groups (clusters) that are then used to identify the cut points that result in the creation of a pre-specified number \n",
            "of categories. \n",
            "For Star Ratings, the algorithm is run with the goal of determining the four cut points (labeled in the Figure J-1 \n",
            "below as A, B, C, and D) that are used to create the five non-overlapping groups that correspond to each of the \n",
            "Star Ratings (labeled in the diagram below as G1, G2, G3, G4, and G5). For Part D measures, CMS determines \n",
            "MA-PD and PDP cut points separately. Data identified to be biased, erroneous, or excluded by disaster rules are \n",
            "removed from the algorithm. The scores are grouped such that scores within the same Star Rating category are \n",
            "as similar as possible, and scores in different categories are as different as possible.  \n",
            " \n",
            "Figure K-1: Diagram showing gaps in data where cut points are assigned. \n",
            " \n",
            "As mentioned, the cut points are used to create five non-overlapping groups. The value of the lower bound for \n",
            "each group is included in the category, while the value of the upper bound is not included in the category. CMS \n",
            "does not require the same number of observations (contracts) within each group. The groups are identified such \n",
            "that within a group the measure scores must be similar to each other and between groups, the measure scores in \n",
            "one group are not similar to measure scores in another group. The groups are then used for the conversion of the \n",
            "measure scores to one of five Star Ratings categories. For most measures, a higher score is better, and thus, the \n",
            "group with the highest range of measure scores is converted to a rating of five stars. An example of a measure \n",
            "for which higher is better is Medication Adherence for Diabetes Medications. For some measures a lower score \n",
            "is better, and thus, the group with the lowest range of measure scores is converted to a rating of five stars. An \n",
            "example of a measure for which a lower score is better is Members Choosing to Leave the Plan. \n",
            "Example 1 – Clustering Methodology for a Higher is Better measure \n",
            "Consider the information provided for the cut points for Medication Adherence for Diabetes Medications in \n",
            "Table K-1 below. As stated previously, for Part D measures CMS calculates MA-PD and PDP cut points \n",
            "separately (e.g., different cut points are calculated for MA-PD and PDPs). If the MA-PD cut points identified \n",
            "using the clustering algorithm are 80%, 85%, 87%, and 91%; for PDPs, the cut points are 84%, 86%, 88%, and \n",
            "90%. (The set of values corresponds to the cut points in figure J-2 below as A, B, C, and D and the categories \n",
            "for each of the five Star Ratings are indicated above each group.) Since a measure score can only assume a \n",
            "value between 0% and 100% (including 0% and 100%), the one-star and five-star categories contain only a \n",
            "single value in the table below as the upper or lower bound. \n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "t_HgH1itEZl0"
      },
      "outputs": [],
      "source": [
        "# top_3_indices\n",
        "# paragraph = Df1[top_3_indices[0]]\n",
        "# print(paragraph)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "# top 5 retrieved text for question 3\n",
        "top_3_indices3 = descending_indices3[:5]\n",
        "print(\"top_3_indices: \", top_3_indices3)\n",
        "for index in top_3_indices3:\n",
        "  print(\"With stopwords embedding retrieved abstract : \",Question3[0],'\\n',Df1[index], '\\n')\n",
        "\n"
      ],
      "metadata": {
        "id": "dx7Zs2pTgp6-",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "fe465b46-26e5-4529-b4b7-b2f9d5644c15"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "top_3_indices:  [ 55 101 129  93 104]\n",
            "With stopwords embedding retrieved abstract :  CBP calculation? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 48 \n",
            " \n",
            "Measure: C11 - Controlling Blood Pressure \n",
            "Title \n",
            "Description \n",
            "Label for Stars: Controlling Blood Pressure \n",
            "Label for Data: Controlling Blood Pressure \n",
            "Description: Percent of plan members with high blood pressure who got treatment and were able to \n",
            "maintain a healthy pressure. \n",
            "HEDIS Label: Controlling High Blood Pressure (CBP) \n",
            "Measure Reference: NCQA HEDIS MY 2023 Technical Specifications Volume 2, page 152 \n",
            "Metric: The percentage of MA members 18–85 years of age who had a diagnosis of \n",
            "hypertension (HTN) (denominator) and whose blood pressure (BP) was adequately \n",
            "controlled (<140/90 mm Hg) (numerator). \n",
            "Primary Data Source: HEDIS \n",
            "Data Source Category: Health and Drug Plans \n",
            "Exclusions: Exclude members who meet any of the following criteria: \n",
            "• Members 66 years of age and older as of December 31 of the measurement year who \n",
            "meet either of the following: \n",
            "– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \n",
            "– Living long-term in an institution any time during the measurement year as identified \n",
            "by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \n",
            "to determine if a member had an LTI flag during the measurement year. \n",
            "• Members 81 years of age and older as of December 31 of the measurement year with \n",
            "at least two indications of frailty with different dates of service during the measurement \n",
            "year. \n",
            "• Members 66–80 years of age and older as of December 31 of the measurement year \n",
            "with frailty and advanced illness. Members must meet both of the following frailty and \n",
            "advanced illness criteria to be excluded: \n",
            "• \n",
            "At least two indications of frailty with different dates of service during the \n",
            "measurement year.  \n",
            "• \n",
            "Any of the following during the measurement year or the year prior to the \n",
            "measurement year (count services that occur over both years): \n",
            "• \n",
            "At least two outpatient visits, observation visits, ED visits, \n",
            "telephone visits, e-visits or virtual check-ins, nonacute inpatient \n",
            "encounters, or nonacute inpatient discharges on different dates \n",
            "of service, with an advanced illness diagnosis.  \n",
            "• \n",
            "At least one acute inpatient encounter with an advanced illness \n",
            "diagnosis. \n",
            "• \n",
            "At least one acute inpatient discharge with an advanced illness \n",
            "diagnosis on the discharge claim.  \n",
            "• \n",
            "A dispensed dementia medication. \n",
            "  \n",
            "• (Required) Exclude members who meet any of the following criteria: \n",
            " \n",
            "– • Members with evidence of end-stage renal \n",
            "\n",
            "With stopwords embedding retrieved abstract :  CBP calculation? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 94 \n",
            " \n",
            "Title \n",
            "Description \n",
            "reenrolled for a three-month episode, and meets the measure criteria during each \n",
            "enrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + \n",
            "3/12 = 6/12).  \n",
            " \n",
            "The PDC calculation is adjusted for overlapping prescriptions for the same drug which is \n",
            "defined by the active ingredient at the generic name level using the NDC list maintained \n",
            "by PQA. The calculation also adjusts for Part D beneficiaries’ stays in IP settings, and \n",
            "stays in SNFs. The discharge date is included as an adjustment for IP/SNF stays. \n",
            "Please see Attachment L: Medication Adherence Measure Calculations for more \n",
            "information about these calculation adjustments. \n",
            " \n",
            "When available, beneficiary death date from the CME is the end date of a beneficiary’s \n",
            "measurement period. \n",
            "Data Time Frame: 01/01/2023 – 12/31/2023 \n",
            "General Trend: Higher is better \n",
            "Statistical Method: Clustering \n",
            "Improvement Measure: Included \n",
            "CAI Usage: Included \n",
            "Case-Mix Adjusted: No \n",
            "Weighting Category: Intermediate Outcome Measure \n",
            "Weighting Value: 3 \n",
            "Major Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \n",
            "2023 disasters. \n",
            "Meaningful Measure Area: Chronic Conditions \n",
            "CMIT #: 00436-01-C-PARTD \n",
            "Data Display: Percentage with no decimal place \n",
            "Reporting Requirements: \n",
            "1876 Cost \n",
            "CCP w/o SNP \n",
            "CCP with SNP \n",
            "CCP with Only I-SNP \n",
            "MSA \n",
            "PDP \n",
            "PFFS \n",
            "Yes \n",
            "Yes \n",
            "Yes \n",
            "Yes \n",
            "No \n",
            "Yes \n",
            "Yes \n",
            "Cut Points: Type \n",
            "1 Star \n",
            "2 Stars \n",
            "3 Stars \n",
            "4 Stars \n",
            "5 Stars \n",
            "MA-PD \n",
            "< 80 % \n",
            ">= 80 % to < 85 % \n",
            ">= 85 % to < 87 % \n",
            ">= 87 % to < 91 % \n",
            ">= 91 % \n",
            "PDP \n",
            "< 85 % \n",
            ">= 85 % to < 87 % \n",
            ">= 87 % to < 89 % \n",
            ">= 89 % to < 93 % \n",
            ">= 93 % \n",
            "\n",
            "With stopwords embedding retrieved abstract :  CBP calculation? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 122 \n",
            " \n",
            "Attachment F: Calculating Measure C15: Plan All-Cause Readmissions \n",
            "All data are available in the CMS MY 2023 HEDIS® Public Use File (PUF)1 and can be looked up by \n",
            "IndicatorKey (row) and Variable name (column). \n",
            "The calculations below use the Denominator, ObservedCount and ExpectedCount values from the PCR (18-64) \n",
            "indicator (IndicatorKey = 202025_20) and the PCR (65+) indicator (IndicatorKey = 202111_20). \n",
            "For each contract, calculate the (18+) Denominator, ObservedCount, and ExpectedCount: \n",
            " \n",
            "Denominator(18+)  \n",
            "= Denominator(18-64) + Denominator(65+) \n",
            " \n",
            "ObservedCount(18+)  = ObservedCount(18-64) + ObservedCount(65+) \n",
            " \n",
            "ExpectedCount(18+)  = ExpectedCount(18-64) + ExpectedCount(65+) \n",
            " \n",
            "Using these (18+) values, calculate the (18+) Observed-over-Expected ratio (OE): \n",
            "OE(18+) = ቀ\n",
            "ObservedCount(18+)\n",
            "ExpectedCount(18+)ቁ \n",
            "And the national average of the (18+) Observed Rate: \n",
            "NatAvgObs(18+) = Average ቆ൬\n",
            "ObservedCount(18+)1\n",
            "Denominator(18+)1 ൰ + … + ൬\n",
            "ObservedCount(18+)n\n",
            "Denominator(18+)n ൰ቇ \n",
            "Where 1 through n are all contracts with a (18+) Denominator larger than or equal to 150, and a (18+) OE larger \n",
            "than or equal to 0.2 and less than or equal to 5.0. \n",
            "For each contract, calculate the Final Rate and convert to percentages: \n",
            "Final Rate(18+) = OE(18+) x NatAvgObs(18+) x 100  \n",
            "And round to the nearest integer. \n",
            "Example: Calculating the final rate for Contract 1 \n",
            "Contract IndicatorKey Denominator ObservedCount ExpectedCount \n",
            "Contract 1 \n",
            "202025_20 \n",
            "214 \n",
            "8 \n",
            "12 \n",
            "Contract 1 \n",
            "202111_20 \n",
            "4,792 \n",
            "641 \n",
            "642 \n",
            "Contract 2 \n",
            "202025_20 \n",
            "225 \n",
            "12 \n",
            "7 \n",
            "Contract 2 \n",
            "202111_20 \n",
            "4,761 \n",
            "688 \n",
            "668 \n",
            "Contract 3 \n",
            "202025_20 \n",
            "573 \n",
            "31 \n",
            "35 \n",
            "Contract 3 \n",
            "202111_20 \n",
            "8,629 \n",
            "1,126 \n",
            "1,070 \n",
            "Contract 4 \n",
            "202025_20 \n",
            "12 \n",
            "0 \n",
            "1 \n",
            "Contract 4 \n",
            "202111_20 \n",
            "533 \n",
            "79 \n",
            "73 \n",
            "NatAvgObs = Average ቆቀ\n",
            "8+641 \n",
            "214+4,792ቁ + ቀ\n",
            "12+688\n",
            "225+4,761ቁ + ቀ\n",
            "31+1,126\n",
            "573+8,629ቁ + ቀ\n",
            "0+79\n",
            "12+533ቁቇ \n",
            "NatAvgObs = 0.135181 \n",
            "OE Contract 1 = ቀ\n",
            "8+641\n",
            "12+642ቁ = 0.992355 \n",
            "Final Rate Contract 1 = 0.992355 ×  0.135181 x 100 =  13.41 \n",
            "Final Rate reported for Contract 1 = 13% \n",
            " \n",
            "The actual calculated National Observed Rate used in the 2025 Star Ratings was 0.110821345940212. \n",
            " \n",
            "1 https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-\n",
            "Reports/MCRAdvPartDEnrolData/MA-HEDIS-Public-Use-Files \n",
            "\n",
            "With stopwords embedding retrieved abstract :  CBP calculation? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 86 \n",
            " \n",
            "Title \n",
            "Description \n",
            "Exclusions: Contracts must have data in at least half of the measures used to calculate \n",
            "improvement to be rated in this measure. \n",
            "General Notes: Attachment I contains the formulas used to calculate the improvement measure and lists \n",
            "indicating which measures were used. \n",
            "Data Time Frame: Not Applicable \n",
            "General Trend: Higher is better \n",
            "Statistical Method: Clustering \n",
            "Improvement Measure: Not Included \n",
            "CAI Usage: Not Included \n",
            "Case-Mix Adjusted: No \n",
            "Weighting Category: Improvement Measure \n",
            "Weighting Value: 5 \n",
            "Major Disaster: Includes only measures which have data from both years. \n",
            "Meaningful Measure Area: Person-Centered Care \n",
            "CMIT #: 00224-01-C-PARTD \n",
            "Data Display: Not Applicable \n",
            "Reporting Requirements: \n",
            "1876 Cost \n",
            "CCP w/o SNP \n",
            "CCP with SNP \n",
            "CCP with Only I-SNP \n",
            "MSA \n",
            "PDP \n",
            "PFFS \n",
            "Yes \n",
            "Yes \n",
            "Yes \n",
            "Yes \n",
            "No \n",
            "Yes \n",
            "Yes \n",
            "Cut Points: Type \n",
            "1 Star \n",
            "2 Stars \n",
            "3 Stars \n",
            "4 Stars \n",
            "5 Stars \n",
            "MA-PD \n",
            "< -0.218869 \n",
            ">= -0.218869 to < 0 \n",
            ">= 0 to < 0.242468 \n",
            ">= 0.242468 to < \n",
            "0.496603 \n",
            ">= 0.496603 \n",
            "PDP \n",
            "< -0.282500 \n",
            ">= -0.282500 to < 0 \n",
            ">= 0 to < 0.273334 \n",
            ">= 0.273334 to < \n",
            "0.576667 \n",
            ">= 0.576667 \n",
            "\n",
            "With stopwords embedding retrieved abstract :  CBP calculation? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 97 \n",
            " \n",
            "Title \n",
            "Description \n",
            "Please see Attachment L: Medication Adherence Measure Calculations for more \n",
            "information about these calculation adjustments. \n",
            " \n",
            "When available, beneficiary death date from the CME is the end date of a beneficiary’s \n",
            "measurement period. \n",
            "Data Time Frame: 01/01/2023 – 12/31/2023 \n",
            "General Trend: Higher is better \n",
            "Statistical Method: Clustering \n",
            "Improvement Measure: Included \n",
            "CAI Usage: Included \n",
            "Case-Mix Adjusted: No \n",
            "Weighting Category: Intermediate Outcome Measure \n",
            "Weighting Value: 3 \n",
            "Major Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \n",
            "2023 disasters. \n",
            "Meaningful Measure Area: Chronic Conditions \n",
            "CMIT #: 00437-01-C-PARTD \n",
            "Data Display: Percentage with no decimal place \n",
            "Reporting Requirements: \n",
            "1876 Cost \n",
            "CCP w/o SNP \n",
            "CCP with SNP \n",
            "CCP with Only I-SNP \n",
            "MSA \n",
            "PDP \n",
            "PFFS \n",
            "Yes \n",
            "Yes \n",
            "Yes \n",
            "Yes \n",
            "No \n",
            "Yes \n",
            "Yes \n",
            "Cut Points: Type \n",
            "1 Star \n",
            "2 Stars \n",
            "3 Stars \n",
            "4 Stars \n",
            "5 Stars \n",
            "MA-PD \n",
            "< 83 % \n",
            ">= 83 % to < 87 % \n",
            ">= 87 % to < 90 % \n",
            ">= 90 % to < 92 % \n",
            ">= 92 % \n",
            "PDP \n",
            "< 87 % \n",
            ">= 87 % to < 89 % \n",
            ">= 89 % to < 90 % \n",
            ">= 90 % to < 92 % \n",
            ">= 92 % \n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# top 5 retrieved text for question 4\n",
        "top_3_indices4 = descending_indices4[:5]\n",
        "print(\"top_3_indices: \", top_3_indices4)\n",
        "for index in top_3_indices4:\n",
        "  print(\"With stopwords embedding retrieved abstract : \",Question4[0],'\\n',Df1[index], '\\n')\n"
      ],
      "metadata": {
        "id": "VOAGyro4gwdd",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "caae2b5c-eb89-46a0-bc6d-af75d1821308"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "top_3_indices:  [133   9 135  15 134]\n",
            "With stopwords embedding retrieved abstract :  What changed in 2025 compared to 2024? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 126 \n",
            " \n",
            "Attachment I: Calculating the Improvement Measure and the Measures Used \n",
            "Calculating the Improvement Measure \n",
            "Contracts must have data for at least half of the attainment measures used to calculate the Part C or Part D \n",
            "improvement measure to be eligible to receive a rating in that improvement measure. \n",
            "The improvement change score was determined for each measure for which a contract was eligible by \n",
            "calculating the difference in measure scores between Star Rating years 2024 and 2025.  \n",
            "For measures where a higher score is better: \n",
            "Improvement Change Score = Score in 2025 - Score in 2024 \n",
            "For measures where a lower score is better: \n",
            "Improvement Change Score = Score in 2024 - Score in 2025 \n",
            "An eligible measure was defined as a measure for which a contract was scored in both the 2024 and 2025 Star \n",
            "Ratings, and there were no significant measure specification changes or a regional contract reconfiguration for \n",
            "which only contract data is available from the original contract in one or both years. \n",
            "For each measure, significant improvement or decline between Star Ratings years 2024 and 2025 was \n",
            "determined by a two-sided t-test at the 0.05 significance level: \n",
            "If \n",
            "Improvement Change Score\n",
            "Standard Error of Improvement Change Score  > 1.96, then YES = significant improvement \n",
            "If \n",
            "Improvement Change Score\n",
            "Standard Error of Improvement Change Score  < -1.96, then YES = significant decline \n",
            "Hold Harmless Provision for Individual Measures: If a contract demonstrated statistically significant decline (at \n",
            "the 0.05 significance level) on an attainment measure for which they received five stars during both the current \n",
            "contract year and the prior contract year, then this measure will be counted as showing no significant change. \n",
            "Measures that are held harmless as described here will be considered eligible for the improvement measure. \n",
            "Net improvement is calculated for each class of measures (e.g., outcome, access, and process) by subtracting the \n",
            "number of significantly declined measures from the number of significantly improved measures. \n",
            "Net Improvement = Number of significantly improved measures - Number of significantly declined measures \n",
            "The improvement measure score is calculated for Parts C and D separately by taking a weighted sum of net \n",
            "improvement divided by the weighted sum of the number of eligible measures. \n",
            "Measures are generally weighted as follows: \n",
            "Outcome or intermediate outcome measure: Weight of 3 \n",
            "Access or patient experience/complaints measure: Weight of 4 \n",
            "Process measure: Weight of 1 \n",
            "Specific weights for each measure, which may deviate from the general scheme above are described in \n",
            "Attachment G. When the weight of an individual measure changes over the two years of data used, the newer \n",
            "weight value is used in the improvement calculation. \n",
            "Improvement Measure Score = Net_Imp_Process + 3 * Net_Imp_Outcome + 4 * Net_Imp_PtExp\n",
            "Elig_Process  + 3 * Elig_Outcome + 4 * Elig_PtExp \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What changed in 2025 compared to 2024? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 2 \n",
            " \n",
            "about the 2025 Star Ratings. A table with the complete history of measures used in the Star Ratings can be \n",
            "found in Attachment J. \n",
            " Changes \n",
            "a. The weight of the Part C Plan All-Cause Readmissions measure was increased to 3.   \n",
            "b. Since the Medicare Plan Finder measure is no longer treated as a new measure, guardrails are now \n",
            "applied after mean resampling \n",
            " Transitioned measures (Moved to the display page on the CMS website: \n",
            "http://go.cms.gov/partcanddstarratings) \n",
            " None \n",
            " Retired measures \n",
            " None \n",
            "Health/Drug Organization Types Included in the Star Ratings \n",
            "All health and drug plan quality and performance measure data described in this document are reported at the \n",
            "contract/sponsor level. Table 1 lists the contract year 2025 organization types and whether they are included in \n",
            "the Part C and/or Part D Star Ratings. \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What changed in 2025 compared to 2024? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 128 \n",
            " \n",
            "Improvement change score standard error for measure C03 for contract A = sqrt (2.8052 + 3.0002 – 2 * 0.901 * \n",
            "2.805 * 3.000) = 1.305 \n",
            "Standard Error Formulas (SEF) for Specific Measures \n",
            "The following formulas are used for calculating the contract-specific standard errors for specific measures in the \n",
            "2025 Star Ratings. These standard errors are used in calculating the improvement change score standard error. \n",
            "1. SEF for Measures: C01, C02, C04, C05, C08 – C14, C16, C18, C26, C28 – C30, D01, D03, D08 – D12 \n",
            "SEy= ඨ\n",
            "Scorey*(100-Scorey)\n",
            "Denominatory\n",
            " \n",
            "for y = 2024, 2025 \n",
            "Denominatory is as defined in the Measure Details section for each measure. \n",
            "2. SEF for Measures: C06, C07 \n",
            "These measures are rolled up from the plan level to the contract level following the formula outlined in \n",
            "Attachment E: NCQA HEDIS Measures. The standard error at the contract level is calculated as shown below.  \n",
            "The specifications are written for two PBP submissions, which we distinguish as 1 and 2, but the methodology \n",
            "easily extends to any number of submissions. \n",
            "The plan level standard error is calculated as: \n",
            "SEyj= ඨ\n",
            "Scoreyj*(100-Scoreyj)\n",
            "Denominatoryj\n",
            " \n",
            "for y = 2024, 2025 and j = Plan 1, Plan 2 \n",
            "The contract level standard error is then calculated as: \n",
            "Let Wy1 = The weight assigned to the first PBP results (estimated, auditable) for year y, where y = 2024, 2025. \n",
            "This result is estimated by the formula Wy1 = Ny1 / (N y1 + Ny2) \n",
            "Let Wy2 = The weight assigned to the second PBP results (estimated, auditable) for year y, where y = 2024, \n",
            "2025. This result is estimated by the formula  \n",
            "Wy2 = Ny2 / (Ny1+ Ny2) \n",
            "SEyi= ට(Wy1)2*(SEy1)2+(Wy2)2*(SEy2)2   \n",
            "for y = Contract Year 2024, Contract Year 2025 and i = Contract i \n",
            "3. SEF for Measure C15 \n",
            "SEy = 100 ∗National Observed Ratey ∗ඨ\n",
            "Oberved County\n",
            "Expected County2  \n",
            "for y = 2024, 2025 \n",
            "National Observed Rate, Observed Count, and Expected Count as defined in Attachment F. \n",
            "4. SEF for Measure C17 \n",
            "Let T1y, T2y, T3y, and T4y be the four Transitions of Care component measures.  \n",
            "Let Zy be the Transitions of Care measure, which is calculated as an average of the four component measures. \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What changed in 2025 compared to 2024? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 8 \n",
            " \n",
            "• HEDIS adjustments: \n",
            "o All contracts were required to report HEDIS MY 2023 unless the contract requested and CMS \n",
            "approved an exemption. Contracts were able to work with NCQA to adjust samples if necessary. \n",
            "o Contracts with 25% or more affected members received the higher of the 2024 or 2025 Star \n",
            "Rating (and corresponding measure scores) for each HEDIS measure. \n",
            "o In some cases, contracts with at least 25% of enrollees residing in FEMA-designated Individual \n",
            "Assistance areas affected by disasters that began in 2023 were also affected by disasters in 2022. \n",
            "These doubly-affected contracts receive the higher of the 2025 Star Rating or what the 2024 Star \n",
            "Rating would have been in the absence of any adjustments that took into account the effects of \n",
            "the 2022 disaster for each measure (we use the corresponding measure score for the Star Ratings \n",
            "year selected). \n",
            "• Part C and D Call Center: \n",
            "o For all contracts, no adjustments were made. \n",
            " New measures: \n",
            "o Contracts with 25% or more affected members have a hold harmless provision applied which \n",
            "compares the result of a contract’s overall rating “with” and “without” including any new \n",
            "measure(s) and/or respecified measure(s). If the “with” result is lower than the “without” result, \n",
            "then we use the “without” result as the final highest level rating.  Please note that there are no \n",
            "new or respecified measures for the 2025 Star Ratings. \n",
            "o A similar hold harmless provision is applied for the Part C and D summary ratings. If a contract \n",
            "has 25% or more affected members, the Part C and D summary ratings are calculated “with” and \n",
            "“without” any new measure(s) and/or respecified measure(s), and if the “with” result is lower \n",
            "than the “without” result, then we use the “without” result for the final summary ratings. Please \n",
            "note that there are no new or respecified measures for the 2025 Star Ratings. \n",
            "• All other measures: \n",
            "o Contracts with 25% or more affected members receive the higher of the 2024 or 2025 measure \n",
            "stars (and corresponding measure scores). \n",
            "o In some cases, contracts with at least 25% of enrollees residing in FEMA-designated Individual \n",
            "Assistance areas affected by disasters that began in 2023 were also affected by disasters in 2022. \n",
            "These doubly-affected contracts receive the higher of the 2025 Star Rating or what the 2024 Star \n",
            "Rating would have been in the absence of any adjustments that took into account the effects of \n",
            "the 2022 disaster for each measure (we use the corresponding measure score for the Star Ratings \n",
            "year selected). \n",
            "• All adjustments: \n",
            "o For all adjustments, if the Star Rating is the same in both years, the Star Rating and the measure \n",
            "score from the most recent year are used. \n",
            "• Improvement measures: \n",
            "o For affected contracts that reverted back to the data underlying the previous year’s Star Rating \n",
            "for a particular measure for either 2024 or 2025 Star Ratings, that measure is excluded from both \n",
            "the count of measures (used to determine whether the contract has at least half of the measures \n",
            "needed to calculate the relevant improvement measure) and the improvement measures’ \n",
            "calculation. Affected contracts do not have the option of reverting to the prior year’s \n",
            "improvement rating. \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What changed in 2025 compared to 2024? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 127 \n",
            " \n",
            " \n",
            "Net_Imp_Process = Net improvement for process measures \n",
            "Net_Imp_Outcome = Net improvement for outcome and intermediate outcome measures \n",
            "Net_Imp_PtExp = Net improvement for patient experience/complaints and access measures \n",
            "Elig_Process = Number of eligible process measures \n",
            "Elig_Outcome = Number of eligible outcome and intermediate outcome measures \n",
            "Elig_PtExp = Number of eligible patient experience/complaints and access measures \n",
            " \n",
            "The improvement measure score is converted into a Star Rating using the clustering method. Conceptually, the \n",
            "clustering algorithm identifies the “gaps” in the data and creates cut points that result in the creation of five \n",
            "categories (one for each Star Rating) such that scores of contracts in the same score category (Star Rating) are \n",
            "as similar as possible, and scores of contracts in different categories are as different as possible. Improvement \n",
            "scores of 0 (equivalent to no net change on the attainment measures included in the improvement measure \n",
            "calculation) will be centered at 3 stars when assigning the improvement measure Star Rating. Then, the \n",
            "remaining contracts are split into two groups and clustered:  1) improvement scores less than zero receive one or \n",
            "two stars on the improvement measure and 2) improvement scores greater than or equal to zero receive 3, 4, or \n",
            "5 stars. \n",
            "General Standard Error Formula \n",
            "Because a contract’s score on a given measure in one year is not independent of its score in the next year, the \n",
            "standard error for the improvement change score for each measure is calculated using the standard approach for \n",
            "estimating the variance of the difference between two variables that may not be independent. In particular, the \n",
            "standard error of the improvement change score is calculated using the formula: \n",
            "ඥ𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2)2 + 𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1)2 −2 ∗𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) \n",
            "Using measure C01 as an example, the change score standard error is: \n",
            "𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2) Represents the 2025 standard error for contract i on measure C01 \n",
            "𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1) Represents the 2024 standard error for contract i on measure C01 \n",
            "𝑌𝑌𝑖𝑖2 \n",
            "Represents the 2025 rate for contract i on measure C01 \n",
            "𝑌𝑌𝑖𝑖1 \n",
            "Represents the 2024 rate for contract i on measure C01 \n",
            "𝑐𝑐𝑐𝑐𝑐𝑐 \n",
            "Represents the covariance between 𝑌𝑌𝑖𝑖2 and 𝑌𝑌𝑖𝑖1computed using the correlation across all contracts \n",
            "observed at both time points (2025 and 2024). In other words: \n",
            "𝑐𝑐𝑐𝑐𝑐𝑐(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) = 𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2) ∗𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1) ∗𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1)  \n",
            "where the correlation 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) is assumed to be the same for all contracts and is computed using data for \n",
            "all contracts for which both years’ measure scores are available and not excluded by the disaster policy. This \n",
            "assumption is needed because only one score is observed for each contract in each year; therefore, it is not \n",
            "possible to compute a contract-specific correlation. \n",
            "Improvement Change Score Standard Error Numerical Example \n",
            "For measure C03, contract A: \n",
            "𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2) = 2.805 \n",
            "𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1) = 3.000 \n",
            "𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) = 0.901 \n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# top 5 retrieved text for question 5\n",
        "top_3_indices5 = descending_indices5[:5]\n",
        "print(\"top_3_indices: \", top_3_indices5)\n",
        "for index in top_3_indices5:\n",
        "  print(\"With stopwords embedding retrieved abstract : \",Question5[0],'\\n',Df1[index], '\\n')"
      ],
      "metadata": {
        "id": "jq5hp-nyg7gd",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "2f13d39a-fbef-44d2-bead-5b21fcca9f5e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "top_3_indices:  [150  16 152 154 153]\n",
            "With stopwords embedding retrieved abstract :  What is clustering? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 143 \n",
            " \n",
            "Attachment K: Individual Measure Star Assignment Process \n",
            "This attachment provides detailed information about the clustering and the relative distribution and significance \n",
            "testing (CAHPS) methodologies used to assign stars to individual measures. \n",
            "Clustering Methodology Introduction \n",
            "To separate a distribution of scores into distinct groups or categories, a set of values must be identified to \n",
            "separate one group from another group. The set of values that break the distribution of the scores into non-\n",
            "overlapping groups is the set of cut points. \n",
            "For each individual measure, CMS determines the measure cut points using the information provided from the \n",
            "hierarchical clustering algorithm in SAS, described in “Clustering Methodology Detail” below. Conceptually, \n",
            "the clustering algorithm identifies the natural gaps that exist within the distribution of the scores and creates \n",
            "groups (clusters) that are then used to identify the cut points that result in the creation of a pre-specified number \n",
            "of categories. \n",
            "For Star Ratings, the algorithm is run with the goal of determining the four cut points (labeled in the Figure J-1 \n",
            "below as A, B, C, and D) that are used to create the five non-overlapping groups that correspond to each of the \n",
            "Star Ratings (labeled in the diagram below as G1, G2, G3, G4, and G5). For Part D measures, CMS determines \n",
            "MA-PD and PDP cut points separately. Data identified to be biased, erroneous, or excluded by disaster rules are \n",
            "removed from the algorithm. The scores are grouped such that scores within the same Star Rating category are \n",
            "as similar as possible, and scores in different categories are as different as possible.  \n",
            " \n",
            "Figure K-1: Diagram showing gaps in data where cut points are assigned. \n",
            " \n",
            "As mentioned, the cut points are used to create five non-overlapping groups. The value of the lower bound for \n",
            "each group is included in the category, while the value of the upper bound is not included in the category. CMS \n",
            "does not require the same number of observations (contracts) within each group. The groups are identified such \n",
            "that within a group the measure scores must be similar to each other and between groups, the measure scores in \n",
            "one group are not similar to measure scores in another group. The groups are then used for the conversion of the \n",
            "measure scores to one of five Star Ratings categories. For most measures, a higher score is better, and thus, the \n",
            "group with the highest range of measure scores is converted to a rating of five stars. An example of a measure \n",
            "for which higher is better is Medication Adherence for Diabetes Medications. For some measures a lower score \n",
            "is better, and thus, the group with the lowest range of measure scores is converted to a rating of five stars. An \n",
            "example of a measure for which a lower score is better is Members Choosing to Leave the Plan. \n",
            "Example 1 – Clustering Methodology for a Higher is Better measure \n",
            "Consider the information provided for the cut points for Medication Adherence for Diabetes Medications in \n",
            "Table K-1 below. As stated previously, for Part D measures CMS calculates MA-PD and PDP cut points \n",
            "separately (e.g., different cut points are calculated for MA-PD and PDPs). If the MA-PD cut points identified \n",
            "using the clustering algorithm are 80%, 85%, 87%, and 91%; for PDPs, the cut points are 84%, 86%, 88%, and \n",
            "90%. (The set of values corresponds to the cut points in figure J-2 below as A, B, C, and D and the categories \n",
            "for each of the five Star Ratings are indicated above each group.) Since a measure score can only assume a \n",
            "value between 0% and 100% (including 0% and 100%), the one-star and five-star categories contain only a \n",
            "single value in the table below as the upper or lower bound. \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is clustering? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 9 \n",
            " \n",
            "• Affected contracts with missing data: \n",
            "o If an affected contract has missing data in either the current or previous year (e.g., because of a \n",
            "data integrity issue, it is too new, or it is too small), the final measure rating comes from the \n",
            "current year. Missing data includes data where there is a data integrity issue. \n",
            "• Reward Factor: \n",
            "o Affected contracts with 60% or more of their enrollees impacted by a 2023 disaster are excluded \n",
            "from the determination of the performance summary and variance thresholds for the Reward \n",
            "Factor.  \n",
            "• Cut points: \n",
            "o Clustering Methodology: For all measures that use the clustering methodology for cut point \n",
            "generation, the measure scores for contracts with 60% or more of their enrollment affected by a \n",
            "disaster are excluded from creating those cut points. \n",
            "Methodology for Assigning Stars to the Part C and Part D Measures \n",
            "CMS assigns stars for each numeric measure score by applying one of two methods: clustering, or relative \n",
            "distribution and significance testing. Each method is described below. Attachment K explains the clustering and \n",
            "relative distribution and significance testing (used for CAHPS measures) methods in greater detail. \n",
            "A. Clustering \n",
            "This method is applied to the majority of the Star Ratings measures, ranging from operational and process-\n",
            "based measures, to HEDIS and other clinical care measures. Using this method, the Star Rating for each \n",
            "measure is determined by applying a clustering algorithm to the measure’s numeric value scores from all \n",
            "contracts. Conceptually, the clustering algorithm identifies the “gaps” among the scores and creates four cut \n",
            "points resulting in the creation of five levels (one for each Star Rating). The scores in the same Star Rating level \n",
            "are as similar as possible; the scores in different Star Rating levels are as different as possible. Star Rating levels \n",
            "1 through 5 are assigned with 1 being the worst and 5 being the best. \n",
            "Technically, the variance in measure scores is separated into within-cluster and between-cluster sum of squares \n",
            "components. The clusters reflect the groupings of numeric value scores that minimize the variance of scores \n",
            "within the clusters. The Star Ratings levels are assigned to the clusters that minimize the within-cluster sum of \n",
            "squares. The cut points for star assignments are derived from the range of measure scores per cluster, and the \n",
            "star levels associated with each cluster are determined by ordering the means of the clusters. \n",
            "Tukey outlier deletion is used to determine the cut points for all non-CAHPS measures. Tukey outlier deletion \n",
            "involves removing Tukey outer fence outlier contract scores, those defined as measure-specific scores outside \n",
            "the bounds of 3.0 times the measure-specific interquartile range subtracted from the 1st quartile or added to the \n",
            "3rd quartile. Outliers are removed prior to applying mean resampling within the hierarchical clustering \n",
            "algorithm. \n",
            "Mean resampling is used to determine the cut points for all non-CAHPS measures.  With mean resampling, \n",
            "measure-specific scores for the current year’s Star Ratings are randomly separated into 10 equal-sized groups.  \n",
            "The hierarchal clustering algorithm is then applied 10 times, each time leaving one of the 10 groups out of the \n",
            "clustered data.  The method results in 10 sets of measure-specific cut points.  The mean for each 1 through 5 \n",
            "star level cut point is taken across the 10 sets for each measure to produce the final cut points. \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is clustering? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 145 \n",
            " \n",
            "Figure J-3: Diagram showing star assignment based on cut points. \n",
            " \n",
            " \n",
            "Clustering Methodology Detail \n",
            "This section details the steps of the clustering method performed in SAS to allow the conversion of the measure \n",
            "scores to measure-level stars. \n",
            "Tukey outlier deletion is used to determine the cut points for all non-CAHPS measures. Tukey outlier deletion \n",
            "involves removing Tukey outer fence outlier contract scores, those defined as measure-specific scores outside \n",
            "the bounds of 3.0 times the measure-specific interquartile range subtracted from the 1st quartile or added to the \n",
            "3rd quartile. Outliers are removed prior to applying mean resampling to the hierarchical clustering algorithm. \n",
            "The 1st and 3rd quartiles can be obtained by using the MEANS procedure in SAS. The Tukey outer fence outlier \n",
            "cutoffs can then be calculated as: \n",
            "• Lower outlier cutoff: first quartile – 3.0*(third quartile – first quartile) \n",
            "• Upper outlier cutoff: third quartile + 3.0*(third quartile – first quartile). \n",
            "Measures with data displays of percentages with no decimal places ranging from 0 to 100 will have the lower \n",
            "and upper outlier cutoffs capped at those values, respectively. Any other measures with range restrictions, such \n",
            "as have a lower bound of zero, will have the respective outlier cutoff capped at the restricted value. \n",
            "Mean resampling is used to determine the cut points for all non-CAHPS measures.  With mean resampling, \n",
            "measure-specific scores for the current year’s Star Ratings are separated into 10 equal-sized groups, using a \n",
            "random assignment process to assign each contract’s measure score to a group.  The random assignment of \n",
            "contracts into 10 groups can be produced using the SURVEYSELECT procedure in SAS as follows: \n",
            "proc surveyselect data=inclusterdat groups=10 seed=8675309 out=inclusterdat_random; \n",
            "run; \n",
            "In the above code, the input dataset, inclusterdat, is the list of contracts without missing, flagged, excluded by \n",
            "disaster rules or voluntary contract scores for a particular measure. The group=10 option identifies that 10 \n",
            "random groupings of the data should be created. The seed=8675309 option specifies the seed value that controls \n",
            "the starting point of the random sequence of numbers and allows for future replication of the randomization \n",
            "process. The output dataset, inclusterdat_random, is identical to the input dataset with the addition of a new \n",
            "column, named groupid, that has the group assignments (from 1 through 10) for each contract.  \n",
            "The hierarchal clustering algorithm (steps 1 through 4 below) is then applied 10 times, each time leaving out \n",
            "one of the 10 groups. For each measure and leave-one-out contract set, the clustering method does the \n",
            "following: \n",
            " Produces the individual measure distance matrix. \n",
            " Groups the measure scores into an initial set of clusters. \n",
            " Selects the set of clusters.  \n",
            "1. Produce the individual measure distance matrix. \n",
            "For each pair of contracts j and k (j>=k) among the n contracts with measure score data, compute the \n",
            "Euclidian distance of their measure scores (e.g., the absolute value of the difference between the two \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is clustering? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 147 \n",
            " \n",
            " \n",
            " \n",
            "id contract_id; \n",
            " \n",
            "run; \n",
            "The input data set, treedat, is created in Step 2 above. The syntax, ncl=NSTARS, denotes the desired final \n",
            "number of clusters (or star levels). For most measures, NSTARS= 5. In cases where multiple clusters have \n",
            "the same score value range those clusters are combined, leading to fewer than 5 clusters. Since the \n",
            "improvement measures have a constraint that contracts with improvement scores of zero or greater are to be \n",
            "assigned at least 3 stars for improvement, the clustering is conducted separately for contract measure scores \n",
            "that are greater than or equal to zero versus those that are less than zero. Specifically, Steps 1-3 are first \n",
            "applied to contracts with improvement scores that meet or exceed zero, in which case NSTARS equals \n",
            "three. The resulting improvement measure stars can take on values of 3, 4, or 5. For those contracts with \n",
            "improvement scores less than zero, Steps 1-3 are applied with NSTARS=2 and these contracts will either \n",
            "receive 1 or 2 stars. \n",
            "4. Final Thresholds \n",
            "The cluster assignments produced by the above approach have cluster labels that are unordered. The final \n",
            "step after applying the above steps to all contract measure scores is to order the cluster labels so that the 5-\n",
            "star category reflects the cluster with the best performance and the 1-star category reflects the cluster with \n",
            "the worst performance. With the exception of the improvement measures which are assigned lower \n",
            "thresholds of zero for the 3-star category, the measure thresholds are defined by examining the range of \n",
            "measure scores within each of the final clusters. The lower limit of each cluster becomes the cut point for \n",
            "the star categories. \n",
            "Determining Stars from Scores and Thresholds  \n",
            "The mean-resampling approach results in 10 sets of measure-specific cut points, one for each of the 10 \n",
            "implementations of the hierarchical clustering algorithm. For higher-is-better measures, the minimum score \n",
            "observed in each star category defines the effective cut points for the star categories. For lower-is-better \n",
            "measures, the maximum score observed in each star category defines the effective cut points for the star \n",
            "categories.  These cut points are calculated after the application of Tukey outlier deletion. The final set of \n",
            "estimated thresholds are then calculated as the mean cut point for each threshold per measure from the 10 \n",
            "different cut point values. Tables K-3 and K-4 show the mean resampling final estimated thresholds for the \n",
            "2025 Star Ratings. Tables K-5 and K-6 show the upper and lower Tukey outlier cutoffs. \n",
            "\n",
            "With stopwords embedding retrieved abstract :  What is clustering? \n",
            " (Last Updated 10/03/2024)  \n",
            "Page 146 \n",
            " \n",
            "measure scores). Enter this distance in row j and column k of a distance matrix with n rows and n columns. \n",
            "This matrix can be produced using the DISTANCE procedure in SAS as follows: \n",
            "proc distance data= inclusterdat_leave1out out=distancedat method=Euclid; \n",
            " \n",
            " \n",
            "var interval(measure_score); \n",
            " \n",
            " \n",
            "id contract_id; \n",
            " \n",
            "run; \n",
            "In the above code, the input data set, inclusterdat_leave1out, is the list of contracts (excluding the group left \n",
            "out) without missing, flagged, excluded by disaster rules or voluntary contract scores for a particular \n",
            "measure. Each record has a unique contract identifier, contract_id. The option method=Euclid specifies that \n",
            "distances between contract measure scores should be based on Euclidean distance. The input data contain a \n",
            "variable called measure_score that is formatted to the display criteria outlined in the Technical Notes. In the \n",
            "var call, the parentheses around measure_score indicate that measure_score is considered to be an interval \n",
            "or numeric variable. The distances computed by this code are stored to an output data set called distancedat. \n",
            "2. Create a tree of cluster assignments. \n",
            "The distance matrix calculated in Step 1 is the input to the clustering procedure. The stored distance \n",
            "algorithm is implemented to compute cluster assignments. The following process is implemented by using \n",
            "the CLUSTER procedure in SAS: \n",
            " The input measure score distances are squared. \n",
            " The clusters are initialized by assigning each contract to its own cluster. \n",
            " In order to determine which pair of clusters to merge, Ward’s minimum variance method is used to \n",
            "separate the variance of the measure scores into within-cluster and between-cluster sum of squares \n",
            "components. \n",
            " From the existing clusters, two clusters are selected for merging to minimize the within-cluster sum of \n",
            "squares over all possible sets of clusters that might result from a merge. \n",
            " Steps 3 and 4 are repeated to reduce the number of clusters by one until a single cluster containing all \n",
            "contracts results. \n",
            "The result is a data set that contains a tree-like structure of cluster assignments, from which any number of \n",
            "clusters between 1 and the number of contract measure scores could be computed. The SAS code for \n",
            "implementing these steps is: \n",
            "proc cluster data=distancedat method=ward outtree=treedat noprint; \n",
            " \n",
            " \n",
            "id contract_id; \n",
            " \n",
            "run; \n",
            "The distancedat data set containing the Euclidian distances was created in Step 1. The option method=ward \n",
            "indicates that Ward’s minimum variance method should be used to group clusters. The output data set is \n",
            "denoted with the outtree option and is called treedat. \n",
            "3. Select the final set of clusters from the tree of cluster assignments. \n",
            "The process outlined in Step 2 will produce a tree of cluster assignments, from which the final number of \n",
            "clusters is selected using the TREE procedure in SAS as follows: \n",
            "proc tree data=treedat ncl=NSTARS horizontal out=outclusterdat noprint; \n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "co5ThWqK6U-p"
      },
      "outputs": [],
      "source": [
        "%%capture\n",
        "!pip install transformers\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "TFZq8Qlx2nId"
      },
      "source": [
        "## Question Answering with bert and roberta\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "7QXBL252o6t3"
      },
      "outputs": [],
      "source": [
        "# %%capture\n",
        "# !pip install pymupdf  # Install the library"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "lNk_ZZ4Go2xS",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "234d0985-3f2f-4871-c862-eff90b18b9fd"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "['Medicare \\n2025 Part C & D \\nStar Ratings \\nTechnical Notes \\n \\nUpdated – 10/03/2024', '(Last Updated 10/03/2024)  \\nPage i \\n \\nDocument Change Log \\nPrevious \\nVersion \\nDescription of Change \\nRevision \\nDate \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nOMB Approved Data Sources \\nThe data collected for the Part C & D Star Ratings come from a variety of different data sources approved under \\nthe following Office of Management and Budget (OMB) Paperwork Reduction Act numbers: \\nData Source \\nOMB Number \\nConsumer Assessment of Healthcare Providers and Systems (CAHPS) Surveys 0938-0732 \\nHealth Outcomes Survey (HOS) \\n0938-0701 \\nHealthcare Effectiveness Data and Information Set (HEDIS) \\n0938-1028 \\nPart C Reporting Requirements \\n0938-1054 \\nPart D Reporting Requirements \\n0938-0992 \\nData Validation of Part C/D Reporting Requirements data \\n0938-1115', '(Last Updated 10/03/2024)  \\nPage ii \\n \\nTable of Contents \\nDOCUMENT CHANGE LOG ................................................................................................................................. I \\nOMB APPROVED DATA SOURCES ................................................................................................................... I \\nINTRODUCTION .................................................................................................................................................. 1 \\nNOTE ON REFERENCES TO THE 2024 STAR RATINGS ................................................................................. 1 \\nDIFFERENCES BETWEEN THE 2024 STAR RATINGS AND 2025 STAR RATINGS ....................................... 1 \\nHEALTH/DRUG ORGANIZATION TYPES INCLUDED IN THE STAR RATINGS .............................................. 2 \\nTable 1: Contract Year 2025 Organization Types Reported in the 2025 Star Ratings ................................................. 3 \\nTHE STAR RATINGS FRAMEWORK ................................................................................................................. 3 \\nFigure 1: The Four Levels of Star Ratings ....................................................................................................................... 4 \\nTable 2: 5-Star Scale .......................................................................................................................................................... 4 \\nTable 3: Relation of 2025 Organization Types to Contract Types and Highest Rating in the 2025 Star Ratings ..... 4 \\nSOURCES OF THE STAR RATINGS MEASURE DATA .................................................................................... 5 \\nFigure 2: The Four Categories of Data Sources .............................................................................................................. 5 \\nIMPROVEMENT MEASURES .............................................................................................................................. 5 \\nTable 4: Minimum Number of Measure Scores Required for an Improvement Measure Rating by Contract Type . 6 \\nCONTRACT ENROLLMENT DATA ..................................................................................................................... 6 \\nHANDLING OF BIASED, ERRONEOUS, AND/OR NOT REPORTABLE (NR) DATA ....................................... 6 \\nDATA HANDLING OF MEASURES FOR CONTRACTS AFFECTED BY A MAJOR DISASTER ..................... 7 \\nMETHODOLOGY FOR ASSIGNING STARS TO THE PART C AND PART D MEASURES ............................. 9 \\nA. Clustering ....................................................................................................................................................................... 9 \\nB. Relative Distribution and Significance Testing (CAHPS) ........................................................................................ 10 \\nMETHODOLOGY FOR CALCULATING STARS AT THE DOMAIN LEVEL .................................................... 10 \\nTable 5: Minimum Number of Rated Measures Required for a Domain Rating by Contract Type ........................... 11 \\nSUMMARY AND OVERALL RATINGS: WEIGHTING OF MEASURES ........................................................... 11 \\nMETHODOLOGY FOR CALCULATING PART C AND PART D SUMMARY RATINGS ................................. 11 \\nTable 6: Minimum Number of Rated Measures Required for Part C and Part D Ratings by Contract Type ........... 12 \\nMETHODOLOGY FOR CALCULATING THE OVERALL MA-PD RATING ...................................................... 12 \\nTable 7: Minimum Number of Rated Measures Required for an Overall Rating by Contract Type ......................... 13 \\nCOMPLETING THE SUMMARY AND OVERALL RATING CALCULATIONS ................................................. 13 \\nAPPLYING THE IMPROVEMENT MEASURE(S) .............................................................................................. 13 \\nAPPLYING THE REWARD FACTOR ................................................................................................................ 14 \\nTable 8: Performance Summary Thresholds ................................................................................................................. 15 \\nTable 9: Variance Thresholds.......................................................................................................................................... 15 \\nCATEGORICAL ADJUSTMENT INDEX (CAI) .................................................................................................. 15 \\nTable 10: Categorization of Contract’s Members into LIS/DE Initial Groups for the Overall Rating ....................... 17 \\nTable 11: Categorization of Contract’s Members into Disability Quintiles for the Overall Rating ........................... 18 \\nTable 12: Final Adjustment Categories and CAI Values for the Overall Rating ......................................................... 18 \\nTable 13: Categorization of Contract’s Members into LIS/DE Initial Groups for the Part C Summary .................... 19 \\nTable 14: Categorization of Contract’s Members into Disability Quintiles for the Part C Summary ....................... 19 \\nTable 15: Final Adjustment Categories and CAI Values for the Part C Summary ..................................................... 20', '(Last Updated 10/03/2024)  \\nPage iii \\n \\nTable 16: Categorization of Contract’s Members into LIS/DE Initial Groups for the MA-PD Part D Summary ....... 20 \\nTable 17: Categorization of Contract’s Members into Disability Quintiles for the MA-PD Part D Summary .......... 21 \\nTable 18: Final Adjustment Categories and CAI Values for the MA-PD Part D Summary ........................................ 21 \\nTable 19: Categorization of Contract’s Members into  Quartiles of LIS/DE for the PDP Part D Summary ............. 21 \\nTable 20: Categorization of Contract’s Members into  Quartiles of Disability for the PDP Part D Summary ......... 22 \\nTable 21: Final Adjustment Categories and CAI Values for the PDP Part D Summary ............................................. 22 \\nCALCULATION PRECISION ............................................................................................................................. 22 \\nROUNDING RULES FOR MEASURE SCORES ............................................................................................... 22 \\nROUNDING RULES FOR SUMMARY AND OVERALL RATINGS ................................................................... 23 \\nTable 22: Rounding Rules for Summary and Overall Ratings ..................................................................................... 23 \\nMETHODOLOGY FOR CALCULATING THE HIGH PERFORMING ICON ...................................................... 23 \\nFigure 3: The High Performing Icon ............................................................................................................................... 24 \\nMETHODOLOGY FOR CALCULATING THE LOW PERFORMING ICON ....................................................... 24 \\nFigure 4: The Low Performing Icon ................................................................................................................................ 24 \\nTable 23: Example LPI Contracts .................................................................................................................................... 24 \\nMERGERS, NOVATIONS, AND CONSOLIDATIONS ....................................................................................... 24 \\nRELIABILITY REQUIREMENT FOR LOW-ENROLLMENT CONTRACTS ...................................................... 25 \\nSPECIAL NEEDS PLAN (SNP) DATA .............................................................................................................. 25 \\nSTAR RATINGS AND MARKETING ................................................................................................................. 26 \\nCONTACT INFORMATION ................................................................................................................................ 26 \\nFRAMEWORK AND DEFINITIONS FOR THE DOMAIN AND MEASURE DETAILS SECTION ...................... 28 \\nPART C DOMAIN AND MEASURE DETAILS ................................................................................................... 30 \\nDomain: 1 - Staying Healthy: Screenings, Tests and Vaccines ................................................................................... 30 \\nMeasure: C01 - Breast Cancer Screening ........................................................................................................................ 30 \\nMeasure: C02 - Colorectal Cancer Screening .................................................................................................................. 32 \\nMeasure: C03 - Annual Flu Vaccine ................................................................................................................................. 34 \\nMeasure: C04 - Monitoring Physical Activity ..................................................................................................................... 35 \\nDomain: 2 - Managing Chronic (Long Term) Conditions ............................................................................................. 37 \\nMeasure: C05 - Special Needs Plan (SNP) Care Management ....................................................................................... 37 \\nMeasure: C06 - Care for Older Adults – Medication Review ............................................................................................ 39 \\nMeasure: C07 - Care for Older Adults – Pain Assessment............................................................................................... 40 \\nMeasure: C08 - Osteoporosis Management in Women who had a Fracture .................................................................... 42 \\nMeasure: C09 - Diabetes Care – Eye Exam ..................................................................................................................... 44 \\nMeasure: C10 - Diabetes Care – Blood Sugar Controlled ................................................................................................ 46 \\nMeasure: C11 - Controlling Blood Pressure ..................................................................................................................... 48 \\nMeasure: C12 - Reducing the Risk of Falling ................................................................................................................... 50 \\nMeasure: C13 - Improving Bladder Control ...................................................................................................................... 51 \\nMeasure: C14 - Medication Reconciliation Post-Discharge .............................................................................................. 53 \\nMeasure: C15 - Plan All-Cause Readmissions ................................................................................................................. 54 \\nMeasure: C16 - Statin Therapy for Patients with Cardiovascular Disease ....................................................................... 56 \\nMeasure: C17 - Transitions of Care .................................................................................................................................. 58 \\nMeasure: C18 - Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions ... 60 \\nDomain: 3 - Member Experience with Health Plan ........................................................................................................ 62 \\nMeasure: C19 - Getting Needed Care .............................................................................................................................. 62 \\nMeasure: C20 - Getting Appointments and Care Quickly ................................................................................................. 63 \\nMeasure: C21 - Customer Service .................................................................................................................................... 64 \\nMeasure: C22 - Rating of Health Care Quality ................................................................................................................. 66 \\nMeasure: C23 - Rating of Health Plan .............................................................................................................................. 67 \\nMeasure: C24 - Care Coordination ................................................................................................................................... 68', \"(Last Updated 10/03/2024)  \\nPage iv \\n \\nDomain: 4 - Member Complaints and Changes in the Health Plan's Performance ................................................... 70 \\nMeasure: C25 - Complaints about the Health Plan ........................................................................................................... 70 \\nMeasure: C26 - Members Choosing to Leave the Plan .................................................................................................... 71 \\nMeasure: C27 - Health Plan Quality Improvement ........................................................................................................... 73 \\nDomain: 5 - Health Plan Customer Service .................................................................................................................... 75 \\nMeasure: C28 - Plan Makes Timely Decisions about Appeals ......................................................................................... 75 \\nMeasure: C29 - Reviewing Appeals Decisions ................................................................................................................. 76 \\nMeasure: C30 - Call Center – Foreign Language Interpreter and TTY Availability .......................................................... 78 \\nPART D DOMAIN AND MEASURE DETAILS ................................................................................................... 80 \\nDomain: 1 - Drug Plan Customer Service ...................................................................................................................... 80 \\nMeasure: D01 - Call Center – Foreign Language Interpreter and TTY Availability .......................................................... 80 \\nDomain: 2 - Member Complaints and Changes in the Drug Plan’s Performance ...................................................... 82 \\nMeasure: D02 - Complaints about the Drug Plan ............................................................................................................. 82 \\nMeasure: D03 - Members Choosing to Leave the Plan .................................................................................................... 83 \\nMeasure: D04 - Drug Plan Quality Improvement .............................................................................................................. 85 \\nDomain: 3 - Member Experience with the Drug Plan .................................................................................................... 87 \\nMeasure: D05 - Rating of Drug Plan ................................................................................................................................. 87 \\nMeasure: D06 - Getting Needed Prescription Drugs ........................................................................................................ 88 \\nDomain: 4 - Drug Safety and Accuracy of Drug Pricing ............................................................................................... 90 \\nMeasure: D07 - MPF Price Accuracy ................................................................................................................................ 90 \\nMeasure: D08 - Medication Adherence for Diabetes Medications .................................................................................... 92 \\nMeasure: D09 - Medication Adherence for Hypertension (RAS antagonists) ................................................................... 95 \\nMeasure: D10 - Medication Adherence for Cholesterol (Statins) ..................................................................................... 98 \\nMeasure: D11 - MTM Program Completion Rate for CMR ............................................................................................. 100 \\nMeasure: D12 - Statin Use in Persons with Diabetes (SUPD) ....................................................................................... 103 \\nATTACHMENT A: CAHPS CASE-MIX ADJUSTMENT .................................................................................. 106 \\nCAHPS Case-Mix Adjustment ....................................................................................................................................... 106 \\nTable A-1: Coefficients of Part C Getting Needed Care (C19) CAHPS Measure Composite Items............................... 107 \\nTable A-2: Coefficients of Part C Getting Appointments and Care Quickly (C20) CAHPS Measure Composite Items . 108 \\nTable A-3: Coefficients of Part C Customer Service (C21) CAHPS Measure Composite Items .................................... 109 \\nTable A-4: Coefficients of Part C Stand-alone CAHPS Measures .................................................................................. 110 \\nTable A-5: Coefficients of Part C Care Coordination (C24) CAHPS Measure Composite Items ................................... 111 \\nTable A-6: Coefficients of Part D CAHPS Stand-alone Measures .................................................................................. 112 \\nTable A-7: Coefficients of Part D Getting Needed Prescription Drugs (D06) CAHPS Measure Composite Items ......... 113 \\nATTACHMENT B: CALCULATING MEASURE DATA FOR THE SURVIVING CONTRACT OF A \\nCONSOLIDATION ............................................................................................................................................ 114 \\nFirst Year Following a Consolidation ........................................................................................................................... 114 \\nTable B-1: Enrollment Month Used in Calculating Measure Scores for the Surviving Contract of a Consolidation ....... 114 \\nTable B-2: Example of Calculating the Measure Score for the Surviving Contract of a Consolidation .......................... 114 \\nSecond Year Following a Consolidation ...................................................................................................................... 114 \\nATTACHMENT C: NATIONAL AVERAGES FOR PART C AND D MEASURES ........................................... 115 \\nTable C-1: National Averages for Part C Measures ........................................................................................................ 115 \\nTable C-2: National Averages for Part D Measures ........................................................................................................ 116 \\nATTACHMENT D: PART C AND D DATA TIME FRAMES ............................................................................ 117 \\nTable D-1: Part C Measure Data Time Frames .............................................................................................................. 117 \\nTable D-2: Part D Measure Data Time Frames .............................................................................................................. 118 \\nATTACHMENT E: SNP MEASURE SCORING METHODOLOGIES .............................................................. 119 \\n1. Medicare Part C Reporting Requirements Measure (C05: SNP Care Management) .............................................. 119 \\n2. NCQA HEDIS Measures - (C06 – C07: Care for Older Adults) ................................................................................ 120 \\nTable E-1: Example Calculation Using Effectiveness of Care Rate ............................................................................... 121 \\nATTACHMENT F: CALCULATING MEASURE C15: PLAN ALL-CAUSE READMISSIONS ........................ 122 \\nExample: Calculating the final rate for Contract 1 ........................................................................................................... 122\", '(Last Updated 10/03/2024)  \\nPage v \\n \\nATTACHMENT G: WEIGHTS ASSIGNED TO INDIVIDUAL PERFORMANCE MEASURES ........................ 123 \\nTable G-1: Part C Measure Weights ............................................................................................................................... 123 \\nTable G-2: Part D Measure Weights ............................................................................................................................... 124 \\nATTACHMENT H: CALCULATION OF WEIGHTED STAR RATING AND VARIANCE ESTIMATES ........... 125 \\nATTACHMENT I: CALCULATING THE IMPROVEMENT MEASURE AND THE MEASURES USED .......... 126 \\nCalculating the Improvement Measure ........................................................................................................................ 126 \\nGeneral Standard Error Formula................................................................................................................................... 127 \\nImprovement Change Score Standard Error Numerical Example ............................................................................. 127 \\nStandard Error Formulas (SEF) for Specific Measures .............................................................................................. 128 \\n1. SEF for Measures: C01, C02, C04, C05, C08 – C14, C16, C18, C26, C28 – C30, D01, D03, D08 – D12 ............. 128 \\n2. SEF for Measures: C06, C07 .................................................................................................................................... 128 \\n3. SEF for Measure C15................................................................................................................................................ 128 \\n4. SEF for Measure C17................................................................................................................................................ 128 \\n5. SEF for Measures: C03, C19 – C24, and D05, D06 ................................................................................................. 129 \\n6. SEF for Measures: C25, D02 .................................................................................................................................... 129 \\n7. SEF for Measure D07................................................................................................................................................ 129 \\nStar Ratings Measures Used in the Improvement Measures ..................................................................................... 131 \\nTable I-1: Part C Measures Used in the Improvement Measure .................................................................................... 131 \\nATTACHMENT J: STAR RATINGS MEASURE HISTORY ............................................................................. 133 \\nTable J-1: Part C Measure History .................................................................................................................................. 133 \\nTable J-2: Part D Measure History .................................................................................................................................. 138 \\nTable J-3: Common Part C & Part D Measure History ................................................................................................... 142 \\nATTACHMENT K: INDIVIDUAL MEASURE STAR ASSIGNMENT PROCESS ............................................. 143 \\nClustering Methodology Introduction .......................................................................................................................... 143 \\nFigure K-1: Diagram showing gaps in data where cut points are assigned. ................................................................... 143 \\nExample 1 – Clustering Methodology for a Higher is Better measure ...................................................................... 143 \\nTable K-1: Medication Adherence for Diabetes Medications cut points example: cut points are for illustrative purposes\\n \\n144 \\nFigure K-2: Diagram showing star assignment based cut points. ................................................................................... 144 \\nExample 2 – Clustering Methodology for a Lower is Better measure....................................................................... 144 \\nTable K-2: Members Choosing to Leave the Plan cut points example: cut points are for illustrative purposes ............. 144 \\nClustering Methodology Detail ...................................................................................................................................... 145 \\n1. Produce the individual measure distance matrix. ..................................................................................................... 145 \\n2. Create a tree of cluster assignments. ....................................................................................................................... 146 \\n3. Select the final set of clusters from the tree of cluster assignments. ........................................................................ 146 \\n4. Final Thresholds ........................................................................................................................................................ 147 \\nDetermining Stars from Scores and Thresholds ......................................................................................................... 147 \\nTable K-3: 2025 Star Ratings Part C non-CAHPS Measure Mean Resampling Estimated Thresholds ........................ 148 \\nTable K-4: 2025 Star Ratings Part D non-CAHPS Measure Mean Resampling Estimated Thresholds ........................ 149 \\nTable K-5: 2025 Star Ratings Part C non-CAHPS Measure Tukey Outlier Cutoffs ........................................................ 150 \\nTable K-6: 2025 Star Ratings Part D non-CAHPS Measure Tukey Outlier Cutoffs ........................................................ 151 \\nRelative Distribution and Significance Testing (CAHPS) Methodology ................................................................... 153 \\nTable K-8: CAHPS Star Assignment Rules .................................................................................................................... 154 \\nTable K-9: CAHPS Star Assignment Alternate Representation ...................................................................................... 155 \\nTable K-10: CAHPS Measure 12% Reliability Cutoffs .................................................................................................... 155 \\nATTACHMENT L: MEDICATION ADHERENCE MEASURE CALCULATIONS............................................. 156 \\nProportion of Days Covered Calculation ..................................................................................................................... 156 \\nExample 1: Non-Overlapping Fills of Two Different Drugs ........................................................................................ 156 \\nTable L-1: No Adjustment ............................................................................................................................................... 156 \\nExample 2: Overlapping Fills of the Same Generic Ingredient across Single and Combination Products .......... 156 \\nTable L-2: Before Overlap Adjustment ............................................................................................................................ 157 \\nTable L-3: After Overlap Adjustment ............................................................................................................................... 157', '(Last Updated 10/03/2024)  \\nPage vi \\n \\nExample 3: Overlapping Fills of the Same and Different Target Drugs .................................................................... 157 \\nTable L-4: Before Overlap Adjustment ............................................................................................................................ 157 \\nTable L-5: After Overlap Adjustment ............................................................................................................................... 158 \\nPDC Adjustment for Inpatient, and Skilled Nursing Facility Stays Examples ......................................................... 158 \\nCalculating the PDC Adjustment for IP Stays and SNF Stays ................................................................................... 159 \\nExample 1: Gap in Coverage after IP Stay ................................................................................................................... 159 \\nTable L-6: Before Adjustment ......................................................................................................................................... 159 \\nTable L-7: After Adjustment ............................................................................................................................................ 160 \\nExample 2: Gap in Coverage before IP Stay ................................................................................................................ 160 \\nTable L-8: Before Adjustment ......................................................................................................................................... 160 \\nTable L-9: After Adjustment ............................................................................................................................................ 160 \\nExample 3: Gap in Coverage Before and After IP Stay .............................................................................................. 160 \\nTable L-10: Before Adjustment ....................................................................................................................................... 161 \\nTable L-11: After Adjustment .......................................................................................................................................... 161 \\nExample 4: Gap in Coverage After IP Stay and Overlap with Subsequent Fill of the Same Drug Class ............... 161 \\nTable L-12: Before Adjustment ....................................................................................................................................... 161 \\nTable L-13: After Adjustment .......................................................................................................................................... 162 \\nATTACHMENT M: METHODOLOGY FOR MPF PRICE ACCURACY MEASURE ........................................ 163 \\nContract Selection .......................................................................................................................................................... 163 \\nMPF Composite Price Accuracy Score ........................................................................................................................ 163 \\nExample of Accuracy Index Calculation ...................................................................................................................... 166 \\nTable M-1: Example of Price Accuracy Index Calculation .............................................................................................. 167 \\nATTACHMENT N: MTM CMR COMPLETION RATE MEASURE SCORING METHODOLOGIES ................ 168 \\nMedicare Part D Reporting Requirements Measure (D11: MTM CMR Completion Rate Measure) ........................ 168 \\nATTACHMENT O: METHODOLOGY FOR THE PUERTO RICO MODEL ...................................................... 170 \\nModel ............................................................................................................................................................................... 171 \\nExample ........................................................................................................................................................................... 172 \\nATTACHMENT P: IDENTIFICATION OF CONTRACTS AFFECTED BY DISASTERS ................................. 173 \\nOperational Steps to Calculating Enrollment Impacted in Affected Contracts. ...................................................... 173 \\nTable P-1: Section 1135 waivers issued in relation to the FEMA major disaster declarations ....................................... 173 \\nTable P-2: Individual Assistance counties in FEMA Major Disaster Declared States .................................................... 174 \\nTable P-3: Organization type service areas and necessary transformations ................................................................. 174 \\nTable P-4: Major Disasters with associated enrollment months ..................................................................................... 175 \\nTable P-5: How enrollment periods were combined for contracts experiencing multiple disasters ................................ 175 \\nExample: .......................................................................................................................................................................... 176 \\nTable P-6: Example Contract HAAAA’s Service Areas and Enrollment during Relevant Disasters ............................... 176 \\nATTACHMENT Q: MISSING DATA MESSAGES ........................................................................................... 178 \\nMeasure level messages ................................................................................................................................................ 178 \\nTable Q-1: Measure level missing data messages ......................................................................................................... 178 \\nAssignment rules for Part C measure messages........................................................................................................ 178 \\nAssignment rules for Part D measure messages........................................................................................................ 182 \\nTable Q-2: MTM CMR Reason(s) for Display Message conversion ............................................................................... 184 \\nDomain, Summary, and Overall level messages ......................................................................................................... 184 \\nTable Q-3: Domain, Summary, and Overall level missing data messages ..................................................................... 184 \\nAssignment rules for Part C & Part D domain rating level messages ...................................................................... 184 \\nAssignment rules for Part C & Part D summary rating level messages ................................................................... 184 \\nAssignment rules for overall rating level messages .................................................................................................. 185 \\nDisenrollment Reasons messages ............................................................................................................................... 185 \\nTable Q-4: Disenrollment Reason missing data messages ............................................................................................ 185 \\nATTACHMENT R: GLOSSARY OF TERMS ................................................................................................... 186', '(Last Updated 10/03/2024)  \\nPage vii \\n \\nATTACHMENT S: HEALTH PLAN MANAGEMENT SYSTEM MODULE REFERENCE ............................... 190 \\nHPMS Star Ratings Module ........................................................................................................................................... 190 \\n1. Measure Data page ................................................................................................................................................... 190 \\nTable S-1: Measure Data page sample .......................................................................................................................... 190 \\n2. Measure Detail – CTM Summary page ..................................................................................................................... 190 \\nTable S-2: Measure Detail – CTM Summary page fields ................................................................................................ 191 \\n3. Measure Detail – Part C Appeals page ..................................................................................................................... 191 \\nTable S-3: Measure Detail – Part C Appeals page fields ................................................................................................ 191 \\n4. Measure Detail – SNP CM page ............................................................................................................................... 192 \\nTable S-4: Measure Detail – SNP CM page fields .......................................................................................................... 192 \\n5. Measure Detail – HEDIS page .................................................................................................................................. 192 \\nTable S-5: Measure Detail – HEDIS page fields ............................................................................................................. 193 \\nTable S-6: HEDIS 2023 Audit Designations and 2025 Star Ratings .............................................................................. 193 \\n6. Measure Detail – CTM page ..................................................................................................................................... 193 \\nTable S-7: Measure Detail – CTM page fields ................................................................................................................ 194 \\n7. Measure Detail – Disenrollment ................................................................................................................................ 194 \\nTable S-8: Measure Detail – Disenrollment page fields .................................................................................................. 194 \\n8. Measure Detail – DR (Disenrollment Reasons) ........................................................................................................ 194 \\nTable S-9: Measure Detail – Disenrollment Reasons page fields .................................................................................. 195 \\n9. Measure Detail – MTM page ..................................................................................................................................... 195 \\nTable S-10: Measure Detail – MTM page fields .............................................................................................................. 195 \\n10. Measure Detail – CAHPS page ................................................................................................................................. 196 \\nTable S-11: Measure Detail – CAHPS page fields ......................................................................................................... 196 \\n11. Calculation Detail – MD ............................................................................................................................................. 196 \\nTable S-12: Calculation Detail – MD page fields ............................................................................................................ 197 \\n12. Calculation Detail – CAI ............................................................................................................................................ 197 \\nTable S-13: Measure Detail – CAI page fields ................................................................................................................ 198 \\n13. Measure Detail – HEDIS LE page ............................................................................................................................. 198 \\nTable S-14: Measure Detail – HEDIS LE page fields ..................................................................................................... 199 \\n14. Measure Detail – C MD Results ................................................................................................................................ 199 \\nTable S-15: Measure Detail – C MD Results .................................................................................................................. 199 \\n15. Measure Detail – D MD Results ................................................................................................................................ 199 \\nTable S-16: Measure Detail – D MD Results .................................................................................................................. 200 \\n16. Measure Detail – C Improvement page .................................................................................................................... 200 \\nTable S-17: Part C Measure Improvement Results ........................................................................................................ 200 \\n17. Measure Detail – D Improvement page .................................................................................................................... 200 \\nTable S-18: Part D Measure Improvement Results ........................................................................................................ 201 \\n18. Measure Stars page .................................................................................................................................................. 201 \\nTable S-19: Measure Stars page sample........................................................................................................................ 201 \\n19. Domain Stars page .................................................................................................................................................... 201 \\nTable S-20: Domain Star page sample ........................................................................................................................... 202 \\n20. Part C Summary Rating page ................................................................................................................................... 202 \\nTable S-21: Part C Summary Rating page fields ............................................................................................................ 202 \\n21. Part D Summary Rating page ................................................................................................................................... 203 \\nTable S-22: Part D Summary Rating View ...................................................................................................................... 203 \\n22. Overall Rating page ................................................................................................................................................... 203 \\nTable S-23: Overall Rating View ..................................................................................................................................... 204 \\n23. Low Performing Contract List .................................................................................................................................... 204 \\nTable S-24: Low Performing Contract List ...................................................................................................................... 205 \\n24. High Performing Contract List ................................................................................................................................... 205 \\nTable S-25: High Performing Contract List ..................................................................................................................... 205 \\n25. Technical Notes link .................................................................................................................................................. 205 \\n26. Medication NDC List .................................................................................................................................................. 206 \\n27. Part C and Part D Example Measure Data ............................................................................................................... 206', '(Last Updated 10/03/2024)  \\nPage 1 \\n \\nIntroduction \\nCMS created the Part C & D Star Ratings to provide quality and performance information to Medicare \\nbeneficiaries to assist them in choosing their health and drug services during the annual fall open enrollment \\nperiod. We refer to them as the ‘2025 Medicare Part C & D Star Ratings’ because they are posted prior to the \\n2025 open enrollment period. \\nThis document describes the methodology for creating the Part C & D Star Ratings displayed on the Medicare \\nPlan Finder (MPF) at http://www.medicare.gov/ and posted on the CMS website at \\nhttp://go.cms.gov/partcanddstarratings. A Glossary of Terms used in this document can be found in Attachment \\nR. \\nThe Star Ratings data are also displayed in the Health Plan Management System (HPMS). In HPMS, the data \\ncan be found by selecting: “Quality and Performance,” then “Performance Metrics,” then “Reports,” then “Star \\nRatings and Display Measures,” then “Star Ratings” for the report type, and “2025” for the report period. See \\nAttachment S: Health Plan Management System Module Reference for descriptions of the HPMS pages. \\nThe Star Ratings Program is consistent with the “Meaningful Measures” framework which focuses on measures \\nrelated to person-centered care, equity, safety, affordability and efficiency, chronic conditions, wellness and \\nprevention, seamless care coordination, and behavioral health. With Meaningful Measures 2.0, CMS plans to \\nbetter address health care priorities and gaps, emphasize digital quality measurement, and promote patient \\nperspectives of care. The Star Ratings include measures applying to the following five broad categories: \\n Outcomes: Outcome measures reflect improvements in a beneficiary’s health and are central to assessing \\nquality of care. \\n Intermediate outcomes: Intermediate outcome measures reflect actions taken which can assist in \\nimproving a beneficiary’s health status. Diabetes Care – Blood Sugar Controlled is an example of an \\nintermediate outcome measure where the related outcome of interest would be better health status for \\nbeneficiaries with diabetes. \\n Patient experience: Patient experience measures reflect beneficiaries’ perspectives of the care they \\nreceived. \\n Access: Access measures reflect processes and issues that could create barriers to receiving needed care. \\nPlan Makes Timely Decisions about Appeals is an example of an access measure. \\n Process: Process measures capture the health care services provided to beneficiaries which can assist in \\nmaintaining, monitoring, or improving their health status. \\nNote on References to the 2024 Star Ratings \\nThroughout these technical notes, previous year and 2024 Star Ratings refer to the recalculated 2024 Star \\nRatings and cut points which were recalculated using the published 2023 Star Ratings cut points to determine \\nthe guardrails for 2024 Star Ratings (i.e., Tukey outliers were not removed from the 2023 Star Ratings measure \\nscores when determining cut points). \\nDifferences between the 2024 Star Ratings and 2025 Star Ratings \\nThere have been several changes between the 2024 Star Ratings and the 2025 Star Ratings. This section \\nprovides a synopsis of the notable differences; the reader should examine the entire document for full details', '(Last Updated 10/03/2024)  \\nPage 2 \\n \\nabout the 2025 Star Ratings. A table with the complete history of measures used in the Star Ratings can be \\nfound in Attachment J. \\n Changes \\na. The weight of the Part C Plan All-Cause Readmissions measure was increased to 3.   \\nb. Since the Medicare Plan Finder measure is no longer treated as a new measure, guardrails are now \\napplied after mean resampling \\n Transitioned measures (Moved to the display page on the CMS website: \\nhttp://go.cms.gov/partcanddstarratings) \\n None \\n Retired measures \\n None \\nHealth/Drug Organization Types Included in the Star Ratings \\nAll health and drug plan quality and performance measure data described in this document are reported at the \\ncontract/sponsor level. Table 1 lists the contract year 2025 organization types and whether they are included in \\nthe Part C and/or Part D Star Ratings.', '(Last Updated 10/03/2024)  \\nPage 3 \\n \\nTable 1: Contract Year 2025 Organization Types Reported in the 2025 Star Ratings \\nOrganization Type \\nTechnical \\nNotes \\nAbbreviation \\nMedicare \\nAdvantage \\n(MA) \\nCan \\nOffer \\nSNPs \\nPart C \\nRatings \\nPart D Ratings \\n1876 Cost \\n1876 Cost \\nNo \\nNo \\nYes \\nYes (if drugs \\noffered) \\nDemonstration (Medicare-Medicaid \\nPlan) † \\nMMP \\nNo \\nNo \\nNo \\nNo \\nEmployer/Union Only Direct \\nContract Local Coordinated Care \\nPlan (CCP) \\nCCP \\nYes \\nNo \\nYes \\nYes \\nEmployer/Union Only Direct \\nContract Prescription Drug Plan \\n(PDP) \\nPDP \\nNo \\nNo \\nNo \\nYes \\nEmployer/Union Only Direct \\nContract Private Fee-for-Service \\n(PFFS) \\nPFFS \\nYes \\nNo \\nYes \\nYes (if drugs \\noffered) \\nHCPP 1833 Cost \\nHCPP \\nNo \\nNo \\nNo \\nNo \\nLocal Coordinated Care Plan \\n(CCP) \\nCCP \\nYes \\nYes \\nYes \\nYes \\nMedical Savings Account (MSA) \\nMSA \\nYes \\nNo \\nYes \\nNo \\nNational PACE \\nPACE \\nNo \\nNo \\nNo \\nNo \\nMedicare Prescription Drug Plan \\n(PDP) \\nPDP \\nNo \\nNo \\nNo \\nYes \\nPrivate Fee-for-Service (PFFS) \\nPFFS \\nYes \\nNo \\nYes \\nYes (if drugs \\noffered) \\nRegional Coordinated Care Plan \\n(CCP) \\nCCP \\nYes \\nYes \\nYes \\nYes \\nReligious Fraternal Benefit Private \\nFee-for-Service (RFB PFFS) \\nPFFS \\nYes \\nNo \\nYes \\nYes (if drugs \\noffered) \\n† Note: The measure scores from these organizations are displayed in HPMS only during the first plan preview. Data from these \\norganizations are not used in calculating the Part C & D Star Ratings. \\nThe Star Ratings Framework \\nThe Star Ratings are based on health and drug plan quality and performance measures.  Each measure is \\nreported in two ways: \\nScore: \\nA score is either a numeric value or an assigned ‘missing data’ message. \\nStar: \\nThe measure numeric value is converted to a Star Rating. \\nThe measure Star Ratings are combined into three groups and each group is assigned 1 to 5 stars. The three \\ngroups are: \\nDomain: Domains group together measures of similar services. Star Ratings for domains are calculated \\nusing the non-weighted average Star Ratings of the included measures. \\nSummary: Part C measures are grouped to calculate a Part C Rating; Part D measures are grouped to \\ncalculate a Part D Rating. Summary ratings are calculated from the weighted average Star Ratings \\nof the included measures.', '(Last Updated 10/03/2024)  \\nPage 4 \\n \\nOverall: \\nFor MA-PDs, all unique Part C and Part D measures are grouped to create an overall rating. The \\noverall rating is calculated from the weighted average Star Ratings of the included measures. \\n \\nFigure 1 shows the four levels of Star Ratings that are calculated and reported publicly. \\nFigure 1: The Four Levels of Star Ratings \\n \\nThe whole star scale used at the measure and domain levels is shown in Table 2. \\nTable 2: 5-Star Scale \\nNumeric \\nGraphic \\nDescription \\n5 \\nExcellent \\n4 \\nAbove Average \\n3 \\nAverage \\n2 \\nBelow Average \\n1 \\nPoor \\nTo allow for more variation across contracts, CMS assigns half stars to the summary and overall ratings. \\nAs different organization types offer different benefits, CMS classifies contracts into three contract types. The \\nhighest level Star Rating differs among the contract types because the set of required measures differs by contract \\ntype. Table 3 clarifies how CMS classifies contracts for purposes of the Star Ratings and indicates the highest \\nrating available for each organization type. \\n \\nTable 3: Relation of 2025 Organization Types to Contract Types and Highest Rating in the 2025 Star Ratings \\nOrganization \\nType \\n1876 Cost (no \\ndrugs) † \\n1876 Cost \\n(offers drugs) † \\nCCP \\nMSA \\nPDP \\nPFFS (no drugs) \\nPFFS (offers \\ndrugs) \\nRated As \\nMA-Only \\nMA-PD \\nMA-PD \\nMA-Only \\nPDP \\nMA-Only \\nMA-PD \\nHighest Rating Part C rating \\nOverall Rating \\nOverall \\nRating \\nPart C Rating Part D Rating \\nPart C Rating \\nOverall Rating \\n† Note: While 1876 contracts are not MA contracts, for the purposes of determining the highest rating they are considered to be rated \\nas either “MA-only” or “MA-PD” depending on whether they offer drugs.', '(Last Updated 10/03/2024)  \\nPage 5 \\n \\nSources of the Star Ratings Measure Data \\nThe 2025 Star Ratings include a maximum of 9 domains comprised of a maximum of 42 measures. \\n MA-Only contracts are measured on 5 domains with a maximum of 30 measures. \\n PDPs are measured on 4 domains with a maximum of 12 measures. \\n MA-PD contracts are measured on all 9 domains with a maximum of 42 measures, 40 of which are \\nunique measures. Two of the measures are shown in both Part C and Part D so that the results for a MA-\\nPD contract can be compared to an MA-Only contract or a PDP contract. Only one instance of those two \\nmeasures is used in calculating the overall rating. The two duplicated measures are Complaints about the \\nHealth/Drug Plan (CTM) and Members Choosing to Leave the Plan (MCLP). \\n \\nFor a health and/or drug plan to be included in the Part C & D Star Ratings, they must have an active contract \\nwith CMS to provide health and/or drug services to Medicare beneficiaries. All of the data used to rate the plans \\nare collected through normal contractual requirements or directly from CMS systems. Information about \\nMedicare Advantage contracting can be found at: https://www.cms.gov/Medicare/Medicare-\\nAdvantage/MedicareAdvantageApps/index.html and Prescription Drug Coverage contracting at: \\nhttps://www.cms.gov/Medicare/Prescription-Drug-coverage/PrescriptionDrugCovContra/index.html. \\nThe data used in the Star Ratings come from four categories of data sources which are shown in Figure 2. \\nFigure 2: The Four Categories of Data Sources \\n \\nImprovement Measures \\nUnlike the other Star Rating measures which are derived from data sources external to the Star Ratings, the Part \\nC and Part D improvement measures are derived through comparisons of a contract’s current and prior year \\nmeasure scores. For a measure to be included in the improvement calculation the measure must not have had a \\nsignificant specification change during those years. The Part C improvement measure includes only Part C \\nmeasure scores and the Part D improvement measure includes only Part D measure scores. The measures and \\nformulas for the improvement measure calculations are found in Attachment I. If a scaled reduction is applied to \\nthe Part C appeals measure in the previous year, the associated appeals measures will not be included in the \\nHealth Plan Quality Improvement measure. \\nThe numeric results of these calculations are not publicly posted; only the measure ratings are reported publicly. \\nFurther, to receive a Star Rating in the improvement measures, a contract must have measure scores for both \\nyears in at least half of the required measures used to calculate the Part C improvement or Part D improvement \\nmeasures. Improvement scores are not calculated for reconfigured regional contracts until data is available for \\nthe reconfigured structure from both years. Improvement scores are not calculated for consolidated contracts in \\ntheir first year. Table 4 presents the minimum number of measure scores required to receive a rating for the \\nimprovement measures.', '(Last Updated 10/03/2024)  \\nPage 6 \\n \\nTable 4: Minimum Number of Measure Scores Required for an Improvement Measure Rating by Contract Type \\nPart \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nC \\n11 of 22 \\n13 of 26 \\n15 of 29 \\n9 of 17 \\n13 of 25 \\nN/A \\n13 of 26 \\nD \\n5 of 10* \\n6 of 11 \\n6 of 11 \\n5 of 9 \\nN/A \\n6 of 11 \\n6 of 11* \\n* Note: Does not apply to MA-Only, 1876 Cost, and PFFS contracts which do not offer drug benefits. \\nFor a detailed description of all Part C and Part D measures, see the section entitled “Framework and \\nDefinitions for the Domain and Measure Details.” \\nContract Enrollment Data \\nThe enrollment data used in the Part C and Part D \"Complaints about the Health/Drug Plan\" measures are \\npulled from HPMS. These data may also be accessed on the Monthly Enrollment by Contract page on \\nCMS.gov.  These enrollment files represent the number of enrolled beneficiaries the contract was paid for in a \\nspecific month. For these measures, twelve months of enrollment files are pulled (January 2023 through \\nDecember 2023) and the average enrollment across those months is used in the calculations. \\nEnrollment data are also used when combining the plan-level data into contract-level data in the two Part C \\n“Care for Older Adults” Healthcare Effectiveness Data and Information Set (HEDIS) measures. (“The Care for \\nOlder Adults – Functional Status Assessment” measure is currently on the display page). When there is a \\nreported rate, the eligible population in the plan benefit package (PBP) submitted with the HEDIS data is used. \\nIf the audit designation for the PBP level HEDIS data is set to “Not Reported” (NR) or “Biased Rate” (BR) by \\nthe auditor (see following section), there is no value in the eligible population field. In these instances, twelve \\nmonths of PBP-level enrollment files are pulled (January 2023 through December 2023), and the average \\nenrollment in the plan across those months is used in calculating the combined rate. \\nHandling of Biased, Erroneous, and/or Not Reportable (NR) Data \\nThe data used for CMS’s Star Ratings must be accurate and reliable. CMS has identified issues with some \\ncontracts’ data and has taken steps to protect the integrity of the data. For any measure scores CMS identifies to \\nbe based on inaccurate or biased data, CMS’s policy is to reduce a contract’s measure rating to 1 star and set the \\nmeasure score to “CMS identified issues with this plan’s data.” \\nInaccurate or biased data result from the mishandling of data, inappropriate processing, or implementation of \\nincorrect practices. Examples include, but are not limited to: a contract’s failure to adhere to HEDIS, Health \\nOutcomes Survey (HOS), or CAHPS reporting requirements; a contract’s failure to adhere to Medicare Plan \\nFinder data requirements; a contract’s errors in processing organization determinations and appeals; compliance \\nactions taken against the contract due to errors in operational areas that impact the data reported or processed \\nfor specific measures; or a contract’s failure to pass validation of the data reported for specific measures. \\nFor HEDIS data, CMS uses the audit designation information assigned by the HEDIS auditor. An audit \\ndesignation of ‘NR’ (Not reported) is assigned when the contract chooses not to report the measure. An audit \\ndesignation of ‘BR’ (Biased rate) is assigned when the individual measure score is materially biased (e.g., the \\nauditor informs the contract the data cannot be reported to the National Committee for Quality Assurance \\n(NCQA) or to CMS). When either a ‘BR’ or ‘NR’ designation is assigned to a HEDIS measure audit \\ndesignation, the contract receives 1 star for the measure and the measure score is set to “CMS identified issues \\nwith this plan’s data.” In addition, CMS reduces contracts’ HEDIS measure ratings to 1 star if the patient-level \\ndata files are not successfully submitted and validated by the submission deadline. Also, if the HEDIS \\nsummary-level data value varies substantially from the value in the patient-level data, the measure is reduced to \\na rating of 1 star. If an approved CAHPS or HOS vendor does not submit a contract’s CAHPS or HOS data by', '(Last Updated 10/03/2024)  \\nPage 7 \\n \\nthe data submission deadline, the contract automatically receives a rating of 1 star for the CAHPS or HOS \\nmeasures and the measure scores are set to “CMS identified issues with this plan’s data.” \\nData Handling of Measures for Contracts Affected by a Major Disaster \\nCMS has a policy for making adjustments in the Star Ratings to take into account major disasters. That policy \\nwas described in the 2025 Rate Announcement (https://www.cms.gov/Medicare/Health-\\nPlans/MedicareAdvtgSpecRateStats/Announcements-and-Documents.html.)  This is also codified in regulation \\nat §422.166(i) and §423.186(i). \\nThis section describes how the policy is implemented for measures from each of the different data sources in the \\n2025 Star Ratings. The methodology used by CMS to identify the major disaster geographic areas, determine \\nwhich contracts were affected, and how much of their geographic service area and percent of enrollment resided \\nin an affected area can be found in Attachment P. \\nThe disaster policy specified two distinct thresholds of “25% or more” and “60% or more” of the contract’s \\nmembership at the time of the disaster resided in a FEMA-designated Individual Assistance area. CMS \\ncalculated the percentage of enrollment affected for every contract being rated and applied the following rules \\nto the data from those contracts that meet or exceed either of the two thresholds. \\n• CAHPS adjustments: \\no All contracts were required to administer the 2024 CAHPS survey unless the contract requested \\nand CMS approved an exemption. \\no All affected contracts with at least 25% of beneficiaries in Individual Assistance areas at the time \\nof the disaster receive the higher of the 2024 or the 2025 Star Rating (and corresponding measure \\nscore) for each CAHPS measure (including the annual flu vaccine measure). \\no In some cases, contracts with at least 25% of enrollees residing in FEMA-designated individual \\nAssistance areas that were affected by disasters that began in 2023 were also affected by \\ndisasters in 2022.  These doubly-affected contracts receive the higher of the 2025 Star Rating or \\nwhat the 2024 Star Ratings would have been in the absence of any adjustments that took into \\naccount the effects of the 2022 disaster for each measure (we use the corresponding measure \\nscore for the Star Ratings year selected).  For example, if a doubly-affected contract reverted \\nback to the 2023 Star Rating on a given measure in the 2024 Star Ratings, the 2023 Star Rating is \\nnot used in determining the 2025 Star Rating.  Rather the 2025 Star Rating is compared to what \\nthe 2024 Star Rating would have been absent any disaster adjustments. \\n HEDIS-HOS adjustments: \\no The HEDIS-HOS data used in the 2025 Star Ratings are adjusted for 2022 disasters (see \\nAttachment P of the 2024 Star Ratings Technical Notes for the identification of contracts \\naffected by 2022 disasters).  \\no All affected contracts (i.e., contracts affected by 2022 disasters) with at least 25% of \\nbeneficiaries in Individual Assistance areas at the time of the disaster received the higher of the \\n2024 or the 2025 Star Rating (and corresponding measure score) for each HEDIS-HOS measure. \\no In some cases, contracts with at least 25% of enrollees residing in FEMA-designated Individual \\nAssistance areas affected by disasters that began in 2022 were also affected by disasters in 2021. \\nThese doubly-affected contracts receive the higher of the 2025 Star Rating or what the 2024 Star \\nRating would have been in the absence of any adjustments that took into account the effects of \\nthe 2021 disaster for each measure (we use the corresponding measure score for the Star Ratings \\nyear selected).', '(Last Updated 10/03/2024)  \\nPage 8 \\n \\n• HEDIS adjustments: \\no All contracts were required to report HEDIS MY 2023 unless the contract requested and CMS \\napproved an exemption. Contracts were able to work with NCQA to adjust samples if necessary. \\no Contracts with 25% or more affected members received the higher of the 2024 or 2025 Star \\nRating (and corresponding measure scores) for each HEDIS measure. \\no In some cases, contracts with at least 25% of enrollees residing in FEMA-designated Individual \\nAssistance areas affected by disasters that began in 2023 were also affected by disasters in 2022. \\nThese doubly-affected contracts receive the higher of the 2025 Star Rating or what the 2024 Star \\nRating would have been in the absence of any adjustments that took into account the effects of \\nthe 2022 disaster for each measure (we use the corresponding measure score for the Star Ratings \\nyear selected). \\n• Part C and D Call Center: \\no For all contracts, no adjustments were made. \\n New measures: \\no Contracts with 25% or more affected members have a hold harmless provision applied which \\ncompares the result of a contract’s overall rating “with” and “without” including any new \\nmeasure(s) and/or respecified measure(s). If the “with” result is lower than the “without” result, \\nthen we use the “without” result as the final highest level rating.  Please note that there are no \\nnew or respecified measures for the 2025 Star Ratings. \\no A similar hold harmless provision is applied for the Part C and D summary ratings. If a contract \\nhas 25% or more affected members, the Part C and D summary ratings are calculated “with” and \\n“without” any new measure(s) and/or respecified measure(s), and if the “with” result is lower \\nthan the “without” result, then we use the “without” result for the final summary ratings. Please \\nnote that there are no new or respecified measures for the 2025 Star Ratings. \\n• All other measures: \\no Contracts with 25% or more affected members receive the higher of the 2024 or 2025 measure \\nstars (and corresponding measure scores). \\no In some cases, contracts with at least 25% of enrollees residing in FEMA-designated Individual \\nAssistance areas affected by disasters that began in 2023 were also affected by disasters in 2022. \\nThese doubly-affected contracts receive the higher of the 2025 Star Rating or what the 2024 Star \\nRating would have been in the absence of any adjustments that took into account the effects of \\nthe 2022 disaster for each measure (we use the corresponding measure score for the Star Ratings \\nyear selected). \\n• All adjustments: \\no For all adjustments, if the Star Rating is the same in both years, the Star Rating and the measure \\nscore from the most recent year are used. \\n• Improvement measures: \\no For affected contracts that reverted back to the data underlying the previous year’s Star Rating \\nfor a particular measure for either 2024 or 2025 Star Ratings, that measure is excluded from both \\nthe count of measures (used to determine whether the contract has at least half of the measures \\nneeded to calculate the relevant improvement measure) and the improvement measures’ \\ncalculation. Affected contracts do not have the option of reverting to the prior year’s \\nimprovement rating.', '(Last Updated 10/03/2024)  \\nPage 9 \\n \\n• Affected contracts with missing data: \\no If an affected contract has missing data in either the current or previous year (e.g., because of a \\ndata integrity issue, it is too new, or it is too small), the final measure rating comes from the \\ncurrent year. Missing data includes data where there is a data integrity issue. \\n• Reward Factor: \\no Affected contracts with 60% or more of their enrollees impacted by a 2023 disaster are excluded \\nfrom the determination of the performance summary and variance thresholds for the Reward \\nFactor.  \\n• Cut points: \\no Clustering Methodology: For all measures that use the clustering methodology for cut point \\ngeneration, the measure scores for contracts with 60% or more of their enrollment affected by a \\ndisaster are excluded from creating those cut points. \\nMethodology for Assigning Stars to the Part C and Part D Measures \\nCMS assigns stars for each numeric measure score by applying one of two methods: clustering, or relative \\ndistribution and significance testing. Each method is described below. Attachment K explains the clustering and \\nrelative distribution and significance testing (used for CAHPS measures) methods in greater detail. \\nA. Clustering \\nThis method is applied to the majority of the Star Ratings measures, ranging from operational and process-\\nbased measures, to HEDIS and other clinical care measures. Using this method, the Star Rating for each \\nmeasure is determined by applying a clustering algorithm to the measure’s numeric value scores from all \\ncontracts. Conceptually, the clustering algorithm identifies the “gaps” among the scores and creates four cut \\npoints resulting in the creation of five levels (one for each Star Rating). The scores in the same Star Rating level \\nare as similar as possible; the scores in different Star Rating levels are as different as possible. Star Rating levels \\n1 through 5 are assigned with 1 being the worst and 5 being the best. \\nTechnically, the variance in measure scores is separated into within-cluster and between-cluster sum of squares \\ncomponents. The clusters reflect the groupings of numeric value scores that minimize the variance of scores \\nwithin the clusters. The Star Ratings levels are assigned to the clusters that minimize the within-cluster sum of \\nsquares. The cut points for star assignments are derived from the range of measure scores per cluster, and the \\nstar levels associated with each cluster are determined by ordering the means of the clusters. \\nTukey outlier deletion is used to determine the cut points for all non-CAHPS measures. Tukey outlier deletion \\ninvolves removing Tukey outer fence outlier contract scores, those defined as measure-specific scores outside \\nthe bounds of 3.0 times the measure-specific interquartile range subtracted from the 1st quartile or added to the \\n3rd quartile. Outliers are removed prior to applying mean resampling within the hierarchical clustering \\nalgorithm. \\nMean resampling is used to determine the cut points for all non-CAHPS measures.  With mean resampling, \\nmeasure-specific scores for the current year’s Star Ratings are randomly separated into 10 equal-sized groups.  \\nThe hierarchal clustering algorithm is then applied 10 times, each time leaving one of the 10 groups out of the \\nclustered data.  The method results in 10 sets of measure-specific cut points.  The mean for each 1 through 5 \\nstar level cut point is taken across the 10 sets for each measure to produce the final cut points.', '(Last Updated 10/03/2024)  \\nPage 10 \\n \\nGuardrails are used to cap the amount of increase or decrease in measure cut point values from one year to the \\nnext. Specifically, each 1 to 5 star level cut point is compared to the prior year’s value and capped at an increase \\nor decrease of at most 5 percentage points for measures having a 0 to 100 scale (absolute percentage cap) or at \\nmost 5 percent of the prior year’s restricted score range for measures not having a 0 to 100 scale (restricted \\nrange cap). The final capped cut points after comparing each 1 through 5 star level cut point to the prior year’s \\nvalues are used for assigning measure stars. \\nB. Relative Distribution and Significance Testing (CAHPS) \\nThis method is applied to determine valid star cut points for CAHPS measures. In order to account for the \\nreliability of scores produced from the CAHPS survey, the method combines evaluating the relative percentile \\ndistribution with significance testing. For example, to obtain 5 stars, a contract’s CAHPS measure score needs \\nto be ranked at least at the 80th percentile and be statistically significantly higher than the national average \\nCAHPS measure score, as well as either have not low reliability or have a measure score more than one \\nstandard error above the 80th percentile. To obtain 1 star, a contract’s CAHPS measure score needs to be ranked \\nbelow the 15th percentile and be statistically significantly lower than the national average CAHPS measure \\nscore, as well as either have not low reliability or have a measure score more than one standard error below the \\n15th percentile. \\nMethodology for Calculating Stars at the Domain Level \\nA domain rating is the average, unweighted mean, of the domain’s measure stars. To receive a domain rating, a \\ncontract must meet or exceed the minimum number of rated measures required for the domain. The minimum \\nnumber of rated measures required for a domain is determined based on whether the total number of measures \\nin the domain for a contract type is odd or even: \\n• If the total number of measures that comprise the domain for a contract type is odd, divide the number of \\nmeasures in the domain by two and round the quotient to the next whole number. \\no Example: If the total number of measures required in a domain for a contract type is 3, the value \\n3 is divided by 2. The quotient, in this case 1.5, is then rounded to the next whole number. To \\nreceive a domain rating, the contract must have a Star Rating for at least 2 of the 3 required \\nmeasures. \\n• If the total number of measures that comprise the domain for a contract type is even, divide the number \\nof measures in the domain by two and add one to the quotient. \\no Example: If the total number of measures required in a domain for a contract type is 6, the value \\n6 is divided by 2. In this example, 1 is then added to the quotient of 3. To receive a domain \\nrating, the contract must have a Star Rating for at least 4 of the 6 required measures. \\nTable 5 details the minimum number of rated measures required for a domain rating by contract type.', \"(Last Updated 10/03/2024)  \\nPage 11 \\n \\nTable 5: Minimum Number of Rated Measures Required for a Domain Rating by Contract Type \\nPart \\nDomain Name (Identifier) \\n1876  \\nCost † \\nCCP  \\nw/o SNP \\nCCP  \\nwith SNP \\nCCP with \\nOnly I-SNP \\nMSA \\nPDP \\nPFFS \\nC \\nStaying Healthy: Screenings, \\nTests and Vaccines (HD1) \\n3 of 4 \\n3 of 4 \\n3 of 4 \\n2 of 2 \\n3 of 4 \\nN/A \\n3 of 4 \\nC \\nManaging Chronic (Long \\nTerm) Conditions (HD2) \\n5 of 8 \\n6 of 11 \\n8 of 14 \\n6 of 10 \\n6 of 11 \\nN/A \\n6 of 11 \\nC \\nMember Experience with \\nHealth Plan (HD3) \\n4 of 6 \\n4 of 6 \\n4 of 6 \\nN/A \\n4 of 6 \\nN/A \\n4 of 6 \\nC \\nMember Complaints and \\nChanges in the Health Plan's \\nPerformance (HD4) \\n2 of 3 \\n2 of 3 \\n2 of 3 \\n2 of 3 \\n2 of 3 \\nN/A \\n2 of 3 \\nC \\nHealth Plan Customer \\nService (HD5) \\n2 of 2 \\n2 of 3 \\n2 of 3 \\n2 of 3 \\n2 of 2 \\nN/A \\n2 of 3 \\nD \\nDrug Plan Customer Service \\n(DD1) \\nN/A* \\n1 of 1 \\n1 of 1 \\n1 of 1 \\nN/A \\n1 of 1 \\n1 of 1* \\nD \\nMember Complaints and \\nChanges in the Drug Plan’s \\nPerformance (DD2) \\n2 of 3* \\n2 of 3 \\n2 of 3 \\n2 of 3 \\nN/A \\n2 of 3 \\n2 of 3* \\nD \\nMember Experience with the \\nDrug Plan (DD3) \\n2 of 2* \\n2 of 2 \\n2 of 2 \\nN/A \\nN/A \\n2 of 2 \\n2 of 2* \\nD \\nDrug Safety and Accuracy of \\nDrug Pricing (DD4) \\n4 of 6* \\n4 of 6 \\n4 of 6 \\n4 of 6 \\nN/A \\n4 of 6 \\n4 of 6* \\n* Note: Does not apply to MA-Only, 1876 Cost, and PFFS contracts which do not offer drug benefits. \\n† Note: 1876 Cost contracts that offer drug benefits and which do not submit data for the MPF measure must have a rating in 3 out of 5 \\nDrug Safety and Accuracy of Drug Pricing (DD4) measures to receive a rating in that domain. \\nSummary and Overall Ratings: Weighting of Measures \\nThe summary and overall ratings are calculated as weighted averages of the measure stars. For the 2025 Star \\nRatings, CMS assigns the highest weight to the improvement measures, followed by patient \\nexperience/complaints and access measures, then by outcome and intermediate outcome measures, and finally \\nprocess measures. New measures included in the Star Ratings are given a weight of 1 for their first year of \\ninclusion in the ratings; in subsequent years the weight associated with the measure weighting category is used. \\nThe weights assigned to each measure and their weighting category are shown in Attachment G. \\nIn calculating the summary and overall ratings, a measure given a weight of 3 counts three times as much as a \\nmeasure given a weight of 1. For any given contract, any measure without a rating is not included in the \\ncalculation. The first step in the calculation is to multiply each measure’s weight by the measure’s rating and \\nsum these results. The second step is to divide this sum by the sum of the weights of the contract’s rated \\nmeasures. For the summary and overall ratings, half stars are assigned to allow for more variation across \\ncontracts. \\nMethodology for Calculating Part C and Part D Summary Ratings \\nThe Part C and Part D summary ratings are calculated by taking a weighted average of the measure stars for \\nParts C and D, respectively. To receive a Part C and/or Part D summary rating, a contract must meet the \\nminimum number of rated measures. The Parts C and D improvement measures are not included in the count of \\nthe minimum number of rated measures. The minimum number of rated measures required is determined as \\nfollows:\", '(Last Updated 10/03/2024)  \\nPage 12 \\n \\n• If the total number of measures required for the organization type is odd, divide the number by two and \\nround it to a whole number. \\no Example: if there are 13 required Part D measures for the organization, 13 / 2 = 6.5, when \\nrounded the result is 7. The contract needs at least 7 measures with ratings out of the 13 total \\nmeasures to receive a Part D summary rating. \\n• If the total number of measures required for the organization type is even, divide the number of \\nmeasures by two. \\no Example: if there are 30 required Part C measures for the organization, 30 / 2 = 15. The contract \\nneeds at least 15 measures with ratings out of the 30 total measures to receive a Part C summary \\nrating. \\nTable 6 shows the minimum number of rated measures required by each contract type to receive a summary \\nrating. \\nTable 6: Minimum Number of Rated Measures Required for Part C and Part D Ratings by Contract Type \\nRating \\n1876 Cost † CCP w/o SNP CCP with SNP CCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nPart C summary \\n11 of 22 \\n13 of 26 \\n15 of 29 \\n9 of 17 \\n13 of 25 \\nN/A \\n13 of 26 \\nPart D summary \\n5 of 10* \\n6 of 11 \\n6 of 11 \\n5 of 9 \\nN/A \\n6 of 11 \\n6 of 11* \\n* Note: Does not apply to MA-Only, 1876 Cost, and PFFS contracts which do not offer drug benefits. \\n† Note: 1876 Cost contracts which do not submit data for the MPF measure must have ratings in 5 out of 9measures to receive a Part \\nD rating. \\nMethodology for Calculating the Overall MA-PD Rating \\nFor MA-PDs to receive an overall rating, the contract must have stars assigned to both the Part C and Part D \\nsummary ratings. If an MA-PD contract has only one of the two required summary ratings, the overall rating \\nwill show as “Not enough data available.” \\nThe overall rating for a MA-PD contract is calculated using a weighted average of the Part C and Part D \\nmeasure stars. The weights assigned to each measure are shown in Attachment G. \\nThere are a total of 42 measures (30 in Part C, 12 in Part D) in the 2025 Star Ratings. The following two \\nmeasures are contained in both the Part C and D measure lists: \\n• Complaints about the Health/Drug Plan (CTM) \\n• Members Choosing to Leave the Plan (MCLP) \\nThese measures share the same data source, so CMS includes only one instance of each of these two measures \\nin the calculation of the overall rating. In addition, the Part C and D improvement measures are not included in \\nthe count for the minimum number of measures. Therefore, a total of 38 distinct measures plus the two \\nimprovement measures are used in the calculation of the overall rating. \\nThe minimum number of rated measures required for an overall MA-PD rating is determined using the same \\nmethodology as for the Part C and D summary ratings. Table 7 provides the minimum number of rated \\nmeasures required for an overall Star Rating by contract type.', '(Last Updated 10/03/2024)  \\nPage 13 \\n \\nTable 7: Minimum Number of Rated Measures Required for an Overall Rating by Contract Type \\nRating \\n1876 Cost † CCP w/o SNP CCP with SNP CCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nOverall Rating \\n15 of 30* \\n18 of 35 \\n19 of 38 \\n12 of 24 \\nN/A \\nN/A \\n18 of 35* \\n* Note: Does not apply to MA-Only, 1876 Cost, and PFFS contracts which do not offer drug benefits. \\n† Note: 1876 Cost contracts which do not submit data for the MPF measure must have ratings in 15 out of 29 measures to receive an \\noverall rating. \\n \\nThe overall and summary Star Ratings are calculated based on the measures required to be collected and \\nreported for the contract type being offered for the Star Ratings year.  For example, the 2025 Star Ratings are \\ncalculated for the 2025 contract year using data primarily from measurement year 2023.  If a contract offered a \\nSNP PBP in measurement year 2023, but is no longer offering a SNP PBP for the 2025 contract year, the 2025 \\nStar Ratings exclude the SNP-only measures and the contract is rated as ‘‘Coordinated Care Plan without \\nSNP.’’ \\nCompleting the Summary and Overall Rating Calculations \\nThere are two adjustments made to the results of the summary and overall calculations described above.  First, \\nto reward consistently high performance, CMS utilizes both the mean and the variance of the measure stars to \\ndifferentiate contracts for the summary and overall ratings. If a contract has both high and stable relative \\nperformance, a reward factor is added to the contract’s ratings. Details about the reward factor can be found in \\nthe section entitled “Applying the Reward Factor.” Second, the summary and overall ratings include a \\nCategorical Adjustment Index (CAI) factor, which is added to or subtracted from a contract’s summary and \\noverall ratings. Details about the CAI can be found in the section entitled “Categorical Adjustment Index \\n(CAI).” \\nThe summary and overall rating calculations are run twice, once including the improvement measures and once \\nwithout including the improvement measures. Based on a comparison of the results of these two calculations a \\ndecision is made as to whether the improvement measures are to be included in calculating a contract’s final \\nsummary and overall ratings. Details about the application of the improvement measures can be found in the \\nsection entitled “Applying the Improvement Measure(s).” \\nLastly, standard rounding rules are applied to convert the results of the final summary and overall ratings \\ncalculations into the publicly reported Star Ratings. Details about the rounding rules are presented in the section \\n“Rounding Rules for Summary and Overall Ratings.” \\nApplying the Improvement Measure(s) \\nThe Part C Improvement Measure - Health Plan Quality Improvement (C27) and the Part D Improvement \\nMeasure - Drug Plan Quality Improvement (D04) were introduced earlier in this document in the section \\nentitled “Improvement Measures.” The measures and formulas for the improvement measures can be found in \\nAttachment I. This section discusses whether and how to apply the improvement measures in calculating a \\ncontract’s final summary and overall ratings. \\nSince high performing contracts have less room for improvement and consequently may have lower ratings on \\nthese measure(s), CMS has developed the following rules to not penalize contracts receiving 4 or more stars for \\ntheir highest rating.', '(Last Updated 10/03/2024)  \\nPage 14 \\n \\nMA-PD Contracts \\n1. There are separate Part C and Part D improvement measures (C27 & D04) for MA-PD contracts. \\na. C27 is used in calculating the Part C summary rating of an MA-PD contract. \\nb. D04 is used in calculating the Part D summary rating for an MA-PD contract. \\nc. Both improvement measures will be used when calculating the overall rating in step 3. \\n2. Calculate the overall rating for MA-PD contracts without including either improvement measure. \\n3. Calculate the overall rating for MA-PD contracts with both improvement measures included. \\n4. If an MA-PD contract in step 2 has 4 or more stars, compare the two overall ratings. If the rating in step \\n3 is less than the value in step 2, use the overall rating from step 2; otherwise use the result from step 3. \\n5. For all other MA-PD contracts, use the overall rating from step 3. \\n \\nMA-Only Contracts \\n1. Only the Part C improvement measure (C27) is used for MA-Only contracts. \\n2. Calculate the Part C summary rating for MA-Only contracts without including the improvement \\nmeasure. \\n3. Calculate the Part C summary rating for MA-Only contracts with the Part C improvement measure. \\n4. If an MA-Only contract in step 2 has 4 or more stars, compare the two Part C summary ratings. If the \\nrating in step 3 is less than the value in step 2, use the Part C summary rating from step 2; otherwise use \\nthe result from step 3. \\n5. For all other MA-Only contracts, use the Part C summary rating from step 3. \\n \\nPDP Contracts \\n1. Only the Part D improvement measure (D04) is used for PDP contracts. \\n2. Calculate the Part D summary rating for PDP contracts without including the improvement measure. \\n3. Calculate the Part D summary rating for PDP contracts with the Part D improvement measure. \\n4. If a PDP contract in step 2 has 4 or more stars, compare the two Part D summary ratings. If the rating in \\nstep 3 is less than the value in step 2, use the Part D summary rating from step 2; otherwise use the result \\nfrom step 3. \\n5. For all other PDP contracts, use the Part D summary rating from step 3. \\nApplying the Reward Factor \\nThe following represents the steps taken to calculate and include the reward factor (r-Factor) in the Star Ratings \\nsummary and overall ratings. These calculations are performed both with and without the improvement \\nmeasures included. \\n• Calculate the mean and the variance of all of the individual quality and performance measure stars at the \\ncontract level. \\no The mean is equal to the summary or overall rating before the reward factor is applied, which is \\ncalculated as described in the section entitled “Weighting of Measures.” \\no Using weights in the variance calculation accounts for the relative importance of measures in the \\nreward factor calculation. To incorporate the weights shown in Attachment G into the variance \\ncalculation of the available individual performance measures for a given contract, the steps are as \\nfollows:', '(Last Updated 10/03/2024)  \\nPage 15 \\n \\n• Subtract the summary or overall star from each performance measure’s star; square the \\nresults; and multiply each squared result by the corresponding individual performance \\nmeasure weight. \\n• Sum these results; call this ‘SUMWX.’ \\n• Set n equal to the number of individual performance measures available for the given \\ncontract. \\n• Set W equal to the sum of the weights assigned to the n individual performance measures \\navailable for the given contract. \\n• The weighted variance for the given contract is calculated as: n * SUMWX / (W * (n-1)). \\nFor the complete formula, please see Attachment H: Calculation of Weighted Star Rating \\nand Variance Estimates. \\n• Categorize the variance into three categories: \\no low (0 to < 30th percentile), \\no medium (≥ 30th to < 70th percentile) and \\no high (≥ 70th percentile) \\n• Develop the reward factor as follows: \\no r-Factor = 0.4 (for contract w/ low variance & high mean (mean ≥ 85th percentile)) \\no r-Factor = 0.3 (for contract w/ medium variance & high mean (mean ≥ 85th percentile)) \\no r-Factor = 0.2 (for contract w/ low variance & relatively high mean (mean ≥ 65th & < 85th \\npercentile)) \\no r-Factor = 0.1 (for contract w/ medium variance & relatively high mean (mean ≥ 65th & < 85th \\npercentile)) \\no r-Factor = 0.0 (for all other contracts) \\nTables 8 and 9 show the final threshold values used in reward factor calculations for the 2025 Star Ratings. \\nTable 8: Performance Summary Thresholds \\nImprovement Percentile \\nPart C Rating \\nPart D Rating (MA-PD) \\nPart D Rating (PDP) \\nOverall Rating \\nWith \\n65th \\n3.703125 \\n3.666667 \\n3.535714 \\n3.646465 \\nWith \\n85th \\n4.014493 \\n4.000000 \\n4.035714 \\n3.949495 \\nWithout \\n65th \\n3.707692 \\n3.718750 \\n3.687500 \\n3.662921 \\nWithout \\n85th \\n4.044118 \\n4.062500 \\n4.173913 \\n3.977528 \\n \\nTable 9: Variance Thresholds \\nImprovement Percentile \\nPart C Rating  \\nPart D Rating (MA-PD) \\nPart D Rating (PDP) \\nOverall Rating \\nWith \\n30th \\n0.820452 \\n0.742679 \\n0.847865 \\n0.828220 \\nWith \\n70th \\n1.275376 \\n1.268610 \\n1.533170 \\n1.240423 \\nWithout \\n30th \\n0.807024 \\n0.654297 \\n0.717578 \\n0.795388 \\nWithout \\n70th \\n1.256410 \\n1.210645 \\n1.508203 \\n1.216635 \\nCategorical Adjustment Index (CAI) \\nCMS has implemented an analytical adjustment called the Categorical Adjustment Index (CAI). The CAI is a \\nfactor that is added to or subtracted from a contract’s Overall and/or Summary Star Ratings to adjust for the', '(Last Updated 10/03/2024)  \\nPage 16 \\n \\naverage within-contract disparity in performance for Low Income Subsidy/Dual Eligible (LIS/DE) beneficiaries \\nand disabled beneficiaries.  The CAI value (factor) depends on the contract’s percentage of beneficiaries with \\nLIS/DE and the contract’s percentage of beneficiaries with disabled status. These adjustments are performed \\nboth with and without the improvement measures included. The value of the CAI varies by the contract’s \\npercentage of beneficiaries with LIS/DE and disability status. \\nThe CAI values use data collected for the 2024 Star Ratings. To calculate the CAI, case-mix adjustment is \\napplied to all clinical Star Rating measure scores that are not adjusted for SES using a beneficiary-level logistic \\nregression model with contract fixed effects and beneficiary-level indicators of LIS/DE and disability status, \\nsimilar to the approach currently used to adjust CAHPS patient experience measures. However, unlike CAHPS \\ncase-mix adjustment, the only adjusters are LIS/DE and disability status. Adjusted measure scores are then \\nconverted to measure stars using the 2024 rating year measure cutoffs and used to calculate Adjusted Overall \\nand Summary Star Ratings. Unadjusted Overall and Summary Star Ratings are also determined for each \\ncontract. \\nThe 2024 measures used in the 2025 CAI adjustment calculations are: \\n• Breast Cancer Screening (Part C) \\n• Colorectal Cancer Screening (Part C) \\n• Annual Flu Vaccine (Part C) \\n• Monitoring Physical Activity (Part C) \\n• Osteoporosis Management in Women who had a Fracture (Part C) \\n• Diabetes Care – Eye Exam (Part C) \\n• Diabetes Care – Blood Sugar Controlled (Part C) \\n• Controlling Blood Pressure (Part C) \\n• Reducing the Risk of Falling (Part C) \\n• Improving Bladder Control (Part C) \\n• Medication Reconciliation Post-Discharge (Part C) \\n• Plan All-Cause Readmissions (Part C) \\n• Statin Therapy for Patients with Cardiovascular Disease (Part C) \\n• Transitions of Care (Part C) \\n• Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions \\n(Part C) \\n• Medication Adherence for Diabetes Medication (Part D) \\n• Medication Adherence for Hypertension (RAS antagonists) (Part D) \\n• Medication Adherence for Cholesterol (Statins) (Part D) \\n• MTM Program Completion Rate for CMR (Part D) \\n• Statin Use in Patients with Diabetes (SUPD) (Part D) \\nTo determine the value of the CAI, contracts are first divided into an initial set of categories based on the \\ncombination of a contract’s LIS/DE and disability percentages. For the adjustment for the overall and summary \\nratings for MA-Only and MA-PD contracts, the initial groups are formed by the ten groups of LIS/DE and \\nquintiles of disability, thus resulting in 50 initial categories. For PDPs, the initial groups are formed using quartiles \\nfor both LIS/DE and disability. The mean differences between the Adjusted Overall or Summary Star Rating and \\nthe corresponding Unadjusted Star Rating for contracts in each initial category are determined and examined. \\nThe initial categories are collapsed to form final adjustment groups. The CAI values are the mean differences \\nbetween the Adjusted Overall or Summary Star Rating and the corresponding Unadjusted Star Rating for \\ncontracts within each final adjustment group. Separate CAI values are computed for the overall and summary', '(Last Updated 10/03/2024)  \\nPage 17 \\n \\nratings, and the rating-specific CAI value is the same for all contracts that fall within the same final adjustment \\ncategory. \\nThe categorization of contracts into final adjustment categories for the CAI relies on both the use of a contract’s \\npercentages of LIS/DE and disabled beneficiaries. Categories were chosen to enforce monotonicity. Puerto Rico \\nhas a unique health care market with a large percentage of low-income individuals in both Medicare and \\nMedicaid and a complex legal history that affects the health care system in many ways. Puerto Rican \\nbeneficiaries are not eligible for LIS. Since the percentage of LIS/DE is a critical element in the categorization \\nof contracts to identify the contract’s CAI, an additional adjustment is done for contracts that solely serve the \\npopulation of beneficiaries in Puerto Rico to address the lack of LIS. The additional analysis for the adjustment \\nresults in a modified percentage of LIS/DE beneficiaries that is subsequently used to categorize the contract in \\nits final adjustment category for the CAI. Details regarding the methodology for the Puerto Rico model are \\nprovided in Attachment O. \\nTables 10 and 11 provide the range of the percentages that correspond to the LIS/DE initial groups and \\ndisability quintiles for the determination of the CAI values for the Overall Rating. For example, if a contract’s \\npercentage of LIS/DE beneficiaries is 13.60%, the contract’s LIS/DE initial group would be L4. The upper limit \\nfor each initial category is only included for the highest categories (L10 and D5), and the upper limit is equal to \\n100% for both of these categories. \\n \\nTable 10: Categorization of Contract’s Members into LIS/DE Initial Groups for the Overall Rating \\nLIS/DE Initial Group \\nPercentage of Contract’s Beneficiaries who are LIS/DE \\n1 \\n \\n0.000000 to less than 6.130891 \\n2 \\n \\n6.130891 to less than 9.037945 \\n3 \\n \\n9.037945 to less than 13.131086 \\n4 \\n \\n13.131086 to less than 18.030927 \\n5 \\n \\n18.030927 to less than 25.257942 \\n6 \\n \\n25.257942 to less than 35.188560 \\n7 \\n \\n35.188560 to less than 50.161404 \\n8 \\n \\n50.161404 to less than 79.983090 \\n9 \\n \\n79.983090 to less than 100.000000 \\n10 \\n100.000000', '(Last Updated 10/03/2024)  \\nPage 18 \\n \\nTable 11: Categorization of Contract’s Members into Disability Quintiles for the Overall Rating \\nDisability Quintile \\nPercentage of Contract’s Beneficiaries who are Disabled \\n1 \\n \\n0.000000 to less than 14.607385 \\n2 \\n \\n14.607385 to less than 21.923598 \\n3 \\n \\n21.923598 to less than 31.057866 \\n4 \\n \\n31.057866 to less than 44.050502 \\n5 \\n \\n44.050502 to 100.000000 \\n \\nTable 12 provides the description of each of the final adjustment categories and the associated value of the CAI \\nper category for the overall rating. \\n \\nTable 12: Final Adjustment Categories and CAI Values for the Overall Rating \\nFinal Adjustment Category \\nLIS/DE Initial Group \\nDisability Quintile \\nCAI Value \\n1 \\nL1- L2 \\nD1 \\n-0.058127 \\n  \\nL1 \\nD2 \\n \\n2 \\nL1- L2 \\nD3 \\n-0.033597 \\n  \\nL2-L3 \\nD2 \\n \\n  \\nL3 \\nD1 \\n \\n3 \\nL4-L6 \\nD1 \\n-0.014802 \\n  \\nL4-L5 \\nD2 \\n \\n4 \\nL1-L5 \\nD4-D5 \\n0.002506 \\n  \\nL3-L6 \\nD3 \\n \\n  \\nL6-L7 \\nD2 \\n \\n  \\nL7-L8 \\nD1 \\n \\n5 \\nL6-L7 \\nD4-D5 \\n0.045230 \\n  \\nL7-L9 \\nD3 \\n \\n  \\nL8 \\nD2 \\n \\n  \\nL9-L10 \\nD1-D2 \\n \\n6 \\nL8 \\nD4-D5 \\n0.064707 \\n  \\nL9-L10 \\nD4 \\n \\n  \\nL10 \\nD3 \\n \\n7 \\nL9 \\nD5 \\n0.112056 \\n8 \\nL10 \\nD5 \\n0.134761 \\n \\nTables 13 and 14 provide the range of the percentages that correspond to the LIS/DE initial groups and \\ndisability quintiles for the initial categories for the determination of the CAI values for the Part C summary.', '(Last Updated 10/03/2024)  \\nPage 19 \\n \\nTable 13: Categorization of Contract’s Members into LIS/DE Initial Groups for the Part C Summary \\nLIS/DE Initial Group \\nPercentage of Contract’s Beneficiaries who \\nare LIS/DE \\n1 \\n \\n0.000000 to less than 5.855856 \\n2 \\n \\n5.855856 to less than 8.734793 \\n3 \\n \\n8.734793 to less than 12.640171 \\n4 \\n \\n12.640171 to less than 17.492877 \\n5 \\n \\n17.492877 to less than 24.793782 \\n6 \\n \\n24.793782 to less than 34.766754 \\n7 \\n \\n34.766754 to less than 49.936168 \\n8 \\n \\n49.936168 to less than 79.344262 \\n9 \\n \\n79.344262 to less than 100.000000 \\n10 \\n100.000000 \\n \\nTable 14: Categorization of Contract’s Members into Disability Quintiles for the Part C Summary \\nDisability Quintile \\nPercentage of Contract’s \\nBeneficiaries who are Disabled \\n1 \\n \\n0.000000 to less than 14.372597 \\n2 \\n \\n14.372597 to less than 21.743800 \\n3 \\n \\n21.743800 to less than 30.716563 \\n4 \\n \\n30.716563 to less than 44.001563 \\n5 \\n \\n44.001563 to 100.000000 \\n \\nTable 15 provides the description of each of the final adjustment categories for the Part C summary and the \\nassociated value of the CAI for each final adjustment category.', '(Last Updated 10/03/2024)  \\nPage 20 \\n \\nTable 15: Final Adjustment Categories and CAI Values for the Part C Summary  \\nFinal \\nAdjustment \\nCategory \\nLIS/DE Initial \\nGroup \\nDisability \\nQuintile \\nCAI Value \\n1 \\nL1 \\nD1 \\n-0.037897 \\n2 \\n L2 \\nD1 \\n-0.025930 \\n \\n L1-L2 \\nD2-D3 \\n \\n3 \\nL3-L4 \\nD1-D2 \\n-0.013018 \\n4 \\nL5-L8 \\nD1 \\n0.004257 \\n \\nL5-L7 \\nD2 \\n \\n \\nL3-L7 \\nD3 \\n \\n \\nL1-L5 \\nD4-D5 \\n \\n5 \\nL6-L7 \\nD4-D5 \\n0.023880 \\n6 \\nL8 \\nD2-D5 \\n0.038923 \\n \\nL9-10 \\nD1-D2 \\n \\n \\nL9 \\nD3 \\n \\n7 \\nL9 \\nD4-D5 \\n0.078480 \\n \\nL10 \\nD3-D4 \\n \\n8 \\nL10 \\nD5 \\n0.094759 \\n \\nTables 16 and 17 provide the range of the percentages that correspond to the LIS/DE initial groups and the \\ndisability quintiles for the initial categories for the determination of the CAI values for the Part D summary \\nrating for MA-PDs. \\n \\nTable 16: Categorization of Contract’s Members into LIS/DE Initial Groups for the MA-PD Part D Summary \\nLIS/DE Initial Group \\nPercentage of Contract’s Beneficiaries \\nwho are LIS/DE \\n1 \\n \\n0.000000 to less than 6.229975 \\n2 \\n \\n6.229975 to less than 9.567309 \\n3 \\n \\n9.567309 to less than 14.176508 \\n4 \\n \\n14.176508 to less than 19.916254 \\n5 \\n \\n19.916254 to less than 27.960199 \\n6 \\n \\n27.960199 to less than 40.979534 \\n7 \\n \\n40.979534 to less than 59.964116 \\n8 \\n \\n59.964116 to less than 91.207503 \\n9 \\n \\n91.207503 to less than 100.000000 \\n10 \\n100.000000', '(Last Updated 10/03/2024)  \\nPage 21 \\n \\nTable 17: Categorization of Contract’s Members into Disability Quintiles for the MA-PD Part D Summary \\nDisability Quintile \\nPercentage of Contract’s \\nBeneficiaries who are Disabled \\n1 \\n \\n0.000000 to less than 14.987453 \\n2 \\n \\n14.987453 to less than 22.882693 \\n3 \\n \\n22.882693 to less than 32.500000 \\n4 \\n \\n32.500000 to less than 45.560408 \\n5 \\n \\n45.560408 to 100.000000 \\n \\nTable 18 provides the description of each of the final adjustment categories for the MA-PD Part D summary and \\nthe associated values of the CAI for each final adjustment category. \\n \\nTable 18: Final Adjustment Categories and CAI Values for the MA-PD Part D Summary \\nFinal Adjustment \\nCategory \\nLIS/DE Initial \\nGroup \\nDisability \\nQuintile \\nCAI Value \\n1 \\nL1-L4 \\nD1 \\n-0.048532 \\n \\nL1 \\nD2 \\n \\n2 \\nL2-L4 \\nD2 \\n-0.031119 \\n3 \\nL1-L5 \\nD3 \\n-0.002424 \\n \\nL5-L8  \\nD1-D2 \\n \\n \\nL9-L10 \\nD1 \\n \\n4 \\nL1-L6 \\nD4-D5 \\n0.022709 \\nL6-L8 \\nD3 \\n \\n5 \\nL7-L8 \\nD4-D5 \\n0.074098 \\n \\nL9-L10 \\nD2-D4 \\n \\n6 \\nL9-L10 \\nD5 \\n0.126344 \\n \\nTables 19 and 20 provide the range of the percentages that correspond to the LIS/DE and disability quartiles for \\nthe initial categories for the determination of the CAI values for the PDP Part D summary. Quartiles are used \\nfor both dimensions due to the limited number of PDPs as compared to MA-PD contracts. \\n \\nTable 19: Categorization of Contract’s Members into Quartiles of LIS/DE for the PDP Part D Summary \\nLIS/DE Quartile \\nPercentage of Contract’s \\nBeneficiaries who are LIS/DE \\n1 \\n \\n0.000000 to less than 1.542070 \\n2 \\n \\n1.542070 to less than 3.159360 \\n3 \\n \\n3.159360 to less than 8.410224 \\n4 \\n \\n8.410224 to 100.000000', '(Last Updated 10/03/2024)  \\nPage 22 \\n \\nTable 20: Categorization of Contract’s Members into Quartiles of Disability for the PDP Part D Summary \\nDisability Quartile \\nPercentage of Contract’s \\nBeneficiaries who are Disabled \\n1 \\n \\n0.000000 to less than 6.593595 \\n2 \\n6.593595 to less than 10.621062 \\n3 \\n \\n10.621062 to less than 14.589481 \\n4 \\n \\n14.589481 to 100.000000 \\n \\nTable 21 provides the description of each of the final adjustment categories for the PDP Part D summary and \\nthe associated value of the CAI per final adjustment category. Note that the CAI values for the PDP Part D \\nsummary are different from the CAI values for the MA-PD Part D summary. There are three final adjustment \\ncategories for the PDP Part D summary. \\n \\nTable 21: Final Adjustment Categories and CAI Values for the PDP Part D Summary \\nFinal Adjustment \\nCategory \\nLIS/DE Quartile \\nDisability Quartile \\nCAI Value \\n1 \\nL1-L2 \\nD1-D2 \\n-0.230036 \\n2 \\nL1-L3 \\nD3-D4 \\n-0.081240 \\n  \\nL3-L4 \\nD1-D2 \\n \\n3 \\nL4 \\nD3-D4 \\n0.004293 \\nCalculation Precision \\nCMS and its contractors have always used software called SAS (an integrated system of software products \\nprovided by SAS Institute Inc.) to perform the calculations used in producing the Star Ratings. For all measures, \\nexcept the improvement measures, the precision used in scoring the measure is indicated next to the label “Data \\nDisplay” within the detailed description of each measure. The improvement measures are discussed below. The \\ndomain ratings are the unweighted average of the star measures and are rounded to the nearest integer. \\nThe improvement measures, summary, and overall ratings are calculated with at least six digits of precision \\nafter the decimal whenever the data allow it. The HEDIS measure scores have two digits of precision after the \\ndecimal. All other measures have at least six digits of precision when used in the improvement calculation. \\nContracts may request a contract-specific calculation spreadsheet which emulates the actual SAS calculations \\nfrom the Star Ratings mailbox during the second plan preview. \\nIt is not possible to replicate CMS’s calculations exactly due to factors including, but not limited to: using \\npublished measure data from sources other than CMS’s Star Rating program which use different rounding rules, \\nand exclusion of some contracts’ ratings from publicly-posted data (e.g., terminated contracts). \\nRounding Rules for Measure Scores \\nMeasure scores are rounded to the precision indicated next to the label “Data Display” within the detailed \\ndescription of each measure. Measure scores are rounded using traditional rounding rules. These are standard \\n“round to nearest” rules prior to cut point analysis. To obtain a value with the specified level of precision, the \\nsingle digit following the level of precision will be rounded. If the digit to be rounded is 0, 1, 2, 3 or 4, the value', '(Last Updated 10/03/2024)  \\nPage 23 \\n \\nis rounded down, with no adjustment to the preceding digit. If the digit to be rounded is 5, 6, 7, 8 or 9, the value \\nis rounded up, and a value of one is added to the preceding digit. After rounding, all digits after the specified \\nlevel of precision are removed. If rounding to a whole number, the digit to be rounded is in the first decimal \\nplace. If the digit in the first decimal place is below 5, then after rounding the whole number remains unchanged \\nand fractional parts of the number are deleted. If the digit in the first decimal place is 5 or greater, then the \\nwhole number is rounded up by adding a value of 1 and fractional parts of the number are deleted.  For \\nexample, a measure listed with a Data Display of “Percentage with no decimal point” that has a value of \\n83.499999 rounds down to 83, while a value of 83.500000 rounds up to 84. \\nRounding Rules for Summary and Overall Ratings \\nThe results of the summary and overall calculations are rounded to the nearest half star (i.e., 0.5, 1.0, 1.5, 2.0, \\n2.5, 3.0, 3.5, 4.0, 4.5, 5.0). Table 22 summarizes the rounding rules for converting the Part C and D summary \\nand overall ratings into the publicly reported Star Ratings. \\nTable 22: Rounding Rules for Summary and Overall Ratings \\nRaw Summary / Overall Score \\nFinal Summary / Overall \\nRating \\n≥ 0.000000 and < 0.250000 \\n0 \\n≥ 0.250000 and < 0.750000 \\n0.5 \\n≥ 0.750000 and < 1.250000 \\n1.0 \\n≥ 1.250000 and < 1.750000 \\n1.5 \\n≥ 1.750000 and < 2.250000 \\n2.0 \\n≥ 2.250000 and < 2.750000 \\n2.5 \\n≥ 2.750000 and < 3.250000 \\n3.0 \\n≥ 3.250000 and < 3.750000 \\n3.5 \\n≥ 3.750000 and < 4.250000 \\n4.0 \\n≥ 4.250000 and < 4.750000 \\n4.5 \\n≥ 4.750000 and ≤ 5.000000 \\n5.0 \\n \\nFor example, a summary or overall rating of 3.749999 rounds down to a rating of 3.5, and a rating of 3.750000 \\nrounds up to rating of 4. That is, a score would need to be at least halfway between 3.5 and 4 (having a \\nminimum value of 3.750000) in order to obtain the higher rating of 4. \\nMethodology for Calculating the High Performing Icon \\nA contract may receive a high performing icon as a result of its performance on the Parts C and/or D measures. \\nThe high performing icon is assigned to an MA-Only contract for achieving a 5-star Part C summary rating, a \\nPDP contract for a 5-star Part D summary rating, and an MA-PD contract for a 5-star overall rating. Figure 3 \\nshows the high performing icon used in the MPF:', '(Last Updated 10/03/2024)  \\nPage 24 \\n \\nFigure 3: The High Performing Icon \\n \\nMethodology for Calculating the Low Performing Icon \\nA contract can receive a low performing icon as a result of its performance on the Part C and/or Part D \\nsummary ratings. The low performing icon is calculated by evaluating the Part C and Part D summary ratings \\nfor the current year and the past two years (i.e., the 2023, 2024, and 2025 Star Ratings). If the contract had any \\ncombination of Part C and/or Part D summary ratings of 2.5 or lower in all three years of data, it is marked with \\na low performing icon (LPI). A contract must have a rating in either Part C and/or Part D for all three years to \\nbe considered for this icon. \\nFigure 4 shows the low performing contract icon used in the MPF: \\nFigure 4: The Low Performing Icon \\n \\n \\nTable 23 shows example contracts which would receive an LPI. \\nTable 23: Example LPI Contracts \\nContract/Rating Rated As 2023 C 2024 C 2025 C 2023 D 2024 D 2025 D LPI Awarded LPI Reason \\nHAAAA \\nMA-PD \\n2 \\n2.5 \\n2.5 \\n3 \\n3 \\n3 \\nYes \\nPart C \\nHBBBB \\nMA-PD \\n3 \\n3 \\n3 \\n2.5 \\n2 \\n2.5 \\nYes \\nPart D \\nHCCCC \\nMA-PD \\n2.5 \\n3 \\n3 \\n3 \\n2.5 \\n2.5 \\nYes \\nPart C or D \\nHDDDD \\nMA-PD \\n3 \\n2.5 \\n3 \\n2.5 \\n3 \\n2.5 \\nYes \\nPart C or D \\nHEEEE \\nMA-PD \\n2.5 \\n2 \\n2.5 \\n2 \\n2.5 \\n2.5 \\nYes \\nPart C and D \\nHFFFF \\nMA-Only \\n2.5 \\n2 \\n2.5 \\n- \\n- \\n- \\nYes \\nPart C \\nSAAAA \\nPDP \\n- \\n- \\n- \\n2.5 \\n2.5 \\n2 \\nYes \\nPart D \\nMergers, Novations, and Consolidations \\nThis section covers how the Star Ratings are affected by mergers, novation and consolidations. To ensure a \\ncommon understanding, we begin by defining each of the terms. \\n Merger: when two (or more) companies join together to become a single business. Each of these \\nseparate businesses had one or more contracts with CMS for offering health and/or drug services to \\nMedicare beneficiaries. After the merger, all of those individual contracts with CMS are still intact, only \\nthe ownership changes in each of the contracts to the name of the new single business. Mergers can \\noccur at any time during a contract year. \\n Novation: when one company acquires another company. Each of these separate businesses had one or \\nmore contracts with CMS for offering health and/or drug services to beneficiaries. After the novation, all \\nof those individual contracts with CMS are still intact. The owner’s names of the contracts acquired are \\nchanged to the new owner’s name. Novations can occur at any time during the contract year.', '(Last Updated 10/03/2024)  \\nPage 25 \\n \\n Consolidation: when an organization/sponsor that has at least two contracts with CMS for offering \\nhealth and/or drug services to beneficiaries combines multiple contracts into a single contract with CMS. \\nConsolidations occur only at the change of the contract year. The one or more contracts that will no \\nlonger exist at contract year’s end are known as the consumed contracts. The contract that will still exist \\nis known as the surviving contract and all of the beneficiaries still enrolled in the consumed contract(s) \\nare moved to the surviving contract.  \\nMergers and novations do not change the ratings earned by an individual contract in any way. \\nFor a merger or novation, the only change is the company listed as owning the contract; there is no change in \\ncontract structure, so the Star Ratings earned by the contract remains with them until the next rating cycle. This \\nincludes any High Performing or Low Performing icons earned by any of the contracts. \\nConsolidations become effective the first day of the calendar year. The Star Ratings are released the previous \\nOctober so they are available when open enrollment begins. In the first year following a consolidation, the \\nmeasure values used in calculating the Star Ratings of the surviving contract will be based on the enrollment-\\nweighted mean of all contracts in the consolidation (see Attachment B). The surviving contract’s ratings are \\nposted publicly, used in determining QBP ratings, and included in the Past Performance Analysis. \\nReliability Requirement for Low-enrollment Contracts \\nHEDIS measures for contracts whose enrollment as of July 2023 was at least 500 but less than 1,000 will be \\nincluded in the Star Ratings in 2025 when the contract-specific measure score reliability is equal to or greater \\nthan 0.7. The reliability calculations are implemented using SAS PROC MIXED as documented on pages 31-32 \\nof the report “The Reliability of Provider Profiling – A Tutorial,” available at \\nhttps://www.rand.org/pubs/technical_reports/TR653.html. \\nThe within-contract variance for the Transitions of Care composite measure utilizes a different formula than \\nother HEDIS pass/fail measures because it is an average of four component measures. First, the binomial \\nvariances and standard deviations (i.e. the square root of a variance term), as discussed in the report “The \\nReliability of Provider Profiling – A Tutorial”, are calculated for each of the four component measures. Next, \\npairwise correlations are computed among the four component measures. Pairwise covariance terms among the \\nfour component measures are calculated by multiplying the respective pairwise correlation and two items’ \\nstandard deviations together. The final within-contract variance for the Transitions of Care composite measure \\nis computed by summing the four variance terms and each pairwise covariance term multiplied by 2.0. \\nSpecial Needs Plan (SNP) Data \\nA Special Needs Plan (SNP) is a Medicare Advantage (MA) coordinated care plan (CCP) specifically designed \\nto provide targeted care and limits enrollment to special needs individuals. There are three major types of SNPs: \\n1) Chronic Condition SNP (C-SNP), 2) Dual Eligible SNP (D-SNP), and 3) Institutional SNP (I-SNP).  Further \\ndetails on SNP plans can be found in the glossary, Attachment R. \\nCMS has included three SNP-specific measures in the 2025 Star Ratings. The Part C ‘Special Needs Plan Care \\nManagement’ measure is based on data reported by contracts through the Medicare Part C Reporting \\nRequirements. The two Part C ‘Care for Older Adults’ measures are based on HEDIS data. The data for all of \\nthese measures are reported at the plan benefit package (PBP) level, while the Star Ratings are reported at the \\ncontract level.', '(Last Updated 10/03/2024)  \\nPage 26 \\n \\nThe methodology used to combine the PBP data to the contract level is different between the two data sources. \\nThe Part C Reporting Requirements data are summed into a contract-level rate after excluding PBPs that do not \\nmap to any PBP offered by the contract in the calendar year for which the Reporting Requirements data \\nunderwent data validation. The HEDIS data are summed into a contract-level rate as long as the contract will be \\noffering a SNP PBP in the Star Ratings year. \\nThe two methodologies used to combine the PBP data within a contract for these measures are described further \\nin Attachment E. \\nStar Ratings and Marketing \\nPlan sponsors must ensure the Star Ratings document and all marketing of Star Ratings information is \\ncompliant with CMS’s Medicare Marketing Guidelines. Failure to follow CMS’s guidance may result in \\ncompliance action against the contract. The Medicare Marketing Guidelines were issued as Chapters 2 and 3 of \\nthe Prescription Drug Benefit Manual and the Medicare Managed Care Manual, respectively. Please direct \\nquestions about marketing Star Ratings information to your Account Manager. \\nContact Information \\nThe contact below can assist you with various aspects of the Star Ratings. \\n• Part C & D Star Ratings: PartCandDStarRatings@cms.hhs.gov \\nIf you have questions or require information about the specific subject areas associated with the Star \\nRatings please write to those contacts directly and cc the Part C & D Star Ratings mailbox. \\n• CAHPS (MA & Part D): MP-CAHPS@cms.hhs.gov \\n• Call Center Monitoring: CallCenterMonitoring@cms.hhs.gov \\n• Compliance Activity Module issues (Part C): PartCCompliance@cms.hhs.gov \\n• Compliance Activity Module issues (Part D): PartD_Monitoring@cms.hhs.gov \\n• Demonstration (Medicare-Medicaid Plan) Ratings: mmcocapsmodel@cms.hhs.gov \\n• Disenrollment Reasons Survey: DisenrollSurvey@cms.hhs.gov \\n• HEDIS: HEDISquestions@cms.hhs.gov \\n• HOS: HOS@cms.hhs.gov \\n• HPMS Access issues: HPMS_Access@cms.hhs.gov \\n• HPMS Help Desk (all other HPMS issues): HPMS@cms.hhs.gov \\n• Marketing: marketing@cms.hhs.gov \\n• Part C Compliance Activity issues: PartCCompliance@cms.hhs.gov \\n• Part D Compliance Activity issues: PartD_Monitoring@cms.hhs.gov \\n• Plan Reporting (Part C): Partcplanreporting@cms.hhs.gov \\n• Plan Reporting (Part D): Partd-planreporting@cms.hhs.gov \\n• Plan Reporting Data Validation (Part C & D): PartCandD_Data_Validation@cms.hhs.gov', '(Last Updated 10/03/2024)  \\nPage 27 \\n \\n• QBP Ratings and Appeals questions: QBPAppeals@cms.hhs.gov \\n• QBP Payment or Risk Analysis questions: riskadjustment@cms.hhs.gov', '(Last Updated 10/03/2024)  \\nPage 28 \\n \\nFramework and Definitions for the Domain and Measure Details Section \\nThis page contains the formatting framework and definition of each sub-section that is used to describe the \\ndomain and measure details on the following pages. \\nDomain: The name of the domain to which the measures following this heading belong \\nMeasure: The measure ID and common name of the ratings measure \\nTitle \\nDescription \\nLabel for Stars: The label that appears with the stars for this measure on Medicare.gov. \\nLabel for Data: The label that appears with the numeric data for this measure on HPMS and \\nCMS.gov. \\nDescription: The English language description shown for the measure on Medicare.gov. The text \\nin this sub-section has been prepared to aid beneficiaries’ understanding of the \\nnature and the purpose of the measure. We strongly encourage any public-facing \\nexplanation of the measure to use this description. \\n \\nHEDIS Label: Optional – contains the full NCQA HEDIS measure name. \\nMeasure Reference: Optional – this sub-section contains the location of the detailed measure specification \\nin the NCQA documentation for all HEDIS and HEDIS-HOS measures. \\nMetric: Defines how the measure is calculated. \\nPrimary Data Source: The primary source of the data used in the measure. \\nData Source Description: Optional – contains information about additional data sources needed for calculating \\nthe measure. \\nData Source Category: The category of this data source. \\nExclusions: Optional – lists any exclusions applied to the data used for the measure. \\nGeneral Notes: Optional – contains additional information about the measure and the data used. \\nData Time Frame: The time frame of data used from the data source. In some HEDIS measures this \\ndate range may appear to conflict with the specific data time frame defined in the \\nNCQA Technical Specifications. In those cases, the data used by CMS are \\nunchanged from what was submitted to NCQA. CMS uses the data time frame of the \\noverall HEDIS submission which is the HEDIS measurement year. \\nGeneral Trend: Indicates whether high values are better or low values are better for the measure. \\nStatistical Method: The methodology used for assigning stars in this measure; see the section entitled \\n“Methodology for Assigning Part C and Part D Measure Star Ratings” for an \\nexplanation of each of the possible entries in this sub-section. \\nImprovement Measure: Indicates whether this measure is included in the improvement measure. \\nCAI Usage: Indicates if the measure is used in the Categorical Adjustment Index calculation. \\nCase-Mix Adjusted: Indicates if the data are case mix adjusted prior to being used for the Star Ratings.', '(Last Updated 10/03/2024)  \\nPage 29 \\n \\nTitle \\nDescription \\nWeighting Category: The weighting category of this measure. \\nWeighting Value: The numeric weight for this measure in the summary and overall rating calculations. \\nMeaningful Measure Area: Contains the area where this measure fits into the Meaningful Measure Framework. \\nCMIT #: The CMS Measure Inventory Tool (CMIT) is the repository of record for information \\nabout the measures which CMS uses to promote healthcare quality and quality \\nimprovement. \\nData Display: The format used to the display the numeric data on Medicare.gov \\nReporting Requirements: Table indicating which organization types are required to report the measure. “Yes” \\nfor organizations required to report; “No” for organizations not required to report. \\nCut Points: Table containing the cut points used in the measure.  For non-CAHPS measures, \\nexcluding new measures and measures with substantive specification changes that \\nhave been in the Part C and D Star Ratings for three years or less, the cut points are \\nafter the application of Tukey outlier deletion, mean resampling, and guardrails. New \\nmeasures and measures with substantive specification changes that have been in \\nthe Part C and D Star Ratings program for three years or less, and the Health Plan \\nQuality Improvement and Drug Plan Quality Improvement measure cut points are \\nafter the application of Tukey outlier deletion and mean resampling. For CAHPS \\nmeasures, the table contains the base group cut points which are used prior to the \\nfinal star assignment rules being applied.', '(Last Updated 10/03/2024)  \\nPage 30 \\n \\nPart C Domain and Measure Details \\nSee Attachment C for the national averages of individual Part C measures. \\nDomain: 1 - Staying Healthy: Screenings, Tests and Vaccines \\nMeasure: C01 - Breast Cancer Screening \\nTitle \\nDescription \\nLabel for Stars: Breast Cancer Screening \\nLabel for Data: Breast Cancer Screening \\nDescription: Percent of female plan members aged 52-74 who had a mammogram during the past \\ntwo years. \\nHEDIS Label: Breast Cancer Screening (BCS) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 606 \\nMetric: The percentage of women MA enrollees 50 to 74 years of age (denominator) as of \\nDecember 31 of the measurement year who had a mammogram to screen for breast \\ncancer in the past two years (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: • Members in hospice or using hospice services any time during the measurement \\nperiod. \\n• Members receiving palliative care any time during the measurement period. \\n• Medicare members 66 years of age and older as of December 31 of the measurement \\nyear who meet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \\nto determine if a member had an LTI flag during the measurement year. \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nfrailty and advanced illness during the measurement year. Members must meet BOTH \\nof the following frailty and advanced illness criteria to be excluded: \\n– At least two indications of frailty with different dates of service during the \\nmeasurement period. \\n– At least two outpatient visits, observation visits, ED visits, telephone visits, e-visits or \\nvirtual check-ins, or nonacute inpatient encounters or nonacute inpatient discharges on \\ndifferent dates of service, with an advanced illness diagnosis. Visit type need not be the \\nsame for the two visits.  \\n• Members receiving palliative care during the measurement year \\n• Members who had a bilateral mastectomy or both right and left unilateral \\nmastectomies any time during the member’s history through December 31 of the \\nmeasurement year. Any of the following meet criteria for bilateral mastectomy: \\n– Bilateral mastectomy.  \\n– Unilateral mastectomy with a bilateral modifier (same procedure). \\n– Two unilateral mastectomies found in clinical data with a bilateral modifier (same \\nprocedure).', '(Last Updated 10/03/2024)  \\nPage 31 \\n \\nTitle \\nDescription \\n– History of bilateral mastectomy.  \\n• Any combination of the following that indicate a mastectomy on both the left and right \\nside on the same or on different dates of service: \\n–Unilateral mastectomy with a right-side modifier (same procedure). \\n– Unilateral mastectomy with a left-side modifier (same procedure). \\n        \\n– Absence of the left breast. \\n– Absence of the right breast.    \\n– Left unilateral mastectomy. \\n– Right unilateral mastectomy.  \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00093-02-C-PARTC \\nData Display: Percentage with no decimal place', '(Last Updated 10/03/2024)  \\nPage 32 \\n \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 53 % \\n>= 53 % to < 67 % \\n>= 67 % to < 75 % \\n>= 75 % to < 82 % \\n>= 82 % \\n \\nMeasure: C02 - Colorectal Cancer Screening \\nTitle \\nDescription \\nLabel for Stars: Colorectal Cancer Screening \\nLabel for Data: Colorectal Cancer Screening \\nDescription: Percent of plan members aged 50-75 who had appropriate screening for colon cancer. \\nHEDIS Label: Colorectal Cancer Screening (COL) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 102 \\nMetric: The percentage of MA enrollees aged 50 to 75 (denominator) as of December 31 of the \\nmeasurement year who had appropriate screenings for colorectal cancer (numerator). \\nPrimary Data Source: HEDIS Patient-level Data \\nData Source Category: Health and Drug Plans \\nExclusions: • Medicare members 66 years of age and older as of December 31 of the measurement \\nyear who meet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File. \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nfrailty and advanced illness during the measurement year. Members must meet both of \\nthe frailty and advanced illness criteria to be excluded: \\n1. – At least two indications of frailty with different dates of service during the \\nmeasurement year. \\n2. – Any of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years): \\n– At least two outpatient visits, observation visits, ED visits, telephone visits, e-\\nvisits or virtual check-ins, nonacute inpatient encounters, or nonacute inpatient \\ndischarges. Visit type need not be the same for the two visits.  \\n– At least one acute inpatient encounter with an advanced illness diagnosis. \\n– At least one acute inpatient discharge with an advanced illness diagnosis on \\nthe discharge claim.  \\n– A dispensed dementia medication.  \\n \\n• (Required) Exclude members who meet any of the following criteria: \\n– Members who had colorectal cancer or a total colectomy any time during the \\nmember’s history through December 31 of the measurement year. \\n– Members receiving palliative care during the measurement year. \\n– Members in hospice or using hospice services during the measurement year.', '(Last Updated 10/03/2024)  \\nPage 33 \\n \\nTitle \\nDescription \\n– Members receiving palliative care during the measurement year. \\n– Members who died during the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the enrollment \\nreport and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00139-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 53 % \\n>= 53 % to < 65 % \\n>= 65 % to < 75 % \\n>= 75 % to < 83 % \\n>= 83 %', \"(Last Updated 10/03/2024)  \\nPage 34 \\n \\nMeasure: C03 - Annual Flu Vaccine \\nTitle \\nDescription \\nLabel for Stars: Yearly Flu Vaccine \\nLabel for Data: Yearly Flu Vaccine \\nDescription: Percent of plan members who got a vaccine (flu shot). \\nMetric: The percentage of sampled Medicare enrollees (denominator) who received an \\ninfluenza vaccination (numerator). \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Question (question number varies depending on survey type): \\n \\n• Have you had a flu shot since July 1, 2023? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: This measure is not case-mix adjusted. \\n \\nCAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00259-01-C-PARTC \\nData Display: Percentage with no decimal place\", '(Last Updated 10/03/2024)  \\nPage 35 \\n \\nTitle \\nDescription \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 61 \\n>= 61 to < 65 \\n>= 65 to < 71 \\n>= 71 to < 76 \\n>= 76 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C04 - Monitoring Physical Activity \\nTitle \\nDescription \\nLabel for Stars: Monitoring Physical Activity \\nLabel for Data: Monitoring Physical Activity \\nDescription: Percent of senior plan members who discussed exercise with their doctor and were \\nadvised to start, increase, or maintain their physical activity during the year. \\nHEDIS Label: Physical Activity in Older Adults (PAO) \\nMeasure Reference: NCQA HEDIS Measurement Year 2022 Specifications for the Medicare Health \\nOutcomes Survey Volume 6, page 36 \\nMetric: The percentage of sampled Medicare members 65 years of age or older who had a \\ndoctor’s visit in the past 12 months (denominator) and who received advice to start, \\nincrease or maintain their level exercise or physical activity (numerator). \\nPrimary Data Source: HEDIS-HOS \\nData Source Description: Cohort 24 Follow-up Data collection (2023) and Cohort 26 Baseline data collection \\n(2023). \\n \\nHOS Survey Question 42: In the past 12 months, did you talk with a doctor or other \\nhealth provider about your level of exercise or physical activity? For example, a doctor \\nor other health provider may ask if you exercise regularly or take part in physical \\nexercise. \\n \\nHOS Survey Question 43: In the past 12 months, did a doctor or other health care \\nprovider advise you to start, increase or maintain your level of exercise or physical \\nactivity? For example, in order to improve your health, your doctor or other health \\nprovider may advise you to start taking the stairs, increase walking from 10 to 20 \\nminutes every day or to maintain your current exercise program. \\nData Source Category: Survey of Enrollees \\nExclusions: Members who responded \"I had no visits in the past 12 months\" to Question 42 are \\nexcluded from results calculations for Question 43. Contracts must achieve a \\ndenominator of at least 100 to obtain a reportable result. If the denominator is less than \\n100, the measure result will be \"Not enough data available.\" Members with evidence \\nfrom CMS administrative records of a hospice start date are excluded. \\nData Time Frame: 07/17/2023 – 11/01/2023', '(Last Updated 10/03/2024)  \\nPage 36 \\n \\nTitle \\nDescription \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2022 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00450-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 41 % \\n>= 41 % to < 47 % \\n>= 47 % to < 52 % \\n>= 52 % to < 60 % \\n>= 60 %', '(Last Updated 10/03/2024)  \\nPage 37 \\n \\nDomain: 2 - Managing Chronic (Long Term) Conditions \\nMeasure: C05 - Special Needs Plan (SNP) Care Management \\nTitle \\nDescription \\nLabel for Stars: Members Whose Plan Did an Assessment of Their Health Needs and Risks \\nLabel for Data: Members Whose Plan Did an Assessment of Their Health Needs and Risks \\nDescription: Percent of members whose plan did an assessment of their health needs and risks in \\nthe past year. The results of this review are used to help the member get the care they \\nneed. (Medicare does not collect this information from all plans. Medicare collects it only \\nfor Special Needs Plans. These plans are a type of Medicare Advantage plan designed \\nfor certain people with Medicare. Some Special Needs Plans are for people with certain \\nchronic diseases and conditions, some are for people who have both Medicare and \\nMedicaid, and some are for people who live in an institution such as a nursing home.) \\nMetric: This measure is defined as the percent of eligible Special Needs Plan (SNP) enrollees \\nwho received a health risk assessment (HRA) during the measurement year. The \\ndenominator for this measure is the sum of the number of new enrollees due for an \\nInitial HRA (Element A) and the number of enrollees eligible for an annual reassessment \\nHRA (Element B). The numerator for this measure is the sum of the number of initial \\nHRAs performed on new enrollees (Element C) and the number of annual \\nreassessments performed on enrollees eligible for a reassessment (Element F). The \\nequation for calculating the SNP Care Management Assessment Rate is: \\n \\n [Number of initial HRAs performed on new enrollees (Element C)  \\n + Number of annual reassessments performed on enrollees eligible for a reassessment \\n(Element F)]  \\n / [Number of new enrollees due for an Initial HRA (Element A)  \\n + Number of enrollees eligible for an annual reassessment HRA (Element B)] \\nPrimary Data Source: Part C Plan Reporting \\nData Source Description: Data reported by contracts to CMS per the 2023 Part C Reporting Requirements. \\nValidation for data performed during the 2024 Data Validation cycle (data pulled June \\n2023). Validation of these data was performed retrospectively during the 2024 data \\nvalidation cycle (deadline June 15, 2024 and data validation results pulled July 2024). \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts and PBPs with an effective termination date on or before the deadline to \\nsubmit data validation results to CMS (June 15, 2024) are excluded and listed as “No \\ndata available.” \\n \\nSNP Care Management Assessment Rates are not provided for contracts that did not \\nscore at least 95% on data validation for the SNP Care Management reporting section \\nor were not compliant with data validation standards/sub-standards for any of the \\nfollowing SNP Care Management data elements. We define a contract as being non-\\ncomplaint if either it receives a \"No\" or a 1, 2, or 3 on the 5-point Likert scale in the \\nspecific data element\\'s data validation. \\n   • Number of new enrollees due for an initial HRA (Element A) \\n   • Number of enrollees eligible for an annual reassessment HRA (Element B) \\n   • Number of initial HRAs performed on new enrollees (Element C)', '(Last Updated 10/03/2024)  \\nPage 38 \\n \\nTitle \\nDescription \\n   • Number of annual reassessments performed on enrollees eligible for reassessment \\n(Element F) \\n \\nContracts excluded from the SNP Care Management Assessment Rates due to data \\nvalidation issues are shown as “CMS identified issues with this plan\\'s data.” \\n \\nContracts can view their data validation results in HPMS (https://hpms.cms.gov/). To \\naccess this page, from the top menu select “Monitoring,” then “Plan Reporting Data \\nValidation.” Select the appropriate contract year. Select the PRDVM Reports. Select \\n“Score Detail Report.” Select the applicable reporting section.  If you cannot see the \\nPlan Reporting Data Validation module, contact CMSHPMS_Access@cms.hhs.gov. \\n \\nAdditionally, contracts must have 30 or more enrollees in the denominator [Number of \\nnew enrollees due for an Initial HRA (Element A) + Number of enrollees eligible for an \\nannual HRA (Element B) ≥ 30] in order to have a calculated rate. Contracts with fewer \\nthan 30 eligible enrollees are listed as \"No data available.” \\nGeneral Notes: More information about the data used to calculate this measure can be found in \\nAttachment E. \\n \\nThe Part C reporting requirement fields listed below are not used in calculating this \\nmeasure: \\n      • Data Element D Number of initial HRA refusals \\n      • Data Element E Number of initial HRAs where SNP is unable to reach new \\nenrollees \\n      • Data Element G Number of annual reassessment refusals \\n      • Data Element H Number of annual reassessments where SNP is unable to reach \\nenrollee \\n \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions', '(Last Updated 10/03/2024)  \\nPage 39 \\n \\nTitle \\nDescription \\nCMIT #: 00685-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nNo \\nYes \\nYes \\nNo \\nNo \\nNo \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 46 % \\n>= 46 % to < 62 % \\n>= 62 % to < 76 % \\n>= 76 % to < 89 % \\n>= 89 % \\n \\nMeasure: C06 - Care for Older Adults – Medication Review \\nTitle \\nDescription \\nLabel for Stars: Yearly Review of All Medications and Supplements Being Taken \\nLabel for Data: Yearly Review of All Medications and Supplements Being Taken \\nDescription: Percent of plan members whose doctor or clinical pharmacist reviewed a list of \\neverything they take (prescription and non-prescription drugs, vitamins, herbal \\nremedies, other supplements) at least once a year.  \\n(Medicare does not collect this information from all plans. Medicare collects it only for \\nSpecial Needs Plans. These plans are a type of Medicare Advantage plan designed for \\ncertain people with Medicare. Some Special Needs Plans are for people with certain \\nchronic diseases and conditions, some are for people who have both Medicare and \\nMedicaid, and some are for people who live in an institution such as a nursing home.) \\nHEDIS Label: Care for Older Adults (COA) – Medication Review \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 115 \\nMetric: The percentage of Medicare Advantage Special Needs Plan enrollees 66 years and \\nolder (denominator) who received at least one medication review (Medication Review \\nValue Set) conducted by a prescribing practitioner or clinical pharmacist during the \\nmeasurement year and the presence of a medication list in the medical record \\n(Medication List Value Set) (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: SNP benefit packages whose enrollment was less than 30 as of February 2023 SNP \\nComprehensive Report were excluded from this measure. \\n \\nExclude members in hospice or using hospice services or who died any time during the \\nmeasurement year. \\nGeneral Notes: The formula used to calculate this measure can be found in Attachment E. \\nData Time Frame: 01/01/2023 – 12/31/2023', '(Last Updated 10/03/2024)  \\nPage 40 \\n \\nTitle \\nDescription \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00110-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nNo \\nYes \\nYes \\nNo \\nNo \\nNo \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 53 % \\n>= 53 % to < 80 % \\n>= 80 % to < 92 % \\n>= 92 % to < 98 % \\n>= 98 % \\n \\nMeasure: C07 - Care for Older Adults – Pain Assessment \\nTitle \\nDescription \\nLabel for Stars: Yearly Pain Screening or Pain Management Plan \\nLabel for Data: Yearly Pain Screening or Pain Management Plan \\nDescription: Percent of plan members who had a pain screening at least once during the year.  \\n(Medicare does not collect this information from all plans. Medicare collects it only for \\nSpecial Needs Plans. These plans are a type of Medicare Advantage plan designed for \\ncertain people with Medicare. Some Special Needs Plans are for people with certain \\nchronic diseases and conditions, some are for people who have both Medicare and \\nMedicaid, and some are for people who live in an institution such as a nursing home.) \\nHEDIS Label: Care for Older Adults (COA) – Pain Screening \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 115', '(Last Updated 10/03/2024)  \\nPage 41 \\n \\nTitle \\nDescription \\nMetric: The percentage of Medicare Advantage Special Needs Plan enrollees 66 years and \\nolder (denominator) who received at least one pain assessment (Pain Assessment \\nValue Set) plan during the measurement year (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: SNP benefit packages whose enrollment was less than 30 as of February 2023 SNP \\nComprehensive Report were excluded from this measure. \\n \\nExclude members in hospice or using hospice services or who died any time during the \\nmeasurement year. \\nGeneral Notes: The formula used to calculate this measure can be found in Attachment E. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Wellness and Prevention \\nCMIT #: 00111-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nNo \\nYes \\nYes \\nNo \\nNo \\nNo \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 60 % \\n>= 60 % to < 81 % \\n>= 81 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 %', '(Last Updated 10/03/2024)  \\nPage 42 \\n \\nMeasure: C08 - Osteoporosis Management in Women who had a Fracture \\nTitle \\nDescription \\nLabel for Stars: Osteoporosis Management \\nLabel for Data: Osteoporosis Management \\nDescription: Percent of female plan members who broke a bone and got screening or treatment for \\nosteoporosis within 6 months. \\nHEDIS Label: Osteoporosis Management in Women Who Had a Fracture (OMW) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 232 \\nMetric: The percentage of woman MA enrollees 67 - 85 who suffered a fracture (denominator) \\nand who had either a bone mineral density (BMD) test or prescription for a drug to treat \\nosteoporosis in the six months after the fracture (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: • Members who had a BMD test (Bone Mineral Density Tests Value Set) during the 730 \\ndays (24 months) prior to the IESD.  \\n• Members who had a claim/encounter for osteoporosis therapy (Osteoporosis \\nMedications Value Set) during the 365 days (12 months) prior to the IESD. \\n• Members who received a dispensed prescription or had an active prescription to treat \\nosteoporosis (Osteoporosis Medications List) during the 365 days (12 months) prior to \\nthe IESD.  \\n• Members in hospice or using hospice services any time during the measurement year. \\n• Members who died any time during the measurement year. \\n• Members who received palliative care any time during the intake period through the \\nend of the measurement year. \\n• Members 67 years of age and older as of December 31 of the measurement year who \\nmeet either of the following: \\n– \\nMembers who are enrolled in an Institutional SNP (I-SNP) any time during \\nthe measurement year. \\n– \\nMembers living long-term in an institution any time during the measurement \\nyear. \\n• Members 67-80 years of age as of December 31 of the measurement year with frailty \\nand advanced illness. Members must meet both of the following frailty and advanced \\nillness criteria to be excluded: \\n• At least two indications of frailty with different dates of service during the intake \\nperiod through the end of the measurement year. \\n• Any of the following during the measurement year or the year prior to the \\nmeasurement year: \\n• At least two outpatient visits, observation visits, ED visits, telephone \\nvisits, e-visits or virtual check-ins, nonacute inpatient encounters or \\nnonacute inpatient discharges on different dates of service, with an \\nadvanced illness diagnosis.  \\n• At least one acute inpatient encounter with an advanced illness \\ndiagnosis.  \\n• At least on acute inpatient discharge with an advanced illness diagnosis \\non the discharge claim.', '(Last Updated 10/03/2024)  \\nPage 43 \\n \\nTitle \\nDescription \\n• A dispenses dementia medication. \\n• Members 81 years of age and older as of December 31 of the measurement year with \\nat least two indications of frailty with different dates of service during the intake period \\nthrough the end of the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00484-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 27 % \\n>= 27 % to < 39 % \\n>= 39 % to < 52 % \\n>= 52 % to < 71 % \\n>= 71 %', '(Last Updated 10/03/2024)  \\nPage 44 \\n \\nMeasure: C09 - Diabetes Care – Eye Exam \\nTitle \\nDescription \\nLabel for Stars: Eye Exam to Check for Damage from Diabetes \\nLabel for Data: Eye Exam to Check for Damage from Diabetes \\nDescription: Percent of plan members with diabetes who had an eye exam to check for damage from \\ndiabetes during the year. \\nHEDIS Label: Eye Exam for Patients with Diabetes (EED) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 203 \\nMetric: The percentage of diabetic MA enrollees age 18-75 with diabetes (type 1 and type 2) \\n(denominator) who had an eye exam (retinal) performed during the measurement year \\n(numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: • Medicare members 66 years of age and older as of December 31 of the measurement \\nyear who meet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File.  \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nboth frailty and advanced illness during the measurement year. Members must meet \\nboth the following frailty and advanced illness criteria to be excluded: \\n \\nAt least two indications of frailty with different dates of service during the \\nmeasurement year.  \\n \\nAny of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years): \\no At least two outpatient visits, observation visits, ED visits, telephone \\nvisits, e-visits or virtual check-ins, nonacute inpatient encounters, \\nnonacute inpatient discharges on different dates of service, with an \\nadvanced illness diagnosis.  \\no At least one acute inpatient encounter with an advanced illness \\ndiagnosis.  \\no At least one acute inpatient discharge with an advanced illness diagnosis \\non the discharge claim.  \\no A dispensed dementia medication.  \\n \\n• (Required) Exclude members who meet any of the following criteria: \\n– Members who did not have a diagnosis of diabetes, in any setting, during the \\nmeasurement year or the year prior to the measurement year and who had a diagnosis \\nof polycystic ovarian syndrome, gestational diabetes or steroid-induced diabetes, in any \\nsetting, during the measurement year or the year prior to the measurement year. \\n– Members in hospice or using hospice services any time during the measurement year.', '(Last Updated 10/03/2024)  \\nPage 45 \\n \\nTitle \\nDescription \\n– Members who died any time during the measurement year.  \\n– Members receiving palliative care any time during the measurement year.  \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00203-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 57 % \\n>= 57 % to < 70 % \\n>= 70 % to < 77 % \\n>= 77 % to < 83 % \\n>= 83 %', '(Last Updated 10/03/2024)  \\nPage 46 \\n \\nMeasure: C10 - Diabetes Care – Blood Sugar Controlled \\nTitle \\nDescription \\nLabel for Stars: Plan Members with Diabetes whose Blood Sugar is Under Control \\nLabel for Data: Plan Members with Diabetes whose Blood Sugar is Under Control \\nDescription: Percent of plan members with diabetes who had an A1c lab test during the year that \\nshowed their average blood sugar is under control. \\nHEDIS Label: Hemoglobin A1c Control for Patients with Diabetes (HBD) – HbA1c poor control (>9.0%) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 184 \\nMetric: The percentage of diabetic MA enrollees age 18-75 (denominator) whose most recent \\nHbA1c level is greater than 9%, or who were not tested during the measurement year \\n(numerator). (This measure for public reporting is reverse scored so higher scores are \\nbetter.) To calculate this measure, subtract the submitted rate from 100. \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: • Medicare members 66 years of age and older as of December 31 of the measurement \\nyear who meet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File.  \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nboth frailty and advanced illness during the measurement year. Members must meet \\nboth the following frailty and advanced illness criteria to be excluded: \\n \\n \\nAt least two indications of frailty with different dates of service during the \\nmeasurement year.  \\n \\nAny of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years): \\no At least two outpatient visits, observation visits, ED visits, telephone \\nvisits, e-visits or virtual check-ins, nonacute inpatient encounters, or \\nnonacute inpatient discharges on different dates of service, with an \\nadvanced illness diagnosis.  \\no At least one acute inpatient encounter with an advanced illness \\ndiagnosis.  \\no At least one acute inpatient discharge with an advanced illness diagnosis \\non the discharge claim.  \\no A dispensed dementia medication.  \\n \\n• (Required) Exclude members who meet any of the following criteria: \\n– Members who did not have a diagnosis of diabetes, in any setting, during the \\nmeasurement year or the year prior to the measurement year and who had a diagnosis \\nof polycystic ovarian syndrome, gestational diabetes or steroid-induced diabetes, in any \\nsetting, during the measurement year or the year prior to the measurement year.', '(Last Updated 10/03/2024)  \\nPage 47 \\n \\nTitle \\nDescription \\n \\n– Members in hospice or using hospice services any time during the measurement year.  \\n– Members who died any time during the measurement year.  \\n– Members receiving palliative care any time during the measurement year.  \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00204-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 49 % \\n>= 49 % to < 72 % \\n>= 72 % to < 84 % \\n>= 84 % to < 90 % \\n>= 90 %', '(Last Updated 10/03/2024)  \\nPage 48 \\n \\nMeasure: C11 - Controlling Blood Pressure \\nTitle \\nDescription \\nLabel for Stars: Controlling Blood Pressure \\nLabel for Data: Controlling Blood Pressure \\nDescription: Percent of plan members with high blood pressure who got treatment and were able to \\nmaintain a healthy pressure. \\nHEDIS Label: Controlling High Blood Pressure (CBP) \\nMeasure Reference: NCQA HEDIS MY 2023 Technical Specifications Volume 2, page 152 \\nMetric: The percentage of MA members 18–85 years of age who had a diagnosis of \\nhypertension (HTN) (denominator) and whose blood pressure (BP) was adequately \\ncontrolled (<140/90 mm Hg) (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Exclude members who meet any of the following criteria: \\n• Members 66 years of age and older as of December 31 of the measurement year who \\nmeet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \\nto determine if a member had an LTI flag during the measurement year. \\n• Members 81 years of age and older as of December 31 of the measurement year with \\nat least two indications of frailty with different dates of service during the measurement \\nyear. \\n• Members 66–80 years of age and older as of December 31 of the measurement year \\nwith frailty and advanced illness. Members must meet both of the following frailty and \\nadvanced illness criteria to be excluded: \\n• \\nAt least two indications of frailty with different dates of service during the \\nmeasurement year.  \\n• \\nAny of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years): \\n• \\nAt least two outpatient visits, observation visits, ED visits, \\ntelephone visits, e-visits or virtual check-ins, nonacute inpatient \\nencounters, or nonacute inpatient discharges on different dates \\nof service, with an advanced illness diagnosis.  \\n• \\nAt least one acute inpatient encounter with an advanced illness \\ndiagnosis. \\n• \\nAt least one acute inpatient discharge with an advanced illness \\ndiagnosis on the discharge claim.  \\n• \\nA dispensed dementia medication. \\n  \\n• (Required) Exclude members who meet any of the following criteria: \\n \\n– • Members with evidence of end-stage renal', '(Last Updated 10/03/2024)  \\nPage 49 \\n \\nTitle \\nDescription \\ndisease (ESRD), dialysis, nephrectomy, or kidney transplant any time during the \\nmember’s history on or prior to December 31 of the measurement year.   \\n– • Members receiving palliative care during the measurement year. \\n– • Members with a diagnosis of pregnancy \\n  during the measurement year. \\n– • Members in hospice or using hospice services any time during the \\nmeasurement year. \\n– • Members who died any time during the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcomes Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00167-02-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 69 % \\n>= 69 % to < 74 % \\n>= 74 % to < 80 % \\n>= 80 % to < 85 % \\n>= 85 %', '(Last Updated 10/03/2024)  \\nPage 50 \\n \\nMeasure: C12 - Reducing the Risk of Falling \\nTitle \\nDescription \\nLabel for Stars: Reducing the Risk of Falling \\nLabel for Data: Reducing the Risk of Falling \\nDescription: Percent of plan members with a problem falling, walking, or balancing who discussed it \\nwith their doctor and received a recommendation for how to prevent falls during the \\nyear. \\nHEDIS Label: Fall Risk Management (FRM) \\nMeasure Reference: NCQA HEDIS Measurement Year 2022 Specifications for the Medicare Health \\nOutcomes Survey Volume 6, page 38 \\nMetric: The percentage of Medicare members 65 years of age and older who had a fall or had \\nproblems with balance or walking in the past 12 months, who were seen by a \\npractitioner in the past 12 months (denominator) and who received a recommendation \\nfor how to prevent falls or treat problems with balance or walking from their current \\npractitioner (numerator). \\nPrimary Data Source: HEDIS-HOS \\nData Source Description: Cohort 24 Follow-up Data collection (2023) and Cohort 26 Baseline data collection \\n(2023). \\n \\nHOS Survey Question 44: A fall is when your body goes to the ground without being \\npushed. In the past 12 months, did you talk with your doctor or other health provider \\nabout falling or problems with balance or walking? \\n \\nHOS Survey Question 45: Did you fall in the past 12 months? \\n \\nHOS Survey Question 46: In the past 12 months have you had a problem with balance \\nor walking? \\n \\nHOS Survey Question 47: Has your doctor or other health provider done anything to \\nhelp prevent falls or treat problems with balance or walking? Some things they might do \\ninclude:  \\n   • Suggest that you use a cane or walker. \\n   • Suggest that you do an exercise or physical therapy program. \\n   • Suggest a vision or hearing test. \\nData Source Category: Survey of Enrollees \\nExclusions: Members who responded \"I had no visits in the past 12 months\" to Question 44 or \\nQuestion 47 are excluded from results calculations. Contracts must achieve a \\ndenominator of at least 100 to obtain a reportable result. If the denominator is less than \\n100, the measure result will be \"Not enough data available.\"  Members with evidence \\nfrom CMS administrative records of a hospice start date are excluded. \\nData Time Frame: 07/17/2023 – 11/01/2023 \\nGeneral Trend: Higher is better', '(Last Updated 10/03/2024)  \\nPage 51 \\n \\nTitle \\nDescription \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2022 disasters. \\nMeaningful Measure Area: Safety \\nCMIT #: 00646-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 50 % \\n>= 50 % to < 56 % \\n>= 56 % to < 63 % \\n>= 63 % to < 73 % \\n>= 73 % \\n \\nMeasure: C13 - Improving Bladder Control \\nTitle \\nDescription \\nLabel for Stars: Improving Bladder Control \\nLabel for Data: Improving Bladder Control \\nDescription: Percent of plan members with a urine leakage problem in the past 6 months who \\ndiscussed treatment options with a provider. \\nHEDIS Label: Management of Urinary Incontinence in Older Adults (MUI) \\nMeasure Reference: NCQA HEDIS Measurement Year 2022 Specifications for the Medicare Health \\nOutcomes Survey Volume 6, page 33 \\nMetric: The percentage of Medicare members 65 years of age or older who reported having any \\nurine leakage in the past six months (denominator) and who discussed treatment \\noptions for their urinary incontinence with a provider (numerator). \\nPrimary Data Source: HEDIS-HOS \\nData Source Description: Cohort 24 Follow-up Data collection (2023) and Cohort 26 Baseline data collection \\n(2023).', '(Last Updated 10/03/2024)  \\nPage 52 \\n \\nTitle \\nDescription \\n \\nHOS Survey Question 38: Many people experience leaking of urine, also called urinary \\nincontinence. In the past six months, have you experienced leaking of urine? \\n \\nHOS Survey Question 41: There are many ways to control or manage the leaking of \\nurine, including bladder training exercises, medication and surgery. Have you ever \\ntalked with a doctor, nurse, or other health care provider about any of these \\napproaches?  \\n \\nMember choices must be as follows to be included in the denominator: \\n  • Q38 = \"Yes.\" \\n  • Q41 = \"Yes\" or \"No.\" \\n \\nThe numerator contains the number of members in the denominator who indicated they \\ndiscussed treatment options for their urinary incontinence with a health care provider. \\n \\nMember choice must be as follows to be included in the numerator: \\n  • Q41 = \"Yes.\" \\nData Source Category: Survey of Enrollees \\nExclusions: Contracts must achieve a denominator of at least 100 to obtain a reportable result. If the \\ndenominator is less than 100, the measure result will be \"Not enough data available.\" \\nMembers with evidence from CMS administrative records of a hospice start date are \\nexcluded. \\nData Time Frame: 07/17/2023 – 11/01/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2022 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00378-01-C-PARTC \\nData Display: Percentage with no decimal place', '(Last Updated 10/03/2024)  \\nPage 53 \\n \\nTitle \\nDescription \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 39 % \\n>= 39 % to < 44 % \\n>= 44 % to < 48 % \\n>= 48 % to < 52 % \\n>= 52 % \\n \\n \\nMeasure: C14 - Medication Reconciliation Post-Discharge \\nTitle \\nDescription \\nLabel for Stars: The Plan Makes Sure Member Medication Records Are Up-to-Date After Hospital \\nDischarge \\nLabel for Data: The Plan Makes Sure Member Medication Records Are Up-to-Date After Hospital \\nDischarge \\nDescription: This shows the percent of plan members whose medication records were updated \\nwithin 30 days after leaving the hospital. To update the record, a doctor or other health \\ncare professional looks at the new medications prescribed in the hospital and compares \\nthem with the other medications the patient takes. Updating medication records can \\nhelp to prevent errors that can occur when medications are changed. \\nHEDIS Label: Medication Reconciliation Post-Discharge (MRP) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 330 \\nMetric: The percentage of discharges from January 1–December 1 of the measurement year for \\nmembers 18 years of age and older for whom medications were reconciled the date of \\ndischarge through 30 days after discharge (31 total days). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Members in hospice or using hospice services any time during the measurement year. \\n \\nMembers who died any time during the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included', '(Last Updated 10/03/2024)  \\nPage 54 \\n \\nTitle \\nDescription \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00441-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 42 % \\n>= 42 % to < 57 % \\n>= 57 % to < 73 % \\n>= 73 % to < 87 % \\n>= 87 % \\n \\n \\nMeasure: C15 - Plan All-Cause Readmissions \\nTitle \\nDescription \\nLabel for Stars: Readmission to a Hospital within 30 Days of Being Discharged (more stars are better \\nbecause it means fewer members are being readmitted) \\nLabel for Data: Readmission to a Hospital within 30 Days of Being Discharged (lower percentages are \\nbetter because it means fewer members are being readmitted) \\nDescription: Percent of plan members aged 18 and older discharged from a hospital stay who were \\nreadmitted to a hospital within 30 days, either for the same condition as their recent \\nhospital stay or for a different reason.  \\n(Patients may have been readmitted back to the same hospital or to a different one. \\nRates of readmission take into account how sick patients were when they went into the \\nhospital the first time. This “risk-adjustment” helps make the comparisons between \\nplans fair and meaningful.)  \\nHEDIS Label: Plan All-Cause Readmissions (PCR) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 498 \\nMetric: The percentage of acute inpatient stays during the measurement year that were \\nfollowed by an unplanned acute readmission for any diagnosis within 30 days, for \\nmembers 18 years of age and older using the following formula to control for differences \\nin the case mix of patients across different contracts. \\n \\nFor contract A, their case-mix adjusted readmission rate relative to the national average', '(Last Updated 10/03/2024)  \\nPage 55 \\n \\nTitle \\nDescription \\nis the observed readmission rate for contract A divided by the expected readmission \\nrate for contract A. This ratio is then multiplied by the national average observed rate. \\n \\nSee Attachment F: Calculating Measure C15: Plan All-Cause Readmissions (18+) for \\nthe complete formula, example calculation and National Average Observation value \\nused to complete this measure. \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Exclude hospital stays for the following reasons: \\n• The member died during the stay. \\n• Members with a principal diagnosis of pregnancy on the discharge claim.  \\n• A principal diagnosis of a condition originating in the perinatal period on the discharge \\nclaim. \\n \\n(Required) Exclude members in hospice or using hospice services any time during the \\nmeasurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\n \\nAs listed in the HEDIS Technical Specifications. CMS has excluded contracts whose \\ndenominator was less than 150. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Admissions and Readmissions to Hospitals', '(Last Updated 10/03/2024)  \\nPage 56 \\n \\nTitle \\nDescription \\nCMIT #: 00561-02-C-PARTC \\n \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n> 14 % \\n> 12 % to <= 14 % \\n> 10 % to <= 12 % \\n> 8 % to <= 10 % \\n<= 8 % \\n \\nMeasure: C16 - Statin Therapy for Patients with Cardiovascular Disease \\nTitle \\nDescription \\nLabel for Stars: The Plan Makes Sure Members with Heart Disease Get the Most Effective Drugs to \\nTreat High Cholesterol \\nLabel for Data: The Plan Makes Sure Members with Heart Disease Get the Most Effective Drugs to \\nTreat High Cholesterol \\nDescription: This rating is based on the percent of plan members with heart disease who get the \\nright type of cholesterol-lowering drugs. Health plans can help make sure their members \\nare prescribed medications that are more effective for them. \\nHEDIS Label: Statin Therapy for Patients with Cardiovascular Disease (SPC) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 168 \\nMetric: The percentage of males 21–75 years of age and females 40–75 years of age during \\nthe measurement year, who were identified as having clinical atherosclerotic \\ncardiovascular disease (ASCVD) (denominator) and were dispensed at least one high \\nor moderate-intensity statin medication during the measurement year (numerator). \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Exclude members who meet any of the following criteria: \\n• Pregnancy during the measurement year or year prior to the measurement year. \\n• In vitro fertilization in the measurement year or year prior to the measurement year. \\n• Dispensed at least one prescription for clomiphene (Table SPC-A) during the \\nmeasurement year or the year prior to the measurement year.  \\n• ESRD or dialysis during the measurement year or the year prior to the measurement \\nyear. \\n• Cirrhosis during the measurement year or the year prior to the measurement year. \\n• Myalgia, myositis, myopathy, or rhabdomyolysis during the measurement year. \\n• Members in hospice or using hospice services any time during the measurement year. \\n• Members who died any time during the measurement year.  \\n• Members receiving palliative care any time during the measurement year. \\n• Members 66 years of age and older as of December 31 of the measurement year who \\nmeet either of the following: \\n– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year.', '(Last Updated 10/03/2024)  \\nPage 57 \\n \\nTitle \\nDescription \\n– Living long-term in an institution any time during the measurement year as identified \\nby the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \\nto determine if a member had an LTI flag during the measurement year. \\n• Members 66 years of age and older as of December 31 of the measurement year with \\nfrailty and advanced illness during the measurement year. Members must meet both of \\nthe following frailty and advanced illness criteria to be excluded:  \\n– At least two indications of frailty with different dates of service during the \\nmeasurement year.  \\n– Any of the following during the measurement year or the year prior to the \\nmeasurement year (count services that occur over both years):  \\n1. At least two outpatient visits, observation visits, ED visits, telephone \\nvisits, e-visits, virtual check-ins, nonacute inpatient encounters, or \\nnonacute inpatient discharges on different dates of service, with an \\nadvanced illness diagnosis. Visit type need not be the same for the \\ntwo visits.  \\n2. At least one acute inpatient encounter with an advanced illness \\ndiagnosis.  \\n3. At least one acute inpatient discharge with an advanced illness \\ndiagnosis on the discharge claim. \\n4. A dispensed dementia medication. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00700-01-C-PARTC', '(Last Updated 10/03/2024)  \\nPage 58 \\n \\nTitle \\nDescription \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 81 % \\n>= 81 % to < 85 % \\n>= 85 % to < 88 % \\n>= 88 % to < 92 % \\n>= 92 % \\n \\nMeasure: C17 - Transitions of Care \\nTitle \\nDescription \\nLabel for Stars: After hospital stay, members receive information and care they need  \\nLabel for Data: After hospital stay, members receive information and care they need  \\nDescription: This rating is based on the percent of plan members who got follow-up care after a \\nhospital stay. Follow-up care includes: getting information about their health problem \\nand what to do next, having a visit or call with a doctor, and having a doctor or \\npharmacist make sure the plan member’s medication records are up to date. \\nHEDIS Label: Transitions of Care (TRC) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 330 \\nMetric: The average of the rates for Transitions of Care - Medication Reconciliation Post-\\nDischarge, Transitions of Care - Notification of Inpatient Admission, Transitions of Care \\n- Patient Engagement After Inpatient Discharge, and Transitions of Care - Receipt of \\nDischarge Information. \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: If the discharge is followed by a readmission or direct transfer to an acute or nonacute \\ninpatient care setting on the date of discharge through 30 days after discharge (31 days \\ntotal), use the admit date from the first admission and the discharge date from the last \\ndischarge. To identify readmissions and direct transfers during the 31-day period: \\n1. Identify all acute and nonacute inpatient stays (Inpatient Stay Value Set). \\n2. Identify the admission date for the stay (the admission date must occur during the 31-\\nday period). \\n3. Identify the discharge date for the stay (the discharge date is the event date). \\n \\nIf the admission dates and the discharge date for an acute inpatient stay occur between \\nthe admission and discharge dates for a nonacute inpatient stay, include only the \\nnonacute inpatient discharge.  \\n \\nRequired exclusions: \\n• \\nMembers in hospice or using hospice services any time during the measurement \\nyear. \\n• \\nMembers who died any time during the measurement year.', '(Last Updated 10/03/2024)  \\nPage 59 \\n \\nTitle \\nDescription \\n \\nExclude both the initial and the readmission/direct transfer discharge if the last \\ndischarge occurs after December 1 of the measurement year. \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\n \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00729-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 44 % \\n>= 44 % to < 52 % \\n>= 52 % to < 63 % \\n>= 63 % to < 77 % \\n>= 77 %', '(Last Updated 10/03/2024)  \\nPage 60 \\n \\nMeasure: C18 - Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic \\nConditions \\nTitle \\nDescription \\nLabel for Stars: Members with 2 or more chronic conditions receive follow-up care within 7 days after an \\nemergency department visit  \\n \\nLabel for Data: Members with 2 or more chronic conditions receive follow-up care within 7 days after an \\nemergency department visit  \\nDescription: This rating is based on the percent of plan members with 2 or more chronic conditions \\nwho got follow-up care within 7 days after they had an emergency department (ED) visit. \\nDepending on the person’s needs this might be a visit with a health care provider, an \\nappointment with a case manager, or a home visit. \\nHEDIS Label: Follow-up After Emergency Department Visit for People with Multiple High-Risk Chronic \\nConditions (FMC) \\nMeasure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 340 \\nMetric: The percentage of emergency department (ED) visits for members 18 years and older \\nwho have multiple high-risk chronic conditions who had a follow-up service within 7 days \\nof the ED visit. \\nPrimary Data Source: HEDIS \\nData Source Category: Health and Drug Plans \\nExclusions: Exclude ED visits that result in an inpatient stay. Exclude ED visits followed by \\nadmission to an acute or nonacute inpatient care setting on the date of the ED visit or \\nwithin 7 days after the ED visit, regardless of the principal diagnosis for admission. To \\nidentify admissions to an acute or nonacute inpatient care setting: \\n1. Identify all acute and nonacute inpatient stays. \\n2. Identify the admission date for the stay. \\n \\nThese events are excluded from the measure because admission to an acute or \\nnonacute setting may prevent an outpatient follow-up visit from taking place \\n \\nRequired exclusions: \\n• \\nMembers in hospice or using hospice services any time during the measurement \\nyear. \\n• \\nMembers who died any time during the measurement year.  \\n \\nContracts whose enrollment was at least 500 but less than 1,000 as of the July 2023 \\nenrollment report and having measure score reliability less than 0.7 are excluded.  \\n \\nContracts whose enrollment was less than 500 as of the July 2023 enrollment report are \\nexcluded from this measure. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering', '(Last Updated 10/03/2024)  \\nPage 61 \\n \\nTitle \\nDescription \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00263-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 39 % \\n>= 39 % to < 53 % \\n>= 53 % to < 60 % \\n>= 60 % to < 69 % \\n>= 69 %', \"(Last Updated 10/03/2024)  \\nPage 62 \\n \\nDomain: 3 - Member Experience with Health Plan \\nMeasure: C19 - Getting Needed Care \\nTitle \\nDescription \\nLabel for Stars: Ease of Getting Needed Care and Seeing Specialists \\nLabel for Data: Ease of Getting Needed Care and Seeing Specialists (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned on how easy it is for members to get \\nneeded care, including care from specialists. \\nMetric: This case-mix adjusted composite measure is used to assess how easy it was for a \\nmember to get needed care and see specialists. The Consumer Assessment of \\nHealthcare Providers and Systems (CAHPS) score uses the mean of the distribution of \\nresponses converted to a scale from 0 to 100. The score shown is the percentage of the \\nbest possible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type): \\n \\n• In the last 6 months, how often did you get an appointment to see a specialist as soon \\n  as you needed? \\n \\n• In the last 6 months, how often was it easy to get the care, tests or treatment you  \\n  needed? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters.\", \"(Last Updated 10/03/2024)  \\nPage 63 \\n \\nTitle \\nDescription \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00293-02-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 77 \\n>= 77 to < 79 \\n>= 79 to < 82 \\n>= 82 to < 83 \\n>= 83 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C20 - Getting Appointments and Care Quickly \\nTitle \\nDescription \\nLabel for Stars: Getting Appointments & Care Quickly \\nLabel for Data: Getting Appointments & Care Quickly (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned on how quickly members get \\nappointments and care. \\nMetric: This case-mix adjusted composite measure is used to assess how quickly the member \\nwas able to get appointments and care. The Consumer Assessment of Healthcare \\nProviders and Systems (CAHPS) score uses the mean of the distribution of responses \\nconverted to a scale from 0 to 100. The score shown is the percentage of the best \\npossible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type): \\n \\n• In the last 6 months, when you needed care right away, how often did you get care as \\n  soon as you needed? \\n \\n• In the last 6 months, how often did you get an appointment for a check-up or routine  \\n  care as soon as you needed? \\n \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better\", '(Last Updated 10/03/2024)  \\nPage 64 \\n \\nTitle \\nDescription \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00292-01-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 80 \\n>= 80 to < 82 \\n>= 82 to < 84 \\n>= 84 to < 86 \\n>= 86 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C21 - Customer Service \\nTitle \\nDescription \\nLabel for Stars: Health Plan Provides Information or Help When Members Need It \\nLabel for Data: Health Plan Provides Information or Help When Members Need It (on a scale from 0 to \\n100) \\nDescription: Percent of the best possible score the plan earned on how easy it is for members to get \\ninformation and help from the plan when needed. \\nMetric: This case-mix adjusted composite measure is used to assess how easy it was for the \\nmember to get information and help when needed. The Consumer Assessment of \\nHealthcare Providers and Systems (CAHPS) score uses the mean of the distribution of \\nresponses converted to a scale from 0 to 100. The score shown is the percentage of the \\nbest possible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type): \\n \\n• In the last 6 months, how often did your health plan’s customer service give you the', \"(Last Updated 10/03/2024)  \\nPage 65 \\n \\nTitle \\nDescription \\n  information or help you needed? \\n \\n• In the last 6 months, how often did your health plan’s customer service treat you with \\n  courtesy and respect? \\n \\n• In the last 6 months, how often were the forms from your health plan easy to fill out? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00181-01-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 88 \\n>= 88 to < 89 \\n>= 89 to < 91 \\n>= 91 to < 92 \\n>= 92 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules.\", \"(Last Updated 10/03/2024)  \\nPage 66 \\n \\nMeasure: C22 - Rating of Health Care Quality \\nTitle \\nDescription \\nLabel for Stars: Members' Rating of Health Care Quality \\nLabel for Data: Members' Rating of Health Care Quality (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned from members who rated the quality \\nof the health care they received. \\nMetric: This case-mix adjusted measure is used to assess members' view of the quality of care \\nreceived from the health plan. The Consumer Assessment of Healthcare Providers and \\nSystems (CAHPS) score uses the mean of the distribution of responses converted to a \\nscale from 0 to 100. The score shown is the percentage of the best possible score each \\ncontract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Question (question numbers vary depending on survey type): \\n \\n• Using any number from 0 to 10, where 0 is the worst health care possible and 10 is \\n  the best health care possible, what number would you use to rate all your health care \\n  in the last 6 months? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00642-01-C-PARTC\", \"(Last Updated 10/03/2024)  \\nPage 67 \\n \\nTitle \\nDescription \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 84 \\n>= 84 to < 85 \\n>= 85 to < 87 \\n>= 87 to < 88 \\n>= 88 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C23 - Rating of Health Plan \\nTitle \\nDescription \\nLabel for Stars: Members' Rating of Health Plan \\nLabel for Data: Members’ Rating of Health Plan (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned from members who rated the health \\nplan. \\nMetric: This case-mix adjusted measure is used to assess members' overall view of their health \\nplan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score \\nuses the mean of the distribution of responses converted to a scale from 0 to 100. The \\nscore shown is the percentage of the best possible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Question (question numbers vary depending on survey type): \\n \\n• Using any number from 0 to 10, where 0 is the worst health plan possible and 10 is \\n  the best health plan possible, what number would you use to rate your health plan? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes\", \"(Last Updated 10/03/2024)  \\nPage 68 \\n \\nTitle \\nDescription \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\n Person-Centered Care \\nCMIT #: 00643-02-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 84 \\n>= 84 to < 86 \\n>= 86 to < 88 \\n>= 88 to < 89 \\n>= 89 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: C24 - Care Coordination \\nTitle \\nDescription \\nLabel for Stars: Coordination of Members' Health Care Services \\nLabel for Data: Coordination of Members' Health Care Services (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned on how well the plan coordinates \\nmembers’ care. (This includes whether doctors had the records and information they \\nneeded about members’ care and how quickly members got their test results.) \\nMetric: This case-mix adjusted composite measure is used to assess Care Coordination. The \\nConsumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the \\nmean of the distribution of responses converted to a scale of 0 to 100. The score shown \\nis the percentage of the best possible score each contract earned.  \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type):  \\n \\n• In the last 6 months, when you talked with your personal doctor during a scheduled \\n  appointment, how often did he or she have your medical records or other information \\n  about your care? \\n• In the last 6 months, when your personal doctor ordered a blood test, x-ray or other \\n  test for you, how often did someone from your personal doctor’s office follow up to \\n  give you those results? \\n• In the last 6 months, when your personal doctor ordered a blood test, x-ray or other \\n  test for you, how often did you get those results as soon as you needed them? \\n• In the last 6 months, how often did you and your personal doctor talk about all the \\n  prescription medicines you were taking?\", \"(Last Updated 10/03/2024)  \\nPage 69 \\n \\nTitle \\nDescription \\n• In the last 6 months, did you get the help you needed from your personal doctor’s \\n  office to manage your care among these different providers and services? \\n• In the last 6 months, how often did your personal doctor seem informed and up-to- \\n  date about the care you got from specialists? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00106-02-C-PARTC \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nYes \\nNo \\nYes \\nBase Group Cut Points: \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\n< 84 \\n>= 84 to < 85 \\n>= 85 to < 87 \\n>= 87 to < 88 \\n>= 88 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules.\", \"(Last Updated 10/03/2024)  \\nPage 70 \\n \\nDomain: 4 - Member Complaints and Changes in the Health Plan's Performance \\nMeasure: C25 - Complaints about the Health Plan \\nTitle \\nDescription \\nLabel for Stars: Complaints about the Health Plan (more stars are better because it means fewer \\ncomplaints) \\nLabel for Data: Complaints about the Health Plan (lower numbers are better because it means fewer \\ncomplaints) \\nDescription: Rate of complaints filed with Medicare about the health plan. \\nMetric: Rate of complaints about the health plan per 1,000 members. For each contract, this \\nrate is calculated as:  \\n[ (Total number of all complaints logged into the Complaints Tracking Module (CTM))  \\n/ (Average Contract enrollment) ] * 1,000 * 30 / (Number of Days in Period). \\n \\nNumber of Days in Period = 366 for leap years, 365 for all other years. \\n \\n• Complaints data are pulled after the end of the measurement timeframe to serve as a  \\n  snapshot of CTM data. \\n• Enrollment numbers used to calculate the complaint rate were based on the average \\n  enrollment for the time period measured for each contract. \\n• A contract’s failure to follow CMS’s CTM Standard Operating Procedures will not result \\nin CMS’s adjustment of the data used for these measures. \\nPrimary Data Source: Complaints Tracking Module (CTM) \\nData Source Description: Data were obtained from the CTM in the Health Plan Management System (HPMS) \\nbased on the contract entry date (the date that complaints are assigned or re-assigned \\nto contracts; also known as the contract assignment/reassignment date) for the \\nreporting period specified. The status of any specific complaint at the time the data are \\npulled stands for use in the reports. Any changes to the complaints data subsequent to \\nthe data pull cannot be excluded retroactively. CMS allows for an approximate 6-month \\n“wash out” period to account for any adjustments per CMS’s CTM Standard Operating \\nProcedures. Therefore, all Plan Requests for 2023 complaints made by the June 28, \\n2024 deadline are captured. Complaint rates per 1,000 enrollees are adjusted to a 30-\\nday basis. Monthly enrollment files from HPMS were used to calculate the average \\nenrollment for the contract for the measurement period.   \\nData Source Category: CMS Administrative Data \\nExclusions: On May 10, 2019, CMS released an HPMS memo on the Complaints Tracking Module \\n(CTM) Updated Standard Operating Procedures (SOP). Plans should review all \\ncomplaints at intake and verify the contract assignment and issue level. The APPENDIX \\nA - Category and Subcategory Listing in the SOP lists the subcategories that are \\nexcluded. \\n \\nComplaint rates are not calculated for contracts with average enrollment of less than \\n800 enrollees during the measurement period. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better\", '(Last Updated 10/03/2024)  \\nPage 71 \\n \\nTitle \\nDescription \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00142-02-C-PARTC \\nData Display: Numeric with 2 decimal places \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n> 1.39 \\n> 0.76 to <= 1.39 \\n> 0.37 to <= 0.76 \\n> 0.12 to <= 0.37 \\n<= 0.12 \\n \\nMeasure: C26 - Members Choosing to Leave the Plan \\nTitle \\nDescription \\nLabel for Stars: Members Choosing to Leave the Plan (more stars are better because it means fewer \\nmembers choose to leave the plan) \\nLabel for Data: Members Choosing to Leave the Plan (lower percentages are better because that \\nindicates fewer members choose to leave the plan) \\nDescription: Percent of plan members who chose to leave the plan. \\nMetric: The percent of members who chose to leave the contract comes from disenrollment \\nreason codes in Medicare’s enrollment system. The percent is calculated as the number \\nof members who chose to leave the contract between January 1, 2023–December 31, \\n2023 (numerator) divided by all members enrolled in the contract at any time during \\n2023 (denominator). \\nPrimary Data Source: MBDSS \\nData Source Description: Medicare Beneficiary Database Suite of Systems (MBDSS) \\nData Source Category: CMS Administrative Data', '(Last Updated 10/03/2024)  \\nPage 72 \\n \\nTitle \\nDescription \\nExclusions: Members who involuntarily left their contract due to circumstances beyond their control \\nare removed from the final numerator, specifically: \\n    • Members affected by a contract service area reduction \\n    • Members affected by PBP termination \\n    • Members in PBPs that were granted special enrollment exceptions \\n    • Members affected by PBP service area reductions where there are no PBPs left  \\n      within the contract that the enrollee is eligible to enroll into \\n    • Members affected by LIS reassignments \\n    • Members who are enrolled in employer group plans \\n    • Members who were passively enrolled into a Demonstration (MMP) \\n    • Contracts with less than 1,000 enrollees \\n    • 1876 Cost contract disenrollments into the transition MA contract (H contract) \\n    • Members who moved out of the service area of the contract from which they \\n      disenrolled (based on the member’s address as submitted by the plan into which \\n      the member enrolled or the member’s current SSA address if there is no address \\n      submitted by the plan into which the member enrolled) or where the service area \\n      of the contract they enrolled into does not intersect with the service area of the \\n      contract from which they disenrolled. \\n \\nGeneral Notes: This measure includes members with a disenrollment effective date between 1/1/2023 \\nand 12/31/2023 who disenrolled from the contract with any one of the following \\ndisenrollment reason codes: \\n    11 - Voluntary Disenrollment through plan \\n    13 - Disenrollment because of enrollment in another Plan  \\n    14 - Retroactive \\n    99 - Other (not supplied by beneficiary). \\n \\nIf all potential members in the numerator meet one or more of the exclusion criteria, the \\nmeasure result will be “Not enough data available”. \\n \\nThe Disenrollment Reasons Survey (DRS) data available in the HPMS plan preview and \\nin the CMS downloadable Master Table, are not used in the calculation of this measure. \\nThe DRS data are presented in each of the systems for information purposes only. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4', '(Last Updated 10/03/2024)  \\nPage 73 \\n \\nTitle \\nDescription \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00446-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n> 36 % \\n> 24 % to <= 36 % \\n> 17 % to <= 24 % \\n> 8 % to <= 17 % \\n<= 8 % \\n \\nMeasure: C27 - Health Plan Quality Improvement \\nTitle \\nDescription \\nLabel for Stars: Improvement (if any) in the Health Plan’s Performance \\nLabel for Data: Improvement (if any) in the Health Plan’s Performance \\nDescription: This shows how much the health plan’s performance improved or declined from one \\nyear to the next. \\nIf a plan receives 1 or 2 stars, it means, on average, the plan’s scores declined (got \\nworse). \\nIf a plan receives 3 stars, it means, on average, the plan’s scores stayed about the \\nsame. \\nIf a plan receives 4 or 5 stars, it means, on average, the plan’s scores improved. \\n  \\nKeep in mind that a plan that is already doing well in most areas may not show much \\nimprovement. It is also possible that a plan can start with low ratings, show a lot of \\nimprovement, and still not be performing very well. \\nMetric: The numerator is the net improvement, which is a weighted sum of the number of \\nsignificantly improved measures minus the number of significantly declined measures. \\nThe denominator is the sum of the weights associated with the measures eligible for the \\nimprovement measure (i.e., the measures that were included in the 2024 and 2025 Star \\nRatings for this contract and had no specification changes). \\nPrimary Data Source: Star Ratings \\nData Source Description: 2024 and 2025 Star Ratings \\nData Source Category: Star Ratings \\nExclusions: Contracts must have data in at least half of the measures used to calculate \\nimprovement to be rated in this measure. \\nGeneral Notes: Attachment H contains the formulas used to calculate the improvement measure and \\nlists indicating which measures were used.', '(Last Updated 10/03/2024)  \\nPage 74 \\n \\nTitle \\nDescription \\nData Time Frame: Not Applicable \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Not Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Improvement Measure \\nWeighting Value: 5 \\nMajor Disaster: Includes only measures which have data from both years. \\nMeaningful Measure Area: Person-centered Care \\nCMIT #: 00300-01-C-PARTC \\nData Display: Not Applicable \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< -0.179809 \\n>= -0.179809 to < 0 \\n>= 0 to < 0.174445 \\n>= 0.174445 to < 0.421057 \\n>= 0.421057', '(Last Updated 10/03/2024)  \\nPage 75 \\n \\nDomain: 5 - Health Plan Customer Service \\nMeasure: C28 - Plan Makes Timely Decisions about Appeals \\nTitle \\nDescription \\nLabel for Stars: Health Plan Makes Timely Decisions about Appeals \\nLabel for Data: Health Plan Makes Timely Decisions about Appeals \\nDescription: This rating shows how fast a plan sends information for an independent review. \\nMetric: Percent of appeals timely processed by the plan (numerator) out of all the plan‘s \\nappeals decided by the Independent Review Entity (IRE) (includes upheld, overturned, \\npartially overturned appeals and appeals not evaluated by the IRE because plan agreed \\nto cover) (denominator). This is calculated as: \\n \\n([Number of Timely Appeals] / ([Appeals Upheld] + [Appeals Overturned] + [Appeals \\nPartially Overturned] + [Appeals Not Evaluated by the IRE Because Plan Agreed to \\nCover])) * 100. \\n \\nPrimary Data Source: Independent Review Entity (IRE) \\nData Source Description: Data were obtained from the Independent Review Entity (IRE) contracted by CMS for \\nPart C appeals. The appeals used in this measure are based on the date in the calendar \\nyear the appeal was received by the IRE, not the date a decision was reached by the \\nIRE. The timeliness is based on the actual IRE received date and is compared to the \\ndate the appeal should have been received by the IRE. \\nData Source Category: Data Collected by CMS Contractors \\nExclusions: If the denominator is ≤ 10, the result is “Not enough data available.” Dismissed appeals \\n(except appeals not evaluated by the IRE because plan agreed to cover) and Withdrawn \\nappeals are excluded from this measure. \\nGeneral Notes: This measure includes all Standard Coverage, Standard Claim, and Expedited appeals \\nreceived by the IRE, regardless of the appellant. This includes appeals requested by a \\nbeneficiary, appeals requested by a party on behalf of a beneficiary, and appeals \\nrequested by non-contract providers. \\n \\nThe number of timely appeals can be calculated using this formula:  \\n[Number of Timely Appeals] = ([Appeals Upheld] + [Appeals Overturned] + [Appeals \\nPartially Overturned]) + [Appeals Not Evaluated by the IRE Because Plan Agreed to \\nCover]) - [Late] \\n \\nNote: Appeals Not Evaluated by the IRE Because Plan Agreed to Cover were formerly \\ncalled Dismissed Because Plan Agreed to Cover. \\n \\nWhen reviewing IRE data from the Maximus appeals website found at  \\nhttp://www.medicareappeal.com/AppealSearch and in data files, appeal disposition \\ncodes have been updated from the prior codes. Below is a crosswalk of previous appeal \\ndisposition codes and current codes:', '(Last Updated 10/03/2024)  \\nPage 76 \\n \\nTitle \\nDescription \\n \\n \\n \\n \\nPrevious Field Name \\nCurrent Field Name \\nUpheld \\nUnfavorable \\nOverturn \\nFavorable \\nPartially Overturn \\nPartially favorable \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Measures Capturing Access \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Affordability and Efficiency \\nCMIT #: 00562-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 69 % \\n>= 69 % to < 85 % \\n>= 85 % to < 95 % \\n>= 95 % to < 99 % \\n>= 99 % \\n \\n \\nMeasure: C29 - Reviewing Appeals Decisions \\nTitle \\nDescription \\n \\nLabel for Stars: Fairness of the Health Plan’s Appeal Decisions, Based on an Independent Reviewer \\nLabel for Data: Fairness of the Health Plan’s Appeal Decisions, Based on an Independent Reviewer \\nDescription: This rating shows how often an independent reviewer found the health plan’s decision to \\ndeny coverage to be reasonable.', '(Last Updated 10/03/2024)  \\nPage 77 \\n \\nTitle \\nDescription \\n \\nMetric: Percent of appeals where a plan‘s decision was “upheld” by the Independent Review \\nEntity (IRE) (numerator) out of all the plan‘s appeals (upheld, overturned, and partially \\noverturned appeals only) that the IRE reviewed (denominator). This is calculated as: \\n \\n([Appeals Upheld] / ([Appeals Upheld] + [Appeals Overturned] + [Appeals Partially \\nOverturned]))* 100. \\nPrimary Data Source: Independent Review Entity (IRE) \\nData Source Description: Data were obtained from the Independent Review Entity (IRE) contracted by CMS for \\nPart C appeals. The appeals used in this measure are based on the date in the calendar \\nyear the appeal was received by the IRE, not the date a decision was reached by the \\nIRE. If a Reopening occurs and is decided prior to June 30, 2024, the Reopened \\ndecision is used in place of the Reconsideration decision. Reopenings decided on or \\nafter June 30, 2024 are not reflected in these data and the original decision result is \\nused. The results of appeals that occur beyond Level 2 (i.e., Administrative Law Judge \\nor Medicare Appeals Council appeals) are not included in the data. \\nData Source Category: Data Collected by CMS Contractors \\nExclusions: If the minimum number of appeals (upheld + overturned + partially overturned) is ≤ 10, \\nthe result is “Not enough data available.” Dismissed and Withdrawn appeals are \\nexcluded from this measure. \\nGeneral Notes: This measure includes all Standard Coverage, Standard Claim, and Expedited appeals \\nreceived by the IRE, regardless of the appellant. This includes appeals requested by a \\nbeneficiary, appeals requested by a party on behalf of a beneficiary, and appeals \\nrequested by non-contract providers. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Measures Capturing Access \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Affordability and Efficiency \\nCMIT #: 00652-01-C-PARTC', '(Last Updated 10/03/2024)  \\nPage 78 \\n \\nTitle \\nDescription \\n \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 78 % \\n>= 78 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 % to < 99 % \\n>= 99 % \\n \\n \\nMeasure: C30 - Call Center – Foreign Language Interpreter and TTY Availability \\nTitle \\nDescription \\nLabel for Stars: Availability of TTY Services and Foreign Language Interpretation When Prospective \\nMembers Call the Health Plan \\nLabel for Data: Availability of TTY Services and Foreign Language Interpretation When Prospective \\nMembers Call the Health Plan \\nDescription: Percent of time that TTY services and foreign language interpretation were available \\nwhen needed by people who called the health plan’s prospective enrollee customer \\nservice phone line. \\nMetric: The calculation of this measure is the number of completed contacts with the interpreter \\nand TTY divided by the number of attempted contacts.  Completed contact with an \\ninterpreter is defined as establishing contact with an interpreter and confirming that the \\ncustomer service representative can answer questions about the plan’s Medicare Part C \\nbenefit within eight minutes. Completed TTY contact is defined as establishing contact \\nwith and confirming that the customer service representative can answer questions \\nabout the plan’s Medicare Part C benefit within seven minutes.  \\nPrimary Data Source: Call Center \\nData Source Description: Call center monitoring data collected by CMS. The Customer Service Contact for \\nProspective Members phone number associated with each contract was monitored. \\nData Source Category: Data Collected by CMS Contractors \\nExclusions: Data were collected from contracts that cover U.S territories but were not collected from \\nthe following organization types: 1876 Cost, Employer/Union Only Direct Contract PDP, \\nEmployer/Union Only Direct Contract PFFS, National PACE, MSA, employer contracts, \\norganizations that did not have a phone number accessible to survey callers, and \\nMAOs, MA-PDs, and MMPs under sanction. \\nGeneral Notes: Specific questions about Call Center Monitoring and requests for detail data should be \\ndirected to CallCenterMonitoring@cms.hhs.gov. \\nData Time Frame: 02/2024 – 05/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering', '(Last Updated 10/03/2024)  \\nPage 79 \\n \\nTitle \\nDescription \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Measures Capturing Access \\nWeighting Value: 4 \\nMajor Disaster: No adjustment for 2022 or 2023 disasters. \\nMeaningful Measure Area: Person-centered Care \\nCMIT #: 00096-01-C-PARTC \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nYes \\nNo \\nNo \\nYes \\nCut Points: \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\n< 46 % \\n>= 46 % to < 69 % \\n>= 69 % to < 93 % \\n>= 93 % to < 100 % \\n 100 %', '(Last Updated 10/03/2024)  \\nPage 80 \\n \\nPart D Domain and Measure Details \\nSee Attachment C for the national averages of individual Part D measures. \\nDomain: 1 - Drug Plan Customer Service \\nMeasure: D01 - Call Center – Foreign Language Interpreter and TTY Availability \\nTitle \\nDescription \\nLabel for Stars: Availability of TTY Services and Foreign Language Interpretation When Prospective \\nMembers Call the Drug Plan \\nLabel for Data: Availability of TTY Services and Foreign Language Interpretation When Prospective \\nMembers Call the Drug Plan \\nDescription: Percent of time that TTY services and foreign language interpretation were available \\nwhen needed by people who called the drug plan’s prospective enrollee customer \\nservice line. \\nMetric: The calculation of this measure is the number of completed contacts with the interpreter \\nand TTY divided by the number of attempted contacts.  Completed contact with an \\ninterpreter is defined as establishing contact with an interpreter and confirming that the \\ncustomer service representative can answer questions about the plan’s Medicare Part D \\nbenefit within eight minutes. Completed TTY contact is defined as establishing contact \\nwith and confirming that the customer service representative can answer questions \\nabout the plan’s Medicare Part D benefit within seven minutes.  \\nPrimary Data Source: Call Center \\nData Source Description: Call center monitoring data collected by CMS. The Customer Service Contact for \\nProspective Members phone number associated with each contract was monitored. \\nData Source Category: Data Collected by CMS Contractors \\nExclusions: Data were collected from contracts that cover U.S territories but were not collected from \\nthe following organization types: 1876 Cost, Employer/Union Only Direct Contract PDP, \\nEmployer/Union Only Direct Contract PFFS, National PACE, MSA, employer contracts, \\norganizations that did not have a phone number accessible to survey callers, and MA-\\nPDs, PDPs, and MMPs under sanction. \\nGeneral Notes: Specific questions about Call Center Monitoring and requests for detail data should be \\ndirected to CallCenterMonitoring@cms.hhs.gov. \\nData Time Frame: 02/2024 – 05/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Measures Capturing Access', '(Last Updated 10/03/2024)  \\nPage 81 \\n \\nTitle \\nDescription \\nWeighting Value: 4 \\nMajor Disaster: No adjustment for 2022 or 2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00096-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nNo \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: Type \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 40 % \\n>= 40 % to < 74 % \\n>= 74 % to < 90 % \\n>= 90 % to < 100 % \\n 100 % \\nPDP \\n< 70 % \\n>= 70 % to < 85 % \\n>= 85 % to < 98 % \\n>= 98 % to < 100 % \\n 100 %', '(Last Updated 10/03/2024)  \\nPage 82 \\n \\nDomain: 2 - Member Complaints and Changes in the Drug Plan’s Performance \\nMeasure: D02 - Complaints about the Drug Plan \\nTitle \\nDescription \\nLabel for Stars: Complaints about the Drug Plan (more stars are better because it means fewer \\ncomplaints) \\nLabel for Data: Complaints about the Drug Plan (number of complaints for every 1,000 members). \\n(Lower numbers are better because it means fewer complaints.) \\nDescription: Rate of complaints filed with Medicare about the drug plan. \\nMetric: Rate of complaints about the drug plan per 1,000 members. For each contract, this rate \\nis calculated as:  \\n[ (Total number of all complaints logged into the Complaints Tracking Module (CTM))  \\n/ (Average Contract enrollment) ] * 1,000 * 30 / (Number of Days in Period). \\n \\nNumber of Days in Period = 366 for leap years, 365 for all other years. \\n \\n• Complaints data are pulled after the end of the measurement timeframe to serve as a  \\n  snapshot of CTM data. \\n• Enrollment numbers used to calculate the complaint rate were based on the average \\n  enrollment for the time period measured for each contract. \\n• A contract’s failure to follow CMS’s CTM Standard Operating Procedures will not result \\nin CMS’s adjustment of the data used for these measures. \\nPrimary Data Source: Complaints Tracking Module (CTM) \\nData Source Description: Data were obtained from the CTM in the Health Plan Management System (HPMS) \\nbased on the contract entry date (the date that complaints are assigned or re-assigned \\nto contracts; also known as the contract assignment/reassignment date) for the \\nreporting period specified. The status of any specific complaint at the time the data are \\npulled stands for use in the reports. Any changes to the complaints data subsequent to \\nthe data pull cannot be excluded retroactively. CMS allows for an approximate 6-month \\n“wash out” period to account for any adjustments per CMS’s CTM Standard Operating \\nProcedures. Therefore, all Plan Requests for 2023 complaints made by the June 28, \\n2024 deadline are captured. Complaint rates per 1,000 enrollees are adjusted to a 30-\\nday basis. Monthly enrollment files from HPMS were used to calculate the average \\nenrollment for the contract for the measurement period.   \\nData Source Category: CMS Administrative Data \\nExclusions: On May 10, 2019, CMS released an HPMS memo on the Complaints Tracking Module \\n(CTM) Updated Standard Operating Procedures (SOP). Plans should review all \\ncomplaints at intake and verify the contract assignment and issue level. The APPENDIX \\nA - Category and Subcategory Listing in the SOP lists the subcategories that are \\nexcluded.  \\n \\nComplaint rates are not calculated for contracts with average enrollment of less than \\n800 enrollees during the measurement period. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better', '(Last Updated 10/03/2024)  \\nPage 83 \\n \\nTitle \\nDescription \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00142-02-C-PARTD \\nData Display: Numeric with 2 decimal places \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n> 1.39 \\n> 0.76 to <= 1.39 \\n> 0.37 to <= 0.76 \\n> 0.12 to <= 0.37 \\n<= 0.12 \\nPDP \\n> 0.32 \\n> 0.2 to <= 0.32 \\n> 0.11 to <= 0.2 \\n> 0.04 to <= 0.11 \\n<= 0.04 \\n \\nMeasure: D03 - Members Choosing to Leave the Plan \\nTitle \\nDescription \\nLabel for Stars: Members Choosing to Leave the Plan (more stars are better because it means fewer \\nmembers choose to leave the plan) \\nLabel for Data: Members Choosing to Leave the Plan (lower percentages are better because that \\nindicates fewer members choose to leave the plan) \\nDescription: Percent of plan members who chose to leave the plan. \\nMetric: The percent of members who chose to leave the contract comes from disenrollment \\nreason codes in Medicare’s enrollment system. The percent is calculated as the number \\nof members who chose to leave the contract between January 1, 2023–December 31, \\n2023 (numerator) divided by all members enrolled in the contract at any time during \\n2023 (denominator). \\nPrimary Data Source: MBDSS \\nData Source Description: Medicare Beneficiary Database Suite of Systems (MBDSS)', '(Last Updated 10/03/2024)  \\nPage 84 \\n \\nTitle \\nDescription \\nData Source Category: CMS Administrative Data \\nExclusions: Members who involuntarily left their contract due to circumstances beyond their control \\nare removed from the final numerator, specifically: \\n    • Members affected by a contract service area reduction \\n    • Members affected by PBP termination \\n    • Members in PBPs that were granted special enrollment exceptions \\n    • Members affected by PBP service area reductions where there are no PBPs left  \\n      within the contract that the enrollee is eligible to enroll into \\n    • Members affected by LIS reassignments \\n    • Members who are enrolled in employer group plans \\n    • Members who were passively enrolled into a Demonstration (MMP) \\n    • Contracts with less than 1,000 enrollees \\n    • 1876 Cost contract disenrollments into the transition MA contract (H contract) \\n    • Members who moved out of the service area of the contract from which they \\n      disenrolled (based on the member’s address as submitted by the plan into which \\n      the member enrolled or the member’s current SSA address if there is no address \\n      submitted by the plan into which the member enrolled) or where the service area \\n      of the contract they enrolled into does not intersect with the service area of the \\n      contract from which they disenrolled. \\n \\nGeneral Notes: This measure includes members with a disenrollment effective date between 1/1/2023 \\nand 12/31/2023 who disenrolled from the contract with any one of the following \\ndisenrollment reason codes: \\n    11 - Voluntary Disenrollment through plan \\n    13 - Disenrollment because of enrollment in another Plan  \\n    14 - Retroactive \\n    99 - Other (not supplied by beneficiary). \\n \\nIf all potential members in the numerator meet one or more of the exclusion criteria, the \\nmeasure result will be “Not enough data available”. \\n \\nThe Disenrollment Reasons Survey (DRS) data available in the HPMS plan preview and \\nin the CMS downloadable Master Table, are not used in the calculation of this measure. \\nThe DRS data are presented in each of the systems for information purposes only. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Lower is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Patients’ Experience and Complaints Measure', '(Last Updated 10/03/2024)  \\nPage 85 \\n \\nTitle \\nDescription \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00446-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n> 36 % \\n> 24 % to <= 36 % \\n> 17 % to <= 24 % \\n> 8 % to <= 17 % \\n<= 8 % \\nPDP \\n> 22 % \\n> 16 % to <= 22 % \\n> 9 % to <= 16 % \\n> 5 % to <= 9 % \\n<= 5 % \\n \\nMeasure: D04 - Drug Plan Quality Improvement \\nTitle \\nDescription \\nLabel for Stars: Improvement (if any) in the Drug Plan’s Performance \\nLabel for Data: Improvement (If any) in the Drug Plan’s Performance \\nDescription: This shows how much the drug plan’s performance has improved or declined from one \\nyear to the next year. \\nIf a plan receives 1 or 2 stars, it means, on average, the plan’s scores declined (got \\nworse). \\nIf a plan receives 3 stars, it means, on average, the plan’s scores stayed about the \\nsame. \\nIf a plan receives 4 or 5 stars, it means, on average, the plan’s scores improved. \\n  \\nKeep in mind that a plan that is already doing well in most areas may not show much \\nimprovement. It is also possible that a plan can start with low ratings, show a lot of \\nimprovement, and still not be performing very well. \\nMetric: The numerator is the net improvement, which is a weighted sum of the number of \\nsignificantly improved measures minus the number of significantly declined measures. \\nThe denominator is the sum of the weights associated with the measures eligible for the \\nimprovement measure (i.e., the measures that were included in the 2024 and 2025 Star \\nRatings for this contract and had no specification changes). \\nPrimary Data Source: Star Ratings \\nData Source Description: 2024 and 2025 Star Ratings \\nData Source Category: Star Ratings', '(Last Updated 10/03/2024)  \\nPage 86 \\n \\nTitle \\nDescription \\nExclusions: Contracts must have data in at least half of the measures used to calculate \\nimprovement to be rated in this measure. \\nGeneral Notes: Attachment I contains the formulas used to calculate the improvement measure and lists \\nindicating which measures were used. \\nData Time Frame: Not Applicable \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Not Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Improvement Measure \\nWeighting Value: 5 \\nMajor Disaster: Includes only measures which have data from both years. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00224-01-C-PARTD \\nData Display: Not Applicable \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: Type \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< -0.218869 \\n>= -0.218869 to < 0 \\n>= 0 to < 0.242468 \\n>= 0.242468 to < \\n0.496603 \\n>= 0.496603 \\nPDP \\n< -0.282500 \\n>= -0.282500 to < 0 \\n>= 0 to < 0.273334 \\n>= 0.273334 to < \\n0.576667 \\n>= 0.576667', \"(Last Updated 10/03/2024)  \\nPage 87 \\n \\nDomain: 3 - Member Experience with the Drug Plan \\nMeasure: D05 - Rating of Drug Plan \\nTitle \\nDescription \\nLabel for Stars: Members’ Rating of Drug Plan \\nLabel for Data: Members’ Rating of Drug Plan (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned from members who rated the \\nprescription drug plan. \\nMetric: This case-mix adjusted measure is used to assess members' overall view of their \\nprescription drug plan. The Consumer Assessment of Healthcare Providers and \\nSystems (CAHPS) score uses the mean of the distribution of responses converted to a \\nscale from 0 to 100. The score shown is the percentage of the best possible score each \\ncontract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Question (question numbers vary depending on survey type): \\n \\n• Using any number from 0 to 10, where 0 is the worst prescription drug plan possible \\n  and 10 is the best prescription drug plan possible, what number would you use to rate \\n  your prescription drug plan? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care\", \"(Last Updated 10/03/2024)  \\nPage 88 \\n \\nTitle \\nDescription \\nCMIT #: 00641-01-C-PARTD \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nNo \\nYes \\nYes \\nBase Group Cut Points: Type \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\nMA-PD \\n< 84 \\n>= 84 to < 86 \\n>= 86 to < 87 \\n>= 87 to < 89 \\n>= 89 \\nPDP \\n< 79 \\n>= 79 to < 82 \\n>= 82 to < 85 \\n>= 85 to < 87 \\n>= 87 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules. \\n \\nMeasure: D06 - Getting Needed Prescription Drugs \\nTitle \\nDescription \\nLabel for Stars: Ease of Getting Prescriptions Filled When Using the Plan \\nLabel for Data: Ease of Getting Prescriptions Filled When Using the Plan (on a scale from 0 to 100) \\nDescription: Percent of the best possible score the plan earned on how easy it is for members to get \\nthe prescription drugs they need using the plan. \\nMetric: This case-mix adjusted measure is used to assess the ease with which a beneficiary \\ngets the medicines their doctor prescribed. The Consumer Assessment of Healthcare \\nProviders and Systems (CAHPS) score uses the mean of the distribution of responses \\nconverted to a scale from 0 to 100. The score shown is the percentage of the best \\npossible score each contract earned. \\nPrimary Data Source: CAHPS \\nData Source Description: CAHPS Survey Questions (question numbers vary depending on survey type): \\n \\n• In the last 6 months, how often was it easy to use your prescription drug plan to get \\n  the medicines your doctor prescribed? \\n \\n• In the last 6 months, how often was it easy to use your prescription drug plan to fill a \\n  prescription at your local pharmacy? \\n \\n• In the last 6 months, how often was it easy to use your prescription drug plan to fill a \\n  prescription by mail? \\nData Source Category: Survey of Enrollees \\nGeneral Notes: CAHPS Survey results were sent to each contract's Medicare Compliance Officer in \\nAugust 2024. These reports provide further explanation of the CAHPS scoring \\nmethodology and provide detailed information on why a specific rating was assigned. \\nData Time Frame: 03/2024 – 06/2024 \\nGeneral Trend: Higher is better\", '(Last Updated 10/03/2024)  \\nPage 89 \\n \\nTitle \\nDescription \\nStatistical Method: Relative Distribution and Significance Testing \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: Yes \\nWeighting Category: Patients’ Experience and Complaints Measure \\nWeighting Value: 4 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Person-Centered Care \\nCMIT #: 00294-01-C-PARTD \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nNo \\nNo \\nYes \\nYes \\nBase Group Cut Points: \\nType \\nBase Group 1 \\nBase Group 2 \\nBase Group 3 \\nBase Group 4 \\nBase Group 5 \\nMA-PD \\n< 87 \\n>= 87 to < 88 \\n>= 88 to < 90 \\n>= 90 to < 91 \\n>= 91 \\nPDP \\n< 86 \\n>= 86 to < 87 \\n>= 87 to < 89 \\n>= 89 to < 90 \\n>= 90 \\nThese technical notes show the base group cut points for CAHPS measures; please \\nsee the Attachment K for the CAHPS Methodology for final star assignment rules.', '(Last Updated 10/03/2024)  \\nPage 90 \\n \\nDomain: 4 - Drug Safety and Accuracy of Drug Pricing \\nMeasure: D07 - MPF Price Accuracy \\nTitle \\nDescription \\nLabel for Stars: Plan Provides Accurate Drug Pricing Information for This Website \\nLabel for Data: Plan Provides Accurate Drug Pricing Information for This Website (higher scores are \\nbetter because they mean more accurate prices) \\nDescription:  A score comparing the drug’s total cost at the pharmacy to the drug prices the plan \\nprovided for the Medicare Plan Finder (MPF) website. Higher scores are better because \\nthey mean the plan provided more accurate prices. \\n \\nMetric: This measure evaluates the accuracy of drug prices posted on the MPF tool. A \\ncontract’s score is based on the accuracy index, or magnitude of difference, and the \\nclaim percentage index, or frequency of difference. \\n \\nThe accuracy index – or magnitude of difference - considers both ingredient cost and \\ndispensing fee and measures the amount that the PDE price is higher than the MPF \\nprice. The claim percentage index – or frequency of difference - also considers both \\ningredient cost and dispensing fee while measuring how often the PDE price is higher \\nthan the MPF price. Therefore, prices that are overstated on MPF will not count against \\na plan’s score. \\n \\nThe accuracy index is computed as: (Total amount that PDE is higher than MPF + Total \\nPDE cost) / (Total PDE cost).  \\n \\nThe claim percentage index is computed as: (Total number of PDEs where PDE cost is \\nhigher than MPF) / (Total number of PDEs). \\n  \\nThe best possible accuracy index is 1 and claim percentage index is 0. Indexes with \\nthese values indicate that a plan did not have PDE prices greater than MPF prices.  \\n \\nA contract’s score is computed using its accuracy index and claim percentage index as: \\n0.5 x (100 – ((accuracy index – 1) x 100)) + 0.5 x ((1 – claim percentage index) x 100). \\nPrimary Data Source: PDE data, MPF Pricing Files \\nData Source Description: Data used in this measure are obtained from a number of sources: MPF Pricing Files \\nand PDE data are the primary data sources. The PDE data were submitted by drug \\nplans to CMS Drug Data Processing Systems (DDPS) and accepted by the 2023 PDE \\nsubmission deadline for annual Part D payment reconciliation with dates of service from \\nJanuary 1, 2023- September 30, 2023. If the PDE edit results in the PDE being rejected \\nby DDPS, then the PDE is not used in the measure. If the PDE edit is informational, and \\ntherefore does not result in the PDE being rejected, then the PDE is used. Reminder, \\nCMS uses the term “final action” PDE to describe the most recently accepted original, \\nadjustment, or deleted PDE record representing a single dispensing event. Original and \\nadjustment final action PDEs submitted by the sponsor and accepted by DDPS prior to \\nthe 2023 PDE submission deadline are used to calculate this measure. The HPMS-\\napproved formulary extracts, and data from First DataBank and Medi-span are also \\nused.   \\nData Source Category: Data Collected by CMS Contractors', '(Last Updated 10/03/2024)  \\nPage 91 \\n \\nTitle \\nDescription \\nExclusions: A contract with less than 30 PDE claims over the measurement period. PDEs must also \\nmeet the following criteria:  \\n \\n• If the NPI in the Pharmacy Cost (PC) file represents a retail only pharmacy or retail \\nand limited access drug only pharmacy, all corresponding PDEs will be eligible for the \\nmeasure. However, if the NPI in the PC file represents a retail and other pharmacy type \\n(such as Mail, Home Infusion or Long Term Care pharmacy), only the PDE where the \\npharmacy service type is identified as either Community/Retail or Managed Care \\nOrganization (MCO) will be eligible. \\n• Drug must appear in formulary file and in MPF pricing file  \\n• PDE must be a 28-34, 60-62, or 90-93 day supply. If a plan’s bid indicates a 1, 2, or 3 \\nmonth retail days supply amount outside of the 28-34, 60-62, or 90-93 windows, then \\nadditional days supply values may be included in the accuracy measure for the plan. \\n• Date of service must occur at a time that data are not suppressed for the plan on MPF \\n• PDE must not be a compound claim \\n• PDE must not be a non-covered drug \\nGeneral Notes: Please see Attachment M: Methodology for Price Accuracy Measure for more \\ninformation about this measure. \\nData Time Frame: 01/01/2023 – 09/30/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Not Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Affordability and Efficiency \\nCMIT #: 00452-01-C-PARTD \\nData Display: Numeric with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes', '(Last Updated 10/03/2024)  \\nPage 92 \\n \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 97 \\n>= 97 to < 98 \\n>= 98 to < 99 \\n>= 99 to < 100 \\n 100 \\nPDP \\n< 97 \\n>= 97 to < 98 \\n>= 98 to < 99 \\n>= 99 to < 100 \\n 100 \\n \\nMeasure: D08 - Medication Adherence for Diabetes Medications \\nTitle \\nDescription \\nLabel for Stars: Taking Diabetes Medication as Directed \\nLabel for Data: Taking Diabetes Medication as Directed \\nDescription: Percent of plan members with a prescription for diabetes medication who fill their \\nprescription often enough to cover 80% or more of the time they are supposed to be \\ntaking the medication.  \\n  \\nOne of the most important ways people with diabetes can manage their health is by \\ntaking their medication as directed. The plan, the doctor, and the member can work \\ntogether to find ways to do this. (“Diabetes medication” means a biguanide drug, a \\nsulfonylurea drug, a thiazolidinedione drug, a DPP-4 inhibitor, a GIP/GLP-1 receptor \\nagonist, a meglitinide drug, or an SGLT2 inhibitor. Plan members who take insulin are \\nnot included.) \\nMetric: This measure is defined as the percent of Medicare Part D beneficiaries 18 years and \\nolder who adhere to their prescribed drug therapy across classes of diabetes \\nmedications: biguanides, sulfonylureas, thiazolidinediones, DiPeptidyl Peptidase (DPP)-\\n4 Inhibitors, GIP/GLP-1 receptor agonists, meglitinides, and sodium glucose \\ncotransporter 2 (SGLT2) inhibitors. This percentage is calculated as the number of \\nmember-years of enrolled beneficiaries 18 years and older with a proportion of days \\ncovered (PDC) at 80 percent or higher across the classes of diabetes medications \\nduring the measurement period (numerator) divided by the number of member-years of \\nenrolled beneficiaries 18 years and older with at least two fills of diabetes medication(s) \\non unique dates of service during the measurement period (denominator). \\n \\nThe PDC is the percent of days in the measurement period “covered” by prescription \\nclaims for the same medication or another in its therapeutic category. Beneficiaries are \\nonly included in the measure calculation if the first fill of their diabetes medication occurs \\nat least 91 days before the end of the enrollment period, end of measurement period, or \\ndeath, whichever comes first. \\n \\nThe Medication Adherence measure is adapted from the Medication Adherence-\\nProportion of Days Covered measure that was developed and endorsed by the \\nPharmacy Quality Alliance (PQA).  \\n \\nSee the medication list for this measure. The Medication Adherence rate is calculated \\nusing the National Drug Code (NDC) list maintained by the PQA. The complete NDC \\nlist, including diagnosis codes, is posted along with these technical notes. \\nPrimary Data Source: Prescription Drug Event (PDE) data \\nData Source Description: The data for this measure come from PDE data submitted by drug plans to CMS Drug \\nData Processing Systems (DDPS) and accepted by the 2023 PDE submission deadline \\nfor annual Part D payment reconciliation with dates of service from January 1, 2023-\\nDecember 31, 2023. If the PDE edit results in the PDE being rejected by DDPS, then', '(Last Updated 10/03/2024)  \\nPage 93 \\n \\nTitle \\nDescription \\nthe PDE is not used in the Patient Safety measure calculations. If the PDE edit is \\ninformational and therefore, does not result in the PDE being rejected, then the PDE is \\nused in the Patient Safety measure calculations. Reminder, CMS uses the term “final \\naction” PDE to describe the most recently accepted original, adjustment, or deleted PDE \\nrecord representing a single dispensing event. Original and adjustment final action \\nPDEs submitted by the sponsor and accepted by DDPS prior to the 2023 PDE \\nsubmission deadline are used to calculate this measure. PDE claims are limited to \\nmembers who received at least two prescriptions on unique dates of service for \\ndiabetes medication(s). PDE adjustments made post-reconciliation were not reflected in \\nthis measure.  \\n \\nAdditional data sources include the Common Medicare Environment (CME), the \\nMedicare Enrollment Database (EDB), the Common Working File (CWF), and the \\nEncounter Data Systems (EDS). The data cut off date for all the additional data sources \\nlisted below such as the CME, CWF, and EDS is determined by the same PDE \\nsubmission deadline for the annual Part D payment reconciliation.  \\n• CME is used for enrollment information. \\n• EDB is used to identify beneficiaries who elected to receive hospice care or with ESRD \\nstatus (dialysis start and end dates within the measurement period). Due to CMS’s \\nmigration of the beneficiary database, including the EDB and CME, to the Amazon Web \\nServices (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated \\nData Repository (CME IDRC), sourced from the same upstream database. \\n• CWF is used to identify exclusion diagnoses based on ICD-10-CM codes, inpatient \\n(IP) and skilled nursing facility (SNF) stays for PDPs and MA-PDs (if available). \\n• EDS is used to identify diagnoses based on ICD-10-CM codes, and SNF/IP stays for \\nMA-PD beneficiaries.  \\n \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts with 30 or fewer enrolled member-years (in the denominator). The following \\nbeneficiaries are also excluded from the denominator if at any time during the \\nmeasurement period: \\n \\n• In hospice \\n• ESRD diagnosis or dialysis coverage dates \\n• One or more prescriptions for insulin \\n \\nGeneral Notes: Part D drugs do not include drugs or classes of drugs, or their medical uses, which may \\nbe excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, \\nexcept for smoking cessation agents. As such, these drugs, which may be included in \\nthe PQA medication or NDC lists, are excluded from CMS analyses. Also, the member-\\nyears of enrollment adjustment is made by CMS to account for partial enrollment within \\nthe benefit year. Enrollment is measured at the episode level, and inclusion in the \\nmeasure is determined separately for each episode – i.e., to be included for a given \\nepisode, the beneficiary must meet the initial inclusion criteria for the measure during \\nthat episode.  \\n \\nThe measure is weighted based on the total number of member-years for each \\nenrollment episode in which the beneficiary meets the measure criteria. For instance, if \\na beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode,', '(Last Updated 10/03/2024)  \\nPage 94 \\n \\nTitle \\nDescription \\nreenrolled for a three-month episode, and meets the measure criteria during each \\nenrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + \\n3/12 = 6/12).  \\n \\nThe PDC calculation is adjusted for overlapping prescriptions for the same drug which is \\ndefined by the active ingredient at the generic name level using the NDC list maintained \\nby PQA. The calculation also adjusts for Part D beneficiaries’ stays in IP settings, and \\nstays in SNFs. The discharge date is included as an adjustment for IP/SNF stays. \\nPlease see Attachment L: Medication Adherence Measure Calculations for more \\ninformation about these calculation adjustments. \\n \\nWhen available, beneficiary death date from the CME is the end date of a beneficiary’s \\nmeasurement period. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00436-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: Type \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 91 % \\n>= 91 % \\nPDP \\n< 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 %', '(Last Updated 10/03/2024)  \\nPage 95 \\n \\nMeasure: D09 - Medication Adherence for Hypertension (RAS antagonists) \\nTitle \\nDescription \\nLabel for Stars: Taking Blood Pressure Medication as Directed \\nLabel for Data: Taking Blood Pressure Medication as Directed \\nDescription: Percent of plan members with a prescription for a blood pressure medication who fill \\ntheir prescription often enough to cover 80% or more of the time they are supposed to \\nbe taking the medication.  \\n  \\nOne of the most important ways people with high blood pressure can manage their \\nhealth is by taking medication as directed. The plan, the doctor, and the member can \\nwork together to do this. (“Blood pressure medication” means an ACEI (angiotensin \\nconverting enzyme inhibitor), an ARB (angiotensin receptor blocker), or a direct renin \\ninhibitor drug.) \\nMetric: This measure is defined as the percent of Medicare Part D beneficiaries 18 years and \\nolder who adhere to their prescribed drug therapy for renin angiotensin system (RAS) \\nantagonists: angiotensin converting enzyme inhibitor (ACEI), angiotensin receptor \\nblocker (ARB), or direct renin inhibitor medications. This percentage is calculated as the \\nnumber of member-years of enrolled beneficiaries 18 years and older with a proportion \\nof days covered (PDC) at 80 percent or higher for RAS antagonist medications during \\nthe measurement period (numerator) divided by the number of member-years of \\nenrolled beneficiaries 18 years and older with at least two RAS antagonist medication \\nfills on unique dates of service during the measurement period (denominator).  \\n \\nThe PDC is the percent of days in the measurement period “covered” by prescription \\nclaims for the same medication or another in its therapeutic category. Beneficiaries are \\nonly included in the measure calculation if the first fill of their RAS antagonist medication \\noccurs at least 91 days before the end of the enrollment period, end of measurement \\nperiod, or death, whichever comes first. \\n \\nThe Part D Medication Adherence measure is adapted from the Medication Adherence-\\nProportion of Days Covered measure that was developed and endorsed by the PQA.  \\n \\nSee the medication list for this measure. The Part D Medication Adherence rate is \\ncalculated using the NDC list maintained by the PQA. The complete NDC list, including \\ndiagnosis codes, is posted along with these technical notes. \\nPrimary Data Source: Prescription Drug Event (PDE) data \\nData Source Description: The data for this measure come from PDE data submitted to the CMS DDPS and \\naccepted by the 2023 PDE submission deadline for annual Part D payment \\nreconciliation with dates of service from January 1, 2023-December 31, 2023. If the \\nPDE edit results in the PDE being rejected by DDPS, then the PDE is not used in the \\nPatient Safety measure calculations. If the PDE edit is informational and therefore, does \\nnot result in the PDE being rejected, then the PDE is used in the Patient Safety \\nmeasure calculations. Reminder, CMS uses the term “final action” PDE to describe the \\nmost recently accepted original, adjustment, or deleted PDE record representing a \\nsingle dispensing event. Original and adjustment final action PDEs submitted by the \\nsponsor and accepted by DDPS prior to the 2023 PDE submission deadline are used to \\ncalculate this measure. PDE claims are limited to members who received at least two', '(Last Updated 10/03/2024)  \\nPage 96 \\n \\nTitle \\nDescription \\nprescriptions on unique dates of service for RAS antagonist medication(s). PDE \\nadjustments made post-reconciliation were not reflected in this measure. \\n \\nAdditional data sources include the CME, the EDB, and the CWF, and the EDS. The \\ndata cut off date for all the additional data sources listed below such as the CME, CWF, \\nand EDS is determined by the same PDE submission deadline for the annual Part D \\npayment reconciliation.   \\n• CME is used for enrollment information.  \\n• EDB is used to identify beneficiaries who elected to receive hospice care or with ESRD \\nstatus (dialysis start and end dates within the measurement period). Due to CMS’s \\nmigration of the beneficiary database, including the EDB and CME, to the Amazon Web \\nServices (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated \\nData Repository (CME IDRC), sourced from the same upstream database. \\n• CWF is used to identify exclusion diagnoses based on ICD-10-CM codes, inpatient  \\n  and SNF stays for PDPs and MA-PDs (if available). \\n• EDS is used to identify diagnoses based on ICD-10-CM codes, and SNF/IP stays for \\nMA-PD beneficiaries.  \\n \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts with 30 or fewer enrolled member-years (in the denominator). The following \\nbeneficiaries are also excluded from the denominator if at any time during the \\nmeasurement period: \\n \\n• In hospice \\n• ESRD diagnosis or dialysis coverage dates \\n• One or more prescriptions for sacubitril/valsartan \\n \\nGeneral Notes: Part D drugs do not include drugs or classes of drugs, or their medical uses, which may \\nbe excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, \\nexcept for smoking cessation agents. As such, these drugs, which may be included in \\nthe PQA medication or NDC lists, are excluded from CMS analyses. Also, the member-\\nyears of enrollment adjustment is made by CMS to account for partial enrollment within \\nthe benefit year. Enrollment is measured at the episode level, and inclusion in the \\nmeasure is determined separately for each episode – i.e., to be included for a given \\nepisode, the beneficiary must meet the initial inclusion criteria for the measure during \\nthat episode. \\n \\nThe measure is weighted based on the total number of member-years for each \\nenrollment episode in which the beneficiary meets the measure criteria. For instance, if \\na beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode, \\nreenrolled for a three-month episode, and meets the measure criteria during each \\nenrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + \\n3/12 = 6/12).  \\n \\nThe PDC calculation is adjusted for overlapping prescriptions for the same drug which is \\ndefined by active ingredient at the generic name level using the NDC list maintained by \\nPQA. The calculation also adjusts for Part D beneficiaries’ stays in IP settings, and \\nstays in SNFs. The discharge date is included as an adjustment day for IP/SNF stays.', '(Last Updated 10/03/2024)  \\nPage 97 \\n \\nTitle \\nDescription \\nPlease see Attachment L: Medication Adherence Measure Calculations for more \\ninformation about these calculation adjustments. \\n \\nWhen available, beneficiary death date from the CME is the end date of a beneficiary’s \\nmeasurement period. \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00437-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: Type \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 83 % \\n>= 83 % to < 87 % \\n>= 87 % to < 90 % \\n>= 90 % to < 92 % \\n>= 92 % \\nPDP \\n< 87 % \\n>= 87 % to < 89 % \\n>= 89 % to < 90 % \\n>= 90 % to < 92 % \\n>= 92 %', '(Last Updated 10/03/2024)  \\nPage 98 \\n \\nMeasure: D10 - Medication Adherence for Cholesterol (Statins) \\nTitle \\nDescription \\nLabel for Stars: Taking Cholesterol Medication as Directed \\nLabel for Data: Taking Cholesterol Medication as Directed \\nDescription: Percent of plan members with a prescription for a cholesterol medication (a statin drug) \\nwho fill their prescription often enough to cover 80% or more of the time they are \\nsupposed to be taking the medication. \\n  \\nOne of the most important ways people with high cholesterol can manage their health is \\nby taking medication as directed. The plan, the doctor, and the member can work \\ntogether to do this. \\nMetric: This measure is defined as the percent of Medicare Part D beneficiaries 18 years and \\nolder who adhere to their prescribed drug therapy for statin cholesterol medications. \\nThis percentage is calculated as the number of member-years of enrolled beneficiaries \\n18 years and older with a proportion of days covered (PDC) at 80 percent or higher for \\nstatin cholesterol medication(s) during the measurement period (numerator) divided by \\nthe number of member-years of enrolled beneficiaries 18 years and older with at least \\ntwo statin cholesterol medication fills on unique dates of service during the \\nmeasurement period (denominator).  \\n \\nThe PDC is the percent of days in the measurement period “covered” by prescription \\nclaims for the same medication or another in the therapeutic category. Beneficiaries are \\nonly included in the measure calculation if the first fill of their statin medication occurs at \\nleast 91 days before the end of the enrollment period, end of measurement period, or \\ndeath, whichever comes first. \\n \\nThe Medication Adherence measure is adapted from the Medication Adherence-\\nProportion of Days Covered measure that was developed and endorsed by the PQA.  \\n \\nSee the medication list for this measure. The Medication Adherence rate is calculated \\nusing the NDC list maintained by the PQA. The complete NDC list, including diagnosis \\ncodes, is posted along with these technical notes. \\nPrimary Data Source: Prescription Drug Event (PDE) data \\nData Source Description: The data for this measure come from PDE data submitted by drug plans to the CMS \\nDDPS and accepted by the 2023 PDE submission deadline for annual Part D payment \\nreconciliation with dates of service from January 1, 2023-December 31, 2023. If the \\nPDE edit results in the PDE being rejected by DDPS, then the PDE is not used in the \\nPatient Safety measure calculations. If the PDE edit is informational and therefore, does \\nnot result in the PDE being rejected, then the PDE is used in the Patient Safety \\nmeasure calculations. Reminder, CMS uses the term “final action” PDE to describe the \\nmost recently accepted original, adjustment, or deleted PDE record representing a \\nsingle dispensing event. Original and adjustment final action PDEs submitted by the \\nsponsor and accepted by DDPS prior to the 2023 PDE submission deadline are used to \\ncalculate this measure. PDE claims are limited to members who received at least two \\nprescriptions on unique dates of service for statin medication. PDE adjustments made \\npost-reconciliation were not reflected in this measure.', '(Last Updated 10/03/2024)  \\nPage 99 \\n \\nTitle \\nDescription \\nAdditional data sources include the CME, the EDB, the CWF, and the EDS. The data \\ncut off date for all the additional data sources listed below such as the CME, CWF, and \\nEDS is determined by the same PDE submission deadline for the annual Part D \\npayment reconciliation.    \\n• CME is used for enrollment information. \\n• EDB is used to identify beneficiaries who elected to receive hospice care or with ESRD \\nstatus (dialysis start and end dates within the measurement period). Due to CMS’s \\nmigration of the beneficiary database, including the EDB and CME, to the Amazon Web \\nServices (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated \\nData Repository (CME IDRC), sourced from the same upstream database. \\n• CWF is used to identify exclusion diagnoses based on ICD-10-CM codes, IP and SNF \\nstays for PDPs and MA-PDs (if available). \\n• EDS is used to identify diagnoses based on ICD-10-CM codes, and SNF/IP stays for \\nMA-PD beneficiaries.  \\n \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts with 30 or fewer enrolled member-years (in the denominator). The following \\nbeneficiaries are also excluded from the denominator if at any time during the \\nmeasurement period: \\n \\n• In hospice \\n• ESRD diagnosis or dialysis coverage dates  \\n \\nGeneral Notes: Part D drugs do not include drugs or classes of drugs, or their medical uses, which may \\nbe excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, \\nexcept for smoking cessation agents. As such, these drugs, which may be included in \\nthe PQA medication or NDC lists, are excluded from CMS analyses. Also, the member-\\nyears of enrollment adjustment is made by CMS to account for partial enrollment within \\nthe benefit year. Enrollment is measured at the episode level, and inclusion in the \\nmeasure is determined separately for each episode – i.e., to be included for a given \\nepisode, the beneficiary must meet the initial inclusion criteria for the measure during \\nthat episode.  \\n \\nThe measure is weighted based on the total number of member-years for each \\nenrollment episode in which the beneficiary meets the measure criteria. For instance, if \\na beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode, \\nreenrolled for a three-month episode, and meets the measure criteria during each \\nenrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + \\n3/12 = 6/12).  \\n \\nThe PDC calculation is adjusted for overlapping prescriptions for the same drug which is \\ndefined by active ingredient at the generic name level using the NDC list maintained by \\nPQA. The calculation also adjusts for Part D beneficiaries’ stays in IP settings, and \\nstays in SNFs. The discharge date is included as an adjustment day for IP/SNF stays. \\nPlease see Attachment L: Medication Adherence Measure Calculations for more \\ninformation about these calculation adjustments. \\n \\nWhen available, beneficiary death date from the CME is the end date of a beneficiary’s \\nmeasurement period.', '(Last Updated 10/03/2024)  \\nPage 100 \\n \\nTitle \\nDescription \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Intermediate Outcome Measure \\nWeighting Value: 3 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00435-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % >= 85 % to < 89 % >= 89 % to < 93 % \\n>= 93 % \\nPDP \\n< 86 % \\n>= 86 % to < 88 % >= 88 % to < 89 % >= 89 % to < 92 % \\n>= 92 % \\n \\nMeasure: D11 - MTM Program Completion Rate for CMR \\nTitle \\nDescription \\nLabel for Stars: Members Who Had a Pharmacist (or Other Health Professional) Help them Understand \\nand Manage Their Medications \\nLabel for Data: Members Who Had a Pharmacist (or Other Health Professional) Help them Understand \\nand Manage Their Medications \\nDescription: Some plan members are in a program (called a Medication Therapy Management \\nprogram) to help them manage their drugs. The measure shows how many members in \\nthe program had an assessment of their medications from the plan. \\nThe assessment includes a discussion between the member and a pharmacist (or other \\nhealth care professional) about all of the member’s medications. The member also \\nreceives a written summary of the discussion, including an action plan that recommends \\nwhat the member can do to better understand and use his or her medications.', '(Last Updated 10/03/2024)  \\nPage 101 \\n \\nTitle \\nDescription \\nMetric: This measure is defined as the percent of Medication Therapy Management (MTM) \\nprogram enrollees who received a Comprehensive Medication Review (CMR) during the \\nreporting period.  \\n \\nNumerator = Number of beneficiaries from the denominator who received a CMR at any \\ntime during their period of MTM enrollment in the reporting period. \\n \\nDenominator = Number of beneficiaries who were at least 18 years or older as of the \\nbeginning of the reporting period and who were enrolled in the MTM program for at least \\n60 days during the reporting period. Only those beneficiaries who meet the contracts’ \\nspecified targeting criteria per CMS – Part D requirements pursuant to §423.153(d) of \\nthe regulations at any time in the reporting period are included in this measure. \\nBeneficiaries who were in hospice at any point during the reporting period are excluded. \\nBeneficiaries who were enrolled in the contract’s MTM program for less than 60 days at \\nany time in the measurement year are only included in the denominator and the \\nnumerator if they received a CMR within this timeframe. Beneficiaries are excluded from \\nthe measure calculation if they were enrolled in the contract’s MTM program for less \\nthan 60 days and did not receive a CMR within this timeframe. The date of enrollment is \\ncounted towards the 60 days but the opt-out date is not. \\n \\nA beneficiary’s MTM eligibility, receipt of CMRs, etc., is determined for each contract \\nhe/she was enrolled in during the measurement period. Similarly, a contract’s CMR \\ncompletion rate is calculated based on each of its eligible MTM enrolled beneficiaries. \\nFor example, a beneficiary must meet the inclusion criteria for the contract to be \\nincluded in the contract’s CMR rate. A beneficiary who is enrolled in two different \\ncontracts’ MTM programs for 30 days each is therefore excluded from both contracts’ \\nCMR rates. The beneficiary is only included in the measure calculation for the \\ncontract(s) where they were enrolled at least 60 days or received a CMR if enrolled for \\nless than 60 days. Beneficiaries with multiple records that contain varying information \\nfor the same contract are excluded from the measure calculation for that contract. \\n \\nBeneficiaries may be enrolled in MTM based on the contracts’ specified targeting criteria \\nper CMS – Part D requirements and/or based on expanded, other plan-specific targeting \\ncriteria. Beneficiaries who were initially enrolled in MTM due to other plan-specific \\n(expanded) criteria and then later met the contracts’ specified targeting criteria per CMS \\n– Part D requirements at any time in the reporting period are included in this measure. \\nIn these cases, a CMR received after the date of MTM enrollment but before the date \\nthe beneficiary met the specified targeting criteria per CMS – Part D requirements are \\nincluded. \\nPrimary Data Source: Part D Plan Reporting \\nData Source Description: The data for this measure were reported by contracts to CMS per the 2023 Part D \\nReporting Requirements (data pulled June 2024). Validation of these data was \\nperformed retrospectively during the 2024 data validation cycle (deadline June 15, 2024 \\nand data validation results pulled July 2024). Additionally, the Medicare Enrollment \\nDatabase (EDB) from the Integrated Data Repository (CME IDRC) is used to identify \\nbeneficiaries in hospice (data pulled June 2024).  \\n \\nData Source Category: Health and Drug Plans', '(Last Updated 10/03/2024)  \\nPage 102 \\n \\nTitle \\nDescription \\nExclusions: Contracts with an effective termination date on or before the deadline to submit data \\nvalidation results to CMS (June 15, 2024) are excluded and listed as “Not required to \\nreport.”  \\n \\nMTM CMR rates are not provided for contracts that did not score at least 95% on data \\nvalidation for the Medication Therapy Management Program reporting section or were \\nnot compliant with data validation standards/sub-standards for any of the following \\nMedication Therapy Management Program data elements. We define a contract as \\nbeing non-complaint if either it receives a \"No\" or a 1, 2, or 3 on the 5-point Likert scale \\nin the specific data element\\'s data validation. \\n \\n• MBI Number (Element B) \\n• Date of MTM program enrollment (Element H) \\n• Met the specified targeting criteria per CMS – Part D requirements (Element I) \\n• Date met the specified targeting criteria per CMS – Part D requirements (Element J) \\n• Date of MTM program opt-out, if applicable (Element K) \\n• Received annual CMR with written summary in CMS standardized format (Element O) \\n• Date(s) of CMR(s) (Element P) \\n \\nMTM CMR rates are also not provided for contracts that failed to submit their MTM file \\nand pass system validation by the reporting deadline or who had a missing data \\nvalidation score for MTM.  Contracts excluded from the MTM CMR Rates due to data \\nvalidation issues are shown as “CMS identified issues with this plan\\'s data.” See \\nAttachment N for more details on the MTM CMR completion rate measure scoring \\nmethodology. \\n \\nContracts can view their data validation results in HPMS (https://hpms.cms.gov/). To \\naccess this page, from the top menu select “Monitoring,” then “Plan Reporting Data \\nValidation.” Select the appropriate contract year. Select the PRDVM Reports. Select \\n“Score Detail Report.” Select the applicable reporting section.  If you cannot see the \\nPlan Reporting Data Validation module, contact CMS at HPMS_Access@cms.hhs.gov. \\n \\nAdditionally, contracts must have 31 or more enrollees in the denominator in order to \\nhave a calculated rate. Contracts with fewer than 31 eligible enrollees are listed as \"Not \\nenough data available\". \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure', '(Last Updated 10/03/2024)  \\nPage 103 \\n \\nTitle \\nDescription \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Seamless Care Coordination \\nCMIT #: 00454-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 57 % \\n>= 57 % to < 77 % \\n>= 77 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nPDP \\n< 30 % \\n>= 30 % to < 55 % \\n>= 55 % to < 68 % \\n>= 68 % to < 80 % \\n>= 80 % \\n \\nMeasure: D12 - Statin Use in Persons with Diabetes (SUPD) \\nTitle \\nDescription \\nLabel for Stars: The Plan Makes Sure Members with Diabetes Take the Most Effective Drugs to Treat \\nHigh Cholesterol \\nLabel for Data: The Plan Makes Sure Members with Diabetes Take the Most Effective Drugs to Treat \\nHigh Cholesterol \\nDescription: To lower their risk of developing heart disease, most people with diabetes should take \\ncholesterol medication. This rating is based on the percent of plan members with \\ndiabetes who take the most effective cholesterol-lowering drugs. Plans can help make \\nsure their members get these prescriptions filled. \\nMetric: This measure is defined as the percent of Medicare Part D beneficiaries 40-75 years old \\nwho were dispensed at least two diabetes medication fills on unique dates of service \\nand received a statin medication fill during the measurement period. The percentage is \\ncalculated as the number of member-years of enrolled beneficiaries 40-75 years old \\nwho received a statin medication fill during the measurement period (numerator) divided \\nby the number of member-years of enrolled beneficiaries 40-75 years old with at least \\ntwo diabetes medication fills on unique dates of service during the measurement period \\n(denominator).  \\n \\nBeneficiaries are only included in the measure calculation if the first fill of their diabetes \\nmedication occurs at least 90 days before the end of the measurement year or end of \\nthe enrollment episode. \\n \\nThe SUPD measure is adapted from the measure concept that was developed and \\nendorsed by the PQA.  \\n \\nSee the medication list for this measure. The SUPD measure is calculated using the \\nNDC lists updated by the PQA. The complete NDC lists, including diagnosis codes, are \\nposted along with these technical notes.', '(Last Updated 10/03/2024)  \\nPage 104 \\n \\nTitle \\nDescription \\nPrimary Data Source: Prescription Drug Event (PDE) data \\nData Source Description: The data for this measure come from Prescription Drug Event (PDE) data submitted by \\ndrug plans to the CMS DDPS and accepted by the 2023 PDE submission deadline for \\nannual Part D payment reconciliation with dates of service from January 1, 2023 – \\nDecember 31, 2023. If the PDE edit results in the PDE being rejected by DDPS, then \\nthe PDE is not used in the Patient Safety measure calculations. If the PDE edit is \\ninformational and therefore, does not result in the PDE being rejected, then the PDE is \\nused in the Patient Safety measure calculations. Reminder, CMS uses the term “final \\naction” PDE to describe the most recently accepted original, adjustment, or deleted PDE \\nrecord representing a single dispensing event. Original and adjustment final action \\nPDEs submitted by the sponsor and accepted by DDPS prior to the 2023 PDE \\nsubmission deadline are used to calculate this measure. PDE adjustments made post-\\nreconciliation were not reflected in this measure.  \\n \\nAdditional data sources include the CME, the EDB, the CWF, and the EDS. The data \\ncut off date for all the additional data sources listed below such as the CME, CWF, and \\nEDS is determined by the same PDE submission deadline for the annual Part D \\npayment reconciliation. \\n• CME is used for enrollment information. \\n• EDB is used to identify beneficiaries who elected to receive hospice care or with ESRD \\nstatus (dialysis start and end dates within the measurement period). Due to CMS’s \\nmigration of the beneficiary database, including the EDB and CME, to the Amazon Web \\nServices (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated \\nData Repository (CME IDRC), sourced from the same upstream database. \\n• CWF is used to identify exclusion diagnoses based on ICD-10-CM codes. \\n• EDS is used to identify diagnoses based on ICD-10-CM codes. \\n \\nData Source Category: Health and Drug Plans \\nExclusions: Contracts with 30 or fewer enrolled member-years (in the denominator). The following \\nbeneficiaries are excluded from the denominator if at any time during the measurement \\nperiod: \\n \\n• Hospice enrollment \\n• ESRD diagnosis or dialysis coverage dates \\n• Rhabdomyolysis and myopathy \\n• Pregnancy, Lactation, and fertility \\n• Cirrhosis \\n• Pre-Diabetes \\n• Polycystic Ovary Syndrome  \\n \\nGeneral Notes: Part D drugs do not include drugs or classes of drugs, or their medical uses, which may \\nbe excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, \\nexcept for smoking cessation agents. As such, these drugs, which may be included in \\nthe PQA medication or NDC lists, are excluded from CMS analyses. Also, the member-\\nyears of enrollment adjustment is made by CMS to account for partial enrollment within \\nthe benefit year. Enrollment is measured at the episode level, and inclusion in the \\nmeasure is determined separately for each episode – i.e., to be included for a given', '(Last Updated 10/03/2024)  \\nPage 105 \\n \\nTitle \\nDescription \\nepisode, the beneficiary must meet the initial inclusion criteria for the measure during \\nthat episode.  \\n \\nThe measure is weighted based on the total number of member years for each episode \\nin which the beneficiary meets the measure criteria. For instance, if a beneficiary is \\nenrolled for a three-month episode, disenrolled for a six-month episode, reenrolled for a \\nthree-month episode, and meets the measure criteria during each enrollment episode, \\ns/he will count as 0.5 member years in the rate calculation (3/12 + 3/12 = 6/12). \\n \\nData Time Frame: 01/01/2023 – 12/31/2023 \\nGeneral Trend: Higher is better \\nStatistical Method: Clustering \\nImprovement Measure: Included \\nCAI Usage: Included \\nCase-Mix Adjusted: No \\nWeighting Category: Process Measure \\nWeighting Value: 1 \\nMajor Disaster: Higher measure star (2024-2025) for contracts with 25% or more enrolled affected by \\n2023 disasters. \\nMeaningful Measure Area: Chronic Conditions \\nCMIT #: 00702-01-C-PARTD \\nData Display: Percentage with no decimal place \\nReporting Requirements: \\n1876 Cost \\nCCP w/o SNP \\nCCP with SNP \\nCCP with Only I-SNP \\nMSA \\nPDP \\nPFFS \\nYes \\nYes \\nYes \\nYes \\nNo \\nYes \\nYes \\nCut Points: \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 81 % \\n>= 81 % to < 86 % \\n>= 86 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nPDP \\n< 80 % \\n>= 80 % to < 83 % \\n>= 83 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 %', '(Last Updated 10/03/2024)  \\nPage 106 \\n \\nAttachment A: CAHPS Case-Mix Adjustment \\nCAHPS Case-Mix Adjustment \\nThe CAHPS measures are case-mix adjusted to take into account the mix of enrollees. Case-mix variables \\ninclude administrative age, dual eligibility status, low-income subsidy (LIS) indicator, and use of Asian \\nlanguage survey, and self-reported education, general health status, mental health status, and proxy usage status. \\nThe tables below include the case-mix variables and show the case-mix coefficients for each of the CAHPS \\nmeasures included in the Star Ratings. The coefficients indicate how much higher or lower people with a given \\ncharacteristic tend to respond compared to otherwise similar people with the baseline value for that \\ncharacteristic (e.g. reference group), on the original scale of the item or composite, as presented in plan reports. \\nThe reference group for each characteristic will have a coefficient value of zero. \\nFor example, for the Part C measure \"Rating of Health Plan,\" the model coefficient for \"age 75-79\" is 0.0511, \\nindicating that respondents in that age range tend to score their plans 0.0511 points higher than otherwise similar \\npeople in the 70-74 age range (the baseline or reference category). Similarly, respondents who had a proxy help \\naside from answering for them tend to respond 0.0850 points lower on this item than otherwise similar \\nrespondents without proxy help. Contracts with higher proportions of beneficiaries who are in the 75-79 age range \\nwill be adjusted downward on this measure to compensate for the positive response tendency of their respondents. \\nSimilarly, contracts with higher proportions of respondents who had proxy help will be adjusted upward on this \\nmeasure to compensate for their respondents’ negative response tendency. The case-mix patterns are not always \\nconsistent across measures. Missing case-mix adjustors are imputed as the contract mean. \\nThe composites consist of multiple items, each of which is adjusted separately before combining the adjusted \\nscores into a composite score. Item-level coefficients are presented below separately for each composite. For \\nmore detailed information on the application of CAHPS case-mix adjustment, please review the materials at \\nhttps://ma-pdpcahps.org/en/scoring-and-star-ratings/.', \"(Last Updated 10/03/2024)  \\nPage 107 \\n \\nTable A-1: Coefficients of Part C Getting Needed Care (C19) CAHPS Measure Composite Items \\nPredictor \\nGet appointment with specialist Easy to get care \\nAge: 64 or under \\n0.0576 \\n-0.0150 \\nAge: 65 – 69 \\n-0.0251 \\n-0.0157 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0043 \\n0.0207 \\nAge: 80 – 84 \\n0.0083 \\n-0.0005 \\nAge: 85 and older \\n0.0364 \\n0.0224 \\nEducation: Less than an 8th grade education \\n0.0136 \\n-0.0402 \\nEducation: Some high school \\n-0.0119 \\n0.0065 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0661 \\n-0.0536 \\nEducation: College graduate \\n-0.0921 \\n-0.0552 \\nEducation: More than a bachelor's degree \\n-0.1588 \\n-0.0844 \\nGeneral health rating: excellent \\n0.1392 \\n0.0480 \\nGeneral health rating: very good \\n0.0816 \\n0.0596 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0612 \\n-0.0669 \\nGeneral health rating: poor \\n-0.0762 \\n-0.1168 \\nMental health rating: excellent \\n0.1772 \\n0.1754 \\nMental health rating: very good \\n0.0943 \\n0.0933 \\nMental health rating: good \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0630 \\n-0.0547 \\nMental health rating: poor \\n-0.1618 \\n-0.1287 \\nProxy helped \\n-0.0084 \\n0.0039 \\nProxy answered \\n0.0104 \\n0.0574 \\nMedicaid dual eligible \\n0.0075 \\n0.0107 \\nLow-income subsidy (LIS) \\n-0.0226 \\n0.0136 \\nAsian survey language \\n-0.0145 \\n0.0455\", \"(Last Updated 10/03/2024)  \\nPage 108 \\n \\nTable A-2: Coefficients of Part C Getting Appointments and Care Quickly (C20) CAHPS Measure Composite \\nItems \\nPredictor \\nGetting needed care as soon \\nas wanted \\nGetting routine care as soon \\nas wanted \\nAge: 64 or under \\n0.0052 \\n0.0177 \\nAge: 65 – 69 \\n0.0448 \\n-0.0035 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0285 \\n0.0115 \\nAge: 80 – 84 \\n0.0628 \\n0.0301 \\nAge: 85 and older \\n0.0724 \\n0.0412 \\nEducation: Less than an 8th grade education \\n0.0703 \\n-0.0390 \\nEducation: Some high school \\n0.0187 \\n-0.0160 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0269 \\n-0.0469 \\nEducation: College graduate \\n-0.0042 \\n-0.0517 \\nEducation: More than a bachelor's degree \\n-0.0735 \\n-0.0857 \\nGeneral health rating: excellent \\n0.0512 \\n0.0604 \\nGeneral health rating: very good \\n0.0377 \\n0.0348 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0808 \\n-0.0496 \\nGeneral health rating: poor \\n-0.1089 \\n-0.0725 \\nMental health rating: excellent \\n0.0984 \\n0.1447 \\nMental health rating: very good \\n0.0586 \\n0.0665 \\nMental health rating: good \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0341 \\n-0.0278 \\nMental health rating: poor \\n-0.2374 \\n-0.1584 \\nProxy helped \\n0.0194 \\n0.0273 \\nProxy answered \\n0.1571 \\n0.0589 \\nMedicaid dual eligible \\n0.0120 \\n0.0277 \\nLow-income subsidy (LIS) \\n0.0166 \\n-0.0116 \\nAsian survey language \\n-0.1069 \\n-0.2643\", \"(Last Updated 10/03/2024)  \\nPage 109 \\n \\nTable A-3: Coefficients of Part C Customer Service (C21) CAHPS Measure Composite Items \\nPredictor \\nPaperwork easy \\nPlan customer service gives \\ninformation \\nPlan customer service \\ncourtesy and respect \\nAge: 64 or under \\n0.0067 \\n-0.0433 \\n-0.0186 \\nAge: 65 – 69 \\n0.0039 \\n-0.0283 \\n-0.0223 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n-0.0126 \\n-0.0091 \\n0.0032 \\nAge: 80 – 84 \\n-0.0191 \\n0.0003 \\n-0.0052 \\nAge: 85 and older \\n-0.0239 \\n0.0045 \\n0.0078 \\nEducation: Less than an 8th grade education \\n-0.0235 \\n-0.0688 \\n-0.0201 \\nEducation: Some high school \\n-0.0090 \\n-0.0231 \\n-0.0195 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0196 \\n-0.0765 \\n-0.0353 \\nEducation: College graduate \\n-0.0184 \\n-0.1060 \\n-0.0363 \\nEducation: More than a bachelor's degree \\n-0.0397 \\n-0.1479 \\n-0.0425 \\nGeneral health rating: excellent \\n0.0259 \\n0.0870 \\n0.0223 \\nGeneral health rating: very good \\n0.0134 \\n0.0376 \\n-0.0053 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0402 \\n-0.0437 \\n-0.0171 \\nGeneral health rating: poor \\n-0.0413 \\n-0.0276 \\n0.0087 \\nMental health rating: excellent \\n0.0509 \\n0.1242 \\n0.1019 \\nMental health rating: very good \\n0.0205 \\n0.0551 \\n0.0648 \\nMental health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0361 \\n-0.0286 \\n0.0012 \\nMental health rating: poor \\n-0.0703 \\n-0.1172 \\n-0.1081 \\nProxy helped \\n-0.0304 \\n0.0160 \\n0.0023 \\nProxy answered \\n0.0124 \\n0.0268 \\n0.0287 \\nMedicaid dual eligible \\n-0.0443 \\n0.0649 \\n0.0278 \\nLow-income subsidy (LIS) \\n-0.0180 \\n0.0242 \\n0.0426 \\nAsian survey language \\n-0.0613 \\n-0.0596 \\n-0.1666\", \"(Last Updated 10/03/2024)  \\nPage 110 \\n \\nTable A-4: Coefficients of Part C Stand-alone CAHPS Measures \\nPredictor \\nC22: Rating of Health Care \\nQuality \\nC23: Rating of Health \\nPlan \\nAge: 64 or under \\n-0.0683 \\n-0.0969 \\nAge: 65 – 69 \\n-0.0669 \\n-0.0754 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0311 \\n0.0511 \\nAge: 80 – 84 \\n0.0347 \\n0.0804 \\nAge: 85 and older \\n0.0006 \\n0.0934 \\nEducation: Less than an 8th grade education \\n0.0607 \\n0.1276 \\nEducation: Some high school \\n0.0131 \\n0.0340 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.1325 \\n-0.2128 \\nEducation: College graduate \\n-0.1729 \\n-0.3380 \\nMore than a bachelor's degree \\n-0.2509 \\n-0.4173 \\nGeneral health rating: excellent \\n0.3339 \\n0.2631 \\nGeneral health rating: very good \\n0.1949 \\n0.1386 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.2529 \\n-0.1497 \\nGeneral health rating: poor \\n-0.5774 \\n-0.3155 \\nMental health rating: excellent \\n0.5053 \\n0.3642 \\nMental health rating: very good \\n0.2545 \\n0.1767 \\nMental health rating: good \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.1320 \\n-0.1231 \\nMental health rating: poor \\n-0.4610 \\n-0.4146 \\nProxy helped \\n-0.1008 \\n-0.0850 \\nProxy answered \\n0.1089 \\n0.0348 \\nMedicaid dual eligible \\n0.0297 \\n0.3065 \\nLow-income subsidy (LIS) \\n0.0581 \\n0.0833 \\nAsian survey language \\n0.3586 \\n-0.0170\", \"(Last Updated 10/03/2024)  \\nPage 111 \\n \\nTable A-5: Coefficients of Part C Care Coordination (C24) CAHPS Measure Composite Items \\nPredictor \\nMD/office help to \\nmanage care \\nMD informed \\nabout specialist \\ncare \\nMD follows up \\nabout test \\nresults and gives \\nresults as soon as \\nneeded \\nTalk with MD \\nabout medicines \\nMD has medical \\nrecords about \\ncare \\nAge: 64 or under \\n-0.0404 \\n-0.0041 \\n0.0356 \\n0.0425 \\n-0.0061 \\nAge: 65 – 69 \\n-0.0251 \\n-0.0170 \\n-0.0259 \\n0.0149 \\n-0.0136 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n-0.0102 \\n-0.0218 \\n-0.0080 \\n-0.0555 \\n-0.0049 \\nAge: 80 – 84 \\n-0.0051 \\n-0.0313 \\n-0.0090 \\n-0.1083 \\n-0.0133 \\nAge: 85 and older \\n-0.0266 \\n-0.0063 \\n-0.0133 \\n-0.1635 \\n-0.0106 \\nEducation: Less than an 8th grade education \\n-0.0246 \\n0.0271 \\n-0.0308 \\n-0.0168 \\n-0.0375 \\nEducation: Some high school \\n-0.0010 \\n-0.0244 \\n0.0147 \\n0.0249 \\n-0.0091 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0510 \\n-0.0476 \\n-0.0252 \\n-0.0008 \\n-0.0048 \\nEducation: College graduate \\n-0.0379 \\n-0.1104 \\n-0.0310 \\n-0.0753 \\n-0.0164 \\nEducation: More than a bachelor's degree \\n-0.0738 \\n-0.0889 \\n-0.0302 \\n-0.0625 \\n0.0017 \\nGeneral health rating: excellent \\n0.0385 \\n-0.0025 \\n0.0792 \\n0.0775 \\n0.0122 \\nGeneral health rating: very good \\n0.0009 \\n0.0080 \\n0.0469 \\n0.0468 \\n0.0154 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0492 \\n0.0003 \\n-0.0734 \\n-0.0501 \\n-0.0346 \\nGeneral health rating: poor \\n-0.0881 \\n-0.0275 \\n-0.1290 \\n-0.1341 \\n-0.0521 \\nMental health rating: excellent \\n0.0986 \\n0.1768 \\n0.1502 \\n0.1614 \\n0.0852 \\nMental health rating: very good \\n0.0071 \\n0.0787 \\n0.0791 \\n0.0788 \\n0.0450 \\nMental health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0564 \\n-0.0687 \\n-0.0206 \\n-0.0232 \\n-0.0299 \\nMental health rating: poor \\n-0.1419 \\n-0.2305 \\n-0.0954 \\n-0.1066 \\n-0.0564 \\nProxy helped \\n0.0165 \\n0.0216 \\n-0.0137 \\n0.1030 \\n0.0004 \\nProxy answered \\n0.0379 \\n-0.0010 \\n0.0008 \\n0.0992 \\n0.0375 \\nMedicaid dual eligible \\n-0.0100 \\n0.0766 \\n-0.0199 \\n0.0224 \\n-0.0219 \\nLow-income subsidy (LIS) \\n-0.0464 \\n0.0204 \\n-0.0139 \\n0.0548 \\n-0.0098 \\nAsian survey language \\n0.1072 \\n-0.0794 \\n0.1495 \\n-0.2609 \\n-0.1476\", \"(Last Updated 10/03/2024)  \\nPage 112 \\n \\nTable A-6: Coefficients of Part D CAHPS Stand-alone Measures \\nPredictor \\nMA-PD D05: Rating of Drug Plan \\nPDP D05: Rating of Drug Plan \\nAge: 64 or under \\n-0.1745 \\n-0.1359 \\nAge: 65 – 69 \\n-0.1126 \\n-0.1746 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0812 \\n0.1899 \\nAge: 80 – 84 \\n0.1529 \\n0.2057 \\nAge: 85 and older \\n0.1693 \\n0.3164 \\nEducation: Less than an 8th grade education \\n-0.0030 \\n0.0608 \\nEducation: Some high school \\n0.0428 \\n-0.0614 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.2084 \\n-0.2944 \\nEducation: College graduate \\n-0.3313 \\n-0.1121 \\nEducation: More than a bachelor's degree \\n-0.4213 \\n-0.4179 \\nGeneral health rating: excellent \\n0.2766 \\n0.1603 \\nGeneral health rating: very good \\n0.1651 \\n0.1845 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.1816 \\n-0.2015 \\nGeneral health rating: poor \\n-0.3960 \\n-0.4735 \\nMental health rating: excellent \\n0.3083 \\n0.2269 \\nMental health rating: very good \\n0.1538 \\n-0.0462 \\nMental health rating: good \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0273 \\n-0.2564 \\nMental health rating: poor \\n-0.3236 \\n-0.0325 \\nProxy helped \\n-0.0567 \\n-0.1165 \\nProxy answered \\n-0.0633 \\n0.0282 \\nMedicaid dual eligible \\n0.5296 \\n0.7997 \\nLow-income subsidy (LIS) \\n0.3751 \\n0.8174 \\nAsian survey language \\n-0.3403 \\n0.0000\", \"(Last Updated 10/03/2024)  \\nPage 113 \\n \\nTable A-7: Coefficients of Part D Getting Needed Prescription Drugs (D06) CAHPS Measure Composite Items \\nPredictor \\nMA-PD: Get needed \\nprescription drugs \\nMA-PD: Get \\nprescription drugs \\nfrom mail or \\npharmacy \\nPDP: Get needed \\nprescription drugs \\nPDP: Get \\nprescription drugs \\nfrom mail or \\npharmacy \\nAge: 64 or under \\n-0.0756 \\n-0.0361 \\n-0.0220 \\n-0.0216 \\nAge: 65 – 69 \\n-0.0437 \\n-0.0178 \\n-0.0322 \\n-0.0191 \\nAge: 70 – 74 \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nAge: 75 – 79 \\n0.0032 \\n0.0069 \\n0.0131 \\n0.0043 \\nAge: 80 – 84 \\n0.0197 \\n0.0014 \\n0.0063 \\n0.0059 \\nAge: 85 and older \\n0.0158 \\n-0.0083 \\n0.0017 \\n0.0091 \\nEducation: Less than an 8th grade education \\n-0.0518 \\n-0.0477 \\n-0.1331 \\n-0.0453 \\nEducation: Some high school \\n0.0003 \\n0.0033 \\n-0.1127 \\n-0.0492 \\nEducation: High school graduate \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nEducation: Some college \\n-0.0366 \\n-0.0400 \\n-0.0942 \\n-0.1147 \\nEducation: College graduate \\n-0.0405 \\n-0.0579 \\n-0.0563 \\n-0.0801 \\nEducation: More than a bachelor's degree \\n-0.0638 \\n-0.0784 \\n-0.1285 \\n-0.1741 \\nGeneral health rating: excellent \\n0.0200 \\n0.0621 \\n0.0942 \\n0.1142 \\nGeneral health rating: very good \\n0.0530 \\n0.0570 \\n0.1182 \\n0.0770 \\nGeneral health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nGeneral health rating: fair \\n-0.0611 \\n-0.0548 \\n-0.0367 \\n-0.0675 \\nGeneral health rating: poor \\n-0.0913 \\n-0.0676 \\n-0.1688 \\n-0.0735 \\nMental health rating: excellent \\n0.0856 \\n0.0862 \\n0.0591 \\n0.0890 \\nMental health rating: very good \\n0.0544 \\n0.0532 \\n0.0056 \\n0.0065 \\nMental health rating: good \\n0.0000 \\n0.0000 \\n0.0000 \\n0.0000 \\nMental health rating: fair \\n-0.0299 \\n-0.0438 \\n0.0195 \\n-0.0041 \\nMental health rating: poor \\n-0.1165 \\n-0.1001 \\n-0.0153 \\n-0.0692 \\nProxy helped \\n0.0036 \\n0.0117 \\n0.0688 \\n0.0576 \\nProxy answered \\n0.0331 \\n0.0030 \\n0.1382 \\n0.1257 \\nMedicaid dual eligible \\n0.0571 \\n0.0223 \\n0.0252 \\n0.0005 \\nLow-income subsidy (LIS) \\n0.0487 \\n-0.0139 \\n-0.0508 \\n0.0457 \\nAsian survey language \\n-0.0582 \\n-0.0015 \\n0.0000 \\n0.0000\", '(Last Updated 10/03/2024)  \\nPage 114 \\n \\nAttachment B: Calculating Measure Data for the Surviving Contract of a Consolidation \\nFirst Year Following a Consolidation \\nIn the first year following a consolidation, the measure values for the surviving contract of a consolidation are \\ncalculated as the enrollment-weighted mean of all contracts in the consolidation. The month(s) of enrollment \\nused to calculate the enrollment weighted means varies by the type of measure. Table B-1 below lists the \\nenrollment used for each type of measure and the rule followed to determine the month(s) of enrollment. Table \\nB-2 provides an example calculation. \\nTable B-1: Enrollment Month Used in Calculating Measure Scores for the Surviving Contract of a Consolidation \\nType of Measure Rule for Which Month of Enrollment is Used Month(s) of Enrollment Used for 2025 Star Ratings \\nCAHPS \\nEnrollment at the time survey sample is pulled \\nJanuary 2024 \\nCall Center \\nAverage enrollment during the study period \\nFeb 2024 – May 2024 \\nHOS \\nEnrollment at the time survey sample is pulled \\nApril 2023 \\nHEDIS-HOS \\nEnrollment at the time survey sample is pulled \\nApril 2023 \\nHEDIS \\nEnrollment in July of the measurement period \\nJuly 2023 \\nAll Other Measures Enrollment in July of the measurement period \\nJuly 2023 \\n \\nTable B-2: Example of Calculating the Measure Score for the Surviving Contract of a Consolidation \\nContract ID Surviving or Consumed Contract Value for Breast Cancer Screening (BCS) Measure July 2023 Enrollment \\nHAAAA \\nSurviving \\n75.13 \\n43,326 \\nHAAAB \\nConsumed \\n50.91 \\n20,933 \\nValue for BCS for HAAAA  =   \\n75.13∗43,326+50.91∗20,933\\n43,326+20,933\\n = 67.240097 \\nSecond Year Following a Consolidation \\nIn the second year following a consolidation, the measure values for the surviving contract of a consolidation \\nare as reported for CAHPS, call center, HOS, and HEDIS measures. For all other measures, the measure values \\nfor the surviving contract of a consolidation are calculated as the enrollment weighted mean of all contracts in \\nthe consolidation.', '(Last Updated 10/03/2024)  \\nPage 115 \\n \\nAttachment C: National Averages for Part C and D Measures \\nThe tables below contain the average of contract numeric and star values for each measure reported in the 2025 \\nStar Ratings. The averages are calculated after the disaster adjustment has been applied. \\nTable C-1: National Averages for Part C Measures \\nMeasure ID \\nMeasure Name \\nNumeric Average \\nStar Average \\nC01 \\nBreast Cancer Screening \\n73% \\n3.4 \\nC02 \\nColorectal Cancer Screening \\n73% \\n3.4 \\nC03 \\nAnnual Flu Vaccine \\n69% \\n3.2 \\nC04 \\nMonitoring Physical Activity \\n50% \\n3.1 \\nC05 \\nSpecial Needs Plan (SNP) Care Management \\n75% \\n3.4 \\nC06 \\nCare for Older Adults – Medication Review \\n93% \\n4.1 \\nC07 \\nCare for Older Adults – Pain Assessment \\n93% \\n4.2 \\nC08 \\nOsteoporosis Management in Women who had a \\nFracture \\n43% \\n2.7 \\nC09 \\nDiabetes Care – Eye Exam \\n75% \\n3.4 \\nC10 \\nDiabetes Care – Blood Sugar Controlled \\n83% \\n3.7 \\nC11 \\nControlling Blood Pressure \\n76% \\n3.0 \\nC12 \\nReducing the Risk of Falling \\n57% \\n2.6 \\nC13 \\nImproving Bladder Control \\n45% \\n3.0 \\nC14 \\nMedication Reconciliation Post-Discharge \\n73% \\n3.6 \\nC15 \\nPlan All-Cause Readmissions \\n11% \\n3.1 \\nC16 \\nStatin Therapy for Patients with Cardiovascular \\nDisease \\n86% \\n3.0 \\nC17 \\nTransitions of Care \\n59% \\n3.0 \\nC18 \\nFollow-up after Emergency Department Visit for \\nPeople with Multiple High-Risk Chronic Conditions \\n58% \\n3.2 \\nC19 \\nGetting Needed Care \\n81 \\n3.3 \\nC20 \\nGetting Appointments and Care Quickly \\n84 \\n3.5 \\nC21 \\nCustomer Service \\n90 \\n3.5 \\nC22 \\nRating of Health Care Quality \\n87 \\n3.5 \\nC23 \\nRating of Health Plan \\n87 \\n3.2 \\nC24 \\nCare Coordination \\n87 \\n3.6 \\nC25 \\nComplaints about the Health Plan \\n0.23 \\n4.2 \\nC26 \\nMembers Choosing to Leave the Plan \\n17% \\n3.6 \\nC27 \\nHealth Plan Quality Improvement \\nMedicare only shows a Star \\nRating for this measure \\n3.6 \\nC28 \\nPlan Makes Timely Decisions about Appeals \\n96% \\n4.2 \\nC29 \\nReviewing Appeals Decisions \\n95% \\n3.7 \\nC30 \\nCall Center – Foreign Language Interpreter and \\nTTY Availability \\n94% \\n4.0', '(Last Updated 10/03/2024)  \\nPage 116 \\n \\nTable C-2: National Averages for Part D Measures \\nMeasure ID \\nMeasure Name \\nMA-PD \\nNumeric \\nAverage \\nMA-PD  \\nStar \\nAverage \\nPDP  \\nNumeric \\nAverage \\nPDP  \\nStar \\nAverage \\nD01 \\nCall Center – Foreign Language Interpreter and TTY Availability \\n94 \\n4.0 \\n97 \\n3.6 \\nD02 \\nComplaints about the Drug Plan \\n0.23 \\n4.2 \\n0.04 \\n4.6 \\nD03 \\nMembers Choosing to Leave the Plan \\n17 \\n3.6 \\n10 \\n3.7 \\nD04 \\nDrug Plan Quality Improvement \\nMedicare \\nonly shows \\na Star \\nRating for \\nthis \\nmeasure \\n3.3 \\nMedicare \\nonly shows \\na Star \\nRating for \\nthis \\nmeasure \\n3.0 \\nD05 \\nRating of Drug Plan \\n87 \\n3.4 \\n84 \\n3.5 \\nD06 \\nGetting Needed Prescription Drugs \\n89 \\n3.3 \\n89 \\n3.7 \\nD07 \\nMPF Price Accuracy \\n98 \\n3.4 \\n97 \\n3.1 \\nD08 \\nMedication Adherence for Diabetes Medications \\n86 \\n3.2 \\n86 \\n2.4 \\nD09 \\nMedication Adherence for Hypertension (RAS antagonists) \\n89 \\n3.3 \\n89 \\n2.9 \\nD10 \\nMedication Adherence for Cholesterol (Statins) \\n88 \\n3.3 \\n88 \\n2.9 \\nD11 \\nMTM Program Completion Rate for CMR \\n87 \\n3.7 \\n55 \\n3.0 \\nD12 \\nStatin Use in Persons with Diabetes (SUPD) \\n86 \\n2.8 \\n83 \\n2.7', '(Last Updated 10/03/2024)  \\nPage 117 \\n \\nAttachment D: Part C and D Data Time Frames \\n \\nTable D-1: Part C Measure Data Time Frames \\nMeasure \\nID \\nMeasure Name \\nPrimary Data Source \\nData Time Frame \\nC01 \\nBreast Cancer Screening \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC02 \\nColorectal Cancer Screening \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC03 \\nAnnual Flu Vaccine \\nCAHPS \\n03/2024 – 06/2024 \\nC04 \\nMonitoring Physical Activity \\nHEDIS-HOS \\n07/17/2023 – 11/01/2023 \\nC05 \\nSpecial Needs Plan (SNP) Care Management \\nPart C Plan Reporting \\n01/01/2023 – 12/31/2023 \\nC06 \\nCare for Older Adults – Medication Review \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC07 \\nCare for Older Adults – Pain Assessment \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC08 \\nOsteoporosis Management in Women who had a Fracture \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC09 \\nDiabetes Care – Eye Exam \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC10 \\nDiabetes Care – Blood Sugar Controlled \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC11 \\nControlling Blood Pressure \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC12 \\nReducing the Risk of Falling \\nHEDIS-HOS \\n07/17/2023 – 11/01/2023 \\nC13 \\nImproving Bladder Control \\nHEDIS-HOS \\n07/17/2023 – 11/01/2023 \\nC14 \\nMedication Reconciliation Post-Discharge \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC15 \\nPlan All-Cause Readmission \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC16 \\nStatin Therapy for Patients with Cardiovascular Disease \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC17 \\nTransitions of Care \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC18 \\nFollow-up after Emergency Department Visit for People with Multiple \\nHigh-Risk Chronic Conditions \\nHEDIS \\n01/01/2023 – 12/31/2023 \\nC19 \\nGetting Needed Care \\nCAHPS \\n03/2024 – 06/2024 \\nC20 \\nGetting Appointments and Care Quickly \\nCAHPS \\n03/2024 – 06/2024 \\nC21 \\nCustomer Service \\nCAHPS \\n03/2024 – 06/2024 \\nC22 \\nRating of Health Care Quality \\nCAHPS \\n03/2024 – 06/2024 \\nC23 \\nRating of Health Plan \\nCAHPS \\n03/2024 – 06/2024 \\nC24 \\nCare Coordination \\nCAHPS \\n03/2024 – 06/2024 \\nC25 \\nComplaints about the Health Plan \\nComplaints Tracking Module \\n(CTM) \\n01/01/2023 – 12/31/2023 \\nC26 \\nMembers Choosing to Leave the Plan \\nMBDSS \\n01/01/2023 – 12/31/2023 \\nC27 \\nHealth Plan Quality Improvement \\nStar Ratings \\nNot Applicable \\nC28 \\nPlan Makes Timely Decisions about Appeals \\nIndependent Review Entity (IRE) \\n01/01/2023 – 12/31/2023 \\nC29 \\nReviewing Appeals Decisions \\nIndependent Review Entity (IRE) \\n01/01/2023 – 12/31/2023 \\nC30 \\nCall Center – Foreign Language Interpreter and TTY Availability \\nCall Center \\n02/2024 – 05/2024', '(Last Updated 10/03/2024)  \\nPage 118 \\n \\nTable D-2: Part D Measure Data Time Frames \\nMeasure \\nID \\nMeasure Name \\nPrimary Data Source \\nData Time Frame \\nD01 \\nCall Center – Foreign Language Interpreter and TTY Availability \\nCall Center \\n02/2024 – 05/2024 \\nD02 \\nComplaints about the Drug Plan \\nComplaints Tracking Module \\n(CTM) \\n01/01/2023 – 12/31/2023 \\nD03 \\nMembers Choosing to Leave the Plan \\nMBDSS \\n01/01/2023 – 12/31/2023 \\nD04 \\nDrug Plan Quality Improvement \\nStar Ratings \\nNot Applicable \\nD05 \\nRating of Drug Plan \\nCAHPS \\n03/2024 – 06/2024 \\nD06 \\nGetting Needed Prescription Drugs \\nCAHPS \\n03/2024 – 06/2024 \\nD07 \\nMPF Price Accuracy \\nPDE data, MPF Pricing Files \\n01/01/2023 – 09/30/2023 \\nD08 \\nMedication Adherence for Diabetes Medications \\nPrescription Drug Event (PDE) \\ndata \\n01/01/2023 – 12/31/2023 \\nD09 \\nMedication Adherence for Hypertension (RAS antagonists) \\nPrescription Drug Event (PDE) \\ndata \\n01/01/2023 – 12/31/2023 \\nD10 \\nMedication Adherence for Cholesterol (Statins) \\nPrescription Drug Event (PDE) \\ndata \\n01/01/2023 – 12/31/2023 \\nD11 \\nMTM Program Completion Rate for CMR \\nPart D Plan Reporting \\n01/01/2023 – 12/31/2023 \\nD12 \\nStatin Use in Persons with Diabetes (SUPD) \\nPrescription Drug Event (PDE) \\ndata \\n01/01/2023 – 12/31/2023', '(Last Updated 10/03/2024)  \\nPage 119 \\n \\nAttachment E: SNP Measure Scoring Methodologies \\n \\n1. Medicare Part C Reporting Requirements Measure (C05: SNP Care Management) \\nStep 1: Start with all contracts that offer at least one SNP plan that was active at any point during contract \\nyear 2023. \\nStep 2: Exclude contracts that did not have 30 or more enrollees in the denominator [Number of new \\nenrollees due for an Initial HRA (Element A) + Number of enrollees eligible for an annual HRA \\n(Element B) ≥ 30] during contract year 2023.   \\nExclude any contracts with an effective termination date on or before the deadline to submit data \\nvalidation results to CMS (June 15, 2024), or that were not required to participate in data validation. \\nThis exclusion is consistent with the statement from page 6 of the CY 2023 Medicare Part C Plan \\nReporting Requirements Technical Specifications Document: “Note: If a contract terminates before \\nJuly 1 in the following year after the contract year (CY) reporting period, the contract is not \\nrequired to report any data for the respective two years – the CY reporting period, and the following \\nyear… If a PBP (Plan) under a contract terminates at any time in the CY reporting period and the \\ncontract remains active through July 1 of the following year, the contract must still report data for \\nall PBPs, including the terminated PBP.” \\nThis excludes: \\n• Contracts that terminate on or before 07/01/2024 according to the Contract Info extract. \\nAdditionally, exclude contracts that did not score at least 95% on data validation for their plan \\nreporting of the SNP Care Management section and contracts that scored 95% or higher on data \\nvalidation for the SNP Care Management section but that were not compliant with data validation \\nstandards/sub-standards for at least one of the following SNP data elements. We define a contract \\nas being non-complaint if either it receives a \"No\" or a 1, 2, or 3 on the 5-point Likert scale in the \\nspecific data element\\'s data validation. \\n \\n• Number of new enrollees due for an initial HRA (Element A) \\n• Number of enrollees eligible for an annual reassessment HRA (Element B) \\n• Number of initial HRAs performed on new enrollees (Element C) \\n• Number of annual reassessments performed on enrollees eligible for reassessment (Element \\nF) \\n \\nStep 3: After removing contract data excluded above, suppress contract rates based on the following rules: \\nSection-level DV failure: Contracts that score less than 95% in DV for their CY 2023 SNP Care \\nReporting Requirements data are listed as “CMS identified issues with this plan’s data.” \\nElement-level DV failure: Contracts that score 95% or higher in DV for their CY 2023 SNP Care \\nReporting Requirements data but that failed at least one of the four data elements (elements A, B, \\nC, and F) are listed as “CMS identified issues with this plan’s data.” \\nSmall size: Contracts that have not yet been suppressed and have a SNP Care Assessment rate \\ndenominator [Number of New Enrollees due for an Initial HRA (Element A) + Number of enrollees \\neligible for an annual reassessment HRA (Element B)] of fewer than 30 are listed as “No data \\navailable.”', '(Last Updated 10/03/2024)  \\nPage 120 \\n \\nOrganizations can view their own plan reporting data validation results in HPMS \\n(https://hpms.cms.gov/). From the home page, select Monitoring | Plan Reporting Data Validation. \\nStep 4: Calculate the rate for the remaining contract using the formula: \\n[ Number of initial HRAs performed on new enrollees (Element C) \\n+ Number of annual reassessments performed on enrollees eligible for a reassessment (Element F) ] \\n/ [ Number of new enrollees due for an Initial HRA (Element A) \\n+ Number of enrollees eligible for an annual reassessment HRA (Element B) ] \\n2. NCQA HEDIS Measures - (C06 – C07: Care for Older Adults) \\nThe example NCQA measure combining methodology specifications below are written for two Plan Benefit \\nPackage (PBP) submissions, which we distinguish as 1 and 2, but the methodology easily extends to any \\nnumber of submissions. \\nRates are produced for any contract offering a SNP in the ratings year which provided SNP HEDIS data in \\nthe measurement year. \\nDefinitions \\nLet N1 = The Total Number of Members Eligible for the HEDIS measure in the first PBP (\"fixed\" and \\nauditable) \\nLet N2 = The Total Number of Members Eligible for the HEDIS measure in the second PBP (\"fixed\" and \\nauditable) \\nLet P1 = The estimated rate (mean) for the HEDIS measure in the first PBP (auditable) \\nLet P2 = The estimated rate (mean) for the same HEDIS measure in the second PBP (auditable) \\nSetup Calculations \\nBased on the above definitions, there are two additional calculations: \\nLet W1 = The weight assigned to the first PBP results (estimated, auditable). This is estimated from the \\nformula W1 = N1 / (N1 + N2) \\nLet W2 = The weight assigned to the second PBP results (estimated, auditable). This is estimated from the \\nformula W2 = N2 / (N1 + N2) \\nPooled Analysis \\nThe pooled result from the two rates (means) is calculated as: Ppooled = W1 * P1 + W2 * P2 \\nNOTES: \\nWeights are based on the eligible member population. While it may be more accurate to remove all \\nexcluded members before weighting, NCQA and CMS have chosen not to do this (to simplify the method) \\nfor two reasons: 1) the number of exclusions relative to the size of the population should be small, and 2) \\nexclusion rates (as a percentage of the eligible population) should be similar for each PBP and negligibly \\naffect the weights. \\nIf one or more of the submissions has a status of NA, those submissions are dropped and not included in the \\nweighted rate (mean) calculations. If one or more of the submissions has an audit designation of BR or NR \\n(which has been determined to be biased or is not reported by choice of the contract), the rate is set to zero as \\ndetailed in the section titled “Handling of Biased, Erroneous and/or Not Reportable (NR) Data” and the', '(Last Updated 10/03/2024)  \\nPage 121 \\n \\naverage enrollment for the year is used for the eligible population in the PBP. An example is shown in table E-\\n1. \\nTable E-1: Example Calculation Using Effectiveness of Care Rate \\nNumeric Example Using an Effectiveness of Care Rate \\n  \\n# of Total Members Eligible for the HEDIS measure in PBP 1, N1 =  \\n1500 \\n# of Total Members Eligible for the HEDIS measure in PBP 2, N2 =  \\n2500 \\nHEDIS Result for PBP 1, Enter as a Proportion between 0 and 1, P1 = \\n0.75 \\nHEDIS Result for PBP 2, Enter as a Proportion between 0 and 1, P2 = \\n0.5 \\nSetup Calculations - Initialize Some Intermediate Results \\n \\nThe weight for PBP 1 product estimated by W1 = N1 / (N1 + N2) \\n0.375 \\nThe weight for PBP 2 product estimated by W2 = N2 / (N1 + N2) \\n0.625 \\nPooled Results \\n \\nPpooled = W1 * P1 + W2 * P2 \\n0.59375', '(Last Updated 10/03/2024)  \\nPage 122 \\n \\nAttachment F: Calculating Measure C15: Plan All-Cause Readmissions \\nAll data are available in the CMS MY 2023 HEDIS® Public Use File (PUF)1 and can be looked up by \\nIndicatorKey (row) and Variable name (column). \\nThe calculations below use the Denominator, ObservedCount and ExpectedCount values from the PCR (18-64) \\nindicator (IndicatorKey = 202025_20) and the PCR (65+) indicator (IndicatorKey = 202111_20). \\nFor each contract, calculate the (18+) Denominator, ObservedCount, and ExpectedCount: \\n \\nDenominator(18+)  \\n= Denominator(18-64) + Denominator(65+) \\n \\nObservedCount(18+)  = ObservedCount(18-64) + ObservedCount(65+) \\n \\nExpectedCount(18+)  = ExpectedCount(18-64) + ExpectedCount(65+) \\n \\nUsing these (18+) values, calculate the (18+) Observed-over-Expected ratio (OE): \\nOE(18+) = ቀ\\nObservedCount(18+)\\nExpectedCount(18+)ቁ \\nAnd the national average of the (18+) Observed Rate: \\nNatAvgObs(18+) = Average ቆ൬\\nObservedCount(18+)1\\nDenominator(18+)1 ൰ + … + ൬\\nObservedCount(18+)n\\nDenominator(18+)n ൰ቇ \\nWhere 1 through n are all contracts with a (18+) Denominator larger than or equal to 150, and a (18+) OE larger \\nthan or equal to 0.2 and less than or equal to 5.0. \\nFor each contract, calculate the Final Rate and convert to percentages: \\nFinal Rate(18+) = OE(18+) x NatAvgObs(18+) x 100  \\nAnd round to the nearest integer. \\nExample: Calculating the final rate for Contract 1 \\nContract IndicatorKey Denominator ObservedCount ExpectedCount \\nContract 1 \\n202025_20 \\n214 \\n8 \\n12 \\nContract 1 \\n202111_20 \\n4,792 \\n641 \\n642 \\nContract 2 \\n202025_20 \\n225 \\n12 \\n7 \\nContract 2 \\n202111_20 \\n4,761 \\n688 \\n668 \\nContract 3 \\n202025_20 \\n573 \\n31 \\n35 \\nContract 3 \\n202111_20 \\n8,629 \\n1,126 \\n1,070 \\nContract 4 \\n202025_20 \\n12 \\n0 \\n1 \\nContract 4 \\n202111_20 \\n533 \\n79 \\n73 \\nNatAvgObs = Average ቆቀ\\n8+641 \\n214+4,792ቁ + ቀ\\n12+688\\n225+4,761ቁ + ቀ\\n31+1,126\\n573+8,629ቁ + ቀ\\n0+79\\n12+533ቁቇ \\nNatAvgObs = 0.135181 \\nOE Contract 1 = ቀ\\n8+641\\n12+642ቁ = 0.992355 \\nFinal Rate Contract 1 = 0.992355 ×  0.135181 x 100 =  13.41 \\nFinal Rate reported for Contract 1 = 13% \\n \\nThe actual calculated National Observed Rate used in the 2025 Star Ratings was 0.110821345940212. \\n \\n1 https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-\\nReports/MCRAdvPartDEnrolData/MA-HEDIS-Public-Use-Files', '(Last Updated 10/03/2024)  \\nPage 123 \\n \\n \\nAttachment G: Weights Assigned to Individual Performance Measures \\n \\nTable G-1: Part C Measure Weights \\nMeasure \\nID \\nMeasure Name \\nWeighting Category \\nPart C \\nSummary and \\nMA-PD Overall \\nC01 \\nBreast Cancer Screening \\nProcess Measure \\n1 \\nC02 \\nColorectal Cancer Screening \\nProcess Measure \\n1 \\nC03 \\nAnnual Flu Vaccine \\nProcess Measure \\n1 \\nC04 \\nMonitoring Physical Activity \\nProcess Measure \\n1 \\nC05 \\nSpecial Needs Plan (SNP) Care Management \\nProcess Measure \\n1 \\nC06 \\nCare for Older Adults – Medication Review \\nProcess Measure \\n1 \\nC07 \\nCare for Older Adults – Pain Assessment \\nProcess Measure \\n1 \\nC08 \\nOsteoporosis Management in Women who had a Fracture \\nProcess Measure \\n1 \\nC09 \\nDiabetes Care – Eye Exam \\nProcess Measure \\n1 \\nC10 \\nDiabetes Care – Blood Sugar Controlled \\nIntermediate Outcome Measure \\n3 \\nC11 \\nControlling Blood Pressure \\nIntermediate Outcome Measure \\n3 \\nC12 \\nReducing the Risk of Falling \\nProcess Measure \\n1 \\nC13 \\nImproving Bladder Control \\nProcess Measure \\n1 \\nC14 \\nMedication Reconciliation Post-Discharge \\nProcess Measure \\n1 \\nC15 \\nPlan All-Cause Readmissions \\nOutcome Measure \\n3 \\nC16 \\nStatin Therapy for Patients with Cardiovascular Disease \\nProcess Measure \\n1 \\nC17 \\nTransitions of Care \\nProcess Measure \\n1 \\nC18 \\nFollow-up after Emergency Department Visit for People with Multiple \\nHigh-Risk Chronic Conditions \\nProcess Measure \\n1 \\nC19 \\nGetting Needed Care \\nPatients’ Experience and Complaints Measure \\n4 \\nC20 \\nGetting Appointments and Care Quickly \\nPatients’ Experience and Complaints Measure \\n4 \\nC21 \\nCustomer Service \\nPatients’ Experience and Complaints Measure \\n4 \\nC22 \\nRating of Health Care Quality \\nPatients’ Experience and Complaints Measure \\n4 \\nC23 \\nRating of Health Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nC24 \\nCare Coordination \\nPatients’ Experience and Complaints Measure \\n4 \\nC25 \\nComplaints about the Health Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nC26 \\nMembers Choosing to Leave the Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nC27 \\nHealth Plan Quality Improvement \\nImprovement Measure \\n5 \\nC28 \\nPlan Makes Timely Decisions about Appeals \\nMeasures Capturing Access \\n4 \\nC29 \\nReviewing Appeals Decisions \\nMeasures Capturing Access \\n4 \\nC30 \\nCall Center – Foreign Language Interpreter and TTY Availability \\nMeasures Capturing Access \\n4', '(Last Updated 10/03/2024)  \\nPage 124 \\n \\nTable G-2: Part D Measure Weights \\nMeasure \\nID \\nMeasure Name \\nWeighting Category \\nPart D \\nSummary and \\nMA-PD Overall \\nD01 \\nCall Center – Foreign Language Interpreter and TTY Availability \\nMeasures Capturing Access \\n4 \\nD02 \\nComplaints about the Drug Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nD03 \\nMembers Choosing to Leave the Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nD04 \\nDrug Plan Quality Improvement \\nImprovement Measure \\n5 \\nD05 \\nRating of Drug Plan \\nPatients’ Experience and Complaints Measure \\n4 \\nD06 \\nGetting Needed Prescription Drugs \\nPatients’ Experience and Complaints Measure \\n4 \\nD07 \\nMPF Price Accuracy \\nProcess Measure \\n1 \\nD08* \\nMedication Adherence for Diabetes Medications \\nIntermediate Outcome Measure \\n3 \\nD09* \\nMedication Adherence for Hypertension (RAS antagonists) \\nIntermediate Outcome Measure \\n3 \\nD10* \\nMedication Adherence for Cholesterol (Statins) \\nIntermediate Outcome Measure \\n3 \\nD11 \\nMTM Program Completion Rate for CMR \\nProcess Measure \\n1 \\nD12 \\nStatin Use in Persons with Diabetes (SUPD) \\nProcess Measure \\n1 \\n*For contracts whose service area only covers Puerto Rico, the weight for each adherence measure is set to zero (0) when calculating \\nthe summary and overall rating.', '(Last Updated 10/03/2024)  \\nPage 125 \\n \\nAttachment H: Calculation of Weighted Star Rating and Variance Estimates \\nThe weighted summary (or overall) Star Rating for contract j is estimated as: \\n𝑥𝑥̅𝑗𝑗=\\n\\u0dcd\\n𝑤𝑤𝑖𝑖𝑖𝑖𝑥𝑥𝑖𝑖𝑖𝑖\\n𝑛𝑛𝑗𝑗\\n𝑖𝑖=1\\n\\u0dcd\\n𝑤𝑤𝑖𝑖𝑖𝑖\\n𝑛𝑛𝑗𝑗\\n𝑖𝑖=1\\n \\nwhere nj is the number of performance measures for which contract j is eligible; wij is the weight assigned to \\nperformance measure i for contract j; and xij is the measure star for performance measure i for contract j. The \\nvariance of the Star Ratings for each contract 𝑗𝑗, 𝑠𝑠𝑗𝑗\\n2, must also be computed in order to estimate the reward factor \\n(r-Factor): \\n𝑠𝑠𝑗𝑗\\n2 =\\n𝑛𝑛𝑗𝑗\\n൫𝑛𝑛𝑗𝑗−1൯൫∑\\n𝑤𝑤𝑖𝑖𝑖𝑖\\n𝑛𝑛𝑗𝑗\\n𝑖𝑖=1\\n൯\\n\\u0d64\\u0dcd\\n𝑤𝑤𝑖𝑖𝑖𝑖\\n𝑛𝑛𝑗𝑗\\n𝑖𝑖=1\\n൫𝑥𝑥𝑖𝑖𝑖𝑖−𝑥𝑥𝚥𝚥ഥ൯\\n2൨ \\nThus, the 𝑥𝑥𝚥𝚥ഥ’s are the new summary (or overall) Star Ratings for the contracts. The variance estimate, 𝑠𝑠𝑗𝑗\\n2, simply \\nreplaces the non-weighted variance estimate that was previously used for the r-Factor calculation. For all \\ncontracts j, wij = wi (i.e., the performance measure weights are the same for all contracts when estimating a \\ngiven Star Rating (Part C or Part D summary or MA-PD overall ratings).', '(Last Updated 10/03/2024)  \\nPage 126 \\n \\nAttachment I: Calculating the Improvement Measure and the Measures Used \\nCalculating the Improvement Measure \\nContracts must have data for at least half of the attainment measures used to calculate the Part C or Part D \\nimprovement measure to be eligible to receive a rating in that improvement measure. \\nThe improvement change score was determined for each measure for which a contract was eligible by \\ncalculating the difference in measure scores between Star Rating years 2024 and 2025.  \\nFor measures where a higher score is better: \\nImprovement\\u2008Change\\u2008Score\\u2008=\\u2008Score\\u2008in\\u20082025\\u2008-\\u2008Score\\u2008in\\u20082024 \\nFor measures where a lower score is better: \\nImprovement\\u2008Change\\u2008Score\\u2008=\\u2008Score\\u2008in\\u20082024\\u2008-\\u2008Score\\u2008in\\u20082025 \\nAn eligible measure was defined as a measure for which a contract was scored in both the 2024 and 2025 Star \\nRatings, and there were no significant measure specification changes or a regional contract reconfiguration for \\nwhich only contract data is available from the original contract in one or both years. \\nFor each measure, significant improvement or decline between Star Ratings years 2024 and 2025 was \\ndetermined by a two-sided t-test at the 0.05 significance level: \\nIf \\nImprovement Change Score\\nStandard Error of Improvement Change Score  > 1.96, then YES = significant improvement \\nIf \\nImprovement Change Score\\nStandard Error of Improvement Change Score  < -1.96, then YES = significant decline \\nHold Harmless Provision for Individual Measures: If a contract demonstrated statistically significant decline (at \\nthe 0.05 significance level) on an attainment measure for which they received five stars during both the current \\ncontract year and the prior contract year, then this measure will be counted as showing no significant change. \\nMeasures that are held harmless as described here will be considered eligible for the improvement measure. \\nNet improvement is calculated for each class of measures (e.g., outcome, access, and process) by subtracting the \\nnumber of significantly declined measures from the number of significantly improved measures. \\nNet Improvement = Number of significantly improved measures - Number of significantly declined measures \\nThe improvement measure score is calculated for Parts C and D separately by taking a weighted sum of net \\nimprovement divided by the weighted sum of the number of eligible measures. \\nMeasures are generally weighted as follows: \\nOutcome or intermediate outcome measure: Weight of 3 \\nAccess or patient experience/complaints measure: Weight of 4 \\nProcess measure: Weight of 1 \\nSpecific weights for each measure, which may deviate from the general scheme above are described in \\nAttachment G. When the weight of an individual measure changes over the two years of data used, the newer \\nweight value is used in the improvement calculation. \\nImprovement Measure Score = Net_Imp_Process + 3 * Net_Imp_Outcome + 4 * Net_Imp_PtExp\\nElig_Process  + 3 * Elig_Outcome + 4 * Elig_PtExp', '(Last Updated 10/03/2024)  \\nPage 127 \\n \\n \\nNet_Imp_Process = Net improvement for process measures \\nNet_Imp_Outcome = Net improvement for outcome and intermediate outcome measures \\nNet_Imp_PtExp = Net improvement for patient experience/complaints and access measures \\nElig_Process = Number of eligible process measures \\nElig_Outcome = Number of eligible outcome and intermediate outcome measures \\nElig_PtExp = Number of eligible patient experience/complaints and access measures \\n \\nThe improvement measure score is converted into a Star Rating using the clustering method. Conceptually, the \\nclustering algorithm identifies the “gaps” in the data and creates cut points that result in the creation of five \\ncategories (one for each Star Rating) such that scores of contracts in the same score category (Star Rating) are \\nas similar as possible, and scores of contracts in different categories are as different as possible. Improvement \\nscores of 0 (equivalent to no net change on the attainment measures included in the improvement measure \\ncalculation) will be centered at 3 stars when assigning the improvement measure Star Rating. Then, the \\nremaining contracts are split into two groups and clustered:  1) improvement scores less than zero receive one or \\ntwo stars on the improvement measure and 2) improvement scores greater than or equal to zero receive 3, 4, or \\n5 stars. \\nGeneral Standard Error Formula \\nBecause a contract’s score on a given measure in one year is not independent of its score in the next year, the \\nstandard error for the improvement change score for each measure is calculated using the standard approach for \\nestimating the variance of the difference between two variables that may not be independent. In particular, the \\nstandard error of the improvement change score is calculated using the formula: \\nඥ𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2)2 + 𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1)2 −2 ∗𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) \\nUsing measure C01 as an example, the change score standard error is: \\n𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2) Represents the 2025 standard error for contract i on measure C01 \\n𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1) Represents the 2024 standard error for contract i on measure C01 \\n𝑌𝑌𝑖𝑖2 \\nRepresents the 2025 rate for contract i on measure C01 \\n𝑌𝑌𝑖𝑖1 \\nRepresents the 2024 rate for contract i on measure C01 \\n𝑐𝑐𝑐𝑐𝑐𝑐 \\nRepresents the covariance between 𝑌𝑌𝑖𝑖2 and 𝑌𝑌𝑖𝑖1computed using the correlation across all contracts \\nobserved at both time points (2025 and 2024). In other words: \\n𝑐𝑐𝑐𝑐𝑐𝑐(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) = 𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2) ∗𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1) ∗𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1)  \\nwhere the correlation 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) is assumed to be the same for all contracts and is computed using data for \\nall contracts for which both years’ measure scores are available and not excluded by the disaster policy. This \\nassumption is needed because only one score is observed for each contract in each year; therefore, it is not \\npossible to compute a contract-specific correlation. \\nImprovement Change Score Standard Error Numerical Example \\nFor measure C03, contract A: \\n𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖2) = 2.805 \\n𝑠𝑠𝑠𝑠(𝑌𝑌𝑖𝑖1) = 3.000 \\n𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶(𝑌𝑌𝑖𝑖2, 𝑌𝑌𝑖𝑖1) = 0.901', '(Last Updated 10/03/2024)  \\nPage 128 \\n \\nImprovement change score standard error for measure C03 for contract A = sqrt (2.8052 + 3.0002 – 2 * 0.901 * \\n2.805 * 3.000) = 1.305 \\nStandard Error Formulas (SEF) for Specific Measures \\nThe following formulas are used for calculating the contract-specific standard errors for specific measures in the \\n2025 Star Ratings. These standard errors are used in calculating the improvement change score standard error. \\n1. SEF for Measures: C01, C02, C04, C05, C08 – C14, C16, C18, C26, C28 – C30, D01, D03, D08 – D12 \\nSEy= ඨ\\nScorey*(100-Scorey)\\nDenominatory\\n \\nfor y = 2024, 2025 \\nDenominatory is as defined in the Measure Details section for each measure. \\n2. SEF for Measures: C06, C07 \\nThese measures are rolled up from the plan level to the contract level following the formula outlined in \\nAttachment E: NCQA HEDIS Measures. The standard error at the contract level is calculated as shown below.  \\nThe specifications are written for two PBP submissions, which we distinguish as 1 and 2, but the methodology \\neasily extends to any number of submissions. \\nThe plan level standard error is calculated as: \\nSEyj= ඨ\\nScoreyj*(100-Scoreyj)\\nDenominatoryj\\n \\nfor y = 2024, 2025 and j = Plan 1, Plan 2 \\nThe contract level standard error is then calculated as: \\nLet Wy1 = The weight assigned to the first PBP results (estimated, auditable) for year y, where y = 2024, 2025. \\nThis result is estimated by the formula Wy1 = Ny1 / (N y1 + Ny2) \\nLet Wy2 = The weight assigned to the second PBP results (estimated, auditable) for year y, where y = 2024, \\n2025. This result is estimated by the formula  \\nWy2 = Ny2 / (Ny1+ Ny2) \\nSEyi= ට(Wy1)2*(SEy1)2+(Wy2)2*(SEy2)2   \\nfor y = Contract Year 2024, Contract Year 2025 and i = Contract i \\n3. SEF for Measure C15 \\nSEy = 100 ∗National Observed Ratey ∗ඨ\\nOberved County\\nExpected County2  \\nfor y = 2024, 2025 \\nNational Observed Rate, Observed Count, and Expected Count as defined in Attachment F. \\n4. SEF for Measure C17 \\nLet T1y, T2y, T3y, and T4y be the four Transitions of Care component measures.  \\nLet Zy be the Transitions of Care measure, which is calculated as an average of the four component measures.', '(Last Updated 10/03/2024)  \\nPage 129 \\n \\nVar(Zy) = 1\\n16 ∗[Var൫T1y൯+ Var൫T2y൯+ Var൫T3y൯+ Var൫T4y൯+ 2Cov൫T1y, T2y൯+ 2Cov൫T1y, T3y൯\\n+ 2Cov൫T1y, T4y൯+ 2Cov൫T2y, T3y൯+ 2Cov൫T2y, T4y൯+ 2Cov൫T3y, T4y൯] \\nSEy = ටVar(Zy) \\nfor y = 2024, 2025 \\nIn the above formula, 𝑉𝑉𝑉𝑉𝑉𝑉൫𝑇𝑇1𝑦𝑦൯= (100 ∗\\n𝑛𝑛1𝑦𝑦\\n𝑑𝑑1𝑦𝑦) ∗\\n(100−(100∗\\n𝑛𝑛1𝑦𝑦\\n𝑑𝑑1𝑦𝑦)\\n𝑑𝑑1𝑦𝑦\\n where n1y is the numerator for T1y and d1y the \\ndenominator, and so on for each of the four component measures.  \\n𝐶𝐶𝐶𝐶𝐶𝐶൫𝑇𝑇1𝑦𝑦, 𝑇𝑇2𝑦𝑦൯= 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶൫𝑇𝑇1𝑦𝑦, 𝑇𝑇2𝑦𝑦൯∗ඥ𝑉𝑉𝑉𝑉𝑉𝑉(𝑇𝑇1𝑦𝑦) ∗ඥ𝑉𝑉𝑉𝑉𝑉𝑉(𝑇𝑇2𝑦𝑦)  and so on for each pair of component measures. \\nWe estimate the correlations between pairs of component measures by calculating the sample correlation across \\nall contract scores. These correlations are shown in the table below. \\n \\nMeasures \\n2024 Correlation \\n2025 Correlation \\nPatient Engagement After Inpatient Discharge \\nReceipt of Discharge Information \\n0.5365156597 \\n0.5723177632 \\nPatient Engagement After Inpatient Discharge \\nNotification of Inpatient Admission \\n0.5772548760 \\n0.4998099740 \\nPatient Engagement After Inpatient Discharge \\nMedication Reconciliation Post-Discharge \\n0.6402980802 \\n0.5632670669 \\nReceipt of Discharge Information \\nNotification of Inpatient Admission \\n0.8834120211 \\n0.7605860074 \\nReceipt of Discharge Information \\nMedication Reconciliation Post-Discharge \\n0.4149497554 \\n0.4270200633 \\nNotification of Inpatient Admission \\nMedication Reconciliation Post-Discharge \\n0.5010530425 \\n0.5317177847 \\n \\n5. SEF for Measures: C03, C19 – C24, and D05, D06 \\nThe CAHPS measure standard errors for 2024 and 2025 were provided to CMS by the CAHPS contractor \\nfollowing the formulas documented in the CAHPS Macro Manual. The actual values used for each contract are \\nincluded on the Measure Detail CAHPS page in the HPMS preview area. \\n6. SEF for Measures: C25, D02 \\nSEy=ඨ\\nTotal Number of Complaintsy\\n(Average Contract Enrollmenty)2 * 1000*30\\nNumDays \\nNumDays: 2024 = 365, 2025 = 365 \\n7. SEF for Measure D07 \\nThe standard error of the MPF Composite Price Accuracy Score for each contract is calculated by using \\nbinomial approximations for each of the component scores (Price Accuracy Score and Claim Percentage Score, \\nas described in Attachment M). Since the MPF Composite Price Accuracy Score is equal to (0.5 x Price \\nAccuracy Score) + (0.5 x Claim Percentage Score), the composite measure’s variance (and standard error) is a \\nfunction of the variance of the Price Accuracy Score, the variance of the Claim Percentage Score, and the \\ncovariance between them. We assume that the product of the total PDE cost and the Price Accuracy Score (on a \\n0-1 scale) follows a binomial distribution, and likewise that the product of the number of PDE claims and the \\nClaims Percentage Score (on a 0-1 scale) also follows a binomial distribution. With these assumptions in place, \\nthe standard error of the MPF Composite Accuracy Score is calculated as follows:', '(Last Updated 10/03/2024)  \\nPage 130 \\n \\n1. The contract’s component scores, on their original 0-100 scale, have variances calculable using formulas \\nbased on the binomial variance assumptions described above, separately for each year y = 2024, 2025. \\n \\na. For the Price Accuracy Score, the variance in year y is represented by  \\n \\n𝑉𝑉𝑉𝑉𝑉𝑉൫𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯=\\nቀ𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦× ൫100 −𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯ቁ\\n𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑃𝑃𝑃𝑃𝑃𝑃 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝑦𝑦\\n \\n \\nb. For the Claim Percentage Score, the variance in year y is represented by  \\n \\n𝑉𝑉𝑉𝑉𝑉𝑉൫𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯=\\nቀ𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦× ൫100 −𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃. 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯ቁ\\n𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 𝑜𝑜𝑜𝑜 𝑃𝑃𝑃𝑃𝑃𝑃 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝑦𝑦\\n \\n \\n2. The contract-specific covariance between the component scores, shown as \\n𝐶𝐶𝐶𝐶𝐶𝐶൫𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦, 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯ in step 3 below, is calculated as the product of:  \\na. the contract-specific standard errors of the two component scores, which are the square roots of \\nthe two variance estimates shown above in step 1, and  \\nb. the correlation between the two component scores estimated based on all contracts. The \\ncorrelations for the two measurement years are show below. \\n \\n2024 Correlation \\n2025 Correlation \\n0.6214825861 \\n0.5681259498 \\n \\n3. The standard error of the MPF Composite Price Accuracy Score is calculated from the components \\ncalculated in steps 1 and 2 as shown below: \\n \\n𝑆𝑆𝑆𝑆𝑦𝑦\\n= ඨ𝑉𝑉𝑉𝑉𝑉𝑉൫𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯\\n4\\n+ 𝑉𝑉𝑉𝑉𝑉𝑉൫𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯\\n4\\n+ 𝐶𝐶𝐶𝐶𝐶𝐶൫𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐴𝐴𝐴𝐴𝐴𝐴.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦, 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑃𝑃𝑃𝑃𝑃𝑃.  𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑦𝑦൯\\n2\\n \\n \\nfor y = 2024, 2025', '(Last Updated 10/03/2024)  \\nPage 131 \\n \\nStar Ratings Measures Used in the Improvement Measures \\nTable I-1: Part C Measures Used in the Improvement Measure \\nMeasure ID \\nMeasure Name \\nMeasure Usage \\nCorrelation \\nC01 \\nBreast Cancer Screening \\nIncluded \\n0.950135 \\nC02 \\nColorectal Cancer Screening \\nIncluded \\n0.896510 \\nC03 \\nAnnual Flu Vaccine \\nIncluded \\n0.888026 \\nC04 \\nMonitoring Physical Activity \\nIncluded \\n0.845098 \\nC05 \\nSpecial Needs Plan (SNP) Care \\nManagement \\nIncluded \\n0.889508 \\nC06 \\nCare for Older Adults – Medication \\nReview \\nIncluded \\n0.651050 \\nC07 \\nCare for Older Adults – Pain \\nAssessment \\nIncluded \\n0.472401 \\nC08 \\nOsteoporosis Management in \\nWomen who had a Fracture \\nIncluded \\n0.848314 \\nC09 \\nDiabetes Care – Eye Exam \\nIncluded \\n0.855310 \\nC10 \\nDiabetes Care – Blood Sugar \\nControlled \\nIncluded \\n0.779129 \\nC11 \\nControlling Blood Pressure \\nIncluded \\n0.787937 \\nC12 \\nReducing the Risk of Falling \\nIncluded \\n0.842070 \\nC13 \\nImproving Bladder Control \\nIncluded \\n0.480390 \\nC14 \\nMedication Reconciliation Post-\\nDischarge \\nIncluded \\n0.818848 \\nC15 \\nPlan All-Cause Readmissions \\nIncluded \\n0.622494 \\nC16 \\nStatin Therapy for Patients with \\nCardiovascular Disease \\nIncluded \\n0.730543 \\nC17 \\nTransitions of Care \\nIncluded \\n0.845898 \\nC18 \\nFollow-up after Emergency \\nDepartment Visit for People with \\nMultiple High-Risk Chronic \\nConditions \\nIncluded \\n0.739526 \\nC19 \\nGetting Needed Care \\nIncluded \\n0.796622 \\nC20 \\nGetting Appointments and Care \\nQuickly \\nIncluded \\n0.477681 \\nC21 \\nCustomer Service \\nIncluded \\n0.709932 \\nC22 \\nRating of Health Care Quality \\nIncluded \\n0.715693 \\nC23 \\nRating of Health Plan \\nIncluded \\n0.859045 \\nC24 \\nCare Coordination \\nIncluded \\n0.670450 \\nC25 \\nComplaints about the Health Plan \\nIncluded \\n0.826982 \\nC26 \\nMembers Choosing to Leave the \\nPlan \\nIncluded \\n0.887075 \\nC27 \\nHealth Plan Quality Improvement \\nNot Included \\n - \\nC28 \\nPlan Makes Timely Decisions about \\nAppeals \\nIncluded \\n0.329153 \\nC29 \\nReviewing Appeals Decisions \\nIncluded \\n0.610325 \\nC30 \\nCall Center – Foreign Language \\nInterpreter and TTY Availability \\nIncluded \\n0.280278', '(Last Updated 10/03/2024)  \\nPage 132 \\n \\nTable I-2: Part D Measures Used in the Improvement Measure \\nMeasure ID \\nMeasure Name \\nMeasure Usage \\nCorrelation \\nD01 \\nCall Center – Foreign Language \\nInterpreter and TTY Availability \\nIncluded \\n0.303658 \\nD02 \\nComplaints about the Drug Plan \\nIncluded \\n0.832704 \\nD03 \\nMembers Choosing to Leave the \\nPlan \\nIncluded \\n0.881507 \\nD04 \\nDrug Plan Quality Improvement \\nNot Included \\n - \\nD05 \\nRating of Drug Plan \\nIncluded \\n0.817940 \\nD06 \\nGetting Needed Prescription Drugs \\nIncluded \\n0.659200 \\nD07 \\nMPF Price Accuracy \\nIncluded \\n0.643115 \\nD08 \\nMedication Adherence for Diabetes \\nMedications \\nIncluded \\n0.644643 \\nD09 \\nMedication Adherence for \\nHypertension (RAS antagonists) \\nIncluded \\n0.812564 \\nD10 \\nMedication Adherence for \\nCholesterol (Statins) \\nIncluded \\n0.807284 \\nD11 \\nMTM Program Completion Rate for \\nCMR \\nIncluded \\n0.867800 \\nD12 \\nStatin Use in Persons with Diabetes \\n(SUPD) \\nIncluded \\n0.836392', '(Last Updated 10/03/2024)  \\nPage 133 \\n \\nAttachment J: Star Ratings Measure History \\nThe tables below cross-reference the measures code in each of the yearly Star Ratings releases. Measure codes that begin with DM are display measures \\nwhich are posted on CMS.gov on this page: http://go.cms.gov/partcanddstarratings. \\nTable J-1: Part C Measure History \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Access to Primary Care Doctor Visits \\nHEDIS \\n \\n \\nDMC08 DMC09 DMC09 DMC09 DMC09 DMC10 DMC10 DMC11 DMC10 DMC12 DMC12 C11 \\nC Adult BMI Assessment \\nHEDIS \\n \\n \\n \\n \\nC07 \\nC07 \\nC07 \\nC07 \\nC07 \\nC07 \\nC08 \\nC10 \\nC10 \\nC12 \\nC Annual Flu Vaccine \\nCAHPS \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC03 \\nC04 \\nC06 \\nC06 \\nC06 \\nC Antidepressant Medication \\nManagement (6 months) \\nHEDIS \\nDMC02 DMC02 DMC02 DMC02 DMC02 DMC02 DMC02 DMC02 DMC02 DMC03 DMC03 DMC03 DMC03 DMC03 \\nC Appropriate Monitoring of Patients \\nTaking Long-term Medications \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\nDMC04 DMC04 DMC05 DMC05 DMC05 DMC05 DMC05 \\nC Asthma Medication Ratio \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\nDMC18 DMC27   \\n  \\n  \\n  \\n  \\nC Beneficiary Access and Performance \\nProblems \\nAdministrative \\nData \\nDME07 DME07 DME07 DME07 DME07 DME07 DME07 C30 \\nC28 \\nC28 \\nDME08 C31 \\nC31 \\nC32 \\nC Breast Cancer Screening \\nHEDIS \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nC01 \\nDMC22 C01 \\nC01 \\nC01 \\nC Call Answer Timeliness \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\nDMC02 DMC02 DMC02 DMC02 DMC02 \\nC Call Center – Beneficiary Hold Time \\nCall Center \\nMonitoring \\nDMC06 DMC06 DMC06 DMC07 DMC07 DMC07 DMC07 DMC08 DMC08 DMC09   \\nDMC09 DMC09 DMC09 \\nC Call Center - Calls Disconnected When \\nCustomer Calls Health Plan \\nCall Center \\nMonitoring \\nDMC09 DMC09 DMC09 DMC10 DMC10 DMC10 DMC10 DMC11 DMC11 DMC12   \\nDMC15 DMC15   \\nC Call Center – CSR Understandability \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nC Call Center – Foreign Language \\nInterpreter and TTY Availability \\nCall Center \\nMonitoring \\nC30 \\nC30 \\nC28 \\nC28 \\nC32 \\nC33 \\nC34 \\nC34 \\nC32 \\nC32 \\n  \\nC36 \\nC36 \\nC36 \\nC Call Center – Information Accuracy \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\nDMC10 DMC10 DMC10 \\nC Cardiac Rehabilitation – Achievement  HEDIS \\nDMC25 DMC25 DMC29  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Cardiac Rehabilitation – Engagement 1 HEDIS \\nDMC26 DMC26 DMC30  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Cardiac Rehabilitation – Engagement 2 HEDIS \\nDMC27 DMC27 DMC31  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Cardiac Rehabilitation – Initiation \\nHEDIS \\nDMC28 DMC28 DCM32  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Cardiovascular Care – Cholesterol \\nScreening \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nC02 \\nC03 \\nC03 \\nC03 \\nC Care Coordination \\nCAHPS \\nC24 \\nC24 \\nC22 \\nC22 \\nC26 \\nC27 \\nC28 \\nC27 \\nC25 \\nC25 \\nC28 \\nC29 \\nC29', '(Last Updated 10/03/2024)  \\nPage 134 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Care for Older Adults – Functional \\nStatus Assessment \\nHEDIS \\nDMC21 DMC21 DMC25 DCM25 C10 \\nC10 \\nC10 \\nC10 \\nC10 \\nC10 \\nC11 \\nC12 \\nC12 \\nC14 \\nC Care for Older Adults – Medication \\nReview \\nHEDIS \\nC06 \\nC06 \\nC06 \\nC06 \\nC09 \\nC09 \\nC09 \\nC09 \\nC09 \\nC09 \\nC10 \\nC11 \\nC11 \\nC13 \\nC Care for Older Adults – Pain \\nAssessment \\nHEDIS \\nC07 \\nC07 \\nC07 \\nC07 \\nC11 \\nC11 \\nC11 \\nC11 \\nC11 \\nC11 \\nC12 \\nC13 \\nC13 \\nC15 \\nC Colorectal Cancer Screening \\nHEDIS \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC02 \\nC01 \\nC02 \\nC02 \\nC02 \\nC Colorectal Cancer Screening – Age 45-\\n75 \\nHEDIS \\nDMC29 DMC29  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Complaints about the Health Plan \\nCTM \\nC25/D02 C25/D02 C23/D02 C23/D02 C27/ \\nD04 \\nC28/ \\nD04 \\nC29 / \\nD04 \\nC28 / \\nD04 \\nC26 / \\nD04 \\nC26 / \\nD04 \\nC29 / \\nD03 \\nC30 / \\nD04 \\nC30 / \\nD06 \\nC31 / \\nD06 \\nC Computer use by provider helpful \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC20 DMC21 DMC20   \\n  \\n  \\nC Computer use made talking to provider \\neasier \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC21 DMC22 DMC21   \\n  \\n  \\nC Computer used during office visits \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC19 DMC20 DMC19   \\n  \\n  \\nC Continuous Beta Blocker Treatment \\nHEDIS \\nDMC03 DMC03 DMC03 DMC03 DMC03 DMC03 DMC03 DMC03 DMC03 DMC04 DMC04 DMC04 DMC04 DMC04 \\nC Controlling Blood Pressure \\nHEDIS \\nC11 \\nC11 \\nC12 \\nDMC16 DMC16 DMC17 C16 \\nC16 \\nC16 \\nC16 \\nC18 \\nC19 \\nC19 \\nC21 \\nC Customer Service \\nCAHPS \\nC21 \\nC21 \\nC19 \\nC19 \\nC23 \\nC24 \\nC25 \\nC24 \\nC22 \\nC22 \\nC25 \\nC26 \\nC26 \\nC28 \\nC Diabetes Care – Blood Sugar \\nControlled \\nHEDIS \\nC10 \\nC10 \\nC11 \\nC11 \\nC15 \\nC15 \\nC15 \\nC15 \\nC15 \\nC15 \\nC16 \\nC17 \\nC17 \\nC19 \\nC Diabetes Care – Cholesterol Controlled HEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nC17 \\nC18 \\nC18 \\nC20 \\nC Diabetes Care – Cholesterol Screening HEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nC03 \\nC04 \\nC04 \\nC04 \\nC Diabetes Care – Eye Exam \\nHEDIS \\nC09 \\nC09 \\nC09 \\nC09 \\nC13 \\nC13 \\nC13 \\nC13 \\nC13 \\nC13 \\nC14 \\nC15 \\nC15 \\nC17 \\nC Diabetes Care – Kidney Disease \\nMonitoring \\nHEDIS \\n \\n \\nC10 \\nC10 \\nC14 \\nC14 \\nC14 \\nC14 \\nC14 \\nC14 \\nC15 \\nC16 \\nC16 \\nC18 \\nC Doctors who Communicate Well \\nCAHPS \\nDMC05 DMC05 DMC05 DMC06 DMC06 DMC06 DMC06 DMC07 DMC07 DMC08 DMC08 DMC08 DMC08 DMC08 \\nC Engagement of Substance Use \\nDisorder (SUD) Treatment \\nHEDIS \\nDMC13 DMC13 DMC13 DMC14 DMC14 DMC14 DMC14 DMC15 DMC15 DMC16 DMC15 DMC19   \\n  \\nC Enrollment Timeliness \\nMARx \\n \\n \\n \\n \\n \\n \\n  \\nDME01 DME01 DME01 DME01 DME01 C37 / \\nD05 \\nD05 \\nC Follow-up after Emergency Department \\nVisit for People with Multiple High-Risk \\nChronic Conditions \\nHEDIS \\nC18 \\nC18 \\nDMC15 DMC17 DMC17 DMC18', '(Last Updated 10/03/2024)  \\nPage 135 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Follow-up visit after Hospital Stay for \\nMental Illness (within 30 days of \\nDischarge) \\nHEDIS \\nDMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 DMC01 \\nC Getting Appointments and Care Quickly CAHPS \\nC20 \\nC20 \\nC18 \\nC18 \\nC22 \\nC23 \\nC24 \\nC23 \\nC21 \\nC21 \\nC24 \\nC25 \\nC25 \\nC27 \\nC Getting Needed Care \\nCAHPS \\nC19 \\nC19 \\nC17 \\nC17 \\nC21 \\nC22 \\nC23 \\nC22 \\nC20 \\nC20 \\nC23 \\nC24 \\nC24 \\nC26 \\nC Glaucoma Testing \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\nC05 \\nC05 \\nC05 \\nC Grievance Rate \\nPart C & D \\nPlan Reporting \\nDME01 DME01 DME01 DME01 DME01 DME01 DME01 DME02 DME02 DME02 DME02 DMC13 \\n/ \\nDMD11 \\nDMC13 \\n/ \\nDMD11 \\n  \\nC Health Plan Quality Improvement \\nStar Ratings \\nC27 \\nC27 \\nC25 \\nC25 \\nC29 \\nC30 \\nC31 \\nC31 \\nC29 \\nC29 \\nC31 \\nC33 \\nC33 \\n  \\nC Hospitalizations for Potentially \\nPreventable Complications \\nHEDIS \\nDMC15 DMC15 DMC14 DMC15 DMC15 DMC15 DMC15 DMC16 DMC24   \\n  \\n  \\n  \\n  \\nC Improving Bladder Control \\nHEDIS-HOS \\nC13 \\nC13 \\nC14 \\nC14 \\nC18 \\nC18 \\nC19 \\nC19 \\nDMC22 DMC23 C20 \\nC21 \\nC21 \\nC23 \\nC Improving or Maintaining Mental Health HOS \\nDMC23 DMC23 DMC27 DMC27 C05 \\nC05 \\nC05 \\nC05 \\nC05 \\nC05 \\nC06 \\nC08 \\nC08 \\nC09 \\nC Improving or Maintaining Physical \\nHealth \\nHOS \\nDMC24 DMC24 DMC28 DMC28 C04 \\nC04 \\nC04 \\nC04 \\nC04 \\nC04 \\nC05 \\nC07 \\nC07 \\nC08 \\nC Initiation and Engagement of Substance \\nUse Disorder (SUD) Treatment Average \\nHEDIS \\nDMC14 DMC14  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Initiation of Substance Use Disorder \\n(SUD) Treatment \\nHEDIS \\nDMC12 DMC12 DMC12 DMC13 DMC13 DMC13 DMC13 DMC14 DMC14 DMC15 DMC14 DMC18   \\n  \\nC Kidney Health Evaluation for Patients \\nwith Diabetes \\nHEDIS \\nDMC22 DMC22 DMC26  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Medication Management for People \\nWith Asthma \\nHEDIS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC26   \\n  \\n  \\n  \\n  \\nC Medication Reconciliation Post-\\nDischarge \\nHEDIS \\nC14 \\nC14 \\nC15 \\nC15 \\nC19 \\nC19 \\nC20 \\nC20 \\nDMC23   \\n  \\n  \\n  \\n  \\nC Members Choosing to Leave the Plan \\nMBDSS \\nC26/D03 C26/D03 C24/D03 C24/D03 C28/ \\nD05 \\nC29/ \\nD05 \\nC30 / \\nD05 \\nC29 / \\nD05 \\nC27 / \\nD05 \\nC27 / \\nD05 \\nC30 / \\nD04 \\nC32 / \\nD06 \\nC32 / \\nD08 \\nC33 / \\nD08 \\nC Monitoring Physical Activity \\nHEDIS-HOS \\nC04 \\nC04 \\nC04 \\nC04 \\nC06 \\nC06 \\nC06 \\nC06 \\nC06 \\nC06 \\nC07 \\nC09 \\nC09 \\nC10 \\nC Osteoporosis Management in Women \\nwho had a Fracture \\nHEDIS \\nC08 \\nC08 \\nC08 \\nC08 \\nC12 \\nC12 \\nC12 \\nC12 \\nC12 \\nC12 \\nC13 \\nC14 \\nC14 \\nC16 \\nC Osteoporosis Testing \\nHEDIS-HOS \\n \\n \\n \\nDMC04 DMC04 DMC04 DMC04 DMC05 DMC05 DMC06 DMC06 DMC06 DMC06 DMC06 \\nC Pharmacotherapy Management of \\nCOPD Exacerbation – Bronchodilator \\nHEDIS \\nDMC11 DMC11 DMC11 DMC12 DMC12 DMC12 DMC12 DMC13 DMC13 DMC14 DMC13 DMC17', '(Last Updated 10/03/2024)  \\nPage 136 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Pharmacotherapy Management of \\nCOPD Exacerbation – Systemic \\nCorticosteroid \\nHEDIS \\nDMC10 DMC10 DMC10 DMC11 DMC11 DMC11 DMC11 DMC12 DMC12 DMC13 DMC12 DMC16   \\n  \\nC Physical Functioning Activities of Daily \\nLiving \\nHOS \\nDMC20 DMC20 DMC24  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nC Plan All-Cause Readmissions \\nHEDIS \\nC15 \\nC15 \\nDMC21 DMC23 DMC23 C20 \\nC21 \\nC21 \\nC19 \\nC19 \\nC22 \\nC23 \\nC23 \\nC25 \\nC Plan Makes Timely Decisions about \\nAppeals \\nIndependent \\nReview Entity \\n(IRE) / \\nMaximus \\nC28 \\nC28 \\nC26 \\nC26 \\nC30 \\nC31 \\nC32 \\nC32 \\nC30 \\nC30 \\nC32 \\nC34 \\nC34 \\nC34 \\nC Pneumonia Vaccine \\nCAHPS \\nDMC07 DMC07 DMC07 DMC08 DMC08 DMC08 DMC08 DMC09 DMC09 DMC10 DMC09 DMC11 DMC11 C07 \\nC Rating of Health Care Quality \\nCAHPS \\nC22 \\nC22 \\nC20 \\nC20 \\nC24 \\nC25 \\nC26 \\nC25 \\nC23 \\nC23 \\nC26 \\nC27 \\nC27 \\nC29 \\nC Rating of Health Plan \\nCAHPS \\nC23 \\nC23 \\nC21 \\nC21 \\nC25 \\nC26 \\nC27 \\nC26 \\nC24 \\nC24 \\nC27 \\nC28 \\nC28 \\nC30 \\nC Reducing the Risk of Falling \\nHEDIS-HOS \\nC12 \\nC12 \\nC13 \\nC13 \\nC17 \\nC17 \\nC18 \\nC18 \\nC18 \\nC18 \\nC21 \\nC22 \\nC22 \\nC24 \\nC Reminders for appointments \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC16 DMC17 DMC16   \\n  \\n  \\nC Reminders for immunizations \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC17 DMC18 DMC17   \\n  \\n  \\nC Reminders for screening tests \\nCAHPS \\n \\n \\n \\n \\n \\n \\n  \\n  \\nDMC18 DMC19 DMC18   \\n  \\n  \\nC Reviewing Appeals Decisions \\nIndependent \\nReview Entity \\n(IRE) / \\nMaximus \\nC29 \\nC29 \\nC27 \\nC27 \\nC31 \\nC32 \\nC33 \\nC33 \\nC31 \\nC31 \\nC33 \\nC35 \\nC35 \\nC35 \\nC Rheumatoid Arthritis Management \\nHEDIS \\n \\n \\n \\nC12 \\nC16 \\nC16 \\nC17 \\nC17 \\nC17 \\nC17 \\nC19 \\nC20 \\nC20 \\nC22 \\nC Special Needs Plan (SNP) Care \\nManagement \\nPart C Plan \\nReporting \\nC05 \\nC05 \\nC05 \\nC05 \\nC08 \\nC08 \\nC08 \\nC08 \\nC08 \\nC08 \\nC09 \\nDMC14 DMC14   \\nC Statin Therapy for Patients with \\nCardiovascular Disease \\nHEDIS \\nC16 \\nC16 \\nC16 \\nC16 \\nC20 \\nC21 \\nC22 \\nDMC17 DMC25   \\n  \\n  \\n  \\n  \\nC Testing to Confirm Chronic Obstructive \\nPulmonary Disease \\nHEDIS \\nDMC04 DMC04 DMC04 DMC05 DMC05 DMC05 DMC05 DMC06 DMC06 DMC07 DMC07 DMC07 DMC07 DMC07 \\nC Transitions of Care – Average \\nHEDIS \\nC17 \\nC17 \\nDMC20 DMC22 DMC22 DMC23  \\n \\n \\n \\n \\n \\n \\n \\nC Transitions of Care – Medication \\nReconciliation Post-Discharge \\nHEDIS \\nDMC16 DMC16 DMC16 DMC18 DMC18 DMC19  \\n \\n \\n \\n \\n \\n \\n \\nC Transitions of Care – Notification of \\nInpatient Admission \\nHEDIS \\nDMC17 DMC17 DMC17 DMC19 DMC19 DMC20  \\n \\n \\n \\n \\n \\n \\n \\nC Transitions of Care – Patient \\nEngagement After Inpatient Discharge \\nHEDIS \\nDMC18 DMC18 DMC18 DMC20 DMC20 DMC21', '(Last Updated 10/03/2024)  \\nPage 137 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 \\nC Transitions of Care – Receipt of \\nDischarge Information \\nHEDIS \\nDMC19 \\n \\nDMC19 DMC19 DMC21 DMC21 DMC22', '(Last Updated 10/03/2024)  \\nPage 138 \\n \\nTable J-2: Part D Measure History \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 Notes \\nD 4Rx Timeliness \\nAcumen / OIS (4Rx)  \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nDMD03 \\nD Adherence – Proportion of Days Covered Prescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nD Antipsychotic Use in Persons with \\nDementia \\nPrescription Drug \\nEvent (PDE) Data \\nDMD08 DMD08 DMD08 \\nDMD08 DMD12 DMD14 DMD16 DMD18   \\n  \\n  \\n  \\n  \\n  \\nD Appeals Auto–Forward \\nIndependent Review \\nEntity (IRE) / \\nMaximus \\n \\n \\n \\n \\nD02 \\nD02 \\nD02 \\nD02 \\nD02 \\nD02 \\nD01 \\nD02 \\nD03 \\nD03 \\nD Appeals Upheld \\nIndependent Review \\nEntity (IRE) / \\nMaximus \\n \\n \\n \\n \\nD03 \\nD03 \\nD03 \\nD03 \\nD03 \\nD03 \\nD02 \\nD03 \\nD04 \\nD04 \\nD Beneficiary Access and Performance \\nProblems \\nAdministrative Data DME07 DME07 DME07 \\nDME07 DME07 DME07 DME07 D06 \\nD06 \\nD06 \\nDME08 D05 \\nD07 \\nD07 \\nD Call Center – Beneficiary Hold Time \\nCall Center \\nMonitoring \\nDMD02 DMD02 DMD02 \\nDMD02 DMD04 DMD04 DMD04 DMD04 DMD04 DMD04   \\nDMD04 DMD04 DMD05 \\n \\nD Call Center – Calls Disconnected – \\nPharmacist \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nD Call Center – Calls Disconnected When \\nCustomer Calls Drug Plan \\nCall Center \\nMonitoring \\nDMD01 DMD01 DMD01 \\nDMD01 DMD03 DMD03 DMD03 DMD03 DMD03 DMD03   \\nDMD03 DMD03 DMD04 \\nD Call Center – CSR Understandability \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nD Call Center – Foreign Language \\nInterpreter and TTY Availability \\nCall Center \\nMonitoring \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\nD01 \\n  \\nD01 \\nD02 \\nD02 \\nD Call Center – Information Accuracy \\nCall Center \\nMonitoring \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nDMD05 DMD05 DMD06 \\nD Call Center – Pharmacy Hold Time \\nCall Center \\nMonitoring \\nDMD04 DMD04 DMD04 \\nDMD04 DMD08 DMD09 DMD09 DMD09 DMD11 DMD11   \\nDMD15 D01 \\nD01 \\nD Complaint Resolution \\nComplaints Tracking \\nModule (CTM) \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nD Complaints – Enrollment \\nComplaints Tracking \\nModule (CTM) \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nD Complaints – Other \\nComplaints Tracking \\nModule (CTM)', '(Last Updated 10/03/2024)  \\nPage 139 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 Notes \\nD Complaints about the Drug Plan \\nComplaints Tracking \\nModule (CTM) \\nC25/ \\nD02 \\nC25/ \\nD02 \\nC23/ \\nD02 \\nC23/ \\nD02 \\nC27 / \\nD04 \\nC28 / \\nD04 \\nC29 / \\nD04 \\nC28 / \\nD04 \\nC26 / \\nD04 \\nC26 / \\nD04 \\nC29 / \\nD03 \\nC30 / \\nD04 \\nC30 / \\nD06 \\nC31 / \\nD06 \\nD Diabetes Medication Dosing \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\n \\nDMD06 DMD06 DMD06 DMD06 DMD06 DMD04 DMD07 DMD07 DMD08 \\nD Diabetes Treatment \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\nD10 \\nD12 \\nD15 \\nD14 \\nD Drug Plan Provides Current Information \\non Costs and Coverage for Medicare’s \\nWebsite \\nAcumen / OIT (LIS \\nMatch Rates) \\n \\n \\n \\n \\nDMD06 DMD07 DMD07 DMD07 DMD07 DMD07 DMD05 DMD08 DMD08 DMD09 \\nD Drug Plan Quality Improvement \\nStar Ratings \\nD04 \\nD04 \\nD04 \\nD04 \\nD06 \\nD06 \\nD06 \\nD07 \\nD07 \\nD07 \\nD05 \\nD07 \\nD09 \\n  \\nD Drug-Drug Interactions \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\nDMD05 DMD05 DMD05 DMD05 DMD05 DMD05 DMD03 DMD06 DMD06 DMD07 \\n \\nD Enrollment Timeliness \\nMARx \\n \\n \\n \\n \\n  \\n  \\n  \\nDME01 DME01 DME01 DME01 DME01 C37 / \\nD05 \\nD05 \\n \\nD Formulary Administration Analysis \\nPart D Sponsor \\n \\n \\n \\n \\n \\n \\nDMD15 DMD17   \\n  \\n  \\n  \\n  \\n  \\nD Getting Information From Drug Plan \\nCAHPS \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nDMD10 DMD10 DMD09 DMD14 D10 \\nD09 \\n \\nD Getting Needed Prescription Drugs \\nCAHPS \\nD06 \\nD06 \\nD06 \\nD06 \\nD08 \\nD08 \\nD08 \\nD09 \\nD09 \\nD09 \\nD07 \\nD09 \\nD12 \\nD11 \\nD Grievance Rate \\nPart C & D Plan \\nReporting \\nDME01 DME01 DME01 \\nDME01 DME01 DME01 DME01 DME02 DME02 DME02 DME02 DMC13 \\n/ \\nDMD11 \\nDMC13 \\n/ \\nDMD11 \\n  \\nD High Risk Medication \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\n \\nDMD14 DMD14 DMD16 D11 \\nD11 \\nD09 \\nD11 \\nD14 \\nD13 \\nD Initial Opioid Prescribing \\nPrescription Drug \\nEvent (PDE) Data \\nDMD15 DMD15 DMD15 \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Medication Adherence for Cholesterol \\n(Statins) \\nPrescription Drug \\nEvent (PDE) Data \\nD10 \\nD10 \\nD10 \\nD10 \\nD12 \\nD12 \\nD12 \\nD13 \\nD14 \\nD14 \\nD13 \\nD15 \\nD18 \\nD17 \\nD Medication Adherence for Diabetes \\nMedications \\nPrescription Drug \\nEvent (PDE) Data \\nD08 \\nD08 \\nD08 \\nD08 \\nD10 \\nD10 \\nD10 \\nD11 \\nD12 \\nD12 \\nD11 \\nD13 \\nD16 \\nD15 \\n \\nD Medication Adherence for Hypertension \\n(RAS antagonists) \\nPrescription Drug \\nEvent (PDE) Data \\nD09 \\nD09 \\nD09 \\nD09 \\nD11 \\nD11 \\nD11 \\nD12 \\nD13 \\nD13 \\nD12 \\nD14 \\nD17 \\nD16 \\nD Members Choosing to Leave the Plan \\nMBDSS \\nC26/ \\nD03 \\nC26/ \\nD03 \\nC24/ \\nD03 \\nC24/ \\nD03 \\nC28 / \\nD05 \\nC29 / \\nD05 \\nC30 / \\nD05 \\nC29 / \\nD05 \\nC27 / \\nD05 \\nC27 / \\nD05 \\nC30 / \\nD04 \\nC32 / \\nD06 \\nC32 / \\nD08 \\nC33 / \\nD08 \\nD MPF – Composite \\nPDE Data, MPF \\nPricing Files \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nD12 \\nB', '(Last Updated 10/03/2024)  \\nPage 140 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 Notes \\nD MPF – Stability \\nPDE Data, MPF \\nPricing Files \\nDMD03 DMD03 DMD03 \\nDMD03 DMD07 DMD08 DMD08 DMD08 DMD08 DMD08 DMD06 DMD10 DMD10   \\nA \\nD MPF – Updates \\nPDE Data, MPF \\nPricing Files \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nDMD09 DMD09 DMD10 \\nD MPF Price Accuracy \\nPDE Data, MPF \\nPricing Files \\nD07 \\nD07 \\nD07 \\nD07 \\nD09 \\nD09 \\nD09 \\nD10 \\nD10 \\nD10 \\nD08 \\nD10 \\nD13 \\n  \\nA \\nD MTM Program Completion Rate for CMR Prescription Drug \\nEvent (PDE) Data \\nD11 \\nD11 \\nD11 \\nD11 \\nD13 \\nD13 \\nD13 \\nD14 \\nD15 \\nD15 \\nDMD07 DMD12 DMD12   \\nD Persistence to Basal Insulin (PST-INS) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD16 DMD16  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Plan Submitted Higher Prices for Display \\non MPF \\nPDE Data, MPF \\nPricing Files \\nDMD05 DMD05 DMD05 \\nDMD05 DMD09 DMD10 DMD10 DMD10 DMD12 DMD12 DMD10 DMD16   \\n  \\n \\nD Polypharmacy: Use of Multiple \\nAnticholinergic Medications in Older \\nAdults (Poly-ACH) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD13 DMD13 DMD13 \\nDMD13 DMD20  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Polypharmacy: Use of Multiple CNS-\\nActive Medications in Older Adults (Poly-\\nCNS) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD14 DMD14 DMD14 \\nDMD14 DMD21  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Rate of Chronic Use of Atypical \\nAntipsychotics by Elderly Beneficiaries in \\nNursing Homes \\nFu Associates \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\nDMD09 DMD09 DMD08 DMD13 DMD13   \\nD Rating of Drug Plan \\nCAHPS \\nD05 \\nD05 \\nD05 \\nD05 \\nD07 \\nD07 \\nD07 \\nD08 \\nD08 \\nD08 \\nD06 \\nD08 \\nD11 \\nD10 \\n \\nD Reminders to fill prescriptions \\nCAHPS \\nDMD06 DMD06 DMD06 \\nDMD06 DMD10 DMD11 DMD12 DMD13 DMD15 DMD15 DMD13   \\n  \\n  \\nD Reminders to take medications \\nCAHPS \\nDMD07 DMD07 DMD07 \\nDMD07 DMD11 DMD12 DMD13 DMD14 DMD16 DMD16 DMD14   \\n  \\n  \\n \\nD Statin Use in Persons with Diabetes \\n(SUPD) \\nPrescription Drug \\nEvent (PDE) Data \\nD12 \\nD12 \\nD12 \\nD12 \\nD14 \\nD14 \\nD14 \\nDMD15 DMD17   \\n  \\n  \\n  \\n  \\nD Timely Effectuation of Appeals \\nIndependent Review \\nEntity (IRE) / \\nMaximus \\n \\n \\n \\n \\nDMD02 DMD02 DMD02 DMD02 DMD02 DMD02 DMD02 DMD02 DMD02 DMD02 \\nD Timely Receipt of Case Files for Appeals Independent Review \\nEntity (IRE) / \\nMaximus \\n \\n \\n \\n \\nDMD01 DMD01 DMD01 DMD01 DMD01 DMD01 DMD01 DMD01 DMD01 DMD01 \\nD Transition monitoring \\nTransition Monitoring \\nProgram Analysis \\n \\n \\n \\n \\n \\n \\nDMD11   \\n  \\n  \\n  \\n  \\n  \\n  \\nD \\nD Transition monitoring – failure rate for all \\nother drugs \\nTransition Monitoring \\nProgram Analysis \\n \\n \\n \\n \\n  \\n  \\n  \\nDMD12 DMD14 DMD14 DMD12   \\n  \\n  \\nC', '(Last Updated 10/03/2024)  \\nPage 141 \\n \\nPart \\nMeasure Name \\nData Source \\n2025 \\n2024 \\n2023 \\n2022 \\n2021 \\n2020 \\n2019 \\n2018 \\n2017 \\n2016 \\n2015 \\n2014 \\n2013 \\n2012 Notes \\nD Transition monitoring – failure rate for \\ndrugs within classes of clinical concern \\nTransition Monitoring \\nProgram Analysis \\n \\n \\n \\n \\n  \\n  \\n  \\nDMD11 DMD13 DMD13 DMD11   \\n  \\n  \\nC \\nD Use of Opioids at High Dosage and from \\nMultiple Providers in Persons Without \\nCancer (OHDMP) \\nPrescription Drug \\nEvent (PDE) Data \\n \\n \\n \\n \\nDMD15  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Use of Opioids at High Dosage in \\nPersons Without Cancer (OHD) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD11 DMD11 DMD11 DMD11 DMD18  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nD Use of Opioids from Multiple Providers in \\nPersons Without Cancer (OMP) \\nPrescription Drug \\nEvent (PDE) Data \\nDMD12 DMD12 DMD12 DMD12 DMD19  \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNotes: \\nA: \\nPart of composite measure MPF - Composite in 2011 – 2012 \\nB: \\nComposite measure - combined MPF - Accuracy and MPF Stability \\nC: \\nPart of composite measure Transition Monitoring - Composite starting in 2019 \\nD: \\nComposite Measure – “Transition monitoring - failure rate for drugs within classes of clinical concern” and “Transition monitoring - failure rate for all other drugs”', '(Last Updated 10/03/2024)  \\nPage 142 \\n \\nTable J-3: Common Part C & Part D Measure History \\nPart \\nMeasure Name \\nData Source \\n2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 \\nE \\nBeneficiary Access and Performance Problems Administrative Data \\nDME07 DME07 DME07 DME07 DME07 DME07 DME07 C30 / \\nD06 \\nC28 / \\nD06 \\nC28 / \\nD06 \\nDME08 C31 / \\nD05 \\nC31 / \\nD07 \\nC32 / \\nD07 \\nE \\nDisenrollment Reasons - Financial Reasons for \\nDisenrollment (MA-PD, MA-Only, PDP) \\nDisenrollment Reasons \\nSurvey \\nDME04 DME04 DME04 DME04 DME04 DME04 DME04 DME05 DME05 DME05 DME05   \\n  \\n  \\nE \\nDisenrollment Reasons - Problems Getting \\nInformation and Help from the Plan (MA-PD, \\nPDP) \\nDisenrollment Reasons \\nSurvey \\nDME06 DME06 DME06 DME06 DME06 DME06 DME06 DME07 DME07 DME07 DME07   \\n  \\n  \\nE \\nDisenrollment Reasons - Problems Getting the \\nPlan to Provide and Pay for Needed Care (MA-\\nPD, MA-Only) \\nDisenrollment Reasons \\nSurvey \\nDME02 DME02 DME02 DME02 DME02 DME02 DME02 DME03 DME03 DME03 DME03   \\n  \\n  \\nE \\nDisenrollment Reasons - Problems with \\nCoverage of Doctors and Hospitals (MA-PD, \\nMA-Only) \\nDisenrollment Reasons \\nSurvey \\nDME03 DME03 DME03 DME03 DME03 DME03 DME03 DME04 DME04 DME04 DME04   \\n  \\n  \\nE \\nDisenrollment Reasons - Problems with \\nPrescription Drug Benefits and Coverage (MA-\\nPD, PDP) \\nDisenrollment Reasons \\nSurvey \\nDME05 DME05 DME05 DME05 DME05 DME05 DME05 DME06 DME06 DME06 DME06   \\n  \\n  \\nE \\nEnrollment Timeliness \\nMARx \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\nDME01 DME01 DME01 DME01 DME01 C37 / \\nD05 \\nD05 \\nE \\nGrievance Rate \\nPart C & D Plan Reporting DME01 DME01 DME01 DME01 DME01 DME01 DME01 DME02 DME02 DME02 DME02 DMC13 \\n/ \\nDMD11 \\nDMC13 \\n/ \\nDMD11', '(Last Updated 10/03/2024)  \\nPage 143 \\n \\nAttachment K: Individual Measure Star Assignment Process \\nThis attachment provides detailed information about the clustering and the relative distribution and significance \\ntesting (CAHPS) methodologies used to assign stars to individual measures. \\nClustering Methodology Introduction \\nTo separate a distribution of scores into distinct groups or categories, a set of values must be identified to \\nseparate one group from another group. The set of values that break the distribution of the scores into non-\\noverlapping groups is the set of cut points. \\nFor each individual measure, CMS determines the measure cut points using the information provided from the \\nhierarchical clustering algorithm in SAS, described in “Clustering Methodology Detail” below. Conceptually, \\nthe clustering algorithm identifies the natural gaps that exist within the distribution of the scores and creates \\ngroups (clusters) that are then used to identify the cut points that result in the creation of a pre-specified number \\nof categories. \\nFor Star Ratings, the algorithm is run with the goal of determining the four cut points (labeled in the Figure J-1 \\nbelow as A, B, C, and D) that are used to create the five non-overlapping groups that correspond to each of the \\nStar Ratings (labeled in the diagram below as G1, G2, G3, G4, and G5). For Part D measures, CMS determines \\nMA-PD and PDP cut points separately. Data identified to be biased, erroneous, or excluded by disaster rules are \\nremoved from the algorithm. The scores are grouped such that scores within the same Star Rating category are \\nas similar as possible, and scores in different categories are as different as possible.  \\n \\nFigure K-1: Diagram showing gaps in data where cut points are assigned. \\n \\nAs mentioned, the cut points are used to create five non-overlapping groups. The value of the lower bound for \\neach group is included in the category, while the value of the upper bound is not included in the category. CMS \\ndoes not require the same number of observations (contracts) within each group. The groups are identified such \\nthat within a group the measure scores must be similar to each other and between groups, the measure scores in \\none group are not similar to measure scores in another group. The groups are then used for the conversion of the \\nmeasure scores to one of five Star Ratings categories. For most measures, a higher score is better, and thus, the \\ngroup with the highest range of measure scores is converted to a rating of five stars. An example of a measure \\nfor which higher is better is Medication Adherence for Diabetes Medications. For some measures a lower score \\nis better, and thus, the group with the lowest range of measure scores is converted to a rating of five stars. An \\nexample of a measure for which a lower score is better is Members Choosing to Leave the Plan. \\nExample 1 – Clustering Methodology for a Higher is Better measure \\nConsider the information provided for the cut points for Medication Adherence for Diabetes Medications in \\nTable K-1 below. As stated previously, for Part D measures CMS calculates MA-PD and PDP cut points \\nseparately (e.g., different cut points are calculated for MA-PD and PDPs). If the MA-PD cut points identified \\nusing the clustering algorithm are 80%, 85%, 87%, and 91%; for PDPs, the cut points are 84%, 86%, 88%, and \\n90%. (The set of values corresponds to the cut points in figure J-2 below as A, B, C, and D and the categories \\nfor each of the five Star Ratings are indicated above each group.) Since a measure score can only assume a \\nvalue between 0% and 100% (including 0% and 100%), the one-star and five-star categories contain only a \\nsingle value in the table below as the upper or lower bound.', '(Last Updated 10/03/2024)  \\nPage 144 \\n \\nTable K-1: Medication Adherence for Diabetes Medications cut points example: cut points are for illustrative \\npurposes \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 91 % \\n>= 91 % \\nPDP \\n< 84 % \\n>= 84 % to < 86 % \\n>= 86 % to < 88 % \\n>= 88 % to < 90 % \\n>= 90 % \\n \\nFigure K-2: Diagram showing star assignment based cut points. \\n \\n \\nSince higher is better for Medication Adherence for Diabetes Medications, a rating of one star is assigned to all \\nMA-PD measure scores below 80% in this example. For each of the other Star Rating categories, the value of \\nthe lower bound is included in the rating category, while the upper bound value is not included. Focusing solely \\non the cut points for MA-PDs, a rating of two stars is assigned to each measure score that is at least 80% (the \\nfirst cut point) to less than 85% (the second cut point) in this example. Since measure scores are reported as \\npercentages with no decimal places, any measure score of 80% to 84% would be assigned two stars, while a \\nmeasure score of 85% would be assigned a rating of three stars. Measure scores that are at least 85% to less than \\n87% would be assigned a rating of three stars. For a conversion to four stars, a measure score of at least 87% to \\nless than 91% would be needed. A rating of five stars would be assigned to any measure score of 91% or more. \\nPDPs have different cut points, but the same overall rules apply for converting the measure score to a Star \\nRating. \\nExample 2 – Clustering Methodology for a Lower is Better measure \\nConsider the information provided for the cut points for Members Choosing to Leave the Plan in Table K-2 \\nbelow. As stated previously, for Part D measures CMS calculates MA-PD and PDP cut points separately. In the \\nexample, the MA-PD cut points for Members Choosing to Leave the Plan determined using the clustering \\nalgorithm are 44%, 29%, 16%, and 9%; for PDPs, the cut points are 20%, 13%, 19%, and 6%. (These \\ncorrespond to the cut points in figure J-3 as A, B, C, and D). \\nSince lower is better for this measure, the five-star category will have the lowest measure score range, while the \\none-star category will have scores that are highest in value. For each of the other Star Rating categories, the \\nvalue of the lower bound is not included in the rating category, while the upper bound value is included. (The \\ninclusivity and exclusivity of the upper and lower bounds is opposite for a measure score where lower is better \\nas compared to higher is better.) For MA-PDs, a rating of five stars would be assigned to measure scores of 9% \\nor less. Measure scores that are greater than 9% up to a maximum value of 16% (including a measure score of \\n16%) would be assigned a rating of four stars. A rating of three stars would be assigned to measure scores \\ngreater than 16% up to a maximum value of 29%. A rating of two stars would be assigned to a measure score \\nthat is greater than 29% up to and including 44%. A rating of one star would be assigned to any measure score \\ngreater than 44%. PDPs have different cut points, but the same overall rules apply for converting the measure \\nscore to a Star Rating. \\nTable K-2: Members Choosing to Leave the Plan cut points example: cut points are for illustrative purposes \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nMA-PD \\n> 44 % \\n> 29 % to <= 44 % \\n> 16 % to <= 29 % \\n> 9 % to <= 16 % \\n<= 9 % \\nPDP \\n> 20 % \\n> 13 % to <= 20 % \\n> 9 % to <= 13 % \\n> 6 % to <= 9 % \\n<= 6 %', '(Last Updated 10/03/2024)  \\nPage 145 \\n \\nFigure J-3: Diagram showing star assignment based on cut points. \\n \\n \\nClustering Methodology Detail \\nThis section details the steps of the clustering method performed in SAS to allow the conversion of the measure \\nscores to measure-level stars. \\nTukey outlier deletion is used to determine the cut points for all non-CAHPS measures. Tukey outlier deletion \\ninvolves removing Tukey outer fence outlier contract scores, those defined as measure-specific scores outside \\nthe bounds of 3.0 times the measure-specific interquartile range subtracted from the 1st quartile or added to the \\n3rd quartile. Outliers are removed prior to applying mean resampling to the hierarchical clustering algorithm. \\nThe 1st and 3rd quartiles can be obtained by using the MEANS procedure in SAS. The Tukey outer fence outlier \\ncutoffs can then be calculated as: \\n• Lower outlier cutoff: first quartile – 3.0*(third quartile – first quartile) \\n• Upper outlier cutoff: third quartile + 3.0*(third quartile – first quartile). \\nMeasures with data displays of percentages with no decimal places ranging from 0 to 100 will have the lower \\nand upper outlier cutoffs capped at those values, respectively. Any other measures with range restrictions, such \\nas have a lower bound of zero, will have the respective outlier cutoff capped at the restricted value. \\nMean resampling is used to determine the cut points for all non-CAHPS measures.  With mean resampling, \\nmeasure-specific scores for the current year’s Star Ratings are separated into 10 equal-sized groups, using a \\nrandom assignment process to assign each contract’s measure score to a group.  The random assignment of \\ncontracts into 10 groups can be produced using the SURVEYSELECT procedure in SAS as follows: \\nproc surveyselect data=inclusterdat groups=10 seed=8675309 out=inclusterdat_random; \\nrun; \\nIn the above code, the input dataset, inclusterdat, is the list of contracts without missing, flagged, excluded by \\ndisaster rules or voluntary contract scores for a particular measure. The group=10 option identifies that 10 \\nrandom groupings of the data should be created. The seed=8675309 option specifies the seed value that controls \\nthe starting point of the random sequence of numbers and allows for future replication of the randomization \\nprocess. The output dataset, inclusterdat_random, is identical to the input dataset with the addition of a new \\ncolumn, named groupid, that has the group assignments (from 1 through 10) for each contract.  \\nThe hierarchal clustering algorithm (steps 1 through 4 below) is then applied 10 times, each time leaving out \\none of the 10 groups. For each measure and leave-one-out contract set, the clustering method does the \\nfollowing: \\n Produces the individual measure distance matrix. \\n Groups the measure scores into an initial set of clusters. \\n Selects the set of clusters.  \\n1. Produce the individual measure distance matrix. \\nFor each pair of contracts j and k (j>=k) among the n contracts with measure score data, compute the \\nEuclidian distance of their measure scores (e.g., the absolute value of the difference between the two', '(Last Updated 10/03/2024)  \\nPage 146 \\n \\nmeasure scores). Enter this distance in row j and column k of a distance matrix with n rows and n columns. \\nThis matrix can be produced using the DISTANCE procedure in SAS as follows: \\nproc distance data= inclusterdat_leave1out out=distancedat method=Euclid; \\n \\n \\nvar interval(measure_score); \\n \\n \\nid contract_id; \\n \\nrun; \\nIn the above code, the input data set, inclusterdat_leave1out, is the list of contracts (excluding the group left \\nout) without missing, flagged, excluded by disaster rules or voluntary contract scores for a particular \\nmeasure. Each record has a unique contract identifier, contract_id. The option method=Euclid specifies that \\ndistances between contract measure scores should be based on Euclidean distance. The input data contain a \\nvariable called measure_score that is formatted to the display criteria outlined in the Technical Notes. In the \\nvar call, the parentheses around measure_score indicate that measure_score is considered to be an interval \\nor numeric variable. The distances computed by this code are stored to an output data set called distancedat. \\n2. Create a tree of cluster assignments. \\nThe distance matrix calculated in Step 1 is the input to the clustering procedure. The stored distance \\nalgorithm is implemented to compute cluster assignments. The following process is implemented by using \\nthe CLUSTER procedure in SAS: \\n The input measure score distances are squared. \\n The clusters are initialized by assigning each contract to its own cluster. \\n In order to determine which pair of clusters to merge, Ward’s minimum variance method is used to \\nseparate the variance of the measure scores into within-cluster and between-cluster sum of squares \\ncomponents. \\n From the existing clusters, two clusters are selected for merging to minimize the within-cluster sum of \\nsquares over all possible sets of clusters that might result from a merge. \\n Steps 3 and 4 are repeated to reduce the number of clusters by one until a single cluster containing all \\ncontracts results. \\nThe result is a data set that contains a tree-like structure of cluster assignments, from which any number of \\nclusters between 1 and the number of contract measure scores could be computed. The SAS code for \\nimplementing these steps is: \\nproc cluster data=distancedat method=ward outtree=treedat noprint; \\n \\n \\nid contract_id; \\n \\nrun; \\nThe distancedat data set containing the Euclidian distances was created in Step 1. The option method=ward \\nindicates that Ward’s minimum variance method should be used to group clusters. The output data set is \\ndenoted with the outtree option and is called treedat. \\n3. Select the final set of clusters from the tree of cluster assignments. \\nThe process outlined in Step 2 will produce a tree of cluster assignments, from which the final number of \\nclusters is selected using the TREE procedure in SAS as follows: \\nproc tree data=treedat ncl=NSTARS horizontal out=outclusterdat noprint;', '(Last Updated 10/03/2024)  \\nPage 147 \\n \\n \\n \\nid contract_id; \\n \\nrun; \\nThe input data set, treedat, is created in Step 2 above. The syntax, ncl=NSTARS, denotes the desired final \\nnumber of clusters (or star levels). For most measures, NSTARS= 5. In cases where multiple clusters have \\nthe same score value range those clusters are combined, leading to fewer than 5 clusters. Since the \\nimprovement measures have a constraint that contracts with improvement scores of zero or greater are to be \\nassigned at least 3 stars for improvement, the clustering is conducted separately for contract measure scores \\nthat are greater than or equal to zero versus those that are less than zero. Specifically, Steps 1-3 are first \\napplied to contracts with improvement scores that meet or exceed zero, in which case NSTARS equals \\nthree. The resulting improvement measure stars can take on values of 3, 4, or 5. For those contracts with \\nimprovement scores less than zero, Steps 1-3 are applied with NSTARS=2 and these contracts will either \\nreceive 1 or 2 stars. \\n4. Final Thresholds \\nThe cluster assignments produced by the above approach have cluster labels that are unordered. The final \\nstep after applying the above steps to all contract measure scores is to order the cluster labels so that the 5-\\nstar category reflects the cluster with the best performance and the 1-star category reflects the cluster with \\nthe worst performance. With the exception of the improvement measures which are assigned lower \\nthresholds of zero for the 3-star category, the measure thresholds are defined by examining the range of \\nmeasure scores within each of the final clusters. The lower limit of each cluster becomes the cut point for \\nthe star categories. \\nDetermining Stars from Scores and Thresholds  \\nThe mean-resampling approach results in 10 sets of measure-specific cut points, one for each of the 10 \\nimplementations of the hierarchical clustering algorithm. For higher-is-better measures, the minimum score \\nobserved in each star category defines the effective cut points for the star categories. For lower-is-better \\nmeasures, the maximum score observed in each star category defines the effective cut points for the star \\ncategories.  These cut points are calculated after the application of Tukey outlier deletion. The final set of \\nestimated thresholds are then calculated as the mean cut point for each threshold per measure from the 10 \\ndifferent cut point values. Tables K-3 and K-4 show the mean resampling final estimated thresholds for the \\n2025 Star Ratings. Tables K-5 and K-6 show the upper and lower Tukey outlier cutoffs.', '(Last Updated 10/03/2024)  \\nPage 148 \\n \\nTable K-3: 2025 Star Ratings Part C non-CAHPS Measure Mean Resampling Estimated Thresholds \\nMeasure ID \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nC01 \\n< 58 % \\n>= 58 % to < 67 % \\n>= 67 % to < 75 % \\n>= 75 % to < 82 % \\n>= 82 % \\nC02 \\n< 58 % \\n>= 58 % to < 67 % \\n>= 67 % to < 75 % \\n>= 75 % to < 83 % \\n>= 83 % \\nC04 \\n< 41 % \\n>= 41 % to < 47 % \\n>= 47 % to < 52 % \\n>= 52 % to < 60 % \\n>= 60 % \\nC05 \\n< 46 % \\n>= 46 % to < 63 % \\n>= 63 % to < 76 % \\n>= 76 % to < 89 % \\n>= 89 % \\nC06 \\n< 83 % \\n>= 83 % to < 90 % \\n>= 90 % to < 94 % \\n>= 94 % to < 98 % \\n>= 98 % \\nC07 \\n< 79 % \\n>= 79 % to < 86 % \\n>= 86 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 % \\nC08 \\n< 27 % \\n>= 27 % to < 39 % \\n>= 39 % to < 52 % \\n>= 52 % to < 71 % \\n>= 71 % \\nC09 \\n< 62 % \\n>= 62 % to < 70 % \\n>= 70 % to < 77 % \\n>= 77 % to < 83 % \\n>= 83 % \\nC10 \\n< 69 % \\n>= 69 % to < 78 % \\n>= 78 % to < 84 % \\n>= 84 % to < 90 % \\n>= 90 % \\nC11 \\n< 69 % \\n>= 69 % to < 74 % \\n>= 74 % to < 80 % \\n>= 80 % to < 85 % \\n>= 85 % \\nC12 \\n< 50 % \\n>= 50 % to < 56 % \\n>= 56 % to < 63 % \\n>= 63 % to < 73 % \\n>= 73 % \\nC13 \\n< 39 % \\n>= 39 % to < 44 % \\n>= 44 % to < 48 % \\n>= 48 % to < 52 % \\n>= 52 % \\nC14 \\n< 42 % \\n>= 42 % to < 59 % \\n>= 59 % to < 73 % \\n>= 73 % to < 87 % \\n>= 87 % \\nC15 \\n> 14 % \\n> 12 % to <= 14 % \\n> 10 % to <= 12 % \\n> 8 % to <= 10 % \\n<= 8 % \\nC16 \\n< 81 % \\n>= 81 % to < 85 % \\n>= 85 % to < 88 % \\n>= 88 % to < 92 % \\n>= 92 % \\nC17 \\n< 44 % \\n>= 44 % to < 52 % \\n>= 52 % to < 63 % \\n>= 63 % to < 77 % \\n>= 77 % \\nC18 \\n< 39 % \\n>= 39 % to < 53 % \\n>= 53 % to < 60 % \\n>= 60 % to < 69 % \\n>= 69 % \\nC25 \\n> 0.66 \\n> 0.41 to <= 0.66 \\n> 0.24 to <= 0.41 \\n> 0.12 to <= 0.24 \\n<= 0.12 \\nC26 \\n> 36 % \\n> 24 % to <= 36 % \\n> 17 % to <= 24 % \\n> 8 % to <= 17 % \\n<= 8 % \\nC27 \\n< -0.179809 \\n>= -0.179809 to < 0 \\n>= 0 to < 0.174445 \\n>= 0.174445 to < \\n0.421057 \\n>= 0.421057 \\nC28 \\n< 87 % \\n>= 87 % to < 91 % \\n>= 91 % to < 95 % \\n>= 95 % to < 99 % \\n>= 99 % \\nC29 \\n< 88 % \\n>= 88 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 % to < 99 % \\n>= 99 % \\nC30 \\n< 89 % \\n>= 89 % to < 94 % \\n>= 94 % to < 97 % \\n>= 97 % to < 100 % \\n= 100 % \\nNotes: These are not the final thresholds for the 2025 Star Ratings. See the Measure Details section for final thresholds after guardrails \\nhave been applied.', '(Last Updated 10/03/2024)  \\nPage 149 \\n \\nTable K-4: 2025 Star Ratings Part D non-CAHPS Measure Mean Resampling Estimated Thresholds \\nNotes: These are not the final thresholds for the 2025 Star Ratings. See the Measure Details section for final thresholds after guardrails \\nhave been applied. \\n \\n \\n \\nMeasure ID \\nType \\n1 Star \\n2 Stars \\n3 Stars \\n4 Stars \\n5 Stars \\nD01 \\nMA-PD \\n< 85 % \\n>= 85 % to < 92 % \\n>= 92 % to < 96 % \\n>= 96 % to < 100 % \\n= 100 % \\nD01 \\nPDP \\n< 94 % \\n>= 94 % to < 97 % \\n>= 97 % to < 98 % \\n>= 98 % to < 100 % \\n= 100 % \\nD02 \\nMA-PD \\n> 0.66 \\n> 0.41 to <= 0.66 \\n> 0.24 to <= 0.41 \\n> 0.12 to <= 0.24 \\n<= 0.12 \\nD02 \\nPDP \\n> 0.1 \\n> 0.06 to <= 0.1 \\n> 0.04 to <= 0.06 \\n> 0.02 to <= 0.04 \\n<= 0.02 \\nD03 \\nMA-PD \\n> 36 % \\n> 24 % to <= 36 % \\n> 17 % to <= 24 % \\n> 8 % to <= 17 % \\n<= 8 % \\nD03 \\nPDP \\n> 22 % \\n> 16 % to <= 22 % \\n> 9 % to <= 16 % \\n> 5 % to <= 9 % \\n<= 5 % \\nD04 \\nMA-PD \\n< -0.218869 \\n>= -0.218869 to < 0 \\n>= 0 to < 0.242468 \\n>= 0.242468 to < \\n0.496603 \\n>= 0.496603 \\nD04 \\nPDP \\n< -0.282500 \\n>= -0.282500 to < 0 \\n>= 0 to < 0.273334 \\n>= 0.273334 to < \\n0.576667 \\n>= 0.576667 \\nD07 \\nMA-PD \\n< 97 \\n>= 97 to < 98 \\n>= 98 to < 99 \\n>= 99 to < 100 \\n= 100 \\nD07 \\nPDP \\n< 97 \\n>= 97 to < 98 \\n>= 98 to < 99 \\n>= 99 to < 100 \\n= 100 \\nD08 \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 91 % \\n>= 91 % \\nD08 \\nPDP \\n< 85 % \\n>= 85 % to < 87 % \\n>= 87 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nD09 \\nMA-PD \\n< 83 % \\n>= 83 % to < 87 % \\n>= 87 % to < 90 % \\n>= 90 % to < 92 % \\n>= 92 % \\nD09 \\nPDP \\n< 87 % \\n>= 87 % to < 89 % \\n>= 89 % to < 90 % \\n>= 90 % to < 92 % \\n>= 92 % \\nD10 \\nMA-PD \\n< 80 % \\n>= 80 % to < 85 % \\n>= 85 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nD10 \\nPDP \\n< 86 % \\n>= 86 % to < 88 % \\n>= 88 % to < 89 % \\n>= 89 % to < 92 % \\n>= 92 % \\nD11 \\nMA-PD \\n< 76 % \\n>= 76 % to < 84 % \\n>= 84 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nD11 \\nPDP \\n< 30 % \\n>= 30 % to < 55 % \\n>= 55 % to < 68 % \\n>= 68 % to < 80 % \\n>= 80 % \\nD12 \\nMA-PD \\n< 81 % \\n>= 81 % to < 86 % \\n>= 86 % to < 89 % \\n>= 89 % to < 93 % \\n>= 93 % \\nD12 \\nPDP \\n< 80 % \\n>= 80 % to < 83 % \\n>= 83 % to < 85 % \\n>= 85 % to < 87 % \\n>= 87 %', '(Last Updated 10/03/2024)  \\nPage 150 \\n \\nTable K-5: 2025 Star Ratings Part C non-CAHPS Measure Tukey Outlier Cutoffs \\nMeasure ID \\nLower Cutoff \\nUpper Cutoff \\nC01 \\n31 \\n100 \\nC02 \\n24 \\n100 \\nC04 \\n21 \\n77 \\nC05 \\n0 \\n100 \\nC06 \\n71 \\n100 \\nC07 \\n66 \\n100 \\nC08 \\n0 \\n100 \\nC09 \\n29 \\n100 \\nC10 \\n52 \\n100 \\nC11 \\n48 \\n100 \\nC12 \\n17 \\n94 \\nC13 \\n24 \\n66 \\nC14 \\n0 \\n100 \\nC15 \\n4 \\n18 \\nC16 \\n72 \\n100 \\nC17 \\n0 \\n100 \\nC18 \\n22 \\n92 \\nC25 \\n0 \\n1.08 \\nC26 \\n0 \\n79 \\nC27 (improve) \\n0 \\n1 \\nC27 (decline) \\n-0.582088 \\n0 \\nC28 \\n80 \\n100 \\nC29 \\n82 \\n100 \\nC30 \\n82 \\n100 \\nNotes: If the calculated lower or upper outer fence exceeds the minimum or maximum range of the measure, then the minimum or \\nmaximum measure score is shown in the table. This means that no outliers were identified at that end of the measure score range. For \\nC27 (decline) group, the upper cut off is technically the lowest value below zero since zero is included in the C27 (improved) group.', '(Last Updated 10/03/2024)  \\nPage 151 \\n \\nTable K-6: 2025 Star Ratings Part D non-CAHPS Measure Tukey Outlier Cutoffs \\nMeasure ID \\nType \\nLower Cutoff \\nUpper Cutoff \\nD01 \\nMA-PD \\n74 \\n100 \\nD02 \\nMA-PD \\n0 \\n1.08 \\nD03 \\nMA-PD \\n0 \\n79 \\nD04 (improve) \\nMA-PD \\n0 \\n1 \\nD04 (decline) \\nMA-PD \\n-0.96875 \\n0 \\nD07 \\nMA-PD \\n95 \\n100 \\nD08 \\nMA-PD \\n72 \\n100 \\nD09 \\nMA-PD \\n75 \\n100 \\nD10 \\nMA-PD \\n74 \\n100 \\nD11 \\nMA-PD \\n61 \\n100 \\nD12 \\nMA-PD \\n68 \\n100 \\nD01 \\nPDP \\n86 \\n100 \\nD02 \\nPDP \\n0 \\n0.22 \\nD03 \\nPDP \\n0 \\n45 \\nD04 (improve) \\nPDP \\n0 \\n1 \\nD04 (decline) \\nPDP \\n-1 \\n0 \\nD07 \\nPDP \\n95 \\n100 \\nD08 \\nPDP \\n76 \\n97 \\nD09 \\nPDP \\n82 \\n96 \\nD10 \\nPDP \\n81 \\n95 \\nD11 \\nPDP \\n0 \\n100 \\nD12 \\nPDP \\n76 \\n90 \\nNote: If the calculated lower or upper outer fence exceeds the minimum or maximum range of the measure, then the minimum or \\nmaximum measure score is shown in the table. This means that no outliers were identified at that end of the measure score range. For \\nD04 (decline) group, the upper cut off is technically the lowest value below zero since zero is included in the D04 (improved) group. \\n \\nGuardrails are then applied to all non-CAHPS measures, with a few exceptions. Guardrails are not applied to \\nthe Part C and Part D improvement measures. Additionally, guardrails are not applied to new measures that \\nhave been in the Part C and D Star Rating program for 3 years or less. Measures returning to the Star Ratings \\nafter a substantive measure specification change are treated as new measures.  Cut points for these new \\nmeasures and improvement measures are based on the hierarchal clustering methodology with mean \\nresampling. When applying guardrails, the difference between the current year and prior year’s cut point is \\ncalculated for each of the 1 to 5 star levels. A cap value is then calculated and compared to the observed \\nthreshold difference.  \\n• For measures having a 0 to 100 scale, an absolute percentage cap of 5 percentage point is applied. \\no If the absolute difference between the current and prior year’s cut point is less than or equal \\nto 5 percentage points, the current year’s cut point is used as the final cut point value.', '(Last Updated 10/03/2024)  \\nPage 152 \\n \\no If the absolute difference between the current and prior year’s cut point is greater than 5 \\npercentage points, a 5 percentage point cap is applied. That is, 5 percentage points are added \\nto or subtracted from the prior year’s cut point value (depending on the direction of \\nmovement for the cut point value in the current year) to obtain the final cut point value for \\nthe current year. \\n• For measures not having a 0 to 100 scale, a restricted range cap of 5 percent of the prior year’s score \\nrange is applied. Specifically, the restricted range cap is equal to the prior year’s (maximum score \\nvalue – minimum score value excluding outer fence outliers) * 0.05.  \\no If the absolute difference between the current and prior year’s is less than or equal to the \\ncalculated restricted range cap value, the current year’s cut point is used as the final cut point \\nvalue.  \\no If the absolute difference between the current and prior year’s is greater than the calculated \\nrestricted range cap value, then the restricted range cap is applied. That is, the calculated \\nrestricted range cap value is added to or subtracted from the prior year’s cut point value \\n(depending on the direction of the movement of the cut point value in the current year) to \\nobtain the final cut point value for the current year.', '(Last Updated 10/03/2024)  \\nPage 153 \\n \\n \\n \\nRelative Distribution and Significance Testing (CAHPS) Methodology \\nThe CAHPS measures are case-mix adjusted to take into account differences in the characteristics of enrollees \\nacross contracts that may potentially impact survey responses. See Attachment A for the case-mix adjusters. \\nThe percentile cut points for base groups are defined by current-year distribution of case-mix adjusted contract \\nmeans. Percentile cut points are rounded to the nearest integer on the 0-100 reporting scale, and each base group \\nincludes those contracts whose rounded mean score is at or above the lower limit and below the upper limit. The \\nnumber of stars assigned is determined by the position of the contract mean score relative to percentile cutoffs \\nfrom the distribution of contract weighted mean scores from all contracts (which determines the base group); \\nstatistical significance of the difference of the contract mean from the national mean along with the direction of \\nthe difference; the statistical reliability of the estimate (based on the ratio of sampling variation for each \\ncontract mean to between-contract variation); and the standard error of the mean score. All statistical tests, \\nincluding comparisons involving standard errors, are computed using unrounded scores. \\nCAHPS reliability calculation details are provided under the section header, “MA & PDP CAHPS Between-\\nContract Variances for Reported Measures” at https://www.ma-pdpcahps.org/en/scoring-and-star-ratings.  \\nTables K-8 and K-9 contain the rules applied to determine the final CAHPS measure star value.', '(Last Updated 10/03/2024)  \\nPage 154 \\n \\nTable K-8: CAHPS Star Assignment Rules \\nStar \\nCriteria for Assigning Star Ratings \\n1 \\nA contract is assigned one star if both criteria (a) and (b) are met plus at least one of criteria (c) and (d): \\n(a) \\nits average CAHPS measure score is lower than the 15th percentile; AND \\n(b) \\nits average CAHPS measure score is statistically significantly lower than the national average CAHPS measure score; \\n(c) \\nthe reliability is not low; OR \\n(d) \\nits average CAHPS measure score is more than one standard error (SE) below the 15th percentile. \\n2 \\nA contract is assigned two stars if it does not meet the one-star criteria and meets at least one of these three criteria: \\n(a) \\nits average CAHPS measure score is lower than the 30th percentile and the measure does not have low reliability; OR \\n(b) \\nits average CAHPS measure score is lower than the 15th percentile and the measure has low reliability; OR \\n(c) \\nits average CAHPS measure score is statistically significantly lower than the national average CAHPS measure score and \\nbelow the 60th percentile. \\n3 \\nA contract is assigned three stars if it meets at least one of these three criteria: \\n(a) \\nits average CAHPS measure score is at or above the 30th percentile and lower than the 60th percentile, AND it is not \\nstatistically significantly different from the national average CAHPS measure score; OR \\n(b) \\nits average CAHPS measure score is at or above the 15th percentile and lower than the 30th percentile, AND the reliability is \\nlow, AND the score is not statistically significantly lower than the national average CAHPS measure score; OR \\n(c) \\nits average CAHPS measure score is at or above the 60th percentile and lower than the 80th percentile, AND the reliability is \\nlow, AND the score is not statistically significantly higher than the national average CAHPS measure score. \\n4 \\nA contract is assigned four stars if it does not meet the five-star criteria and meets at least one of these three criteria: \\n(a) \\nits average CAHPS measure score is at or above the 60th percentile and the measure does not have low reliability; OR \\n(b) \\nits average CAHPS measure score is at or above the 80th percentile and the measure has low reliability; OR \\n(c) \\nits average CAHPS measure score is statistically significantly higher than the national average CAHPS measure score and \\nabove the 30th percentile. \\n5 \\nA contract is assigned five stars if both criteria (a) and (b) are met plus at least one of criteria (c) and (d): \\n(a) \\nits average CAHPS measure score is at or above the 80th percentile; AND \\n(b) \\nits average CAHPS measure score is statistically significantly higher than the national average CAHPS measure score; \\n(c) \\nthe reliability is not low; OR \\n(d) \\nits average CAHPS measure score is more than one standard error (SE) above the 80th percentile.', '(Last Updated 10/03/2024)  \\nPage 155 \\n \\nTable K-9: CAHPS Star Assignment Alternate Representation \\nMean Score \\nBase \\nGroup \\nSignif. below \\navg., low \\nreliability \\nSignif. below \\navg., not low \\nreliability \\nNot signif. diff. \\nfrom avg., low \\nreliability \\nNot signif. diff. \\nfrom avg., not low \\nreliability \\nSignif. above \\navg., low \\nreliability \\nSignif. above \\navg., not low \\nreliability \\n< 15th percentile by > 1 SE \\n1 \\n1 \\n1 \\n2 \\n2 \\n2 \\n2 \\n< 15th percentile by ≤ 1 SE \\n2 \\n1 \\n2 \\n2 \\n2 \\n2 \\n≥ 15th to < 30th percentile \\n2 \\n2 \\n2 \\n3 \\n2 \\n3 \\n2 \\n≥ 30th to < 60th percentile \\n3 \\n2 \\n2 \\n3 \\n3 \\n4 \\n4 \\n≥ 60th to < 80th percentile \\n4 \\n3 \\n4 \\n3 \\n4 \\n4 \\n4 \\n≥ 80th percentile by ≤ 1 SE \\n5 \\n4 \\n4 \\n4 \\n4 \\n4 \\n5 \\n≥ 80th percentile by > 1 SE \\n4 \\n4 \\n4 \\n4 \\n5 \\n5 \\nNotes: If reliability is very low (<0.60), the contract does not receive a Star Rating. Low reliability scores are defined as those with at \\nleast 11 respondents and reliability ≥0.60 but <0.75 and also in the lowest 12% of contracts ordered by reliability. The SE is considered \\nwhen the measure score is below the 15th percentile (in base group 1), significantly below average, and has low reliability: in this case, \\n1 star is assigned if and only if the measure score is at least 1 SE below the unrounded base group 1/2 cut point. Similarly, the SE is \\nconsidered when the measure score is at or above the 80th percentile (in base group 5), significantly above average, and has low \\nreliability: in this case, 5 stars are assigned if and only if the measure score is at least 1 SE above the unrounded base group 4/5 cut \\npoint. \\nFor example, a contract in base group 4 that was not significantly different from average and had low reliability would receive 3 final \\nstars. \\nAs noted above, low reliability scores for CAHPS measures are defined as those with at least 11 respondents \\nand reliability ≥0.60 but <0.75 and also in the lowest 12% of contracts ordered by reliability. Table K-10 \\ncontains the 12% reliability cutoffs. \\n \\nTable K-10: CAHPS Measure 12% Reliability Cutoffs \\nMeasure \\n12% reliability cutoff \\nAnnual Flu Vaccine \\n0.827223* \\nGetting Needed Care \\n0.712319 \\nGetting Appointments and Care \\nQuickly \\n0.605448 \\nCustomer Service \\n0.624047 \\nRating of Health Care Quality \\n0.603043 \\nRating of Health Plan \\n0.802531* \\nCare Coordination \\n0.575592* \\nRating of Drug Plan (MA-PD) \\n0.729239 \\nGetting Needed Prescription Drugs \\n(MA-PD) \\n0.591102* \\nRating of Drug Plan (PDP) \\n0.950393* \\nGetting Needed Prescription Drugs \\n(PDP) \\n0.875199* \\n*Note: Reliabilities must be ≥0.60 but <0.75 and also in the lowest 12% of contracts ordered by reliability to be designated as low \\nreliability, thus these cutoffs did not affect low reliability designation.', '(Last Updated 10/03/2024)  \\nPage 156 \\n \\nAttachment L: Medication Adherence Measure Calculations \\n \\nPart D sponsors currently have access to monthly Patient Safety Reports via the Patient Safety Analysis Web \\nPortal to compare their performance to overall rates and monitor their progress in improving the Part D patient \\nsafety measures over time. Sponsors may use the website to view and download the reports for performance \\nmonitoring. \\n \\nReport User Guides are available on the Patient Safety Analysis Web Portal under Help Documents and provide \\ndetailed information about the measure calculations and reports. The following information is an excerpt from \\nthe Adherence Measures Report Guide (Appendices A and B) and illustrates the days covered calculation and \\nthe modification for inpatient stays and skilled nursing facility stays. \\nProportion of Days Covered Calculation \\n \\nIn calculating the Proportion of Days Covered (PDC), we first count the number of days the patient was \\n“covered” by at least one drug in the target drug class. The number of days is based on the prescription fill date \\nand days’ supply. PDC is calculated by dividing the number of covered days by the number of days in the \\nmeasurement period. Both of these numbers may be adjusted for IP/SNF stays, as described in the ‘Calculating \\nthe PDC Adjustment for IP Stays and SNF Stays’ section that follows. \\nExample 1: Non-Overlapping Fills of Two Different Drugs \\n \\nIn this example, a beneficiary fills Benazepril and Captopril, two drugs in the RAS antagonist hypertension \\ntarget drug class. The covered days do not overlap, meaning the beneficiary filled the Captopril prescription \\nafter the days’ supply for the Benazepril medication ended. \\nTable L-1: No Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX \\nBenazepril \\n15 \\n16 \\n15 \\n13 \\n \\n \\nCaptopril \\n \\n \\n \\n \\n15 \\n16 \\n \\nPDC Calculation \\nCovered Days: 90 \\nMeasurement Period: 90 \\nPDC: 90/90 = 100% \\nExample 2: Overlapping Fills of the Same Generic Ingredient across Single and Combination Products \\n \\nIn this example, a beneficiary fills a drug with the same target generic ingredient prior to the end of the days’ \\nsupply of the first fill. In rows one and two, there is an overlap between a single and combination drug product, \\nboth containing Lisinopril. For this scenario, the overlapping days are shifted because the combination drug \\nproduct includes the targeted generic ingredient. An adjustment is made to the PDC to account for the overlap \\nin days covered. \\n \\nIn rows two and three, there is an overlap between two combination drug products, both containing \\nHydrochlorothiazide. However, Hydrochlorothiazide is not a RAS antagonist or targeted generic ingredient, so \\nthis overlap is not shifted.', '(Last Updated 10/03/2024)  \\nPage 157 \\n \\nTable L-2: Before Overlap Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX \\nLisinopril \\n15 \\n16 \\n \\n \\n \\n \\nLisinopril & HCTZ \\n \\n16 \\n15 \\n \\n \\n \\nBenazepril & HCTZ \\n \\n \\n15 \\n13 \\n \\n \\n \\nPDC Calculation \\nCovered Days: 59 \\nMeasurement Period: 90 \\nPDC: 59/90 = 66% \\nTable L-3: After Overlap Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX \\nLisinopril \\n15 \\n16 \\n \\n \\n \\n \\nLisinopril & HCTZ \\n \\n \\n15 \\n13 \\n3 \\n \\nBenazepril & HCTZ \\n \\n \\n15 \\n13 \\n \\n \\n \\nPDC Calculation \\nCovered Days: 62 \\nMeasurement Period: 90 \\nPDC: 62/90 = 69% \\nExample 3: Overlapping Fills of the Same and Different Target Drugs \\nIn this example, a beneficiary is refilling both Lisinopril and Captopril. When a single and combination product \\nboth containing Lisinopril overlap, there is an adjustment to the PDC. When Lisinopril overlaps with Captopril, \\nwe do not make any adjustment to the days covered. \\nTable L-4: Before Overlap Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\nApril \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX 4/1/20XX 4/16/20XX \\nLisinopril \\n15 \\n16 \\n \\n \\n \\n \\n \\n \\nLisinopril & HCTZ  \\n16 \\n15 \\n \\n \\n \\n \\n \\nCaptopril \\n \\n \\n \\n \\n15 \\n16 \\n \\n \\nLisinopril \\n \\n \\n \\n \\n \\n16 \\n15 \\n \\n \\nPDC Calculation \\nCovered Days: 92 \\nMeasurement Period: 120 \\nPDC: 92/120: 77%', '(Last Updated 10/03/2024)  \\nPage 158 \\n \\nTable L-5: After Overlap Adjustment \\n \\nJanuary \\nFebruary \\nMarch \\nApril \\n1/1/20XX 1/16/20XX 2/1/20XX 2/16/20XX 3/1/20XX 3/16/20XX 4/1/20XX 4/16/20XX \\nLisinopril \\n15 \\n16 \\n \\n \\n \\n \\n \\n \\nLisinopril & HCTZ \\n \\n \\n15 \\n13 \\n3 \\n \\n \\n \\nCaptopril \\n \\n \\n \\n \\n15 \\n16 \\n \\n \\nLisinopril \\n \\n \\n \\n \\n \\n16 \\n15 \\n \\n \\nPDC Calculation \\nCovered Days: 105 \\nMeasurement Period: 120 \\nPDC: 105/120: 88% \\nPDC Adjustment for Inpatient, and Skilled Nursing Facility Stays Examples \\n \\nIn response to Part D sponsor feedback, CMS modified the PDC calculation, starting with the 2013 Star Ratings \\n(using 2011 PDE data) to adjust for beneficiary stays in inpatient (IP) facilities, and with the 2015 Star Ratings \\n(using 2013 PDE data) to also adjust for hospice enrollments and beneficiary stays in skilled nursing facilities \\n(SNF). These adjustments account for periods that the Part D sponsor would not be responsible for providing \\nprescription fills for targeted medications or more accurately reflect drugs covered under the hospice benefit or \\nwaived through the beneficiary’s hospice election; thus, their medication fills during an IP or SNF stay or \\nduring hospice enrollment would not be included in the PDE claims used to calculate the Patient Safety \\nadherence measures. \\n \\nThe PDC modification for IP stays, hospice enrollments, and SNF stays reflects this situation. Please note that \\nwhile this modification will enhance the adherence measure calculation, extensive testing indicates that most \\nPart D contracts will experience a negligible impact on their adherence rates. On average, the 2011 adherence \\nrates increased 0.4 to 0.6 percentage points due to the inpatient stay adjustment, and the adjustment may impact \\nthe rates positively or negatively. \\n \\nThe hospice and SNF adjustments were tested on 2013 PDE data and overall increased the rates by 0.13 to 0.15 \\npercentage points and 0.29 to 0.35 percentage points, respectively. Hospice information from the Medicare \\nEnrollment Database (EDB) and inpatient claims from the Common Working File (CWF) are available for both \\nPDPs and MA-PDs. NOTE: Due to CMS’s migration of the beneficiary database, including the EDB and CME, \\nto the Amazon Web Services (AWS Cloud), equivalent EDB information to identify beneficiaries in hospice \\nand with ESRD status is pulled from the CME beneficiary tables from the Integrated Data Repository (CME \\nIDRC), sourced from the same upstream database. \\n \\nSNF claims from the CWF have been used to adjust the SNF PDC adjustments for PDPs. Starting in the 2019 \\nmeasurement year, when available for MA-PDs in the CWF, adjust the SNF PDC adjustments. Additionally, \\nstarting in 2020 measurement year, when available for MA-PDs in the encounter data, adjust for SNF/IP stays \\nfor MA-PD beneficiaries.  \\n \\nNote: Hospice enrollment is no longer a PDC adjustment but rather an exclusion starting with the 2020 Star \\nRatings (2018 YOS).', '(Last Updated 10/03/2024)  \\nPage 159 \\n \\nCalculating the PDC Adjustment for IP Stays and SNF Stays \\n \\nThe PDC modification for IP stays and SNF stays is based on two assumptions: 1) a beneficiary receives their \\nmedications through the facility during the IP or SNF stay, and 2) if a beneficiary accumulates an extra supply \\nof their Part D medication during an IP stay or SNF stay, that supply can be used once he/she returns home. The \\nmodification is applied using the steps below: \\n Identify start and end dates of relevant types of stays for beneficiaries included in adherence measures. \\nThe discharge date is included in the PDC adjustment.  \\no Use IP claims from the CWF to identify IP stays, and when available for MA-PDs. \\no Use SNF claims from the CWF for PDPs, and when available for MA-PD beneficiaries, for SNF \\nPDC adjustments. (1) Use SNF claims from the CWF with either a positive or negative paid \\namount with Medicare utilization days to identify Medicare Part A covered SNF stays. (2) Use \\nSNF claims from the CWF with a condition code 04 (Beneficiary enrolled in a MA-PD) not \\nassociated with a condition code 21 and/or a no payment reason code.  \\no Use IP and SNF stay encounter data when available for MA-PD beneficiaries. Additionally, if IP \\nand SNF stay claims for MA-PD enrolled beneficiaries are reported in the CWF, the CWF will \\nremain as an additional data source.  \\n Remove days of relevant stays occurring during the measurement period from the numerator and \\ndenominator of the proportion of days covered calculation. \\n Shift days’ supply from Part D prescription fills that overlap with the stay or subsequent fills for the \\nsame drug class to uncovered days after the end of the relevant stay, if applicable. This assumes the \\nbeneficiary receives the relevant medication from a different source during the stay and accumulates the \\nPart D prescription fills for later use. \\nIf SNF and IP stays span all of the beneficiary’s enrollment episodes within the measurement period, that meets \\nthe inclusion criteria, the associated proportion of member-years is not included in the rate calculation.  \\n \\nThe following examples provide illustrations of the implementation of these assumptions when calculating PDC. \\nExample 1: Gap in Coverage after IP Stay \\n \\nIn this example, the measurement period is 15 days and the beneficiary qualifies for inclusion in the measure by \\nreceiving at least 2 fills on different dates of service. This beneficiary had drug coverage on days 1-8 and 12-15 \\nand an IP stay on days 5 and 6, as illustrated in Table L-6. \\nTable L-6: Before Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\n  \\n  \\n  \\nX2 \\nX2 \\nX2 \\nX2 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n+ \\n+ \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 12 \\nMeasurement Period: 15 \\nPDC: 12/15 = 80% \\n \\nWith the adjustment for the IP stay, days 5 and 6 are deleted from the measurement period.  Additionally, the \\ndrug coverage during the IP stay is shifted to subsequent days of no supply (in this case, days 9 and 10), based \\non the assumption that if a beneficiary received his/her medication through the hospital on days 5 and 6, then', '(Last Updated 10/03/2024)  \\nPage 160 \\n \\nhe/she accumulated two extra days’ supply during the IP stay. The two extra days’ supply is used to cover the \\ngaps in Part D drug coverage in days 9 and 10.  This is illustrated in Table L-7. \\nTable L-7: After Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\n+ \\n+ \\n  \\nX2 \\nX2 \\nX2 \\nX2 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 12 \\nMeasurement Period: 13 \\nPDC: 12/13 = 92% \\nExample 2: Gap in Coverage before IP Stay \\nIn this example, the measurement period is 15 days and the beneficiary qualifies for inclusion in the measure by \\nreceiving at least 2 fills on different dates of service. This beneficiary had drug coverage from days 1-7 and 12-\\n15, and an IP stay on days 12 and 13, as illustrated in Table L-8. \\nTable L-8: Before Adjustment  \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\n  \\n  \\n  \\n  \\nX2 \\nX2 \\nX2 \\nX2 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n+ \\n+ \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 11 \\nMeasurement Period: 15 \\nPDC: 11/15 = 73% \\n \\nWith the adjustment for the IP stay, days 12 and 13 are deleted from the measurement period. While there are \\ntwo days’ supply from the IP stay on days 12 and 13, there are no days without drug coverage after the IP stay.  \\nThus, the extra days’ supply are not shifted. This is illustrated in Table L-9. \\nTable L-9: After Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\nX1 \\n  \\n  \\n  \\n  \\nX2 \\nX2 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 9 \\nMeasurement Period: 13 \\nPDC: 9/13 = 69% \\nExample 3: Gap in Coverage Before and After IP Stay \\n \\nIn this example, the measurement period is 15 days and the beneficiary qualifies for inclusion in the measure by \\nreceiving at least 2 fills on different dates of service. This beneficiary had drug coverage from days 1-3, 6-9, \\nand 12-15, and an IP stay on days 6-9, as illustrated in Table L-10.', '(Last Updated 10/03/2024)  \\nPage 161 \\n \\nTable L-10: Before Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\n  \\n  \\nX2 \\nX2 \\nX2 \\nX2 \\n  \\n  \\nX3 \\nX3 \\nX3 \\nX3 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n+ \\n+ \\n+ \\n+ \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 11 \\nMeasurement Period: 15 \\nPDC: 11/15 = 73% \\n \\nWith the adjustment for the IP stay, days 6-9 are deleted from the measurement period. Additionally, the drug \\ncoverage during the IP stay can be applied to any days without drug coverage after the IP stay, based on the \\nassumption that the beneficiary received his/her medication through the hospital on days 6-9. In this case, only \\ndays 10 and 11 do not have drug coverage and are after the IP stay, so two days’ supply are shifted to days 10 \\nand 11. This is illustrated in Table L-11. \\nTable L-11: After Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\n  \\n  \\n+ \\n+ \\nX2 \\nX2 \\nX3 \\nX3 \\nInpatient Stay \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 9 \\nMeasurement Period: 11 \\nPDC: 9/11 = 82% \\nExample 4: Gap in Coverage After IP Stay and Overlap with Subsequent Fill of the Same Drug Class \\n \\nIn this example, the measurement period is 15 days and the beneficiary qualifies for inclusion in the measure by \\nreceiving at least 2 fills on different dates of service. This beneficiary had drug coverage from days 1-4, and 7-\\n11 for the same drug class, and an IP stay on days 2-4, as illustrated in Table L-12. \\nTable L-12: Before Adjustment \\nDay \\n1 \\n2 \\n3 \\n4 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\nX1 \\nX1 \\nX1 \\n \\nX2 \\nX2 \\nX2 \\nX2 \\nX2 \\n \\n \\n \\n \\nInpatient Stay \\n+ \\n+ \\n+ \\n  \\n \\n \\n \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 9 \\nMeasurement Period: 15 \\nPDC: 9/15 = 60% \\n \\nWith the adjustment for the IP stay, days 2-4 are deleted from the measurement period. Additionally, the drug \\ncoverage during the IP stay can be applied to any days without drug coverage after the IP stay. In the case of \\noverlapping days with a subsequent fill of the same drug class, the days supply of the subsequent fill are shifted. \\nIn this example, the days supply of 2 to 4 during the IP stay are shifted to days 5 to 7 after the IP stay. Because \\nday 7 includes 1 days supply of a subsequent fill (X2) of the same drug class, days 7 to 11 that corresponds to \\nthe subsequent fill are shifted to days 8 to 12. This is illustrated in Table L-13.', '(Last Updated 10/03/2024)  \\nPage 162 \\n \\nTable L-13: After Adjustment \\nDay \\n1 \\n5 \\n6 \\n7 \\n8 \\n9 \\n10 \\n11 \\n12 \\n13 \\n14 \\n15 \\nDrug Coverage \\nX1 \\n+ \\n+ \\n+ \\n X2 \\nX2  \\nX2 \\nX2 \\nX2 \\nInpatient Stay \\n \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n  \\n \\nPDC Calculation: \\nCovered Days: 9 \\nMeasurement Period: 12 \\nPDC: 9/12 = 75%', '(Last Updated 10/03/2024)  \\nPage 163 \\n \\nAttachment M: Methodology for MPF Price Accuracy Measure \\nCMS’s drug pricing performance measure evaluates the accuracy of prices displayed on Medicare Plan Finder \\n(MPF) for beneficiaries’ comparison of plan options. The accuracy score is calculated by comparing the MPF \\nprice to the PDE price and determining the magnitude and frequency of differences found when the PDE price \\nexceeds the MPF price. This document summarizes the methods currently used to construct each contract’s \\nMPF Composite Price Accuracy Score. \\n \\nContract Selection \\nThe Part D Star Ratings rely in part on the submission of pricing data to MPF. Therefore, only contracts with at \\nleast one plan meeting all of the following criteria are included in the analysis: \\nNot a PACE plan \\nNot a demonstration plan \\nNot an employer plan \\nPart D plan \\nPlan not terminated during the contract year \\nOnly contracts with at least 30 eligible claims throughout the year are included in the accuracy measure. This \\nensures that the sample size of PDEs is large enough to produce a reliable accuracy score. \\n \\nMPF Composite Price Accuracy Score \\nTo calculate the MPF Composite Price Accuracy Score, the point of sale cost (ingredient costs plus dispensing \\nfee) reported on each PDE claim is compared to the cost resulting from using the unit price reported on Plan \\nFinder.1 This comparison includes only PDEs for which a MPF cost can be assigned. In particular, a PDE must \\nmeet seven conditions to be included in the analysis: \\n1. If the NPI in the Pharmacy Cost (PC) file represents a retail only pharmacy or retail and limited access \\ndrug only pharmacy, all corresponding PDEs will be eligible for the measure. However, if the NPI in the \\nPC file represents a retail and other pharmacy type (such as Mail, Home Infusion or Long Term Care \\npharmacy), only the PDE where the pharmacy service type is identified as either Community/Retail or \\nManaged Care Organization (MCO) will be eligible. NCPDP numbers are mapped to their \\ncorresponding NPI numbers. \\n2. The corresponding reference NDC must appear under the relevant price ID for the pharmacy in the \\npricing file.2 \\n3. The reference NDC must be on the plan’s formulary. \\n4. Because the retail unit cost reported on Plan Finder is intended to apply to a 1, 2, or 3-month supply of a \\ndrugs, only claims with a Days Supply of 28-34, 60-62, or 90-93 are included. If a plan’s bid indicates a \\n1, 2, or 3 month retail days supply amount outside of the 28-34, 60-62, or 90-93 windows, then \\n \\n1 Medicare Plan Finder unit costs are reported by plan, drug, days of supply, and pharmacy.  The plan, drug, days of supply and \\npharmacy from the PDE are used to assign the corresponding Medicare Plan Finder unit cost posted on medicare.gov on the date of \\nthe PDE. \\n2 Medicare Plan Finder prices are reported at the reference NDC level.  A reference NDC is a representative NDC of drugs with the \\nsame brand name, generic name, strength, and dosage form.  To map NDCs on PDEs to a reference NDC, we use First Data Bank \\n(FDB) and Medi-Span to create an expanded list of NDCs for each reference NDC, consisting of NDCs with the same brand name, \\ngeneric name, strength, and dosage form as the reference NDC.  This expanded NDC list allows us to map PDE NDCs to MPF \\nreference NDCs.', '(Last Updated 10/03/2024)  \\nPage 164 \\n \\nadditional days supply values may be included in the accuracy measure for the plan. For example, a plan \\nthat submits a 3 month retail supply of 100 days in their bid will have claims with a days supply of 90-\\n100 included in their accuracy measure calculation. \\n5. PDEs for dates of service during which the plan was suppressed from Plan Finder or where the relevant \\npharmacy or drug was not reported in Plan Finder are not included since no Plan Finder cost can be \\nassigned.3 \\n6. PDEs for compound drugs or non-covered drugs are not included. \\n7. The PDE must occur in Quarter 1 through 3 of the year. Quarter 4 PDEs are not included because MPF \\nprices are not updated during this last quarter. \\nThe MPF Composite Price Accuracy Measure factors in both how much and how often PDE prices exceeded \\nthe prices reflected on the MPF. The contract’s MPF Composite Price Accuracy score is the average of the \\nPrice Accuracy Score, which measures the difference between PDE total cost and MPF total cost,4 and the \\nClaim Percentage Score, which measures the share of claims where PDE prices are less than or equal to MPF \\nprices. \\nOnce MPF unit ingredient costs are assigned, the MPF ingredient cost is calculated by multiplying the unit costs \\nreported on MPF by the quantity listed on the PDE. The PDE total cost (TC) is the sum of the PDE ingredient \\ncost paid and the PDE dispensing fee. Likewise, the MPF TC is the sum of the MPF ingredient cost and the \\nMPF dispensing fee that corresponds to the same pharmacy, plan, and days of supply as that observed in the \\nPDE. Each claim is then given a score based on the difference between the PDE TC and the MPF TC. If the \\nPDE TC is lower than or equal to the MPF TC, the claim receives a score equal to zero. In other words, \\ncontracts are not penalized when point of sale costs are lower than or equal to the advertised costs. However, if \\nthe PDE TC is higher than the MPF TC, then the claim receives a score equal to the difference between the PDE \\nTC and the MPF TC. 5, 6 The contract level MPF Price Accuracy Index is the sum of the claim level scores and \\nPDE TC across all PDEs that meet the inclusion criteria, divided by the PDE TC for those same claims.  \\nThe MPF Claim Percentage Index is the percent of all PDEs that meet the inclusion criteria with a PDE TC \\nhigher than the MPF TC. Note that the best possible MPF Price Accuracy Index is 1, and the best possible MPF \\nClaim Percentage Index is 0. This occurs when the MPF TC is never lower than the PDE TC. The formulas \\nbelow illustrate the calculation of the contract level MPF Price Accuracy Index and MPF Claim Percentage  \\nIndex: \\nPrice Accuracy Index= ∑max(TCiPDE - TCiMPF, 0)  + ∑TCiPDE\\ni\\ni\\n∑TCiPDE\\ni\\n \\nwhere \\nTCiPDE is the ingredient cost plus dispensing fee reported in PDEi, and \\n \\n3 Because CMS continues to display pharmacy and drug pricing data for sanctioned plans on MPF to their current enrollees, \\nsanctioned plans are not excluded from this measure. If, however, CMS completely suppresses a sanctioned contract’s data from MPF \\ndisplay, then they would be excluded from the measure. \\n4 MPF total costs are rounded to the nearest cent. For example, if the MPF total cost is $10.237, then it is rounded to $10.24. MPF unit \\ncosts are not rounded. \\n5 To account for potential rounding errors, this analysis requires that the PDE cost exceed the rounded MPF cost by at least a two cent \\n($0.02) in order to be counted towards the accuracy score. For example, if the PDE cost is $10.25 and the rounded MPF cost is $10.23, \\nthe 2-cent difference would be counted towards plan’s accuracy score. However, if the rounded MPF cost is higher than $10.23, the \\ndifference would not count towards the plan’s accuracy score. \\n6 The MPF data includes floor pricing.  For plan-pharmacy drugs with a floor price, if the MPF price is lower than the floor price, the \\nPDE price is compared against the floor price.', '(Last Updated 10/03/2024)  \\nPage 165 \\n \\nTCiMPF is the ingredient cost plus dispensing fee calculated from MPF data, based on the PDEi \\nreported NDC, days of supply, and pharmacy, then rounded to the nearest cent. \\nClaim Percentage Index= ∑ClaimsiPDE>MPF\\ni\\n∑ClaimsiTotal\\ni\\n \\nwhere \\nClaimsiPDE>MPF is the total number of claims where the PDE price is greater than the rounded \\nMPF price \\nClaimsiTotal is the total number of claims \\n \\nWe use the following formulas to convert the Claim Percentage Index and Price Accuracy Index into the MPF \\nComposite Price Accuracy score: \\n \\nPrice Accuracy Score= 100-[(Price Accuracy Index -1) x 100] \\nClaim Percentage Score=(1 - Claim Percentage Index) x 100 \\nMPF Composite Price Accuracy Score=(0.5 x Price Accuracy Score)+(0.5 x Claim Percentage Score) \\n \\nThe MPF Composite Price Accuracy Score is rounded to the nearest whole number.', '(Last Updated 10/03/2024)  \\nPage 166 \\n \\nExample of Accuracy Index Calculation \\nTable M-1 shows an example of the MPF Composite Price Accuracy Score calculation. This contract has 4 claims, for 4 different NDCs and 4 \\ndifferent pharmacies. This is an abbreviated example for illustrative purposes only; in the actual accuracy index, a contract must have 30 eligible \\nclaims to be evaluated. \\nFrom each of the 4 claims, the PDE ingredient cost, dispensing fee, and quantity dispensed are obtained. Additionally, the plan ID, days of supply, \\ndate of service, and pharmacy number are collected from each PDE to identify the MPF data that had been submitted by the contract and posted on \\nMPF on the PDE dates of service. The NDC on the claim is first assigned the appropriate reference NDC, based on the brand name, generic name, \\nstrength, and dosage form. Using the reference NDC, the following MPF data are obtained: brand/generic dispensing fee (as assigned by the \\npharmacy cost file) and unit cost (as assigned by the Price File corresponding to that pharmacy and days of supply on the date of service). The PDE \\ncost is the sum of the PDE ingredient cost and dispensing fee. The MPF cost is computed as the quantity dispensed from PDE multiplied by the MPF \\nunit cost plus the MPF brand/generic dispensing fee (brand or generic status is assigned based on the NDC), and then rounded to the nearest cent. \\nThe last column shows the amount by which the PDE cost is higher than the rounded MPF cost. When PDE cost is less than or equal to the rounded \\nMPF cost, this value is zero. The Price Accuracy Index is the sum of the last column plus the sum of PDE costs all divided by the sum of PDE costs. \\nThe Claim Percentage Index is the number of rows where the last column is greater than zero divided by the total number of rows.', '(Last Updated 10/03/2024)  \\nPage 167 \\n \\nTable M-1: Example of Price Accuracy Index Calculation \\nNDC Pharmacy \\nNumber \\nPDE Data \\nDOS \\nPDE Data \\nIngredient \\nCost \\nPDE Data \\nDispensing \\nFee \\nPDE Data \\nQuantity \\nDispensed \\nPDE \\nDays of \\nSupply \\nMPF Data \\nBiweekly \\nPosting \\nPeriod \\nMPF \\nData \\nUnit \\nCost \\nMPF Data \\nDispensing \\nFee Brand \\nMPF Data \\nDispensing \\nFee \\nGeneric \\nCalculated \\nValue \\nBrand or \\nGeneric \\nStatus \\nCalculated \\nValue Total \\nCost PDE \\nCalculated \\nValue Total \\nCost MPF \\nCalculated Value \\nAmount that PDE \\nis higher than \\nMPF \\nA \\n111 \\n01/08/2023 \\n3.82 \\n2 \\n60 \\n60 \\n01/06/23 - \\n01/19/23 \\n0.014 \\n2.25 \\n2.75 \\nB \\n5.82 \\n3.09 \\n2.73 \\nB \\n222 \\n01/24/2023 \\n0.98 \\n2 \\n30 \\n60 \\n01/20/23 - \\n02/02/23 \\n0.83 \\n1.75 \\n2.5 \\nG \\n2.98 \\n27.40 \\n0 \\nC \\n333 \\n02/11/2023 \\n10.48 \\n1.5 \\n24 \\n28 \\n02/03/23 - \\n02/16/23 \\n0.483 \\n2.5 \\n2.5 \\nB \\n11.98 \\n14.09 \\n0 \\nD \\n444 \\n02/21/2023 \\n47 \\n1.5 \\n90 \\n30 \\n02/17/23 - \\n03/01/23 \\n0.48 \\n1.5 \\n2.25 \\nG \\n48.50 \\n45.45 \\n3.05 \\n \\nPDE = Prescription Drug Event \\nMPF = Medicare Plan Finder \\n \\nTotals \\n69.28 \\n  \\n5.78 \\n \\nPrice Accuracy Index  \\n1.08343 \\n \\nClaim Percentage Index \\n0.5 \\n \\nMPF Composite Price Accuracy Score \\n71', '(Last Updated 10/03/2024)  \\nPage 168 \\n \\nAttachment N: MTM CMR Completion Rate Measure Scoring Methodologies \\nMedicare Part D Reporting Requirements Measure (D11: MTM CMR Completion Rate Measure) \\nStep 1: Start with all contracts that enrolled beneficiaries in MTM at any point during contract year 2023. \\nBeneficiaries with multiple records that contain varying information for the same contract are \\nexcluded from the measure calculation for that contract. \\n \\nStep 2: Exclude contracts that did not enroll 31 or more beneficiaries in their MTM program who met the \\nmeasure denominator criteria during contract year 2023. \\n \\nNext, exclude contracts with an effective termination date on or before the deadline to submit data \\nvalidation results to CMS (June 15, 2024), or that were not required to participate in data \\nvalidation.  \\n• Contracts that terminate on or before 07/01/2024 according to the Contract Info extract. \\n \\nAdditionally, exclude contracts that did not score at least 95% on data validation for their plan \\nreporting of the MTM Program section and contracts that scored 95% or higher on data validation \\nfor the MTM Program section but that were not compliant with data validation standards/sub-\\nstandards for at least one of the following MTM data elements. We define a contract as being non-\\ncomplaint if either it receives a \"No\" or a 1, 2, or 3 on the 5-point Likert scale in the specific data \\nelement\\'s data validation. \\n \\n• MBI Number (Element B) \\n• Date of MTM program enrollment (Element H) \\n• Met the specified targeting criteria per CMS – Part D requirements (Element I) \\n• Date met the specified targeting criteria per CMS – Part D requirements (Element J) \\n• Date of MTM program opt-out, if applicable (Element K) \\n• Received annual CMR with written summary in CMS standardized format (Element O) \\n• Date(s) of CMR(s) (Element P) \\nStep 3: After removing contracts’ and beneficiaries’ data excluded above, suppress contract rates based on \\nthe following rules: \\nFile DV failure: Contracts that failed to submit the CY 2023 MTM Program Reporting \\nRequirements data file or who had a missing DV score for MTM are listed as “CMS identified \\nissues with this plan\\'s data.” \\nSection-level DV failure: Contracts that score less than 95% in DV for their CY 2023 MTM \\nProgram Reporting Requirements data are listed as “CMS identified issues with this plan\\'s data.” \\nElement-level DV failure: Contracts that score 95% or higher in DV for their CY 2023 MTM \\nProgram Reporting Requirements data but that failed at least one of the seven data elements are \\nlisted as “CMS identified issues with this plan\\'s data.” \\nSmall size: Contracts that have not yet been suppressed and have fewer than 31 beneficiaries \\nenrolled are listed as “Not enough data available.” \\nOrganizations can view their own plan reporting data validation results in HPMS \\n(https://hpms.cms.gov/). From the home page, select Monitoring | Plan Reporting Data Validation. \\nStep 4: Calculate the rate for the remaining contracts using the following formula:', '(Last Updated 10/03/2024)  \\nPage 169 \\n \\nNumber of beneficiaries from the denominator who received a CMR at any time during their \\nperiod of MTM enrollment in the reporting period / Number of beneficiaries who were at least 18 \\nyears or older as of the beginning of the reporting period, met the specified targeting criteria per \\nCMS during the reporting period, weren’t in hospice at any point during the reporting period, and \\nwho were enrolled in the MTM program for at least 60 days during the reporting period. \\nBeneficiaries who were enrolled in the contract’s MTM program for less than 60 days at any time \\nin the measurement year are included in the denominator and the numerator if they received a \\nCMR within this timeframe. Beneficiaries are excluded from the measure calculation if they were \\nenrolled in the contract’s MTM program for less than 60 days and did not receive a CMR within \\nthis timeframe.', '(Last Updated 10/03/2024)  \\nPage 170 \\n \\nAttachment O: Methodology for the Puerto Rico Model \\nPuerto Rico has a unique health care market with a large percentage of low-income individuals in both \\nMedicare and Medicaid and a complex legal history that affects the health care system in many ways. Puerto \\nRican beneficiaries are not eligible for LIS. The categorization of contracts into final adjustment categories for \\nthe Categorical Adjustment Index (CAI) relies on both the use of a contract’s percentages of beneficiaries with \\nLow Income Subsidy/Dual Eligible (LIS/DE) and disabled beneficiaries.  Since the percentage of LIS/DE is a \\ncritical element in the categorization of contracts to identify the contract’s CAI, an additional adjustment is \\ndone for contracts that solely serve the population of beneficiaries in Puerto Rico to address the lack of LIS. The \\nadditional analysis for the adjustment results in a modified percentage of LIS/DE beneficiaries that is \\nsubsequently used to categorize the contract in its final adjustment category for the CAI. \\n \\nThe contract-level modified LIS/DE percentages for Puerto Rico contracts for the 2025 Star Ratings are \\ndeveloped using the following sources of information: \\n The 2022 1-year American Community Survey (ACS) estimates for the percentage of people living \\nbelow the Federal Poverty Level (FPL). \\n The 2022 ACS 5-year estimates for the percentage of people living below 150% of the FPL; for Puerto \\nRico and for the 10 poorest US states (which may include the District of Columbia). \\n The Medicare enrollment data file for those enrolled during 2023 provided for beneficiaries who were \\nalive at least through December 2023, the percentage of each contract’s beneficiaries who were DE, and \\nfor non-Puerto Rico contracts, the percentage who were LIS/DE. Beneficiary DE status was determined \\nusing a) the monthly beneficiary dual status codes, b) identification of Low Income Part D enrollees \\nwho reside in the US Territories, and c) beneficiaries with Medicaid coverage/who are Medicaid eligible \\nby the Point of Sale contractor. For non-Puerto Rico contracts, beneficiaries who were LIS were \\ndetermined using the monthly beneficiary LIS status codes, and beneficiaries were classified LIS/DE by \\ncombining the beneficiaries identified as DE and beneficiaries identified as LIS. \\nThe following steps are employed to determine the modified percentages of LIS/DE for MA contracts solely \\nserving the population of beneficiaries in Puerto Rico. All references to contracts in Puerto Rico are limited to \\nthe contracts solely serving the population of beneficiaries in Puerto Rico. \\n The 10 states with the highest proportion of people living below the FPL are identified, based on 2022 \\n1-year data from ACS \\n(https://www.census.gov/content/dam/Census/library/publications/2023/acs/acsbr-016.pdf, see Table 1). \\nThe states identified are: Alabama, Arkansas, Kentucky, Louisiana, Mississippi, New Mexico, New York, \\nOklahoma, South Carolina, and West Virginia. \\n Data are aggregated from Medicare Advantage contracts that had at least 90% of their beneficiaries \\nenrolled with mailing addresses within the 10 highest poverty states identified in step (1). \\nFor the 2025 Star Ratings adjustment, the data used for the model development included a total of 150 \\nMedicare Advantage contracts with at least 90% of their beneficiaries with mailing addresses in one of \\nthe ten poorest states listed above. \\n A linear regression model is developed using the known LIS/DE percentage and the corresponding DE \\npercentage from the MA contracts in the 10 highest poverty states with at least 90% of their \\nbeneficiaries with mailing addresses in one of the ten states. \\n \\nThe model for Puerto Rico is developed using the model in step (3) as its base. \\n \\nThe estimated slope from the linear fit in the previous step (3) is retained to approximate the expected', \"(Last Updated 10/03/2024)  \\nPage 171 \\n \\nrelationship between LIS/DE for each contract in Puerto Rico and its DE percentage. However, as \\nPuerto Rico contracts are expected to have a larger percentage of low-income beneficiaries, the intercept \\nterm is adjusted to be more suitable for use with Puerto Rico contracts as follows:  \\n \\nThe intercept term for the Puerto Rico model is estimated by assuming that the Puerto Rico model will \\npass through the point (x, y) where x is the observed average DE percentage in the Puerto Rico \\ncontracts, and y is the expected average percentage of LIS/DE in Puerto Rico. The expected average \\npercentage of LIS/DE in Puerto Rico (the y value) is not observable but is estimated by multiplying the \\nobserved average percentage of LIS/DE in the 10 highest poverty states identified in step (1) by the ratio \\nbased on the 2022 5-year ACS estimates of the percentage living below 150% of the FPL in Puerto Rico \\ncompared to the corresponding percentage in the 10 poorest US states. \\n To obtain each Puerto Rico contract’s modified LIS/DE percentage, a contract’s observed DE \\npercentage is used in the Puerto Rico model developed in the previous step (4). \\n \\nA contract’s observed DE percentage is multiplied by the slope estimate, and then, the newly derived \\nintercept term is added to the product. The estimated modified LIS/DE percentage is capped at 100%. \\nAny estimated LIS/DE percentage that exceeds 100% is categorized in the final adjustment category for \\nLIS/DE with an upper bound of 100%. \\n \\nNote that the District of Columbia is included with the 50 US states when determining the 10 poorest in \\n2022. All estimated modified LIS/DE values for Puerto Rico are rounded to six decimal places when \\nexpressed as a percentage. (This rounding rule aligns with the limits for the adjustment categories for \\nLIS/DE for the CAI.) \\nModel \\nThe generic model developed to estimate a contract’s LIS/DE percentage using its DE percentage is as follows: \\nLIS/DE\\n\\u0de3 = ( Slope × contract's DE percentage ) + ( intercept ) \\nUsing the data from the 10 highest poverty states, the estimated slope was calculated to be 0.946906. \\nLIS/DE\\n\\u0de3 = (0.946906 × contract's DE percentage ) + ( intercept ) \\nNext, the intercept for the Puerto Rico model was determined using the point (x, y) where x is the observed \\naverage DE percentage in Puerto Rico contracts (28.653926%) and y is an estimated expected average \\npercentage of LIS/DE in Puerto Rico. \\nTo calculate the estimated expected average percentage of LIS/DE in Puerto Rico, the observed average \\npercentage of LIS/DE in the 10 poorest US states identified in step (1) is multiplied by the ratio of the \\npercentage of Puerto Rico residents living below 150% of the FPL to the analogous percentage in the 10 poorest \\nUS states. \\nDescription \\nValue \\nPercent of PR residents below 150% of FPL \\n59.100000% \\nPercent of residents in the 10 poorest US states below 150% of FPL 24.390525% \\nObserved average LIS/DE percentage in the 10 poorest US states \\n45.503047% \\nObserved average DE percentage in Puerto Rico contracts  \\n28.653926%\", \"(Last Updated 10/03/2024)  \\nPage 172 \\n \\nThe product thus becomes ቀ45.503047 × \\n59.100000\\n24.390525  ቁ. \\nThe new intercept for the Puerto Rico model is as follows: \\nnew intercept = ൬45.503047 × 59.100000\\n24.390525  ൰- (0.946906 × 28.653926) \\nThe final model to estimate the percentage of LIS/DE in Puerto Rico model is as follows: \\nLIS/DE\\n\\u0de3=൫0.946906 × contract's DE percentage൯ + ൬45.503047 × 59.100000\\n24.390525  ൰- (0.946906 × 28.653926) \\nExample \\nTo calculate the contract-level modified LIS/DE percentage for a hypothetical contract from Puerto Rico with \\nan observed DE percentage of 15%, the value of 15.000000% is used in the model developed. \\nLIS/DE\\n\\u0de3=(0.946906 × contract's DE percentage) + ൬45.503047 × 59.100000\\n24.390525  ൰- (0.946906 × 28.653926) \\nThe contracts percentage of 15.000000% is substituted into the Puerto Rico model. \\nLIS/DE\\n\\u0de3=(0.946906 × 15.000000) + ൬45.503047 × 59.100000\\n24.3905251  ൰- (0.946906 × 28.653926) \\nThe contract-level modified LIS/DE percentage for a hypothetical Puerto Rico contract that has an observed DE \\npercentage of 15.000000% is 97.328178%. \\nThe final adjustment category for the CAI adjustment is identified using the LIS/DE percentage 97.328178%.\", '(Last Updated 10/03/2024)  \\nPage 173 \\n \\nAttachment P: Identification of Contracts Affected by Disasters \\nNatural disasters such as hurricanes and wildfires can directly affect Medicare beneficiaries and providers, as \\nwell as the Parts C and D organizations that provide them with important medical care and prescription drug \\ncoverage. These disasters may negatively affect the underlying operational and clinical systems that CMS relies \\non for accurate performance measurement in the Star Ratings program. \\nThe 2025 Rate Announcement (https://www.cms.gov/Medicare/Health-\\nPlans/MedicareAdvtgSpecRateStats/Announcements-and-Documents.html) describes CMS’s policy for making \\nadjustments in the Star Ratings to take into account the effects of extreme and uncontrollable circumstances \\nwhich occurred during the performance period. This is also codified in regulation at §422.166(i) and \\n§423.186(i). \\nOperational Steps to Calculating Enrollment Impacted in Affected Contracts. \\n Identify the areas which experienced both extreme and uncontrollable circumstances as defined in \\nSection 1135 (g) of the Act and also are within a county or statistically equivalent entity, U.S. territory \\nor tribal government designated in a major disaster declaration under the Stafford Act. \\no Areas where the Health and Human Services (HHS) Secretary exercised their authority under \\nSection 1135 of the Act can be found at the Public Health Emergency website at \\nhttps://www.phe.gov/emergency/news/healthactions/section1135/Pages/default.aspx \\no Major disaster areas are identified by the Federal Emergency Management Agency (FEMA) website \\nat: https://www.fema.gov/disasters. \\nTable P-1 lists the Section 1135 waivers issued by the HHS Secretary along with associated FEMA \\nmajor disaster information that falls within the performance period for the 2025 Star Ratings.  \\nTable P-1: Section 1135 waivers issued in relation to the FEMA major disaster declarations \\nSection 1135 \\nWaiver Date \\nIssued \\nWaiver or Modification of \\nRequirements Under Section 1135 of \\nthe Social Security Act \\nFEMA Incident Type \\nAffected State \\nIncident Start \\nDate \\n3/27/2023 \\nSevere Storms, Straight-Line Winds, and \\nTornadoes \\nSevere Storms, Straight-Line \\nWinds, and Tornadoes \\nMississippi \\n3/24/2023 \\n6/2/2023 \\nTyphoon Mawar \\nTyphoon Mawar \\nGuam \\n5/22/2023 \\n8/11/2023 \\nWildfires \\nWildfires \\nHawaii \\n8/8/2023 \\n8/30/2023 \\nHurricane Idalia \\nHurricane \\nFlorida \\n8/27/2023 \\n9/12/2023 \\nHurricane Idalia \\nHurricane \\nGeorgia \\n8/30/2023 \\n Identify the counties or statistically equivalent entities which were declared as Individual Assistance \\nareas by each of the FEMA major disaster declarations that meet the criteria set out in Step 1 below. \\nTable P-2 lists all of the relevant FEMA major disaster declarations along with the state and associated \\nIndividual Assistance counties.', '(Last Updated 10/03/2024)  \\nPage 174 \\n \\nTable P-2: Individual Assistance counties in FEMA Major Disaster Declared States  \\nFEMA \\nDeclaration \\nState \\nFEMA Individual Assistance Counties or County-Equivalents \\nDR-4697-MS \\nMississippi \\nCarroll, Humphreys, Monroe, Montgomery, Panola, Sharkey \\nDR-4715-GU \\nGuam \\nGuam \\nDR-4724-HI \\nHawaii \\nMaui \\nDR-4734-FL \\nFlorida \\nCharlotte, Citrus, Columbia, Dixie, Gilchrist, Hamilton, Hernando, Hillsborough, Jefferson, \\nLafayette, Levy, Madison, Manatee, Pasco, Pinellas, Sarasota, Suwannee, Taylor \\nDR-4738-GA \\nGeorgia \\nBerrien, Brooks, Cook, Glynn, Lowndes \\n \\n Identify the service area at the state/county level for each contract in operation during the performance \\nperiod. The service area of some organization types rated in the Star Ratings are not defined at the \\nstate/county level, so their service area must be transformed to include all states and counties covered by \\ntheir service area. \\nTable P-3 lists how the service area for each organization type rated in the Star Ratings is defined and \\nwhat transformation, if any, is needed to create a common state/county level file for all contracts. \\nTable P-3: Organization type service areas and necessary transformations \\nStar Rating Organization Types \\nHow Service \\nArea \\nis defined \\nHow Service Area is transformed \\n1876 Cost, E-CCP, E-PDP, E-PFFS, Local CCP, MSA, PFFS, R-PFFS \\n& R-CCP \\nState/County \\nNot necessary, service area is defined at the \\nstate/county level \\nRegional CCP \\nMA Region \\nA record is created for each state/county within the MA \\nregion \\nPDP \\nPDP Region \\nA record is created for each state/county within the PDP \\nregion \\n Compare the Individual Assistance states and counties from Step 2 below to the service area from all \\ncontracts created in Step 3 below with the state and counties. Create a list of all contracts which have \\nany county that matches in both lists. \\n Create a second list of all contracts that do not share any service area with the Individual Assistance \\ncounties, so that information on the status of all contracts is accounted for during the performance period. \\n Identify the timeframe for each disaster and the associated enrollment files. Each of the disasters \\noccurred during a specific period of time. Since the enrollment in a contract is constantly changing, \\nCMS used the enrollment the contract was paid for in a month that as closely matched the disaster \\nperiod in the specific state/county as possible for all further processing, following the months in the \\ntable below. \\nTable P-4 shows each of the disasters where relief was granted along with the disaster start date, and the \\nenrollment file month that was used for that specific disaster. The enrollment file choice was based on \\nthe enrollment file cut-off date the file was created.', '(Last Updated 10/03/2024)  \\nPage 175 \\n \\nTable P-4: Major Disasters with associated enrollment months \\nFEMA \\nDeclaration \\nState \\nStart Date \\nEnroll File \\nEnroll Cut Off \\nDR-4697-MS Mississippi \\n3/24/2023 \\nMay 2023 \\nApril 7, 2023 \\nDR-4715-GU Guam \\n5/22/2023 \\nJuly 2023 \\nJune 2, 2023 \\nDR-4724-HI \\nHawaii \\n8/8/2023 \\nSeptember 2023 \\nAugust 4, 2023 \\nDR-4734-FL \\nFlorida \\n8/27/2023 \\nOctober 2023 \\nSeptember 8, 2023 \\nDR-4738-GA Georgia \\n8/30/2023 \\nOctober 2023 \\nSeptember 8, 2023 \\n Calculate disaster impacted enrollment for contracts experiencing multiple disasters. Because the \\ncontracts serve areas of different sizes and can sometimes serve large, diverse areas, it is common for a \\ncontract to be affected by more than one of the disasters. To account for this, CMS averaged the \\ncounty/state level enrollments from each of corresponding enrollment periods in which the contract was \\naffected. \\nTable P-5 shows an example where all possible enrollment periods are accounted for and how the \\nenrollment for a contract in a state/county which matched the contract’s service area state/county was \\ncalculated. Enrollment in out of service area state/counties was not included. \\nTable P-5: How enrollment periods were combined for contracts experiencing multiple disasters \\nFormula \\nID \\nEnrolled \\n202X_10 \\nEnrolled \\n202X_11 \\nEnrolled \\n202X_12 \\nEnrollment Used \\nB \\nTrue \\nTrue \\nTrue \\n(202X_10 + 202X_11 + 202X_12) / 3 \\nC \\nTrue \\nTrue \\n \\n(202X_10 + 202X_11) / 2 \\nF \\nTrue \\nTrue \\n(202X_10 + 202X_12) / 2 \\nH \\nTrue \\n \\n \\n202X_10 \\nJ \\n \\nTrue \\nTrue \\n(202X_11 + 202X_12) / 2 \\nL \\n \\nTrue \\n \\n202X_11 \\nN \\n \\n \\nTrue \\n202X_12 \\nP \\n \\n \\n \\n0 (zero) \\n Using the enrollment for the contract developed in Step 7 below, take the sum of the enrollment in the \\nentire service area for the contract to be used in further processing. \\n Using the enrollment for the contract developed in Step 7 below, take the sum of the enrollment in all of \\nthe Individual Assistance counties that correspond to the contract service area. \\n Using the final list of affected contracts from Step 4 below, calculate the percentage of the contract’s \\ntotal service area enrollment that was affected by the Individual Assistance area enrollment. Create flags \\nfor the ≥25% and ≥60% thresholds for processing of the ratings data for those contracts.', '(Last Updated 10/03/2024)  \\nPage 176 \\n \\nExample: \\nSteps 1 and 2 use the disasters and counties that have already been defined in Tables P-1 & P-2. For Steps 3 \\nthrough 10, we use an example contract, HAAAA, which offers services to some counties from both \\nCalifornia and Texas. \\nStep 3, Table P-6 below contains the full list of counties that make up the service area for contract HAAAA. \\nStep 4, the Individual Assistance County column is included in Table P-6. Rows marked TRUE are matches \\nfrom Individual Assistance counties in the disasters for year 202X and the service areas of HAAAA. The rows \\nmarked FALSE were not Individual Assistance counties for any of the disasters in HAAAA. \\nStep 5, since the example contract HAAAA has service areas that coincide with disaster counties, it is not \\nincluded in the list of contracts not affected. \\nStep 6, there are two separate enrollment periods associated with the disasters that match example contract \\nHAAAA’s service area. Those enrollment periods are 202X/09 & 202X/11. Columns for all enrollment \\nperiods are included in Table P-6, but only the valid enrollment periods contain the necessary data. \\nStep 7, the average enrollment is calculated for the included enrollment periods. The result of each average \\nenrollment calculation for each county in the example contract’s service area is shown in the final column of \\nTable P-6. \\nTable P-6: Example Contract HAAAA’s Service Areas and Enrollment during Relevant Disasters \\nFIPS \\nCode \\nCounty \\nName \\nST \\nCD \\nEGHP \\nCounty \\nIndividual Assistance \\nCounty \\nEnrolled \\n202X/09 \\nEnrolled \\n202X/10 \\nEnrolled \\n202X/11 \\nAverage \\nEnrollment \\n06003 Alpine \\nCA \\nNo \\nFALSE \\n8 \\n- \\n8 \\n8 \\n06009 Calaveras CA \\nNo \\nFALSE \\n849 \\n- \\n850 \\n850 \\n06011 Colusa \\nCA \\nNo \\nFALSE \\n168 \\n- \\n166 \\n167 \\n06015 Del Norte CA \\nNo \\nFALSE \\n369 \\n- \\n360 \\n364 \\n06023 Humboldt CA \\nNo \\nFALSE \\n702 \\n- \\n710 \\n706 \\n06045 Mendocino CA \\nNo \\nTRUE \\n428 \\n- \\n429 \\n428 \\n06049 Modoc \\nCA \\nNo \\nFALSE \\n157 \\n- \\n158 \\n158 \\n06063 Plumas \\nCA \\nNo \\nFALSE \\n182 \\n- \\n181 \\n182 \\n06093 Siskiyou \\nCA \\nNo \\nFALSE \\n798 \\n- \\n800 \\n799 \\n06105 Trinity \\nCA \\nNo \\nFALSE \\n150 \\n- \\n150 \\n150 \\n48043 Brewster \\nTX \\nYes \\nFALSE \\n16 \\n- \\n15 \\n16 \\n48047 Brooks \\nTX \\nYes \\nFALSE \\n28 \\n- \\n27 \\n28 \\n48049 Brown \\nTX \\nYes \\nFALSE \\n64 \\n- \\n65 \\n64 \\n48057 Calhoun \\nTX \\nYes \\nTRUE \\n28 \\n- \\n28 \\n28 \\n48093 Comanche TX \\nYes \\nFALSE \\n33 \\n- \\n32 \\n32 \\n48103 Crane \\nTX \\nYes \\nFALSE \\n8 \\n- \\n8 \\n8 \\n48109 Culberson TX \\nYes \\nFALSE \\n3 \\n- \\n3 \\n3 \\n48123 DeWitt \\nTX \\nYes \\nTRUE \\n26 \\n- \\n26 \\n26 \\n48131 Duval \\nTX \\nYes \\nFALSE \\n30 \\n- \\n28 \\n29 \\n48133 Eastland \\nTX \\nYes \\nFALSE \\n64 \\n- \\n62 \\n63 \\n48143 Erath \\nTX \\nYes \\nFALSE \\n61 \\n- \\n59 \\n60 \\n48163 Frio \\nTX \\nYes \\nFALSE \\n43 \\n- \\n42 \\n42', '(Last Updated 10/03/2024)  \\nPage 177 \\n \\nFIPS \\nCode \\nCounty \\nName \\nST \\nCD \\nEGHP \\nCounty \\nIndividual Assistance \\nCounty \\nEnrolled \\n202X/09 \\nEnrolled \\n202X/10 \\nEnrolled \\n202X/11 \\nAverage \\nEnrollment \\n48171 Gillespie \\nTX \\nYes \\nFALSE \\n17 \\n- \\n17 \\n17 \\n48175 Goliad \\nTX \\nYes \\nTRUE \\n18 \\n- \\n18 \\n18 \\n48177 Gonzales TX \\nYes \\nTRUE \\n41 \\n- \\n41 \\n41 \\n48237 Jack \\nTX \\nYes \\nFALSE \\n35 \\n- \\n34 \\n34 \\n48239 Jackson \\nTX \\nYes \\nTRUE \\n30 \\n- \\n30 \\n30 \\n48255 Karnes \\nTX \\nYes \\nTRUE \\n19 \\n- \\n19 \\n19 \\n48265 Kerr \\nTX \\nYes \\nFALSE \\n85 \\n- \\n86 \\n86 \\n48283 La Salle \\nTX \\nYes \\nFALSE \\n25 \\n- \\n25 \\n25 \\n48297 Live Oak \\nTX \\nYes \\nFALSE \\n24 \\n- \\n24 \\n24 \\n48301 Loving \\nTX \\nYes \\nFALSE \\n0 \\n- \\n0 \\n0 \\n48311 McMullen TX \\nYes \\nFALSE \\n4 \\n- \\n4 \\n4 \\n48321 Matagorda TX \\nYes \\nTRUE \\n144 \\n- \\n140 \\n142 \\n48323 Maverick TX \\nYes \\nFALSE \\n160 \\n- \\n156 \\n158 \\n48371 Pecos \\nTX \\nYes \\nFALSE \\n20 \\n- \\n21 \\n20 \\n48377 Presidio \\nTX \\nYes \\nFALSE \\n50 \\n- \\n49 \\n50 \\n48389 Reeves \\nTX \\nYes \\nFALSE \\n8 \\n- \\n8 \\n8 \\n48391 Refugio \\nTX \\nYes \\nTRUE \\n21 \\n- \\n21 \\n21 \\n48443 Terrell \\nTX \\nYes \\nFALSE \\n9 \\n- \\n9 \\n9 \\n48463 Uvalde \\nTX \\nYes \\nFALSE \\n13 \\n- \\n10 \\n12 \\n48469 Victoria \\nTX \\nYes \\nTRUE \\n158 \\n- \\n154 \\n156 \\n48475 Ward \\nTX \\nYes \\nFALSE \\n15 \\n- \\n15 \\n15 \\n48495 Winkler \\nTX \\nYes \\nFALSE \\n20 \\n- \\n20 \\n20 \\nStep 8, sum the average enrollment from all rows from Table P-6. The total comes out to 5,120 for contract \\nHAAAA. \\nStep 9, sum the average enrollment from all the rows from Table P-6 where the Individual Assistance \\ncounties is TRUE for contract HAAAA. The Individual Assistance total comes out to 909. \\nStep 10, calculate the final percentage for contract HAAAA. (909 / 5,120) * 100 = 17.753906 = 18%. Both \\nflags for >=25% and >=60% are set to false since the example contract did not meet those thresholds.', '(Last Updated 10/03/2024)  \\nPage 178 \\n \\n \\nAttachment Q: Missing Data Messages \\nCMS uses a standard set of messages in the Star Ratings when there are no numeric data available for a contract. \\nThis attachment provides the rules for assignment of those messages in each level of the Star Ratings. \\nMeasure level messages \\nTable Q-1 contains all of the possible messages that could be assigned to missing data at the measure level. \\nTable Q-1: Measure level missing data messages \\nMessage \\nMeasure Level \\nComing Soon \\nUsed for all measures in MPF between Oct 1 and when the actual Star Rating data go live \\nMedicare shows only a Star Rating for this topic \\nUsed in the numeric data for the Part C & D improvement measures in MPF and Plan Preview 2 \\nNot enough data available \\nThere were data for the contract, but not enough to pass the measure exclusion rules \\nCMS identified issues with this plan’s data \\nData were materially biased, erroneous and/or not reported by a contract required to report \\nNot Applicable \\nUsed in the numeric data for the improvement measures in Plan Preview 1. In the HPMS \\nMeasure Star Page when a measure does not apply for a contract. When a Disenrollment \\nReasons Survey measure does not apply to the contract type. \\nBenefit not offered by plan \\nThe contract was required to report this HEDIS measure but doesn’t offer the benefit to members \\nPlan too new to be measured \\nThe contract is too new to have submitted measure data \\nNo data available \\nThere were no data for the contract included in the source data for the measure \\nPlan too small to be measured \\nThe contract had data but did not have enough enrollment to pass the measure exclusion rules \\nPlan not required to report measure \\nThe contract was not required to report the measure \\nAssignment rules for Part C measure messages \\nPart C uses a set of rules for assigning the missing data message that varies by the data source. The rules for \\neach data source are defined below. \\nAppeals (IRE) measures (C28 & C29): \\nHas CMS identified issues with the contract’s data? \\n \\nYes: Display message: CMS identified issues with this plan’s data \\n \\nNo: \\nIs there a valid numeric measure rate? \\n \\n \\nYes: Display the numeric measure rate \\n \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nCAHPS measures (C03, C19, C20, C21, C22, C23, & C24): \\nIs there a valid numeric CAHPS measure rate? \\n \\nYes: Display the numeric CAHPS measure rate  \\n \\nNo: \\nIs the contract effective date > 07/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nIs the CAHPS measure rate NR? \\n \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\n \\nNo: \\nIs the CAHPS measure rate NA? \\n \\n \\n \\n \\nYes: Display message: No data available \\n \\n \\n \\n \\nNo: \\nDisplay message: Plan too small to be measured', '(Last Updated 10/03/2024)  \\nPage 179 \\n \\nCall Center – Foreign Language Interpreter and TTY Availability measure (C30): \\nIs there a valid call center numeric rate? \\n \\nYes: Display the call center numeric rate \\n \\nNo: \\nIs the organization type 1876 Cost, MSA, or Employer/Union Only Direct Contract PDP? \\n \\n \\nYes: Display message: Plan not required to report measure \\n \\n \\nNo: \\nIs the contract effective date > 01/01/2024? \\n \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nComplaints (CTM) measure (C25): \\nIs the contract effective date > 01/01/2023? \\n \\nYes: Display message: Plan too new to be measured \\n \\nNo: \\nWas the average contract enrollment < 800 in 2023? \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\nNo: \\nIs there a valid numeric CTM rate? \\n \\n \\n \\nYes: Display the numeric CTM rate \\n \\n \\n \\nNo: \\nDisplay message: No data available \\nHEDIS measures except PCR and TRC (C01, C02, C08 – C11, C14, C16, C18): \\nWas the contract required to report HEDIS? \\n \\nYes: Was the contract enrollment < 500 in July 2023? \\n \\n \\nYes: Display message: Plan too small to be measured \\n \\n \\nNo: \\nWhat is the HEDIS measure audit designation? \\n \\n \\n \\nBD: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nBR: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nNB: Display message: Benefit not offered by plan \\n \\n \\n \\nNR: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nNQ: Display message: Plan not required to report measure \\n \\n \\n \\nR: \\nWas a valid patient level detail file 1 submitted and the measure data usable? \\n \\n \\n \\n \\nYes: Is the status NA? \\n \\n \\n \\n \\n \\n \\nYes:    Display message: Not enough data available \\n \\n \\n \\n \\n \\n \\nNo:      Was contract enrollment at least 500 but less than 1,000? \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Is the measure reliability at least 0.7? \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\nNo: \\nDisplay message: CMS identified issues with this plan’s data \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Plan not required to report measure', '(Last Updated 10/03/2024)  \\nPage 180 \\n \\nHEDIS PCR 18 and older (C15) \\nWas the contract required to report HEDIS? \\n \\nYes: Was the contract enrollment < 500 in July 2023? \\n \\n \\nYes: Display message: Plan too small to be measured \\n \\n \\nNo: \\nWhat is the HEDIS measure audit designation? \\n \\n \\n \\nBD: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nBR: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nNB: Display message: Benefit not offered by plan \\n \\n \\n \\nNR: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\nNQ: Display message: Plan not required to report measure \\n \\n \\n \\nR: \\nWas a valid patient level detail file 1 submitted and the measure data usable? \\n \\n \\n \\n \\nYes: Is the combined denominator for the 18-64 and 65+ measures <150? \\n \\n \\n \\n \\n \\n \\nYes:    Display message: Not enough data available \\n \\n \\n \\n \\n \\n \\nNo:      Was contract enrollment at least 500 but less than 1,000? \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Is the measure reliability at least 0.7? \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\nNo: \\nDisplay message: CMS identified issues with this plan’s data \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Plan not required to report measure \\nHEDIS TRC average (C17): \\nWas the contract required to report HEDIS? \\n \\nYes: Was the contract enrollment < 500 in July 2023? \\n \\n \\nYes: Display message: Plan too small to be measured \\n \\n \\nNo: \\nIs the audit designation for all four TRC measures R? \\n \\n \\n \\nNo: \\nIs the audit designation for any of the four TRC measures BD, BR, or NR? \\n \\n \\n \\n \\nYes: Display message: CMS identified issues with this plan’s data \\n \\n \\n \\n \\nNo: \\nIs the audit designation for any of the four TRC measures NB?  \\n \\n \\n \\n \\n \\nYes: Display message: Benefit not offered by plan \\n \\n \\n \\n \\n \\nNo:  The audit designation for one of the four TRC measures is NQ. \\n \\n \\n \\n \\n \\n \\nDisplay message: Plan not required to report measure \\n \\n \\n \\nYes: Was a valid patient level detail file 1 submitted and the measure data usable? \\n \\n \\n \\n \\nYes: Is the status for any component of the TRC average measure NA? \\n \\n \\n \\n \\n \\n \\nYes:    Display message: Not enough data available \\n \\n \\n \\n \\n \\n \\nNo:      Was contract enrollment at least 500 but less than 1,000? \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Is the measure reliability at least 0.7? \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nYes: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available \\n \\n \\n \\n \\n \\n \\n \\n \\nNo: Display the HEDIS measure numeric rate \\n \\n \\n \\n \\nNo: \\nDisplay message: CMS identified issues with this plan’s data \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Plan not required to report measure', '(Last Updated 10/03/2024)  \\nPage 181 \\n \\nHEDIS SNP measures (C06 & C07): \\nIs the organization type (1876 Cost, PFFS, MSA) or is SNP not offered in 2025? \\n \\nYes: \\nDisplay message: Plan not required to report measure \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: \\nDisplay message: Plan too new to be measured \\n \\n \\nNo: \\nWhat is the HEDIS measure audit designation? \\n \\n \\n \\nBD: \\nDisplay message: CMS identified issues with this plan’s data \\n \\n \\n \\nBR: \\nDisplay message: CMS identified issues with this plan’s data \\n \\n \\n \\n \\n \\nNB: \\nDisplay message: Benefit not offered by plan \\n \\n \\n \\nNR: \\nDisplay message: CMS identified issues with this plan’s data \\n \\n \\n \\nNQ: \\nDisplay message: Plan not required to report measure \\n \\n \\n \\nR: \\nIs there a valid HEDIS measure numeric rate? \\n \\n \\n \\n \\nYes: \\nWhat is the status? \\nNA:   Display message: Not enough data available \\nR:     Display the HEDIS measure numeric rate \\nNo: \\nDisplay message: No data available \\nHEDIS-HOS measures (C04, C12, & C13): \\nIs there a valid HEDIS-HOS numeric rate? \\n \\nYes: Display the HEDIS-HOS numeric rate \\n \\nNo: \\nIs the contract effective date > 01/01/2022? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nIs the February 2023 contract enrollment < 500? \\n \\n \\n \\nYes: Display message: Plan too small to be measured \\n \\n \\n \\nNo: \\nIs there a HEDIS-HOS rate code? \\n \\n \\n \\n \\nYes: Assign message according to value below: \\n \\n \\n \\n \\n \\nNA: Display message: Not enough data available \\n \\n \\n \\n \\n \\nNB: Display message: Benefit not offered by plan \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available \\nMembers Choosing to Leave the Plan (C26): \\nIs there a valid numeric voluntary disenrollment rate? \\n \\nYes: Display the numeric voluntary disenrollment rate \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nPlan Reporting SNP measure (C05): \\nIs the organization type (1876 Cost, PFFS, MSA) or is SNP not offered in 2025? \\n \\nYes: \\nDisplay message: Plan not required to report measure \\n \\nNo: \\nIs there a valid Plan Reporting numeric rate? \\n \\n \\nYes: \\nDisplay the Plan Reporting numeric rate \\n \\n \\nNo: \\nWere there Data Issues Found? \\n \\n \\n \\nYes: \\nDisplay message: CMS identified issues with this plan’s data \\n \\n \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\n \\n \\nYes: \\nDisplay message: Plan too new to be measured \\n \\n \\n \\n \\nNo: \\nDisplay message: No data available', '(Last Updated 10/03/2024)  \\nPage 182 \\n \\nImprovement (Star Ratings) measure (C27): \\nIs there a valid improvement measure rate? \\n \\nYes: Display message: Medicare shows only a Star Rating for this topic \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nAssignment rules for Part D measure messages \\nCAHPS measures (D05, D06): \\nIs there a valid numeric CAHPS measure rate? \\n \\nYes: Display the numeric CAHPS measure rate  \\n \\nNo: \\nIs the contract effective date > 07/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nIs the CAHPS measure rate NR? \\n \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\n \\nNo: \\nIs the CAHPS measure rate NA? \\n \\n \\n \\n \\nYes: Display message: No data available \\n \\n \\n \\n \\nNo: \\nDisplay message: Plan too small to be measured \\nCall Center – Foreign Language Interpreter and TTY Availability measure (D01): \\nIs there a valid call center numeric rate? \\n \\nYes: Display the call center numeric rate \\n \\nNo: \\nIs the organization type 1876 Cost? \\n \\n \\nYes: Display message: Plan not required to report measure \\n \\n \\nNo: \\nIs the contract effective date > 01/01/2024? \\n \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nComplaints (CTM) measure (D02): \\nIs the contract effective date > 01/01/2023? \\n \\nYes:  Display message: Plan too new to be measured \\n \\nNo: \\n Was the average contract enrollment < 800 in 2023? \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\nNo: \\nIs there a valid numeric CTM rate? \\n \\n \\n \\nYes: Display the numeric CTM rate \\n \\n \\n \\nNo: \\nDisplay message: No data available \\nImprovement (Star Ratings) measure (D04): \\nIs there a valid improvement measure rate? \\n \\nYes: Display message: Medicare shows only a Star Rating for this topic \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available', '(Last Updated 10/03/2024)  \\nPage 183 \\n \\nMembers Choosing to Leave the Plan (D03): \\nIs there a valid numeric voluntary disenrollment rate? \\n \\nYes: Display the numeric voluntary disenrollment rate \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nMPF Price Accuracy measure (D07): \\nIs the contract effective date > 9/30/2023?  \\n \\nYes: Display message: Plan too new to be measured \\n \\nNo: \\nDoes contract have at least 30 claims over the measurement period for the price accuracy index? \\n \\n \\nYes: Display the numeric price accuracy rate \\n \\n \\nNo:  Is the organization type 1876 Cost and does not offer Drugs? \\n \\n \\n \\nYes: Display message: Plan not required to report measure \\n \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nPatient Safety measures – Adherence (D08 - D10) & SUPD (D12): \\n   Does the contract offer Part D? \\n      Yes: Is the contract effective date > 12/31/2023? \\n \\n     Yes:   Display message: Plan too new to be measured \\n \\n     No:     Does contract have 30 or fewer enrolled beneficiary member years (measure denominator)? \\n \\n \\nYes: Display message: Not enough data available \\n \\n \\nNo: \\nDisplay numeric measure percentage \\n      No: Plan not required to report measure \\nPatient Safety measure – MTM CMR (D11) \\nIs the contract effective date > 12/31/2023? \\n \\nYes:  Display message: Plan too new to be measured \\n \\nNo: \\nIs Part D offered? \\n \\n \\nYes: \\nIs there a numeric rate? \\n \\n \\n \\nYes: \\nDisplay numeric measure percentage \\n \\n \\n \\nNo: \\nIs there a Reason(s) for Display Message? \\n \\n \\n \\n \\nYes: \\nDisplay appropriate message per table Q-2 \\n \\n \\nNo: \\nDisplay message: Plan not required to report measure', \"(Last Updated 10/03/2024)  \\nPage 184 \\n \\nTable Q-2: MTM CMR Reason(s) for Display Message conversion \\nReason(s) for Display Message \\nStar Ratings Message \\nContract failed to submit file and pass system validation by the reporting deadline CMS identified issues with this plan's data \\nContract did not pass element-level DV for at least one element \\nCMS identified issues with this plan's data \\nContract had missing score on MTM section DV \\nCMS identified issues with this plan's data \\nContract scored less than 95% on MTM section DV \\nCMS identified issues with this plan's data \\nContract had 30 or fewer beneficiaries meeting denominator criteria \\nNot enough data available \\nContract had all plans terminate by validation deadline \\nNot required to report \\nContract had no MTM enrollees to report \\nNot required to report \\nContract has 0 Part D enrollees \\nNot required to report \\nContract not required to submit MTM program \\nNot required to report \\nDomain, Summary, and Overall level messages \\nTable Q-3 contains all of the possible messages that could be assigned to missing data at the domain, summary, \\nand overall levels. \\nTable Q-3: Domain, Summary, and Overall level missing data messages \\nMessage \\nDomain Level \\nSummary & Overall Level \\nComing Soon \\nUsed for all domain ratings in MPF between Oct 1 and \\nwhen the actual Star Rating data go live \\nUsed for all summary and overall ratings in MPF between \\nOct 1 and when the actual Star Rating data go live \\nNot enough data available \\nThe contract did not have enough rated measures to \\ncalculate the domain rating \\nThe contract did not have enough rated measures to \\ncalculate the summary or overall rating \\nPlan too new to be measured The contract is too new to have submitted measure data \\nfor a domain rating to be calculated \\nThe contract is too new to have submitted data to be \\nrated in the summary or overall levels \\nAssignment rules for Part C & Part D domain rating level messages \\nPart C & D domain message assignment rules: \\nIs there a numeric domain star? \\n \\nYes: Display the numeric domain star \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\nAssignment rules for Part C & Part D summary rating level messages \\nPart C & D summary rating message assignment rules: \\nIs there a numeric summary rating star? \\n \\nYes: Display the numeric summary rating star \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available\", '(Last Updated 10/03/2024)  \\nPage 185 \\n \\nAssignment rules for overall rating level messages \\nOverall rating message assignment rules: \\nIs there a numeric overall rating star? \\n \\nYes: Display the numeric overall rating star \\n \\nNo: \\nIs the contract effective date > 01/01/2023? \\n \\n \\nYes: Display message: Plan too new to be measured \\n \\n \\nNo: \\nDisplay message: Not enough data available \\n \\nDisenrollment Reasons messages \\nThe 2025 Star Ratings posted to the CMS downloadable Master Table and HPMS includes data collected from \\nthe Disenrollment Reasons Survey (DRS). The DRS data was not used at any point in the calculation of the Star \\nRatings. The data are provided for information only at this time and are shown in HPMS with the Star Ratings \\ndata and on the display page at http://go.cms.gov/partcanddstarratings. \\nBecause there are instances where a contract does not have data to display, a set of rules was developed to \\nassign messages where data was missing so the data area would not be left blank. \\nTable Q-4 contains all of the possible messages that could be assigned to missing data in the disenrollment \\nreason data displayed in HPMS. \\nTable Q-4: Disenrollment Reason missing data messages \\nMessage \\nMeaning \\nNot Applicable \\nUsed when the DRS measure does not apply to the contract type \\nNot Available \\nUsed when there is no numeric data available or data reliability indicated the value should be suppressed \\nPlan too new to be measured The contract is too new for data to be collected for the measure \\nDisenrollment Reasons message assignment rules: \\nIs the contract effective date > 1/1/2023? \\n \\nYes: Display message: Plan too new to be measured \\n \\nNo: \\nIs there numeric data for the contract in this DRS measure? \\n \\n \\nYes: Did the data reliability check indicate the data should be suppressed? \\n \\n \\n \\nYes: Display message: Not Available \\n \\n \\n \\nNo: Display the numeric DRS rate \\n \\n \\nNo: \\nDoes the DRS measure apply to the organization type \\n \\n \\n \\nYes: Display message: Not Available \\n \\n \\n \\nNo: \\nDisplay message: Not Applicable', '(Last Updated 10/03/2024)  \\nPage 186 \\n \\nAttachment R: Glossary of Terms \\nAEP \\nThe annual period from October 15 until December 7 when a Medicare beneficiary \\ncan enroll into a Medicare Part C or D plan or re-enroll into their existing Medicare \\nPart C or D Plan or change into another Medicare plan is known as the Annual \\nElection Period (AEP). The chosen Medicare Part C or D plan coverage begins on \\nJanuary 1st. \\nC-SNP \\nChronic Condition Special Needs Plans (C-SNPs) are SNPs that restrict enrollment to \\nspecial needs individuals with specific severe or disabling chronic conditions, defined \\nin 42 CFR 422.2. \\nCAHPS \\nThe term CAHPS refers to a comprehensive and evolving family of surveys that ask \\nconsumers and patients to evaluate the interpersonal aspects of health care. CAHPS \\nsurveys probe those aspects of care for which consumers and patients are the best \\nand/or only source of information, as well as those that consumers and patients have \\nidentified as being important. CAHPS initially stood for the Consumer Assessment of \\nHealth Plans Study, but as the products have evolved beyond health plans, the \\nacronym now stands for Consumer Assessment of Healthcare Providers and Systems. \\nCCP \\nA Coordinated Care Plan (CCP) is a health plan that includes a network of providers \\nthat are under contract or arrangement with the organization to deliver the benefit \\npackage approved by CMS. The CCP network is approved by CMS to ensure that all \\napplicable requirements are met, including access and availability, service area, and \\nquality requirements. CCPs may use mechanisms to control utilization, such as \\nreferrals from a gatekeeper for an enrollee to receive services within the plan, and \\nfinancial arrangements that offer incentives to providers to furnish high quality and \\ncost-effective care. CCPs include HMOs, PSOs, local and regional PPOs, and senior \\nhousing facility plans. SNPs can be offered under any type of CCP that meets CMS’s \\nrequirements. \\nCohort \\nA cohort is a group of people who share a common designation, experience, or \\ncondition (e.g., Medicare beneficiaries). For the HOS, a cohort refers to a random \\nsample of Medicare beneficiaries that is drawn from each Medicare Advantage \\nOrganization (MAO) with a minimum of 500 enrollees and surveyed every spring \\n(i.e., a baseline survey is administered to a new cohort each year). Two years later, \\nthe baseline respondents are surveyed again (i.e., follow up measurement). For data \\ncollection years 1998-2006, the MAO sample size was 1,000. Effective 2007, the \\nMAO sample size was increased to 1,200. \\nCost Plan \\nA plan operated by a Health Maintenance Organization (HMO) or Competitive \\nMedical Plan in accordance with a cost reimbursement contract under §1876(h) of the \\nAct. In the Star Ratings, CMS classifies a Cost Plan not offering Part D as MA-Only \\nand a Cost Plan offering Part D as MA-PD. \\nD-SNP \\nDual Eligible Special Needs Plans (D-SNPs) enroll individuals who are entitled to \\nboth Medicare (title XVIII) and medical assistance from a state plan under Medicaid \\n(title XIX).  States cover some Medicare costs, depending on the state and the \\nindividual’s eligibility.', '(Last Updated 10/03/2024)  \\nPage 187 \\n \\nDisability Status \\nBased on the original reason for entitlement for Medicare (Disability insurance \\nbenefits or both Disability insurance benefits and End-Stage Renal Disease). \\nDual eligibles \\nIndividuals who are entitled to Medicare Part A and/or Part B and are eligible for \\nsome form of Medicaid benefit. \\nEuclidean distance \\nThe absolute value of the difference between two points, x-y. \\nHEDIS \\nThe Healthcare Effectiveness Data and Information Set (HEDIS) is a widely used set \\nof performance measures in the managed care industry, developed and maintained by \\nthe National Committee for Quality Assurance (NCQA). \\nHOS \\nThe Medicare Health Outcomes Survey (HOS) is the first patient reported outcomes \\nmeasure used in Medicare managed care. The goal of the Medicare HOS program is \\nto gather valid, reliable, and clinically meaningful health status data in the Medicare \\nAdvantage (MA) program for use in quality improvement activities, pay for \\nperformance, program oversight, public reporting, and improving health. All \\nmanaged care organizations with MA contracts must participate. \\nI-SNP \\nInstitutional Special Needs Plans (I-SNPs) are SNPs that restrict enrollment to \\ninstitutionalized special needs individuals defined in 42 CFR 422.2. \\nIRE \\nThe Independent Review Entity (IRE) is an independent entity contracted by CMS to \\nreview Medicare health and drug plans’ adverse reconsiderations of organization \\ndeterminations. \\nLIS \\nThe Low Income Subsidy (LIS) from Medicare provides financial assistance for \\nbeneficiaries who have limited income and resources. Those who receive the LIS get \\nhelp paying for their monthly premium, yearly deductible, prescription coinsurance, \\nand copayments and they will have no gap in coverage. \\nLIS/DE \\nBeneficiaries who qualify at any point in the year for a low income subsidy through \\nthe application process and/or who are full or partial Dual (Medicare and Medicaid) \\nbeneficiaries. \\nMA \\nA Medicare Advantage (MA) organization is a public or private entity organized and \\nlicensed by a State as a risk-bearing entity (with the exception of provider-sponsored \\norganizations receiving waivers) that is certified by CMS as meeting the MA contract \\nrequirements. \\nMA-Only \\nAn MA organization that does not offer Medicare prescription drug coverage. \\nMA-PD \\nAn MA organization that offers Medicare prescription drug coverage and Part A and \\nPart B benefits in one plan. \\nMSA \\nMedicare Medical Savings Account (MSA) plans combine a high deductible MA plan \\nand a medical savings account (which is an account established for the purpose of \\npaying the qualified medical expenses of the account holder). \\nPercentage \\nA part of a whole expressed in hundredths. For example, a score of 45 out of 100 \\npossible points is the same as 45%.', \"(Last Updated 10/03/2024)  \\nPage 188 \\n \\nPercentile \\nThe value below which a certain percent of observations fall. For example, a score \\nequal to or greater than 97 percent of other scores attained on the same measure is \\nsaid to be in the 97th percentile. \\nPDP \\nA Prescription Drug Plan (PDP) is a stand-alone drug plan, offered by insurers and \\nother private companies to beneficiaries who receive their Medicare Part A and/or B \\nbenefits either through the Original Medicare Plan, Medicare Private Fee-for-Service \\nPlans that do not offer prescription drug coverage, or Medicare Cost Plans that do not \\noffer Medicare prescription drug coverage. \\nPFFS \\nPrivate Fee-for-Service (PFFS) is defined as an MA plan that pays providers of \\nservices at a rate determined by the plan on a fee-for-service basis without placing the \\nprovider at financial risk; does not vary the rates for a provider based on the \\nutilization of that provider's services; and does not restrict enrollees' choices among \\nproviders who are lawfully authorized to provide services and agree to accept the \\nplan's terms and conditions of payment. The Medicare Improvements for Patients and \\nProviders Act (MIPPA) added that although payment rates cannot vary based solely \\non utilization of services by a provider, a PFFS plan is permitted to vary the payment \\nrates for a provider based on the specialty of the provider, the location of the \\nprovider, or other factors related to the provider that are not related to utilization. \\nFurthermore, MIPPA also allows PFFS plans to increase payment rates to a provider \\nbased on increased utilization of specified preventive or screening services. See \\nsection 30.4 of the Medicare Managed Care Manual Chapter 1 for further details on \\nPFFS plans. \\nReliability \\nA measure of the fraction of the variation among the observed measure values that is \\ndue to real differences in quality (“signal”) rather than random variation (“noise”). On \\na scale from 0 (all differences among plans are due to randomness of sampling) to 1 \\n(every plan's quality is measured with perfect accuracy). \\nSNP \\nA Special Needs Plan (SNP) is a Medicare Advantage (MA) coordinated care plan \\n(CCP) specifically designed to provide targeted care and limits enrollment to special \\nneeds individuals. A special needs individual could be any one of the following: 1) an \\ninstitutionalized individual, 2) a dual eligible beneficiary, or 3) an individual with a \\nsevere or disabling chronic condition, as specified by CMS. A SNP may be any type \\nof MA CCP. There are three major types of SNPs: 1) Chronic Condition SNP (C-\\nSNP), 2) Dual Eligible SNP (D-SNP), and 3) Institutional SNP (I-SNP). \\nSponsor \\nAn entity that sponsors a health or drug plan. \\nStatistical Significance \\nStatistical significance assesses how likely differences observed are due to chance \\nwhen plans are actually the same. CMS uses statistical tests (e.g., t-test) to determine \\nif a contract’s measure value is statistically significantly greater or less than the \\nnational average for that measure, or whether conversely the observed differences \\nfrom the national average could have arisen by chance. \\nSum of Squares \\nMethod used to measure variation or deviation from the mean. \\nTTY \\nA teletypewriter (TTY) is an electronic device for text communication via a telephone \\nline, used when one or more of the parties has hearing or speech difficulties.\", '(Last Updated 10/03/2024)  \\nPage 189 \\n \\nVery Low Reliability \\nFor CAHPS, an indication that reliability is less than 0.6, indicating that 40% or more \\nof observed variation is due to random noise.', '(Last Updated 10/03/2024)  \\nPage 190 \\n \\nAttachment S: Health Plan Management System Module Reference \\nThis attachment is designed to assist reviewers of the data displayed in HPMS (https://hpms.cms.gov) to \\nunderstand the various pages and fields shown in the HPMS Star Ratings module. This module employs \\nstandard HPMS user access rights so that users can only see contracts associated with their user id. \\nHPMS Star Ratings Module \\nThe HPMS Star Ratings module contains the Part C & Part D data and stars for all contracts that were rated in \\nthe ratings year along with much of the detailed data that went into the various calculations. To access the Star \\nRatings module you must be logged into HPMS. If you do not have access to HPMS, information on how to \\nobtain access can be found here: https://www.cms.gov/Research-Statistics-Data-and-Systems/Computer-Data-\\nand-Systems/HPMS/Overview.html \\nOnce you are logged into HPMS, from the home page, select Performance Metrics from the Quality and \\nPerformance menu; the Performance Metrics page will be displayed. If you do not see Performance Metrics, \\nyour user id does not have the correct access permissions; please contact CMSHPMS_Access@cms.hhs.gov \\nFrom the Performance Metrics page, select Reports and then Star Ratings and Display Measures from the left \\nside menu. The Star Ratings and Display Measures home page will be displayed. \\nOn the Star Ratings and Display Measures home page, select Star Ratings as the Report Type and select a \\nreporting period. The remainder of this attachment describes the HPMS pages available for the 2025 Star \\nRatings. \\n1. Measure Data page \\nThe Measure Data page displays the numeric data for all Part C and Part D measures. This page is available \\nduring the first plan preview. \\nThe first four columns contain contract identifying information. The remaining columns contain the \\nmeasures which will display in MPF. There is one column for each of the Part C and Part D measures. The \\nmeasure columns are identified by measure id and measure name. The row immediately above this measure \\ninformation contains the domain name. The row immediately below the measure information contains the \\ndata time frame of the measure. All subsequent rows contain the data for all individual contracts associated \\nwith the user’s login id. Table S-1 below shows a sample of the left hand most columns shown in HPMS. \\nTable S-1: Measure Data page sample \\nMedicare Star Ratings Report Card Master Table \\nContract \\nNumber \\nOrganization \\nMarketing \\nName \\nContract \\nName \\nParent \\nOrganization \\nHD1: Staying Healthy: Screenings, Tests and Vaccines \\nC01: Breast Cancer Screening C02: Colorectal Cancer Screening C03: Annual Flu Vaccine \\n01/01/2023 - 12/31/2023 \\n01/01/2023 - 12/31/2023 \\n03/2024 - 06/2024 \\nHAAAA Market A \\nContract A PO A \\nPlan too new to be measured Plan too new to be measured \\nNot enough data available \\nHBBBB Market B \\nContract B PO B \\nNot enough data available \\n73% \\n81% \\nHCCCC Market C \\nContract C PO C \\n63% \\n71% \\n80% \\n2. Measure Detail – CTM Summary page \\nThe Measure Detail – CTM Summary page contains the underlying data used for the Part C and Part D \\nComplaints (C25/D02) measures. This page is available during the first plan preview. Table S-2 below \\nexplains each of the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 191 \\n \\nTable S-2: Measure Detail – CTM Summary page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nTotal Number of Complaints \\nNumber of non-excluded complaints for the contract \\nComplaint Average Enrollment \\nThe average enrollment used in the final calculation \\nComplaints Less Than 800 \\nEnrolled \\nYes / No, Yes = average enrollment < 800, No = average enrollment ≥ 800 \\n3. Measure Detail – Part C Appeals page \\nThe Measure Detail – Part C Appeals page contains the case-level data of the non-excluded cases used in \\nproducing the Part C Appeals measures Plan Makes Timely Decisions about Appeals (C28) and Reviewing \\nAppeals Decisions (C29). The data displayed on this page reflect the state of the appeals case at the time the \\ndata were pulled for use in the 2025 Star Ratings. This page is available during the first plan preview. Table \\nS-3 below explains each of the columns displayed on this page. \\nTable S-3: Measure Detail – Part C Appeals page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nAppeal Number \\nThe case ID assigned to the appeal request \\nAppeal Priority \\nThe priority of the appeal (Std Pre-Service, Exp Pre-Service, Pre-Service B Drug, or Retro) \\nStatus \\nThe status of the appeal (Closed, Decided, Pending, Promoted, Remanded, Reopened, Requested) \\nDate Appeal Filed \\nThe Date the Plan Reconsideration was requested, as reported by the Part C Plan \\nCorrected Appeal Date \\nThe Date Appeal Filed, as determined by the IRE/QIC \\nDate File Received (QIC) \\nThe Date the IRE/QIC received the Appeal from the Part C Plan \\nLevel 1 Extension \\nIndicates if the contract took an extension during their processing of the reconsideration, as reported by the contract \\nAdjusted Plan Interval \\nThe number of days between the Date Appeal Filed (or Corrected Appeal Date, if applicable) and the Date File \\nReceived (QIC) adjusted based on the Appeal Priority (Std Pre-Service, Exp Pre-Service, or Retro) and adjusted to \\naccount for 5 mailing days \\nAppeal Decision \\nDecision associated with the appeal: Dismiss Appeal, Dismissed – Plan Approved Coverage, Favorable (Overturn \\nMCO Denial), Partially Favorable (Partly Overturn MCO Denial), Unfavorable (Uphold MCO Denial), Withdraw \\nAppeal, Remand to Plan. \\nLate Indicator \\nIndicates if the appeal case was considered late or not (0=Not Late, 1=Late)', '(Last Updated 10/03/2024)  \\nPage 192 \\n \\n4. Measure Detail – SNP CM page \\nThe Measure Detail – SNP CM page contains the underlying data used in calculating the Part C SNP Care \\nManagement measure (C05). The formulas used to calculate the SNP CM measure are detailed in \\nAttachment E. This page is available during the first plan preview. Table S-4 below explains each of the \\ncolumns displayed on this page. \\nTable S-4: Measure Detail – SNP CM page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nNumber of new enrollees \\nNumber of new SNP enrollees eligible for an initial assessment (Data Element A) \\nNumber of enrollees eligible for an annual HRA \\nNumber of SNP enrollees eligible for an annual reassessment (Data Element B) \\nNumber of initial HRAs performed on new enrollees \\nNumber of initial assessments performed on new SNP enrollees (Data Element C) \\nNumber of annual reassessments performed \\nNumber of annual reassessments performed on eligible SNP enrollees (Data Element \\nF) \\nTotal Number of SNP Enrollees Eligible \\nFinal measure numerator (Data Elements A + B) \\nTotal Number of Assessments Performed \\nFinal measure denominator (Data Elements C + F) \\nPercent of Eligible SNP Enrollees Receiving an Assessment Final measure score \\nData Validation Score \\nThe data validation score for the contract \\nReason for Exclusion \\nReason (if any) contract submitted data was not used to generate a score \\n5. Measure Detail – HEDIS page \\nThe Measure Detail – HEDIS page contains the underlying data used in calculating the Part C HEDIS SNP \\nCare for Older Adults measures, the Transitions of Care measure and the Plan All-Cause readmissions \\nmeasure. The formulas used to calculate the SNP measures are detailed in Attachment E. The formula used \\nto calculate the PCR measure is detailed in Attachment F. This page is available during the first plan \\npreview. Table S-5 below explains each of the columns displayed on this page and Table S-6 explains the \\nHEDIS audit designations.', '(Last Updated 10/03/2024)  \\nPage 193 \\n \\nTable S-5: Measure Detail – HEDIS page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nPBP ID \\nThe Plan Benefit Package number associated with the data \\nMeasure ID \\nThe Star Ratings measure ID that corresponds to the data in the given row \\nMeasure Name \\nThe measure name that corresponds to the data in the given row \\nRate \\nThe measure rate \\nEligible Population \\nThe measure eligible population \\nObserved Count \\nThe measure observed count (only applicable for PCR) \\nExpected Count \\nThe expected count (only applicable for PCR) \\nDenominator \\nThe measure denominator \\nAudit Designation \\nThe audit designation (the audit codes are defined in the next table) \\nStatus \\nThe status (the status codes are defined in the next table) \\nAverage Plan Enrollment \\nThe average enrollment in the PBP during 2023 (see section Contract Enrollment Data) \\n \\nTable S-6: HEDIS 2023 Audit Designations and 2025 Star Ratings \\nAudit Designation \\nStatus \\nNCQA Description \\nResultant Star Rating \\nR  \\nR \\nReportable \\nAssigned 1 to 5 stars depending on reported value \\nBR \\nR or NA \\nBiased Rate  \\n1 star, numeric data set to “CMS identified issues with this plan’s data” \\nR \\nNA \\nSmall Denominator “Not enough data available” \\nNB \\nR or NA \\nNo Benefit \\n“Benefit not offered by plan” \\nNR \\nR or NA \\nNot Reported \\n1 star, numeric data set to “CMS identified issues with this plan’s data” \\nNQ \\nR or NA \\nNot Required \\n“Plan not required to report measure” (applies only to 1876 Cost in the PCRb measure) \\nUN \\n \\nUn-Audited \\nNot possible in Star Ratings measures which only use audited data \\n6. Measure Detail – CTM page \\nThe Measure Detail – CTM page contains the case level data of the non-excluded cases used in producing \\nthe Part C & Part D Complaints measure (C25/D02). This page is available during the first plan preview. \\nTable S-7 below explains each of the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 194 \\n \\nTable S-7: Measure Detail – CTM page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nComplaint ID \\nThe case number associated with the complaint in the HPMS CTM module \\nComplaint Category \\nThe complaint category code \\nCMS Issue \\nIs the complaint designated as a CMS issue? (Yes/No) \\nCategory \\nThe complaint category description of CMS or plan lead \\nSubcategory \\nThe complaint subcategory description associated with this case \\nSubcategory — Other \\nThe complaint additional subcategory description associated with this case \\nContract Assignment / Reassignment Date The date that complaints are assigned or re-assigned to contracts \\n7. Measure Detail – Disenrollment \\nThe Measure Detail – Disenrollment page contains data that are used in calculating the Part C & Part D \\ndisenrollment measure (C26/D03). The page shows the denominator, unadjusted numerator and original rate \\nreceived from the MBDSS annual report. It also contains the adjusted numerator and final rate after all \\nmembers meeting the measure exclusion criteria described in the measure description have been removed. \\nThis page is available during the first plan preview. Table S-8 below explains each of the columns displayed \\non this page. \\nTable S-8: Measure Detail – Disenrollment page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nNumber Enrolled \\nThe number of all members in the contract from MBDSS annual report \\nNumber Disenrolled \\nThe number disenrolled with a disenrollment reason code of 11, 13, 14 or 99, from the MBDSS annual report \\nOriginal Rate \\nThe disenrollment rate as calculated by the annual MBDSS report \\nAdjusted Disenrolled \\nThe adjusted numerator when all members who meet the measure exclusion criteria are removed \\nAdjusted Rate \\nThe final adjusted disenrollment rate used in the Star Ratings \\n>1000 Enrolled \\nFlag indicates contract non-employer group enrollment >1,000 members during the year or contracts that did not \\nhave any disenrollments meeting the inclusion criteria (True = Yes, False = No) \\n8. Measure Detail – DR (Disenrollment Reasons) \\nThe Measure Detail – Disenrollment Reasons page contains the data from the Disenrollment Reasons \\nSurvey (DRS). The Disenrollment Reasons data are not used at any point in the calculations of the Star \\nRatings but are provided in HPMS for information only at this time. The data come from surveys sent to \\nenrollees who disenrolled between 1/1/2023 and 12/31/2023. Scores are suppressed if they are measured \\nwith very low reliability (< 0.60) and not statistically different from the national mean. This page is \\navailable during the first plan preview. Table S-9 below explains each of the columns displayed on this \\npage.', \"(Last Updated 10/03/2024)  \\nPage 195 \\n \\nTable S-9: Measure Detail – Disenrollment Reasons page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nDR PGPPPNC \\nDisenrollment Reasons - Problems Getting the Plan to Provide and Pay for Needed Care (MA-PD, MA-Only) \\nDR PCDH \\nDisenrollment Reasons - Problems with Coverage of Doctors and Hospitals (MA-PD, MA-Only) \\nDR FRD \\nDisenrollment Reasons - Financial Reasons for Disenrollment (MA-PD, MA-Only, PDP) \\nDR PPDBC \\nDisenrollment Reasons - Problems with Prescription Drug Benefits and Coverage (MA-PD, PDP) \\nDR PGIHP \\nDisenrollment Reasons - Problems Getting Information and Help from the Plan (MA-PD, PDP) \\n9. Measure Detail – MTM page \\nThe Measure Detail – MTM page contains each contract’s underlying denominator and numerator after \\nmeasure specifications have been applied to the plan-reported validated data to calculate the Part D MTM \\nProgram Completion Rate for CMR (D11). The formulas used to calculate the MTM measure are detailed in \\nAttachment N. This page is available during the first plan preview. Table S-10 below explains each of the \\ncolumns displayed on this page. \\nTable S-10: Measure Detail – MTM page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nTotal Part D Enrollees \\nThe number of Part D enrollees in the contract (average monthly HPMS enrollment) \\nTotal MTM Enrollees, All \\nThe number of Part D enrollees enrolled in the contract’s MTM program (as reported in the Part D MTM plan-\\nreported data).  Includes beneficiaries that had an enrollment start date anytime in the measurement period, \\nregardless of age, hospice status, or duration of MTM enrollment.  Excludes records where the MBI could not be \\nmapped to a valid beneficiary or where the beneficiary was reported with multiple, conflicting records in the same \\ncontract's data. \\nTotal MTM Enrollees, Targeted \\nThe number of Part D enrollees enrolled in the contract’s MTM program that met the specified targeting criteria per \\nCMS-Part D requirements pursuant to §423.153(d) of the regulations (as reported in the Part D MTM plan-\\nreported data).  Includes beneficiaries that had an enrollment start date anytime in the measurement period, \\nregardless of age, hospice status, or duration of MTM enrollment.  Excludes records where the MBI could not be \\nmapped to a valid beneficiary or where the beneficiary was reported with multiple, conflicting records in the same \\ncontract's data. \\nTotal MTM Enrollees, Targeted, \\nAdjusted \\nThe number of Part D enrollees enrolled in the contract’s MTM program that met the specified targeting criteria per \\nCMS-Part D requirements pursuant to §423.153(d) of the regulations (as reported in the Part D plan-reported \\ndata) after measure specifications applied as detailed in Attachment N. (Measure Denominator) \\nTotal MTM Enrollees, Targeted, \\nAdjusted, Who Received a CMR \\nThe number of beneficiaries from the denominator who received a CMR. (Measure Numerator) \\nMTM Program Completion Rate for \\nCMR \\nThe percent of MTM program enrollees who received a CMR. (Measure Numerator)/(Measure Denominator) \\nMTM Section Data Validation \\nScore \\nContract’s score in data validation (DV) for their MTM Program Reporting Requirements data \\nReason(s) for Display Message  \\nReason(s) for display message assignment (if applicable)\", '(Last Updated 10/03/2024)  \\nPage 196 \\n \\n10. Measure Detail – CAHPS page \\nThe Measure Detail – CAHPS page contains the underlying data used in calculating the Part C & D CAHPS \\nmeasures: Annual Flu Vaccine (C03), Getting Needed Care (C19), Getting Appointments and Care Quickly \\n(C20), Customer Service (C21), Rating of Health Care Quality (C22), Rating of Health Plan (C23), Care \\nCoordination (C24), Rating of Drug Plan (D05), and Getting Needed Prescription Drugs (D06). This page is \\navailable during the first plan preview. Table S-11 below explains each of the columns displayed on this \\npage. \\nTable S-11: Measure Detail – CAHPS page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nCAHPS Measure \\nThe CAHPS measure identifier followed by the Star Ratings measure id in parenthesis \\nReliability \\nThe contract-level reliability of the measure data \\nStatistical Significance \\nThe statistical significance of the measure data (Below Average, No Difference, Above Average) \\nUse N \\nThe number of usable surveys with responses to the item, or at least one item of a composite \\nMean Score on Original Scale \\nThe mean score on the original survey response scale \\nVariance of Mean on Original Scale The sampling variance of contract mean (\"Mean score\") on the original scale \\nStandard Error on Original Scale \\nThe standard error of the contract mean (\"Mean score\") on the original scale; square root of \"variance\" \\nScaled Mean \\nThe contract mean score rescaled to a 0-100 scale \\nScaled SE \\nThe standard error of the 0-100 scaled mean \\nBase Group \\nCategories determined by the percentile cutoffs from the distribution of mean scores  \\nStar Rating \\nDetermined by the percentile cutoffs, statistical significance of the difference of the contract mean from the \\noverall mean, the statistical reliability of the estimate, and standard error of the mean score \\n \\n11. Calculation Detail – MD \\nThe Calculation Detail – MD page contains the summary of service area and enrollment data used to \\ncalculate the percentages for use in the Major Disaster rules for the individual measures. This page is \\navailable during the first plan preview. Table S-12 below explains the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 197 \\n \\nTable S-12: Calculation Detail – MD page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing \\nName \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nDisaster Flag 2023 \\nIndicates if the contract was affected by a 2023 disaster or not (valid values “Affected”, “Not Affected” or “Too New“) \\nTotal Cnty in SA 2023 \\nThe total number of counties in the contract’s 2023 service area (SA) \\nNum Cnty IA 2023 \\nThe number of counties from the contract’s total SA designated as FEMA Individual Assistance (IA) counties in a 2023 \\ndisaster \\nIA Enrolled 2023 \\nThe number of members residing in the contract SA designated FEMA IA counties in a 2023 disaster \\nTotal Enrolled 2023 \\nThe total number of members residing in the contract’s 2023 SA \\nIA % 2023 \\nThe percent of members living in IA areas in a 2023 disaster (IA Enrolled)/(Total Enrolled) \\nIA % Rounded 2023 \\nThe percent of members living in IA areas in a 2023 disaster rounded to an integer \\n>25% 2023 \\nFlag that indicates if the contract has met the 25% threshold for 2023 disasters (Yes: >= 25 %, No: <25%) \\n>60% 2023 \\nFlag that indicates if the contract has met the 60% threshold for 2023 disasters (Yes: >= 60 %, No: <60%) \\nDisaster Flag 2022 \\nIndicates if the contract was affected by a 2022 disaster or not (valid values “Affected”, “Not Affected” or “Too New“) \\nTotal Cnty in SA 2022 \\nThe total number of counties in the contract’s 2022 service area (SA) \\nNum Cnty IA 2022 \\nThe number of counties from the contract’s total SA designated as FEMA Individual Assistance (IA) counties in a 2022 \\ndisaster \\nIA Enrolled 2022 \\nThe number of members residing in the contract SA designated FEMA IA counties in a 2022 disaster \\nTotal Enrolled 2022 \\nThe total number of members residing in the contract’s 2022 SA \\nIA % 2022 \\nThe percent of members living in IA areas in a 2022 disaster (IA Enrolled)/(Total Enrolled) \\nIA % Rounded 2022 \\nThe percent of members living in IA areas in a 2022 disaster rounded to an integer \\n>=25% 2022 \\nFlag that indicates if the contract has met the 25% threshold for 2022 disasters (Yes: >= 25 %, No: <25%) \\n \\n12. Calculation Detail – CAI \\nThe Calculation Detail – CAI page contains the enrollment data used to calculate the percentages for use in \\nthe Categorical Adjustment Index (CAI) to determine the Final Adjustment Categories for each of the \\nsummary and overall rating calculations. This page is available during the first plan preview. Table S-13 \\nbelow explains the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 198 \\n \\nTable S-13: Measure Detail – CAI page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nPuerto Rico Only \\nDoes the contract’s non-employer service area only cover Puerto Rico? Yes or No \\nContract Type \\nThe contract plan type used to compute the ratings \\nPart D Offered \\nIs Part D offered by the contract? Yes or No \\nEnrolled \\nThe total number enrolled in the contract used to determine the % LIS/DE and % Disabled \\nNum LIS/DE \\nThe number of LIS/DE enrolled in the contract \\nNum Disabled \\nThe number of Disabled enrolled in the contract \\n% LIS/DE \\nThe percent of LIS/DE in the contract \\n% Disabled \\nThe percent Disabled in the contract \\nPart C LIS/DE Initial Group \\nThe Part C LIS/DE initial group this contract is in \\nPart C Disabled Quintile \\nThe Part C Disabled Quintile group this contract is in \\nPart C FAC \\nThe Part C Final adjustment category this contract is in \\nPart C CAI Value \\nThe CAI value that will be combined with the final Part C summary score prior to rounding to half stars \\nPart D MA-PD LIS/DE Initial Group The Part D MA-PD LIS/DE initial group this contract is in \\nPart D MA-PD Disabled Quintile \\nThe Part D MA-PD Disabled Quintile group this contract is in \\nPart D MA-PD FAC \\nThe Part D MA-PD Final adjustment category this contract is in \\nPart D MA-PD CAI Value \\nThe CAI value that will be combined with the final Part D MA-PD summary score prior to rounding to half stars \\nPart D PDP LIS/DE Quartile \\nThe Part D PDP LIS/DE Quartile group this contract is in \\nPart D PDP Disabled Quartile \\nThe Part D PDP Disabled Quartile group this contract is in \\nPart D PDP FAC \\nThe Part D PDP Final adjustment category this contract is in \\nPart D PDP CAI Value \\nThe CAI value that will be combined with the final Part D PDP summary score prior to rounding to half stars \\nOverall LIS/DE Initial Group \\nThe overall LIS/DE initial group this contract is in \\nOverall Disabled Quintile \\nThe overall disabled Quintile group this contract is in \\nOverall FAC \\nThe overall final adjustment category this contract is in \\nOverall CAI Value \\nThe CAI value that will be combined with the final overall score prior to rounding to half stars \\n13. Measure Detail – HEDIS LE page \\nThe Measure Detail – HEDIS LE page contains the data used to calculate the reliability of the HEDIS \\nmeasures (C01, C02, C08 – C11, C14 – C18) data for contracts with ≥ 500 and < 1,000 members enrolled in \\nJuly of the measurement year (July 01, 2023). This page is available during the second plan preview. Table \\nS-14 below explains each of the columns displayed on this page.', '(Last Updated 10/03/2024)  \\nPage 199 \\n \\nTable S-14: Measure Detail – HEDIS LE page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe parent organization of the contract \\nMeasure ID \\nThe Star Ratings measure that the other data on this row is associated with \\nRate \\nThe submitted HEDIS rate \\nScore \\nThe rounded value used for the measure in the Star Ratings \\nEnrollment \\nThe contract enrollment for July 2023 \\nReliability \\nThe computed reliability for the contract measure \\nUsable \\nThe computed reliability ≥ 0.7 and rate is used = True, reliability < 0.7 and rate was not used = False \\n14. Measure Detail – C MD Results \\nThe Part C Disaster Results page displays the measure level data handling results for contracts which had \\n≥25% of their enrollment living in areas affected by major disasters during the measurement period. Only \\nthe measures where the disaster policy required a comparison between two ratings years are displayed in the \\ndata. This page is available during the second plan preview. Table S-15 below explains the columns \\ndisplayed on this page. \\nTable S-15: Measure Detail – C MD Results \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nMeasure ID \\nThe 2025 Star Ratings Part C measure ID \\n2024 Value \\nThe numeric measure value for the contract from the 2024 Star Ratings \\n2024 Star \\nThe measure star for the contract from the 2024 Star Ratings \\n2025 Value \\nThe numeric measure value for the contract from the 2025 Star Ratings \\n2025 Star \\nThe measure star for the contract from the 2025 Star Ratings \\nFinal Value \\nThe measure value to be used in the 2025 Star Ratings after the data handling policy for disasters was applied \\nFinal Star \\nThe measure star to be used in the 2025 Star Ratings after the data handling policy for disasters was applied \\nFinal From \\nThe Star Ratings year where the final data for the measure came from \\n15. Measure Detail – D MD Results \\nThe Part D Disaster Results page displays the measure level data handling results for contracts which had \\n≥25% of their enrollment living in areas affected by major disasters during the measurement period. Only \\nthe measures where the disaster policy required a comparison between two ratings years are displayed in the \\ndata. This page is available during the second plan preview. Table S-16 below explains the columns \\ndisplayed on this page.', '(Last Updated 10/03/2024)  \\nPage 200 \\n \\nTable S-16: Measure Detail – D MD Results \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nMeasure ID \\nThe 2025 Star Ratings Part D measure ID \\n2024 Value \\nThe numeric measure value for the contract from the 2024 Star Ratings \\n2024 Star \\nThe measure star for the contract from the 2024 Star Ratings \\n2025 Value \\nThe numeric measure value for the contract from the 2025 Star Ratings \\n2025 Star \\nThe measure star for the contract from the 2025 Star Ratings \\nFinal Value \\nThe measure value to be used in the 2025 Star Ratings after the data handling policy for disasters was applied \\nFinal Star \\nThe measure star to be used in the 2025 Star Ratings after the data handling policy for disasters was applied \\nFinal From \\nThe Star Ratings year where the final data for the measure came from \\n16. Measure Detail – C Improvement page \\nThe Improvement page is constructed in a similar manner as the Measure Data page. This page is available \\nduring the second plan preview. \\nThe first four columns contain contract identifying information. The remaining columns contain the results \\nof the improvement calculation for the specific Part C measures. There is one column for each Part C \\nmeasure. The measure columns are identified by measure id and measure name. There is an additional \\ncolumn to the right of the Part C measure columns which contains the final numeric Part C improvement \\nscore. This numeric result is described in Attachment I: “Calculating the Improvement Measure and the \\nMeasures Used.” \\nThe row immediately above this measure information contains the domain id and domain name. The row \\nimmediately below the measure information contains a flag (Included or Not Included) to show if the \\nmeasure was used to calculate the final improvement measure. All subsequent rows contain the data \\nassociated with an individual contract. The possible results for Part C measure calculations are shown in \\nTable S-17 below. \\nTable S-17: Part C Measure Improvement Results \\nImprovement Measure Result \\nDescription \\nNo significant change \\nThere was no significant change in the values between the two years \\nSignificant improvement \\nThere was a significant improvement from last year to this year \\nSignificant decline \\nThere was a significant decline from last year to this year \\nNot included in calculation \\nThere was only one year of data available so the calculation could not be completed \\nNot Applicable \\nThe measure is not an improvement measure \\nNot Eligible \\nThe contract did not have data in more than half of the improvement measures or was too new  \\nHeld Harmless \\nThe contract had 5 stars in this measure last year and this year \\nLow reliability and low enrollment The low-enrollment contract measure score did not have sufficiently high reliability \\n17. Measure Detail – D Improvement page \\nThe Improvement page is constructed in a similar manner as the Measure Data page. This page is available \\nduring the second plan preview.', '(Last Updated 10/03/2024)  \\nPage 201 \\n \\nThe first four columns contain contract identifying information. The remaining columns contain the results \\nof the improvement calculation for the specific Part D measures. There is one column for each Part D \\nmeasure. The measure columns are identified by measure id and measure name. There is an additional \\ncolumn to the right of the Part D measure columns which contains the final numeric Part D improvement \\nscore. This numeric result is described in Attachment I: “Calculating the Improvement Measure and the \\nMeasures Used.” \\nThe row immediately above this measure information contains the domain id and domain name. The row \\nimmediately below the measure information contains a flag (Included or Not Included) to show if the \\nmeasure was used to calculate the final improvement measure. All subsequent rows contain the data \\nassociated with an individual contract. The possible results for Part D measure calculations are shown in \\nTable S-18 below. \\nTable S-18: Part D Measure Improvement Results \\nImprovement Measure Result \\nDescription \\nNo significant change \\nThere was no significant change in the values between the two years \\nSignificant improvement \\nThere was a significant improvement from last year to this year \\nSignificant decline \\nThere was a significant decline from last year to this year \\nNot included in calculation \\nThere was only one year of data available so the calculation could not be completed \\nNot Applicable \\nThe measure is not an improvement measure \\nNot Eligible \\nThe contract did not have data in more than half of the improvement measures or was too new  \\nHeld Harmless \\nThe contract had 5 stars in this measure last year and this year \\n18. Measure Stars page \\nThe Measure Stars page displays the Star Rating for each Part C and Part D measure. This page is available \\nduring the second plan preview. \\nThe first four columns contain contract identifying information. The remaining columns contain the measure \\nstars which will display in MPF. There is one column for each of the Part C and Part D measures. The \\nmeasure columns are identified by measure id and measure name. The row immediately above this measure \\ninformation contains the domain id and domain name. The row immediately below the measure information \\ncontains the data time frame. All subsequent rows contain the data for all individual contracts associated \\nwith the user’s login id. Table S-19 below shows a sample of the left hand most columns shown in HPMS. \\nTable S-19: Measure Stars page sample \\nMedicare Star Ratings Report Card Master Table \\nContract \\nNumber \\nOrganization \\nMarketing Name \\nContract \\nName \\nParent \\nOrganization \\nHD1: Staying Healthy: Screenings, Tests and Vaccines \\nC01: Breast Cancer Screening C02: Colorectal Cancer Screening C03: Annual Flu Vaccine \\n01/01/2023 - 12/31/2023 \\n01/01/2023 - 12/31/2023 \\n03/2024 - 06/2024 \\nHAAAA Market A \\nContract A PO A \\nPlan too new to be measured \\nPlan too new to be measured \\nNot enough data available \\nHBBBB Market B \\nContract B PO B \\nNot enough data available \\n4 \\n5 \\nHCCCC Market C \\nContract C PO C \\n3 \\n4 \\n5 \\n19. Domain Stars page \\nThe Domain Stars page displays the Star Rating for each Part C and Part D domain. This page is available \\nduring the second plan preview.', '(Last Updated 10/03/2024)  \\nPage 202 \\n \\nThe first four columns contain contract identifying information. The remaining columns contain the domain \\nstars which will display in MPF. There is one column for each of the Part C and Part D domains. The \\ndomain columns are identified by the domain id and domain name. All subsequent rows contain the stars \\nassociated with an individual contract. Table S-20 below shows a sample of the left hand most columns \\nshown in HPMS. \\nTable S-20: Domain Star page sample \\nMedicare Star Ratings Report Card Master Table \\nContract \\nNumber \\nOrganization \\nMarketing Name \\nContract \\nName \\nParent \\nOrganization \\nHD1: Staying Healthy: Screenings, \\nTests and Vaccines \\nHD2: Managing Chronic \\n(Long Term) Conditions \\nHD3: Member Experience \\nwith Health Plan \\nHAAAA Market A \\nContract A PO A \\n4 \\n3 \\n4 \\nHBBBB Market B \\nContract B PO B \\n3 \\n3 \\n3 \\nHCCCC Market C \\nContract C PO C \\n3 \\n3 \\n4 \\n20. Part C Summary Rating page \\nThe Part C Summary Rating page displays the Part C rating and data associated with calculating the final \\nPart C summary rating. This page is available during the second plan preview. There are flags to indicate if \\nthe final rating came from the without improvement measures calculation. Table S-21 below explains each \\nof the columns contained on this page. \\nTable S-21: Part C Summary Rating page fields \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nContract Type \\nThe contract plan type used to compute the ratings \\nSNP Plans \\nDoes the contract offer a SNP? (Yes/No) \\nMajor Disaster Percentage 2022 \\nThe percentage of members living in an Individual Assistance area in 2022 rounded to an integer \\nMajor Disaster Percentage 2023 \\nThe percentage of members living in an Individual Assistance area in 2023 rounded to an integer \\nNumber Measures Required \\nThe minimum number of measures required to calculate a rating out all required for the contract type. \\nNumber Missing Measures \\nThe number of measures that were missing stars \\nNumber Rated Measures \\nThe number of measures that were assigned stars \\nCalculated Summary Mean \\nContains the mean of the stars for rated measures \\nCalculated Variance \\nThe variance of the calculated summary mean \\nCalculated Score Percentile Rank Percentile ranking of Calculated Summary Mean \\nVariance Percentile Rank \\nPercentile ranking of Calculated Variance \\nVariance Category \\nThe reward factor variance category for the contract (low, medium, or high) \\nReward Factor \\nThe calculated reward factor for the contract (0, 0.1, 0.2, 0.3, or 0.4) \\nInterim Summary \\nThe sum of the Calculated Summary Mean and the Reward Factor \\nPart C Summary FAC \\nPart C summary final adjustment category for the contract \\nCAI Value \\nThe Part C summary CAI value for the contract \\nFinal Summary \\nThe sum of the Interim Summary and the CAI Value \\nImprovement Measure Usage \\nDid the final Part C summary rating come from the calculation using the improvement measure? (Yes/No) \\nNew Measure Usage \\nDid the final Part C summary rating come from the calculation using the new measures? (Yes/No) \\n2025 Part C Summary Rating \\nThe final rounded 2025 Part C Summary Rating', '(Last Updated 10/03/2024)  \\nPage 203 \\n \\n21. Part D Summary Rating page \\nThe Part D Summary Rating page displays the Part D rating and data associated with calculating the final \\nPart D summary rating. This page is available during the second plan preview. There are flags to indicate if \\nthe final rating came from the without improvement measures calculation. Table S-22 below explains each \\nof the columns contained on this page. \\nTable S-22: Part D Summary Rating View \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nContract Type \\nThe contract plan type used to compute the ratings \\nMajor Disaster Percentage 2022 \\nThe percentage of members living in an Individual Assistance area in 2022 rounded to an integer \\nMajor Disaster Percentage 2023 \\nThe percentage of members living in an Individual Assistance area in 2023 rounded to an integer \\nNumber Measures Required \\nThe minimum number of measures required to calculate a rating out all required for the contract type \\nNumber Missing Measures \\nThe number of measures that were missing stars \\nNumber Rated Measures \\nThe number of measures that were assigned stars \\nCalculated Summary Mean \\nContains the mean of the stars for rated measures \\nCalculated Variance \\nThe variance of the calculated summary mean \\nCalculated Score Percentile Rank Percentile ranking of Calculated Summary Mean \\nVariance Percentile Rank \\nPercentile ranking of Calculated Variance \\nVariance Category \\nThe reward factor variance category for the contract (low, medium, or high) \\nReward Factor \\nThe calculated reward factor for the contract (0, 0.1, 0.2, 0.3, or 0.4) \\nInterim Summary \\nThe sum of the Calculated Summary Mean and the Reward Factor \\nPart D Summary FAC \\nPart D summary final adjustment category for the contract \\nCAI Value \\nThe Part D summary CAI value for the contract \\nFinal Summary \\nThe sum of the Interim Summary and the CAI Value \\nImprovement Measure Usage \\nDid the final Part D summary rating come from the calculation using the improvement measure? (Yes/No) \\n2025 Part D Summary Rating \\nThe final rounded 2025 Part D Summary Rating \\n22. Overall Rating page \\nThe Overall Rating page displays the overall rating for MA-PD contracts and data associated with \\ncalculating the final overall rating. This page is available during the second plan preview. There are flags to \\nindicate if the final rating came from the without improvement measures calculation. Table S-23 below \\nexplains each of the columns contained on this page.', '(Last Updated 10/03/2024)  \\nPage 204 \\n \\nTable S-23: Overall Rating View \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name \\nThe name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nContract Type \\nThe contract plan type used to compute the ratings \\nSNP Plans \\nDoes the contract offer a SNP? (Yes/No) \\nMajor Disaster Percentage 2022 \\nThe percentage of members living in an Individual Assistance area in 2022 rounded to an integer \\nMajor Disaster Percentage 2023 \\nThe percentage of members living in an Individual Assistance area in 2023 rounded to an integer \\nNumber Measures Required \\nThe minimum number of measures required to calculate a rating out all required for the contract type \\nNumber Missing Measures \\nThe number of measures that were missing stars \\nNumber Rated Measures \\nThe number of measures that were assigned stars \\n2025 Part C Summary Rating \\nThe 2025 Part C Summary Rating \\n2025 Part D Summary Rating \\nThe 2025 Part D Summary Rating \\nCalculated Summary Mean \\nContains the weighted mean of the stars for rated measures  \\nCalculated Variance \\nThe variance of the calculated summary mean \\nCalculated Score Percentile Rank Percentile ranking of Calculated Summary Mean \\nVariance Percentile Rank \\nPercentile ranking of Calculated Variance \\nVariance Category \\nThe reward factor variance category for the contract (low, medium, or high) \\nReward Factor \\nThe calculated reward factor for the contract (0, 0.1, 0.2, 0.3, or 0.4) \\nInterim Summary \\nThe sum of the Calculated Summary Mean and the Reward Factor \\nOverall FAC \\nOverall final adjustment category for the contract \\nCAI Value \\nThe Overall CAI value for the contract \\nFinal Summary \\nThe sum of the Interim Summary and the CAI Value \\nImprovement Measure Usage \\nDid the final overall rating come from the calculation using the improvement measures? (Yes/No) \\nNew Measure Usage \\nDid the final overall rating come from the calculation using the new measures? (Yes/No) \\n2025 Overall Rating \\nThe final 2025 Overall Rating \\n23. Low Performing Contract List \\nThe Low Performing Contract List page displays the contracts that received a Low Performing Icon and the \\ndata used to calculate the assignment. This page is available during the second plan preview. HPMS users in \\ncontracting organizations will see only their own contracts in this list. None will be displayed if no contract \\nin the organization was assigned a Low Performing Icon. Table S-24 below explains each of the columns \\ncontained on this page.', '(Last Updated 10/03/2024)  \\nPage 205 \\n \\nTable S-24: Low Performing Contract List \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nRated As \\nThe type of rating for this contract, valid values are “MA-Only,” “MA-PD,” and “PDP” \\n2023 C Summary \\nThe 2023 Part C Summary Rating earned by the contract \\n2023 D Summary \\nThe 2023 Part D Summary Rating earned by the contract \\n2024 C Summary \\nThe 2024 Part C Summary Rating earned by the contract \\n2024 D Summary \\nThe 2024 Part D Summary Rating earned by the contract \\n2025 C Summary \\nThe 2025 Part C Summary Rating earned by the contract \\n2025 D Summary \\nThe 2025 Part D Summary Rating earned by the contract \\nReason for LPI \\nThe combination of ratings that met the Low Performing Icon rules. Valid values are “Part C,” “Part D,” “Part C and \\nD,” & “Part C or D.” See the section titled “Methodology for Calculating the Low Performing Icon” for details. \\n24. High Performing Contract List \\nThe High Performing Contract List page displays the contracts that received a High Performing Icon. This \\npage is available during the second plan preview. HPMS users in contracting organizations will see only \\ntheir own contracts in this list. None will be displayed if no contract in the organization was assigned a High \\nPerforming Icon. Table S-25 below explains each of the columns contained on this page. \\nTable S-25: High Performing Contract List \\nHPMS Field Label \\nField Description \\nContract Number \\nThe contract number associated with the data \\nOrganization Marketing Name The name the contract markets to members \\nContract Name \\nThe name the contract is known by in HPMS \\nParent Organization \\nThe name of the parent organization for the contract \\nRated As \\nThe type of rating for this contract, valid values are “MA-Only,” “MA-PD,” and “PDP” \\nHighest Rating \\nThe highest level of rating that can be achieved for this organization, valid values are “Part C Summary,” “Part D \\nSummary,” “Overall Rating” \\nRating \\nThe star value attained in the highest rating for the organization type \\n25. Technical Notes link \\nThe Technical Notes link provides the user with a copy of the 2025 Star Ratings Technical Notes. A draft \\nversion of these technical notes is available during the first plan preview. The draft is then updated for the \\nsecond plan preview, and then finalized when the ratings data have been posted to MPF. Other updates may \\noccur to the technical notes if errors are identified outside of the plan preview periods and after MPF data \\nrelease. \\nLeft clicking on the Technical Notes link will open a new browser window which will display a PDF \\n(portable document format) copy of the 2025 Star Ratings Technical Notes. Right clicking on the Technical \\nNotes link will pop up a context menu which contains Save Target As…; clicking on this will allow the user \\nto download and save a copy of the PDF document.', '(Last Updated 10/03/2024)  \\nPage 206 \\n \\n26. Medication NDC List \\nThe Medication NDC List link provides the user a means to download a copy of the medication lists used \\nfor the Medication Adherence measures (D08 – D10) & SUPD (D12). This downloadable file is in Zip \\nformat and contains two Excel files. \\n27. Part C and Part D Example Measure Data \\nThe Part C and Part D Example Measure Data link provides the user with a means to download a copy of \\nthe data for the Breast Cancer Screening Part C measure, the Rating of Health Plan Part C measure, the \\nComplaints about the Plan Part C measure and the MTM Program Completion Rate for CMR Part D \\nmeasure for the full set of contracts used to calculate the cut points. The data are de-identified such that \\nindividual contract’s data cannot be determined. The data include the measure value, a flag for contracts that \\nhad data issues where applicable, and two flags identifying contracts with >= 25 percent and >= 60 percent \\nof enrollees living in an area affected by a disaster. There is also a flag in the Breast Cancer Screening Part \\nC measure file to identify HEDIS low enrollment contracts. There is also a flag in the MTM Program \\nCompletion Rate for CMR Part D measure file identifying contracts as MAPD or PDP. This downloadable \\nis in Zip format and contains four Excel files.']\n"
          ]
        }
      ],
      "source": [
        "# !pip install pymupdf  # Install the library\n",
        "\n",
        "import fitz  # PyMuPDF\n",
        "\n",
        "def read_pdf_paragraphs(file_path):\n",
        "    doc = fitz.open(file_path)\n",
        "    text = \"\"\n",
        "    for page in doc:\n",
        "        text += page.get_text() + \"\\n\"  # Collect text with spacing\n",
        "\n",
        "    paragraphs = [para.strip() for para in text.split(\"\\n\\n\") if para.strip()]  # Split and clean paragraphs\n",
        "    return paragraphs\n",
        "\n",
        "# Example usage\n",
        "pdf_pages = read_pdf_paragraphs(\"2025_tech_notes_2024_10_03_0.pdf\")\n",
        "print(pdf_pages)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "YB9_b8h-s4v-",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "f5952459-5cb3-4350-d6c1-942f158bf774"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "(Last Updated 10/03/2024)  \n",
            "Page 11 \n",
            " \n",
            "Table 5: Minimum Number of Rated Measures Required for a Domain Rating by Contract Type \n",
            "Part \n",
            "Domain Name (Identifier) \n",
            "1876  \n",
            "Cost † \n",
            "CCP  \n",
            "w/o SNP \n",
            "CCP  \n",
            "with SNP \n",
            "CCP with \n",
            "Only I-SNP \n",
            "MSA \n",
            "PDP \n",
            "PFFS \n",
            "C \n",
            "Staying Healthy: Screenings, \n",
            "Tests and Vaccines (HD1) \n",
            "3 of 4 \n",
            "3 of 4 \n",
            "3 of 4 \n",
            "2 of 2 \n",
            "3 of 4 \n",
            "N/A \n",
            "3 of 4 \n",
            "C \n",
            "Managing Chronic (Long \n",
            "Term) Conditions (HD2) \n",
            "5 of 8 \n",
            "6 of 11 \n",
            "8 of 14 \n",
            "6 of 10 \n",
            "6 of 11 \n",
            "N/A \n",
            "6 of 11 \n",
            "C \n",
            "Member Experience with \n",
            "Health Plan (HD3) \n",
            "4 of 6 \n",
            "4 of 6 \n",
            "4 of 6 \n",
            "N/A \n",
            "4 of 6 \n",
            "N/A \n",
            "4 of 6 \n",
            "C \n",
            "Member Complaints and \n",
            "Changes in the Health Plan's \n",
            "Performance (HD4) \n",
            "2 of 3 \n",
            "2 of 3 \n",
            "2 of 3 \n",
            "2 of 3 \n",
            "2 of 3 \n",
            "N/A \n",
            "2 of 3 \n",
            "C \n",
            "Health Plan Customer \n",
            "Service (HD5) \n",
            "2 of 2 \n",
            "2 of 3 \n",
            "2 of 3 \n",
            "2 of 3 \n",
            "2 of 2 \n",
            "N/A \n",
            "2 of 3 \n",
            "D \n",
            "Drug Plan Customer Service \n",
            "(DD1) \n",
            "N/A* \n",
            "1 of 1 \n",
            "1 of 1 \n",
            "1 of 1 \n",
            "N/A \n",
            "1 of 1 \n",
            "1 of 1* \n",
            "D \n",
            "Member Complaints and \n",
            "Changes in the Drug Plan’s \n",
            "Performance (DD2) \n",
            "2 of 3* \n",
            "2 of 3 \n",
            "2 of 3 \n",
            "2 of 3 \n",
            "N/A \n",
            "2 of 3 \n",
            "2 of 3* \n",
            "D \n",
            "Member Experience with the \n",
            "Drug Plan (DD3) \n",
            "2 of 2* \n",
            "2 of 2 \n",
            "2 of 2 \n",
            "N/A \n",
            "N/A \n",
            "2 of 2 \n",
            "2 of 2* \n",
            "D \n",
            "Drug Safety and Accuracy of \n",
            "Drug Pricing (DD4) \n",
            "4 of 6* \n",
            "4 of 6 \n",
            "4 of 6 \n",
            "4 of 6 \n",
            "N/A \n",
            "4 of 6 \n",
            "4 of 6* \n",
            "* Note: Does not apply to MA-Only, 1876 Cost, and PFFS contracts which do not offer drug benefits. \n",
            "† Note: 1876 Cost contracts that offer drug benefits and which do not submit data for the MPF measure must have a rating in 3 out of 5 \n",
            "Drug Safety and Accuracy of Drug Pricing (DD4) measures to receive a rating in that domain. \n",
            "Summary and Overall Ratings: Weighting of Measures \n",
            "The summary and overall ratings are calculated as weighted averages of the measure stars. For the 2025 Star \n",
            "Ratings, CMS assigns the highest weight to the improvement measures, followed by patient \n",
            "experience/complaints and access measures, then by outcome and intermediate outcome measures, and finally \n",
            "process measures. New measures included in the Star Ratings are given a weight of 1 for their first year of \n",
            "inclusion in the ratings; in subsequent years the weight associated with the measure weighting category is used. \n",
            "The weights assigned to each measure and their weighting category are shown in Attachment G. \n",
            "In calculating the summary and overall ratings, a measure given a weight of 3 counts three times as much as a \n",
            "measure given a weight of 1. For any given contract, any measure without a rating is not included in the \n",
            "calculation. The first step in the calculation is to multiply each measure’s weight by the measure’s rating and \n",
            "sum these results. The second step is to divide this sum by the sum of the weights of the contract’s rated \n",
            "measures. For the summary and overall ratings, half stars are assigned to allow for more variation across \n",
            "contracts. \n",
            "Methodology for Calculating Part C and Part D Summary Ratings \n",
            "The Part C and Part D summary ratings are calculated by taking a weighted average of the measure stars for \n",
            "Parts C and D, respectively. To receive a Part C and/or Part D summary rating, a contract must meet the \n",
            "minimum number of rated measures. The Parts C and D improvement measures are not included in the count of \n",
            "the minimum number of rated measures. The minimum number of rated measures required is determined as \n",
            "follows:\n"
          ]
        }
      ],
      "source": [
        "print(pdf_pages[18])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "sD4yTh2FTUFa",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 35
        },
        "outputId": "4424ade9-b2fe-421e-8546-52e7491ffb0f"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'What is clustering?'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 34
        }
      ],
      "source": [
        "#Keeping Questions the same\n",
        "question1 = Question1[0]\n",
        "question2 = Question2[0]\n",
        "question3 = Question3[0]\n",
        "question4 = Question4[0]\n",
        "question5 = Question5[0]\n",
        "question5"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#Question 1 paragraph\n",
        "a1 = [top_3_indices1[0]]\n",
        "a1\n",
        "paragraph1 = Df1[a1[0]]\n",
        "print(paragraph1,'/n')\n",
        "\n",
        "#Question 2 paragraph\n",
        "a2 = [top_3_indices2[0]]\n",
        "a2\n",
        "paragraph2 = Df1[a2[0]]\n",
        "print(paragraph2,'/n')\n",
        "\n",
        "#Question 3 paragraph\n",
        "a3 = [top_3_indices3[0]]\n",
        "a3\n",
        "paragraph3 = Df1[a3[0]]\n",
        "print(paragraph3,'/n')\n",
        "\n",
        "#Question 4 paragraph\n",
        "a4 = [top_3_indices4[0]]\n",
        "a4\n",
        "paragraph4 = Df1[a4[0]]\n",
        "print(paragraph4,'/n')\n",
        "\n",
        "#Question 5 paragraph\n",
        "a5 = [top_3_indices5[0]]\n",
        "a5\n",
        "paragraph5 = Df1[a5[0]]\n",
        "print(paragraph5, '/n')"
      ],
      "metadata": {
        "id": "PzkU4BEBCy71",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "4637ef37-c6d8-4577-b913-8520e10f6412"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "(Last Updated 10/03/2024)  \n",
            "Page 170 \n",
            " \n",
            "Attachment O: Methodology for the Puerto Rico Model \n",
            "Puerto Rico has a unique health care market with a large percentage of low-income individuals in both \n",
            "Medicare and Medicaid and a complex legal history that affects the health care system in many ways. Puerto \n",
            "Rican beneficiaries are not eligible for LIS. The categorization of contracts into final adjustment categories for \n",
            "the Categorical Adjustment Index (CAI) relies on both the use of a contract’s percentages of beneficiaries with \n",
            "Low Income Subsidy/Dual Eligible (LIS/DE) and disabled beneficiaries.  Since the percentage of LIS/DE is a \n",
            "critical element in the categorization of contracts to identify the contract’s CAI, an additional adjustment is \n",
            "done for contracts that solely serve the population of beneficiaries in Puerto Rico to address the lack of LIS. The \n",
            "additional analysis for the adjustment results in a modified percentage of LIS/DE beneficiaries that is \n",
            "subsequently used to categorize the contract in its final adjustment category for the CAI. \n",
            " \n",
            "The contract-level modified LIS/DE percentages for Puerto Rico contracts for the 2025 Star Ratings are \n",
            "developed using the following sources of information: \n",
            " The 2022 1-year American Community Survey (ACS) estimates for the percentage of people living \n",
            "below the Federal Poverty Level (FPL). \n",
            " The 2022 ACS 5-year estimates for the percentage of people living below 150% of the FPL; for Puerto \n",
            "Rico and for the 10 poorest US states (which may include the District of Columbia). \n",
            " The Medicare enrollment data file for those enrolled during 2023 provided for beneficiaries who were \n",
            "alive at least through December 2023, the percentage of each contract’s beneficiaries who were DE, and \n",
            "for non-Puerto Rico contracts, the percentage who were LIS/DE. Beneficiary DE status was determined \n",
            "using a) the monthly beneficiary dual status codes, b) identification of Low Income Part D enrollees \n",
            "who reside in the US Territories, and c) beneficiaries with Medicaid coverage/who are Medicaid eligible \n",
            "by the Point of Sale contractor. For non-Puerto Rico contracts, beneficiaries who were LIS were \n",
            "determined using the monthly beneficiary LIS status codes, and beneficiaries were classified LIS/DE by \n",
            "combining the beneficiaries identified as DE and beneficiaries identified as LIS. \n",
            "The following steps are employed to determine the modified percentages of LIS/DE for MA contracts solely \n",
            "serving the population of beneficiaries in Puerto Rico. All references to contracts in Puerto Rico are limited to \n",
            "the contracts solely serving the population of beneficiaries in Puerto Rico. \n",
            " The 10 states with the highest proportion of people living below the FPL are identified, based on 2022 \n",
            "1-year data from ACS \n",
            "(https://www.census.gov/content/dam/Census/library/publications/2023/acs/acsbr-016.pdf, see Table 1). \n",
            "The states identified are: Alabama, Arkansas, Kentucky, Louisiana, Mississippi, New Mexico, New York, \n",
            "Oklahoma, South Carolina, and West Virginia. \n",
            " Data are aggregated from Medicare Advantage contracts that had at least 90% of their beneficiaries \n",
            "enrolled with mailing addresses within the 10 highest poverty states identified in step (1). \n",
            "For the 2025 Star Ratings adjustment, the data used for the model development included a total of 150 \n",
            "Medicare Advantage contracts with at least 90% of their beneficiaries with mailing addresses in one of \n",
            "the ten poorest states listed above. \n",
            " A linear regression model is developed using the known LIS/DE percentage and the corresponding DE \n",
            "percentage from the MA contracts in the 10 highest poverty states with at least 90% of their \n",
            "beneficiaries with mailing addresses in one of the ten states. \n",
            " \n",
            "The model for Puerto Rico is developed using the model in step (3) as its base. \n",
            " \n",
            "The estimated slope from the linear fit in the previous step (3) is retained to approximate the expected /n\n",
            "(Last Updated 10/03/2024)  \n",
            "Page 30 \n",
            " \n",
            "Part C Domain and Measure Details \n",
            "See Attachment C for the national averages of individual Part C measures. \n",
            "Domain: 1 - Staying Healthy: Screenings, Tests and Vaccines \n",
            "Measure: C01 - Breast Cancer Screening \n",
            "Title \n",
            "Description \n",
            "Label for Stars: Breast Cancer Screening \n",
            "Label for Data: Breast Cancer Screening \n",
            "Description: Percent of female plan members aged 52-74 who had a mammogram during the past \n",
            "two years. \n",
            "HEDIS Label: Breast Cancer Screening (BCS) \n",
            "Measure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 606 \n",
            "Metric: The percentage of women MA enrollees 50 to 74 years of age (denominator) as of \n",
            "December 31 of the measurement year who had a mammogram to screen for breast \n",
            "cancer in the past two years (numerator). \n",
            "Primary Data Source: HEDIS \n",
            "Data Source Category: Health and Drug Plans \n",
            "Exclusions: • Members in hospice or using hospice services any time during the measurement \n",
            "period. \n",
            "• Members receiving palliative care any time during the measurement period. \n",
            "• Medicare members 66 years of age and older as of December 31 of the measurement \n",
            "year who meet either of the following: \n",
            "– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \n",
            "– Living long-term in an institution any time during the measurement year as identified \n",
            "by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \n",
            "to determine if a member had an LTI flag during the measurement year. \n",
            "• Members 66 years of age and older as of December 31 of the measurement year with \n",
            "frailty and advanced illness during the measurement year. Members must meet BOTH \n",
            "of the following frailty and advanced illness criteria to be excluded: \n",
            "– At least two indications of frailty with different dates of service during the \n",
            "measurement period. \n",
            "– At least two outpatient visits, observation visits, ED visits, telephone visits, e-visits or \n",
            "virtual check-ins, or nonacute inpatient encounters or nonacute inpatient discharges on \n",
            "different dates of service, with an advanced illness diagnosis. Visit type need not be the \n",
            "same for the two visits.  \n",
            "• Members receiving palliative care during the measurement year \n",
            "• Members who had a bilateral mastectomy or both right and left unilateral \n",
            "mastectomies any time during the member’s history through December 31 of the \n",
            "measurement year. Any of the following meet criteria for bilateral mastectomy: \n",
            "– Bilateral mastectomy.  \n",
            "– Unilateral mastectomy with a bilateral modifier (same procedure). \n",
            "– Two unilateral mastectomies found in clinical data with a bilateral modifier (same \n",
            "procedure). /n\n",
            "(Last Updated 10/03/2024)  \n",
            "Page 48 \n",
            " \n",
            "Measure: C11 - Controlling Blood Pressure \n",
            "Title \n",
            "Description \n",
            "Label for Stars: Controlling Blood Pressure \n",
            "Label for Data: Controlling Blood Pressure \n",
            "Description: Percent of plan members with high blood pressure who got treatment and were able to \n",
            "maintain a healthy pressure. \n",
            "HEDIS Label: Controlling High Blood Pressure (CBP) \n",
            "Measure Reference: NCQA HEDIS MY 2023 Technical Specifications Volume 2, page 152 \n",
            "Metric: The percentage of MA members 18–85 years of age who had a diagnosis of \n",
            "hypertension (HTN) (denominator) and whose blood pressure (BP) was adequately \n",
            "controlled (<140/90 mm Hg) (numerator). \n",
            "Primary Data Source: HEDIS \n",
            "Data Source Category: Health and Drug Plans \n",
            "Exclusions: Exclude members who meet any of the following criteria: \n",
            "• Members 66 years of age and older as of December 31 of the measurement year who \n",
            "meet either of the following: \n",
            "– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \n",
            "– Living long-term in an institution any time during the measurement year as identified \n",
            "by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \n",
            "to determine if a member had an LTI flag during the measurement year. \n",
            "• Members 81 years of age and older as of December 31 of the measurement year with \n",
            "at least two indications of frailty with different dates of service during the measurement \n",
            "year. \n",
            "• Members 66–80 years of age and older as of December 31 of the measurement year \n",
            "with frailty and advanced illness. Members must meet both of the following frailty and \n",
            "advanced illness criteria to be excluded: \n",
            "• \n",
            "At least two indications of frailty with different dates of service during the \n",
            "measurement year.  \n",
            "• \n",
            "Any of the following during the measurement year or the year prior to the \n",
            "measurement year (count services that occur over both years): \n",
            "• \n",
            "At least two outpatient visits, observation visits, ED visits, \n",
            "telephone visits, e-visits or virtual check-ins, nonacute inpatient \n",
            "encounters, or nonacute inpatient discharges on different dates \n",
            "of service, with an advanced illness diagnosis.  \n",
            "• \n",
            "At least one acute inpatient encounter with an advanced illness \n",
            "diagnosis. \n",
            "• \n",
            "At least one acute inpatient discharge with an advanced illness \n",
            "diagnosis on the discharge claim.  \n",
            "• \n",
            "A dispensed dementia medication. \n",
            "  \n",
            "• (Required) Exclude members who meet any of the following criteria: \n",
            " \n",
            "– • Members with evidence of end-stage renal /n\n",
            "(Last Updated 10/03/2024)  \n",
            "Page 126 \n",
            " \n",
            "Attachment I: Calculating the Improvement Measure and the Measures Used \n",
            "Calculating the Improvement Measure \n",
            "Contracts must have data for at least half of the attainment measures used to calculate the Part C or Part D \n",
            "improvement measure to be eligible to receive a rating in that improvement measure. \n",
            "The improvement change score was determined for each measure for which a contract was eligible by \n",
            "calculating the difference in measure scores between Star Rating years 2024 and 2025.  \n",
            "For measures where a higher score is better: \n",
            "Improvement Change Score = Score in 2025 - Score in 2024 \n",
            "For measures where a lower score is better: \n",
            "Improvement Change Score = Score in 2024 - Score in 2025 \n",
            "An eligible measure was defined as a measure for which a contract was scored in both the 2024 and 2025 Star \n",
            "Ratings, and there were no significant measure specification changes or a regional contract reconfiguration for \n",
            "which only contract data is available from the original contract in one or both years. \n",
            "For each measure, significant improvement or decline between Star Ratings years 2024 and 2025 was \n",
            "determined by a two-sided t-test at the 0.05 significance level: \n",
            "If \n",
            "Improvement Change Score\n",
            "Standard Error of Improvement Change Score  > 1.96, then YES = significant improvement \n",
            "If \n",
            "Improvement Change Score\n",
            "Standard Error of Improvement Change Score  < -1.96, then YES = significant decline \n",
            "Hold Harmless Provision for Individual Measures: If a contract demonstrated statistically significant decline (at \n",
            "the 0.05 significance level) on an attainment measure for which they received five stars during both the current \n",
            "contract year and the prior contract year, then this measure will be counted as showing no significant change. \n",
            "Measures that are held harmless as described here will be considered eligible for the improvement measure. \n",
            "Net improvement is calculated for each class of measures (e.g., outcome, access, and process) by subtracting the \n",
            "number of significantly declined measures from the number of significantly improved measures. \n",
            "Net Improvement = Number of significantly improved measures - Number of significantly declined measures \n",
            "The improvement measure score is calculated for Parts C and D separately by taking a weighted sum of net \n",
            "improvement divided by the weighted sum of the number of eligible measures. \n",
            "Measures are generally weighted as follows: \n",
            "Outcome or intermediate outcome measure: Weight of 3 \n",
            "Access or patient experience/complaints measure: Weight of 4 \n",
            "Process measure: Weight of 1 \n",
            "Specific weights for each measure, which may deviate from the general scheme above are described in \n",
            "Attachment G. When the weight of an individual measure changes over the two years of data used, the newer \n",
            "weight value is used in the improvement calculation. \n",
            "Improvement Measure Score = Net_Imp_Process + 3 * Net_Imp_Outcome + 4 * Net_Imp_PtExp\n",
            "Elig_Process  + 3 * Elig_Outcome + 4 * Elig_PtExp /n\n",
            "(Last Updated 10/03/2024)  \n",
            "Page 143 \n",
            " \n",
            "Attachment K: Individual Measure Star Assignment Process \n",
            "This attachment provides detailed information about the clustering and the relative distribution and significance \n",
            "testing (CAHPS) methodologies used to assign stars to individual measures. \n",
            "Clustering Methodology Introduction \n",
            "To separate a distribution of scores into distinct groups or categories, a set of values must be identified to \n",
            "separate one group from another group. The set of values that break the distribution of the scores into non-\n",
            "overlapping groups is the set of cut points. \n",
            "For each individual measure, CMS determines the measure cut points using the information provided from the \n",
            "hierarchical clustering algorithm in SAS, described in “Clustering Methodology Detail” below. Conceptually, \n",
            "the clustering algorithm identifies the natural gaps that exist within the distribution of the scores and creates \n",
            "groups (clusters) that are then used to identify the cut points that result in the creation of a pre-specified number \n",
            "of categories. \n",
            "For Star Ratings, the algorithm is run with the goal of determining the four cut points (labeled in the Figure J-1 \n",
            "below as A, B, C, and D) that are used to create the five non-overlapping groups that correspond to each of the \n",
            "Star Ratings (labeled in the diagram below as G1, G2, G3, G4, and G5). For Part D measures, CMS determines \n",
            "MA-PD and PDP cut points separately. Data identified to be biased, erroneous, or excluded by disaster rules are \n",
            "removed from the algorithm. The scores are grouped such that scores within the same Star Rating category are \n",
            "as similar as possible, and scores in different categories are as different as possible.  \n",
            " \n",
            "Figure K-1: Diagram showing gaps in data where cut points are assigned. \n",
            " \n",
            "As mentioned, the cut points are used to create five non-overlapping groups. The value of the lower bound for \n",
            "each group is included in the category, while the value of the upper bound is not included in the category. CMS \n",
            "does not require the same number of observations (contracts) within each group. The groups are identified such \n",
            "that within a group the measure scores must be similar to each other and between groups, the measure scores in \n",
            "one group are not similar to measure scores in another group. The groups are then used for the conversion of the \n",
            "measure scores to one of five Star Ratings categories. For most measures, a higher score is better, and thus, the \n",
            "group with the highest range of measure scores is converted to a rating of five stars. An example of a measure \n",
            "for which higher is better is Medication Adherence for Diabetes Medications. For some measures a lower score \n",
            "is better, and thus, the group with the lowest range of measure scores is converted to a rating of five stars. An \n",
            "example of a measure for which a lower score is better is Members Choosing to Leave the Plan. \n",
            "Example 1 – Clustering Methodology for a Higher is Better measure \n",
            "Consider the information provided for the cut points for Medication Adherence for Diabetes Medications in \n",
            "Table K-1 below. As stated previously, for Part D measures CMS calculates MA-PD and PDP cut points \n",
            "separately (e.g., different cut points are calculated for MA-PD and PDPs). If the MA-PD cut points identified \n",
            "using the clustering algorithm are 80%, 85%, 87%, and 91%; for PDPs, the cut points are 84%, 86%, 88%, and \n",
            "90%. (The set of values corresponds to the cut points in figure J-2 below as A, B, C, and D and the categories \n",
            "for each of the five Star Ratings are indicated above each group.) Since a measure score can only assume a \n",
            "value between 0% and 100% (including 0% and 100%), the one-star and five-star categories contain only a \n",
            "single value in the table below as the upper or lower bound. /n\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "YTYk_RmA3KtO",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000,
          "referenced_widgets": [
            "135e00d295624fd2acbaac4af4647d4c",
            "dc3927c261ea48749c52d43a697dc2d1",
            "05b1e85aa60d4e1da891789e7bc53fd4",
            "d311d54acf5e4592aa2f5ce42cc5666f",
            "c3505c8cdb544b21969e1b5163336699",
            "eb7639f506434a3783dc70809913ef13",
            "532a0b16518342c09b8eb1960a78e85a",
            "f38ae76a4cf445c7b1341c3d8d19c3cd",
            "4ec67c7661184459810887800c93a2e6",
            "6af3901a492d4d42815726e20cdd345c",
            "a026d09e1c154135acda1087da3b4ef0",
            "b55eff533c334e318afd661f2bc662a4",
            "658748d51471418a9b3f60e1179055a5",
            "65ff6f26662349b2aed026577ba96f41",
            "ac44e368189d40cc85e29f8557e3c7c8",
            "6fb676583ce34d9bbfc689d0d09f96b0",
            "09234909dd3f49c48008068f4379075a",
            "1d7d5cdd91bf47d6849ff606c01cee85",
            "17ecb18052c04807911254b57dbe3445",
            "75c428637bd649218177673adc14def7",
            "5fac8e7d465c45269748ab49ca2dd9b6",
            "3406021b60ee425497e9b9973a4b210a",
            "0c0c2b49ef1540a992a5dd66c4acff3c",
            "a242de1f3b3c49d2a2174ac038368ebd",
            "0ba05c9c596c454c96c35feedbfe6468",
            "8fcc444f457d4c54a7b34a824a46b979",
            "c0e4800051614838a6e9f5b718028154",
            "fa5ad01504714bef8360bdca9b1eac27",
            "ad8e9eee7ccd4df3bb11008c4d3e3004",
            "d347b8a449ea47a49736af1145afef0b",
            "f443ef9c979a48a3a818b91c9fc70fa8",
            "5d13193f7f4b44e990b42b211d540a5e",
            "c42eeeb99e164df6ba2a749fab4b7512",
            "426837ca6bad455f8f329920581c802d",
            "08616118b4a343468658651a2a5033a9",
            "9055efa1c2d64fce864edfe6a2e8706c",
            "3882970cc90b4014930ab29398d8b803",
            "56fd5785e1e14a60b9492f99e0322d8d",
            "317140a3fbb84b0591d46a92e0f99cb3",
            "22502594ec2f443391c20fd71dd40fea",
            "87421280f05c479b9a0efcd29d9d9ea2",
            "5cf6082f1cfb48c39ea88d04e3e106ce",
            "4ff4dd868ba64ee390773ed7924e94d7",
            "b860401095854ed19fe117705cc5e4f5",
            "90d8f3276576478695e06b6309620099",
            "f1a49c9131f6403db417a9d6c1da30c8",
            "3c81d8cc41ab40e28c1daba3aed0a667",
            "f56895ccdb414ba8a354077e9d8865c4",
            "c0472434352846548a190718e9caffcc",
            "d69a2156c8ea467fb99793605e83f24f",
            "1041152817a248f88ee9ccf10ff0839d",
            "b2589df4e1054af3bf3cba09e146966e",
            "07f1b0dd3c9149d4890be8bb0ae76ac1",
            "d4d48944fad24214b08a627dac47c834",
            "b7844a0133f041e381f1e9de304c3752",
            "9fddc27a4d864521bf6e0f65f9edddf5",
            "666e3ddeb79d41afb94c97b9e46b07fc",
            "09cf4c8de883493a9ef16d052b004662",
            "a251d9502d4b498383c31fd76166feea",
            "99a2f6b49acc4f1dbd5bcbc89e227e77",
            "94def7309ed74ac7845973d7bdedd37d",
            "07f6909b72064c5c8cd742f3490cc482",
            "3161ae462bee4a45af0d5afb20461fec",
            "f0c7c05a9f21438aa7a5def6e8e989d4",
            "f147f68c8db34959b58222a3f028ca11",
            "a0714798288f4b939a4fb0132499bee0"
          ]
        },
        "outputId": "3de543a9-a8df-40c4-febf-9f769cfdd4fa"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "config.json:   0%|          | 0.00/571 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "135e00d295624fd2acbaac4af4647d4c"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "model.safetensors:   0%|          | 0.00/496M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "b55eff533c334e318afd661f2bc662a4"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer_config.json:   0%|          | 0.00/79.0 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "0c0c2b49ef1540a992a5dd66c4acff3c"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "vocab.json:   0%|          | 0.00/899k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "426837ca6bad455f8f329920581c802d"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "merges.txt:   0%|          | 0.00/456k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "90d8f3276576478695e06b6309620099"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "special_tokens_map.json:   0%|          | 0.00/772 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "9fddc27a4d864521bf6e0f65f9edddf5"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "What is (CAI)? /n\n",
            " Categorical Adjustment Index\n",
            "\n",
            " (Last Updated 10/03/2024)  \n",
            "Page 170 \n",
            " \n",
            "Attachment O: Methodology for the Puerto Rico Model \n",
            "Puerto Rico has a unique health care market with a large percentage of low-income individuals in both \n",
            "Medicare and Medicaid and a complex legal history that affects the health care system in many ways. Puerto \n",
            "Rican beneficiaries are not eligible for LIS. The categorization of contracts into final adjustment categories for \n",
            "the Categorical Adjustment Index (CAI) relies on both the use of a contract’s percentages of beneficiaries with \n",
            "Low Income Subsidy/Dual Eligible (LIS/DE) and disabled beneficiaries.  Since the percentage of LIS/DE is a \n",
            "critical element in the categorization of contracts to identify the contract’s CAI, an additional adjustment is \n",
            "done for contracts that solely serve the population of beneficiaries in Puerto Rico to address the lack of LIS. The \n",
            "additional analysis for the adjustment results in a modified percentage of LIS/DE beneficiaries that is \n",
            "subsequently used to categorize the contract in its final adjustment category for the CAI. \n",
            " \n",
            "The contract-level modified LIS/DE percentages for Puerto Rico contracts for the 2025 Star Ratings are \n",
            "developed using the following sources of information: \n",
            " The 2022 1-year American Community Survey (ACS) estimates for the percentage of people living \n",
            "below the Federal Poverty Level (FPL). \n",
            " The 2022 ACS 5-year estimates for the percentage of people living below 150% of the FPL; for Puerto \n",
            "Rico and for the 10 poorest US states (which may include the District of Columbia). \n",
            " The Medicare enrollment data file for those enrolled during 2023 provided for beneficiaries who were \n",
            "alive at least through December 2023, the percentage of each contract’s beneficiaries who were DE, and \n",
            "for non-Puerto Rico contracts, the percentage who were LIS/DE. Beneficiary DE status was determined \n",
            "using a) the monthly beneficiary dual status codes, b) identification of Low Income Part D enrollees \n",
            "who reside in the US Territories, and c) beneficiaries with Medicaid coverage/who are Medicaid eligible \n",
            "by the Point of Sale contractor. For non-Puerto Rico contracts, beneficiaries who were LIS were \n",
            "determined using the monthly beneficiary LIS status codes, and beneficiaries were classified LIS/DE by \n",
            "combining the beneficiaries identified as DE and beneficiaries identified as LIS. \n",
            "The following steps are employed to determine the modified percentages of LIS/DE for MA contracts solely \n",
            "serving the population of beneficiaries in Puerto Rico. All references to contracts in Puerto Rico are limited to \n",
            "the contracts solely serving the population of beneficiaries in Puerto Rico. \n",
            " The 10 states with the highest proportion of people living below the FPL are identified, based on 2022 \n",
            "1-year data from ACS \n",
            "(https://www.census.gov/content/dam/Census/library/publications/2023/acs/acsbr-016.pdf, see Table 1). \n",
            "The states identified are: Alabama, Arkansas, Kentucky, Louisiana, Mississippi, New Mexico, New York, \n",
            "Oklahoma, South Carolina, and West Virginia. \n",
            " Data are aggregated from Medicare Advantage contracts that had at least 90% of their beneficiaries \n",
            "enrolled with mailing addresses within the 10 highest poverty states identified in step (1). \n",
            "For the 2025 Star Ratings adjustment, the data used for the model development included a total of 150 \n",
            "Medicare Advantage contracts with at least 90% of their beneficiaries with mailing addresses in one of \n",
            "the ten poorest states listed above. \n",
            " A linear regression model is developed using the known LIS/DE percentage and the corresponding DE \n",
            "percentage from the MA contracts in the 10 highest poverty states with at least 90% of their \n",
            "beneficiaries with mailing addresses in one of the ten states. \n",
            " \n",
            "The model for Puerto Rico is developed using the model in step (3) as its base. \n",
            " \n",
            "The estimated slope from the linear fit in the previous step (3) is retained to approximate the expected\n"
          ]
        }
      ],
      "source": [
        "from transformers import AutoTokenizer, AutoModelForQuestionAnswering\n",
        "import torch\n",
        "\n",
        "model = AutoModelForQuestionAnswering.from_pretrained(\"deepset/roberta-base-squad2\")\n",
        "tokenizer = AutoTokenizer.from_pretrained(\"deepset/roberta-base-squad2\")\n",
        "\n",
        "from transformers import AutoTokenizer, AutoModelForQuestionAnswering\n",
        "import torch\n",
        "\n",
        "model = AutoModelForQuestionAnswering.from_pretrained(\"deepset/roberta-base-squad2\")\n",
        "tokenizer = AutoTokenizer.from_pretrained(\"deepset/roberta-base-squad2\")\n",
        "# Answer for question 1\n",
        "question = question1 # Added a question for demonstration. Replace with your actual question variable.\n",
        "context = paragraph1 # Added a context for demonstration. Replace with your actual context variable.\n",
        "inputs = tokenizer(question, context, return_tensors=\"pt\", truncation=True, max_length=512)\n",
        "with torch.no_grad():\n",
        "    outputs = model(**inputs)\n",
        "\n",
        "answer_start_index = outputs.start_logits.argmax()\n",
        "answer_end_index = outputs.end_logits.argmax()\n",
        "\n",
        "answer_tokens = inputs.input_ids[0, answer_start_index : answer_end_index + 1]\n",
        "print(question, \"/n\")\n",
        "print(tokenizer.decode(answer_tokens))\n",
        "print('\\n',paragraph1)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# answer for question 2\n",
        "question = question2 # Added a question for demonstration. Replace with your actual question variable.\n",
        "context = paragraph2 # Added a context for demonstration. Replace with your actual context variable.\n",
        "inputs = tokenizer(question, context, return_tensors=\"pt\", truncation=True, max_length=512)\n",
        "with torch.no_grad():\n",
        "    outputs = model(**inputs)\n",
        "\n",
        "answer_start_index = outputs.start_logits.argmax()\n",
        "answer_end_index = outputs.end_logits.argmax()\n",
        "\n",
        "answer_tokens = inputs.input_ids[0, answer_start_index : answer_end_index + 1]\n",
        "print(question, \"/n\")\n",
        "print(tokenizer.decode(answer_tokens))\n",
        "print('\\n',paragraph2)"
      ],
      "metadata": {
        "id": "4XYyWRGHkeHX",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "c52d5d6b-d36c-4ed8-b952-e8eb1c8b64af"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "What is BCS, describe what BCS stand for? or What measure it is? /n\n",
            " Breast Cancer Screening\n",
            "\n",
            " (Last Updated 10/03/2024)  \n",
            "Page 30 \n",
            " \n",
            "Part C Domain and Measure Details \n",
            "See Attachment C for the national averages of individual Part C measures. \n",
            "Domain: 1 - Staying Healthy: Screenings, Tests and Vaccines \n",
            "Measure: C01 - Breast Cancer Screening \n",
            "Title \n",
            "Description \n",
            "Label for Stars: Breast Cancer Screening \n",
            "Label for Data: Breast Cancer Screening \n",
            "Description: Percent of female plan members aged 52-74 who had a mammogram during the past \n",
            "two years. \n",
            "HEDIS Label: Breast Cancer Screening (BCS) \n",
            "Measure Reference: NCQA HEDIS Measurement Year 2023 Technical Specifications Volume 2, page 606 \n",
            "Metric: The percentage of women MA enrollees 50 to 74 years of age (denominator) as of \n",
            "December 31 of the measurement year who had a mammogram to screen for breast \n",
            "cancer in the past two years (numerator). \n",
            "Primary Data Source: HEDIS \n",
            "Data Source Category: Health and Drug Plans \n",
            "Exclusions: • Members in hospice or using hospice services any time during the measurement \n",
            "period. \n",
            "• Members receiving palliative care any time during the measurement period. \n",
            "• Medicare members 66 years of age and older as of December 31 of the measurement \n",
            "year who meet either of the following: \n",
            "– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \n",
            "– Living long-term in an institution any time during the measurement year as identified \n",
            "by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \n",
            "to determine if a member had an LTI flag during the measurement year. \n",
            "• Members 66 years of age and older as of December 31 of the measurement year with \n",
            "frailty and advanced illness during the measurement year. Members must meet BOTH \n",
            "of the following frailty and advanced illness criteria to be excluded: \n",
            "– At least two indications of frailty with different dates of service during the \n",
            "measurement period. \n",
            "– At least two outpatient visits, observation visits, ED visits, telephone visits, e-visits or \n",
            "virtual check-ins, or nonacute inpatient encounters or nonacute inpatient discharges on \n",
            "different dates of service, with an advanced illness diagnosis. Visit type need not be the \n",
            "same for the two visits.  \n",
            "• Members receiving palliative care during the measurement year \n",
            "• Members who had a bilateral mastectomy or both right and left unilateral \n",
            "mastectomies any time during the member’s history through December 31 of the \n",
            "measurement year. Any of the following meet criteria for bilateral mastectomy: \n",
            "– Bilateral mastectomy.  \n",
            "– Unilateral mastectomy with a bilateral modifier (same procedure). \n",
            "– Two unilateral mastectomies found in clinical data with a bilateral modifier (same \n",
            "procedure).\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# answer for question 3\n",
        "question = question3 # Added a question for demonstration. Replace with your actual question variable.\n",
        "context = paragraph3 # Added a context for demonstration. Replace with your actual context variable.\n",
        "inputs = tokenizer(question, context, return_tensors=\"pt\", truncation=True, max_length=512)\n",
        "with torch.no_grad():\n",
        "    outputs = model(**inputs)\n",
        "\n",
        "answer_start_index = outputs.start_logits.argmax()\n",
        "answer_end_index = outputs.end_logits.argmax()\n",
        "\n",
        "answer_tokens = inputs.input_ids[0, answer_start_index : answer_end_index + 1]\n",
        "print(question, \"/n\")\n",
        "print(tokenizer.decode(answer_tokens))\n",
        "print('\\n',paragraph3)"
      ],
      "metadata": {
        "id": "ATu9nhwSqUGf",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "20ecc61d-bb64-41b5-d219-bede509c1002"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "CBP calculation? /n\n",
            "<s>\n",
            "\n",
            " (Last Updated 10/03/2024)  \n",
            "Page 48 \n",
            " \n",
            "Measure: C11 - Controlling Blood Pressure \n",
            "Title \n",
            "Description \n",
            "Label for Stars: Controlling Blood Pressure \n",
            "Label for Data: Controlling Blood Pressure \n",
            "Description: Percent of plan members with high blood pressure who got treatment and were able to \n",
            "maintain a healthy pressure. \n",
            "HEDIS Label: Controlling High Blood Pressure (CBP) \n",
            "Measure Reference: NCQA HEDIS MY 2023 Technical Specifications Volume 2, page 152 \n",
            "Metric: The percentage of MA members 18–85 years of age who had a diagnosis of \n",
            "hypertension (HTN) (denominator) and whose blood pressure (BP) was adequately \n",
            "controlled (<140/90 mm Hg) (numerator). \n",
            "Primary Data Source: HEDIS \n",
            "Data Source Category: Health and Drug Plans \n",
            "Exclusions: Exclude members who meet any of the following criteria: \n",
            "• Members 66 years of age and older as of December 31 of the measurement year who \n",
            "meet either of the following: \n",
            "– Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. \n",
            "– Living long-term in an institution any time during the measurement year as identified \n",
            "by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file \n",
            "to determine if a member had an LTI flag during the measurement year. \n",
            "• Members 81 years of age and older as of December 31 of the measurement year with \n",
            "at least two indications of frailty with different dates of service during the measurement \n",
            "year. \n",
            "• Members 66–80 years of age and older as of December 31 of the measurement year \n",
            "with frailty and advanced illness. Members must meet both of the following frailty and \n",
            "advanced illness criteria to be excluded: \n",
            "• \n",
            "At least two indications of frailty with different dates of service during the \n",
            "measurement year.  \n",
            "• \n",
            "Any of the following during the measurement year or the year prior to the \n",
            "measurement year (count services that occur over both years): \n",
            "• \n",
            "At least two outpatient visits, observation visits, ED visits, \n",
            "telephone visits, e-visits or virtual check-ins, nonacute inpatient \n",
            "encounters, or nonacute inpatient discharges on different dates \n",
            "of service, with an advanced illness diagnosis.  \n",
            "• \n",
            "At least one acute inpatient encounter with an advanced illness \n",
            "diagnosis. \n",
            "• \n",
            "At least one acute inpatient discharge with an advanced illness \n",
            "diagnosis on the discharge claim.  \n",
            "• \n",
            "A dispensed dementia medication. \n",
            "  \n",
            "• (Required) Exclude members who meet any of the following criteria: \n",
            " \n",
            "– • Members with evidence of end-stage renal\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# answer for question 4\n",
        "question = 'What changed in star rating year 2025?' # Added a question for demonstration. Replace with your actual question variable.\n",
        "context = paragraph4 # Added a context for demonstration. Replace with your actual context variable.\n",
        "inputs = tokenizer(question, context, return_tensors=\"pt\", truncation=True, max_length=512)\n",
        "with torch.no_grad():\n",
        "    outputs = model(**inputs)\n",
        "\n",
        "answer_start_index = outputs.start_logits.argmax()\n",
        "answer_end_index = outputs.end_logits.argmax()\n",
        "\n",
        "answer_tokens = inputs.input_ids[0, answer_start_index : answer_end_index + 1]\n",
        "print(question, \"/n\")\n",
        "print(tokenizer.decode(answer_tokens))\n",
        "print('\\n',paragraph4)"
      ],
      "metadata": {
        "id": "gLDgpNTfqyVQ",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "41c4ac9f-569d-4d2b-9a31-768a67391cd3"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "What changed in star rating year 2025? /n\n",
            "<s>\n",
            "\n",
            " (Last Updated 10/03/2024)  \n",
            "Page 126 \n",
            " \n",
            "Attachment I: Calculating the Improvement Measure and the Measures Used \n",
            "Calculating the Improvement Measure \n",
            "Contracts must have data for at least half of the attainment measures used to calculate the Part C or Part D \n",
            "improvement measure to be eligible to receive a rating in that improvement measure. \n",
            "The improvement change score was determined for each measure for which a contract was eligible by \n",
            "calculating the difference in measure scores between Star Rating years 2024 and 2025.  \n",
            "For measures where a higher score is better: \n",
            "Improvement Change Score = Score in 2025 - Score in 2024 \n",
            "For measures where a lower score is better: \n",
            "Improvement Change Score = Score in 2024 - Score in 2025 \n",
            "An eligible measure was defined as a measure for which a contract was scored in both the 2024 and 2025 Star \n",
            "Ratings, and there were no significant measure specification changes or a regional contract reconfiguration for \n",
            "which only contract data is available from the original contract in one or both years. \n",
            "For each measure, significant improvement or decline between Star Ratings years 2024 and 2025 was \n",
            "determined by a two-sided t-test at the 0.05 significance level: \n",
            "If \n",
            "Improvement Change Score\n",
            "Standard Error of Improvement Change Score  > 1.96, then YES = significant improvement \n",
            "If \n",
            "Improvement Change Score\n",
            "Standard Error of Improvement Change Score  < -1.96, then YES = significant decline \n",
            "Hold Harmless Provision for Individual Measures: If a contract demonstrated statistically significant decline (at \n",
            "the 0.05 significance level) on an attainment measure for which they received five stars during both the current \n",
            "contract year and the prior contract year, then this measure will be counted as showing no significant change. \n",
            "Measures that are held harmless as described here will be considered eligible for the improvement measure. \n",
            "Net improvement is calculated for each class of measures (e.g., outcome, access, and process) by subtracting the \n",
            "number of significantly declined measures from the number of significantly improved measures. \n",
            "Net Improvement = Number of significantly improved measures - Number of significantly declined measures \n",
            "The improvement measure score is calculated for Parts C and D separately by taking a weighted sum of net \n",
            "improvement divided by the weighted sum of the number of eligible measures. \n",
            "Measures are generally weighted as follows: \n",
            "Outcome or intermediate outcome measure: Weight of 3 \n",
            "Access or patient experience/complaints measure: Weight of 4 \n",
            "Process measure: Weight of 1 \n",
            "Specific weights for each measure, which may deviate from the general scheme above are described in \n",
            "Attachment G. When the weight of an individual measure changes over the two years of data used, the newer \n",
            "weight value is used in the improvement calculation. \n",
            "Improvement Measure Score = Net_Imp_Process + 3 * Net_Imp_Outcome + 4 * Net_Imp_PtExp\n",
            "Elig_Process  + 3 * Elig_Outcome + 4 * Elig_PtExp\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# answer for question 5\n",
        "question = question5 # Added a question for demonstration. Replace with your actual question variable.\n",
        "context = paragraph5 # Added a context for demonstration. Replace with your actual context variable.\n",
        "inputs = tokenizer(question, context, return_tensors=\"pt\", truncation=True, max_length=512)\n",
        "with torch.no_grad():\n",
        "    outputs = model(**inputs)\n",
        "\n",
        "answer_start_index = outputs.start_logits.argmax()\n",
        "answer_end_index = outputs.end_logits.argmax()\n",
        "\n",
        "answer_tokens = inputs.input_ids[0, answer_start_index : answer_end_index + 1]\n",
        "print(question, \"/n\")\n",
        "print(tokenizer.decode(answer_tokens))\n",
        "print('\\n',paragraph5)"
      ],
      "metadata": {
        "id": "cMVCaspGq7Ig",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "7ff4617d-d201-4cc5-8adb-dbd960699c9a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "What is clustering? /n\n",
            "<s>What is clustering?</s></s>(Last Updated 10/03/2024)  \n",
            "Page 143 \n",
            " \n",
            "Attachment K: Individual Measure Star Assignment Process \n",
            "This attachment provides detailed information about the clustering and the relative distribution and significance \n",
            "testing (CAHPS) methodologies used to assign stars to individual measures. \n",
            "Clustering Methodology Introduction \n",
            "To separate a distribution of scores into distinct groups or categories, a set of values must be identified to \n",
            "separate one group from another group. The set of values that break the distribution of the scores into non-\n",
            "overlapping groups is the set of cut points. \n",
            "For each individual measure, CMS determines the measure cut points using the information provided from the \n",
            "hierarchical clustering algorithm\n",
            "\n",
            " (Last Updated 10/03/2024)  \n",
            "Page 143 \n",
            " \n",
            "Attachment K: Individual Measure Star Assignment Process \n",
            "This attachment provides detailed information about the clustering and the relative distribution and significance \n",
            "testing (CAHPS) methodologies used to assign stars to individual measures. \n",
            "Clustering Methodology Introduction \n",
            "To separate a distribution of scores into distinct groups or categories, a set of values must be identified to \n",
            "separate one group from another group. The set of values that break the distribution of the scores into non-\n",
            "overlapping groups is the set of cut points. \n",
            "For each individual measure, CMS determines the measure cut points using the information provided from the \n",
            "hierarchical clustering algorithm in SAS, described in “Clustering Methodology Detail” below. Conceptually, \n",
            "the clustering algorithm identifies the natural gaps that exist within the distribution of the scores and creates \n",
            "groups (clusters) that are then used to identify the cut points that result in the creation of a pre-specified number \n",
            "of categories. \n",
            "For Star Ratings, the algorithm is run with the goal of determining the four cut points (labeled in the Figure J-1 \n",
            "below as A, B, C, and D) that are used to create the five non-overlapping groups that correspond to each of the \n",
            "Star Ratings (labeled in the diagram below as G1, G2, G3, G4, and G5). For Part D measures, CMS determines \n",
            "MA-PD and PDP cut points separately. Data identified to be biased, erroneous, or excluded by disaster rules are \n",
            "removed from the algorithm. The scores are grouped such that scores within the same Star Rating category are \n",
            "as similar as possible, and scores in different categories are as different as possible.  \n",
            " \n",
            "Figure K-1: Diagram showing gaps in data where cut points are assigned. \n",
            " \n",
            "As mentioned, the cut points are used to create five non-overlapping groups. The value of the lower bound for \n",
            "each group is included in the category, while the value of the upper bound is not included in the category. CMS \n",
            "does not require the same number of observations (contracts) within each group. The groups are identified such \n",
            "that within a group the measure scores must be similar to each other and between groups, the measure scores in \n",
            "one group are not similar to measure scores in another group. The groups are then used for the conversion of the \n",
            "measure scores to one of five Star Ratings categories. For most measures, a higher score is better, and thus, the \n",
            "group with the highest range of measure scores is converted to a rating of five stars. An example of a measure \n",
            "for which higher is better is Medication Adherence for Diabetes Medications. For some measures a lower score \n",
            "is better, and thus, the group with the lowest range of measure scores is converted to a rating of five stars. An \n",
            "example of a measure for which a lower score is better is Members Choosing to Leave the Plan. \n",
            "Example 1 – Clustering Methodology for a Higher is Better measure \n",
            "Consider the information provided for the cut points for Medication Adherence for Diabetes Medications in \n",
            "Table K-1 below. As stated previously, for Part D measures CMS calculates MA-PD and PDP cut points \n",
            "separately (e.g., different cut points are calculated for MA-PD and PDPs). If the MA-PD cut points identified \n",
            "using the clustering algorithm are 80%, 85%, 87%, and 91%; for PDPs, the cut points are 84%, 86%, 88%, and \n",
            "90%. (The set of values corresponds to the cut points in figure J-2 below as A, B, C, and D and the categories \n",
            "for each of the five Star Ratings are indicated above each group.) Since a measure score can only assume a \n",
            "value between 0% and 100% (including 0% and 100%), the one-star and five-star categories contain only a \n",
            "single value in the table below as the upper or lower bound.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Fine-Tuned Distil-BERT Qeustion Answering"
      ],
      "metadata": {
        "id": "Upy8uQ_QdPp9"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Installing Libraries"
      ],
      "metadata": {
        "id": "i812z1OJdWo0"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "%%capture\n",
        "!pip install datasets\n"
      ],
      "metadata": {
        "id": "K5UHy5LCdPa2"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "yWUtxHqG3Koz"
      },
      "outputs": [],
      "source": [
        "%%capture\n",
        "!pip install transformers"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Import Libraries"
      ],
      "metadata": {
        "id": "Ip3v9wnOdvTt"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from transformers import DistilBertForQuestionAnswering, DistilBertTokenizerFast, \\\n",
        "                         TrainingArguments, Trainer, default_data_collator, pipeline\n",
        "from datasets import load_dataset\n",
        "import os\n",
        "os.environ[\"WANDB_DISABLED\"] = \"true\""
      ],
      "metadata": {
        "id": "Qf96R6hodrMH"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "qa_dataset = load_dataset(\"squad\")\n",
        "print(qa_dataset)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 356,
          "referenced_widgets": [
            "0984111f828c479e96cce498423428ae",
            "8449ded37e5c4c9ba977d822c0b4f039",
            "d0fb99eeac93407b972061ae30c1ea29",
            "ee052d22ac6e482eae26dcdada60426b",
            "f4551e71857545b8a184e50d55d94f56",
            "e4ddd42fe1b1441a9ab9935100e3be98",
            "5ed14a24c44e4906985743080b760706",
            "e70666f2883e4fd1842f011669b65e93",
            "8bcd6a4edb36483aad7152faadd69946",
            "6813efce668f49398dace5f210a74219",
            "0ffafad6c2a949d5a933dc36a75ab049",
            "e4b8cce137194c1b86a54d7cbe562521",
            "cc041a90122745478f92a58deeab4cd7",
            "f541518b26c740c584822cff2003b614",
            "cf6dd221e7a1444793fc3b721df66f0e",
            "c54e92174f9d4ce8b676e8934252440b",
            "f907324511f64b0ebe9cae988ed97287",
            "7d743de0e35f4067aab7ebd36be5b24c",
            "9a76c677001b46b0abc47a9ea76e5f16",
            "974c05387c8a460ca17c2fe6d11c4c8e",
            "980b51fd7f824d829b42b71991e30d5f",
            "7bad3909a2724c09855eb826d1d440d4",
            "88a7313a41984eaaa482e7f28259a4d6",
            "cdd39d6372664671a2d46938154e8948",
            "f527edc28fd84efba5a141651967e5d6",
            "07ffe9fcebf54fc683eadad798383278",
            "74c4658cbb3f4d15a11842fb69f95a51",
            "a337dfccbfed4b9da2472bbbb0f8a5eb",
            "1b6c6ad9a6754a089f63ee2ec7d42d9b",
            "8404132772974166949c8e8a063983f9",
            "589e30e058e64d9ba2c35bf1adc85a1f",
            "76a2c5bec0d24ef39330971b80de1d69",
            "9d279873556b40b5a322419ef59147af",
            "2310fc5454244d1ea8887ef8d798de1a",
            "93319ed508d94e709516ff53e8ce6bf6",
            "26ef7740e34a4eea8c7a20f2424aef80",
            "eee7ecb1d5b54bffaab1aa43389c455b",
            "de07769f914e4b7bad47b0c35fd5ed93",
            "d333e63a8c474ffaa34f83c307a36d6b",
            "576c90bc92fa46e6940ee5ee55b04904",
            "70b9a9ad2ac14a52810401f40a2c49dc",
            "1733769830ba488eb5149e17146be59a",
            "f6366c05c209486ab4d8e5ed201e5c1f",
            "3c47a2548fd540788885e3f6ce3c6290",
            "1f124606d4574aa4a77b4c1c51d21514",
            "46117bbe860f47f793894e72e08bd322",
            "7b9c6d6b5dba4f3e8dbc29118a13f2d3",
            "b0b16cc681cb4bfbaeee5285df63155f",
            "85677f194ffb438db96554be193d933a",
            "54c1442efb1f41c4beba2baec1ea1790",
            "b61393af278c458c8bde900559fb8fb8",
            "b4e7a0366b32404a8fb003aaff9e59e7",
            "f4697f0d5f664caf9c0ee99f2735424e",
            "de344f2f70c14d9fb46acb6b0b64f1a2",
            "b34d6966c1fd4514a22e4c2cf0cbac60"
          ]
        },
        "id": "D_WjjHNDdrIv",
        "outputId": "6a51cdac-9d6a-4590-ad51-605cc6f0fe59"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "README.md:   0%|          | 0.00/7.62k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "0984111f828c479e96cce498423428ae"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "train-00000-of-00001.parquet:   0%|          | 0.00/14.5M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "e4b8cce137194c1b86a54d7cbe562521"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "validation-00000-of-00001.parquet:   0%|          | 0.00/1.82M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "88a7313a41984eaaa482e7f28259a4d6"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Generating train split:   0%|          | 0/87599 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "2310fc5454244d1ea8887ef8d798de1a"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Generating validation split:   0%|          | 0/10570 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "1f124606d4574aa4a77b4c1c51d21514"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "DatasetDict({\n",
            "    train: Dataset({\n",
            "        features: ['id', 'title', 'context', 'question', 'answers'],\n",
            "        num_rows: 87599\n",
            "    })\n",
            "    validation: Dataset({\n",
            "        features: ['id', 'title', 'context', 'question', 'answers'],\n",
            "        num_rows: 10570\n",
            "    })\n",
            "})\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "qa_dataset[\"train\"][0]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "deI9V03OdrCQ",
        "outputId": "d7f217f9-b0e6-47c7-9571-1b0ea435fe47"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'id': '5733be284776f41900661182',\n",
              " 'title': 'University_of_Notre_Dame',\n",
              " 'context': 'Architecturally, the school has a Catholic character. Atop the Main Building\\'s gold dome is a golden statue of the Virgin Mary. Immediately in front of the Main Building and facing it, is a copper statue of Christ with arms upraised with the legend \"Venite Ad Me Omnes\". Next to the Main Building is the Basilica of the Sacred Heart. Immediately behind the basilica is the Grotto, a Marian place of prayer and reflection. It is a replica of the grotto at Lourdes, France where the Virgin Mary reputedly appeared to Saint Bernadette Soubirous in 1858. At the end of the main drive (and in a direct line that connects through 3 statues and the Gold Dome), is a simple, modern stone statue of Mary.',\n",
              " 'question': 'To whom did the Virgin Mary allegedly appear in 1858 in Lourdes France?',\n",
              " 'answers': {'text': ['Saint Bernadette Soubirous'], 'answer_start': [515]}}"
            ]
          },
          "metadata": {},
          "execution_count": 45
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "7tofWGSU3Keq",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 145,
          "referenced_widgets": [
            "150affca0d554509ad21948ff8b48e25",
            "1d69683eb9a542988613bc317a96d59d",
            "0ea783e83ed349478e8ac2c65972fe20",
            "6d25f51bf98a438faf89b98aae1cb204",
            "ed0c9b63015942d0ab2e346918512ab5",
            "425d1467a51d4bfb87b5417f5981f4fc",
            "3b0d99d8d71b4b2aa0bc916b2b8858b2",
            "62370e039f2b4b939dbee647c92286b9",
            "dd0f699bdc224d22a1a2e569db08c8ba",
            "21a8da6a43a7487198bbe6dd8b02c751",
            "b638a2ef295b4096a9b2905f8f173b59",
            "4dfb55b9b190405197ba016c570e7353",
            "8fdf4a32dcdc45e9bf1be06032090b9b",
            "8e0c0bfc3dee413da87b358f66e75bdf",
            "ff3ed0462e764463b089075b71bdaea4",
            "daa4115c41c54e2ebbed754b67880e76",
            "79522cd7f6a34a81910027aeb6a4e2b4",
            "ff13c0246d5843bc9a30668fa175b3d2",
            "47f2e6ed821b4f408ee4c575b05eee39",
            "7c8eae561f6348cab6a4bd72df5c0dce",
            "d9cd4610ab3c47ed98e47fbc21052404",
            "ae99cfc67a3d45c896cc0a0ae70325a0",
            "38cccdb1334c44acaaebe8b6101ed343",
            "95d36bc2bb414c8eb72b1fc6f7b7ac45",
            "cfc7a2a137c44b2d8da56d37c81bff1d",
            "2a8bbb1c504f40739daa6483c4d4ea48",
            "27cab8eee4114bf7806ddedfc533b4f5",
            "346ca0078b274ecfa62a5d18dfdebed0",
            "dc7c054f6d3f47659232e80b163677af",
            "275b65aac2cd46e1bbd66f0334eb6c94",
            "76830ba82c0a48f4aeb165ec2d05ceeb",
            "468817d0920d46bc99c4bbf01c63aeae",
            "7191924e9df84b168328c7eef8e0861a",
            "a930d8ea2c704ae590466401c0667efb",
            "c9c6ddb01d89424aa32f025a6deccdd4",
            "ac40e4b0efdc4b9a9ce912410ace6cb9",
            "1862fd253ec54637b214e68fa0cc315e",
            "c94f1e6706124c3cac92bd3605bbf325",
            "166779cee89d41f7baabd7b2b20f2684",
            "3cc2a6246b364349b90de721c52350d8",
            "2e1db4ba673e4dc5bbc6e8fdbc8c3895",
            "dd4ade68e85c406da5c2e3aca71df72e",
            "d533f2f1f0734bd19544f9cbaefe3f26",
            "575be2bc003e469eaf6eb71c77252325"
          ]
        },
        "outputId": "f2bf3066-2f9f-44fe-f5ff-ccdcadd6b042"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer_config.json:   0%|          | 0.00/48.0 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "150affca0d554509ad21948ff8b48e25"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "vocab.txt:   0%|          | 0.00/232k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "4dfb55b9b190405197ba016c570e7353"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer.json:   0%|          | 0.00/466k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "38cccdb1334c44acaaebe8b6101ed343"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "config.json:   0%|          | 0.00/483 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "a930d8ea2c704ae590466401c0667efb"
            }
          },
          "metadata": {}
        }
      ],
      "source": [
        "tokenizer = DistilBertTokenizerFast.from_pretrained(\"distilbert-base-uncased\")"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Data Preprocessing"
      ],
      "metadata": {
        "id": "AYSsrNJxetzE"
      }
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ICBCLFQa2uBE"
      },
      "outputs": [],
      "source": [
        "def prepare_train_features(examples):\n",
        "  tokenized_examples = tokenizer(\n",
        "      examples[\"question\"],\n",
        "      examples[\"context\"],\n",
        "      truncation=\"only_second\",\n",
        "      max_length=384,\n",
        "      stride=128,\n",
        "      return_overflowing_tokens=True,\n",
        "      return_offsets_mapping=True,\n",
        "      padding=\"max_length\"\n",
        "  )\n",
        "\n",
        "  sample_mapping = tokenized_examples.pop(\"overflow_to_sample_mapping\")\n",
        "  offset_mapping = tokenized_examples.pop(\"offset_mapping\")\n",
        "\n",
        "  tokenized_examples[\"start_positions\"] = []\n",
        "  tokenized_examples[\"end_positions\"] = []\n",
        "\n",
        "  for i, offsets in enumerate(offset_mapping):\n",
        "    input_ids = tokenized_examples[\"input_ids\"][i]\n",
        "    cls_index = input_ids.index(tokenizer.cls_token_id)\n",
        "\n",
        "    sequence_ids = tokenized_examples.sequence_ids(i)\n",
        "    sample_index = sample_mapping[i]\n",
        "    answers = examples[\"answers\"][sample_index]\n",
        "\n",
        "    if len(answers[\"answer_start\"]) == 0:\n",
        "      tokenized_examples[\"start_positions\"].append(cls_index)\n",
        "      tokenized_examples[\"end_positions\"].append(cls_index)\n",
        "    else:\n",
        "      start_char = answers[\"answer_start\"][0]\n",
        "      end_char = start_char + len(answers[\"text\"][0])\n",
        "\n",
        "      token_start_index = 0\n",
        "      while sequence_ids[token_start_index] != 1:\n",
        "        token_start_index += 1\n",
        "\n",
        "      token_end_index = len(input_ids) - 1\n",
        "      while sequence_ids[token_end_index] != 1:\n",
        "        token_end_index -= 1\n",
        "\n",
        "      if not (offsets[token_start_index][0] <= start_char and offsets[token_end_index][1] >= end_char):\n",
        "        tokenized_examples[\"start_positions\"].append(cls_index)\n",
        "        tokenized_examples[\"end_positions\"].append(cls_index)\n",
        "      else:\n",
        "        while token_start_index < len(offsets) and offsets[token_start_index][0] <= start_char:\n",
        "          token_start_index += 1\n",
        "        start_position = token_start_index - 1\n",
        "\n",
        "        while offsets[token_end_index][1] >= end_char:\n",
        "          token_end_index -= 1\n",
        "        end_position = token_end_index + 1\n",
        "\n",
        "        tokenized_examples[\"start_positions\"].append(start_position)\n",
        "        tokenized_examples[\"end_positions\"].append(end_position)\n",
        "  return tokenized_examples"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "tokenized_squad = qa_dataset.map(\n",
        "    prepare_train_features,\n",
        "    batched=True,\n",
        "    remove_columns=qa_dataset[\"train\"].column_names\n",
        ")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 81,
          "referenced_widgets": [
            "1d234bf1cbbe4804b6158f5fcbd2a6b4",
            "3941b25238544e6387270c9203b89a1a",
            "be24cfc87d1c45d09a84c1f18c0e3f39",
            "951312b5a0d94ef1ac9d9d21578ed312",
            "72223c557ca3451aaf280c9bccb813f6",
            "acff940c4c6e47a2943b81f1f3e5db1d",
            "75fead2b88c640749564f8cfed14682a",
            "01676bb04ac742d6acd1b3f4fd02c8a4",
            "4adec2c2c2d54b6dac8e2afd28d2d189",
            "89a3ead7a58a41cda4951b25f793e575",
            "e08627797ff04a7ea4a4eeec7cde7cca",
            "ea6feae642d5433a95751a0eafa64eaa",
            "193f14f6dfe64604a15d9806790391f8",
            "7552c9244fd04c62ae8effcb8fe9eac3",
            "aeabffbcfbe946c1bae071108d5cfc0b",
            "ca50e22abb8e42b2b1c9bbbc7bab3027",
            "34fb0600360e4d7bbe32b16eb49b81b1",
            "af12283c9a104848be3388324afecf56",
            "8c7b2c37e9294e60bb50ed59df188664",
            "05181981bc1a4a5c8550920c15bd38ee",
            "fc4e17c3466c4a1497cefdb2d21f6883",
            "7bd66543d08b4aa79eb5b5e05f64e886"
          ]
        },
        "id": "pkRc2WDnepLN",
        "outputId": "6b82c21e-cdf6-42cd-9473-e6e174f9f18d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Map:   0%|          | 0/87599 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "1d234bf1cbbe4804b6158f5fcbd2a6b4"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Map:   0%|          | 0/10570 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "ea6feae642d5433a95751a0eafa64eaa"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Loading the pre-trained Model"
      ],
      "metadata": {
        "id": "DeuVSy1he7Y0"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "model = DistilBertForQuestionAnswering.from_pretrained(\"distilbert-base-uncased\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 140,
          "referenced_widgets": [
            "2294fd884c3e461b8dd19f5e564ed620",
            "a163789226e945978d32e4e4f648a8c5",
            "9400bf9f0afc450a89aaa1450870cd77",
            "b7460c1c8b574a5fa4044f3dc9c22aed",
            "a9495b0adeca43c9b655bb8e68ce75cd",
            "aac1b70dba624060b8dea001a8051751",
            "b79d3d401ba74435a7d8764c481a8dd0",
            "af2aa7a1c5ca4ac39290b7bec3d43fc9",
            "73ade2e54eda46acbe99119d5db74369",
            "10fd0ba8ee2b491aba4147d9d27f673b",
            "f3d91b616c2748a99fc53178c924e0d7"
          ]
        },
        "id": "-7NxiBBce4GJ",
        "outputId": "e958486a-e8ca-4c29-c619-838174a60783"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Xet Storage is enabled for this repo, but the 'hf_xet' package is not installed. Falling back to regular HTTP download. For better performance, install the package with: `pip install huggingface_hub[hf_xet]` or `pip install hf_xet`\n",
            "WARNING:huggingface_hub.file_download:Xet Storage is enabled for this repo, but the 'hf_xet' package is not installed. Falling back to regular HTTP download. For better performance, install the package with: `pip install huggingface_hub[hf_xet]` or `pip install hf_xet`\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "model.safetensors:   0%|          | 0.00/268M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "2294fd884c3e461b8dd19f5e564ed620"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Some weights of DistilBertForQuestionAnswering were not initialized from the model checkpoint at distilbert-base-uncased and are newly initialized: ['qa_outputs.bias', 'qa_outputs.weight']\n",
            "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Fined-tuning the Pre-trained Model"
      ],
      "metadata": {
        "id": "frBkA9N5fETZ"
      }
    },
    {
      "source": [
        "#Define the training arguments\n",
        "\n",
        "training_args = TrainingArguments(\n",
        "    output_dir='./results',          # output directory\n",
        "    num_train_epochs=2,              # total number of training epochs\n",
        "    per_device_train_batch_size=32,\n",
        "    per_device_eval_batch_size=32,\n",
        "    fp16=True,\n",
        "    logging_steps=100,\n",
        "    log_level='warning',\n",
        "    save_strategy='epoch',\n",
        "    eval_strategy='epoch',\n",
        "    load_best_model_at_end=True,\n",
        ")"
      ],
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "5uecume2jyVS",
        "outputId": "887b0099-67ae-4b7d-cbcf-a9a91cb7b038"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Using the `WANDB_DISABLED` environment variable is deprecated and will be removed in v5. Use the --report_to flag to control the integrations used for logging result (for instance --report_to none).\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#Define the trainer\n",
        "trainer = Trainer(\n",
        "    model = model,\n",
        "    args = training_args,\n",
        "    train_dataset = tokenized_squad[\"train\"],\n",
        "    eval_dataset = tokenized_squad[\"validation\"],\n",
        "    tokenizer = tokenizer,\n",
        "    data_collator = default_data_collator\n",
        ")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "gyaiQKEGe4Bu",
        "outputId": "31a5de5c-5331-433b-b72a-5fdbeac3f218"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-51-b440e5f98e53>:2: FutureWarning: `tokenizer` is deprecated and will be removed in version 5.0.0 for `Trainer.__init__`. Use `processing_class` instead.\n",
            "  trainer = Trainer(\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "trainer.train()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 192
        },
        "id": "UdmToZ8ze3-X",
        "outputId": "adb357d2-9732-40cb-b14d-5fdff6562d82"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <div>\n",
              "      \n",
              "      <progress value='5534' max='5534' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
              "      [5534/5534 27:35, Epoch 2/2]\n",
              "    </div>\n",
              "    <table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              " <tr style=\"text-align: left;\">\n",
              "      <th>Epoch</th>\n",
              "      <th>Training Loss</th>\n",
              "      <th>Validation Loss</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <td>1</td>\n",
              "      <td>1.158500</td>\n",
              "      <td>1.149860</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>2</td>\n",
              "      <td>0.834800</td>\n",
              "      <td>1.105188</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table><p>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "TrainOutput(global_step=5534, training_loss=1.1525733418356092, metrics={'train_runtime': 1656.9242, 'train_samples_per_second': 106.853, 'train_steps_per_second': 3.34, 'total_flos': 1.7348902540849152e+16, 'train_loss': 1.1525733418356092, 'epoch': 2.0})"
            ]
          },
          "metadata": {},
          "execution_count": 52
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Saving the Fined-tuned model"
      ],
      "metadata": {
        "id": "Wencg44QfQkS"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# trainer.save_model()"
      ],
      "metadata": {
        "id": "2FDVEth1epHl"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "##Testing the Fined-tuned model"
      ],
      "metadata": {
        "id": "NKbUpXlFffdY"
      }
    },
    {
      "cell_type": "markdown",
      "source": [],
      "metadata": {
        "id": "gARv_r9NgMTT"
      }
    },
    {
      "cell_type": "markdown",
      "source": [],
      "metadata": {
        "id": "NCHZRrmcgN3Q"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "question = question1\n",
        "context = paragraph1"
      ],
      "metadata": {
        "id": "p8GTRdYDepEu"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Question 1 answer\n",
        "\n",
        "\n",
        "pipe = pipeline(\"question-answering\", model=model, tokenizer=tokenizer)\n",
        "pipe(question = question, context = context)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "knavQGnZepB3",
        "outputId": "2509f7b8-fb7d-4bdd-a2b5-06cca058ee29"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Device set to use cuda:0\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'score': 0.7067930102348328,\n",
              " 'start': 424,\n",
              " 'end': 452,\n",
              " 'answer': 'Categorical Adjustment Index'}"
            ]
          },
          "metadata": {},
          "execution_count": 56
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Question 2 answer\n",
        "\n",
        "question = question2\n",
        "context = paragraph2\n",
        "\n",
        "pipe = pipeline(\"question-answering\", model=model, tokenizer=tokenizer)\n",
        "pipe(question = question, context = context)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "JFw5GdQleo-u",
        "outputId": "ef78c177-460e-4e37-e7c0-b5baab2ea8a6"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Device set to use cuda:0\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'score': 0.8328844308853149,\n",
              " 'start': 470,\n",
              " 'end': 493,\n",
              " 'answer': 'Breast Cancer Screening'}"
            ]
          },
          "metadata": {},
          "execution_count": 57
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Question 3 answer\n",
        "\n",
        "question = question3\n",
        "context = paragraph3\n",
        "\n",
        "pipe = pipeline(\"question-answering\", model=model, tokenizer=tokenizer)\n",
        "pipe(question = question, context = context)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GruypfaAeo61",
        "outputId": "b4903c40-e472-4320-ef16-518b36a639ab"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Device set to use cuda:0\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'score': 0.0027367128059267998,\n",
              " 'start': 332,\n",
              " 'end': 363,\n",
              " 'answer': 'Controlling High Blood Pressure'}"
            ]
          },
          "metadata": {},
          "execution_count": 59
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "o28qSmpV2t6B",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "5dcf0da1-9859-46ff-e506-35cf979bc3a7"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Device set to use cuda:0\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'score': 0.12021833658218384,\n",
              " 'start': 578,\n",
              " 'end': 610,\n",
              " 'answer': 'Improvement\\u2008Change\\u2008Score\\u2008=\\u2008Score'}"
            ]
          },
          "metadata": {},
          "execution_count": 60
        }
      ],
      "source": [
        "# Question 4 answer\n",
        "\n",
        "question = question4\n",
        "context = paragraph4\n",
        "\n",
        "pipe = pipeline(\"question-answering\", model=model, tokenizer=tokenizer)\n",
        "pipe(question = question, context = context)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ZD4aKXmQ2tse",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "f7d82360-eea3-4c0e-e6fd-2e43b4dd78ef"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Device set to use cuda:0\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'score': 0.07295985519886017,\n",
              " 'start': 289,\n",
              " 'end': 397,\n",
              " 'answer': 'Clustering Methodology Introduction \\nTo separate a distribution of scores into distinct groups or categories'}"
            ]
          },
          "metadata": {},
          "execution_count": 61
        }
      ],
      "source": [
        "# Question 5 answer\n",
        "\n",
        "question = question5\n",
        "context = paragraph5\n",
        "\n",
        "pipe = pipeline(\"question-answering\", model=model, tokenizer=tokenizer)\n",
        "pipe(question = question, context = context)"
      ]
    }
  ],
  "metadata": {
    "accelerator": "GPU",
    "colab": {
      "gpuType": "T4",
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    },
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "135e00d295624fd2acbaac4af4647d4c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_dc3927c261ea48749c52d43a697dc2d1",
              "IPY_MODEL_05b1e85aa60d4e1da891789e7bc53fd4",
              "IPY_MODEL_d311d54acf5e4592aa2f5ce42cc5666f"
            ],
            "layout": "IPY_MODEL_c3505c8cdb544b21969e1b5163336699"
          }
        },
        "dc3927c261ea48749c52d43a697dc2d1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_eb7639f506434a3783dc70809913ef13",
            "placeholder": "​",
            "style": "IPY_MODEL_532a0b16518342c09b8eb1960a78e85a",
            "value": "config.json: 100%"
          }
        },
        "05b1e85aa60d4e1da891789e7bc53fd4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f38ae76a4cf445c7b1341c3d8d19c3cd",
            "max": 571,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_4ec67c7661184459810887800c93a2e6",
            "value": 571
          }
        },
        "d311d54acf5e4592aa2f5ce42cc5666f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_6af3901a492d4d42815726e20cdd345c",
            "placeholder": "​",
            "style": "IPY_MODEL_a026d09e1c154135acda1087da3b4ef0",
            "value": " 571/571 [00:00&lt;00:00, 16.1kB/s]"
          }
        },
        "c3505c8cdb544b21969e1b5163336699": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "eb7639f506434a3783dc70809913ef13": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "532a0b16518342c09b8eb1960a78e85a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "f38ae76a4cf445c7b1341c3d8d19c3cd": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4ec67c7661184459810887800c93a2e6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "6af3901a492d4d42815726e20cdd345c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a026d09e1c154135acda1087da3b4ef0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b55eff533c334e318afd661f2bc662a4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_658748d51471418a9b3f60e1179055a5",
              "IPY_MODEL_65ff6f26662349b2aed026577ba96f41",
              "IPY_MODEL_ac44e368189d40cc85e29f8557e3c7c8"
            ],
            "layout": "IPY_MODEL_6fb676583ce34d9bbfc689d0d09f96b0"
          }
        },
        "658748d51471418a9b3f60e1179055a5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_09234909dd3f49c48008068f4379075a",
            "placeholder": "​",
            "style": "IPY_MODEL_1d7d5cdd91bf47d6849ff606c01cee85",
            "value": "model.safetensors: 100%"
          }
        },
        "65ff6f26662349b2aed026577ba96f41": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_17ecb18052c04807911254b57dbe3445",
            "max": 496254442,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_75c428637bd649218177673adc14def7",
            "value": 496254442
          }
        },
        "ac44e368189d40cc85e29f8557e3c7c8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5fac8e7d465c45269748ab49ca2dd9b6",
            "placeholder": "​",
            "style": "IPY_MODEL_3406021b60ee425497e9b9973a4b210a",
            "value": " 496M/496M [00:02&lt;00:00, 191MB/s]"
          }
        },
        "6fb676583ce34d9bbfc689d0d09f96b0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "09234909dd3f49c48008068f4379075a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1d7d5cdd91bf47d6849ff606c01cee85": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "17ecb18052c04807911254b57dbe3445": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "75c428637bd649218177673adc14def7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "5fac8e7d465c45269748ab49ca2dd9b6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3406021b60ee425497e9b9973a4b210a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0c0c2b49ef1540a992a5dd66c4acff3c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_a242de1f3b3c49d2a2174ac038368ebd",
              "IPY_MODEL_0ba05c9c596c454c96c35feedbfe6468",
              "IPY_MODEL_8fcc444f457d4c54a7b34a824a46b979"
            ],
            "layout": "IPY_MODEL_c0e4800051614838a6e9f5b718028154"
          }
        },
        "a242de1f3b3c49d2a2174ac038368ebd": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_fa5ad01504714bef8360bdca9b1eac27",
            "placeholder": "​",
            "style": "IPY_MODEL_ad8e9eee7ccd4df3bb11008c4d3e3004",
            "value": "tokenizer_config.json: 100%"
          }
        },
        "0ba05c9c596c454c96c35feedbfe6468": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d347b8a449ea47a49736af1145afef0b",
            "max": 79,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_f443ef9c979a48a3a818b91c9fc70fa8",
            "value": 79
          }
        },
        "8fcc444f457d4c54a7b34a824a46b979": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5d13193f7f4b44e990b42b211d540a5e",
            "placeholder": "​",
            "style": "IPY_MODEL_c42eeeb99e164df6ba2a749fab4b7512",
            "value": " 79.0/79.0 [00:00&lt;00:00, 1.04kB/s]"
          }
        },
        "c0e4800051614838a6e9f5b718028154": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "fa5ad01504714bef8360bdca9b1eac27": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ad8e9eee7ccd4df3bb11008c4d3e3004": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "d347b8a449ea47a49736af1145afef0b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f443ef9c979a48a3a818b91c9fc70fa8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "5d13193f7f4b44e990b42b211d540a5e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c42eeeb99e164df6ba2a749fab4b7512": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "426837ca6bad455f8f329920581c802d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_08616118b4a343468658651a2a5033a9",
              "IPY_MODEL_9055efa1c2d64fce864edfe6a2e8706c",
              "IPY_MODEL_3882970cc90b4014930ab29398d8b803"
            ],
            "layout": "IPY_MODEL_56fd5785e1e14a60b9492f99e0322d8d"
          }
        },
        "08616118b4a343468658651a2a5033a9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_317140a3fbb84b0591d46a92e0f99cb3",
            "placeholder": "​",
            "style": "IPY_MODEL_22502594ec2f443391c20fd71dd40fea",
            "value": "vocab.json: 100%"
          }
        },
        "9055efa1c2d64fce864edfe6a2e8706c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_87421280f05c479b9a0efcd29d9d9ea2",
            "max": 898822,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_5cf6082f1cfb48c39ea88d04e3e106ce",
            "value": 898822
          }
        },
        "3882970cc90b4014930ab29398d8b803": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_4ff4dd868ba64ee390773ed7924e94d7",
            "placeholder": "​",
            "style": "IPY_MODEL_b860401095854ed19fe117705cc5e4f5",
            "value": " 899k/899k [00:00&lt;00:00, 19.3MB/s]"
          }
        },
        "56fd5785e1e14a60b9492f99e0322d8d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "317140a3fbb84b0591d46a92e0f99cb3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "22502594ec2f443391c20fd71dd40fea": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "87421280f05c479b9a0efcd29d9d9ea2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5cf6082f1cfb48c39ea88d04e3e106ce": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "4ff4dd868ba64ee390773ed7924e94d7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b860401095854ed19fe117705cc5e4f5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "90d8f3276576478695e06b6309620099": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_f1a49c9131f6403db417a9d6c1da30c8",
              "IPY_MODEL_3c81d8cc41ab40e28c1daba3aed0a667",
              "IPY_MODEL_f56895ccdb414ba8a354077e9d8865c4"
            ],
            "layout": "IPY_MODEL_c0472434352846548a190718e9caffcc"
          }
        },
        "f1a49c9131f6403db417a9d6c1da30c8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d69a2156c8ea467fb99793605e83f24f",
            "placeholder": "​",
            "style": "IPY_MODEL_1041152817a248f88ee9ccf10ff0839d",
            "value": "merges.txt: 100%"
          }
        },
        "3c81d8cc41ab40e28c1daba3aed0a667": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b2589df4e1054af3bf3cba09e146966e",
            "max": 456318,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_07f1b0dd3c9149d4890be8bb0ae76ac1",
            "value": 456318
          }
        },
        "f56895ccdb414ba8a354077e9d8865c4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d4d48944fad24214b08a627dac47c834",
            "placeholder": "​",
            "style": "IPY_MODEL_b7844a0133f041e381f1e9de304c3752",
            "value": " 456k/456k [00:00&lt;00:00, 7.23MB/s]"
          }
        },
        "c0472434352846548a190718e9caffcc": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d69a2156c8ea467fb99793605e83f24f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1041152817a248f88ee9ccf10ff0839d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b2589df4e1054af3bf3cba09e146966e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "07f1b0dd3c9149d4890be8bb0ae76ac1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "d4d48944fad24214b08a627dac47c834": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b7844a0133f041e381f1e9de304c3752": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "9fddc27a4d864521bf6e0f65f9edddf5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_666e3ddeb79d41afb94c97b9e46b07fc",
              "IPY_MODEL_09cf4c8de883493a9ef16d052b004662",
              "IPY_MODEL_a251d9502d4b498383c31fd76166feea"
            ],
            "layout": "IPY_MODEL_99a2f6b49acc4f1dbd5bcbc89e227e77"
          }
        },
        "666e3ddeb79d41afb94c97b9e46b07fc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_94def7309ed74ac7845973d7bdedd37d",
            "placeholder": "​",
            "style": "IPY_MODEL_07f6909b72064c5c8cd742f3490cc482",
            "value": "special_tokens_map.json: 100%"
          }
        },
        "09cf4c8de883493a9ef16d052b004662": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3161ae462bee4a45af0d5afb20461fec",
            "max": 772,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_f0c7c05a9f21438aa7a5def6e8e989d4",
            "value": 772
          }
        },
        "a251d9502d4b498383c31fd76166feea": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f147f68c8db34959b58222a3f028ca11",
            "placeholder": "​",
            "style": "IPY_MODEL_a0714798288f4b939a4fb0132499bee0",
            "value": " 772/772 [00:00&lt;00:00, 26.1kB/s]"
          }
        },
        "99a2f6b49acc4f1dbd5bcbc89e227e77": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "94def7309ed74ac7845973d7bdedd37d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "07f6909b72064c5c8cd742f3490cc482": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3161ae462bee4a45af0d5afb20461fec": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f0c7c05a9f21438aa7a5def6e8e989d4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "f147f68c8db34959b58222a3f028ca11": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a0714798288f4b939a4fb0132499bee0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0984111f828c479e96cce498423428ae": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_8449ded37e5c4c9ba977d822c0b4f039",
              "IPY_MODEL_d0fb99eeac93407b972061ae30c1ea29",
              "IPY_MODEL_ee052d22ac6e482eae26dcdada60426b"
            ],
            "layout": "IPY_MODEL_f4551e71857545b8a184e50d55d94f56"
          }
        },
        "8449ded37e5c4c9ba977d822c0b4f039": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e4ddd42fe1b1441a9ab9935100e3be98",
            "placeholder": "​",
            "style": "IPY_MODEL_5ed14a24c44e4906985743080b760706",
            "value": "README.md: 100%"
          }
        },
        "d0fb99eeac93407b972061ae30c1ea29": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e70666f2883e4fd1842f011669b65e93",
            "max": 7620,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_8bcd6a4edb36483aad7152faadd69946",
            "value": 7620
          }
        },
        "ee052d22ac6e482eae26dcdada60426b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_6813efce668f49398dace5f210a74219",
            "placeholder": "​",
            "style": "IPY_MODEL_0ffafad6c2a949d5a933dc36a75ab049",
            "value": " 7.62k/7.62k [00:00&lt;00:00, 497kB/s]"
          }
        },
        "f4551e71857545b8a184e50d55d94f56": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e4ddd42fe1b1441a9ab9935100e3be98": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5ed14a24c44e4906985743080b760706": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e70666f2883e4fd1842f011669b65e93": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8bcd6a4edb36483aad7152faadd69946": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "6813efce668f49398dace5f210a74219": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0ffafad6c2a949d5a933dc36a75ab049": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e4b8cce137194c1b86a54d7cbe562521": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_cc041a90122745478f92a58deeab4cd7",
              "IPY_MODEL_f541518b26c740c584822cff2003b614",
              "IPY_MODEL_cf6dd221e7a1444793fc3b721df66f0e"
            ],
            "layout": "IPY_MODEL_c54e92174f9d4ce8b676e8934252440b"
          }
        },
        "cc041a90122745478f92a58deeab4cd7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f907324511f64b0ebe9cae988ed97287",
            "placeholder": "​",
            "style": "IPY_MODEL_7d743de0e35f4067aab7ebd36be5b24c",
            "value": "train-00000-of-00001.parquet: 100%"
          }
        },
        "f541518b26c740c584822cff2003b614": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_9a76c677001b46b0abc47a9ea76e5f16",
            "max": 14458314,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_974c05387c8a460ca17c2fe6d11c4c8e",
            "value": 14458314
          }
        },
        "cf6dd221e7a1444793fc3b721df66f0e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_980b51fd7f824d829b42b71991e30d5f",
            "placeholder": "​",
            "style": "IPY_MODEL_7bad3909a2724c09855eb826d1d440d4",
            "value": " 14.5M/14.5M [00:00&lt;00:00, 183MB/s]"
          }
        },
        "c54e92174f9d4ce8b676e8934252440b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f907324511f64b0ebe9cae988ed97287": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7d743de0e35f4067aab7ebd36be5b24c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "9a76c677001b46b0abc47a9ea76e5f16": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "974c05387c8a460ca17c2fe6d11c4c8e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "980b51fd7f824d829b42b71991e30d5f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7bad3909a2724c09855eb826d1d440d4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "88a7313a41984eaaa482e7f28259a4d6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_cdd39d6372664671a2d46938154e8948",
              "IPY_MODEL_f527edc28fd84efba5a141651967e5d6",
              "IPY_MODEL_07ffe9fcebf54fc683eadad798383278"
            ],
            "layout": "IPY_MODEL_74c4658cbb3f4d15a11842fb69f95a51"
          }
        },
        "cdd39d6372664671a2d46938154e8948": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_a337dfccbfed4b9da2472bbbb0f8a5eb",
            "placeholder": "​",
            "style": "IPY_MODEL_1b6c6ad9a6754a089f63ee2ec7d42d9b",
            "value": "validation-00000-of-00001.parquet: 100%"
          }
        },
        "f527edc28fd84efba5a141651967e5d6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8404132772974166949c8e8a063983f9",
            "max": 1819889,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_589e30e058e64d9ba2c35bf1adc85a1f",
            "value": 1819889
          }
        },
        "07ffe9fcebf54fc683eadad798383278": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_76a2c5bec0d24ef39330971b80de1d69",
            "placeholder": "​",
            "style": "IPY_MODEL_9d279873556b40b5a322419ef59147af",
            "value": " 1.82M/1.82M [00:00&lt;00:00, 42.2MB/s]"
          }
        },
        "74c4658cbb3f4d15a11842fb69f95a51": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a337dfccbfed4b9da2472bbbb0f8a5eb": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1b6c6ad9a6754a089f63ee2ec7d42d9b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "8404132772974166949c8e8a063983f9": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "589e30e058e64d9ba2c35bf1adc85a1f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "76a2c5bec0d24ef39330971b80de1d69": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "9d279873556b40b5a322419ef59147af": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2310fc5454244d1ea8887ef8d798de1a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_93319ed508d94e709516ff53e8ce6bf6",
              "IPY_MODEL_26ef7740e34a4eea8c7a20f2424aef80",
              "IPY_MODEL_eee7ecb1d5b54bffaab1aa43389c455b"
            ],
            "layout": "IPY_MODEL_de07769f914e4b7bad47b0c35fd5ed93"
          }
        },
        "93319ed508d94e709516ff53e8ce6bf6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d333e63a8c474ffaa34f83c307a36d6b",
            "placeholder": "​",
            "style": "IPY_MODEL_576c90bc92fa46e6940ee5ee55b04904",
            "value": "Generating train split: 100%"
          }
        },
        "26ef7740e34a4eea8c7a20f2424aef80": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_70b9a9ad2ac14a52810401f40a2c49dc",
            "max": 87599,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_1733769830ba488eb5149e17146be59a",
            "value": 87599
          }
        },
        "eee7ecb1d5b54bffaab1aa43389c455b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f6366c05c209486ab4d8e5ed201e5c1f",
            "placeholder": "​",
            "style": "IPY_MODEL_3c47a2548fd540788885e3f6ce3c6290",
            "value": " 87599/87599 [00:00&lt;00:00, 211371.28 examples/s]"
          }
        },
        "de07769f914e4b7bad47b0c35fd5ed93": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d333e63a8c474ffaa34f83c307a36d6b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "576c90bc92fa46e6940ee5ee55b04904": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "70b9a9ad2ac14a52810401f40a2c49dc": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1733769830ba488eb5149e17146be59a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "f6366c05c209486ab4d8e5ed201e5c1f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3c47a2548fd540788885e3f6ce3c6290": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "1f124606d4574aa4a77b4c1c51d21514": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_46117bbe860f47f793894e72e08bd322",
              "IPY_MODEL_7b9c6d6b5dba4f3e8dbc29118a13f2d3",
              "IPY_MODEL_b0b16cc681cb4bfbaeee5285df63155f"
            ],
            "layout": "IPY_MODEL_85677f194ffb438db96554be193d933a"
          }
        },
        "46117bbe860f47f793894e72e08bd322": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_54c1442efb1f41c4beba2baec1ea1790",
            "placeholder": "​",
            "style": "IPY_MODEL_b61393af278c458c8bde900559fb8fb8",
            "value": "Generating validation split: 100%"
          }
        },
        "7b9c6d6b5dba4f3e8dbc29118a13f2d3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b4e7a0366b32404a8fb003aaff9e59e7",
            "max": 10570,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_f4697f0d5f664caf9c0ee99f2735424e",
            "value": 10570
          }
        },
        "b0b16cc681cb4bfbaeee5285df63155f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_de344f2f70c14d9fb46acb6b0b64f1a2",
            "placeholder": "​",
            "style": "IPY_MODEL_b34d6966c1fd4514a22e4c2cf0cbac60",
            "value": " 10570/10570 [00:00&lt;00:00, 88238.04 examples/s]"
          }
        },
        "85677f194ffb438db96554be193d933a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "54c1442efb1f41c4beba2baec1ea1790": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b61393af278c458c8bde900559fb8fb8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b4e7a0366b32404a8fb003aaff9e59e7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f4697f0d5f664caf9c0ee99f2735424e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "de344f2f70c14d9fb46acb6b0b64f1a2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b34d6966c1fd4514a22e4c2cf0cbac60": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "150affca0d554509ad21948ff8b48e25": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_1d69683eb9a542988613bc317a96d59d",
              "IPY_MODEL_0ea783e83ed349478e8ac2c65972fe20",
              "IPY_MODEL_6d25f51bf98a438faf89b98aae1cb204"
            ],
            "layout": "IPY_MODEL_ed0c9b63015942d0ab2e346918512ab5"
          }
        },
        "1d69683eb9a542988613bc317a96d59d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_425d1467a51d4bfb87b5417f5981f4fc",
            "placeholder": "​",
            "style": "IPY_MODEL_3b0d99d8d71b4b2aa0bc916b2b8858b2",
            "value": "tokenizer_config.json: 100%"
          }
        },
        "0ea783e83ed349478e8ac2c65972fe20": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_62370e039f2b4b939dbee647c92286b9",
            "max": 48,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_dd0f699bdc224d22a1a2e569db08c8ba",
            "value": 48
          }
        },
        "6d25f51bf98a438faf89b98aae1cb204": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_21a8da6a43a7487198bbe6dd8b02c751",
            "placeholder": "​",
            "style": "IPY_MODEL_b638a2ef295b4096a9b2905f8f173b59",
            "value": " 48.0/48.0 [00:00&lt;00:00, 1.36kB/s]"
          }
        },
        "ed0c9b63015942d0ab2e346918512ab5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "425d1467a51d4bfb87b5417f5981f4fc": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3b0d99d8d71b4b2aa0bc916b2b8858b2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "62370e039f2b4b939dbee647c92286b9": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "dd0f699bdc224d22a1a2e569db08c8ba": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "21a8da6a43a7487198bbe6dd8b02c751": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b638a2ef295b4096a9b2905f8f173b59": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "4dfb55b9b190405197ba016c570e7353": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_8fdf4a32dcdc45e9bf1be06032090b9b",
              "IPY_MODEL_8e0c0bfc3dee413da87b358f66e75bdf",
              "IPY_MODEL_ff3ed0462e764463b089075b71bdaea4"
            ],
            "layout": "IPY_MODEL_daa4115c41c54e2ebbed754b67880e76"
          }
        },
        "8fdf4a32dcdc45e9bf1be06032090b9b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_79522cd7f6a34a81910027aeb6a4e2b4",
            "placeholder": "​",
            "style": "IPY_MODEL_ff13c0246d5843bc9a30668fa175b3d2",
            "value": "vocab.txt: 100%"
          }
        },
        "8e0c0bfc3dee413da87b358f66e75bdf": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_47f2e6ed821b4f408ee4c575b05eee39",
            "max": 231508,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_7c8eae561f6348cab6a4bd72df5c0dce",
            "value": 231508
          }
        },
        "ff3ed0462e764463b089075b71bdaea4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d9cd4610ab3c47ed98e47fbc21052404",
            "placeholder": "​",
            "style": "IPY_MODEL_ae99cfc67a3d45c896cc0a0ae70325a0",
            "value": " 232k/232k [00:00&lt;00:00, 2.00MB/s]"
          }
        },
        "daa4115c41c54e2ebbed754b67880e76": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "79522cd7f6a34a81910027aeb6a4e2b4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ff13c0246d5843bc9a30668fa175b3d2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "47f2e6ed821b4f408ee4c575b05eee39": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7c8eae561f6348cab6a4bd72df5c0dce": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "d9cd4610ab3c47ed98e47fbc21052404": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ae99cfc67a3d45c896cc0a0ae70325a0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "38cccdb1334c44acaaebe8b6101ed343": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_95d36bc2bb414c8eb72b1fc6f7b7ac45",
              "IPY_MODEL_cfc7a2a137c44b2d8da56d37c81bff1d",
              "IPY_MODEL_2a8bbb1c504f40739daa6483c4d4ea48"
            ],
            "layout": "IPY_MODEL_27cab8eee4114bf7806ddedfc533b4f5"
          }
        },
        "95d36bc2bb414c8eb72b1fc6f7b7ac45": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_346ca0078b274ecfa62a5d18dfdebed0",
            "placeholder": "​",
            "style": "IPY_MODEL_dc7c054f6d3f47659232e80b163677af",
            "value": "tokenizer.json: 100%"
          }
        },
        "cfc7a2a137c44b2d8da56d37c81bff1d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_275b65aac2cd46e1bbd66f0334eb6c94",
            "max": 466062,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_76830ba82c0a48f4aeb165ec2d05ceeb",
            "value": 466062
          }
        },
        "2a8bbb1c504f40739daa6483c4d4ea48": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_468817d0920d46bc99c4bbf01c63aeae",
            "placeholder": "​",
            "style": "IPY_MODEL_7191924e9df84b168328c7eef8e0861a",
            "value": " 466k/466k [00:00&lt;00:00, 6.68MB/s]"
          }
        },
        "27cab8eee4114bf7806ddedfc533b4f5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "346ca0078b274ecfa62a5d18dfdebed0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "dc7c054f6d3f47659232e80b163677af": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "275b65aac2cd46e1bbd66f0334eb6c94": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "76830ba82c0a48f4aeb165ec2d05ceeb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "468817d0920d46bc99c4bbf01c63aeae": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7191924e9df84b168328c7eef8e0861a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "a930d8ea2c704ae590466401c0667efb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_c9c6ddb01d89424aa32f025a6deccdd4",
              "IPY_MODEL_ac40e4b0efdc4b9a9ce912410ace6cb9",
              "IPY_MODEL_1862fd253ec54637b214e68fa0cc315e"
            ],
            "layout": "IPY_MODEL_c94f1e6706124c3cac92bd3605bbf325"
          }
        },
        "c9c6ddb01d89424aa32f025a6deccdd4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_166779cee89d41f7baabd7b2b20f2684",
            "placeholder": "​",
            "style": "IPY_MODEL_3cc2a6246b364349b90de721c52350d8",
            "value": "config.json: 100%"
          }
        },
        "ac40e4b0efdc4b9a9ce912410ace6cb9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_2e1db4ba673e4dc5bbc6e8fdbc8c3895",
            "max": 483,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_dd4ade68e85c406da5c2e3aca71df72e",
            "value": 483
          }
        },
        "1862fd253ec54637b214e68fa0cc315e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d533f2f1f0734bd19544f9cbaefe3f26",
            "placeholder": "​",
            "style": "IPY_MODEL_575be2bc003e469eaf6eb71c77252325",
            "value": " 483/483 [00:00&lt;00:00, 11.5kB/s]"
          }
        },
        "c94f1e6706124c3cac92bd3605bbf325": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "166779cee89d41f7baabd7b2b20f2684": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3cc2a6246b364349b90de721c52350d8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2e1db4ba673e4dc5bbc6e8fdbc8c3895": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "dd4ade68e85c406da5c2e3aca71df72e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "d533f2f1f0734bd19544f9cbaefe3f26": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "575be2bc003e469eaf6eb71c77252325": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "1d234bf1cbbe4804b6158f5fcbd2a6b4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_3941b25238544e6387270c9203b89a1a",
              "IPY_MODEL_be24cfc87d1c45d09a84c1f18c0e3f39",
              "IPY_MODEL_951312b5a0d94ef1ac9d9d21578ed312"
            ],
            "layout": "IPY_MODEL_72223c557ca3451aaf280c9bccb813f6"
          }
        },
        "3941b25238544e6387270c9203b89a1a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_acff940c4c6e47a2943b81f1f3e5db1d",
            "placeholder": "​",
            "style": "IPY_MODEL_75fead2b88c640749564f8cfed14682a",
            "value": "Map: 100%"
          }
        },
        "be24cfc87d1c45d09a84c1f18c0e3f39": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_01676bb04ac742d6acd1b3f4fd02c8a4",
            "max": 87599,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_4adec2c2c2d54b6dac8e2afd28d2d189",
            "value": 87599
          }
        },
        "951312b5a0d94ef1ac9d9d21578ed312": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_89a3ead7a58a41cda4951b25f793e575",
            "placeholder": "​",
            "style": "IPY_MODEL_e08627797ff04a7ea4a4eeec7cde7cca",
            "value": " 87599/87599 [01:17&lt;00:00, 1448.67 examples/s]"
          }
        },
        "72223c557ca3451aaf280c9bccb813f6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "acff940c4c6e47a2943b81f1f3e5db1d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "75fead2b88c640749564f8cfed14682a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "01676bb04ac742d6acd1b3f4fd02c8a4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4adec2c2c2d54b6dac8e2afd28d2d189": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "89a3ead7a58a41cda4951b25f793e575": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e08627797ff04a7ea4a4eeec7cde7cca": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "ea6feae642d5433a95751a0eafa64eaa": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_193f14f6dfe64604a15d9806790391f8",
              "IPY_MODEL_7552c9244fd04c62ae8effcb8fe9eac3",
              "IPY_MODEL_aeabffbcfbe946c1bae071108d5cfc0b"
            ],
            "layout": "IPY_MODEL_ca50e22abb8e42b2b1c9bbbc7bab3027"
          }
        },
        "193f14f6dfe64604a15d9806790391f8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_34fb0600360e4d7bbe32b16eb49b81b1",
            "placeholder": "​",
            "style": "IPY_MODEL_af12283c9a104848be3388324afecf56",
            "value": "Map: 100%"
          }
        },
        "7552c9244fd04c62ae8effcb8fe9eac3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8c7b2c37e9294e60bb50ed59df188664",
            "max": 10570,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_05181981bc1a4a5c8550920c15bd38ee",
            "value": 10570
          }
        },
        "aeabffbcfbe946c1bae071108d5cfc0b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_fc4e17c3466c4a1497cefdb2d21f6883",
            "placeholder": "​",
            "style": "IPY_MODEL_7bd66543d08b4aa79eb5b5e05f64e886",
            "value": " 10570/10570 [00:08&lt;00:00, 1224.32 examples/s]"
          }
        },
        "ca50e22abb8e42b2b1c9bbbc7bab3027": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "34fb0600360e4d7bbe32b16eb49b81b1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "af12283c9a104848be3388324afecf56": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "8c7b2c37e9294e60bb50ed59df188664": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "05181981bc1a4a5c8550920c15bd38ee": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "fc4e17c3466c4a1497cefdb2d21f6883": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7bd66543d08b4aa79eb5b5e05f64e886": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2294fd884c3e461b8dd19f5e564ed620": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_a163789226e945978d32e4e4f648a8c5",
              "IPY_MODEL_9400bf9f0afc450a89aaa1450870cd77",
              "IPY_MODEL_b7460c1c8b574a5fa4044f3dc9c22aed"
            ],
            "layout": "IPY_MODEL_a9495b0adeca43c9b655bb8e68ce75cd"
          }
        },
        "a163789226e945978d32e4e4f648a8c5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_aac1b70dba624060b8dea001a8051751",
            "placeholder": "​",
            "style": "IPY_MODEL_b79d3d401ba74435a7d8764c481a8dd0",
            "value": "model.safetensors: 100%"
          }
        },
        "9400bf9f0afc450a89aaa1450870cd77": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_af2aa7a1c5ca4ac39290b7bec3d43fc9",
            "max": 267954768,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_73ade2e54eda46acbe99119d5db74369",
            "value": 267954768
          }
        },
        "b7460c1c8b574a5fa4044f3dc9c22aed": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_10fd0ba8ee2b491aba4147d9d27f673b",
            "placeholder": "​",
            "style": "IPY_MODEL_f3d91b616c2748a99fc53178c924e0d7",
            "value": " 268M/268M [00:01&lt;00:00, 277MB/s]"
          }
        },
        "a9495b0adeca43c9b655bb8e68ce75cd": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "aac1b70dba624060b8dea001a8051751": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b79d3d401ba74435a7d8764c481a8dd0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "af2aa7a1c5ca4ac39290b7bec3d43fc9": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "73ade2e54eda46acbe99119d5db74369": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "10fd0ba8ee2b491aba4147d9d27f673b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f3d91b616c2748a99fc53178c924e0d7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        }
      }
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}